1	The	DT	O	the	det	3	SENT_1	[p1l459t88r503b110],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_1	[p1l512t88r741b117],
3	journal	NN	O	journal	nsubj	5	SENT_1	[p1l749t88r833b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l844t88r920b116],
5	2008	CD	DATE	2008	_	0	SENT_1	[p1l844t88r920b116],
6	)	NN	O	)	nsubj	17	SENT_1	[p1l844t88r920b116],
7	8	CD	NUMBER	8	num	6	SENT_1	[p1l929t88r949b114],
8	,	,	O	,	_	0	SENT_1	[p1l929t88r949b114],
9	256-267	CD	NUMBER	256-267	num	16	SENT_1	[p1l960t88r1053b110],
10	©	CD	NUMBER	©	number	11	SENT_1	[p1l349t120r365b139],
11	2008	CD	DATE	2008	num	16	SENT_1	[p1l373t120r420b139],
12	Nature	NNP	ORGANIZATION	Nature	nn	16	SENT_1	[p1l429t120r491b139],
13	Publishing	NNP	ORGANIZATION	Publishing	nn	16	SENT_1	[p1l501t119r594b145],
14	Group	NNP	ORGANIZATION	Group	nn	16	SENT_1	[p1l603t120r661b145],
15	All	NNP	ORGANIZATION	All	nn	16	SENT_1	[p1l669t119r691b139],
16	rights	NNS	O	rights	appos	6	SENT_1	[p1l700t119r751b145],
17	reserved	VBD	O	reserve	rcmod	5	SENT_1	[p1l760t119r835b139],
18	1470-269X	NN	O	1470-269x	dobj	17	SENT_1	[p1l845t119r980b141],
19	/	:	O	/	punct	23	SENT_1	[p1l845t119r980b141],
20	08	CD	NUMBER	08	dep	23	SENT_1	[p1l845t119r980b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l989t119r1053b140],
22	30.00	CD	MONEY	30.00	num	21	SENT_1	[p1l989t119r1053b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	5	SENT_1	[p1l857t170r1053b195],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t234r1919b273],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1938t234r2148b273],

1	The	DT	O	the	det	2	SENT_3	[p1l9t367r169b442],
2	influence	NN	O	influence	_	0	SENT_3	[p1l211t367r601b442],
3	of	IN	O	of	_	0	SENT_3	[p1l642t367r725b442],
4	fluorouracil	NN	O	fluorouracil	nn	6	SENT_3	[p1l757t367r1244b442],
5	outcome	NN	O	outcome	nn	6	SENT_3	[p1l1289t376r1674b442],
6	parameters	NNS	O	parameter	prep_of	2	SENT_3	[p1l15t501r496b591],
7	on	IN	O	on	_	0	SENT_3	[p1l536t514r640b567],
8	tolerance	NN	O	tolerance	prep_on	2	SENT_3	[p1l683t492r1083b567],
9	and	CC	O	and	_	0	SENT_3	[p1l1124t492r1280b567],
10	efficacy	NN	O	efficacy	prep_on	2	SENT_3	[p1l1324t492r1647b591],
11	in	IN	O	in	dep	2	SENT_3	[p1l1687t494r1756b566],
12	patients	NNS	O	patient	pobj	11	SENT_3	[p1l1804t494r2142b591],
13	with	IN	O	with	dep	2	SENT_3	[p1l9t617r195b692],
14	advanced	JJ	O	advanced	amod	16	SENT_3	[p1l239t617r652b692],
15	colorectal	JJ	O	colorectal	amod	16	SENT_3	[p1l695t617r1110b692],
16	cancer	NN	O	cancer	pobj	13	SENT_3	[p1l1155t639r1441b692],

1	o	NN	O	o	_	0	SENT_4	[p1l10t779r44b814],
2	Capitain	NN	MISC	capitain	dep	1	SENT_4	[p1l64t779r248b826],
3	,	,	O	,	_	0	SENT_4	[p1l64t779r248b826],
4	M	NN	O	m	nn	5	SENT_4	[p1l272t780r308b814],
5	Boisdron-Celle	NNP	PERSON	Boisdron-Celle	dep	1	SENT_4	[p1l332t778r643b822],
6	,	,	O	,	_	0	SENT_4	[p1l332t778r643b822],
7	A-L	NNP	PERSON	A-L	nn	8	SENT_4	[p1l8t838r74b872],
8	Poirier	NNP	PERSON	Poirier	conj_and	2	SENT_4	[p1l93t837r226b880],
9	,	,	O	,	_	0	SENT_4	[p1l93t837r226b880],
10	S	NNP	O	S	nn	11	SENT_4	[p1l248t838r267b872],
11	Abadie-Lacourtoisie	NNP	O	Abadie-Lacourtoisie	conj_and	2	SENT_4	[p1l285t836r689b880],
12	,	,	O	,	_	0	SENT_4	[p1l285t836r689b880],
13	A	NNP	O	A	nn	14	SENT_4	[p1l8t896r38b930],
14	Morel	NNP	O	Morel	conj_and	2	SENT_4	[p1l56t894r169b931],
15	and	CC	O	and	_	0	SENT_4	[p1l189t894r263b931],
16	E	NNP	O	E	nn	17	SENT_4	[p1l285t896r304b930],
17	Gamelin	NNP	O	Gamelin	conj_and	2	SENT_4	[p1l322t894r488b931],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_5	[p1l11t989r178b1021],
2	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l189t988r218b1013],
3	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_5	[p1l227t988r336b1013],
4	Oncology	NNP	ORGANIZATION	Oncology	prep_of	1	SENT_5	[p1l348t988r480b1021],
5	and	CC	O	and	_	0	SENT_5	[p1l491t988r545b1013],
6	Clinical	JJ	O	clinical	amod	7	SENT_5	[p1l557t988r657b1013],
7	Pharmacology	NN	O	pharmacology	conj_and	1	SENT_5	[p1l11t1025r214b1059],
8	,	,	O	,	_	0	SENT_5	[p1l11t1025r214b1059],
9	INSERM	NNP	ORGANIZATION	INSERM	nn	13	SENT_5	[p1l228t1026r339b1051],
10	U564	NNP	O	U564	nn	13	SENT_5	[p1l350t1026r424b1051],
11	Centre	NNP	O	Centre	nn	13	SENT_5	[p1l438t1026r527b1051],
12	Paul	NNP	PERSON	Paul	nn	13	SENT_5	[p1l537t1026r598b1051],
13	Papin	NNP	PERSON	Papin	appos	7	SENT_5	[p1l607t1026r690b1059],
14	,	,	O	,	_	0	SENT_5	[p1l607t1026r690b1059],
15	Centre	NNP	O	Centre	nn	19	SENT_5	[p1l11t1064r101b1088],
16	Régional	NNP	O	Régional	nn	19	SENT_5	[p1l113t1061r232b1096],
17	de	IN	O	de	amod	19	SENT_5	[p1l243t1063r276b1088],
18	Lutte	NNP	O	Lutte	nn	19	SENT_5	[p1l288t1064r357b1088],
19	Contre	NNP	O	Contre	appos	7	SENT_5	[p1l369t1064r461b1088],
20	le	DT	O	le	det	21	SENT_5	[p1l472t1063r495b1088],
21	Cancer	NN	O	cancer	dep	1	SENT_5	[p1l507t1064r608b1094],
22	,	,	O	,	_	0	SENT_5	[p1l507t1064r608b1094],
23	Angers	NNP	O	Angers	nn	27	SENT_5	[p1l9t1102r109b1134],
24	,	,	O	,	_	0	SENT_5	[p1l9t1102r109b1134],
25	Cedex	NNP	O	Cedex	appos	27	SENT_5	[p1l126t1101r213b1131],
26	,	,	O	,	_	0	SENT_5	[p1l126t1101r213b1131],
27	France	NNP	LOCATION	France	appos	21	SENT_5	[p1l229t1102r319b1126],

1	Correspondence	NN	O	correspondence	_	0	SENT_6	[p1l10t1183r271b1216],
2	:	:	O	:	_	0	SENT_6	[p1l10t1183r271b1216],
3	Professor	NNP	O	Professor	nn	5	SENT_6	[p1l11t1221r140b1246],
4	E	NNP	PERSON	E	nn	5	SENT_6	[p1l153t1222r166b1246],
5	Gamelin	NNP	PERSON	Gamelin	dep	1	SENT_6	[p1l179t1221r307b1251],
6	,	,	O	,	_	0	SENT_6	[p1l179t1221r307b1251],
7	Department	NNP	ORGANIZATION	Department	appos	1	SENT_6	[p1l324t1222r499b1254],
8	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l511t1221r539b1246],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_6	[p1l551t1221r654b1246],
10	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	7	SENT_6	[p1l11t1258r225b1291],
11	,	,	O	,	_	0	SENT_6	[p1l11t1258r225b1291],
12	CRLCC	NNP	O	CRLCC	nn	14	SENT_6	[p1l240t1259r340b1283],
13	Paul	NNP	PERSON	Paul	nn	14	SENT_6	[p1l354t1258r411b1283],
14	Papin	NNP	PERSON	Papin	appos	1	SENT_6	[p1l427t1259r513b1291],
15	,	,	O	,	_	0	SENT_6	[p1l427t1259r513b1291],
16	INSERM	NNP	ORGANIZATION	INSERM	nn	17	SENT_6	[p1l529t1259r641b1283],
17	U564	NN	O	u564	appos	1	SENT_6	[p1l10t1296r95b1326],
18	,	,	O	,	_	0	SENT_6	[p1l10t1296r95b1326],
19	2	CD	NUMBER	2	num	21	SENT_6	[p1l110t1296r126b1320],
20	Rue	NNP	ORGANIZATION	Rue	nn	21	SENT_6	[p1l141t1297r192b1321],
21	Moll	NNP	ORGANIZATION	Moll	appos	1	SENT_6	[p1l206t1295r276b1326],
22	,	,	O	,	_	0	SENT_6	[p1l206t1295r276b1326],
23	Angers	NNP	O	Angers	appos	1	SENT_6	[p1l290t1297r390b1329],
24	49933	CD	NUMBER	49933	num	23	SENT_6	[p1l402t1296r503b1326],
25	,	,	O	,	_	0	SENT_6	[p1l402t1296r503b1326],
26	France	NNP	LOCATION	France	appos	1	SENT_6	[p1l520t1297r620b1321],
27	.	.	O	.	_	0	SENT_6	[p1l520t1297r620b1321],

1	E-mail	NN	O	e-mail	_	0	SENT_7	[p1l11t1333r105b1358],
2	:	:	O	:	_	0	SENT_7	[p1l11t1333r105b1358],
3	e.	VB	O	e.	dep	1	SENT_7	[p1l120t1333r458b1366],
4	game	NN	O	game	nn	6	SENT_7	[p1l120t1333r458b1366],
5	|	NN	O	|	nn	6	SENT_7	[p1l120t1333r458b1366],
6	in@unimedia.fr	NN	O	in@unimedia.fr	dobj	3	SENT_7	[p1l120t1333r458b1366],

1	Received	VBN	O	receive	_	0	SENT_8	[p1l11t2607r145b2632],
2	20	CD	DATE	20	dobj	1	SENT_8	[p1l169t2608r205b2632],
3	March	NNP	DATE	March	tmod	1	SENT_8	[p1l229t2607r324b2632],
4	2007	CD	DATE	2007	num	3	SENT_8	[p1l349t2608r431b2637],
5	;	:	O	;	_	0	SENT_8	[p1l349t2608r431b2637],
6	revised	VBN	O	revise	parataxis	1	SENT_8	[p1l456t2607r563b2632],
7	20	CD	NUMBER	20	num	9	SENT_8	[p1l588t2608r624b2632],
8	lune	JJ	O	lune	amod	9	SENT_8	[p1l646t2608r713b2638],
9	2007	CD	DATE	2007	dobj	6	SENT_8	[p1l9t2645r92b2675],
10	;	:	O	;	_	0	SENT_8	[p1l9t2645r92b2675],
11	accepted	VBN	O	accept	parataxis	1	SENT_8	[p1l107t2644r244b2678],
12	6	CD	DATE	6	dobj	11	SENT_8	[p1l258t2645r276b2670],
13	July	NNP	DATE	July	tmod	11	SENT_8	[p1l288t2644r344b2678],
14	2007	CD	DATE	2007	num	13	SENT_8	[p1l357t2645r439b2675],
15	;	:	O	;	_	0	SENT_8	[p1l357t2645r439b2675],
16	published	VBN	O	publish	parataxis	1	SENT_8	[p1l455t2644r604b2678],
17	online	NN	O	online	prep	16	SENT_8	[p1l618t2644r713b2670],
18	14	CD	DATE	14	dep	17	SENT_8	[p1l11t2683r46b2707],
19	August	NNP	DATE	August	tmod	16	SENT_8	[p1l57t2683r166b2715],
20	2007	CD	DATE	2007	num	19	SENT_8	[p1l178t2683r253b2707],

1	In	IN	O	in	_	0	SENT_9	[p1l86t2872r159b2926],
2	patients	NNS	O	patient	pobj	1	SENT_9	[p1l208t2872r490b2945],
3	with	IN	O	with	_	0	SENT_9	[p1l538t2869r699b2927],
4	below	IN	O	below	quantmod	5	SENT_9	[p1l6t2964r220b3022],
5	20	CD	PERCENT	20	num	6	SENT_9	[p1l268t2965r420b3022],
6	%	NN	PERCENT	%	prep_with	2	SENT_9	[p1l268t2965r420b3022],
7	with	IN	O	with	_	0	SENT_9	[p1l467t2964r628b3022],
8	5The	NN	O	5the	prep_with	6	SENT_9	[p1l679t2966r742b3022, p1l747t769r814b800],

1	purpose	NN	O	purpose	nsubj	5	SENT_10	[p1l831t778r975b810],
2	of	IN	O	of	_	0	SENT_10	[p1l991t769r1025b800],
3	this	DT	O	this	det	4	SENT_10	[p1l1038t769r1101b800],
4	study	NN	O	study	prep_of	1	SENT_10	[p1l1116t769r1214b810],
5	was	VBD	O	be	_	0	SENT_10	[p1l1227t778r1295b800],
6	to	TO	O	to	aux	7	SENT_10	[p1l1309t772r1345b800],
7	determine	VB	O	determine	xcomp	5	SENT_10	[p1l1360t769r1546b800],
8	simple	JJ	O	simple	amod	10	SENT_10	[p1l1561t769r1678b810],
9	genetic	JJ	O	genetic	amod	10	SENT_10	[p1l1693t769r1826b810],
10	factors	NNS	O	factor	nsubj	11	SENT_10	[p1l1839t769r1960b800],
11	helpful	JJ	O	helpful	xcomp	7	SENT_10	[p1l1976t769r2097b810],
12	to	TO	O	to	aux	13	SENT_10	[p1l2113t772r2149b800],
13	tailor	VB	O	tailor	xcomp	11	SENT_10	[p1l748t815r840b847],
14	5-FU	NN	O	5-fu	nn	15	SENT_10	[p1l855t817r937b847],
15	administration	NN	O	administration	dobj	13	SENT_10	[p1l955t815r1215b847],
16	and	CC	O	and	_	0	SENT_10	[p1l1233t815r1298b847],
17	determine	VB	O	determine	xcomp	11	SENT_10	[p1l1316t815r1501b847],
18	strategy	NN	O	strategy	dobj	17	SENT_10	[p1l1518t819r1662b857],
19	in	IN	O	in	_	0	SENT_10	[p1l1679t816r1708b846],
20	first-line	JJ	O	first-line	amod	21	SENT_10	[p1l1724t815r1868b847],
21	chemotherapy	NN	O	chemotherapy	prep_in	17	SENT_10	[p1l1885t815r2149b857],
22	of	IN	O	of	_	0	SENT_10	[p1l749t862r784b893],
23	advanced	JJ	O	advanced	amod	25	SENT_10	[p1l809t862r982b893],
24	colorectal	JJ	O	colorectal	amod	25	SENT_10	[p1l1011t862r1184b893],
25	cancer	NN	O	cancer	prep_of	21	SENT_10	[p1l1213t871r1341b893],
26	.	.	O	.	_	0	SENT_10	[p1l1213t871r1341b893],

1	In	IN	O	in	_	0	SENT_11	[p1l1372t863r1401b893],
2	76	CD	NUMBER	76	num	3	SENT_11	[p1l1433t863r1475b893],
3	patients	NNS	O	patient	prep_in	29	SENT_11	[p1l1504t863r1646b903],
4	initially	RB	O	initially	advmod	5	SENT_11	[p1l1674t862r1801b903],
5	treated	VBN	O	treat	partmod	3	SENT_11	[p1l1827t862r1954b893],
6	by	IN	O	by	_	0	SENT_11	[p1l1984t862r2027b903],
7	5-FU	NN	O	5-fu	nn	13	SENT_11	[p1l2053t863r2146b900],
8	,	,	O	,	_	0	SENT_11	[p1l2053t863r2146b900],
9	thymidylate	NN	O	thymidylate	dep	13	SENT_11	[p1l748t909r964b950],
10	synthase	NN	O	synthase	nn	13	SENT_11	[p1l992t909r1157b950],
11	,	,	O	,	_	0	SENT_11	[p1l992t909r1157b950],
12	dihydropyrimidine	NN	O	dihydropyrimidine	dep	13	SENT_11	[p1l1188t909r1525b950],
13	dehydrogenase	NN	O	dehydrogenase	agent	5	SENT_11	[p1l1554t909r1833b950],
14	and	CC	O	and	_	0	SENT_11	[p1l1861t909r1927b940],
15	methylene	NN	O	methylene	nn	19	SENT_11	[p1l1959t909r2149b950],
16	tetrahydrofolate	JJ	O	tetrahydrofolate	amod	19	SENT_11	[p1l748t955r1041b997],
17	reductase	NN	O	reductase	nn	19	SENT_11	[p1l1075t955r1246b987],
18	germinal	JJ	O	germinal	amod	19	SENT_11	[p1l1279t955r1437b997],
19	polymorphisms	NNS	O	polymorphism	agent	5	SENT_11	[p1l1472t955r1761b997],
20	,	,	O	,	_	0	SENT_11	[p1l1472t955r1761b997],
21	dihydrouracil/uracil	JJ	O	dihydrouracil/uracil	amod	23	SENT_11	[p1l1796t955r2147b997],
22	plasma	NN	O	plasma	nn	23	SENT_11	[p1l750t1002r874b1044],
23	ratio	NN	O	ratio	nsubjpass	31	SENT_11	[p1l898t1003r977b1034],
24	and	CC	O	and	_	0	SENT_11	[p1l998t1002r1064b1034],
25	5-FU	NN	O	5-fu	nn	27	SENT_11	[p1l1087t1004r1168b1034],
26	plasma	NN	O	plasma	nn	27	SENT_11	[p1l1193t1002r1317b1044],
27	clearance	NN	O	clearance	conj_and	23	SENT_11	[p1l1340t1002r1509b1034],
28	were	VBD	O	be	auxpass	29	SENT_11	[p1l1529t1011r1617b1034],
29	investigated	VBN	O	investigate	_	0	SENT_11	[p1l1639t1002r1856b1044],
30	and	CC	O	and	_	0	SENT_11	[p1l1879t1002r1944b1034],
31	correlated	VBN	O	correlate	conj_and	29	SENT_11	[p1l1967t1002r2147b1034],
32	for	IN	O	for	_	0	SENT_11	[p1l747t1049r798b1081],
33	tolerance	NN	O	tolerance	prep_for	31	SENT_11	[p1l813t1049r981b1081],
34	(	CD	PERCENT	(	number	35	SENT_11	[p1l999t1049r1132b1089],
35	10.5	CD	PERCENT	10.5	num	36	SENT_11	[p1l999t1049r1132b1089],
36	%	NN	PERCENT	%	dep	33	SENT_11	[p1l999t1049r1132b1089],
37	grade	NN	O	grade	dep	33	SENT_11	[p1l1150t1049r1253b1090],
38	3	CD	NUMBER	3	num	37	SENT_11	[p1l1273t1050r1291b1080],
39	and	CC	O	and	_	0	SENT_11	[p1l1310t1049r1375b1081],
40	4	CD	NUMBER	4	num	42	SENT_11	[p1l1394t1050r1415b1080],
41	toxicity	NN	O	toxicity	nn	42	SENT_11	[p1l1433t1049r1579b1090],
42	)	NN	O	)	dep	33	SENT_11	[p1l1433t1049r1579b1090],
43	and	CC	O	and	_	0	SENT_11	[p1l1598t1049r1663b1081],
44	efficacy	NN	O	efficacy	conj_and	33	SENT_11	[p1l1682t1049r1818b1091],
45	(	CD	PERCENT	(	number	46	SENT_11	[p1l1835t1049r1968b1088],
46	32.9	CD	PERCENT	32.9	num	47	SENT_11	[p1l1835t1049r1968b1088],
47	%	NN	PERCENT	%	dep	44	SENT_11	[p1l1835t1049r1968b1088],
48	objective	JJ	O	objective	amod	50	SENT_11	[p1l1986t1049r2148b1090],
49	response	NN	O	response	nn	50	SENT_11	[p1l750t1105r907b1137],
50	rate	NN	O	rate	dobj	29	SENT_11	[p1l931t1100r997b1127],
51	and	CC	O	and	_	0	SENT_11	[p1l1020t1096r1086b1127],
52	20	CD	DURATION	20	number	53	SENT_11	[p1l1110t1097r1154b1127],
53	months	NNS	NUMBER	month	num	58	SENT_11	[p1l1178t1096r1314b1127],
54	median	JJ	O	median	amod	58	SENT_11	[p1l1338t1096r1470b1127],
55	overall	JJ	O	overall	amod	58	SENT_11	[p1l1494t1096r1611b1127],
56	survival	NN	O	survival	nn	58	SENT_11	[p1l1634t1096r1766b1127],
57	time	NN	O	time	nn	58	SENT_11	[p1l1789t1096r1895b1135],
58	)	NN	O	)	dobj	29	SENT_11	[p1l1789t1096r1895b1135],
59	.	.	O	.	_	0	SENT_11	[p1l1789t1096r1895b1135],

1	Toxicity	NN	O	toxicity	nsubjpass	3	SENT_12	[p1l1918t1097r2061b1137],
2	was	VBD	O	be	auxpass	3	SENT_12	[p1l2081t1105r2149b1127],
3	linked	VBN	O	link	_	0	SENT_12	[p1l750t1143r854b1174],
4	to	TO	O	to	_	0	SENT_12	[p1l873t1146r909b1174],
5	performance	NN	O	performance	nn	6	SENT_12	[p1l929t1143r1158b1184],
6	status	NN	O	status	prep_to	3	SENT_12	[p1l1177t1146r1279b1174],
7	>	RBR	O	>	amod	6	SENT_12	[p1l1304t1144r1359b1174],
8	2	CD	NUMBER	2	number	9	SENT_12	[p1l1304t1144r1359b1174],
9	(	CD	NUMBER	(	num	10	SENT_12	[p1l1379t1143r1590b1182],
10	P	NN	O	p	npadvmod	11	SENT_12	[p1l1379t1143r1590b1182],
11	=	JJ	O	=	amod	6	SENT_12	[p1l1379t1143r1590b1182],
12	0.004	CD	NUMBER	0.004	num	13	SENT_12	[p1l1379t1143r1590b1182],
13	)	NN	O	)	dobj	3	SENT_12	[p1l1379t1143r1590b1182],
14	,	,	O	,	_	0	SENT_12	[p1l1379t1143r1590b1182],
15	low	JJ	O	low	amod	17	SENT_12	[p1l1612t1143r1675b1174],
16	UH2/U	NN	O	uh2/u	nn	17	SENT_12	[p1l1694t1143r1808b1181],
17	ratio	NN	O	ratio	appos	13	SENT_12	[p1l1829t1143r1918b1181],
18	,	,	O	,	_	0	SENT_12	[p1l1829t1143r1918b1181],
19	2846	CD	DATE	2846	appos	13	SENT_12	[p1l1939t1144r2031b1174],
20	A	DT	O	a	det	22	SENT_12	[p1l2048t1144r2147b1181],
21	>	JJR	O	>	amod	22	SENT_12	[p1l2048t1144r2147b1181],
22	T	NN	O	t	dep	19	SENT_12	[p1l2048t1144r2147b1181],
23	,	,	O	,	_	0	SENT_12	[p1l2048t1144r2147b1181],
24	IVS	NN	O	iv	appos	13	SENT_12	[p1l750t1190r802b1221],
25	14	CD	NUMBER	14	number	26	SENT_12	[p1l821t1190r1033b1224],
26	+1	CD	NUMBER	+1	num	27	SENT_12	[p1l821t1190r1033b1224],
27	G	NN	O	g	npadvmod	28	SENT_12	[p1l821t1190r1033b1224],
28	>	JJR	O	>	dep	40	SENT_12	[p1l821t1190r1033b1224],
29	A	DT	O	a	dep	28	SENT_12	[p1l821t1190r1033b1224],
30	for	IN	O	for	_	0	SENT_12	[p1l1047t1189r1097b1221],
31	DPD	NN	O	dpd	prep_for	28	SENT_12	[p1l1114t1191r1190b1220],
32	(	CD	NUMBER	(	num	33	SENT_12	[p1l1206t1190r1417b1229],
33	P	NN	O	p	dep	40	SENT_12	[p1l1206t1190r1417b1229],
34	=	JJ	O	=	amod	40	SENT_12	[p1l1206t1190r1417b1229],
35	0.031	CD	NUMBER	0.031	num	36	SENT_12	[p1l1206t1190r1417b1229],
36	)	NN	O	)	tmod	34	SENT_12	[p1l1206t1190r1417b1229],
37	,	,	O	,	_	0	SENT_12	[p1l1206t1190r1417b1229],
38	and	CC	O	and	_	0	SENT_12	[p1l1436t1189r1501b1221],
39	homozygoty	NN	O	homozygoty	tmod	34	SENT_12	[p1l1521t1189r1749b1231],
40	C/C	NN	O	c/c	dep	46	SENT_12	[p1l1765t1189r1835b1225],
41	for	IN	O	for	_	0	SENT_12	[p1l1850t1189r1901b1221],
42	MTHFR	NNP	O	MTHFR	prep_for	40	SENT_12	[p1l1917t1191r2041b1221],
43	1298	CD	DATE	1298	num	42	SENT_12	[p1l2058t1190r2148b1221],
44	A	DT	O	a	det	46	SENT_12	[p1l747t1237r841b1268],
45	>	JJR	O	>	amod	46	SENT_12	[p1l747t1237r841b1268],
46	C	NN	O	c	dep	13	SENT_12	[p1l747t1237r841b1268],
47	(	CD	NUMBER	(	num	48	SENT_12	[p1l867t1236r1102b1275],
48	P	NN	O	p	dep	46	SENT_12	[p1l867t1236r1102b1275],
49	=	JJ	O	=	amod	51	SENT_12	[p1l867t1236r1102b1275],
50	0.0018	CD	NUMBER	0.0018	tmod	49	SENT_12	[p1l867t1236r1102b1275],
51	)	NN	O	)	dep	48	SENT_12	[p1l867t1236r1102b1275],
52	.	.	O	.	_	0	SENT_12	[p1l867t1236r1102b1275],

1	The	DT	O	the	det	3	SENT_13	[p1l1128t1236r1195b1268],
2	overall	JJ	O	overall	amod	3	SENT_13	[p1l1220t1236r1337b1268],
3	survival	NN	O	survival	dep	29	SENT_13	[p1l1363t1236r1495b1268],
4	of	IN	O	of	_	0	SENT_13	[p1l1521t1236r1556b1268],
5	the	DT	O	the	det	6	SENT_13	[p1l1579t1236r1636b1268],
6	patients	NNS	O	patient	prep_of	3	SENT_13	[p1l1663t1237r1805b1278],
7	with	IN	O	with	_	0	SENT_13	[p1l1828t1236r1907b1268],
8	a	DT	O	a	det	11	SENT_13	[p1l1933t1245r1950b1268],
9	3R/3R	NN	O	3r/3r	nn	11	SENT_13	[p1l1978t1236r2084b1272],
10	TS	NN	O	t	nn	11	SENT_13	[p1l2112t1237r2151b1268],
11	genotype	NN	O	genotype	prep_with	6	SENT_13	[p1l749t1287r921b1324],
12	associated	VBN	O	associate	partmod	11	SENT_13	[p1l945t1283r1128b1314],
13	with	IN	O	with	_	0	SENT_13	[p1l1152t1283r1230b1314],
14	C/C	NN	O	c/c	prep_with	12	SENT_13	[p1l1256t1283r1326b1318],
15	for	IN	O	for	_	0	SENT_13	[p1l1349t1283r1400b1314],
16	677	CD	NUMBER	677	number	17	SENT_13	[p1l1423t1284r1490b1314],
17	C	NN	O	c	num	19	SENT_13	[p1l1515t1284r1607b1314],
18	>	JJR	O	>	amod	19	SENT_13	[p1l1515t1284r1607b1314],
19	T	NN	O	t	prep_for	14	SENT_13	[p1l1515t1284r1607b1314],
20	or	CC	O	or	_	0	SENT_13	[p1l1629t1292r1666b1314],
21	A/A	NN	O	a/a	conj_or	19	SENT_13	[p1l1687t1283r1755b1318],
22	for	IN	O	for	_	0	SENT_13	[p1l1775t1283r1826b1314],
23	1298	CD	DATE	1298	prep_for	21	SENT_13	[p1l1851t1284r1940b1314],
24	A	DT	O	a	det	26	SENT_13	[p1l1964t1284r2058b1314],
25	>	JJR	O	>	amod	26	SENT_13	[p1l1964t1284r2058b1314],
26	C	NN	O	c	dep	21	SENT_13	[p1l1964t1284r2058b1314],
27	was	VBD	O	be	cop	29	SENT_13	[p1l2081t1292r2149b1314],
28	statistically	RB	O	statistically	advmod	29	SENT_13	[p1l748t1329r944b1371],
29	shorter	JJR	O	shorter	_	0	SENT_13	[p1l967t1329r1094b1361],
30	(	CD	NUMBER	(	num	33	SENT_13	[p1l1118t1329r1282b1371],
31	log-rank	JJ	O	log-rank	amod	33	SENT_13	[p1l1118t1329r1282b1371],
32	test	NN	O	test	nn	33	SENT_13	[p1l1305t1333r1370b1361],
33	P	NN	O	p	nsubj	29	SENT_13	[p1l1395t1330r1615b1369],
34	=	JJ	O	=	amod	33	SENT_13	[p1l1395t1330r1615b1369],
35	0.0065	CD	NUMBER	0.0065	num	36	SENT_13	[p1l1395t1330r1615b1369],
36	)	NN	O	)	dep	34	SENT_13	[p1l1395t1330r1615b1369],
37	.	.	O	.	_	0	SENT_13	[p1l1395t1330r1615b1369],

1	Genetic	JJ	O	genetic	amod	2	SENT_14	[p1l1642t1330r1781b1361],
2	factors	NNS	O	factor	nsubj	3	SENT_14	[p1l1803t1329r1923b1361],
3	permit	VBP	O	permit	_	0	SENT_14	[p1l1950t1330r2069b1371],
4	the	DT	O	the	dobj	3	SENT_14	[p1l2091t1329r2149b1361],
5	tailoring	VBG	O	tailor	amod	4	SENT_14	[p1l748t1376r896b1418],
6	of	IN	O	of	_	0	SENT_14	[p1l910t1376r945b1408],
7	5-FU	NN	O	5-fu	nn	8	SENT_14	[p1l957t1378r1038b1408],
8	treatment	NN	O	treatment	prep_of	4	SENT_14	[p1l1052t1380r1242b1408],
9	.	.	O	.	_	0	SENT_14	[p1l1052t1380r1242b1408],

1	They	PRP	O	they	nsubj	3	SENT_15	[p1l1255t1376r1344b1418],
2	should	MD	O	should	aux	3	SENT_15	[p1l1355t1376r1474b1408],
3	occupy	VB	O	occupy	_	0	SENT_15	[p1l1488t1386r1619b1418],
4	center	NN	O	center	nn	5	SENT_15	[p1l1631t1380r1745b1408],
5	stage	NN	O	stage	dobj	3	SENT_15	[p1l1756t1380r1850b1418],
6	in	IN	O	in	_	0	SENT_15	[p1l1864t1377r1893b1407],
7	future	JJ	DATE	future	amod	9	SENT_15	[p1l1906t1376r2014b1408],
8	clinical	JJ	O	clinical	amod	9	SENT_15	[p1l2027t1376r2147b1408],
9	trials	NNS	O	trial	prep_in	5	SENT_15	[p1l748t1423r831b1455],
10	for	IN	O	for	_	0	SENT_15	[p1l849t1423r900b1455],
11	specifically	RB	O	specifically	advmod	12	SENT_15	[p1l917t1423r1111b1465],
12	designing	VBG	O	design	prepc_for	3	SENT_15	[p1l1129t1423r1305b1465],
13	treatment	NN	O	treatment	dobj	12	SENT_15	[p1l1325t1427r1506b1455],
14	for	IN	O	for	_	0	SENT_15	[p1l1522t1423r1573b1455],
15	patients	NNS	O	patient	prep_for	12	SENT_15	[p1l1592t1424r1734b1465],
16	with	IN	O	with	_	0	SENT_15	[p1l1752t1423r1829b1455],
17	a	DT	O	a	det	20	SENT_15	[p1l1850t1432r1868b1455],
18	given	VBN	O	give	amod	20	SENT_15	[p1l1888t1424r1984b1465],
19	biologic	JJ	O	biologic	amod	20	SENT_15	[p1l2006t1423r2149b1465],
20	feature	NN	O	feature	prep_with	15	SENT_15	[p1l747t1470r883b1502],
21	.	.	O	.	_	0	SENT_15	[p1l747t1470r883b1502],

1	The	DT	O	the	det	3	SENT_16	[p1l753t1517r811b1549],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_16	[p1l822t1517r1145b1559],
3	journal	NN	O	journal	_	0	SENT_16	[p1l1153t1517r1274b1557],
4	(	CD	NUMBER	(	num	5	SENT_16	[p1l1282t1518r1398b1557],
5	2008	CD	DATE	2008	dep	3	SENT_16	[p1l1282t1518r1398b1557],
6	)	NN	O	)	dep	3	SENT_16	[p1l1282t1518r1398b1557],
7	8	CD	NUMBER	8	num	6	SENT_16	[p1l1410t1518r1440b1556],
8	,	,	O	,	_	0	SENT_16	[p1l1410t1518r1440b1556],
9	256-267	CD	NUMBER	256-267	appos	6	SENT_16	[p1l1454t1518r1618b1556],
10	;	:	O	;	_	0	SENT_16	[p1l1454t1518r1618b1556],
11	doi	FW	O	doi	nn	12	SENT_16	[p1l1632t1517r1715b1549],
12	:1	FW	O	:1	dep	3	SENT_16	[p1l1632t1517r1715b1549],
13	0.1	CD	NUMBER	0.1	num	14	SENT_16	[p1l1726t1518r1775b1549],
14	038/sj	NN	O	038/sj	dep	12	SENT_16	[p1l1786t1517r2088b1559],
15	.	.	O	.	_	0	SENT_16	[p1l1786t1517r2088b1559],

1	tpj	NN	O	tpj	_	0	SENT_17	[p1l1786t1517r2088b1559],
2	.65004	CD	NUMBER	.65004	nsubj	5	SENT_17	[p1l1786t1517r2088b1559],
3	76	CD	NUMBER	76	dep	2	SENT_17	[p1l2094t1518r2146b1556],
4	;	:	O	;	_	0	SENT_17	[p1l2094t1518r2146b1556],
5	published	VBN	O	publish	rcmod	1	SENT_17	[p1l750t1565r924b1606],
6	online	NN	O	online	prep	5	SENT_17	[p1l942t1565r1052b1596],
7	14	CD	DATE	14	dep	6	SENT_17	[p1l1071t1566r1113b1596],
8	August	NNP	DATE	August	tmod	5	SENT_17	[p1l1129t1566r1257b1606],
9	2007	CD	DATE	2007	num	8	SENT_17	[p1l1273t1566r1364b1596],

1	Keywords	NNPS	O	Keywords	_	0	SENT_18	[p1l749t1661r920b1695],
2	:	:	O	:	_	0	SENT_18	[p1l749t1661r920b1695],
3	colorectal	JJ	O	colorectal	amod	4	SENT_18	[p1l939t1661r1078b1687],
4	cancer	NN	O	cancer	dep	1	SENT_18	[p1l1094t1669r1196b1692],
5	;	:	O	;	_	0	SENT_18	[p1l1094t1669r1196b1692],
6	fluorouracil	NN	O	fluorouracil	dep	4	SENT_18	[p1l1211t1661r1383b1692],
7	;	:	O	;	_	0	SENT_18	[p1l1211t1661r1383b1692],
8	thymidylate	NN	O	thymidylate	nn	9	SENT_18	[p1l1399t1661r1571b1695],
9	synthase	NN	O	synthase	dep	4	SENT_18	[p1l1586t1661r1718b1695],
10	;	:	O	;	_	0	SENT_18	[p1l1586t1661r1718b1695],
11	dihydropyrimidine	NN	O	dihydropyrimidine	nn	12	SENT_18	[p1l1735t1661r2003b1695],
12	dehydrogenase	NN	O	dehydrogenase	dep	9	SENT_18	[p1l2018t1661r2149b1695, p1l748t1707r857b1732],
13	;	:	O	;	_	0	SENT_18	[p1l2018t1661r2149b1695, p1l748t1707r857b1732],
14	methylene	NN	O	methylene	dep	4	SENT_18	[p1l872t1699r1024b1732],
15	tetrahydrofolate	NN	O	tetrahydrofolate	nn	16	SENT_18	[p1l1036t1699r1270b1732],
16	reductase	NN	O	reductase	dep	14	SENT_18	[p1l1284t1699r1421b1724],

1	Introduction	NN	O	introduction	_	0	SENT_19	[p1l749t1883r987b1912],

1	Over	IN	O	over	_	0	SENT_20	[p1l749t1977r831b2004],
2	the	DT	DURATION	the	det	5	SENT_20	[p1l851t1976r906b2004],
3	past	JJ	DURATION	past	amod	5	SENT_20	[p1l927t1980r996b2013],
4	few	JJ	DURATION	few	amod	5	SENT_20	[p1l1017t1976r1077b2004],
5	years	NNS	DURATION	year	prep_over	15	SENT_20	[p1l1095t1984r1191b2013],
6	,	,	O	,	_	0	SENT_20	[p1l1095t1984r1191b2013],
7	a	DT	O	a	det	9	SENT_20	[p1l1215t1984r1232b2004],
8	central	JJ	O	central	amod	9	SENT_20	[p1l1253t1976r1371b2004],
9	goal	NN	O	goal	nsubj	15	SENT_20	[p1l1392t1976r1463b2013],
10	of	IN	O	of	_	0	SENT_20	[p1l1484t1976r1519b2004],
11	research	NN	O	research	prep_of	9	SENT_20	[p1l1537t1976r1679b2004],
12	in	IN	O	in	_	0	SENT_20	[p1l1699t1978r1734b2004],
13	oncology	NN	O	oncology	prep_in	11	SENT_20	[p1l1755t1976r1915b2013],
14	has	VBZ	O	have	aux	15	SENT_20	[p1l1935t1976r1991b2004],
15	been	VBN	O	be	_	0	SENT_20	[p1l2011t1976r2094b2004],
16	to	TO	O	to	aux	17	SENT_20	[p1l2115t1980r2149b2004],
17	determine	VB	O	determine	xcomp	15	SENT_20	[p1l748t2023r924b2051],
18	main	JJ	O	main	amod	20	SENT_20	[p1l935t2024r1024b2051],
19	molecular	JJ	O	molecular	amod	20	SENT_20	[p1l1035t2023r1208b2051],
20	biomarkers	NNS	O	biomarker	dobj	17	SENT_20	[p1l1217t2023r1409b2051],
21	that	WDT	O	that	nsubj	23	SENT_20	[p1l1420t2023r1490b2051],
22	could	MD	O	could	aux	23	SENT_20	[p1l1501t2023r1596b2051],
23	predict	VB	O	predict	rcmod	20	SENT_20	[p1l1606t2023r1727b2060],
24	response	NN	O	response	dobj	23	SENT_20	[p1l1737t2031r1886b2060],
25	and	CC	O	and	_	0	SENT_20	[p1l1898t2023r1962b2051],
26	toxicity	NN	O	toxicity	conj_and	24	SENT_20	[p1l1972t2024r2106b2060],
27	to	TO	O	to	_	0	SENT_20	[p1l2115t2027r2149b2051],
28	chemotherapeutic	JJ	O	chemotherapeutic	amod	29	SENT_20	[p1l748t2076r1064b2113],
29	agents	NNS	O	agent	prep_to	23	SENT_20	[p1l1079t2079r1197b2113],
30	.	.	O	.	_	0	SENT_20	[p1l1079t2079r1197b2113],

1	Indeed	RB	O	indeed	advmod	13	SENT_21	[p1l786t2130r912b2165],
2	,	,	O	,	_	0	SENT_21	[p1l786t2130r912b2165],
3	the	DT	O	the	det	4	SENT_21	[p1l935t2130r990b2158],
4	understanding	NN	O	understanding	nsubj	13	SENT_21	[p1l1011t2130r1265b2167],
5	of	IN	O	of	_	0	SENT_21	[p1l1285t2130r1320b2158],
6	interindividual	JJ	O	interindividual	amod	7	SENT_21	[p1l1338t2130r1599b2158],
7	heterogeneity	NN	O	heterogeneity	prep_of	4	SENT_21	[p1l1619t2130r1860b2167],
8	in	IN	O	in	_	0	SENT_21	[p1l1879t2131r1914b2158],
9	efficacy	NN	O	efficacy	prep_in	7	SENT_21	[p1l1934t2130r2066b2167],
10	and	CC	O	and	_	0	SENT_21	[p1l2085t2130r2149b2158],
11	toxicity	NN	O	toxicity	prep_in	7	SENT_21	[p1l748t2185r881b2221],
12	could	MD	O	could	aux	13	SENT_21	[p1l903t2184r998b2212],
13	serve	VB	O	serve	_	0	SENT_21	[p1l1021t2192r1106b2212],
14	as	IN	O	as	_	0	SENT_21	[p1l1129t2192r1161b2212],
15	a	DT	O	a	det	17	SENT_21	[p1l1184t2192r1201b2212],
16	rational	JJ	O	rational	amod	17	SENT_21	[p1l1223t2184r1357b2212],
17	basis	NN	O	basis	prep_as	13	SENT_21	[p1l1379t2184r1460b2212],
18	for	IN	O	for	_	0	SENT_21	[p1l1483t2184r1531b2212],
19	tailored	VBN	O	tailor	amod	21	SENT_21	[p1l1553t2184r1685b2212],
20	treatment	NN	O	treatment	nn	21	SENT_21	[p1l1707t2188r1879b2212],
21	(	NN	O	(	prep_for	17	SENT_21	[p1l1902t2184r2048b2221],
22	optimal	JJ	O	optimal	amod	24	SENT_21	[p1l1902t2184r2048b2221],
23	drug	NN	O	drug	nn	24	SENT_21	[p1l2071t2184r2150b2221],
24	therapy	NN	O	therapy	nsubj	32	SENT_21	[p1l748t2237r881b2274],
25	and	CC	O	and	_	0	SENT_21	[p1l897t2237r961b2265],
26	dosage	NN	O	dosage	nsubj	32	SENT_21	[p1l978t2237r1093b2274],
27	for	IN	O	for	_	0	SENT_21	[p1l1111t2237r1159b2265],
28	each	DT	O	each	det	29	SENT_21	[p1l1175t2237r1254b2265],
29	patient	NN	O	patient	prep_for	24	SENT_21	[p1l1270t2237r1405b2274],
30	)	RB	O	)	advmod	32	SENT_21	[p1l1270t2237r1405b2274],
31	as	IN	O	as	advmod	32	SENT_21	[p1l1424t2245r1455b2265],
32	opposed	VBN	O	oppose	rcmod	21	SENT_21	[p1l1473t2237r1617b2274],
33	to	TO	O	to	_	0	SENT_21	[p1l1633t2241r1667b2265],
34	an	DT	O	a	det	39	SENT_21	[p1l1685t2245r1726b2265],
35	empirical	JJ	O	empirical	amod	39	SENT_21	[p1l1743t2237r1904b2274],
36	‘	NN	O	‘	nn	39	SENT_21	[p1l1922t2237r2149b2265, p1l748t2291r936b2328],
37	onesizefitseverybody	NN	O	onesizefitseverybody	nn	39	SENT_21	[p1l1922t2237r2149b2265, p1l748t2291r936b2328],
38	’	CD	NUMBER	’	num	39	SENT_21	[p1l1922t2237r2149b2265, p1l748t2291r936b2328],
39	chemotherapy	NN	O	chemotherapy	prep_to	32	SENT_21	[p1l970t2291r1227b2328],
40	.	.	O	.	_	0	SENT_21	[p1l970t2291r1227b2328],

1	In	IN	O	in	_	0	SENT_22	[p1l1261t2292r1297b2319],
2	this	DT	O	this	det	3	SENT_22	[p1l1329t2291r1392b2319],
3	domain	NN	O	domain	prep_in	14	SENT_22	[p1l1425t2291r1559b2319],
4	of	IN	O	of	_	0	SENT_22	[p1l1591t2291r1626b2319],
5	a	DT	O	a	det	8	SENT_22	[p1l1657t2299r1674b2319],
6	cancer	NN	O	cancer	nn	8	SENT_22	[p1l1706t2299r1818b2319],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_22	[p1l1849t2291r2149b2328],
8	approach	NN	O	approach	prep_of	3	SENT_22	[p1l748t2344r917b2381],
9	,	,	O	,	_	0	SENT_22	[p1l748t2344r917b2381],
10	intense	JJ	O	intense	amod	11	SENT_22	[p1l942t2345r1067b2372],
11	efforts	NNS	O	effort	nsubj	14	SENT_22	[p1l1090t2343r1198b2372],
12	have	VBP	O	have	aux	14	SENT_22	[p1l1220t2344r1301b2372],
13	especially	RB	O	especially	advmod	14	SENT_22	[p1l1324t2344r1491b2381],
14	focused	VBN	O	focus	_	0	SENT_22	[p1l1512t2344r1643b2372],
15	on	IN	O	on	_	0	SENT_22	[p1l1665t2352r1710b2372],
16	ﬂuorouracil	NN	O	ﬂuorouracil	prep_on	14	SENT_22	[p1l1732t2343r1934b2372],
17	and	CC	O	and	_	0	SENT_22	[p1l1957t2344r2021b2372],
18	on	IN	O	on	_	0	SENT_22	[p1l2043t2352r2088b2372],
19	its	PRP$	O	its	poss	21	SENT_22	[p1l2110t2345r2149b2372],
20	metabolic	JJ	O	metabolic	amod	21	SENT_22	[p1l748t2397r919b2426],
21	enzymes	NNS	O	enzyme	prep_on	14	SENT_22	[p1l934t2406r1091b2435],
22	.	.	O	.	_	0	SENT_22	[p1l934t2406r1091b2435],

1	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	nsubjpass	8	SENT_23	[p1l786t2444r1021b2473],
2	(	CD	NUMBER	(	num	4	SENT_23	[p1l1035t2444r1139b2480],
3	5-FU	NN	O	5-fu	nn	4	SENT_23	[p1l1035t2444r1139b2480],
4	)	NN	O	)	dep	1	SENT_23	[p1l1035t2444r1139b2480],
5	has	VBZ	O	have	aux	8	SENT_23	[p1l1152t2444r1209b2473],
6	been	VBN	O	be	auxpass	8	SENT_23	[p1l1220t2444r1303b2473],
7	widely	RB	O	widely	advmod	8	SENT_23	[p1l1313t2444r1429b2482],
8	used	VBN	O	use	_	0	SENT_23	[p1l1438t2444r1517b2473],
9	for	IN	O	for	_	0	SENT_23	[p1l1528t2444r1576b2473],
10	almost	RB	O	almost	quantmod	11	SENT_23	[p1l1588t2444r1703b2473],
11	50	CD	DURATION	50	num	12	SENT_23	[p1l1716t2445r1756b2473],
12	years	NNS	NUMBER	year	prep_for	8	SENT_23	[p1l1766t2453r1853b2482],
13	in	IN	O	in	_	0	SENT_23	[p1l1865t2446r1900b2472],
14	the	DT	O	the	det	15	SENT_23	[p1l1911t2444r1966b2473],
15	treatment	NN	O	treatment	prep_in	12	SENT_23	[p1l1978t2448r2149b2473],
16	of	IN	O	of	_	0	SENT_23	[p1l748t2491r783b2519],
17	solid	JJ	O	solid	amod	18	SENT_23	[p1l793t2491r874b2519],
18	malignancies	NNS	O	malignancy	prep_of	15	SENT_23	[p1l885t2491r1121b2528],
19	,	,	O	,	_	0	SENT_23	[p1l885t2491r1121b2528],
20	especially	RB	O	especially	advmod	12	SENT_23	[p1l1135t2491r1302b2528],
21	in	IN	O	in	_	0	SENT_23	[p1l1312t2493r1346b2519],
22	colorectal	JJ	O	colorectal	amod	25	SENT_23	[p1l1357t2491r1526b2519],
23	cancer	NN	O	cancer	nn	25	SENT_23	[p1l1537t2499r1649b2519],
24	(	CD	NUMBER	(	num	25	SENT_23	[p1l1661t2491r1761b2526],
25	CRC	NN	ORGANIZATION	crc	prep_in	20	SENT_23	[p1l1661t2491r1761b2526],
26	)	CD	NUMBER	)	dep	12	SENT_23	[p1l1661t2491r1761b2526],
27	both	CC	O	both	dep	26	SENT_23	[p1l1773t2491r1854b2519],
28	in	IN	O	in	_	0	SENT_23	[p1l1865t2493r1900b2519],
29	advanced	JJ	O	advanced	amod	32	SENT_23	[p1l1911t2491r2074b2519],
30	and	CC	O	and	_	0	SENT_23	[p1l2085t2491r2149b2519],
31	adjuvant	JJ	O	adjuvant	amod	32	SENT_23	[p1l748t2538r901b2576],
32	settings	NNS	O	setting	prep_in	26	SENT_23	[p1l916t2539r1055b2575],
33	.	.	O	.	_	0	SENT_23	[p1l916t2539r1055b2575],

1	Its	PRP$	O	its	poss	3	SENT_24	[p1l786t2586r826b2614],
2	main	JJ	O	main	amod	3	SENT_24	[p1l838t2587r927b2614],
3	target	NN	O	target	nsubj	5	SENT_24	[p1l938t2589r1037b2622],
4	is	VBZ	O	be	cop	5	SENT_24	[p1l1049t2587r1074b2614],
5	thymidylate	JJ	O	thymidylate	_	0	SENT_24	[p1l1086t2585r1296b2622],
6	synthase	NN	O	synthase	nn	9	SENT_24	[p1l1310t2585r1458b2623],
7	(	CD	NUMBER	(	num	9	SENT_24	[p1l1472t2585r1545b2621],
8	TS	NN	O	t	nn	9	SENT_24	[p1l1472t2585r1545b2621],
9	)	NN	O	)	tmod	5	SENT_24	[p1l1472t2585r1545b2621],
10	,	,	O	,	_	0	SENT_24	[p1l1472t2585r1545b2621],
11	a	DT	O	a	det	13	SENT_24	[p1l1560t2594r1577b2614],
12	key	JJ	O	key	amod	13	SENT_24	[p1l1589t2585r1648b2623],
13	enzyme	NN	O	enzyme	appos	9	SENT_24	[p1l1659t2594r1792b2622],
14	in	IN	O	in	_	0	SENT_24	[p1l1804t2587r1838b2613],
15	cell	NN	O	cell	nn	16	SENT_24	[p1l1850t2585r1908b2614],
16	proliferation	NN	O	proliferation	prep_in	5	SENT_24	[p1l1920t2585r2147b2623],
17	,	,	O	,	_	0	SENT_24	[p1l1920t2585r2147b2623],
18	which	WDT	O	which	nsubjpass	20	SENT_24	[p1l747t2632r855b2660],
19	is	VBZ	O	be	auxpass	20	SENT_24	[p1l867t2633r891b2660],
20	inhibited	VBN	O	inhibit	rcmod	16	SENT_24	[p1l904t2632r1063b2660],
21	by	IN	O	by	_	0	SENT_24	[p1l1074t2632r1117b2669],
22	the	DT	O	the	det	24	SENT_24	[p1l1127t2632r1182b2660],
23	active	JJ	O	active	amod	24	SENT_24	[p1l1195t2633r1295b2660],
24	metabolite	NN	O	metabolite	agent	20	SENT_24	[p1l1307t2632r1501b2666],
25	,	,	O	,	_	0	SENT_24	[p1l1307t2632r1501b2666],
26	ﬂuorodeoxyuridine	NN	O	ﬂuorodeoxyuridine	nn	27	SENT_24	[p1l1515t2632r1851b2669],
27	monophosphate	NN	O	monophosphate	appos	24	SENT_24	[p1l1863t2632r2149b2669],
28	(	CD	NUMBER	(	num	30	SENT_24	[p1l750t2679r910b2714],
29	FdUMP	NN	O	fdump	nn	30	SENT_24	[p1l750t2679r910b2714],
30	)	NN	O	)	dep	27	SENT_24	[p1l750t2679r910b2714],
31	.	.	O	.	_	0	SENT_24	[p1l750t2679r910b2714],

1	metastatic	JJ	O	metastatic	amod	2	SENT_25	[p1l749t2872r1113b2927],
2	disease	NN	O	disease	nsubj	10	SENT_25	[p1l1163t2869r1423b2939],
3	,	,	O	,	_	0	SENT_25	[p1l1163t2869r1423b2939],
4	response	NN	O	response	nn	5	SENT_25	[p1l1477t2886r1783b2945],
5	rates	NNS	O	rate	appos	2	SENT_25	[p1l1833t2876r1995b2927],
6	are	VBP	O	be	cop	8	SENT_25	[p1l2046t2886r2147b2927],
7	FU	NNP	O	FU	nn	8	SENT_25	[p1l748t2966r842b3022],
8	monotherapy	NN	O	monotherapy	_	0	SENT_25	[p1l892t2964r1378b3040],
9	and	CC	O	and	_	0	SENT_25	[p1l1426t2964r1557b3022],
10	go	VB	O	go	conj_and	8	SENT_25	[p1l1606t2981r1688b3040],
11	up	RP	O	up	prt	10	SENT_25	[p1l1736t2981r1826b3040],
12	to	TO	O	to	_	0	SENT_25	[p1l1876t2971r1945b3022],
13	25	CD	PERCENT	25	num	14	SENT_25	[p1l1997t2965r2149b3022],
14	%	NN	PERCENT	%	prep_to	10	SENT_25	[p1l1997t2965r2149b3022],
15	simply	RB	O	simply	advmod	10	SENT_25	[p1l10t3058r247b3134],
16	by	IN	O	by	_	0	SENT_25	[p1l290t3058r377b3134],
17	adding	VBG	O	add	prepc_by	8	SENT_25	[p1l423t3058r667b3134],
18	folinic	JJ	O	folinic	amod	19	SENT_25	[p1l713t3058r940b3116],
19	acid	NN	O	acid	dobj	17	SENT_25	[p1l988t3058r1148b3129],
20	,	,	O	,	_	0	SENT_25	[p1l988t3058r1148b3129],
21	leucovorin	NN	O	leucovorin	appos	19	SENT_25	[p1l1199t3058r1579b3116],
22	(	CD	NUMBER	(	num	24	SENT_25	[p1l1630t3058r2147b3134, p1l9t3153r465b3229],
23	5formyltetrahydrofolate	JJ	O	5formyltetrahydrofolate	amod	24	SENT_25	[p1l1630t3058r2147b3134, p1l9t3153r465b3229],
24	)	NN	O	)	dep	21	SENT_25	[p1l1630t3058r2147b3134, p1l9t3153r465b3229],
25	,	,	O	,	_	0	SENT_25	[p1l1630t3058r2147b3134, p1l9t3153r465b3229],

1	a	DT	O	a	det	2	SENT_26	[p1l542t3170r577b3211],
2	precursor	NN	O	precursor	nsubjpass	22	SENT_26	[p1l647t3170r979b3229],
3	of	IN	O	of	_	0	SENT_26	[p1l1051t3153r1122b3211],
4	the	DT	O	the	det	10	SENT_26	[p1l1189t3153r1302b3211],
5	methyl	NN	O	methyl	nn	10	SENT_26	[p1l1374t3153r1626b3229],
6	donor	NN	O	donor	nn	10	SENT_26	[p1l1699t3153r1912b3211],
7	5-10	CD	NUMBER	5-10	num	10	SENT_26	[p1l1984t3155r2148b3211],
8	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	10	SENT_26	[p1l9t3247r966b3323],
9	(	NN	O	(	nn	10	SENT_26	[p1l998t3240r1382b3319],
10	CH2FH4	NN	O	ch2fh4	prep_of	2	SENT_26	[p1l998t3240r1382b3319],
11	)	CD	NUMBER	)	number	12	SENT_26	[p1l998t3240r1382b3319],
12	.1	CD	NUMBER	.1	dep	10	SENT_26	[p1l998t3240r1382b3319],
13	Indeed	RB	O	indeed	advmod	12	SENT_26	[p1l1413t3247r1672b3317],
14	,	,	O	,	_	0	SENT_26	[p1l1413t3247r1672b3317],
15	the	DT	O	the	det	16	SENT_26	[p1l1704t3247r1817b3305],
16	complex	NN	O	complex	appos	10	SENT_26	[p1l1845t3247r2150b3323],
17	between	IN	O	between	_	0	SENT_26	[p1l6t3343r304b3400],
18	TS	NN	O	t	prep_between	16	SENT_26	[p1l335t3344r417b3400],
19	and	CC	O	and	_	0	SENT_26	[p1l453t3343r583b3400],
20	FdUMP	NN	O	fdump	prep_between	16	SENT_26	[p1l618t3343r876b3400],
21	is	VBZ	O	be	auxpass	22	SENT_26	[p1l909t3346r960b3400],
22	stabilized	VBN	O	stabilize	_	0	SENT_26	[p1l995t3343r1325b3400],
23	in	IN	O	in	_	0	SENT_26	[p1l1359t3346r1429b3400],
24	an	DT	O	a	det	27	SENT_26	[p1l1463t3359r1547b3400],
25	inactive	JJ	O	inactive	amod	27	SENT_26	[p1l1581t3346r1860b3400],
26	ternary	JJ	O	ternary	amod	27	SENT_26	[p1l1894t3350r2151b3418],
27	form	NN	O	form	prep_in	22	SENT_26	[p1l9t3436r178b3494],
28	by	IN	O	by	_	0	SENT_26	[p1l228t3436r316b3512],
29	CHZFH4	NN	O	chzfh4	agent	22	SENT_26	[p1l367t3429r702b3506],
30	?	.	O	?	_	0	SENT_26	[p1l367t3429r702b3506],

1	Clinical	JJ	O	clinical	amod	2	SENT_27	[p1l755t3436r1028b3494],
2	studies	NNS	O	study	nsubj	5	SENT_27	[p1l1082t3436r1322b3494],
3	have	VBP	O	have	aux	5	SENT_27	[p1l1374t3436r1539b3494],
4	clearly	RB	O	clearly	advmod	5	SENT_27	[p1l1592t3436r1825b3512],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_27	[p1l1875t3436r2148b3494, p1l10t3532r247b3590],
6	the	DT	O	the	det	7	SENT_27	[p1l272t3532r384b3590],
7	interest	NN	O	interest	dobj	5	SENT_27	[p1l412t3535r677b3590],
8	of	IN	O	of	_	0	SENT_27	[p1l703t3532r775b3590],
9	this	DT	O	this	det	10	SENT_27	[p1l796t3532r926b3590],
10	association	NN	O	association	prep_of	7	SENT_27	[p1l953t3535r1344b3590],
11	allowing	VBG	O	allow	_	0	SENT_27	[p1l1371t3532r1676b3608],
12	improved	VBN	O	improve	amod	15	SENT_27	[p1l1701t3532r2041b3608],
13	TS	NN	O	t	nn	15	SENT_27	[p1l2065t3534r2148b3590],
14	inhibition	NN	O	inhibition	nn	15	SENT_27	[p1l9t3619r423b3684],
15	.3	NN	NUMBER	.3	prep_allowing	10	SENT_27	[p1l9t3619r423b3684],

1	Despite	IN	O	despite	_	0	SENT_28	[p2l86t29r346b102],
2	the	DT	O	the	det	5	SENT_28	[p2l377t26r489b84],
3	improved	JJ	O	improved	amod	5	SENT_28	[p2l520t26r861b102],
4	response	NN	O	response	nn	5	SENT_28	[p2l890t43r1196b102],
5	rates	NNS	O	rate	prep_despite	18	SENT_28	[p2l1226t33r1388b84],
6	with	IN	O	with	_	0	SENT_28	[p2l1417t26r1578b84],
7	the	DT	O	the	det	8	SENT_28	[p2l1608t26r1721b84],
8	addition	NN	O	addition	prep_with	5	SENT_28	[p2l1752t26r2051b84],
9	of	IN	O	of	_	0	SENT_28	[p2l2081t26r2153b84],
10	oxaliplatin	NN	O	oxaliplatin	prep_of	8	SENT_28	[p2l9t120r393b196],
11	or	CC	O	or	_	0	SENT_28	[p2l441t137r513b178],
12	irinotecan	NN	O	irinotecan	conj_or	10	SENT_28	[p2l559t123r939b191],
13	,	,	O	,	_	0	SENT_28	[p2l559t123r939b191],
14	5-FU	NN	O	5-fu	nsubj	18	SENT_28	[p2l994t123r1157b178],
15	remains	VBZ	O	remain	cop	18	SENT_28	[p2l1205t123r1485b178],
16	a	DT	O	a	det	18	SENT_28	[p2l1534t137r1569b178],
17	major	JJ	O	major	amod	18	SENT_28	[p2l1616t123r1824b196],
18	drug	NN	O	drug	_	0	SENT_28	[p2l1871t120r2032b196],
19	in	IN	O	in	_	0	SENT_28	[p2l2078t123r2149b177],
20	treatment	NN	O	treatment	prep_in	18	SENT_28	[p2l8t221r359b272],
21	of	IN	O	of	_	0	SENT_28	[p2l395t214r467b272],
22	CRC	NN	O	crc	prep_of	20	SENT_28	[p2l500t207r712b272],
23	.4	CD	NUMBER	.4	num	22	SENT_28	[p2l500t207r712b272],
24	However	RB	O	however	advmod	28	SENT_28	[p2l749t216r1074b284],
25	,	,	O	,	_	0	SENT_28	[p2l749t216r1074b284],
26	many	JJ	O	many	amod	27	SENT_28	[p2l1115t231r1318b290],
27	questions	NNS	O	question	nsubj	28	SENT_28	[p2l1352t217r1689b290],
28	persist	VBP	O	persist	rcmod	22	SENT_28	[p2l1725t217r1951b290],
29	such	JJ	O	such	prep	28	SENT_28	[p2l1988t214r2148b272],
30	as	IN	O	as	prep	29	SENT_28	[p2l9t326r93b367],
31	:	:	O	:	_	0	SENT_28	[p2l9t326r93b367],
32	how	WRB	O	how	advmod	35	SENT_28	[p2l133t309r288b367],
33	can	MD	O	can	aux	35	SENT_28	[p2l323t326r445b367],
34	we	PRP	O	we	nsubj	35	SENT_28	[p2l479t326r575b367],
35	enhance	VB	O	enhance	dep	22	SENT_28	[p2l613t309r911b367],
36	the	DT	O	the	det	38	SENT_28	[p2l948t309r1060b367],
37	response	NN	O	response	nn	38	SENT_28	[p2l1097t326r1402b385],
38	rate	NN	O	rate	dobj	35	SENT_28	[p2l1439t317r1570b367],
39	and	CC	O	and	_	0	SENT_28	[p2l1608t309r1739b367],
40	efficacy	NN	O	efficacy	dobj	35	SENT_28	[p2l1776t309r2045b385],
41	in	IN	O	in	_	0	SENT_28	[p2l2078t312r2149b366],
42	terms	NNS	O	term	prep_in	38	SENT_28	[p2l8t412r204b462],
43	of	IN	O	of	_	0	SENT_28	[p2l234t404r305b462],
44	survival	NN	O	survival	prep_of	42	SENT_28	[p2l332t404r640b462],
45	?	.	O	?	_	0	SENT_28	[p2l332t404r640b462],

1	How	WRB	O	how	advmod	4	SENT_29	[p2l670t407r835b462],
2	can	MD	O	can	aux	4	SENT_29	[p2l863t421r985b462],
3	we	PRP	O	we	nsubj	4	SENT_29	[p2l1012t421r1108b462],
4	improve	VB	O	improve	_	0	SENT_29	[p2l1137t407r1430b480],
5	tolerance	NN	O	tolerance	dobj	4	SENT_29	[p2l1460t405r1805b475],
6	,	,	O	,	_	0	SENT_29	[p2l1460t405r1805b475],
7	knowing	VBG	O	know	partmod	4	SENT_29	[p2l1838t404r2150b480],
8	that	IN	O	that	complm	12	SENT_29	[p2l8t500r152b558],
9	treatment	NN	O	treatment	nn	10	SENT_29	[p2l188t507r539b558],
10	efficacy	NN	O	efficacy	nsubjpass	12	SENT_29	[p2l576t500r845b576],
11	is	VBZ	O	be	auxpass	12	SENT_29	[p2l879t503r930b558],
12	correlated	VBN	O	correlate	ccomp	7	SENT_29	[p2l968t500r1320b558],
13	to	TO	O	to	_	0	SENT_29	[p2l1357t507r1426b558],
14	the	DT	O	the	det	16	SENT_29	[p2l1463t500r1576b558],
15	5-FU	NN	O	5-fu	nn	16	SENT_29	[p2l1616t502r1779b558],
16	dose	NN	O	dose	prep_to	12	SENT_29	[p2l1816t500r1990b570],
17	,	,	O	,	_	0	SENT_29	[p2l1816t500r1990b570],
18	but	CC	O	but	_	0	SENT_29	[p2l2030t500r2149b558],
19	dose-intensification	NN	O	dose-intensification	nn	20	SENT_29	[p2l9t594r712b652],
20	strategies	NNS	O	strategy	nsubj	21	SENT_29	[p2l755t598r1079b670],
21	increase	VBP	O	increase	conj_but	12	SENT_29	[p2l1120t598r1403b652],
22	toxicity	NN	O	toxicity	dobj	21	SENT_29	[p2l1445t594r1749b670],
23	?	.	O	?	_	0	SENT_29	[p2l1445t594r1749b670],

1	Moreover	RB	O	moreover	advmod	26	SENT_30	[p2l1790t597r2144b665],
2	,	,	O	,	_	0	SENT_30	[p2l1790t597r2144b665],
3	these	DT	O	these	det	5	SENT_30	[p2l8t690r190b748],
4	toxic	JJ	O	toxic	amod	5	SENT_30	[p2l215t693r391b748],
5	side	NN	O	side	nsubj	26	SENT_30	[p2l417t690r549b748],
6	effects	NNS	O	effect	dep	5	SENT_30	[p2l575t690r815b760],
7	,	,	O	,	_	0	SENT_30	[p2l575t690r815b760],
8	around	IN	O	around	advmod	5	SENT_30	[p2l845t690r1098b748],
9	20-25	CD	PERCENT	20-25	num	10	SENT_30	[p2l1123t692r1401b748],
10	%	NN	PERCENT	%	pobj	8	SENT_30	[p2l1123t692r1401b748],
11	grade	NN	O	grade	dep	5	SENT_30	[p2l1425t690r1614b766],
12	3	CD	NUMBER	3	num	11	SENT_30	[p2l1641t692r1677b748],
13	and	CC	O	and	_	0	SENT_30	[p2l1704t690r1836b748],
14	4	CD	NUMBER	4	num	15	SENT_30	[p2l1860t692r1898b747],
15	events	NNS	O	event	nsubj	26	SENT_30	[p2l1924t697r2148b748],
16	with	IN	O	with	_	0	SENT_30	[p2l7t785r168b843],
17	current	JJ	DATE	current	amod	19	SENT_30	[p2l211t792r468b843],
18	5-FU	NN	O	5-fu	nn	19	SENT_30	[p2l511t788r675b843],
19	regimens	NNS	O	regimen	prep_with	15	SENT_30	[p2l717t788r1038b861],
20	and	CC	O	and	_	0	SENT_30	[p2l1082t785r1213b843],
21	0.2	CD	PERCENT	0.2	number	22	SENT_30	[p2l1255t787r1431b843],
22	%	NN	PERCENT	%	amod	24	SENT_30	[p2l1255t787r1431b843],
23	toxic	JJ	O	toxic	amod	24	SENT_30	[p2l1473t788r1649b843],
24	deaths	NNS	O	death	nsubj	26	SENT_30	[p2l1692t785r1920b843],
25	often	RB	O	often	advmod	26	SENT_30	[p2l1964t785r2149b843],
26	occur	VBP	O	occur	_	0	SENT_30	[p2l9t896r203b937],
27	in	IN	O	in	_	0	SENT_30	[p2l233t883r303b937],
28	patients	NNS	O	patient	prep_in	26	SENT_30	[p2l335t883r617b955],
29	in	IN	O	in	_	0	SENT_30	[p2l650t883r720b937],
30	adjuvant	JJ	O	adjuvant	amod	31	SENT_30	[p2l753t880r1065b955],
31	situations	NNS	O	situation	prep_in	28	SENT_30	[p2l1098t883r1460b949],
32	;	:	O	;	_	0	SENT_30	[p2l1098t883r1460b949],
33	many	JJ	O	many	nsubjpass	39	SENT_30	[p2l1496t896r1699b955],
34	of	IN	O	of	_	0	SENT_30	[p2l1729t879r1801b937],
35	them	PRP	O	they	prep_of	33	SENT_30	[p2l1828t880r2014b937],
36	are	VBP	O	be	auxpass	39	SENT_30	[p2l2046t896r2147b937],
37	either	RB	O	either	advmod	39	SENT_30	[p2l9t975r215b1033],
38	already	RB	O	already	advmod	39	SENT_30	[p2l249t975r505b1051],
39	cured	VBN	O	cure	parataxis	26	SENT_30	[p2l539t975r733b1033],
40	by	IN	O	by	_	0	SENT_30	[p2l765t975r853b1051],
41	surgery	NN	O	surgery	agent	39	SENT_30	[p2l887t992r1144b1051],
42	before	IN	O	before	_	0	SENT_30	[p2l1174t975r1394b1033],
43	chemotherapy	NN	O	chemotherapy	prep_before	41	SENT_30	[p2l1430t975r1956b1051],
44	,	,	O	,	_	0	SENT_30	[p2l1430t975r1956b1051],
45	30	CD	PERCENT	30	num	46	SENT_30	[p2l1997t977r2149b1033],
46	%	NN	PERCENT	%	conj_and	41	SENT_30	[p2l1997t977r2149b1033],
47	in	IN	O	in	_	0	SENT_30	[p2l9t1072r79b1126],
48	pT3N1	NN	O	pt3n1	prep_in	46	SENT_30	[p2l126t1071r359b1145],
49	and	CC	O	and	_	0	SENT_30	[p2l414t1069r545b1127],
50	70	CD	PERCENT	70	num	51	SENT_30	[p2l598t1071r745b1127],
51	%	NN	PERCENT	%	agent	39	SENT_30	[p2l598t1071r745b1127],
52	in	IN	O	in	_	0	SENT_30	[p2l794t1072r864b1126],
53	pT3N0	NN	O	pt3n0	nn	54	SENT_30	[p2l912t1071r1150b1145],
54	stages	NNS	O	stage	prep_in	51	SENT_30	[p2l1201t1077r1422b1145],
55	,	,	O	,	_	0	SENT_30	[p2l1201t1077r1422b1145],
56	or	CC	O	or	_	0	SENT_30	[p2l1476t1086r1547b1127],
57	can	MD	O	can	aux	58	SENT_30	[p2l1594t1086r1716b1127],
58	receive	VB	O	receive	conj_or	39	SENT_30	[p2l1765t1072r2008b1127],
59	no	DT	O	no	det	60	SENT_30	[p2l2057t1086r2148b1127],
60	benefit	NN	O	benefit	dobj	58	SENT_30	[p2l6t1164r255b1221],
61	from	IN	O	from	_	0	SENT_30	[p2l285t1164r454b1221],
62	treatment	NN	O	treatment	prep_from	58	SENT_30	[p2l483t1171r852b1221],
63	.	.	O	.	_	0	SENT_30	[p2l483t1171r852b1221],

1	To	TO	O	to	aux	2	SENT_31	[p2l83t1262r168b1317],
2	answer	VB	O	answer	purpcl	9	SENT_31	[p2l213t1276r458b1317],
3	these	DT	O	these	det	4	SENT_31	[p2l501t1259r683b1317],
4	questions	NNS	O	question	dobj	2	SENT_31	[p2l728t1262r1083b1335],
5	,	,	O	,	_	0	SENT_31	[p2l728t1262r1083b1335],
6	several	JJ	O	several	amod	8	SENT_31	[p2l1133t1259r1370b1317],
7	new	JJ	O	new	amod	8	SENT_31	[p2l1414t1276r1562b1317],
8	approaches	NNS	O	approach	nsubj	9	SENT_31	[p2l1604t1259r2001b1335],
9	are	VBP	O	be	_	0	SENT_31	[p2l2046t1276r2147b1317],
10	under	IN	O	under	_	0	SENT_31	[p2l7t1355r217b1412],
11	investigation	NN	O	investigation	prep_under	9	SENT_31	[p2l249t1357r730b1430],
12	,	,	O	,	_	0	SENT_31	[p2l249t1357r730b1430],
13	such	JJ	O	such	_	0	SENT_31	[p2l770t1354r931b1412],
14	as	IN	O	as	_	0	SENT_31	[p2l965t1371r1029b1412],
15	pharmacogenomics	NNS	O	pharmacogenomic	prep_such_as	11	SENT_31	[p2l1063t1354r1777b1430],
16	,	,	O	,	_	0	SENT_31	[p2l1063t1354r1777b1430],
17	by	IN	O	by	_	0	SENT_31	[p2l1814t1354r1902b1430],
18	analyzing	VBG	O	analyze	prepc_by	9	SENT_31	[p2l1933t1354r2147b1430, p2l8t1453r158b1526],
19	tumor	NN	O	tumor	nn	20	SENT_31	[p2l214t1457r435b1508],
20	tissue	NN	O	tissue	dobj	18	SENT_31	[p2l492t1453r705b1520],
21	,	,	O	,	_	0	SENT_31	[p2l492t1453r705b1520],
22	with	IN	O	with	_	0	SENT_31	[p2l767t1450r928b1508],
23	microarrays	NNS	O	microarray	prep_with	20	SENT_31	[p2l986t1453r1419b1526],
24	,	,	O	,	_	0	SENT_31	[p2l986t1453r1419b1526],
25	for	IN	O	for	_	0	SENT_31	[p2l1483t1450r1581b1508],
26	example	NN	O	example	prep_for	18	SENT_31	[p2l1638t1450r1954b1526],
27	.	.	O	.	_	0	SENT_31	[p2l1638t1450r1954b1526],

1	The	DT	O	the	det	2	SENT_32	[p2l2015t1450r2148b1508],
2	problem	NN	O	problem	nsubj	9	SENT_32	[p2l8t1545r305b1620],
3	with	IN	O	with	_	0	SENT_32	[p2l360t1545r521b1602],
4	pharmacogenomics	NNS	O	pharmacogenomic	prep_with	2	SENT_32	[p2l577t1545r1273b1620],
5	is	VBZ	O	be	cop	9	SENT_32	[p2l1330t1548r1380b1602],
6	the	DT	O	the	det	9	SENT_32	[p2l1437t1545r1550b1602],
7	generally	RB	O	generally	advmod	8	SENT_32	[p2l1607t1545r1933b1620],
8	high	JJ	O	high	amod	9	SENT_32	[p2l1987t1545r2148b1620],
9	number	NN	O	number	_	0	SENT_32	[p2l9t1640r288b1697],
10	of	IN	O	of	_	0	SENT_32	[p2l330t1639r401b1697],
11	genes	NNS	O	gene	prep_of	9	SENT_32	[p2l438t1656r633b1715],
12	requiring	VBG	O	require	partmod	11	SENT_32	[p2l676t1643r1003b1715],
13	bioinformatic	JJ	O	bioinformatic	amod	14	SENT_32	[p2l1042t1639r1532b1697],
14	study	NN	O	study	dobj	12	SENT_32	[p2l1575t1640r1768b1715],
15	that	WDT	O	that	nsubj	18	SENT_32	[p2l1806t1640r1950b1697],
16	does	VBZ	O	do	aux	18	SENT_32	[p2l1992t1640r2148b1697],
17	not	RB	O	not	neg	18	SENT_32	[p2l9t1742r129b1793],
18	make	VB	O	make	rcmod	14	SENT_32	[p2l158t1735r345b1793],
19	it	PRP	O	it	nsubj	21	SENT_32	[p2l376t1738r425b1793],
20	technically	RB	O	technically	advmod	21	SENT_32	[p2l454t1735r848b1811],
21	suitable	JJ	O	suitable	xcomp	18	SENT_32	[p2l877t1735r1147b1793],
22	for	IN	O	for	_	0	SENT_32	[p2l1177t1735r1276b1793],
23	routine	JJ	O	routine	amod	24	SENT_32	[p2l1304t1738r1562b1793],
24	work	NN	O	work	prep_for	21	SENT_32	[p2l1591t1735r1785b1793],
25	.	.	O	.	_	0	SENT_32	[p2l1591t1735r1785b1793],

1	Another	DT	O	another	det	3	SENT_33	[p2l84t1830r377b1887],
2	research	NN	O	research	nn	3	SENT_33	[p2l439t1830r729b1887],
3	approach	NN	O	approach	nsubj	5	SENT_33	[p2l792t1830r1120b1905],
4	is	VBZ	O	be	cop	5	SENT_33	[p2l1183t1833r1234b1887],
5	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_33	[p2l1297t1830r1942b1905],
6	that	WDT	O	that	nsubj	7	SENT_33	[p2l2005t1830r2149b1887],
7	focuses	VBZ	O	focus	rcmod	5	SENT_33	[p2l9t1925r261b1983],
8	on	IN	O	on	_	0	SENT_33	[p2l296t1942r387b1983],
9	the	DT	O	the	det	10	SENT_33	[p2l421t1925r533b1983],
10	effects	NNS	O	effect	prep_on	7	SENT_33	[p2l569t1925r789b1983],
11	of	IN	O	of	_	0	SENT_33	[p2l825t1925r897b1983],
12	polymorphisms	NNS	O	polymorphism	nn	13	SENT_33	[p2l925t1925r1482b2001],
13	(	NN	O	(	prep_of	10	SENT_33	[p2l1520t1925r1887b2001],
14	especially	RB	O	especially	advmod	17	SENT_33	[p2l1520t1925r1887b2001],
15	singlenucleotide	JJ	O	singlenucleotide	amod	16	SENT_33	[p2l1920t1925r2148b2001, p2l9t2019r383b2077],
16	polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_33	[p2l442t2019r998b2095],
17	(	VBP	O	(	ccomp	7	SENT_33	[p2l1060t2019r1305b2092],
18	SNPs	NNS	O	snp	nsubj	20	SENT_33	[p2l1060t2019r1305b2092],
19	)	CD	NUMBER	)	num	20	SENT_33	[p2l1060t2019r1305b2092],
20	)	NN	O	)	xcomp	17	SENT_33	[p2l1060t2019r1305b2092],
21	in	IN	O	in	_	0	SENT_33	[p2l1366t2022r1437b2076],
22	drug-metabolizing	JJ	O	drug-metabolizing	amod	23	SENT_33	[p2l1495t2019r2149b2095],
23	enzymes	NNS	O	enzyme	prep_in	20	SENT_33	[p2l9t2132r313b2191],
24	and	CC	O	and	_	0	SENT_33	[p2l346t2115r478b2173],
25	in	IN	O	in	_	0	SENT_33	[p2l510t2118r580b2172],
26	drug	NN	O	drug	nn	27	SENT_33	[p2l613t2115r774b2191],
27	targets	NNS	O	target	conj_and	23	SENT_33	[p2l805t2122r1057b2191],
28	.	.	O	.	_	0	SENT_33	[p2l805t2122r1057b2191],

1	It	PRP	O	it	nsubj	3	SENT_34	[p2l1094t2117r1146b2173],
2	could	MD	O	could	aux	3	SENT_34	[p2l1178t2115r1374b2173],
3	enable	VB	O	enable	_	0	SENT_34	[p2l1407t2115r1636b2173],
4	the	DT	O	the	det	5	SENT_34	[p2l1669t2115r1782b2173],
5	discovery	NN	O	discovery	dobj	3	SENT_34	[p2l1816t2115r2151b2191],
6	of	IN	O	of	_	0	SENT_34	[p2l9t2209r81b2267],
7	the	DT	O	the	det	13	SENT_34	[p2l104t2209r217b2267],
8	best-tolerated	JJ	O	best-tolerated	amod	13	SENT_34	[p2l244t2209r729b2267],
9	and	CC	O	and	_	0	SENT_34	[p2l758t2209r889b2267],
10	most	RBS	O	most	advmod	11	SENT_34	[p2l917t2217r1092b2267],
11	effective	JJ	O	effective	amod	13	SENT_34	[p2l1120t2209r1414b2267],
12	treatment	NN	O	treatment	nn	13	SENT_34	[p2l1444t2217r1794b2267],
13	strategies	NNS	O	strategy	prep_of	5	SENT_34	[p2l1824t2212r2148b2285],

1	AFUrd	NN	O	afurd	_	0	SENT_35	[p2l414t2443r556b2524],
2	R	NN	O	r	nn	3	SENT_35	[p2l571t2439r765b2500],
3	[	NN	O	[	dep	1	SENT_35	[p2l571t2439r765b2500],
4	+	CC	O	+	_	0	SENT_35	[p2l571t2439r765b2500],
5	F	NN	O	f	nn	6	SENT_35	[p2l781t2443r1126b2492],
6	|	NN	O	|	dep	1	SENT_35	[p2l781t2443r1126b2492],
7	.	.	O	.	_	0	SENT_35	[p2l781t2443r1126b2492],

1	.	.	O	.	_	0	SENT_36	[p2l781t2443r1126b2492],

1	lMP	NN	O	lmp	_	0	SENT_37	[p2l781t2443r1126b2492],
2	:	:	O	:	_	0	SENT_37	[p2l781t2443r1126b2492],
3	*	CD	NUMBER	*	num	4	SENT_37	[p2l781t2443r1126b2492],
4	FUDP	NN	O	fudp	dep	1	SENT_37	[p2l1151t2447r1508b2496],
5	—	CD	NUMBER	—	number	6	SENT_37	[p2l1151t2447r1508b2496],
6	*	CD	NUMBER	*	dep	4	SENT_37	[p2l1151t2447r1508b2496],
7	~	NN	O	~	nn	12	SENT_37	[p2l1151t2447r1508b2496],
8	FTUTP	NN	O	ftutp	nn	12	SENT_37	[p2l1548t2443r1712b2496],
9	j	NN	O	j	nn	12	SENT_37	[p2l1733t2459r1868b2480],
10	“	CD	NUMBER	“	num	12	SENT_37	[p2l1733t2459r1868b2480],
11	RN33	NN	O	rn33	nn	12	SENT_37	[p2l1946t2447r2106b2500],
12	‘	NN	O	‘	dep	6	SENT_37	[p2l1946t2447r2106b2500],
13	.	.	O	.	_	0	SENT_37	[p2l1946t2447r2106b2500],

1	`	``	O	`	_	0	SENT_38	[p2l51t2582r240b2774],
2	R	NN	O	r	_	0	SENT_38	[p2l51t2582r240b2774],
3	[	NN	O	[	dep	2	SENT_38	[p2l51t2582r240b2774],
4	+	CC	O	+	_	0	SENT_38	[p2l51t2582r240b2774],
5	<	JJR	O	<	dep	2	SENT_38	[p2l285t2508r420b2758],
6	\	CD	NUMBER	\	dep	2	SENT_38	[p2l1216t2508r1266b2737],

1	w	NN	O	w	nn	3	SENT_39	[p2l281t2791r309b2815],
2	R	NN	O	r	nn	3	SENT_39	[p2l281t2791r309b2815],
3	[	NN	O	[	_	0	SENT_39	[p2l281t2791r309b2815],
4	+	CC	O	+	_	0	SENT_39	[p2l281t2791r309b2815],
5	w	NN	O	w	nn	6	SENT_39	[p2l338t2791r350b2795],
6	Fdurd	NN	O	fdurd	conj_+	3	SENT_39	[p2l424t2758r597b2807],
7	߶	CD	NUMBER	߶	num	9	SENT_39	[p2l608t2742r785b2823],
8	R	NN	O	r	nn	9	SENT_39	[p2l608t2742r785b2823],
9	[	NN	O	[	dep	3	SENT_39	[p2l608t2742r785b2823],
10	+	CC	O	+	_	0	SENT_39	[p2l608t2742r785b2823],
11	_	NN	O	_	dep	3	SENT_39	[p2l1044t2782r1163b2803],
12	.	.	O	.	_	0	SENT_39	[p2l1044t2782r1163b2803],

1	FdunP	NN	O	fdunp	_	0	SENT_40	[p2l1187t2758r1545b2807],
2	»	NN	O	»	dep	1	SENT_40	[p2l1187t2758r1545b2807],
3	.	.	O	.	_	0	SENT_40	[p2l1187t2758r1545b2807],

1	—	NN	O	—	_	0	SENT_41	[p2l1187t2758r1545b2807],
2	.	.	O	.	_	0	SENT_41	[p2l1187t2758r1545b2807],

1	.	.	O	.	_	0	SENT_42	[p2l1187t2758r1545b2807],

1	Fi	NNP	O	Fi	_	0	SENT_43	[p2l1569t2758r1776b2823],
2	:	:	O	:	_	0	SENT_43	[p2l1569t2758r1776b2823],
3	lLlTPp	NN	O	llltpp	dep	1	SENT_43	[p2l1569t2758r1776b2823],

1	FUH	NNP	O	FUH	_	0	SENT_44	[p2l121t2934r268b2999],
2	?	.	O	?	_	0	SENT_44	[p2l121t2934r268b2999],

1	Main	NNP	O	Main	nn	2	SENT_45	[p2l912t2897r1069b2950],
2	Way	NNP	O	Way	_	0	SENT_45	[p2l1097t2897r1237b2963],
3	gm,-1	NN	O	gm,-1	dep	2	SENT_45	[p2l1913t2917r2073b2971],

1	F-UPA	NN	O	f-upa	nn	2	SENT_46	[p2l121t3122r305b3173],
2	uuwle	NN	O	uuwle	_	0	SENT_46	[p2l518t3119r691b3172],
3	R	NN	O	r	nn	4	SENT_46	[p2l764t3094r887b3193],
4	[	NN	O	[	dep	2	SENT_46	[p2l764t3094r887b3193],
5	+	CC	O	+	rcmod	4	SENT_46	[p2l764t3094r887b3193],
6	.	.	O	.	_	0	SENT_46	[p2l939t3152r945b3156],

1	cl1rwIP	NN	O	cl1rwip	_	0	SENT_47	[p2l978t3119r1315b3173],
2	—	SYM	O	—	prep	1	SENT_47	[p2l978t3119r1315b3173],
3	-	:	O	-	_	0	SENT_47	[p2l978t3119r1315b3173],
4	d'TI	NN	O	d'tus	dep	2	SENT_47	[p2l1339t3118r1635b3173],
5	,	,	O	,	_	0	SENT_47	[p2l1339t3118r1635b3173],
6	]	CD	NUMBER	]	num	7	SENT_47	[p2l1339t3118r1635b3173],
7	F	NN	O	f	appos	4	SENT_47	[p2l1339t3118r1635b3173],
8	'	''	O	'	_	0	SENT_47	[p2l1339t3118r1635b3173],
9	.	.	O	.	_	0	SENT_47	[p2l1339t3118r1635b3173],

1	—	NN	O	—	_	0	SENT_48	[p2l1339t3118r1635b3173],
2	.	.	O	.	_	0	SENT_48	[p2l1339t3118r1635b3173],

1	-	:	O	-	_	0	SENT_49	[p2l1339t3118r1635b3173],
2	ﬁll	NN	O	ﬁll	_	0	SENT_49	[p2l1339t3118r1635b3173],
3	TTP	NN	O	ttp	dep	2	SENT_49	[p2l1638t3091r1757b3173],

1	l	NN	O	l	_	0	SENT_50	[p2l183t3189r207b3308],
2	R	NN	O	r	nn	3	SENT_50	[p2l592t3230r797b3324],
3	[	NN	O	[	dep	1	SENT_50	[p2l592t3230r797b3324],
4	+	CC	O	+	rcmod	3	SENT_50	[p2l592t3230r797b3324],

1	at	IN	O	at	_	0	SENT_51	[p2l1246t3447r1335b3533],
2	Thymine	NNP	O	Thymine	pobj	1	SENT_51	[p2l1643t3480r1885b3541],

1	Hoinao-cysteine	JJ	O	hoinao-cysteine	amod	5	SENT_52	[p3l47t138r444b199],
2	~	NN	O	~	nn	5	SENT_52	[p3l494t168r499b170],
3	~	NN	O	~	nn	5	SENT_52	[p3l830t168r846b170],
4	Methionine	NN	O	methionine	nn	5	SENT_52	[p3l928t138r1233b187],
5	p	NN	O	p	_	0	SENT_52	[p3l1274t154r1585b179],
6	:	:	O	:	_	0	SENT_52	[p3l1274t154r1585b179],
7	+	CC	O	+	cc	8	SENT_52	[p3l1274t154r1585b179],
8	DNA	NN	O	dna	dep	5	SENT_52	[p3l1630t138r1758b187],
9	metiwlatintn	NN	O	metiwlatintn	dep	8	SENT_52	[p3l1782t138r2098b199],

1	Figure	NNP	O	Figure	nn	3	SENT_53	[p3l12t340r204b407],
2	1	CD	NUMBER	1	num	3	SENT_53	[p3l229t341r250b390],
3	5-FU	NN	O	5-fu	_	0	SENT_53	[p3l329t341r463b391],
4	metabolic	JJ	O	metabolic	amod	5	SENT_53	[p3l489t339r779b391],
5	pathways	NNS	O	pathway	dep	3	SENT_53	[p3l802t339r1097b407],
6	.	.	O	.	_	0	SENT_53	[p3l802t339r1097b407],

1	5-FU	NN	O	5-fu	_	0	SENT_54	[p3l1120t341r1273b402],
2	,	,	O	,	_	0	SENT_54	[p3l1120t341r1273b402],
3	5-fluorouracil	NN	O	5-fluorouracil	appos	1	SENT_54	[p3l1297t339r1708b402],
4	;	:	O	;	_	0	SENT_54	[p3l1297t339r1708b402],
5	5-10	CD	NUMBER	5-10	dep	1	SENT_54	[p3l1732t341r1878b391],
6	CHZFH4	NN	O	chzfh4	rcmod	5	SENT_54	[p3l1900t341r2145b402],
7	,	,	O	,	_	0	SENT_54	[p3l1900t341r2145b402],
8	5-10	CD	NUMBER	5-10	appos	6	SENT_54	[p3l9t426r155b476],
9	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	rcmod	8	SENT_54	[p3l191t424r1000b492],
10	;	:	O	;	_	0	SENT_54	[p3l191t424r1000b492],
11	5-CH3FH4	NN	O	5-ch3fh4	rcmod	9	SENT_54	[p3l1037t426r1344b487],
12	,	,	O	,	_	0	SENT_54	[p3l1037t426r1344b487],
13	5-methyltetrahydrofolate	NN	O	5-methyltetrahydrofolate	appos	11	SENT_54	[p3l1382t424r2145b492],
14	;	:	O	;	_	0	SENT_54	[p3l1382t424r2145b492],
15	FH4	NN	O	fh4	rcmod	13	SENT_54	[p3l12t510r130b570],
16	,	,	O	,	_	0	SENT_54	[p3l12t510r130b570],
17	tetrahydrofolate	NN	O	tetrahydrofolate	appos	15	SENT_54	[p3l218t507r712b575],
18	;	:	O	;	_	0	SENT_54	[p3l218t507r712b575],
19	dUMP	NN	O	dump	dep	15	SENT_54	[p3l800t507r999b570],
20	,	,	O	,	_	0	SENT_54	[p3l800t507r999b570],
21	deoxyuridine	NN	O	deoxyuridine	appos	15	SENT_54	[p3l1087t507r1475b575],
22	5	CD	NUMBER	5	dep	21	SENT_54	[p3l1560t506r2145b575],
23	’	SYM	O	’	dep	15	SENT_54	[p3l1560t506r2145b575],
24	-	:	O	-	_	0	SENT_54	[p3l1560t506r2145b575],
25	monophosphate	NN	O	monophosphate	dep	13	SENT_54	[p3l1560t506r2145b575],
26	;	:	O	;	_	0	SENT_54	[p3l1560t506r2145b575],
27	dTMP	NN	O	dtmp	dep	25	SENT_54	[p3l9t592r199b654],
28	,	,	O	,	_	0	SENT_54	[p3l9t592r199b654],
29	deoxythymidine	NN	O	deoxythymidine	appos	11	SENT_54	[p3l255t592r738b659],
30	5	CD	NUMBER	5	dep	29	SENT_54	[p3l791t590r1376b659],
31	’	SYM	O	’	dep	11	SENT_54	[p3l791t590r1376b659],
32	-	:	O	-	_	0	SENT_54	[p3l791t590r1376b659],
33	monophosphate	NN	O	monophosphate	dep	9	SENT_54	[p3l791t590r1376b659],
34	;	:	O	;	_	0	SENT_54	[p3l791t590r1376b659],
35	dTDP	NN	O	dtdp	dep	33	SENT_54	[p3l1432t592r1609b654],
36	,	,	O	,	_	0	SENT_54	[p3l1432t592r1609b654],
37	deoxythymidine	NN	O	deoxythymidine	appos	35	SENT_54	[p3l1665t592r2148b659],
38	5	CD	NUMBER	5	num	37	SENT_54	[p3l9t675r472b744],
39	’	SYM	O	’	dep	9	SENT_54	[p3l9t675r472b744],
40	-	:	O	-	_	0	SENT_54	[p3l9t675r472b744],
41	diphosphate	NN	O	diphosphate	dep	8	SENT_54	[p3l9t675r472b744],
42	;	:	O	;	_	0	SENT_54	[p3l9t675r472b744],
43	dTTP	NN	O	dttp	dep	41	SENT_54	[p3l508t676r672b739],
44	,	,	O	,	_	0	SENT_54	[p3l508t676r672b739],
45	deoxythymidine	NN	O	deoxythymidine	appos	43	SENT_54	[p3l707t676r1190b744],
46	5	CD	NUMBER	5	num	45	SENT_54	[p3l1222t675r1692b744],
47	’	SYM	O	’	dep	6	SENT_54	[p3l1222t675r1692b744],
48	-	:	O	-	_	0	SENT_54	[p3l1222t675r1692b744],
49	triphosphate	NN	O	triphosphate	dep	1	SENT_54	[p3l1222t675r1692b744],
50	;	:	O	;	_	0	SENT_54	[p3l1222t675r1692b744],
51	FdUMP	NN	O	fdump	dep	49	SENT_54	[p3l1730t676r1958b739],
52	,	,	O	,	_	0	SENT_54	[p3l1730t676r1958b739],
53	fluorodeoxythymidine	NN	O	fluorodeoxythymidine	appos	1	SENT_54	[p3l1991t676r2148b728, p3l9t759r531b827],
54	5	CD	NUMBER	5	num	53	SENT_54	[p3l562t758r1148b827],
55	’	SYM	O	’	dep	57	SENT_54	[p3l562t758r1148b827],
56	-	:	O	-	_	0	SENT_54	[p3l562t758r1148b827],
57	monophosphate	NN	O	monophosphate	dep	53	SENT_54	[p3l562t758r1148b827],
58	;	:	O	;	_	0	SENT_54	[p3l562t758r1148b827],
59	FUR	NN	O	fur	dep	57	SENT_54	[p3l1184t762r1310b822],
60	,	,	O	,	_	0	SENT_54	[p3l1184t762r1310b822],
61	fluorouracil	NN	O	fluorouracil	appos	57	SENT_54	[p3l1342t759r1694b822],
62	;	:	O	;	_	0	SENT_54	[p3l1342t759r1694b822],
63	FUdR	NN	O	fudr	dep	61	SENT_54	[p3l1731t759r1897b822],
64	,	,	O	,	_	0	SENT_54	[p3l1731t759r1897b822],
65	5fluorodeoxyuridine	NN	O	5fluorodeoxyuridine	appos	63	SENT_54	[p3l1932t759r2148b811, p3l9t845r452b912],
66	;	:	O	;	_	0	SENT_54	[p3l1932t759r2148b811, p3l9t845r452b912],
67	F-BAL	NN	O	f-bal	dep	63	SENT_54	[p3l523t847r700b907],
68	,	,	O	,	_	0	SENT_54	[p3l523t847r700b907],
69	5-fluoro-ﬂ-alanine	NN	O	5-fluoro-ﬂ-alanine	appos	67	SENT_54	[p3l768t845r1315b910],
70	;	:	O	;	_	0	SENT_54	[p3l768t845r1315b910],
71	DPD	NN	ORGANIZATION	dpd	dep	63	SENT_54	[p3l1385t847r1531b907],
72	,	,	O	,	_	0	SENT_54	[p3l1385t847r1531b907],
73	dihydropyrimidine	NN	O	dihydropyrimidine	nn	74	SENT_54	[p3l1598t845r2148b912],
74	dehydrogenase	NN	O	dehydrogenase	appos	71	SENT_54	[p3l9t930r481b997],
75	;	:	O	;	_	0	SENT_54	[p3l9t930r481b997],
76	TS	NN	O	t	dep	63	SENT_54	[p3l509t931r596b992],
77	,	,	O	,	_	0	SENT_54	[p3l509t931r596b992],
78	thymidylate	NN	O	thymidylate	nn	79	SENT_54	[p3l626t930r979b997],
79	synthase	NN	O	synthase	appos	76	SENT_54	[p3l1005t930r1275b997],
80	;	:	O	;	_	0	SENT_54	[p3l1005t930r1275b997],
81	MS	NN	O	m	dep	63	SENT_54	[p3l1308t931r1416b992],
82	,	,	O	,	_	0	SENT_54	[p3l1308t931r1416b992],
83	methionine	NN	O	methionine	nn	84	SENT_54	[p3l1449t930r1786b981],
84	synthetase	NN	O	synthetase	appos	81	SENT_54	[p3l1812t930r2141b997],
85	.	.	O	.	_	0	SENT_54	[p3l1812t930r2141b997],

1	Fluorouracil	NNP	O	Fluorouracil	nn	3	SENT_55	[p3l9t1110r293b1155],
2	outcome	NN	O	outcome	nn	3	SENT_55	[p3l313t1115r524b1155],
3	parameters	NNS	O	parameter	_	0	SENT_55	[p3l543t1115r817b1169],
4	@	IN	O	@	_	0	SENT_55	[p3l2025t1098r2151b1222],
5	O	NNP	O	O	nn	6	SENT_55	[p3l8t1182r42b1223],
6	Capitain	NNP	MISC	Capitain	prep_@	3	SENT_55	[p3l61t1182r229b1236],
7	et	FW	O	et	nn	8	SENT_55	[p3l251t1186r287b1223],
8	al	FW	O	al	dep	3	SENT_55	[p3l303t1181r339b1223],
9	by	IN	O	by	_	0	SENT_55	[p3l6t1469r94b1545],
10	the	DT	O	the	det	11	SENT_55	[p3l143t1469r255b1527],
11	study	NN	O	study	prep_by	8	SENT_55	[p3l309t1469r501b1545],
12	of	IN	O	of	_	0	SENT_55	[p3l551t1469r622b1527],
13	the	DT	O	the	det	15	SENT_55	[p3l669t1469r782b1527],
14	hereditary	JJ	O	hereditary	amod	15	SENT_55	[p3l834t1469r1200b1545],
15	basis	NN	O	basis	prep_of	11	SENT_55	[p3l1247t1469r1414b1527],
16	for	IN	O	for	_	0	SENT_55	[p3l1466t1469r1565b1527],
17	interindividual	JJ	O	interindividual	amod	18	SENT_55	[p3l1615t1469r2148b1527],
18	differences	NNS	O	difference	prep_for	15	SENT_55	[p3l9t1564r389b1622],
19	in	IN	O	in	_	0	SENT_55	[p3l430t1567r501b1621],
20	drug	NN	O	drug	nn	21	SENT_55	[p3l542t1564r703b1640],
21	response	NN	O	response	prep_in	18	SENT_55	[p3l741t1581r1066b1640],
22	.	.	O	.	_	0	SENT_55	[p3l741t1581r1066b1640],

1	In	IN	O	in	_	0	SENT_56	[p3l1111t1566r1184b1621],
2	our	PRP$	O	we	poss	3	SENT_56	[p3l1224t1581r1343b1622],
3	study	NN	O	study	prep_in	6	SENT_56	[p3l1383t1564r1585b1640],
4	,	,	O	,	_	0	SENT_56	[p3l1383t1564r1585b1640],
5	We	PRP	O	we	nsubj	6	SENT_56	[p3l1628t1581r1724b1622],
6	decided	VBD	O	decide	_	0	SENT_56	[p3l1766t1564r2038b1622],
7	to	TO	O	to	aux	8	SENT_56	[p3l2078t1571r2148b1622],
8	focus	VB	O	focus	xcomp	6	SENT_56	[p3l8t1658r191b1716],
9	on	IN	O	on	_	0	SENT_56	[p3l246t1675r337b1716],
10	three	CD	NUMBER	three	prep_on	8	SENT_56	[p3l391t1658r571b1716],
11	previously	RB	DATE	previously	advmod	12	SENT_56	[p3l626t1658r995b1734],
12	studied	VBN	O	study	partmod	10	SENT_56	[p3l1048t1658r1304b1716],
13	enzymes	NNS	O	enzyme	tmod	12	SENT_56	[p3l1358t1675r1661b1734],
14	involved	VBN	O	involve	partmod	13	SENT_56	[p3l1716t1658r2025b1716],
15	in	IN	O	in	_	0	SENT_56	[p3l2078t1661r2148b1715],
16	ﬂuorouracil	NN	O	ﬂuorouracil	nn	17	SENT_56	[p3l8t1753r422b1811],
17	metabolism	NN	O	metabolism	prep_in	14	SENT_56	[p3l452t1753r868b1811],
18	and	CC	O	and	_	0	SENT_56	[p3l899t1754r1030b1811],
19	activity	NN	O	activity	nn	21	SENT_56	[p3l1060t1756r1324b1829],
20	(	CD	NUMBER	(	num	21	SENT_56	[p3l1355t1754r1594b1829],
21	Figure	NN	O	figure	prep_in	14	SENT_56	[p3l1355t1754r1594b1829],
22	1	CD	NUMBER	1	num	23	SENT_56	[p3l1630t1754r1709b1825],
23	)	NN	O	)	dep	13	SENT_56	[p3l1630t1754r1709b1825],
24	.	.	O	.	_	0	SENT_56	[p3l1630t1754r1709b1825],

1	TS	NN	O	t	nsubj	5	SENT_57	[p3l88t1851r169b1907],
2	is	VBZ	O	be	cop	5	SENT_57	[p3l230t1852r281b1907],
3	the	DT	O	the	det	5	SENT_57	[p3l345t1849r458b1907],
4	primary	JJ	O	primary	amod	5	SENT_57	[p3l521t1852r804b1925],
5	target	NN	O	target	_	0	SENT_57	[p3l865t1856r1085b1925],
6	.	.	O	.	_	0	SENT_57	[p3l865t1856r1085b1925],

1	It	PRP	O	it	nsubj	2	SENT_58	[p3l1154t1851r1205b1907],
2	catalyzes	VBZ	O	catalyze	_	0	SENT_58	[p3l1269t1849r1580b1925],
3	the	DT	O	the	det	5	SENT_58	[p3l1644t1849r1756b1907],
4	reductive	JJ	O	reductive	amod	5	SENT_58	[p3l1821t1849r2147b1907],
5	methylation	NN	O	methylation	dobj	2	SENT_58	[p3l8t1943r448b2019],
6	of	IN	O	of	_	0	SENT_58	[p3l487t1943r559b2001],
7	dUMP	NN	O	dump	prep_of	5	SENT_58	[p3l593t1943r812b2001],
8	by	IN	O	by	_	0	SENT_58	[p3l848t1944r936b2019],
9	CHZFH4	NN	O	chzfh4	prep_by	2	SENT_58	[p3l973t1945r1252b2013],
10	to	TO	O	to	aux	11	SENT_58	[p3l1291t1951r1361b2001],
11	form	VB	O	form	xcomp	2	SENT_58	[p3l1400t1943r1569b2001],
12	dNTP	NN	O	dntp	dobj	11	SENT_58	[p3l1609t1944r1802b2001],
13	which	WDT	O	which	nsubj	17	SENT_58	[p3l1838t1944r2059b2001],
14	is	VBZ	O	be	cop	17	SENT_58	[p3l2097t1947r2148b2001],
15	a	DT	O	a	det	17	SENT_58	[p3l9t2056r44b2097],
16	critical	JJ	O	critical	amod	17	SENT_58	[p3l91t2039r330b2097],
17	reaction	NN	O	reaction	rcmod	12	SENT_58	[p3l377t2042r666b2097],
18	for	IN	O	for	_	0	SENT_58	[p3l713t2039r811b2097],
19	cell	NN	O	cell	nn	20	SENT_58	[p3l857t2039r976b2097],
20	proliferation	NN	O	proliferation	prep_for	17	SENT_58	[p3l1021t2039r1487b2115],
21	.	.	O	.	_	0	SENT_58	[p3l1021t2039r1487b2115],

1	The	DT	O	the	det	4	SENT_59	[p3l1536t2039r1669b2097],
2	T	NN	O	t	nn	4	SENT_59	[p3l1719t2041r1770b2096],
3	S	NN	O	s	nn	4	SENT_59	[p3l1764t2041r1800b2097],
4	gene	NN	O	gene	nsubj	8	SENT_59	[p3l1846t2056r2009b2115],
5	on	IN	O	on	_	0	SENT_59	[p3l2057t2056r2149b2097],
6	chromosome	NN	O	chromosome	prep_on	4	SENT_59	[p3l9t2134r471b2192],
7	18	CD	NUMBER	18	num	6	SENT_59	[p3l524t2136r601b2192],
8	contains	VBZ	O	contain	_	0	SENT_59	[p3l648t2137r949b2192],
9	a	DT	O	a	det	15	SENT_59	[p3l996t2151r1031b2192],
10	unique	JJ	O	unique	amod	15	SENT_59	[p3l1074t2137r1323b2210],
11	28-bp	JJ	O	28-bp	amod	15	SENT_59	[p3l1371t2134r1569b2210],
12	tandem	JJ	O	tandem	amod	15	SENT_59	[p3l1616t2134r1887b2192],
13	repeat	NN	O	repeat	nn	15	SENT_59	[p3l1932t2141r2149b2210],
14	sequence	NN	O	sequence	nn	15	SENT_59	[p3l10t2245r330b2304],
15	(	NN	O	(	dobj	8	SENT_59	[p3l361t2229r590b2301],
16	called	VBN	O	call	partmod	15	SENT_59	[p3l361t2229r590b2301],
17	‘	CD	NUMBER	‘	num	18	SENT_59	[p3l618t2229r727b2301],
18	R	NN	O	r	dobj	16	SENT_59	[p3l618t2229r727b2301],
19	’	CD	NUMBER	’	num	20	SENT_59	[p3l618t2229r727b2301],
20	)	NN	O	)	dep	18	SENT_59	[p3l618t2229r727b2301],
21	within	IN	O	within	_	0	SENT_59	[p3l755t2229r990b2286],
22	the	DT	O	the	det	24	SENT_59	[p3l1016t2229r1129b2286],
23	enhancer	NN	O	enhancer	nn	24	SENT_59	[p3l1157t2229r1486b2286],
24	region	NN	O	region	prep_within	20	SENT_59	[p3l1511t2232r1736b2304],
25	(	CD	NUMBER	(	num	27	SENT_59	[p3l1766t2229r1987b2301],
26	TSER	NN	O	tser	nn	27	SENT_59	[p3l1766t2229r1987b2301],
27	)	NN	O	)	dep	24	SENT_59	[p3l1766t2229r1987b2301],
28	and	CC	O	and	_	0	SENT_59	[p3l2018t2229r2148b2286],
29	within	IN	O	within	_	0	SENT_59	[p3l7t2323r242b2381],
30	the	DT	O	the	det	31	SENT_59	[p3l271t2323r383b2381],
31	5	CD	NUMBER	5	prep_within	20	SENT_59	[p3l415t2321r950b2381],
32	’	SYM	O	’	dep	20	SENT_59	[p3l415t2321r950b2381],
33	-	:	O	-	_	0	SENT_59	[p3l415t2321r950b2381],
34	untranslated	JJ	O	untranslated	amod	35	SENT_59	[p3l415t2321r950b2381],
35	region	NN	O	region	dep	18	SENT_59	[p3l978t2326r1221b2399],
36	.	.	O	.	_	0	SENT_59	[p3l978t2326r1221b2399],

1	The	DT	O	the	det	5	SENT_60	[p3l1253t2323r1386b2381],
2	three	CD	NUMBER	three	num	5	SENT_60	[p3l1415t2323r1596b2381],
3	most	RBS	O	most	advmod	4	SENT_60	[p3l1626t2330r1800b2381],
4	common	JJ	O	common	amod	5	SENT_60	[p3l1829t2340r2148b2381],
5	genotypes	NNS	O	genotype	nsubjpass	19	SENT_60	[p3l8t2425r366b2493],
6	in	IN	O	in	_	0	SENT_60	[p3l401t2420r472b2474],
7	the	DT	O	the	det	9	SENT_60	[p3l506t2417r619b2475],
8	Caucasian	JJ	LOCATION	caucasian	amod	9	SENT_60	[p3l656t2419r1014b2475],
9	population	NN	O	population	prep_in	5	SENT_60	[p3l1048t2417r1442b2493],
10	(	CD	NUMBER	(	num	11	SENT_60	[p3l1480t2417r1731b2490],
11	ZR/2R	NN	O	zr/2r	dep	9	SENT_60	[p3l1480t2417r1731b2490],
12	,	,	O	,	_	0	SENT_60	[p3l1480t2417r1731b2490],
13	ZR/3R	NN	O	zr/3r	prep_in	5	SENT_60	[p3l1772t2417r1983b2483],
14	and	CC	O	and	_	0	SENT_60	[p3l2018t2417r2149b2475],
15	3R/3R	NN	O	3r/3r	prep_in	5	SENT_60	[p3l10t2511r242b2583],
16	)	CD	NUMBER	)	num	15	SENT_60	[p3l10t2511r242b2583],
17	have	VBP	O	have	aux	19	SENT_60	[p3l276t2511r442b2569],
18	been	VBN	O	be	auxpass	19	SENT_60	[p3l470t2511r640b2569],
19	identified	VBN	O	identify	_	0	SENT_60	[p3l671t2504r1066b2569],
20	.5	CD	NUMBER	.5	dobj	19	SENT_60	[p3l671t2504r1066b2569],
21	This	DT	O	this	det	24	SENT_60	[p3l1096t2511r1246b2569],
22	tandem	JJ	O	tandem	amod	24	SENT_60	[p3l1277t2511r1548b2569],
23	repeat	NN	O	repeat	nn	24	SENT_60	[p3l1579t2518r1795b2587],
24	sequence	NN	O	sequence	nsubj	25	SENT_60	[p3l1827t2528r2147b2587],
25	appears	VBZ	O	appear	rcmod	20	SENT_60	[p3l9t2623r273b2682],
26	to	TO	O	to	aux	27	SENT_60	[p3l296t2614r366b2664],
27	function	VB	O	function	xcomp	25	SENT_60	[p3l389t2606r694b2664],
28	as	IN	O	as	_	0	SENT_60	[p3l718t2623r783b2664],
29	an	DT	O	a	det	31	SENT_60	[p3l806t2623r891b2664],
30	enhancer	NN	O	enhancer	nn	31	SENT_60	[p3l914t2607r1244b2664],
31	element	NN	O	element	prep_as	27	SENT_60	[p3l1266t2606r1552b2664],
32	on	IN	O	on	_	0	SENT_60	[p3l1575t2623r1666b2664],
33	transcription	NN	O	transcription	prep_on	31	SENT_60	[p3l1688t2609r2148b2682],
34	as	RB	O	as	_	0	SENT_60	[p3l9t2718r74b2759],
35	well	RB	O	well	_	0	SENT_60	[p3l113t2701r257b2759],
36	as	IN	O	as	_	0	SENT_60	[p3l299t2718r364b2759],
37	on	IN	O	on	_	0	SENT_60	[p3l405t2718r496b2759],
38	translation	NN	O	translation	prep_on	27	SENT_60	[p3l536t2701r922b2759],
39	of	IN	O	of	_	0	SENT_60	[p3l963t2701r1034b2759],
40	TS	NN	O	t	nn	41	SENT_60	[p3l1074t2703r1154b2759],
41	mRNA	NN	O	mrna	prep_of	38	SENT_60	[p3l1193t2703r1424b2758],
42	with	IN	O	with	_	0	SENT_60	[p3l1460t2701r1621b2759],
43	an	DT	O	a	det	45	SENT_60	[p3l1662t2718r1747b2759],
44	increasing	VBG	O	increase	amod	45	SENT_60	[p3l1787t2704r2150b2777],
45	number	NN	O	number	prep_with	27	SENT_60	[p3l8t2795r288b2853],
46	of	IN	O	of	_	0	SENT_60	[p3l309t2795r380b2853],
47	repeat	NN	O	repeat	nn	48	SENT_60	[p3l398t2802r615b2871],
48	sequences	NNS	O	sequence	prep_of	45	SENT_60	[p3l638t2788r1095b2871],
49	.	.	O	.	_	0	SENT_60	[p3l638t2788r1095b2871],

1	“	NN	O	“	dep	43	SENT_61	[p3l638t2788r1095b2871],
2	Despite	IN	O	despite	dep	1	SENT_61	[p3l1118t2798r1379b2871],
3	certain	JJ	O	certain	amod	5	SENT_61	[p3l1403t2798r1646b2853],
4	contradictory	JJ	O	contradictory	amod	5	SENT_61	[p3l1668t2795r2151b2871],
5	results	NNS	O	result	pobj	2	SENT_61	[p3l8t2891r251b2961],
6	,	,	O	,	_	0	SENT_61	[p3l8t2891r251b2961],
7	most	JJS	O	most	amod	9	SENT_61	[p3l286t2898r460b2948],
8	clinical	JJ	O	clinical	amod	9	SENT_61	[p3l489t2891r744b2948],
9	studies	NNS	O	study	nsubj	11	SENT_61	[p3l776t2891r1016b2948],
10	have	VBP	O	have	aux	11	SENT_61	[p3l1046t2891r1211b2948],
11	documented	VBN	O	document	parataxis	43	SENT_61	[p3l1242t2891r1688b2948],
12	the	DT	O	the	det	14	SENT_61	[p3l1717t2891r1829b2948],
13	growing	VBG	O	grow	amod	14	SENT_61	[p3l1860t2894r2150b2966],
14	evidence	NN	O	evidence	dobj	11	SENT_61	[p3l9t2986r318b3044],
15	that	IN	O	that	complm	20	SENT_61	[p3l361t2986r505b3044],
16	the	DT	O	the	det	18	SENT_61	[p3l547t2986r660b3044],
17	TS	NN	O	t	nn	18	SENT_61	[p3l706t2988r787b3044],
18	genotype	NN	O	genotype	nsubjpass	20	SENT_61	[p3l828t2993r1154b3062],
19	is	VBZ	O	be	auxpass	20	SENT_61	[p3l1197t2989r1248b3044],
20	associated	VBN	O	associate	dep	14	SENT_61	[p3l1292t2986r1648b3044],
21	with	IN	O	with	_	0	SENT_61	[p3l1689t2986r1850b3044],
22	clinical	JJ	O	clinical	amod	23	SENT_61	[p3l1893t2986r2148b3044],
23	efficacy	NN	O	efficacy	prep_with	20	SENT_61	[p3l9t3081r278b3157],
24	in	IN	O	in	_	0	SENT_61	[p3l321t3084r391b3138],
25	terms	NNS	O	term	prep_in	20	SENT_61	[p3l436t3088r632b3139],
26	of	IN	O	of	_	0	SENT_61	[p3l679t3081r750b3139],
27	response	NN	O	response	prep_of	25	SENT_61	[p3l792t3098r1097b3157],
28	and	CC	O	and	_	0	SENT_61	[p3l1144t3081r1276b3139],
29	survival	NN	O	survival	prep_of	25	SENT_61	[p3l1323t3081r1597b3139],
30	to	TO	O	to	_	0	SENT_61	[p3l1642t3088r1712b3139],
31	5-FU-based	JJ	O	5-fu-based	amod	32	SENT_61	[p3l1760t3081r2149b3139],
32	chemotherapy	NN	O	chemotherapy	prep_to	20	SENT_61	[p3l9t3166r663b3250],
33	.8	CD	NUMBER	.8	number	34	SENT_61	[p3l9t3166r663b3250],
34	‘“	CD	NUMBER	‘“	num	32	SENT_61	[p3l9t3166r663b3250],
35	Moreover	RB	O	moreover	advmod	20	SENT_61	[p3l723t3176r1077b3244],
36	,	,	O	,	_	0	SENT_61	[p3l723t3176r1077b3244],
37	a	DT	O	a	det	39	SENT_61	[p3l1140t3191r1175b3232],
38	common	JJ	O	common	amod	39	SENT_61	[p3l1233t3191r1552b3232],
39	SNP	NN	O	snp	nsubjpass	43	SENT_61	[p3l1611t3175r1749b3232],
40	has	VBZ	O	have	aux	43	SENT_61	[p3l1806t3174r1922b3232],
41	been	VBN	O	be	auxpass	43	SENT_61	[p3l1979t3174r2148b3232],
42	recently	RB	DATE	recently	advmod	43	SENT_61	[p3l8t3270r295b3346],
43	identified	VBN	O	identify	_	0	SENT_61	[p3l339t3270r682b3328],
44	at	IN	O	at	_	0	SENT_61	[p3l729t3277r792b3328],
45	the	DT	O	the	det	47	SENT_61	[p3l839t3270r951b3328],
46	12th	JJ	ORDINAL	12th	amod	47	SENT_61	[p3l1004t3270r1161b3328],
47	nucleotide	NN	O	nucleotide	prep_at	43	SENT_61	[p3l1208t3270r1582b3328],
48	of	IN	O	of	_	0	SENT_61	[p3l1630t3270r1701b3328],
49	the	DT	O	the	det	51	SENT_61	[p3l1743t3270r1856b3328],
50	second	JJ	ORDINAL	second	amod	51	SENT_61	[p3l1905t3270r2149b3328],
51	repeat	NN	O	repeat	prep_of	47	SENT_61	[p3l8t3372r225b3440],
52	in	IN	O	in	_	0	SENT_61	[p3l253t3367r323b3421],
53	the	DT	O	the	det	55	SENT_61	[p3l351t3364r463b3422],
54	3R	NN	O	3r	nn	55	SENT_61	[p3l494t3366r583b3422],
55	allele	NN	O	allele	prep_in	51	SENT_61	[p3l610t3364r791b3422],
56	within	IN	O	within	_	0	SENT_61	[p3l819t3364r1054b3422],
57	a	DT	O	a	det	62	SENT_61	[p3l1083t3381r1118b3422],
58	USF	NN	O	usf	nn	62	SENT_61	[p3l1146t3366r1280b3422],
59	family	NN	O	family	nn	62	SENT_61	[p3l1308t3364r1535b3440],
60	E-Box	NN	O	e-box	nn	62	SENT_61	[p3l1561t3367r1764b3422],
61	consensus	NN	O	consensus	nn	62	SENT_61	[p3l1791t3381r2148b3422],
62	element	NN	O	element	prep_within	43	SENT_61	[p3l9t3460r313b3518],
63	.	.	O	.	_	0	SENT_61	[p3l9t3460r313b3518],

1	This	DT	O	this	det	2	SENT_62	[p3l338t3460r488b3518],
2	SNP	NN	O	snp	nsubj	8	SENT_62	[p3l513t3461r652b3518],
3	could	MD	O	could	aux	4	SENT_62	[p3l675t3460r871b3518],
4	abolish	VB	O	abolish	_	0	SENT_62	[p3l895t3460r1149b3518],
5	USF-1	NN	MISC	usf-1	nn	6	SENT_62	[p3l1172t3461r1370b3518],
6	binding	NN	O	binding	dobj	4	SENT_62	[p3l1397t3460r1677b3536],
7	and	CC	O	and	_	0	SENT_62	[p3l1700t3460r1831b3518],
8	decrease	VB	O	decrease	conj_and	4	SENT_62	[p3l1855t3460r2147b3518],
9	in	FW	O	in	nn	12	SENT_62	[p3l10t3553r70b3610],
10	vitro	FW	O	vitro	dep	12	SENT_62	[p3l95t3553r241b3610],
11	transcriptional	JJ	O	transcriptional	amod	12	SENT_62	[p3l265t3552r788b3628],
12	activity	NN	O	activity	advmod	8	SENT_62	[p3l814t3545r1238b3628],
13	.12	CD	NUMBER	.12	number	14	SENT_62	[p3l814t3545r1238b3628],
14	'13	CD	NUMBER	'13	dobj	8	SENT_62	[p3l814t3545r1238b3628],
15	From	IN	O	from	_	0	SENT_62	[p3l1265t3555r1448b3610],
16	these	DT	O	these	det	18	SENT_62	[p3l1472t3553r1654b3610],
17	experimental	JJ	O	experimental	amod	18	SENT_62	[p3l1680t3552r2148b3628],
18	observations	NNS	O	observation	prep_from	8	SENT_62	[p3l9t3647r472b3717],
19	,	,	O	,	_	0	SENT_62	[p3l9t3647r472b3717],
20	Kawakami	NNP	PERSON	Kawakami	appos	18	SENT_62	[p3l526t3647r889b3704],
21	et	FW	O	et	nn	22	SENT_62	[p3l938t3652r998b3704],
22	al.	FW	O	al.	dobj	8	SENT_62	[p3l1040t3640r1154b3704],
23	7	CD	NUMBER	7	dobj	4	SENT_62	[p3l1040t3640r1154b3704],
24	classified	VBN	O	classify	partmod	23	SENT_62	[p3l1204t3646r1521b3704],
25	each	DT	O	each	det	26	SENT_62	[p3l1570t3646r1730b3704],
26	patient	NN	O	patient	dobj	24	SENT_62	[p3l1778t3649r2030b3722],
27	in	IN	O	in	prep	24	SENT_62	[p3l2078t3650r2148b3703],

1	‘	NN	O	‘	_	0	SENT_63	[p4l11t17r195b75],
2	Low	JJ	O	low	amod	9	SENT_63	[p4l11t17r195b75],
3	’	CD	NUMBER	’	tmod	2	SENT_63	[p4l11t17r195b75],
4	or	CC	O	or	_	0	SENT_63	[p4l256t34r328b75],
5	‘	CD	NUMBER	‘	tmod	2	SENT_63	[p4l388t17r599b93],
6	High	JJ	O	high	amod	9	SENT_63	[p4l388t17r599b93],
7	’	NN	O	’	nn	9	SENT_63	[p4l388t17r599b93],
8	TS	NN	O	t	nn	9	SENT_63	[p4l663t19r744b75],
9	expression	NN	O	expression	dep	1	SENT_63	[p4l802t20r1175b93],
10	in	IN	O	in	_	0	SENT_63	[p4l1233t20r1304b74],
11	accordance	NN	O	accordance	_	0	SENT_63	[p4l1363t17r1757b75],
12	with	IN	O	with	_	0	SENT_63	[p4l1815t17r1977b75],
13	the	DT	O	the	det	14	SENT_63	[p4l2035t17r2147b75],
14	combination	NN	O	combination	prep_in_accordance_with	9	SENT_63	[p4l9t112r466b169],
15	of	IN	O	of	_	0	SENT_63	[p4l536t111r608b169],
16	this	DT	O	this	det	20	SENT_63	[p4l673t112r803b169],
17	SNP	NN	O	snp	nn	20	SENT_63	[p4l874t113r1012b169],
18	and	CC	O	and	_	0	SENT_63	[p4l1082t112r1214b169],
19	T	NN	O	t	nn	20	SENT_63	[p4l1281t114r1328b169],
20	SER	NN	O	ser	prep_of	14	SENT_63	[p4l1331t113r1459b169],
21	genotypic	JJ	O	genotypic	amod	22	SENT_63	[p4l1527t115r1877b187],
22	status	NN	O	status	dep	1	SENT_63	[p4l1948t119r2147b169],
23	(	CD	NUMBER	(	dep	22	SENT_63	[p4l12t206r218b278],
24	Table	NNP	O	Table	dep	1	SENT_63	[p4l12t206r218b278],
25	1	CD	NUMBER	1	number	26	SENT_63	[p4l252t206r331b278],
26	)	CD	NUMBER	)	dep	24	SENT_63	[p4l252t206r331b278],
27	.	.	O	.	_	0	SENT_63	[p4l252t206r331b278],

1	Two	CD	NUMBER	two	num	3	SENT_64	[p4l359t208r507b263],
2	clinical	JJ	O	clinical	amod	3	SENT_64	[p4l535t206r790b263],
3	studies	NNS	O	study	nsubj	4	SENT_64	[p4l818t206r1058b263],
4	showed	VBD	O	show	_	0	SENT_64	[p4l1086t206r1353b263],
5	a	DT	O	a	det	6	SENT_64	[p4l1379t222r1414b263],
6	correlation	NN	O	correlation	dep	16	SENT_64	[p4l1440t206r1827b263],
7	between	IN	O	between	_	0	SENT_64	[p4l1851t206r2149b263],
8	this	DT	O	this	det	9	SENT_64	[p4l8t302r137b360],
9	combination	NN	O	combination	prep_between	6	SENT_64	[p4l187t302r644b360],
10	and	CC	O	and	_	0	SENT_64	[p4l693t302r824b360],
11	overall	JJ	O	overall	amod	12	SENT_64	[p4l873t302r1111b360],
12	survival	NN	O	survival	prep_between	6	SENT_64	[p4l1161t302r1435b360],
13	(	CD	NUMBER	(	num	14	SENT_64	[p4l1487t302r1631b374],
14	OS	NN	O	os	dep	16	SENT_64	[p4l1487t302r1631b374],
15	)	CD	NUMBER	)	num	16	SENT_64	[p4l1487t302r1631b374],
16	(	NN	O	(	dep	23	SENT_64	[p4l1686t302r2151b378],
17	significantly	RB	O	significantly	advmod	18	SENT_64	[p4l1686t302r2151b378],
18	longer	RBR	O	longer	advmod	16	SENT_64	[p4l8t395r235b471],
19	in	IN	O	in	_	0	SENT_64	[p4l262t398r333b452],
20	the	DT	O	the	det	22	SENT_64	[p4l362t395r475b453],
21	low	JJ	O	low	amod	22	SENT_64	[p4l505t395r633b453],
22	expression	NN	O	expression	prep_in	16	SENT_64	[p4l661t398r1034b471],
23	group	NN	O	group	dep	26	SENT_64	[p4l1064t387r1467b471],
24	)	CD	NUMBER	)	num	23	SENT_64	[p4l1064t387r1467b471],
25	.12	CD	NUMBER	.12	num	26	SENT_64	[p4l1064t387r1467b471],
26	'14	CD	NUMBER	'14	dep	4	SENT_64	[p4l1064t387r1467b471],

1	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	2	SENT_65	[p4l81t491r705b567],
2	dehydrogenase	NN	O	dehydrogenase	nsubj	9	SENT_65	[p4l738t491r1214b567],
3	(	CD	NUMBER	(	num	5	SENT_65	[p4l1249t491r1454b563],
4	DPD	NN	O	dpd	nn	5	SENT_65	[p4l1249t491r1454b563],
5	)	NN	O	)	dep	2	SENT_65	[p4l1249t491r1454b563],
6	is	VBZ	O	be	cop	9	SENT_65	[p4l1490t494r1540b549],
7	the	DT	O	the	det	9	SENT_65	[p4l1574t491r1687b549],
8	key	JJ	O	key	amod	9	SENT_65	[p4l1721t491r1843b567],
9	enzyme	NN	O	enzyme	_	0	SENT_65	[p4l1875t508r2147b567],
10	involved	VBN	O	involve	partmod	9	SENT_65	[p4l8t584r318b641],
11	in	IN	O	in	_	0	SENT_65	[p4l342t587r412b641],
12	the	DT	O	the	det	14	SENT_65	[p4l436t585r549b641],
13	catabolic	JJ	O	catabolic	amod	14	SENT_65	[p4l576t584r891b641],
14	breakdown	NN	O	breakdown	prep_in	10	SENT_65	[p4l914t584r1309b641],
15	of	IN	O	of	_	0	SENT_65	[p4l1334t584r1406b641],
16	5-FU	NN	O	5-fu	prep_of	14	SENT_65	[p4l1427t587r1609b641],
17	.	.	O	.	_	0	SENT_65	[p4l1427t587r1609b641],

1	It	PRP	O	it	nsubjpass	3	SENT_66	[p4l1639t587r1691b641],
2	is	VBZ	O	be	auxpass	3	SENT_66	[p4l1715t587r1765b641],
3	submitted	VBN	O	submit	_	0	SENT_66	[p4l1793t584r2149b641],
4	to	TO	O	to	_	0	SENT_66	[p4l8t687r78b738],
5	a	DT	O	a	det	8	SENT_66	[p4l102t697r137b738],
6	common	JJ	O	common	amod	8	SENT_66	[p4l160t697r479b738],
7	genetic	JJ	O	genetic	amod	8	SENT_66	[p4l501t683r756b756],
8	polymorphism	NN	O	polymorphism	prep_to	3	SENT_66	[p4l778t680r1304b756],
9	and	CC	O	and	_	0	SENT_66	[p4l1328t680r1458b738],
10	its	PRP$	O	its	poss	11	SENT_66	[p4l1481t683r1560b738],
11	activity	NN	O	activity	nsubj	12	SENT_66	[p4l1584t683r1848b756],
12	displays	VBZ	O	display	conj_and	3	SENT_66	[p4l1869t680r2148b756],
13	wide	JJ	O	wide	amod	15	SENT_66	[p4l7t772r172b830],
14	interindividual	JJ	O	interindividual	amod	15	SENT_66	[p4l231t772r764b830],
15	variability	NN	O	variability	dobj	12	SENT_66	[p4l820t772r1182b848],
16	from	IN	O	from	_	0	SENT_66	[p4l1237t772r1406b830],
17	8	CD	NUMBER	8	prep_from	12	SENT_66	[p4l1466t774r1529b830],
18	-	:	O	-	_	0	SENT_66	[p4l1466t774r1529b830],
19	to	TO	O	to	_	0	SENT_66	[p4l1587t780r1657b830],
20	21	CD	NUMBER	21	number	21	SENT_66	[p4l1716t765r2148b830],
21	—	CD	NUMBER	—	num	24	SENT_66	[p4l1716t765r2148b830],
22	fold	JJ	O	fold	quantmod	24	SENT_66	[p4l1716t765r2148b830],
23	.15	CD	NUMBER	.15	number	24	SENT_66	[p4l1716t765r2148b830],
24	‘	CD	NUMBER	‘	prep_to	12	SENT_66	[p4l1716t765r2148b830],
25	16	CD	NUMBER	16	num	28	SENT_66	[p4l1716t765r2148b830],
26	Low	JJ	O	low	amod	28	SENT_66	[p4l9t871r157b926],
27	enzyme	NN	O	enzyme	nn	28	SENT_66	[p4l193t885r465b944],
28	activity	NN	O	activity	nsubj	29	SENT_66	[p4l506t871r770b944],
29	leads	VBZ	O	lead	dep	12	SENT_66	[p4l806t868r980b926],
30	to	TO	O	to	_	0	SENT_66	[p4l1019t876r1089b926],
31	excessive	JJ	O	excessive	amod	32	SENT_66	[p4l1129t871r1448b926],
32	amounts	NNS	O	amount	prep_to	29	SENT_66	[p4l1488t876r1797b926],
33	of	IN	O	of	_	0	SENT_66	[p4l1837t868r1908b926],
34	active	JJ	O	active	amod	35	SENT_66	[p4l1943t871r2147b926],
35	metabolites	NNS	O	metabolite	prep_of	32	SENT_66	[p4l8t964r418b1022],
36	and	CC	O	and	_	0	SENT_66	[p4l475t964r606b1022],
37	consequently	RB	O	consequently	advmod	29	SENT_66	[p4l662t964r1139b1040],
38	to	TO	O	to	_	0	SENT_66	[p4l1191t971r1260b1022],
39	severe	JJ	O	severe	amod	41	SENT_66	[p4l1318t981r1529b1022],
40	adverse	JJ	O	adverse	amod	41	SENT_66	[p4l1586t964r1845b1022],
41	events	NNS	O	event	conj_and	32	SENT_66	[p4l1902t971r2143b1034],
42	,	,	O	,	_	0	SENT_66	[p4l1902t971r2143b1034],
43	hematopoietic	JJ	O	hematopoietic	amod	41	SENT_66	[p4l8t1059r540b1134],
44	,	,	O	,	_	0	SENT_66	[p4l8t1059r540b1134],
45	neurological	JJ	O	neurological	conj_and	43	SENT_66	[p4l607t1059r1048b1134],
46	and	CC	O	and	_	0	SENT_66	[p4l1112t1059r1243b1116],
47	gastrointestinal	JJ	O	gastrointestinal	conj_and	43	SENT_66	[p4l1305t1059r1872b1134],
48	,	,	O	,	_	0	SENT_66	[p4l1305t1059r1872b1134],
49	sometimes	RB	O	sometimes	advmod	50	SENT_66	[p4l1941t1075r2147b1116, p4l8t1157r198b1211],
50	combined	VBN	O	combine	partmod	41	SENT_66	[p4l241t1154r595b1211],
51	in	IN	O	in	_	0	SENT_66	[p4l637t1157r707b1211],
52	a	DT	O	a	det	55	SENT_66	[p4l749t1170r784b1211],
53	polyvisceral	JJ	O	polyvisceral	amod	55	SENT_66	[p4l824t1154r1244b1229],
54	toxic	JJ	O	toxic	amod	55	SENT_66	[p4l1285t1157r1461b1211],
55	syndrome	NN	O	syndrome	prep_in	50	SENT_66	[p4l1504t1154r1871b1229],
56	,	,	O	,	_	0	SENT_66	[p4l1504t1154r1871b1229],
57	potentially	RB	O	potentially	advmod	58	SENT_66	[p4l1917t1161r2147b1229, p4l8t1249r189b1325],
58	fatal	JJ	O	fatal	amod	55	SENT_66	[p4l214t1249r367b1307],
59	in	IN	O	in	_	0	SENT_66	[p4l395t1252r465b1306],
60	0.2	CD	PERCENT	0.2	num	61	SENT_66	[p4l494t1251r669b1307],
61	%	NN	PERCENT	%	prep_in	50	SENT_66	[p4l494t1251r669b1307],
62	of	IN	O	of	_	0	SENT_66	[p4l698t1249r769b1307],
63	cases	NNS	O	case	prep_of	61	SENT_66	[p4l793t1266r984b1307],
64	.	.	O	.	_	0	SENT_66	[p4l793t1266r984b1307],

1	In	IN	O	in	_	0	SENT_67	[p4l1016t1252r1089b1306],
2	the	DT	O	the	det	4	SENT_67	[p4l1117t1249r1229b1307],
3	global	JJ	O	global	amod	4	SENT_67	[p4l1258t1249r1473b1325],
4	population	NN	O	population	prep_in	11	SENT_67	[p4l1500t1249r1911b1325],
5	,	,	O	,	_	0	SENT_67	[p4l1500t1249r1911b1325],
6	3	CD	PERCENT	3	num	7	SENT_67	[p4l1945t1251r2053b1307],
7	%	NN	PERCENT	%	nsubj	11	SENT_67	[p4l1945t1251r2053b1307],
8	of	IN	O	of	_	0	SENT_67	[p4l2081t1249r2152b1307],
9	individuals	NNS	O	individual	prep_of	7	SENT_67	[p4l8t1344r401b1402],
10	are	VBP	O	be	cop	11	SENT_67	[p4l447t1361r548b1402],
11	heterozygous	JJ	O	heterozygous	_	0	SENT_67	[p4l593t1344r1062b1420],
12	and	CC	O	and	_	0	SENT_67	[p4l1107t1344r1238b1402],
13	at	IN	O	at	conj_and	11	SENT_67	[p4l1283t1351r1346b1402],
14	risk	NN	O	risk	pobj	13	SENT_67	[p4l1389t1344r1515b1402],
15	of	IN	O	of	_	0	SENT_67	[p4l1557t1344r1629b1402],
16	adverse	JJ	O	adverse	amod	18	SENT_67	[p4l1669t1344r1928b1402],
17	toxic	JJ	O	toxic	amod	18	SENT_67	[p4l1973t1347r2149b1402],
18	events	NNS	O	event	prep_of	14	SENT_67	[p4l9t1446r251b1497],
19	.	.	O	.	_	0	SENT_67	[p4l9t1446r251b1497],

1	To	TO	O	to	_	0	SENT_68	[p4l291t1442r375b1497],
2	date	NN	O	date	prep_to	17	SENT_68	[p4l414t1439r579b1509],
3	,	,	O	,	_	0	SENT_68	[p4l414t1439r579b1509],
4	around	IN	O	around	amod	6	SENT_68	[p4l622t1439r875b1497],
5	30	CD	NUMBER	30	num	6	SENT_68	[p4l913t1441r995b1497],
6	mutations	NNS	O	mutation	nsubjpass	17	SENT_68	[p4l1032t1442r1395b1497],
7	on	IN	O	on	_	0	SENT_68	[p4l1433t1456r1524b1497],
8	chromosome	NN	O	chromosome	nn	9	SENT_68	[p4l1562t1439r2024b1497],
9	1p	NN	O	1p	prep_on	6	SENT_68	[p4l2068t1441r2148b1515],
10	associated	VBN	O	associate	partmod	9	SENT_68	[p4l9t1533r365b1591],
11	with	IN	O	with	_	0	SENT_68	[p4l401t1533r563b1591],
12	reduced	VBN	O	reduce	amod	14	SENT_68	[p4l601t1533r880b1591],
13	DPD	NN	ORGANIZATION	dpd	nn	14	SENT_68	[p4l919t1536r1077b1590],
14	activity	NN	O	activity	prep_with	10	SENT_68	[p4l1118t1536r1381b1609],
15	have	VBP	O	have	aux	17	SENT_68	[p4l1418t1533r1582b1591],
16	been	VBN	O	be	auxpass	17	SENT_68	[p4l1620t1533r1789b1591],
17	reported	VBN	O	report	_	0	SENT_68	[p4l1828t1533r2144b1609],
18	.	.	O	.	_	0	SENT_68	[p4l1828t1533r2144b1609],

1	For	IN	O	for	_	0	SENT_69	[p4l9t1631r120b1687],
2	example	NN	O	example	prep_for	11	SENT_69	[p4l154t1629r469b1705],
3	,	,	O	,	_	0	SENT_69	[p4l154t1629r469b1705],
4	the	DT	O	the	det	8	SENT_69	[p4l507t1629r620b1687],
5	most	RBS	O	most	advmod	6	SENT_69	[p4l655t1636r829b1687],
6	prominent	JJ	O	prominent	amod	8	SENT_69	[p4l862t1632r1244b1705],
7	DPD	NN	O	dpd	nn	8	SENT_69	[p4l1274t1631r1436b1686],
8	polymorphism	NN	O	polymorphism	nsubj	11	SENT_69	[p4l1468t1629r1994b1705],
9	is	VBZ	O	be	cop	11	SENT_69	[p4l2028t1632r2078b1687],
10	a	DT	O	a	det	11	SENT_69	[p4l2114t1646r2149b1687],
11	G	NN	O	g	_	0	SENT_69	[p4l10t1724r195b1780],
12	>	JJR	O	>	amod	14	SENT_69	[p4l10t1724r195b1780],
13	A	DT	O	a	det	14	SENT_69	[p4l10t1724r195b1780],
14	SNP	NN	ORGANIZATION	snp	dep	11	SENT_69	[p4l229t1724r367b1780],
15	in	IN	O	in	_	0	SENT_69	[p4l400t1725r471b1779],
16	the	DT	O	the	det	17	SENT_69	[p4l504t1722r617b1780],
17	GT	NN	O	gt	prep_in	14	SENT_69	[p4l653t1724r757b1780],
18	5	CD	NUMBER	5	num	17	SENT_69	[p4l791t1721r1074b1798],
19	’	SYM	O	’	dep	14	SENT_69	[p4l791t1721r1074b1798],
20	-	:	O	-	_	0	SENT_69	[p4l791t1721r1074b1798],
21	splice	NN	O	splice	nn	23	SENT_69	[p4l791t1721r1074b1798],
22	recognition	NN	O	recognition	nn	23	SENT_69	[p4l1109t1725r1519b1798],
23	site	NN	O	site	dep	11	SENT_69	[p4l1555t1725r1670b1780],
24	of	IN	O	of	_	0	SENT_69	[p4l1706t1722r1777b1780],
25	intron	NN	O	intron	prep_of	23	SENT_69	[p4l1806t1725r2031b1780],
26	14	CD	NUMBER	14	num	25	SENT_69	[p4l2071t1724r2147b1779],
27	that	WDT	O	that	nsubj	28	SENT_69	[p4l8t1818r152b1875],
28	leads	VBZ	O	lead	rcmod	23	SENT_69	[p4l198t1818r372b1875],
29	to	TO	O	to	_	0	SENT_69	[p4l420t1825r490b1875],
30	skipping	VBG	O	skip	prepc_to	28	SENT_69	[p4l539t1818r840b1893],
31	exon	NN	O	exon	dobj	30	SENT_69	[p4l887t1834r1060b1875],
32	14	CD	NUMBER	14	num	31	SENT_69	[p4l1113t1819r1190b1875],
33	and	CC	O	and	_	0	SENT_69	[p4l1240t1818r1370b1875],
34	the	DT	O	the	det	35	SENT_69	[p4l1417t1818r1530b1875],
35	synthesis	NN	O	synthesis	dobj	30	SENT_69	[p4l1580t1818r1900b1893],
36	of	IN	O	of	_	0	SENT_69	[p4l1948t1817r2020b1875],
37	an	DT	O	a	det	38	SENT_69	[p4l2064t1834r2148b1875],
38	inactive	JJ	O	inactive	prep_of	35	SENT_69	[p4l8t1916r287b1971],
39	truncated	VBN	O	truncate	partmod	38	SENT_69	[p4l317t1913r659b1971],
40	protein	NN	O	protein	dobj	39	SENT_69	[p4l688t1916r947b1989],
41	with	IN	O	with	_	0	SENT_69	[p4l975t1913r1136b1971],
42	severe	JJ	O	severe	amod	44	SENT_69	[p4l1167t1930r1378b1971],
43	DPD	NN	O	dpd	nn	44	SENT_69	[p4l1405t1915r1567b1970],
44	deficiency	NN	O	deficiency	prep_with	39	SENT_69	[p4l1596t1913r1969b1989],
45	.	.	O	.	_	0	SENT_69	[p4l1596t1913r1969b1989],

1	Table	NNP	O	Table	_	0	SENT_70	[p4l7t2148r196b2204],
2	1	CD	NUMBER	1	num	3	SENT_70	[p4l236t2149r259b2203],
3	Classification	NN	O	classification	nsubj	7	SENT_70	[p4l349t2149r784b2204],
4	following	VBG	O	follow	_	0	SENT_70	[p4l819t2149r1134b2221],
5	Kawakami	NNP	PERSON	Kawakami	prep_following	3	SENT_70	[p4l1174t2149r1510b2204],
6	et	FW	O	et	nn	7	SENT_70	[p4l1548t2156r1607b2204],
7	al.	FW	O	al.	rcmod	1	SENT_70	[p4l1637t2143r1743b2204],
8	7	CD	NUMBER	7	dobj	7	SENT_70	[p4l1637t2143r1743b2204],
9	in	IN	O	in	_	0	SENT_70	[p4l1778t2150r1833b2203],
10	’	CD	NUMBER	’	num	16	SENT_70	[p4l1871t2149r2044b2204],
11	Low	JJ	O	low	amod	16	SENT_70	[p4l1871t2149r2044b2204],
12	’	CD	NUMBER	’	tmod	11	SENT_70	[p4l1871t2149r2044b2204],
13	or	CC	O	or	_	0	SENT_70	[p4l2081t2165r2151b2204],
14	’	CD	NUMBER	’	conj_or	12	SENT_70	[p4l10t2235r206b2306],
15	High	JJ	O	high	amod	16	SENT_70	[p4l10t2235r206b2306],
16	’	NN	O	’	prep_in	8	SENT_70	[p4l10t2235r206b2306],
17	TS	NN	O	t	nn	18	SENT_70	[p4l235t2236r306b2289],
18	expression	NN	O	expression	dep	16	SENT_70	[p4l323t2235r677b2306],
19	in	IN	O	in	_	0	SENT_70	[p4l702t2235r758b2289],
20	accordance	NN	O	accordance	prep_in	18	SENT_70	[p4l783t2235r1161b2289],
21	with	IN	O	with	_	0	SENT_70	[p4l1181t2235r1327b2289],
22	the	DT	O	the	det	23	SENT_70	[p4l1350t2235r1458b2289],
23	combination	NN	O	combination	prep_with	7	SENT_70	[p4l1481t2235r1903b2289],
24	of	IN	O	of	_	0	SENT_70	[p4l1927t2235r1995b2289],
25	SNP	NN	O	snp	nn	29	SENT_70	[p4l2015t2236r2148b2289],
26	and	CC	O	and	_	0	SENT_70	[p4l9t2319r130b2374],
27	TSER	NN	O	tser	nn	29	SENT_70	[p4l160t2321r325b2374],
28	genotype	NN	O	genotype	nn	29	SENT_70	[p4l353t2326r671b2391],
29	status	NN	O	status	prep_of	23	SENT_70	[p4l700t2326r895b2374],

1	’	NNP	O	’	nn	2	SENT_71	[p4l16t2493r197b2565],
2	High	NNP	O	High	_	0	SENT_71	[p4l16t2493r197b2565],
3	’	NN	O	’	nn	4	SENT_71	[p4l16t2493r197b2565],
4	expression	NN	O	expression	dep	2	SENT_71	[p4l220t2494r527b2565],
5	’	CD	NUMBER	’	num	8	SENT_71	[p4l1661t2493r1819b2548],
6	Low	JJ	O	low	amod	8	SENT_71	[p4l1661t2493r1819b2548],
7	’	NN	O	’	nn	8	SENT_71	[p4l1661t2493r1819b2548],
8	expression	NN	O	expression	dep	2	SENT_71	[p4l1842t2494r2150b2565],

1	2	CD	NUMBER	2	num	3	SENT_72	[p4l9t2677r44b2730],
2	R/2	NN	O	r/2	nn	3	SENT_72	[p4l53t2676r153b2737],
3	R	NN	O	r	_	0	SENT_72	[p4l163t2678r196b2730],
4	2	CD	NUMBER	2	num	5	SENT_72	[p4l1787t2677r1821b2730],
5	R	NN	O	r	dep	3	SENT_72	[p4l1831t2676r1892b2737],
6	/	:	O	/	punct	3	SENT_72	[p4l1831t2676r1892b2737],
7	3	CD	NUMBER	3	num	8	SENT_72	[p4l1899t2677r1930b2731],
8	Rg	NN	O	rg	dep	3	SENT_72	[p4l1940t2678r2012b2748],
9	2R/3Rc	NN	O	2r/3rc	nn	11	SENT_72	[p4l9t2762r230b2823],
10	3Rc/3Rg	NN	O	3rc/3rg	nn	11	SENT_72	[p4l1772t2762r2029b2834],
11	3R/3Rc	NN	O	3r/3rc	nn	12	SENT_72	[p4l12t2848r230b2910],
12	2Rg/3Rg	NN	O	2rg/3rg	dep	8	SENT_72	[p4l1765t2848r2034b2920],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_73	[p4l6t2994r377b3038],
2	:	:	O	:	_	0	SENT_73	[p4l6t2994r377b3038],
3	CR	NN	O	cr	dep	1	SENT_73	[p4l402t2995r486b3048],
4	,	,	O	,	_	0	SENT_73	[p4l402t2995r486b3048],
5	complete	JJ	O	complete	amod	6	SENT_73	[p4l510t2994r754b3052],
6	response	NN	O	response	appos	3	SENT_73	[p4l777t3007r1018b3052],
7	;	:	O	;	_	0	SENT_73	[p4l777t3007r1018b3052],
8	SNP	NN	ORGANIZATION	snp	dep	1	SENT_73	[p4l1043t2995r1162b3048],
9	,	,	O	,	_	0	SENT_73	[p4l1043t2995r1162b3048],
10	single-nucleotide	JJ	O	single-nucleotide	amod	11	SENT_73	[p4l1186t2994r1632b3052],
11	polymorphism	NN	O	polymorphism	appos	8	SENT_73	[p4l1656t2994r2046b3052],
12	;	:	O	;	_	0	SENT_73	[p4l1656t2994r2046b3052],
13	TS	NN	O	t	dep	1	SENT_73	[p4l2069t2995r2145b3048],
14	,	,	O	,	_	0	SENT_73	[p4l2069t2995r2145b3048],
15	thymidylate	NN	O	thymidylate	nn	16	SENT_73	[p4l8t3068r318b3127],
16	synthase	NN	O	synthase	appos	13	SENT_73	[p4l341t3068r578b3127],
17	;	:	O	;	_	0	SENT_73	[p4l341t3068r578b3127],
18	TSER	NN	O	tser	dep	1	SENT_73	[p4l603t3070r742b3122],
19	,	,	O	,	_	0	SENT_73	[p4l603t3070r742b3122],
20	thymidylate	NN	O	thymidylate	nn	23	SENT_73	[p4l768t3068r1077b3127],
21	synthase	NN	O	synthase	nn	23	SENT_73	[p4l1101t3068r1324b3127],
22	enhancer	NN	O	enhancer	nn	23	SENT_73	[p4l1347t3068r1591b3113],
23	region	NN	O	region	appos	18	SENT_73	[p4l1614t3069r1791b3127],
24	.	.	O	.	_	0	SENT_73	[p4l1614t3069r1791b3127],

1	mg	NN	O	mg	nn	4	SENT_74	[p4l10t3482r137b3606],
2	Fluorouracil	NN	O	fluorouracil	nn	4	SENT_74	[p4l1341t3494r1625b3539],
3	outcome	NN	O	outcome	nn	4	SENT_74	[p4l1645t3499r1855b3539],
4	parameters	NNS	O	parameter	_	0	SENT_74	[p4l1875t3499r2148b3553],
5	o	NN	O	o	nn	6	SENT_74	[p4l1821t3566r1855b3607],
6	Capitain	NNP	MISC	Capitain	dep	4	SENT_74	[p4l1874t3566r2042b3620],
7	et	FW	O	et	nn	8	SENT_74	[p4l2064t3570r2100b3607],
8	al	FW	O	al	dep	4	SENT_74	[p4l2116t3565r2152b3607],

1	Methylene	NN	O	methylene	nn	2	SENT_75	[p5l84t93r423b169],
2	tetrahydrofolate	NN	O	tetrahydrofolate	nsubj	8	SENT_75	[p5l462t93r982b169],
3	reductase	NN	O	reductase	nn	4	SENT_75	[p5l1020t93r1323b151],
4	enzyme	NN	O	enzyme	dep	2	SENT_75	[p5l1361t110r1606b169],
5	(	CD	NUMBER	(	num	6	SENT_75	[p5l1646t93r1953b165],
6	MTHFR	NN	O	mthfr	dep	2	SENT_75	[p5l1646t93r1953b165],
7	)	CD	NUMBER	)	dep	6	SENT_75	[p5l1646t93r1953b165],
8	controls	VBZ	O	control	_	0	SENT_75	[p5l1993t110r2147b151, p5l11t187r164b245],
9	the	DT	O	the	det	12	SENT_75	[p5l213t187r325b245],
10	intracellular	JJ	O	intracellular	amod	12	SENT_75	[p5l373t187r804b245],
11	CHZFH4	NN	O	chzfh4	nn	12	SENT_75	[p5l852t188r1132b256],
12	concentration	NN	O	concentration	dobj	8	SENT_75	[p5l1181t190r1698b245],
13	.	.	O	.	_	0	SENT_75	[p5l1181t190r1698b245],

1	It	PRP	O	it	nsubj	2	SENT_76	[p5l1751t189r1802b245],
2	converts	VBZ	O	convert	_	0	SENT_76	[p5l1849t194r2147b245],
3	CHZFH4	NN	O	chzfh4	dobj	2	SENT_76	[p5l12t284r291b352],
4	into	IN	O	into	_	0	SENT_76	[p5l320t285r463b340],
5	5-methyltetrahydrofolate	JJ	O	5-methyltetrahydrofolate	prep_into	2	SENT_76	[p5l494t282r1391b358],
6	and	CC	O	and	_	0	SENT_76	[p5l1421t282r1552b340],
7	represents	VBZ	O	represent	conj_and	2	SENT_76	[p5l1581t290r1936b358],
8	a	DT	O	a	det	10	SENT_76	[p5l1966t299r2001b340],
9	key	JJ	O	key	amod	10	SENT_76	[p5l2029t282r2150b358],
10	enzyme	NN	O	enzyme	dobj	7	SENT_76	[p5l11t394r283b453],
11	in	IN	O	in	_	0	SENT_76	[p5l313t380r383b434],
12	the	DT	O	the	det	14	SENT_76	[p5l412t377r524b435],
13	folate	NN	O	folate	nn	14	SENT_76	[p5l555t377r751b435],
14	metabolism	NN	O	metabolism	prep_in	10	SENT_76	[p5l782t377r1197b435],
15	at	IN	O	at	_	0	SENT_76	[p5l1228t385r1291b435],
16	the	DT	O	the	det	17	SENT_76	[p5l1319t377r1432b435],
17	crossroads	NNS	O	crossroads	prep_at	14	SENT_76	[p5l1463t377r1823b435],
18	between	IN	O	between	_	0	SENT_76	[p5l1851t378r2147b435],
19	DNA	NN	MISC	dna	nn	20	SENT_76	[p5l11t475r180b530],
20	synthesis	NN	O	synthesis	prep_between	17	SENT_76	[p5l225t473r545b549],
21	and	CC	O	and	_	0	SENT_76	[p5l590t473r721b531],
22	DNA	NN	MISC	dna	nn	23	SENT_76	[p5l764t475r933b530],
23	methylation	NN	O	methylation	prep_between	17	SENT_76	[p5l976t473r1414b549],
24	via	IN	O	via	_	0	SENT_76	[p5l1458t474r1553b531],
25	methylation	NN	O	methylation	prep_via	20	SENT_76	[p5l1597t473r2036b549],
26	of	IN	O	of	_	0	SENT_76	[p5l2081t473r2152b531],
27	homocysteine	NN	O	homocysteine	prep_of	25	SENT_76	[p5l11t568r509b643],
28	to	TO	O	to	_	0	SENT_76	[p5l562t575r631b625],
29	methionine	NN	O	methionine	prep_to	7	SENT_76	[p5l684t568r1119b625],
30	.	.	O	.	_	0	SENT_76	[p5l684t568r1119b625],

1	MTHFR	NN	O	mthfr	nsubj	4	SENT_77	[p5l1173t570r1435b625],
2	is	VBZ	O	be	cop	4	SENT_77	[p5l1488t571r1538b625],
3	also	RB	O	also	advmod	4	SENT_77	[p5l1591t568r1725b625],
4	subject	JJ	O	subject	_	0	SENT_77	[p5l1780t568r2025b643],
5	to	TO	O	to	_	0	SENT_77	[p5l2077t575r2147b625],
6	several	JJ	O	several	amod	8	SENT_77	[p5l12t664r249b722],
7	common	JJ	O	common	amod	8	SENT_77	[p5l295t681r614b722],
8	polymorphisms	NNS	O	polymorphism	prep_to	4	SENT_77	[p5l660t664r1215b740],
9	on	IN	O	on	_	0	SENT_77	[p5l1263t681r1354b722],
10	chromosome	NN	O	chromosome	nn	11	SENT_77	[p5l1401t664r1862b722],
11	1p	NN	O	1p	prep_on	8	SENT_77	[p5l1915t666r2013b740],
12	.	.	O	.	_	0	SENT_77	[p5l1915t666r2013b740],

1	To	TO	O	to	_	0	SENT_78	[p5l2062t666r2147b722],
2	date	NN	O	date	prep_to	8	SENT_78	[p5l11t759r176b829],
3	,	,	O	,	_	0	SENT_78	[p5l11t759r176b829],
4	44	CD	NUMBER	44	num	5	SENT_78	[p5l204t762r286b816],
5	SNPs	NNS	O	snp	nsubjpass	8	SENT_78	[p5l310t761r478b817],
6	have	VBP	O	have	aux	8	SENT_78	[p5l502t759r666b817],
7	been	VBN	O	be	auxpass	8	SENT_78	[p5l688t759r858b817],
8	individualized	VBN	O	individualize	_	0	SENT_78	[p5l880t759r1404b817],
9	.	.	O	.	_	0	SENT_78	[p5l880t759r1404b817],

1	Among	IN	O	among	_	0	SENT_79	[p5l1430t761r1691b835],
2	these	DT	O	these	prep_among	6	SENT_79	[p5l1711t759r1912b829],
3	,	,	O	,	_	0	SENT_79	[p5l1711t759r1912b829],
4	37	CD	NUMBER	37	nsubjpass	6	SENT_79	[p5l1940t761r2020b817],
5	are	VBP	O	be	auxpass	6	SENT_79	[p5l2045t776r2146b817],
6	correlated	VBN	O	correlate	_	0	SENT_79	[p5l11t854r363b911],
7	with	IN	O	with	_	0	SENT_79	[p5l383t854r544b911],
8	severe	JJ	O	severe	amod	10	SENT_79	[p5l569t870r779b911],
9	enzyme	NN	O	enzyme	nn	10	SENT_79	[p5l803t870r1075b929],
10	activity	NN	O	activity	prep_with	6	SENT_79	[p5l1099t857r1363b929],
11	deficiency	NN	O	deficiency	npadvmod	13	SENT_79	[p5l1383t853r1745b929],
12	(	CD	NUMBER	(	num	11	SENT_79	[p5l1769t853r2056b926],
13	inferior	JJ	O	inferior	amod	10	SENT_79	[p5l1769t853r2056b926],
14	to	TO	O	to	_	0	SENT_79	[p5l2077t861r2147b911],
15	20	CD	PERCENT	20	number	16	SENT_79	[p5l12t950r187b1021],
16	%	NN	PERCENT	%	amod	17	SENT_79	[p5l12t950r187b1021],
17	)	CD	NUMBER	)	prep_to	6	SENT_79	[p5l12t950r187b1021],
18	and	CC	O	and	_	0	SENT_79	[p5l231t949r362b1007],
19	hyperhomocysteine	NN	O	hyperhomocysteine	conj_and	17	SENT_79	[p5l401t949r1124b1025],
20	.	.	O	.	_	0	SENT_79	[p5l401t949r1124b1025],

1	The	DT	O	the	det	2	SENT_80	[p5l1167t949r1299b1007],
2	MTHFR	NN	O	mthfr	nsubj	38	SENT_80	[p5l1336t952r1598b1006],
3	677	CD	NUMBER	677	number	4	SENT_80	[p5l1641t951r1764b1007],
4	C	NN	O	c	num	6	SENT_80	[p5l1807t951r1983b1007],
5	>	JJR	O	>	amod	6	SENT_80	[p5l1807t951r1983b1007],
6	T	NN	O	t	nsubj	16	SENT_80	[p5l1807t951r1983b1007],
7	and	CC	O	and	_	0	SENT_80	[p5l2017t949r2148b1007],
8	1298	CD	DATE	1298	num	11	SENT_80	[p5l16t1046r180b1102],
9	A	DT	O	a	dep	10	SENT_80	[p5l206t1046r320b1102],
10	>	JJR	O	>	amod	11	SENT_80	[p5l206t1046r320b1102],
11	C	NN	O	c	conj_and	6	SENT_80	[p5l337t1046r389b1102],
12	are	VBP	O	be	cop	16	SENT_80	[p5l414t1061r515b1102],
13	the	DT	O	the	det	16	SENT_80	[p5l541t1044r654b1102],
14	most	RBS	O	most	advmod	15	SENT_80	[p5l679t1051r853b1102],
15	common	JJ	O	common	amod	16	SENT_80	[p5l879t1061r1197b1102],
16	(	NN	O	(	rcmod	2	SENT_80	[p5l1226t1044r1329b1116],
17	15	CD	NUMBER	15	dep	16	SENT_80	[p5l1226t1044r1329b1116],
18	and	CC	O	and	_	0	SENT_80	[p5l1360t1044r1491b1102],
19	12	CD	PERCENT	12	num	20	SENT_80	[p5l1521t1046r1685b1115],
20	%	NN	PERCENT	%	conj_and	16	SENT_80	[p5l1521t1046r1685b1115],
21	,	,	O	,	_	0	SENT_80	[p5l1521t1046r1685b1115],
22	respectively	RB	O	respectively	advmod	20	SENT_80	[p5l1715t1044r2143b1120],
23	,	,	O	,	_	0	SENT_80	[p5l1715t1044r2143b1120],
24	for	IN	O	for	_	0	SENT_80	[p5l11t1137r109b1195],
25	homozygotes	NNS	O	homozygote	prep_for	20	SENT_80	[p5l130t1130r694b1213],
26	)	CD	NUMBER	)	num	27	SENT_80	[p5l130t1130r694b1213],
27	”	NN	O	”	dep	25	SENT_80	[p5l130t1130r694b1213],
28	and	CC	O	and	_	0	SENT_80	[p5l718t1137r849b1195],
29	homozygous	JJ	O	homozygous	dep	25	SENT_80	[p5l871t1137r1322b1213],
30	mutated	VBN	O	mutate	partmod	20	SENT_80	[p5l1346t1137r1643b1195],
31	genotypes	NNS	O	genotype	nsubjpass	33	SENT_80	[p5l1665t1144r2021b1213],
32	are	VBP	O	be	auxpass	33	SENT_80	[p5l2045t1154r2146b1195],
33	associated	VBN	O	associate	ccomp	30	SENT_80	[p5l11t1232r367b1290],
34	with	IN	O	with	_	0	SENT_80	[p5l389t1232r550b1290],
35	lower	JJR	O	lower	amod	37	SENT_80	[p5l575t1232r769b1290],
36	enzyme	NN	O	enzyme	nn	37	SENT_80	[p5l793t1249r1064b1308],
37	activity	NN	O	activity	prep_with	33	SENT_80	[p5l1091t1235r1354b1308],
38	(	VBD	O	(	_	0	SENT_80	[p5l1380t1233r1439b1304],
39	a	DT	O	a	det	40	SENT_80	[p5l1380t1233r1439b1304],
40	decrease	NN	O	decrease	dobj	38	SENT_80	[p5l1464t1232r1756b1290],
41	of	IN	O	of	_	0	SENT_80	[p5l1782t1232r1853b1290],
42	75	CD	PERCENT	75	num	43	SENT_80	[p5l1878t1234r2026b1290],
43	%	NN	PERCENT	%	prep_of	40	SENT_80	[p5l1878t1234r2026b1290],
44	for	IN	O	for	_	0	SENT_80	[p5l2051t1232r2149b1290],
45	677	CD	NUMBER	677	number	46	SENT_80	[p5l13t1328r136b1384],
46	C	NN	O	c	num	48	SENT_80	[p5l170t1328r346b1384],
47	>	JJR	O	>	amod	48	SENT_80	[p5l170t1328r346b1384],
48	T	NN	O	t	prep_for	38	SENT_80	[p5l170t1328r346b1384],
49	and	CC	O	and	_	0	SENT_80	[p5l371t1326r502b1384],
50	30	CD	PERCENT	30	num	51	SENT_80	[p5l533t1328r685b1384],
51	%	NN	PERCENT	%	prep_for	38	SENT_80	[p5l533t1328r685b1384],
52	for	IN	O	for	_	0	SENT_80	[p5l716t1326r814b1384],
53	1298	CD	DATE	1298	prep_for	51	SENT_80	[p5l849t1328r1013b1384],
54	A	DT	O	a	det	57	SENT_80	[p5l1044t1327r1272b1398],
55	>	JJR	O	>	amod	57	SENT_80	[p5l1044t1327r1272b1398],
56	C	NN	O	c	nn	57	SENT_80	[p5l1044t1327r1272b1398],
57	)	NN	O	)	dep	51	SENT_80	[p5l1044t1327r1272b1398],
58	.	.	O	.	_	0	SENT_80	[p5l1044t1327r1272b1398],

1	However	RB	O	however	advmod	9	SENT_81	[p5l1307t1329r1632b1397],
2	,	,	O	,	_	0	SENT_81	[p5l1307t1329r1632b1397],
3	an	DT	O	a	det	4	SENT_81	[p5l1668t1343r1752b1384],
4	accumulation	NN	O	accumulation	nsubjpass	9	SENT_81	[p5l1783t1326r2146b1384, p5l10t1425r155b1480],
5	of	IN	O	of	_	0	SENT_81	[p5l218t1422r289b1480],
6	intracellular	JJ	O	intracellular	amod	7	SENT_81	[p5l347t1422r778b1480],
7	CHZFH4	NN	O	chzfh4	prep_of	4	SENT_81	[p5l841t1424r1120b1491],
8	is	VBZ	O	be	auxpass	9	SENT_81	[p5l1183t1425r1233b1480],
9	observed	VBN	O	observe	_	0	SENT_81	[p5l1297t1422r1609b1480],
10	which	WDT	O	which	nsubj	12	SENT_81	[p5l1669t1422r1889b1480],
11	could	MD	O	could	aux	12	SENT_81	[p5l1952t1422r2148b1480],
12	enhance	VB	O	enhance	ccomp	9	SENT_81	[p5l11t1518r309b1575],
13	the	DT	O	the	det	14	SENT_81	[p5l346t1518r458b1575],
14	efficacy	NN	O	efficacy	dobj	12	SENT_81	[p5l496t1517r765b1593],
15	of	IN	O	of	_	0	SENT_81	[p5l799t1517r871b1575],
16	5-FU	NN	O	5-fu	nn	17	SENT_81	[p5l905t1520r1068b1575],
17	treatment	NN	O	treatment	prep_of	14	SENT_81	[p5l1104t1525r1454b1575],
18	by	IN	O	by	_	0	SENT_81	[p5l1488t1518r1576b1593],
19	stabilization	NN	O	stabilization	prep_by	12	SENT_81	[p5l1611t1518r2043b1575],
20	of	IN	O	of	_	0	SENT_81	[p5l2080t1517r2152b1575],
21	the	DT	O	the	det	23	SENT_81	[p5l10t1613r123b1671],
22	ternary	JJ	O	ternary	amod	23	SENT_81	[p5l153t1620r410b1689],
23	complex	NN	O	complex	prep_of	19	SENT_81	[p5l438t1613r742b1689],
24	with	IN	O	with	_	0	SENT_81	[p5l769t1613r930b1671],
25	TS	NN	O	t	prep_with	12	SENT_81	[p5l958t1615r1040b1671],
26	and	CC	O	and	_	0	SENT_81	[p5l1072t1613r1203b1671],
27	FdUMP	NN	O	fdump	prep_with	12	SENT_81	[p5l1233t1613r1499b1671],
28	.	.	O	.	_	0	SENT_81	[p5l1233t1613r1499b1671],

1	This	DT	O	this	det	2	SENT_82	[p5l1532t1613r1681b1671],
2	concept	NN	O	concept	nsubjpass	5	SENT_82	[p5l1712t1620r1991b1689],
3	was	VBD	O	be	auxpass	5	SENT_82	[p5l2019t1630r2147b1671],
4	clearly	RB	O	clearly	advmod	5	SENT_82	[p5l11t1708r243b1784],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_82	[p5l280t1708r770b1766],
6	both	CC	O	both	preconj	5	SENT_82	[p5l805t1708r972b1766],
7	in	IN	O	in	_	0	SENT_82	[p5l1011t1711r1081b1765],
8	experimental	JJ	O	experimental	amod	9	SENT_82	[p5l1120t1708r1588b1784],
9	studies	NNS	O	study	prep_in	5	SENT_82	[p5l1629t1708r1868b1766],
10	and	CC	O	and	_	0	SENT_82	[p5l1908t1708r2039b1766],
11	in	IN	O	in	_	0	SENT_82	[p5l2077t1711r2148b1765],
12	clinical	JJ	O	clinical	amod	13	SENT_82	[p5l11t1801r266b1859],
13	settings	NNS	O	setting	prep_in	5	SENT_82	[p5l297t1793r745b1877],
14	.18	CD	NUMBER	.18	number	15	SENT_82	[p5l297t1793r745b1877],
15	‘	CD	NUMBER	‘	dep	13	SENT_82	[p5l297t1793r745b1877],
16	23	CD	NUMBER	23	dep	15	SENT_82	[p5l297t1793r745b1877],

1	The	DT	O	the	det	2	SENT_83	[p5l85t1897r217b1955],
2	purpose	NN	O	purpose	nsubj	6	SENT_83	[p5l251t1914r530b1973],
3	of	IN	O	of	_	0	SENT_83	[p5l565t1897r637b1955],
4	this	DT	O	this	det	5	SENT_83	[p5l665t1897r794b1955],
5	study	NN	O	study	prep_of	2	SENT_83	[p5l831t1897r1022b1973],
6	was	VBD	O	be	_	0	SENT_83	[p5l1051t1914r1179b1955],
7	to	TO	O	to	aux	8	SENT_83	[p5l1213t1904r1282b1955],
8	analyze	VB	O	analyze	xcomp	6	SENT_83	[p5l1318t1897r1580b1973],
9	the	DT	O	the	det	10	SENT_83	[p5l1614t1897r1726b1955],
10	correlation	NN	O	correlation	nn	18	SENT_83	[p5l1761t1897r2147b1955],
11	between	IN	O	between	_	0	SENT_83	[p5l9t1992r305b2049],
12	T5	NN	O	t5	prep_between	10	SENT_83	[p5l341t1993r437b2062],
13	,	,	O	,	_	0	SENT_83	[p5l341t1993r437b2062],
14	DPD	NN	ORGANIZATION	dpd	prep_between	10	SENT_83	[p5l471t1994r633b2048],
15	and	CC	O	and	_	0	SENT_83	[p5l666t1991r797b2049],
16	MTHFR	NN	O	mthfr	prep_between	10	SENT_83	[p5l826t1994r1087b2048],
17	germinal	JJ	O	germinal	amod	18	SENT_83	[p5l1121t1992r1435b2067],
18	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_83	[p5l1467t1991r2023b2067],
19	on	IN	O	on	_	0	SENT_83	[p5l2057t2008r2147b2049],
20	efficacy	NN	O	efficacy	prep_on	18	SENT_83	[p5l11t2087r280b2163],
21	and	CC	O	and	_	0	SENT_83	[p5l309t2087r439b2145],
22	toxicity	NN	O	toxicity	prep_on	18	SENT_83	[p5l469t2090r741b2163],
23	of	IN	O	of	_	0	SENT_83	[p5l770t2087r841b2145],
24	ﬂuorouracil	NN	O	ﬂuorouracil	nn	27	SENT_83	[p5l867t2087r1281b2145],
25	and	CC	O	and	_	0	SENT_83	[p5l1313t2087r1443b2145],
26	leucovorin	NN	O	leucovorin	nn	27	SENT_83	[p5l1473t2087r1852b2145],
27	chemotherapy	NN	O	chemotherapy	prep_of	18	SENT_83	[p5l1883t2087r2146b2145, p5l10t2181r283b2257],
28	in	IN	O	in	_	0	SENT_83	[p5l313t2184r384b2238],
29	patients	NNS	O	patient	prep_in	8	SENT_83	[p5l415t2184r697b2257],
30	with	IN	O	with	_	0	SENT_83	[p5l729t2181r890b2239],
31	advanced	JJ	O	advanced	amod	32	SENT_83	[p5l923t2181r1258b2239],
32	CRC	NN	O	crc	prep_with	29	SENT_83	[p5l1291t2183r1466b2239],
33	.	.	O	.	_	0	SENT_83	[p5l1291t2183r1466b2239],

1	Our	PRP$	O	we	poss	2	SENT_84	[p5l1504t2183r1638b2239],
2	objective	NN	O	objective	nsubj	3	SENT_84	[p5l1670t2181r1987b2257],
3	was	VBD	O	be	_	0	SENT_84	[p5l2019t2198r2147b2239],
4	to	TO	O	to	aux	5	SENT_84	[p5l10t2284r80b2334],
5	provide	VB	O	provide	xcomp	3	SENT_84	[p5l143t2276r411b2352],
6	a	DT	O	a	det	7	SENT_84	[p5l476t2293r510b2334],
7	tool	NN	O	tool	dobj	5	SENT_84	[p5l573t2276r712b2334],
8	for	IN	O	for	_	0	SENT_84	[p5l776t2276r874b2334],
9	physicians	NNS	O	physician	prep_for	7	SENT_84	[p5l936t2276r1307b2352],
10	to	TO	O	to	aux	11	SENT_84	[p5l1370t2284r1440b2334],
11	determine	VB	O	determine	xcomp	5	SENT_84	[p5l1505t2276r1865b2334],
12	before	IN	O	before	_	0	SENT_84	[p5l1927t2276r2146b2334],
13	treatment	NN	O	treatment	nn	14	SENT_84	[p5l10t2379r360b2430],
14	patients	NNS	O	patient	prep_before	11	SENT_84	[p5l393t2375r674b2448],
15	at	IN	O	at	_	0	SENT_84	[p5l709t2379r772b2430],
16	risk	NN	O	risk	prep_at	11	SENT_84	[p5l804t2372r929b2430],
17	of	IN	O	of	_	0	SENT_84	[p5l961t2372r1032b2430],
18	5-FU	NN	O	5-fu	nn	19	SENT_84	[p5l1063t2374r1225b2430],
19	toxicity	NN	O	toxicity	prep_of	16	SENT_84	[p5l1258t2375r1531b2448],
20	or	CC	O	or	_	0	SENT_84	[p5l1562t2389r1634b2430],
21	resistance	NN	O	resistance	conj_or	19	SENT_84	[p5l1666t2375r2027b2430],
22	.	.	O	.	_	0	SENT_84	[p5l1666t2375r2027b2430],

1	To	TO	O	to	_	0	SENT_85	[p5l2062t2374r2147b2430],
2	our	PRP$	O	we	poss	3	SENT_85	[p5l11t2483r130b2524],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_85	[p5l170t2467r569b2542],
4	,	,	O	,	_	0	SENT_85	[p5l170t2467r569b2542],
5	this	DT	O	this	det	6	SENT_85	[p5l616t2467r745b2524],
6	study	NN	O	study	nsubj	9	SENT_85	[p5l789t2467r981b2542],
7	is	VBZ	O	be	cop	9	SENT_85	[p5l1020t2470r1070b2524],
8	the	DT	O	the	det	9	SENT_85	[p5l1112t2467r1225b2524],
9	first	JJ	ORDINAL	first	_	0	SENT_85	[p5l1267t2466r1403b2524],
10	that	DT	O	that	nsubj	11	SENT_85	[p5l1444t2467r1587b2524],
11	analyzes	VBZ	O	analyze	rcmod	9	SENT_85	[p5l1629t2467r1923b2542],
12	these	DT	O	these	det	14	SENT_85	[p5l1965t2467r2147b2524],
13	three	CD	NUMBER	three	num	14	SENT_85	[p5l10t2562r190b2619],
14	enzymes	NNS	O	enzyme	dobj	11	SENT_85	[p5l238t2578r540b2637],
15	in	IN	O	in	_	0	SENT_85	[p5l587t2565r657b2619],
16	a	DT	O	a	det	18	SENT_85	[p5l704t2578r738b2619],
17	homogeneous	JJ	O	homogeneous	amod	18	SENT_85	[p5l784t2562r1284b2637],
18	population	NN	O	population	prep_in	14	SENT_85	[p5l1330t2562r1740b2637],
19	.	.	O	.	_	0	SENT_85	[p5l1330t2562r1740b2637],

1	We	PRP	O	we	nsubj	2	SENT_86	[p5l1789t2564r1899b2619],
2	determined	VBD	O	determine	_	0	SENT_86	[p5l1946t2562r2146b2619, p5l11t2657r238b2715],
3	these	DT	O	these	det	5	SENT_86	[p5l272t2657r454b2715],
4	different	JJ	O	different	amod	5	SENT_86	[p5l490t2657r793b2715],
5	polymorphisms	NNS	O	polymorphism	dobj	2	SENT_86	[p5l828t2657r1383b2733],
6	with	IN	O	with	_	0	SENT_86	[p5l1417t2657r1578b2715],
7	usual	JJ	O	usual	amod	9	SENT_86	[p5l1612t2657r1797b2715],
8	biomolecular	JJ	O	biomolecular	amod	9	SENT_86	[p5l1830t2657r2147b2715, p5l11t2752r185b2810],
9	techniques	NNS	O	technique	prep_with	2	SENT_86	[p5l241t2752r646b2828],
10	,	,	O	,	_	0	SENT_86	[p5l241t2752r646b2828],
11	associated	VBN	O	associate	partmod	9	SENT_86	[p5l710t2752r1065b2810],
12	with	IN	O	with	_	0	SENT_86	[p5l1121t2752r1282b2810],
13	the	DT	O	the	det	14	SENT_86	[p5l1340t2752r1452b2810],
14	determination	NN	O	determination	prep_with	11	SENT_86	[p5l1512t2752r2022b2810],
15	of	IN	O	of	_	0	SENT_86	[p5l2080t2752r2152b2810],
16	ﬂuorouracil	NN	O	ﬂuorouracil	nn	17	SENT_86	[p5l11t2847r424b2905],
17	clearance	NN	O	clearance	prep_of	14	SENT_86	[p5l467t2847r794b2905],
18	and	CC	O	and	_	0	SENT_86	[p5l838t2847r969b2905],
19	a	DT	O	a	det	20	SENT_86	[p5l1012t2864r1047b2905],
20	study	NN	O	study	prep_with	11	SENT_86	[p5l1090t2847r1281b2923],
21	of	IN	O	of	_	0	SENT_86	[p5l1322t2847r1393b2905],
22	uracil	NN	O	uracil	prep_of	20	SENT_86	[p5l1429t2847r1627b2905],
23	and	CC	O	and	_	0	SENT_86	[p5l1670t2847r1801b2905],
24	dihydrouracil	NN	O	dihydrouracil	nn	26	SENT_86	[p5l1843t2847r2147b2923, p5l9t2940r207b2997],
25	(	CD	NUMBER	(	num	26	SENT_86	[p5l243t2939r530b3012],
26	UH2/U	NN	O	uh2/u	conj_and	14	SENT_86	[p5l243t2939r530b3012],
27	)	CD	NUMBER	)	num	29	SENT_86	[p5l243t2939r530b3012],
28	plasma	NN	O	plasma	nn	29	SENT_86	[p5l566t2940r814b3015],
29	ratios	NNS	O	ratio	dep	26	SENT_86	[p5l847t2943r1039b2997],
30	as	IN	O	as	mark	31	SENT_86	[p5l1074t2956r1138b2997],
31	described	VBN	O	describe	advcl	11	SENT_86	[p5l1172t2939r1503b2997],
32	previously	RB	DATE	previously	advmod	31	SENT_86	[p5l1535t2932r1983b3015],
33	.	.	O	.	_	0	SENT_86	[p5l1535t2932r1983b3015],

1	“	NN	O	“	nsubjpass	7	SENT_87	[p5l1535t2932r1983b3015],
2	The	DT	O	the	det	5	SENT_87	[p5l2014t2939r2147b2997],
3	genetic	JJ	O	genetic	amod	5	SENT_87	[p5l11t3039r265b3112],
4	polymorphism	NN	O	polymorphism	nn	5	SENT_87	[p5l320t3036r845b3112],
5	analysis	NN	O	analysis	dep	1	SENT_87	[p5l902t3036r1177b3112],
6	was	VBD	O	be	auxpass	7	SENT_87	[p5l1233t3053r1360b3094],
7	carried	VBN	O	carry	_	0	SENT_87	[p5l1418t3036r1657b3094],
8	out	RP	O	out	prt	7	SENT_87	[p5l1714t3043r1831b3094],
9	from	IN	O	from	_	0	SENT_87	[p5l1887t3036r2056b3094],
10	a	DT	O	a	det	14	SENT_87	[p5l2113t3053r2148b3094],
11	simple	JJ	O	simple	amod	14	SENT_87	[p5l12t3130r241b3206],
12	peripheral	JJ	O	peripheral	amod	14	SENT_87	[p5l274t3130r635b3206],
13	blood	NN	O	blood	nn	14	SENT_87	[p5l664t3130r868b3188],
14	sample	NN	O	sample	prep_from	7	SENT_87	[p5l901t3130r1145b3206],
15	that	WDT	O	that	nsubj	16	SENT_87	[p5l1178t3130r1321b3188],
16	represents	VBZ	O	represent	rcmod	14	SENT_87	[p5l1352t3138r1708b3206],
17	an	DT	O	a	det	22	SENT_87	[p5l1741t3147r1826b3188],
18	interesting	JJ	O	interesting	dep	21	SENT_87	[p5l1858t3133r2147b3188, p5l11t3228r124b3301],
19	and	CC	O	and	_	0	SENT_87	[p5l149t3225r280b3283],
20	easy	JJ	O	easy	conj_and	21	SENT_87	[p5l306t3242r455b3301],
21	non-invasive	JJ	O	non-invasive	amod	22	SENT_87	[p5l478t3228r934b3283],
22	approach	NN	O	approach	dobj	16	SENT_87	[p5l963t3226r1290b3301],
23	for	IN	O	for	_	0	SENT_87	[p5l1317t3225r1415b3283],
24	molecular	JJ	O	molecular	amod	25	SENT_87	[p5l1440t3225r1794b3283],
25	profiling	NN	O	profiling	prep_for	22	SENT_87	[p5l1818t3225r2143b3301],
26	.	.	O	.	_	0	SENT_87	[p5l1818t3225r2143b3301],

1	Finally	RB	O	finally	advmod	4	SENT_88	[p5l11t3321r262b3397],
2	,	,	O	,	_	0	SENT_88	[p5l11t3321r262b3397],
3	we	PRP	O	we	nsubj	4	SENT_88	[p5l323t3338r419b3379],
4	evaluated	VBD	O	evaluate	_	0	SENT_88	[p5l480t3321r818b3379],
5	the	DT	O	the	det	6	SENT_88	[p5l877t3321r989b3379],
6	tolerance	NN	O	tolerance	dobj	4	SENT_88	[p5l1049t3321r1374b3379],
7	to	TO	O	to	infmod	6	SENT_88	[p5l1434t3328r1504b3379],
8	and	CC	O	and	_	0	SENT_88	[p5l1564t3321r1696b3379],
9	efficacy	NN	O	efficacy	dobj	4	SENT_88	[p5l1755t3321r2023b3397],
10	of	IN	O	of	_	0	SENT_88	[p5l2080t3321r2152b3379],
11	ﬂuorouracil	NN	O	ﬂuorouracil	nn	12	SENT_88	[p5l11t3414r424b3472],
12	treatment	NN	O	treatment	prep_of	9	SENT_88	[p5l454t3422r822b3472],
13	.	.	O	.	_	0	SENT_88	[p5l454t3422r822b3472],

1	Results	NNS	O	result	_	0	SENT_89	[p5l13t3626r280b3683],

1	Clinical	JJ	O	clinical	amod	2	SENT_90	[p6l16t71r246b129],
2	data	NNS	O	datum	nsubjpass	18	SENT_90	[p6l272t71r418b129],
3	and	CC	O	and	_	0	SENT_90	[p6l447t71r571b129],
4	frequencies	NNS	O	frequency	nsubjpass	18	SENT_90	[p6l598t71r951b147],
5	of	IN	O	of	_	0	SENT_90	[p6l980t71r1046b129],
6	genotypes	NNS	O	genotype	prep_of	2	SENT_90	[p6l1062t78r1388b147],
7	A	DT	O	a	det	8	SENT_90	[p6l9t168r60b224],
8	total	NN	O	total	dep	6	SENT_90	[p6l101t167r262b225],
9	of	IN	O	of	_	0	SENT_90	[p6l305t167r377b225],
10	76	CD	NUMBER	76	num	11	SENT_90	[p6l420t168r497b225],
11	patients	NNS	O	patient	prep_of	8	SENT_90	[p6l539t170r822b243],
12	who	WP	O	who	nsubj	13	SENT_90	[p6l862t167r1015b225],
13	fulfilled	VBD	O	fulfil	rcmod	11	SENT_90	[p6l1058t167r1333b225],
14	the	DT	O	the	det	16	SENT_90	[p6l1375t167r1488b225],
15	inclusion	NN	O	inclusion	nn	16	SENT_90	[p6l1531t167r1860b225],
16	criteria	NNS	O	criterion	dobj	13	SENT_90	[p6l1902t170r2148b225],
17	were	VBD	O	be	auxpass	18	SENT_90	[p6l9t278r172b319],
18	studied	VBN	O	study	_	0	SENT_90	[p6l207t261r480b319],
19	.	.	O	.	_	0	SENT_90	[p6l207t261r480b319],

1	The	DT	O	the	det	3	SENT_91	[p6l514t261r647b319],
2	median	JJ	O	median	amod	3	SENT_91	[p6l680t261r946b319],
3	follow-up	NN	O	follow-up	nsubj	9	SENT_91	[p6l978t261r1317b337],
4	of	IN	O	of	_	0	SENT_91	[p6l1351t261r1422b319],
5	the	DT	O	the	det	6	SENT_91	[p6l1449t261r1562b319],
6	study	NN	O	study	prep_of	3	SENT_91	[p6l1596t262r1788b337],
7	was	VBD	O	be	cop	9	SENT_91	[p6l1816t278r1944b319],
8	1264	CD	DATE	1264	num	9	SENT_91	[p6l1982t263r2146b319],
9	days	NNS	NUMBER	day	_	0	SENT_91	[p6l11t356r165b432],
10	(	VBP	O	(	rcmod	9	SENT_91	[p6l200t356r326b429],
11	3.5	CD	DURATION	3.5	num	12	SENT_91	[p6l200t356r326b429],
12	years	NNS	NUMBER	year	nsubj	19	SENT_91	[p6l359t357r561b432],
13	)	RB	O	)	advmod	12	SENT_91	[p6l359t357r561b432],
14	with	IN	O	with	_	0	SENT_91	[p6l593t356r755b414],
15	7.7	CD	NUMBER	7.7	number	16	SENT_91	[p6l792t358r1014b414],
16	—	CD	NUMBER	—	prep_with	12	SENT_91	[p6l792t358r1014b414],
17	85	CD	DURATION	85	num	18	SENT_91	[p6l792t358r1014b414],
18	months	NNS	NUMBER	month	tmod	16	SENT_91	[p6l1050t356r1323b414],
19	(	VBP	O	(	ccomp	10	SENT_91	[p6l1359t357r1421b428],
20	7	CD	DURATION	7	num	21	SENT_91	[p6l1359t357r1421b428],
21	years	NNS	NUMBER	year	tmod	19	SENT_91	[p6l1452t357r1653b432],
22	)	RB	O	)	advmod	19	SENT_91	[p6l1452t357r1653b432],
23	as	IN	O	as	_	0	SENT_91	[p6l1689t373r1754b414],
24	the	DT	O	the	det	25	SENT_91	[p6l1786t356r1899b414],
25	range	NN	O	range	prep_as	19	SENT_91	[p6l1931t373r2143b432],
26	.	.	O	.	_	0	SENT_91	[p6l1931t373r2143b432],

1	The	DT	O	the	det	3	SENT_92	[p6l9t452r141b510],
2	clinical	JJ	O	clinical	amod	3	SENT_92	[p6l176t452r431b510],
3	data	NNS	O	datum	nsubjpass	8	SENT_92	[p6l465t452r614b510],
4	of	IN	O	of	_	0	SENT_92	[p6l648t452r719b510],
5	these	DT	O	these	det	6	SENT_92	[p6l749t452r930b510],
6	patients	NNS	O	patient	prep_of	3	SENT_92	[p6l964t455r1246b528],
7	are	VBP	O	be	auxpass	8	SENT_92	[p6l1281t469r1382b510],
8	provided	VBN	O	provide	_	0	SENT_92	[p6l1416t452r1731b528],
9	in	IN	O	in	_	0	SENT_92	[p6l1764t455r1834b509],
10	Table	NNP	O	Table	prep_in	8	SENT_92	[p6l1865t452r2051b510],
11	2	CD	NUMBER	2	num	10	SENT_92	[p6l2086t454r2143b510],
12	.	.	O	.	_	0	SENT_92	[p6l2086t454r2143b510],

1	The	DT	O	the	det	3	SENT_93	[p6l9t547r141b604],
2	median	JJ	O	median	amod	3	SENT_93	[p6l169t547r435b604],
3	age	NN	O	age	nsubj	6	SENT_93	[p6l462t563r575b622],
4	was	VBD	O	be	cop	6	SENT_93	[p6l600t563r729b604],
5	71-years	JJ	DURATION	71-years	amod	6	SENT_93	[p6l761t549r1044b622],
6	old	JJ	DURATION	old	_	0	SENT_93	[p6l1072t547r1183b604],
7	and	CC	O	and	_	0	SENT_93	[p6l1210t547r1342b604],
8	93.4	CD	PERCENT	93.4	num	9	SENT_93	[p6l1369t548r1586b604],
9	%	NN	PERCENT	%	nsubj	12	SENT_93	[p6l1369t548r1586b604],
10	of	IN	O	of	_	0	SENT_93	[p6l1614t546r1686b604],
11	patients	NNS	O	patient	prep_of	9	SENT_93	[p6l1707t550r1989b622],
12	had	VBD	O	have	conj_and	6	SENT_93	[p6l2016t547r2148b604],
13	a	DT	O	a	det	16	SENT_93	[p6l11t658r46b699],
14	good	JJ	O	good	amod	16	SENT_93	[p6l86t642r260b717],
15	performance	NN	O	performance	nn	16	SENT_93	[p6l299t641r747b717],
16	status	NN	O	status	dobj	12	SENT_93	[p6l791t649r1008b712],
17	,	,	O	,	_	0	SENT_93	[p6l791t649r1008b712],
18	that	WDT	O	that	nsubj	20	SENT_93	[p6l1053t642r1195b699],
19	is	VBZ	O	be	cop	20	SENT_93	[p6l1235t645r1285b699],
20	lower	JJR	O	lower	rcmod	16	SENT_93	[p6l1327t642r1522b699],
21	than	IN	O	than	_	0	SENT_93	[p6l1560t642r1724b699],
22	2	CD	NUMBER	2	prep_than	20	SENT_93	[p6l1766t643r1823b699],
23	.	.	O	.	_	0	SENT_93	[p6l1766t643r1823b699],

1	The	DT	O	the	det	3	SENT_94	[p6l1865t642r1997b699],
2	sex	NN	O	sex	nn	3	SENT_94	[p6l2040t658r2149b699],
3	ratio	NN	O	ratio	nsubj	5	SENT_94	[p6l11t738r172b792],
4	was	VBD	O	be	cop	5	SENT_94	[p6l222t752r350b792],
5	1.5	CD	NUMBER	1.5	_	0	SENT_94	[p6l407t735r575b799],
6	/	:	O	/	punct	8	SENT_94	[p6l407t735r575b799],
7	1	CD	NUMBER	1	num	8	SENT_94	[p6l407t735r575b799],
8	male/female	NN	O	male/female	dep	5	SENT_94	[p6l631t735r1086b799],
9	.	.	O	.	_	0	SENT_94	[p6l631t735r1086b799],

1	The	DT	O	the	det	2	SENT_95	[p6l1140t735r1272b792],
2	site	NN	O	site	nsubj	6	SENT_95	[p6l1325t738r1441b792],
3	of	IN	O	of	_	0	SENT_95	[p6l1493t735r1565b792],
4	metastasis	NN	O	metastasis	prep_of	2	SENT_95	[p6l1611t738r1969b792],
5	was	VBD	O	be	cop	6	SENT_95	[p6l2019t752r2147b792],
6	unique	JJ	O	unique	_	0	SENT_95	[p6l9t833r258b906],
7	in	IN	O	in	_	0	SENT_95	[p6l288t833r358b887],
8	76	CD	PERCENT	76	num	9	SENT_95	[p6l392t831r539b888],
9	%	NN	PERCENT	%	prep_in	6	SENT_95	[p6l392t831r539b888],
10	of	IN	O	of	_	0	SENT_95	[p6l569t830r640b888],
11	the	DT	O	the	det	12	SENT_95	[p6l664t830r776b888],
12	cases	NNS	O	case	prep_of	9	SENT_95	[p6l806t847r977b888],
13	and	CC	O	and	_	0	SENT_95	[p6l1007t830r1138b888],
14	then	RB	O	then	advmod	6	SENT_95	[p6l1166t830r1330b888],
15	in	IN	O	in	_	0	SENT_95	[p6l1358t833r1428b887],
16	75	CD	PERCENT	75	num	17	SENT_95	[p6l1462t831r1610b888],
17	%	NN	PERCENT	%	prep_in	6	SENT_95	[p6l1462t831r1610b888],
18	of	IN	O	of	_	0	SENT_95	[p6l1639t830r1711b888],
19	cases	NNS	O	case	prep_of	17	SENT_95	[p6l1735t847r1907b888],
20	in	IN	O	in	_	0	SENT_95	[p6l1936t833r2006b887],
21	the	DT	O	the	det	22	SENT_95	[p6l2034t830r2147b888],
22	liver	NN	O	liver	prep_in	19	SENT_95	[p6l11t925r177b983],
23	.	.	O	.	_	0	SENT_95	[p6l11t925r177b983],

1	These	DT	O	these	det	3	SENT_96	[p6l214t925r416b983],
2	clinical	JJ	O	clinical	amod	3	SENT_96	[p6l452t925r707b983],
3	characteristics	NNS	O	characteristic	nsubj	4	SENT_96	[p6l744t925r1242b983],
4	were	VBD	O	be	_	0	SENT_96	[p6l1277t942r1440b983],
5	in	IN	O	in	_	0	SENT_96	[p6l1476t928r1546b982],
6	agreement	NN	O	agreement	prep_in	4	SENT_96	[p6l1582t932r1954b1001],
7	with	IN	O	with	_	0	SENT_96	[p6l1986t925r2148b983],
8	epidemiological	JJ	O	epidemiological	amod	9	SENT_96	[p6l11t1019r576b1095],
9	data	NNS	O	datum	prep_with	4	SENT_96	[p6l606t1019r754b1077],
10	concerning	VBG	O	concern	_	0	SENT_96	[p6l784t1022r1185b1095],
11	advanced	JJ	O	advanced	amod	12	SENT_96	[p6l1214t1019r1548b1077],
12	CRC	NN	O	crc	prep_concerning	9	SENT_96	[p6l1579t1021r1753b1077],
13	.	.	O	.	_	0	SENT_96	[p6l1579t1021r1753b1077],

1	In	IN	O	in	_	0	SENT_97	[p6l88t1117r161b1172],
2	our	PRP$	O	we	poss	3	SENT_97	[p6l203t1132r322b1173],
3	study	NN	O	study	prep_in	10	SENT_97	[p6l365t1115r567b1191],
4	,	,	O	,	_	0	SENT_97	[p6l365t1115r567b1191],
5	83	CD	PERCENT	83	num	6	SENT_97	[p6l616t1116r767b1173],
6	%	NN	PERCENT	%	nsubjpass	10	SENT_97	[p6l616t1116r767b1173],
7	of	IN	O	of	_	0	SENT_97	[p6l810t1115r882b1173],
8	patients	NNS	O	patient	prep_of	6	SENT_97	[p6l920t1118r1202b1191],
9	were	VBD	O	be	auxpass	10	SENT_97	[p6l1243t1132r1406b1173],
10	treated	VBN	O	treat	_	0	SENT_97	[p6l1450t1115r1695b1173],
11	in	IN	O	in	_	0	SENT_97	[p6l1737t1118r1808b1172],
12	first	JJ	ORDINAL	first	amod	15	SENT_97	[p6l1850t1115r2146b1173],
13	—	NN	O	—	nn	15	SENT_97	[p6l1850t1115r2146b1173],
14	line	NN	O	line	nn	15	SENT_97	[p6l1850t1115r2146b1173],
15	therapy	NN	O	therapy	prep_in	10	SENT_97	[p6l10t1209r293b1285],
16	.	.	O	.	_	0	SENT_97	[p6l10t1209r293b1285],

1	Table	NNP	O	Table	nsubj	3	SENT_98	[p6l85t1304r270b1362],
2	3	CD	NUMBER	3	num	1	SENT_98	[p6l301t1306r336b1362],
3	lists	VBZ	O	list	_	0	SENT_98	[p6l368t1305r502b1362],
4	the	DT	O	the	det	5	SENT_98	[p6l531t1304r643b1362],
5	distribution	NN	O	distribution	dobj	3	SENT_98	[p6l673t1304r1091b1362],
6	of	IN	O	of	_	0	SENT_98	[p6l1121t1304r1192b1362],
7	TS	NN	O	t	nn	13	SENT_98	[p6l1220t1306r1316b1375],
8	,	,	O	,	_	0	SENT_98	[p6l1220t1306r1316b1375],
9	DPD	NN	ORGANIZATION	dpd	nn	13	SENT_98	[p6l1345t1307r1507b1361],
10	and	CC	O	and	_	0	SENT_98	[p6l1537t1304r1667b1362],
11	MTHFR	NN	O	mthfr	nn	13	SENT_98	[p6l1692t1307r1954b1361],
12	gene	NN	O	gene	nn	13	SENT_98	[p6l1984t1321r2147b1380],
13	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_98	[p6l10t1400r584b1476],
14	.	.	O	.	_	0	SENT_98	[p6l10t1400r584b1476],

1	This	DT	O	this	det	2	SENT_99	[p6l639t1400r789b1458],
2	distribution	NN	O	distribution	nsubj	4	SENT_99	[p6l843t1400r1261b1458],
3	was	VBD	O	be	cop	4	SENT_99	[p6l1312t1417r1440b1458],
4	similar	JJ	O	similar	_	0	SENT_99	[p6l1495t1400r1734b1458],
5	with	IN	O	with	_	0	SENT_99	[p6l1784t1400r1946b1458],
6	data	NNS	O	datum	prep_with	4	SENT_99	[p6l1999t1400r2148b1458],
7	previously	RB	DATE	previously	advmod	8	SENT_99	[p6l10t1493r379b1568],
8	described	VBN	O	describe	partmod	6	SENT_99	[p6l433t1493r764b1550],
9	in	IN	O	in	_	0	SENT_99	[p6l820t1496r890b1550],
10	a	DT	O	a	det	13	SENT_99	[p6l947t1510r982b1550],
11	Caucasian	JJ	MISC	caucasian	amod	13	SENT_99	[p6l1039t1494r1397b1550],
12	populati0n	NN	O	populati0n	nn	13	SENT_99	[p6l1453t1485r2148b1568],
13	:5	NN	O	:5	prep_in	8	SENT_99	[p6l1453t1485r2148b1568],
14	'	''	DATE	'	_	0	SENT_99	[p6l1453t1485r2148b1568],
15	16	CD	DATE	16	dobj	8	SENT_99	[p6l1453t1485r2148b1568],
16	'	''	DATE	'	_	0	SENT_99	[p6l1453t1485r2148b1568],
17	17	CD	DATE	17	nn	46	SENT_99	[p6l1453t1485r2148b1568],
18	'	''	O	'	_	0	SENT_99	[p6l1453t1485r2148b1568],
19	2	CD	PERCENT	2	amod	46	SENT_99	[p6l1453t1485r2148b1568],
20	°	CD	PERCENT	°	number	21	SENT_99	[p6l1453t1485r2148b1568],
21	18.4	CD	PERCENT	18.4	num	22	SENT_99	[p6l16t1589r229b1645],
22	%	NN	PERCENT	%	dep	19	SENT_99	[p6l16t1589r229b1645],
23	for	IN	O	for	_	0	SENT_99	[p6l275t1587r373b1645],
24	2R/2R	NN	O	2r/2r	prep_for	22	SENT_99	[p6l418t1587r645b1658],
25	,	,	O	,	_	0	SENT_99	[p6l418t1587r645b1658],
26	9.2	CD	PERCENT	9.2	number	27	SENT_99	[p6l696t1589r870b1645],
27	%	NN	PERCENT	%	appos	22	SENT_99	[p6l696t1589r870b1645],
28	for	IN	O	for	_	0	SENT_99	[p6l916t1587r1014b1645],
29	MTHFR	NNP	O	MTHFR	prep_for	27	SENT_99	[p6l1055t1590r1317b1645],
30	1298	CD	DATE	1298	num	29	SENT_99	[p6l1369t1589r1533b1645],
31	C/C	NNP	O	C/C	dep	29	SENT_99	[p6l1582t1587r1736b1658],
32	,	,	O	,	_	0	SENT_99	[p6l1582t1587r1736b1658],
33	10.6	CD	PERCENT	10.6	num	34	SENT_99	[p6l1792t1589r2005b1645],
34	%	NN	PERCENT	%	prep_for	27	SENT_99	[p6l1792t1589r2005b1645],
35	for	IN	O	for	_	0	SENT_99	[p6l2051t1587r2149b1645],
36	MTHFR	NN	O	mthfr	nn	38	SENT_99	[p6l8t1687r269b1741],
37	677	CD	NUMBER	677	num	38	SENT_99	[p6l307t1686r430b1742],
38	T/T	NN	O	t/t	prep_for	34	SENT_99	[p6l465t1684r597b1755],
39	,	,	O	,	_	0	SENT_99	[p6l465t1684r597b1755],
40	and	CC	O	and	_	0	SENT_99	[p6l637t1684r769b1742],
41	3.9	CD	PERCENT	3.9	num	42	SENT_99	[p6l804t1686r978b1742],
42	%	NN	PERCENT	%	prep_for	27	SENT_99	[p6l804t1686r978b1742],
43	for	IN	O	for	_	0	SENT_99	[p6l1013t1684r1110b1742],
44	DPD	NN	O	dpd	prep_for	42	SENT_99	[p6l1141t1687r1303b1741],
45	polymorphism	NN	O	polymorphism	nn	46	SENT_99	[p6l1336t1684r1861b1760],
46	heteroThe	NN	O	heterothe	dep	8	SENT_99	[p6l1896t1684r2147b1742, p6l9t1952r111b1997],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_100	[p6l138t1952r678b2011],
2	Journal	NNP	O	Journal	nn	3	SENT_100	[p6l700t1952r893b2007],
3	Table	NNP	O	Table	_	0	SENT_100	[p6l7t2041r196b2097],
4	2	CD	NUMBER	2	num	5	SENT_100	[p6l226t2043r264b2096],
5	Patients	NNS	O	patient	dep	3	SENT_100	[p6l346t2043r629b2097],
6	’	CD	NUMBER	’	num	8	SENT_100	[p6l346t2043r629b2097],
7	initial	JJ	O	initial	amod	8	SENT_100	[p6l661t2043r842b2097],
8	characteristics	NNS	O	characteristic	dep	3	SENT_100	[p6l874t2043r1349b2097],

1	Clinical	JJ	O	clinical	amod	3	SENT_101	[p6l13t2216r231b2270],
2	data	NNS	O	datum	nn	3	SENT_101	[p6l256t2215r393b2270],
3	Number	NN	O	number	_	0	SENT_101	[p6l1420t2215r1670b2270],
4	of	IN	O	of	_	0	SENT_101	[p6l1693t2216r1755b2270],
5	patients	NNS	O	patient	prep_of	3	SENT_101	[p6l1771t2217r2015b2287],
6	(	CD	PERCENT	(	num	7	SENT_101	[p6l2044t2216r2149b2284],
7	%	NN	PERCENT	%	dep	3	SENT_101	[p6l2044t2216r2149b2284],
8	)	CD	NUMBER	)	dep	7	SENT_101	[p6l2044t2216r2149b2284],

1	Gender	NN	O	gender	_	0	SENT_102	[p6l13t2398r233b2452],

1	Male	JJ	O	male	_	0	SENT_103	[p6l84t2484r233b2539],
2	46	CD	NUMBER	46	number	3	SENT_103	[p6l1632t2486r1710b2539],
3	(	CD	NUMBER	(	num	5	SENT_103	[p6l1741t2484r1931b2553],
4	60.5	CD	NUMBER	60.5	number	5	SENT_103	[p6l1741t2484r1931b2553],
5	)	CD	NUMBER	)	npadvmod	6	SENT_103	[p6l1741t2484r1931b2553],
6	Female	JJ	O	female	amod	1	SENT_103	[p6l84t2571r302b2626],
7	30	CD	NUMBER	30	dep	1	SENT_103	[p6l1637t2573r1711b2626],
8	(	CD	NUMBER	(	number	9	SENT_103	[p6l1741t2571r1931b2640],
9	39.5	CD	NUMBER	39.5	num	10	SENT_103	[p6l1741t2571r1931b2640],
10	)	NN	O	)	dep	7	SENT_103	[p6l1741t2571r1931b2640],

1	PS	NNP	O	PS	_	0	SENT_104	[p6l12t2747r82b2799],

1	Age	NN	O	age	_	0	SENT_105	[p6l7t3095r122b3165],

1	Median	JJ	O	median	amod	3	SENT_106	[p6l84t3179r316b3234],
2	(	CD	NUMBER	(	num	3	SENT_106	[p6l348t3179r555b3251],
3	years	NNS	NUMBER	year	nsubj	4	SENT_106	[p6l348t3179r555b3251],
4	)	VBP	O	)	_	0	SENT_106	[p6l348t3179r555b3251],
5	71.2	CD	NUMBER	71.2	num	8	SENT_106	[p6l1661t3181r1796b3234],
6	Range	NNP	O	Range	nn	8	SENT_106	[p6l84t3267r274b3337],
7	(	CD	NUMBER	(	num	8	SENT_106	[p6l304t3265r510b3337],
8	years	NNS	NUMBER	year	dobj	4	SENT_106	[p6l304t3265r510b3337],
9	)	VBP	O	)	rcmod	8	SENT_106	[p6l304t3265r510b3337],
10	39-88	CD	NUMBER	39-88	dobj	9	SENT_106	[p6l1688t3267r1880b3320],

1	Tumor	NN	O	tumor	nn	2	SENT_107	[p6l16t3441r212b3493],
2	site	NN	O	site	_	0	SENT_107	[p6l232t3440r334b3493],

1	Colon	NN	O	colon	_	0	SENT_108	[p6l82t3525r265b3580],
2	55	CD	NUMBER	55	number	1	SENT_108	[p6l1633t3527r1708b3580],
3	(	CD	NUMBER	(	number	1	SENT_108	[p6l1741t3525r1931b3593],
4	72.5	CD	NUMBER	72.5	number	1	SENT_108	[p6l1741t3525r1931b3593],
5	)	CD	NUMBER	)	num	6	SENT_108	[p6l1741t3525r1931b3593],
6	Rectum	NN	ORGANIZATION	rectum	dep	1	SENT_108	[p6l84t3615r316b3667],
7	21	CD	NUMBER	21	number	8	SENT_108	[p6l1633t3614r1697b3666],
8	(	CD	NUMBER	(	dep	1	SENT_108	[p6l1741t3612r1931b3681],
9	27.5	CD	NUMBER	27.5	num	10	SENT_108	[p6l1741t3612r1931b3681],
10	)	NN	O	)	dep	8	SENT_108	[p6l1741t3612r1931b3681],

1	Metastatic	JJ	O	metastatic	amod	2	SENT_109	[p7l11t60r332b113],
2	site	NN	O	site	_	0	SENT_109	[p7l356t60r457b113],

1	Liver	NN	O	liver	dep	10	SENT_110	[p7l84t146r228b200],
2	44	CD	NUMBER	44	num	3	SENT_110	[p7l1632t147r1710b199],
3	(	NN	O	(	dep	1	SENT_110	[p7l1741t145r1868b213],
4	58	CD	NUMBER	58	number	5	SENT_110	[p7l1741t145r1868b213],
5	)	CD	NUMBER	)	num	6	SENT_110	[p7l1741t145r1868b213],
6	Lung	NN	O	lung	dep	3	SENT_110	[p7l84t234r235b304],
7	4	CD	NUMBER	4	num	8	SENT_110	[p7l1673t234r1710b286],
8	(	NN	O	(	dep	10	SENT_110	[p7l1741t232r1889b300],
9	5.3	CD	NUMBER	5.3	num	10	SENT_110	[p7l1741t232r1889b300],
10	)	CD	NUMBER	)	dep	17	SENT_110	[p7l1741t232r1889b300],
11	Peritoneal	JJ	ORGANIZATION	peritoneal	amod	12	SENT_110	[p7l84t318r390b373],
12	5	CD	NUMBER	5	dep	10	SENT_110	[p7l1675t320r1708b373],
13	(	CD	NUMBER	(	number	14	SENT_110	[p7l1741t318r1889b386],
14	6.5	CD	NUMBER	6.5	num	15	SENT_110	[p7l1741t318r1889b386],
15	)	NN	O	)	dep	12	SENT_110	[p7l1741t318r1889b386],
16	Carcinomatosis	NNP	O	Carcinomatosis	nn	17	SENT_110	[p7l82t406r563b459],
17	Nodes	NNP	O	Nodes	_	0	SENT_110	[p7l84t491r282b546],
18	5	CD	NUMBER	5	number	19	SENT_110	[p7l1675t493r1708b546],
19	(	CD	NUMBER	(	dep	17	SENT_110	[p7l1741t491r1889b559],
20	6.5	CD	NUMBER	6.5	num	21	SENT_110	[p7l1741t491r1889b559],
21	)	NN	O	)	dep	19	SENT_110	[p7l1741t491r1889b559],

1	Number	NN	O	number	_	0	SENT_111	[p7l12t665r274b720],
2	of	IN	O	of	_	0	SENT_111	[p7l300t665r361b720],
3	sites	NNS	O	site	prep_of	1	SENT_111	[p7l386t666r617b720],
4	>	JJR	O	>	amod	3	SENT_111	[p7l386t666r617b720],
5	1	CD	NUMBER	1	number	6	SENT_111	[p7l386t666r617b720],
6	18	CD	NUMBER	18	num	7	SENT_111	[p7l1637t667r1710b720],
7	(	NN	O	(	dep	1	SENT_111	[p7l1741t665r1931b733],
8	23.5	CD	NUMBER	23.5	num	9	SENT_111	[p7l1741t665r1931b733],
9	)	NN	O	)	dep	7	SENT_111	[p7l1741t665r1931b733],

1	Treatment	NN	O	treatment	nn	2	SENT_112	[p7l16t842r325b894],
2	regimen	NNS	O	regimen	_	0	SENT_112	[p7l351t841r592b911],

1	LV5FU2	NN	O	lv5fu2	_	0	SENT_113	[p7l84t927r319b980],
2	31	CD	NUMBER	31	num	1	SENT_113	[p7l1637t927r1697b980],
3	(	CD	NUMBER	(	number	4	SENT_113	[p7l1741t926r1868b994],
4	41	CD	NUMBER	41	num	8	SENT_113	[p7l1741t926r1868b994],
5	)	NN	O	)	nn	8	SENT_113	[p7l1741t926r1868b994],
6	Fufol	NN	ORGANIZATION	fufol	nn	8	SENT_113	[p7l84t1012r229b1067],
7	4	CD	NUMBER	4	num	8	SENT_113	[p7l260t1015r296b1067],
8	h	NN	O	h	dep	1	SENT_113	[p7l317t1013r350b1067],
9	45	CD	NUMBER	45	number	10	SENT_113	[p7l1632t1015r1708b1067],
10	(	CD	NUMBER	(	dep	1	SENT_113	[p7l1741t1013r1868b1081],
11	59	CD	NUMBER	59	num	12	SENT_113	[p7l1741t1013r1868b1081],
12	)	NN	O	)	dep	10	SENT_113	[p7l1741t1013r1868b1081],

1	First	JJ	ORDINAL	first	amod	2	SENT_114	[p7l12t1188r136b1241],
2	line	NN	O	line	_	0	SENT_114	[p7l165t1187r271b1241],
3	of	IN	O	of	_	0	SENT_114	[p7l300t1187r361b1241],
4	treatment	NN	O	treatment	prep_of	2	SENT_114	[p7l386t1193r701b1241],
5	63	CD	NUMBER	63	number	6	SENT_114	[p7l1634t1188r1709b1241],
6	(	CD	NUMBER	(	dep	2	SENT_114	[p7l1741t1187r1868b1255],
7	83	CD	NUMBER	83	num	8	SENT_114	[p7l1741t1187r1868b1255],
8	)	NN	O	)	dep	6	SENT_114	[p7l1741t1187r1868b1255],

1	zygotes	NNS	O	zygote	_	0	SENT_115	[p7l8t1436r286b1505],
2	.	.	O	.	_	0	SENT_115	[p7l8t1436r286b1505],

1	Moreover	RB	O	moreover	advmod	6	SENT_116	[p7l348t1431r702b1499],
2	,	,	O	,	_	0	SENT_116	[p7l348t1431r702b1499],
3	these	DT	O	these	det	5	SENT_116	[p7l765t1429r947b1487],
4	genotype	NN	O	genotype	nn	5	SENT_116	[p7l1008t1436r1333b1505],
5	frequencies	NNS	O	frequency	nsubj	6	SENT_116	[p7l1394t1429r1796b1505],
6	were	VBD	O	be	_	0	SENT_116	[p7l1854t1446r2018b1487],
7	in	IN	O	in	_	0	SENT_116	[p7l2078t1432r2148b1486],
8	agreement	NN	O	agreement	prep_in	6	SENT_116	[p7l9t1532r381b1600],
9	with	IN	O	with	_	0	SENT_116	[p7l450t1525r611b1582],
10	the	DT	O	the	det	11	SENT_116	[p7l681t1525r793b1582],
11	Hardy	NNP	PERSON	Hardy	prep_with	8	SENT_116	[p7l866t1525r1460b1600],
12	.	.	O	.	_	0	SENT_116	[p7l866t1525r1460b1600],

1	—	NN	O	—	_	0	SENT_117	[p7l866t1525r1460b1600],
2	.	.	O	.	_	0	SENT_117	[p7l866t1525r1460b1600],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_118	[p7l866t1525r1460b1600],
2	equilibrium	NN	O	equilibrium	nsubj	9	SENT_118	[p7l1530t1525r1946b1600],
3	and	CC	O	and	_	0	SENT_118	[p7l2018t1525r2148b1582],
4	populations	NNS	O	population	nsubj	9	SENT_118	[p7l8t1620r431b1695],
5	with	IN	O	with	_	0	SENT_118	[p7l502t1620r663b1677],
6	different	JJ	O	different	amod	7	SENT_118	[p7l735t1619r1039b1677],
7	polymorphisms	NNS	O	polymorphism	prep_with	2	SENT_118	[p7l1110t1620r1666b1695],
8	are	VBP	O	be	cop	9	SENT_118	[p7l1739t1636r1840b1677],
9	homogeneous	JJ	O	homogeneous	_	0	SENT_118	[p7l1913t1620r2147b1677, p7l8t1732r295b1791],
10	with	IN	O	with	_	0	SENT_118	[p7l319t1715r481b1773],
11	respect	NN	O	respect	prep_with	9	SENT_118	[p7l506t1722r752b1791],
12	to	TO	O	to	_	0	SENT_118	[p7l776t1722r846b1773],
13	age	NN	O	age	nn	16	SENT_118	[p7l872t1732r1004b1791],
14	,	,	O	,	_	0	SENT_118	[p7l872t1732r1004b1791],
15	performance	NN	O	performance	conj_and	16	SENT_118	[p7l1034t1715r1482b1791],
16	status	NN	O	status	prep_to	9	SENT_118	[p7l1510t1722r1709b1773],
17	and	CC	O	and	_	0	SENT_118	[p7l1736t1715r1867b1773],
18	gender	NN	O	gender	conj_and	16	SENT_118	[p7l1892t1715r2144b1791],
19	.	.	O	.	_	0	SENT_118	[p7l1892t1715r2144b1791],

1	Correlation	NN	O	correlation	nsubjpass	12	SENT_119	[p7l13t1906r363b1964],
2	between	IN	O	between	_	0	SENT_119	[p7l394t1906r659b1964],
3	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_119	[p7l685t1906r1171b1982],
4	and	CC	O	and	_	0	SENT_119	[p7l1201t1906r1325b1964],
5	toxicity	NN	O	toxicity	prep_between	1	SENT_119	[p7l1354t1907r1581b1982],
6	The	DT	O	the	det	8	SENT_119	[p7l7t2001r139b2058],
7	different	JJ	O	different	amod	8	SENT_119	[p7l188t2000r492b2058],
8	types	NNS	O	type	dep	5	SENT_119	[p7l540t2008r722b2076],
9	of	IN	O	of	_	0	SENT_119	[p7l771t2000r842b2058],
10	toxicity	NN	O	toxicity	prep_of	8	SENT_119	[p7l886t2003r1159b2076],
11	are	VBP	O	be	auxpass	12	SENT_119	[p7l1206t2017r1307b2058],
12	described	VBN	O	describe	_	0	SENT_119	[p7l1357t2000r1688b2058],
13	in	IN	O	in	_	0	SENT_119	[p7l1736t2003r1806b2057],
14	Table	NNP	O	Table	prep_in	12	SENT_119	[p7l1852t2000r2037b2058],
15	4	CD	NUMBER	4	num	14	SENT_119	[p7l2087t2003r2144b2058],
16	.	.	O	.	_	0	SENT_119	[p7l2087t2003r2144b2058],

1	Sixty	CD	NUMBER	sixty	nsubj	6	SENT_120	[p7l9t2097r307b2172],
2	—	CD	NUMBER	—	num	5	SENT_120	[p7l9t2097r307b2172],
3	six	CD	NUMBER	six	num	5	SENT_120	[p7l9t2097r307b2172],
4	adverse	JJ	O	adverse	amod	5	SENT_120	[p7l343t2096r602b2154],
5	events	NNS	O	event	dep	1	SENT_120	[p7l639t2103r863b2154],
6	(	VBP	O	(	_	0	SENT_120	[p7l903t2096r1145b2168],
7	87.9	CD	PERCENT	87.9	num	8	SENT_120	[p7l903t2096r1145b2168],
8	%	NN	PERCENT	%	dobj	6	SENT_120	[p7l903t2096r1145b2168],
9	grade	NN	O	grade	nsubjpass	17	SENT_120	[p7l1181t2096r1371b2172],
10	1	CD	NUMBER	1	num	9	SENT_120	[p7l1414t2098r1443b2153],
11	and	CC	O	and	_	0	SENT_120	[p7l1485t2096r1616b2154],
12	2	CD	NUMBER	2	num	14	SENT_120	[p7l1653t2097r1692b2153],
13	side	JJ	O	side	amod	14	SENT_120	[p7l1729t2096r1862b2154],
14	effects	NNS	O	effect	conj_and	9	SENT_120	[p7l1900t2096r2145b2168],
15	)	CD	NUMBER	)	dep	14	SENT_120	[p7l1900t2096r2145b2168],
16	were	VBD	O	be	auxpass	17	SENT_120	[p7l7t2207r170b2248],
17	notified	VBN	O	notify	rcmod	8	SENT_120	[p7l199t2190r495b2261],
18	,	,	O	,	_	0	SENT_120	[p7l199t2190r495b2261],
19	especially	RB	O	especially	advmod	8	SENT_120	[p7l528t2190r871b2266],
20	skin	NN	O	skin	nn	23	SENT_120	[p7l898t2190r1040b2248],
21	and	CC	O	and	_	0	SENT_120	[p7l1069t2190r1200b2248],
22	gastrointestinal	JJ	O	gastrointestinal	nn	23	SENT_120	[p7l1227t2190r1776b2266],
23	(	NN	O	(	dep	8	SENT_120	[p7l1808t2191r2050b2263],
24	47.5	CD	PERCENT	47.5	num	25	SENT_120	[p7l1808t2191r2050b2263],
25	%	NN	PERCENT	%	dep	23	SENT_120	[p7l1808t2191r2050b2263],
26	in	IN	O	in	_	0	SENT_120	[p7l2078t2193r2148b2247],
27	total	JJ	O	total	amod	28	SENT_120	[p7l8t2284r215b2357],
28	)	NN	O	)	prep_in	25	SENT_120	[p7l8t2284r215b2357],
29	:	:	O	:	_	0	SENT_120	[p7l8t2284r215b2357],
30	mucositis	NN	O	mucositis	conj_and	8	SENT_120	[p7l279t2287r615b2342],
31	(	CD	PERCENT	(	num	30	SENT_120	[p7l679t2285r922b2357],
32	7.5	CD	PERCENT	7.5	number	33	SENT_120	[p7l679t2285r922b2357],
33	%	NN	PERCENT	%	amod	30	SENT_120	[p7l679t2285r922b2357],
34	)	CD	NUMBER	)	dep	30	SENT_120	[p7l679t2285r922b2357],
35	,	,	O	,	_	0	SENT_120	[p7l679t2285r922b2357],
36	diarrhea	NN	O	diarrhea	conj_and	8	SENT_120	[p7l987t2284r1278b2342],
37	(	CD	PERCENT	(	number	38	SENT_120	[p7l1341t2285r1541b2357],
38	22	CD	PERCENT	22	num	39	SENT_120	[p7l1341t2285r1541b2357],
39	%	NN	PERCENT	%	dep	36	SENT_120	[p7l1341t2285r1541b2357],
40	)	CD	NUMBER	)	dep	36	SENT_120	[p7l1341t2285r1541b2357],
41	and	CC	O	and	_	0	SENT_120	[p7l1605t2284r1736b2342],
42	hand-foot	JJ	O	hand-foot	amod	43	SENT_120	[p7l1795t2284r2148b2342],
43	syndrome	NN	O	syndrome	dobj	6	SENT_120	[p7l10t2381r359b2457],
44	(	CD	PERCENT	(	number	45	SENT_120	[p7l429t2381r651b2453],
45	18	CD	PERCENT	18	num	46	SENT_120	[p7l429t2381r651b2453],
46	%	NN	PERCENT	%	dep	43	SENT_120	[p7l429t2381r651b2453],
47	)	CD	NUMBER	)	dep	43	SENT_120	[p7l429t2381r651b2453],
48	.	.	O	.	_	0	SENT_120	[p7l429t2381r651b2453],

1	Conjunctival	JJ	O	conjunctival	amod	2	SENT_121	[p7l723t2381r1186b2457],
2	irritation	NN	O	irritation	nsubj	6	SENT_121	[p7l1252t2384r1571b2439],
3	was	VBD	O	be	cop	6	SENT_121	[p7l1635t2398r1763b2439],
4	not	RB	O	not	neg	6	SENT_121	[p7l1830t2388r1950b2439],
5	rare	JJ	O	rare	amod	6	SENT_121	[p7l2016t2398r2148b2439],
6	(	NN	O	(	_	0	SENT_121	[p7l12t2476r212b2548],
7	17	CD	PERCENT	17	number	8	SENT_121	[p7l12t2476r212b2548],
8	%	NN	PERCENT	%	amod	6	SENT_121	[p7l12t2476r212b2548],
9	)	CD	NUMBER	)	nsubj	14	SENT_121	[p7l12t2476r212b2548],
10	but	CC	O	but	dep	11	SENT_121	[p7l257t2476r376b2533],
11	often	RB	O	often	dep	9	SENT_121	[p7l420t2475r605b2533],
12	not	RB	O	not	dep	13	SENT_121	[p7l648t2483r769b2533],
13	much	JJ	O	much	dep	11	SENT_121	[p7l812t2476r1016b2533],
14	described	VBN	O	describe	rcmod	6	SENT_121	[p7l1060t2476r1392b2533],
15	in	IN	O	in	_	0	SENT_121	[p7l1435t2479r1505b2533],
16	previous	JJ	O	previous	amod	18	SENT_121	[p7l1548t2479r1848b2551],
17	clinical	JJ	O	clinical	amod	18	SENT_121	[p7l1893t2476r2148b2533],
18	data	NNS	O	datum	prep_in	14	SENT_121	[p7l9t2571r158b2628],
19	although	IN	O	although	mark	21	SENT_121	[p7l188t2571r509b2646],
20	it	PRP	O	it	nsubj	21	SENT_121	[p7l540t2574r589b2628],
21	impaired	VBD	O	impair	advcl	14	SENT_121	[p7l619t2571r935b2646],
22	the	DT	O	the	det	23	SENT_121	[p7l964t2571r1077b2628],
23	quality	NN	O	quality	dobj	21	SENT_121	[p7l1109t2571r1358b2646],
24	of	IN	O	of	_	0	SENT_121	[p7l1386t2570r1458b2628],
25	life	NN	O	life	prep_of	23	SENT_121	[p7l1484t2570r1610b2628],
26	.	.	O	.	_	0	SENT_121	[p7l1484t2570r1610b2628],

1	The	DT	O	the	det	2	SENT_122	[p7l1642t2571r1775b2628],
2	incidence	NN	O	incidence	nsubj	8	SENT_122	[p7l1806t2571r2147b2628],
3	of	IN	O	of	_	0	SENT_122	[p7l9t2666r80b2724],
4	hematological	JJ	O	hematological	amod	5	SENT_122	[p7l123t2666r628b2742],
5	events	NNS	O	event	prep_of	2	SENT_122	[p7l676t2673r900b2724],
6	was	VBD	O	be	cop	8	SENT_122	[p7l946t2683r1074b2724],
7	low	JJ	O	low	amod	8	SENT_122	[p7l1121t2666r1249b2724],
8	(	NN	O	(	_	0	SENT_122	[p7l1298t2666r1482b2742],
9	only	RB	O	only	quantmod	10	SENT_122	[p7l1298t2666r1482b2742],
10	3	CD	PERCENT	3	num	11	SENT_122	[p7l1528t2666r1681b2738],
11	%	NN	PERCENT	%	dep	8	SENT_122	[p7l1528t2666r1681b2738],
12	)	CD	NUMBER	)	dep	11	SENT_122	[p7l1528t2666r1681b2738],
13	.	.	O	.	_	0	SENT_122	[p7l1528t2666r1681b2738],

1	Finally	RB	O	finally	advmod	10	SENT_123	[p7l1733t2666r1983b2742],
2	,	,	O	,	_	0	SENT_123	[p7l1733t2666r1983b2742],
3	the	DT	O	the	det	4	SENT_123	[p7l2035t2666r2147b2724],
4	incidence	NN	O	incidence	nsubj	10	SENT_123	[p7l8t2761r349b2819],
5	of	IN	O	of	_	0	SENT_123	[p7l373t2761r445b2819],
6	cardiac	JJ	O	cardiac	amod	7	SENT_123	[p7l463t2761r711b2819],
7	toxicity	NN	O	toxicity	prep_of	4	SENT_123	[p7l733t2764r1006b2837],
8	was	VBD	O	be	cop	10	SENT_123	[p7l1024t2778r1152b2819],
9	6	CD	PERCENT	6	num	10	SENT_123	[p7l1176t2762r1283b2819],
10	%	NN	PERCENT	%	_	0	SENT_123	[p7l1176t2762r1283b2819],
11	but	CC	O	but	cc	10	SENT_123	[p7l1303t2761r1422b2819],
12	without	IN	O	without	_	0	SENT_123	[p7l1442t2761r1725b2819],
13	constituted	VBN	O	constitute	amod	15	SENT_123	[p7l1747t2761r2149b2819],
14	myocardial	JJ	O	myocardial	amod	15	SENT_123	[p7l8t2856r404b2932],
15	infarction	NN	O	infarction	prep_without	10	SENT_123	[p7l433t2856r801b2914],
16	.	.	O	.	_	0	SENT_123	[p7l433t2856r801b2914],

1	With	IN	O	with	_	0	SENT_124	[p7l84t2951r263b3008],
2	the	DT	O	the	det	4	SENT_124	[p7l340t2950r453b3008],
3	tailored	VBN	O	tailor	amod	4	SENT_124	[p7l532t2950r803b3008],
4	regimens	NNS	O	regimen	nsubj	5	SENT_124	[p7l881t2953r1201b3026],
5	using	VBG	O	use	prepc_with	16	SENT_124	[p7l1279t2953r1472b3026],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_124	[p7l1547t2950r2148b3026],
7	monitoring	NN	O	monitoring	dobj	5	SENT_124	[p7l8t3049r433b3122],
8	,	,	O	,	_	0	SENT_124	[p7l8t3049r433b3122],
9	the	DT	O	the	det	11	SENT_124	[p7l472t3046r585b3104],
10	ﬂuorouracil	NN	O	ﬂuorouracil	nn	11	SENT_124	[p7l621t3046r1260b3104],
11	—	NN	O	—	nsubjpass	16	SENT_124	[p7l621t3046r1260b3104],
12	based	VBN	O	base	partmod	11	SENT_124	[p7l621t3046r1260b3104],
13	chemotherapy	NN	O	chemotherapy	dobj	12	SENT_124	[p7l1296t3046r1812b3122],
14	was	VBD	O	be	auxpass	16	SENT_124	[p7l1842t3063r1970b3104],
15	well	RB	O	well	advmod	16	SENT_124	[p7l2003t3046r2148b3104],
16	tolerated	VBN	O	tolerate	_	0	SENT_124	[p7l8t3140r323b3198],
17	(	NN	O	(	dobj	16	SENT_124	[p7l359t3140r543b3216],
18	only	RB	O	only	quantmod	19	SENT_124	[p7l359t3140r543b3216],
19	10.5	CD	PERCENT	10.5	num	20	SENT_124	[p7l579t3142r792b3198],
20	%	NN	PERCENT	%	nsubjpass	34	SENT_124	[p7l579t3142r792b3198],
21	grade	NN	O	grade	dep	20	SENT_124	[p7l825t3140r1015b3216],
22	3	CD	NUMBER	3	num	21	SENT_124	[p7l1050t3142r1085b3198],
23	and	CC	O	and	_	0	SENT_124	[p7l1122t3140r1253b3198],
24	4	CD	NUMBER	4	num	28	SENT_124	[p7l1286t3143r1324b3197],
25	toxic	JJ	O	toxic	amod	28	SENT_124	[p7l1358t3143r1534b3198],
26	side	JJ	O	side	amod	28	SENT_124	[p7l1568t3140r1700b3198],
27	effects	NNS	O	effect	nn	28	SENT_124	[p7l1735t3140r1980b3212],
28	)	NN	O	)	conj_and	20	SENT_124	[p7l1735t3140r1980b3212],
29	and	CC	O	and	_	0	SENT_124	[p7l2018t3140r2149b3198],
30	no	DT	O	no	det	32	SENT_124	[p7l8t3251r99b3291],
31	toxic	JJ	O	toxic	amod	32	SENT_124	[p7l129t3237r305b3291],
32	death	NN	O	death	conj_and	28	SENT_124	[p7l335t3234r533b3291],
33	was	VBD	O	be	auxpass	34	SENT_124	[p7l560t3251r689b3291],
34	noted	VBN	O	note	rcmod	17	SENT_124	[p7l719t3234r942b3291],
35	.	.	O	.	_	0	SENT_124	[p7l719t3234r942b3291],

1	Among	IN	O	among	_	0	SENT_125	[p7l84t3332r344b3406],
2	76	CD	NUMBER	76	num	3	SENT_125	[p7l401t3332r479b3388],
3	patients	NNS	O	patient	prep_among	20	SENT_125	[p7l532t3333r814b3406],
4	of	IN	O	of	_	0	SENT_125	[p7l868t3330r939b3388],
5	this	DT	O	this	det	7	SENT_125	[p7l988t3330r1117b3388],
6	prior	JJ	O	prior	amod	7	SENT_125	[p7l1170t3333r1342b3406],
7	study	NN	O	study	prep_of	3	SENT_125	[p7l1396t3330r1597b3406],
8	,	,	O	,	_	0	SENT_125	[p7l1396t3330r1597b3406],
9	nine	CD	NUMBER	nine	num	10	SENT_125	[p7l1655t3333r1812b3388],
10	patients	NNS	O	patient	nsubjpass	20	SENT_125	[p7l1865t3333r2148b3406],
11	(	IN	O	(	_	0	SENT_125	[p7l12t3425r254b3497],
12	11.8	CD	PERCENT	11.8	num	13	SENT_125	[p7l12t3425r254b3497],
13	%	NN	PERCENT	%	prep_(	10	SENT_125	[p7l12t3425r254b3497],
14	of	IN	O	of	_	0	SENT_125	[p7l290t3424r362b3482],
15	the	DT	O	the	det	18	SENT_125	[p7l392t3425r504b3482],
16	overall	JJ	O	overall	amod	18	SENT_125	[p7l541t3425r779b3482],
17	population	NN	O	population	nn	18	SENT_125	[p7l813t3425r1230b3500],
18	)	NN	O	)	prep_of	13	SENT_125	[p7l813t3425r1230b3500],
19	were	VBD	O	be	auxpass	20	SENT_125	[p7l1266t3441r1430b3482],
20	isolated	VBN	O	isolate	_	0	SENT_125	[p7l1466t3425r1739b3482],
21	because	IN	O	because	_	0	SENT_125	[p7l1771t3425r2045b3482],
22	of	IN	O	of	_	0	SENT_125	[p7l2081t3424r2153b3482],
23	a	DT	O	a	det	25	SENT_125	[p7l9t3536r44b3577],
24	high	JJ	O	high	amod	25	SENT_125	[p7l94t3520r256b3595],
25	risk	NN	O	risk	prep_because_of	20	SENT_125	[p7l307t3520r433b3577],
26	of	IN	O	of	_	0	SENT_125	[p7l482t3519r553b3577],
27	ﬂuorouracil	NN	O	ﬂuorouracil	nn	28	SENT_125	[p7l600t3519r1015b3577],
28	toxicity	NN	O	toxicity	prep_of	25	SENT_125	[p7l1066t3523r1349b3595],
29	.	.	O	.	_	0	SENT_125	[p7l1066t3523r1349b3595],

1	These	DT	O	these	det	3	SENT_126	[p7l1402t3520r1604b3577],
2	nine	CD	NUMBER	nine	num	3	SENT_126	[p7l1656t3523r1814b3577],
3	patients	NNS	O	patient	nsubj	4	SENT_126	[p7l1865t3523r2148b3595],
4	presented	VBD	O	present	_	0	SENT_126	[p7l8t3615r352b3691],
5	abnormally	RB	O	abnormally	advmod	6	SENT_126	[p7l395t3615r803b3691],
6	low	JJ	O	low	amod	8	SENT_126	[p7l844t3615r972b3673],
7	clearance	NN	O	clearance	nn	8	SENT_126	[p7l1014t3615r1342b3673],
8	levels	NNS	O	level	nsubj	27	SENT_126	[p7l1386t3615r1579b3673],
9	of	IN	O	of	_	0	SENT_126	[p7l1623t3615r1695b3673],
10	ﬂuorouracil	NN	O	ﬂuorouracil	prep_of	8	SENT_126	[p7l1734t3615r2148b3673],
11	Table	NNP	O	Table	nn	13	SENT_126	[p7l8t3716r197b3773],
12	3	CD	NUMBER	3	num	13	SENT_126	[p7l226t3718r261b3773],
13	Distribution	NN	O	distribution	dep	10	SENT_126	[p7l345t3718r740b3773],
14	of	IN	O	of	_	0	SENT_126	[p7l769t3718r836b3773],
15	TS	NN	O	t	nn	20	SENT_126	[p7l866t3720r949b3784],
16	,	,	O	,	_	0	SENT_126	[p7l866t3720r949b3784],
17	DPD	NN	ORGANIZATION	dpd	nn	20	SENT_126	[p7l982t3720r1120b3772],
18	and	CC	O	and	_	0	SENT_126	[p7l1144t3718r1265b3773],
19	MTHFR	NN	O	mthfr	nn	20	SENT_126	[p7l1297t3720r1523b3772],
20	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_126	[p7l1548t3718r2063b3790],
21	in	IN	O	in	_	0	SENT_126	[p7l2091t3719r2147b3772],
22	the	DT	O	the	det	24	SENT_126	[p8l9t20r117b75],
23	studied	VBN	O	study	amod	24	SENT_126	[p8l146t21r390b75],
24	population	NN	O	population	prep_in	20	SENT_126	[p8l424t21r786b92],
25	(	CD	NUMBER	(	number	26	SENT_126	[p8l820t21r926b90],
26	76	CD	NUMBER	76	num	27	SENT_126	[p8l820t21r926b90],
27	patients	NNS	O	patient	xcomp	4	SENT_126	[p8l956t21r1251b92],
28	)	IN	O	)	amod	27	SENT_126	[p8l956t21r1251b92],

1	Number	NN	O	number	_	0	SENT_127	[p8l855t194r1106b249],
2	of	IN	O	of	_	0	SENT_127	[p8l1128t194r1191b249],
3	patients	NNS	O	patient	nn	4	SENT_127	[p8l1206t195r1450b266],
4	Frequency	NN	O	frequency	prep_of	1	SENT_127	[p8l1718t197r2021b266],
5	(	CD	PERCENT	(	num	6	SENT_127	[p8l2046t194r2150b263],
6	%	NN	PERCENT	%	dep	1	SENT_127	[p8l2046t194r2150b263],
7	)	CD	NUMBER	)	dep	6	SENT_127	[p8l2046t194r2150b263],

1	TS	NN	O	t	nn	2	SENT_128	[p8l17t378r85b431],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_128	[p8l107t377r566b449],

1	2R/2R	NN	O	2r/2r	_	0	SENT_129	[p8l83t462r270b523],
2	14	CD	NUMBER	14	num	1	SENT_129	[p8l1115t463r1188b515],
3	18.4	CD	NUMBER	18.4	num	4	SENT_129	[p8l1865t463r2001b516],
4	2R/3R	NN	O	2r/3r	dep	1	SENT_129	[p8l83t547r270b608],
5	39	CD	NUMBER	39	number	6	SENT_129	[p8l1115t549r1188b601],
6	51.3	CD	NUMBER	51.3	num	7	SENT_129	[p8l1862t549r2000b601],
7	3R/3R	NN	O	3r/3r	dep	4	SENT_129	[p8l86t632r270b693],
8	23	CD	NUMBER	23	num	9	SENT_129	[p8l1112t634r1187b686],
9	30.3	CD	NUMBER	30.3	dep	1	SENT_129	[p8l1865t634r2000b686],

1	TS	NN	O	t	nn	2	SENT_130	[p8l17t807r84b860],
2	expression	NN	O	expression	_	0	SENT_130	[p8l111t807r419b877],

1	’	NN	O	’	nn	3	SENT_131	[p8l84t891r270b963],
2	High	JJ	O	high	amod	3	SENT_131	[p8l84t891r270b963],
3	’	NN	O	’	_	0	SENT_131	[p8l84t891r270b963],
4	50	CD	NUMBER	50	number	5	SENT_131	[p8l1111t893r1189b946],
5	65.8	CD	NUMBER	65.8	dep	3	SENT_131	[p8l1863t893r2001b946],
6	‘	CD	NUMBER	‘	num	8	SENT_131	[p8l84t978r249b1032],
7	Low	JJ	O	low	amod	8	SENT_131	[p8l84t978r249b1032],
8	’	NN	O	’	dep	5	SENT_131	[p8l84t978r249b1032],
9	26	CD	NUMBER	26	num	10	SENT_131	[p8l1112t979r1189b1032],
10	34.2	CD	NUMBER	34.2	dep	3	SENT_131	[p8l1865t979r2000b1032],

1	MTHFR	NNP	O	MTHFR	_	0	SENT_132	[p8l12t1153r228b1204],
2	1298	CD	DATE	1298	num	1	SENT_132	[p8l266t1152r417b1205],
3	A	DT	O	a	det	5	SENT_132	[p8l443t1153r543b1205],
4	>	JJR	O	>	amod	5	SENT_132	[p8l443t1153r543b1205],
5	C	NN	O	c	dep	1	SENT_132	[p8l563t1152r605b1205],

1	A/A	NN	O	a/a	_	0	SENT_133	[p8l80t1236r197b1297],
2	40	CD	NUMBER	40	num	1	SENT_133	[p8l1110t1238r1189b1290],
3	52.6	CD	NUMBER	52.6	num	4	SENT_133	[p8l1862t1238r2001b1290],
4	A/C	NN	O	a/c	dep	1	SENT_133	[p8l80t1321r199b1382],
5	29	CD	NUMBER	29	number	6	SENT_133	[p8l1112t1323r1188b1375],
6	38.2	CD	NUMBER	38.2	num	7	SENT_133	[p8l1865t1323r2001b1375],
7	C/C	NN	O	c/c	dep	4	SENT_133	[p8l83t1406r205b1467],
8	7	CD	NUMBER	7	number	9	SENT_133	[p8l1156t1409r1188b1460],
9	9.2	CD	NUMBER	9.2	num	7	SENT_133	[p8l1904t1408r2001b1460],

1	MTHFR	NN	O	mthfr	_	0	SENT_134	[p8l12t1582r228b1633],
2	677	CD	NUMBER	677	num	3	SENT_134	[p8l259t1581r379b1633],
3	C	NN	O	c	dep	1	SENT_134	[p8l408t1581r505b1633],
4	>	JJR	O	>	amod	5	SENT_134	[p8l408t1581r505b1633],
5	T	NN	O	t	dep	1	SENT_134	[p8l527t1582r564b1632],

1	C/C	NN	O	c/c	_	0	SENT_135	[p8l83t1664r205b1725],
2	32	CD	NUMBER	32	number	3	SENT_135	[p8l1115t1666r1188b1718],
3	42.1	CD	NUMBER	42.1	num	4	SENT_135	[p8l1860t1666r1988b1718],
4	C/T	NN	O	c/t	dep	1	SENT_135	[p8l83t1749r198b1810],
5	36	CD	NUMBER	36	num	7	SENT_135	[p8l1115t1751r1189b1803],
6	47.3	CD	NUMBER	47.3	num	7	SENT_135	[p8l1860t1751r2000b1803],
7	T/T	NN	O	t/t	dep	1	SENT_135	[p8l80t1834r188b1895],
8	8	CD	NUMBER	8	number	9	SENT_135	[p8l1153t1836r1188b1888],
9	10.6	CD	NUMBER	10.6	dep	7	SENT_135	[p8l1865t1836r2001b1888],

1	DPD	NN	O	dpd	_	0	SENT_136	[p8l13t2010r146b2061],

1	2846	CD	DATE	2846	_	0	SENT_137	[p8l83t2096r243b2148],
2	A	DT	O	a	det	4	SENT_137	[p8l269t2096r426b2148],
3	>	JJR	O	>	amod	4	SENT_137	[p8l269t2096r426b2148],
4	T	NN	O	t	dep	1	SENT_137	[p8l269t2096r426b2148],
5	2	CD	NUMBER	2	number	6	SENT_137	[p8l1153t2096r1188b2147],
6	2.6	CD	NUMBER	2.6	num	10	SENT_137	[p8l1904t2096r2002b2148],
7	|	NN	O	|	nn	10	SENT_137	[p8l86t2182r588b2234],
8	VS14	NN	O	vs14	nn	10	SENT_137	[p8l86t2182r588b2234],
9	+1	CD	NUMBER	+1	num	10	SENT_137	[p8l86t2182r588b2234],
10	G	NN	O	g	dep	4	SENT_137	[p8l86t2182r588b2234],
11	>	JJR	O	>	dep	1	SENT_137	[p8l86t2182r588b2234],
12	A	DT	O	a	det	14	SENT_137	[p8l86t2182r588b2234],
13	1	CD	NUMBER	1	number	14	SENT_137	[p8l1156t2182r1175b2233],
14	1.3	CD	NUMBER	1.3	dep	11	SENT_137	[p8l1907t2182r2000b2234],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_138	[p8l8t2326r379b2370],
2	:	:	O	:	_	0	SENT_138	[p8l8t2326r379b2370],
3	DPD	NN	O	dpd	dep	1	SENT_138	[p8l434t2328r562b2380],
4	,	,	O	,	_	0	SENT_138	[p8l434t2328r562b2380],
5	dihydropyrimidine	NN	O	dihydropyrimidine	nn	6	SENT_138	[p8l617t2326r1099b2384],
6	dehydrogenase	NN	O	dehydrogenase	appos	3	SENT_138	[p8l1151t2326r1565b2384],
7	;	:	O	;	_	0	SENT_138	[p8l1151t2326r1565b2384],
8	MTHFR	NNP	LOCATION	MTHFR	dep	1	SENT_138	[p8l1621t2328r1821b2380],
9	,	,	O	,	_	0	SENT_138	[p8l1621t2328r1821b2380],
10	methylene	NN	O	methylene	nn	12	SENT_138	[p8l1877t2326r2149b2384],
11	tetrahydrofolate	NN	O	tetrahydrofolate	nn	12	SENT_138	[p8l9t2400r429b2459],
12	reductase	NN	O	reductase	appos	8	SENT_138	[p8l455t2400r715b2454],
13	;	:	O	;	_	0	SENT_138	[p8l455t2400r715b2454],
14	TS	NN	O	t	dep	1	SENT_138	[p8l741t2402r817b2454],
15	,	,	O	,	_	0	SENT_138	[p8l741t2402r817b2454],
16	thymidylate	NN	O	thymidylate	nn	17	SENT_138	[p8l843t2400r1153b2459],
17	synthase	NN	O	synthase	appos	14	SENT_138	[p8l1176t2400r1413b2459],
18	.	.	O	.	_	0	SENT_138	[p8l1176t2400r1413b2459],

1	Table	NNP	O	Table	nn	3	SENT_139	[p8l8t2613r197b2669],
2	4	CD	NUMBER	4	num	3	SENT_139	[p8l221t2615r263b2668],
3	Distribution	NN	O	distribution	_	0	SENT_139	[p8l343t2614r738b2669],
4	of	IN	O	of	_	0	SENT_139	[p8l764t2614r831b2669],
5	the	DT	O	the	det	8	SENT_139	[p8l851t2614r959b2669],
6	toxic	JJ	O	toxic	amod	8	SENT_139	[p8l983t2615r1145b2669],
7	side	NN	O	side	nn	8	SENT_139	[p8l1169t2614r1298b2669],
8	effects	NNS	O	effect	prep_of	3	SENT_139	[p8l1323t2614r1543b2669],
9	in	IN	O	in	_	0	SENT_139	[p8l1569t2615r1624b2668],
10	the	DT	O	the	det	11	SENT_139	[p8l1650t2614r1758b2669],
11	population	NN	O	population	prep_in	3	SENT_139	[p8l1785t2614r2147b2686],
12	of	IN	O	of	_	0	SENT_139	[p8l10t2699r78b2754],
13	patients	NNS	O	patient	prep_of	11	SENT_139	[p8l106t2700r373b2771],
14	(	IN	O	(	dep	3	SENT_139	[p8l405t2699r510b2768],
15	76	CD	NUMBER	76	num	16	SENT_139	[p8l405t2699r510b2768],
16	patients	NNS	O	patient	pobj	14	SENT_139	[p8l541t2699r835b2771],
17	)	IN	O	)	dep	3	SENT_139	[p8l541t2699r835b2771],

1	Grade	NNP	O	Grade	_	0	SENT_140	[p8l718t2873r901b2928],
2	1	CD	NUMBER	1	num	11	SENT_140	[p8l936t2875r954b2927],
3	Grade	NNP	O	Grade	nn	11	SENT_140	[p8l1004t2873r1193b2928],
4	2	CD	NUMBER	2	num	11	SENT_140	[p8l1222t2875r1257b2927],
5	Grade	NNP	O	Grade	nn	11	SENT_140	[p8l1305t2873r1487b2928],
6	3	CD	NUMBER	3	num	11	SENT_140	[p8l1515t2875r1547b2928],
7	Grade	NNP	O	Grade	nn	11	SENT_140	[p8l1595t2873r1777b2928],
8	4	CD	NUMBER	4	num	11	SENT_140	[p8l1802t2876r1837b2927],
9	Total	JJ	O	total	amod	11	SENT_140	[p8l1887t2873r2038b2928],
10	(	NN	O	(	nn	11	SENT_140	[p8l2064t2873r2150b2942],
11	n	NN	O	n	rcmod	1	SENT_140	[p8l2064t2873r2150b2942],
12	)	CD	NUMBER	)	dep	1	SENT_140	[p8l2064t2873r2150b2942],

1	Mucositis	NNP	O	Mucositis	nn	5	SENT_141	[p8l13t3056r305b3109],
2	Conjunctivitis	NNP	O	Conjunctivitis	nn	5	SENT_141	[p8l11t3142r439b3213],
3	Diarrhea	NNP	O	Diarrhea	nn	5	SENT_141	[p8l13t3227r276b3281],
4	Hand-foot	NN	O	hand-foot	nn	5	SENT_141	[p8l13t3313r333b3368],
5	syndrome	NN	O	syndrome	_	0	SENT_141	[p8l359t3313r671b3385],
6	Cardiac	JJ	O	cardiac	amod	8	SENT_141	[p8l11t3399r248b3453],
7	Hematologic	JJ	O	hematologic	amod	8	SENT_141	[p8l13t3485r415b3557],
8	Nausea	NN	O	nausea	dep	5	SENT_141	[p8l13t3573r239b3625],
9	Alopecia	NNP	PERSON	Alopecia	nn	10	SENT_141	[p8l8t3657r275b3729],
10	Asthenia	NNP	PERSON	Asthenia	dep	5	SENT_141	[p8l7t3743r276b3797],

1	-	:	O	-	_	0	SENT_142	[p8l839t3057r876b3796],
2	kOl	NN	O	kol	nn	3	SENT_142	[p8l839t3057r876b3796],
3	\	NN	O	\	_	0	SENT_142	[p8l839t3057r876b3796],
4	.	.	O	.	_	0	SENT_142	[p8l839t3057r876b3796],
5	)	SYM	O	)	dep	3	SENT_142	[p8l839t3057r876b3796],

1	OOU‘IU	NN	O	oou‘iu	_	0	SENT_143	[p8l839t3057r876b3796],
2	'	''	O	'	_	0	SENT_143	[p8l839t3057r876b3796],
3	I-hl	JJ	O	i-hl	dep	1	SENT_143	[p8l839t3057r876b3796],
4	\	NN	O	\	dep	3	SENT_143	[p8l839t3057r876b3796],
5	.	.	O	.	_	0	SENT_143	[p8l839t3057r876b3796],
6	)	SYM	O	)	dep	1	SENT_143	[p8l839t3057r876b3796],

1	-	:	O	-	_	0	SENT_144	[p8l1132t3057r1169b3796],
2	k	NN	O	k	dep	8	SENT_144	[p8l1132t3057r1169b3796],
3	—	CD	NUMBER	—	num	2	SENT_144	[p8l1132t3057r1169b3796],
4	‘	CD	NUMBER	‘	num	5	SENT_144	[p8l1132t3057r1169b3796],
5	UU	NN	O	uu	dep	2	SENT_144	[p8l1132t3057r1169b3796],
6	—	NN	O	—	dep	8	SENT_144	[p8l1132t3057r1169b3796],
7	‘	CD	NUMBER	‘	num	6	SENT_144	[p8l1132t3057r1169b3796],
8	UU	NNP	O	UU	dep	14	SENT_144	[p8l1132t3057r1169b3796],
9	\	CD	NUMBER	\	num	8	SENT_144	[p8l1132t3057r1169b3796],
10	lOO	NNP	O	lOO	nn	12	SENT_144	[p8l1132t3057r1169b3796],
11	\	CD	NUMBER	\	num	12	SENT_144	[p8l1132t3057r1169b3796],
12	ll	NN	O	ll	dep	8	SENT_144	[p8l1132t3057r1169b3796],
13	\	CD	NUMBER	\	num	14	SENT_144	[p8l1132t3057r1169b3796],
14	)	NN	O	)	_	0	SENT_144	[p8l1132t3057r1169b3796],
15	.	.	O	.	_	0	SENT_144	[p8l1406t3057r1442b3796],

1	—	NN	O	—	_	0	SENT_145	[p8l1406t3057r1442b3796],
2	.	.	O	.	_	0	SENT_145	[p8l1406t3057r1442b3796],

1	‘	NN	O	‘	_	0	SENT_146	[p8l1406t3057r1442b3796],
2	OO	NN	O	oo	dep	1	SENT_146	[p8l1406t3057r1442b3796],
3	.	.	O	.	_	0	SENT_146	[p8l1406t3057r1442b3796],

1	—	NN	O	—	_	0	SENT_147	[p8l1406t3057r1442b3796],
2	.	.	O	.	_	0	SENT_147	[p8l1406t3057r1442b3796],

1	‘	NN	O	‘	_	0	SENT_148	[p8l1406t3057r1442b3796],
2	.	.	O	.	_	0	SENT_148	[p8l1406t3057r1442b3796],

1	—	NN	O	—	_	0	SENT_149	[p8l1406t3057r1442b3796],
2	.	.	O	.	_	0	SENT_149	[p8l1406t3057r1442b3796],

1	‘	NN	O	‘	nn	2	SENT_150	[p8l1406t3057r1442b3796],
2	Ol	NN	O	ol	_	0	SENT_150	[p8l1406t3057r1442b3796],
3	\	CD	NUMBER	\	number	4	SENT_150	[p8l1406t3057r1442b3796],
4	)	CD	NUMBER	)	dep	2	SENT_150	[p8l1406t3057r1442b3796],
5	OO	NN	O	oo	dep	4	SENT_150	[p8l1406t3057r1442b3796],

1	1	CD	NUMBER	1	number	2	SENT_151	[p8l1699t3057r1718b3108],
2	5	CD	NUMBER	5	num	4	SENT_151	[p8l2017t3058r2051b3109],
3	o	NN	O	o	nn	4	SENT_151	[p8l1696t3142r1732b3195],
4	ll	NN	O	ll	dep	9	SENT_151	[p8l1979t3142r2039b3195],
5	2	CD	NUMBER	2	dep	4	SENT_151	[p8l1696t3228r1731b3280],
6	17	CD	NUMBER	17	num	7	SENT_151	[p8l1979t3228r2053b3281],
7	O	NN	O	o	dep	9	SENT_151	[p8l1696t3314r1732b3367],
8	12	CD	NUMBER	12	num	9	SENT_151	[p8l1979t3314r2052b3367],
9	O	NN	O	o	dep	11	SENT_151	[p8l1696t3401r1732b3453],
10	4	CD	NUMBER	4	dep	9	SENT_151	[p8l2016t3401r2053b3452],
11	O	NN	O	o	dep	13	SENT_151	[p8l1696t3487r1732b3540],
12	2	CD	NUMBER	2	num	11	SENT_151	[p8l2018t3487r2052b3539],
13	O	NN	O	o	dep	15	SENT_151	[p8l1696t3573r1732b3625],
14	5	CD	NUMBER	5	num	13	SENT_151	[p8l2017t3573r2051b3625],
15	O	NN	O	o	dep	17	SENT_151	[p8l1696t3659r1732b3712],
16	1	CD	NUMBER	1	num	15	SENT_151	[p8l2021t3659r2040b3711],
17	O	NN	O	o	_	0	SENT_151	[p8l1696t3745r1732b3797],
18	9	CD	NUMBER	9	num	17	SENT_151	[p8l2018t3745r2053b3797],

1	Total	JJ	O	total	amod	3	SENT_152	[p9l8t23r162b77],
2	(	NN	O	(	nn	3	SENT_152	[p9l194t23r279b91],
3	n	NN	O	n	_	0	SENT_152	[p9l194t23r279b91],
4	)	CD	NUMBER	)	num	5	SENT_152	[p9l194t23r279b91],
5	22	CD	NUMBER	22	dep	3	SENT_152	[p9l799t24r875b77],
6	36	CD	NUMBER	36	number	7	SENT_152	[p9l1096t24r1170b77],
7	5	CD	NUMBER	5	num	9	SENT_152	[p9l1407t25r1440b77],
8	3	CD	NUMBER	3	number	9	SENT_152	[p9l1699t24r1730b77],
9	66	CD	NUMBER	66	dep	5	SENT_152	[p9l1977t24r2053b77],

1	associated	VBN	O	associate	_	0	SENT_153	[p9l10t312r366b370],
2	with	IN	O	with	_	0	SENT_153	[p9l420t312r582b370],
3	an	DT	O	a	det	7	SENT_153	[p9l639t329r724b370],
4	abnormal	JJ	O	abnormal	amod	7	SENT_153	[p9l781t312r1120b370],
5	UH2/U	NN	O	uh2/u	nn	7	SENT_153	[p9l1177t312r1416b381],
6	plasma	NN	O	plasma	nn	7	SENT_153	[p9l1472t312r1721b388],
7	ratio	NN	O	ratio	prep_with	1	SENT_153	[p9l1778t315r1958b370],
8	:	:	O	:	_	0	SENT_153	[p9l1778t315r1958b370],
9	two	CD	NUMBER	two	num	10	SENT_153	[p9l2019t319r2149b370],
10	patients	NNS	O	patient	dep	7	SENT_153	[p9l9t410r291b483],
11	were	VBD	O	be	cop	13	SENT_153	[p9l323t424r487b465],
12	heterozygous	JJ	O	heterozygous	amod	13	SENT_153	[p9l521t407r990b483],
13	A/T	NN	O	a/t	auxpass	1	SENT_153	[p9l1024t407r1152b472],
14	for	IN	O	for	_	0	SENT_153	[p9l1184t407r1282b465],
15	2846	CD	DATE	2846	prep_for	13	SENT_153	[p9l1315t409r1485b465],
16	A	DT	O	a	det	18	SENT_153	[p9l1518t409r1700b477],
17	>	JJR	O	>	amod	18	SENT_153	[p9l1518t409r1700b477],
18	T	NN	O	t	nsubjpass	1	SENT_153	[p9l1518t409r1700b477],
19	,	,	O	,	_	0	SENT_153	[p9l1518t409r1700b477],
20	one	CD	NUMBER	one	appos	18	SENT_153	[p9l1739t424r1867b465],
21	for	IN	O	for	_	0	SENT_153	[p9l1902t407r2001b465],
22	IVS	NNS	O	iv	prep_for	20	SENT_153	[p9l2034t409r2149b465],
23	14	CD	NUMBER	14	dep	22	SENT_153	[p9l15t503r92b559],
24	+	CC	O	+	_	0	SENT_153	[p9l112t513r163b565],
25	1G	CD	NUMBER	1g	npadvmod	26	SENT_153	[p9l187t503r412b559],
26	>	JJR	O	>	conj_+	22	SENT_153	[p9l187t503r412b559],
27	A	DT	O	a	dep	26	SENT_153	[p9l187t503r412b559],
28	and	CC	O	and	_	0	SENT_153	[p9l442t502r574b559],
29	six	CD	NUMBER	six	prep_for	20	SENT_153	[p9l604t505r699b559],
30	without	IN	O	without	_	0	SENT_153	[p9l726t502r1009b559],
31	DPD	NN	O	dpd	nn	32	SENT_153	[p9l1035t504r1197b559],
32	SNP	NN	O	snp	prep_without	29	SENT_153	[p9l1227t503r1366b559],
33	(	CD	NUMBER	(	num	35	SENT_153	[p9l1399t502r1785b577],
34	epigenetic	JJ	O	epigenetic	amod	35	SENT_153	[p9l1399t502r1785b577],
35	factors	NNS	O	factor	dep	32	SENT_153	[p9l1815t501r2048b559],
36	or	CC	O	or	_	0	SENT_153	[p9l2079t518r2151b559],
37	SNP	NN	O	snp	prep_without	29	SENT_153	[p9l10t599r149b655],
38	still	RB	O	still	advmod	39	SENT_153	[p9l188t597r314b655],
39	unknown	JJ	O	unknown	amod	40	SENT_153	[p9l350t597r739b669],
40	)	NN	O	)	dep	37	SENT_153	[p9l350t597r739b669],
41	.	.	O	.	_	0	SENT_153	[p9l350t597r739b669],

1	In	IN	O	in	_	0	SENT_154	[p9l783t599r856b654],
2	this	DT	O	this	det	3	SENT_154	[p9l893t597r1023b655],
3	population	NN	O	population	prep_in	9	SENT_154	[p9l1060t597r1471b673],
4	,	,	O	,	_	0	SENT_154	[p9l1060t597r1471b673],
5	nine	CD	NUMBER	nine	num	7	SENT_154	[p9l1514t600r1672b655],
6	toxic	JJ	O	toxic	amod	7	SENT_154	[p9l1711t600r1887b655],
7	events	NNS	O	event	nsubjpass	9	SENT_154	[p9l1925t604r2149b655],
8	were	VBD	O	be	auxpass	9	SENT_154	[p9l8t709r171b750],
9	described	VBN	O	describe	_	0	SENT_154	[p9l230t692r579b762],
10	,	,	O	,	_	0	SENT_154	[p9l230t692r579b762],
11	with	IN	O	with	_	0	SENT_154	[p9l639t692r801b750],
12	33.3	CD	PERCENT	33.3	num	13	SENT_154	[p9l859t694r1077b750],
13	%	NN	PERCENT	%	prep_with	9	SENT_154	[p9l859t694r1077b750],
14	(	CD	NUMBER	(	dep	13	SENT_154	[p9l1138t692r1293b764],
15	and	CC	O	and	_	0	SENT_154	[p9l1138t692r1293b764],
16	up	RB	O	up	advmod	13	SENT_154	[p9l1349t709r1440b768],
17	to	TO	O	to	_	0	SENT_154	[p9l1497t699r1567b750],
18	66	CD	PERCENT	66	num	19	SENT_154	[p9l1627t694r1778b750],
19	%	NN	PERCENT	%	prep_to	16	SENT_154	[p9l1627t694r1778b750],
20	for	IN	O	for	_	0	SENT_154	[p9l1835t692r1934b750],
21	DPD	NN	O	dpd	nn	22	SENT_154	[p9l1991t695r2148b749],
22	heterozygoty	NN	O	heterozygoty	prep_for	19	SENT_154	[p9l10t787r496b862],
23	)	CD	NUMBER	)	num	24	SENT_154	[p9l10t787r496b862],
24	grade	NN	O	grade	conj_and	13	SENT_154	[p9l526t787r716b862],
25	3	CD	NUMBER	3	num	29	SENT_154	[p9l746t788r781b844],
26	and	CC	O	and	_	0	SENT_154	[p9l812t787r943b844],
27	4	CD	NUMBER	4	conj_and	25	SENT_154	[p9l970t789r1008b844],
28	gastrointestinal	JJ	O	gastrointestinal	amod	29	SENT_154	[p9l1037t787r1586b862],
29	events	NNS	O	event	dep	24	SENT_154	[p9l1614t794r1856b857],
30	,	,	O	,	_	0	SENT_154	[p9l1614t794r1856b857],
31	in	IN	O	in	_	0	SENT_154	[p9l1888t790r1958b844],
32	spite	NN	O	spite	_	0	SENT_154	[p9l1987t790r2149b862],
33	of	IN	O	of	_	0	SENT_154	[p9l10t882r82b940],
34	pharmacological	JJ	O	pharmacological	amod	35	SENT_154	[p9l128t882r719b958],
35	adjustment	NN	O	adjustment	prep_in_spite_of	9	SENT_154	[p9l770t882r1172b958],
36	and	CC	O	and	_	0	SENT_154	[p9l1223t882r1355b940],
37	clinical	JJ	O	clinical	amod	38	SENT_154	[p9l1406t882r1661b940],
38	observation	NN	O	observation	prep_in_spite_of	9	SENT_154	[p9l1713t882r2146b940],
39	.	.	O	.	_	0	SENT_154	[p9l1713t882r2146b940],

1	Concerning	VBG	O	concern	_	0	SENT_155	[p9l11t979r430b1053],
2	toxicity	NN	O	toxicity	prep_concerning	17	SENT_155	[p9l489t980r772b1053],
3	,	,	O	,	_	0	SENT_155	[p9l489t980r772b1053],
4	a	DT	O	a	det	6	SENT_155	[p9l838t994r873b1035],
5	significant	JJ	O	significant	amod	6	SENT_155	[p9l934t977r1306b1053],
6	difference	NN	O	difference	appos	2	SENT_155	[p9l1367t977r1716b1035],
7	(	CD	NUMBER	(	num	8	SENT_155	[p9l1781t978r2144b1049],
8	P	NN	O	p	dep	6	SENT_155	[p9l1781t978r2144b1049],
9	=	JJ	O	=	amod	8	SENT_155	[p9l1781t978r2144b1049],
10	0.048	CD	NUMBER	0.048	tmod	9	SENT_155	[p9l1781t978r2144b1049],
11	,	,	O	,	_	0	SENT_155	[p9l1781t978r2144b1049],
12	Fisher	NNP	PERSON	Fisher	poss	15	SENT_155	[p9l10t1072r267b1130],
13	's	POS	O	's	_	0	SENT_155	[p9l10t1072r267b1130],
14	test	NN	O	test	nn	15	SENT_155	[p9l294t1072r441b1144],
15	)	NN	O	)	nsubjpass	17	SENT_155	[p9l294t1072r441b1144],
16	was	VBD	O	be	auxpass	17	SENT_155	[p9l470t1089r598b1130],
17	found	VBN	O	find	_	0	SENT_155	[p9l626t1072r837b1130],
18	between	IN	O	between	_	0	SENT_155	[p9l862t1072r1159b1130],
19	the	DT	O	the	det	20	SENT_155	[p9l1186t1072r1299b1130],
20	populations	NNS	O	population	prep_between	17	SENT_155	[p9l1326t1072r1749b1148],
21	with	IN	O	with	_	0	SENT_155	[p9l1776t1072r1937b1130],
22	(	NN	O	(	nn	24	SENT_155	[p9l1967t1072r2149b1144],
23	nine	CD	NUMBER	nine	num	24	SENT_155	[p9l1967t1072r2149b1144],
24	patients	NNS	O	patient	prep_with	20	SENT_155	[p9l9t1167r316b1242],
25	)	CD	NUMBER	)	tmod	20	SENT_155	[p9l9t1167r316b1242],
26	and	CC	O	and	_	0	SENT_155	[p9l349t1166r481b1224],
27	without	IN	O	without	_	0	SENT_155	[p9l507t1166r790b1224],
28	a	DT	O	a	det	30	SENT_155	[p9l821t1183r855b1224],
29	risk	NN	O	risk	nn	30	SENT_155	[p9l885t1167r1009b1224],
30	factor	NN	O	factor	prep_without	20	SENT_155	[p9l1037t1166r1240b1224],
31	(	CD	NUMBER	(	number	32	SENT_155	[p9l1272t1166r1378b1239],
32	67	CD	NUMBER	67	num	33	SENT_155	[p9l1272t1166r1378b1239],
33	patients	NNS	O	patient	dep	20	SENT_155	[p9l1408t1166r1736b1242],
34	)	CD	NUMBER	)	tmod	17	SENT_155	[p9l1408t1166r1736b1242],
35	.	.	O	.	_	0	SENT_155	[p9l1408t1166r1736b1242],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_156	[p9l85t1262r519b1320],
2	analysis	NN	O	analysis	_	0	SENT_156	[p9l548t1262r823b1338],
3	of	IN	O	of	_	0	SENT_156	[p9l852t1262r923b1320],
4	clinical	JJ	O	clinical	amod	7	SENT_156	[p9l947t1262r1202b1320],
5	and	CC	O	and	_	0	SENT_156	[p9l1231t1262r1362b1320],
6	biological	JJ	O	biological	amod	7	SENT_156	[p9l1386t1262r1733b1338],
7	parameters	NNS	O	parameter	prep_of	2	SENT_156	[p9l1761t1269r2149b1338],
8	for	IN	O	for	dep	2	SENT_156	[p9l10t1357r108b1415],
9	predicting	VBG	O	predict	pcomp	8	SENT_156	[p9l165t1357r529b1433],
10	toxicity	NN	O	toxicity	dobj	9	SENT_156	[p9l587t1360r860b1433],
11	according	VBG	O	accord	_	0	SENT_156	[p9l917t1357r1264b1433],
12	to	TO	O	to	prepc_according_to	9	SENT_156	[p9l1322t1364r1391b1415],
13	the	DT	O	the	det	14	SENT_156	[p9l1451t1357r1563b1415],
14	Cox-regression	NN	MISC	cox-regression	pobj	9	SENT_156	[p9l1625t1359r2150b1433],

1	Fluorouracil	NNP	O	Fluorouracil	_	0	SENT_157	[p9l10t1598r294b1643],
2	outcome	NN	O	outcome	nn	3	SENT_157	[p9l314t1603r525b1643],
3	parameters	NNS	O	parameter	dep	1	SENT_157	[p9l544t1603r818b1657],
4	@	IN	O	@	_	0	SENT_157	[p9l2026t1586r2152b1710],
5	O	NNP	O	O	nn	6	SENT_157	[p9l9t1670r43b1711],
6	Capitain	NNP	MISC	Capitain	prep_@	3	SENT_157	[p9l62t1670r230b1724],
7	et	FW	O	et	nn	8	SENT_157	[p9l252t1674r288b1711],
8	al	FW	O	al	dep	1	SENT_157	[p9l304t1669r340b1711],

1	Table	NNP	O	Table	_	0	SENT_158	[p9l8t1957r197b2014],
2	5	CD	NUMBER	5	num	1	SENT_158	[p9l235t1960r272b2014],
3	Multivariate	JJ	O	multivariate	amod	4	SENT_158	[p9l355t1959r757b2014],
4	analysis	NN	O	analysis	dep	1	SENT_158	[p9l796t1959r1052b2031],
5	of	IN	O	of	_	0	SENT_158	[p9l1090t1959r1157b2014],
6	clinical	JJ	O	clinical	amod	9	SENT_158	[p9l1191t1959r1414b2014],
7	and	CC	O	and	_	0	SENT_158	[p9l1454t1959r1575b2014],
8	biological	JJ	O	biological	amod	9	SENT_158	[p9l1617t1959r1938b2031],
9	parameters	NNS	O	parameter	prep_of	1	SENT_158	[p9l1980t1975r2148b2031, p9l12t2049r239b2097],
10	for	IN	O	for	dep	1	SENT_158	[p9l268t2043r366b2097],
11	predicting	VBG	O	predict	pcomp	10	SENT_158	[p9l397t2042r738b2114],
12	toxicity	NN	O	toxicity	dobj	11	SENT_158	[p9l771t2043r1018b2114],
13	according	VBG	O	accord	_	0	SENT_158	[p9l1049t2043r1376b2114],
14	to	TO	O	to	prepc_according_to	11	SENT_158	[p9l1409t2049r1477b2097],
15	the	DT	O	the	det	17	SENT_158	[p9l1507t2043r1615b2097],
16	Cox-regression	NN	MISC	cox-regression	nn	17	SENT_158	[p9l1648t2043r2147b2114],
17	model	NN	O	model	pobj	11	SENT_158	[p9l12t2127r217b2181],

1	Odds	NNS	O	odds	nn	2	SENT_159	[p9l1068t2357r1222b2412],
2	ratio	NN	O	ratio	_	0	SENT_159	[p9l1249t2359r1387b2412],
3	(	CD	PERCENT	(	num	6	SENT_159	[p9l1417t2358r1579b2426],
4	95	CD	PERCENT	95	number	5	SENT_159	[p9l1417t2358r1579b2426],
5	%	NN	PERCENT	%	amod	6	SENT_159	[p9l1417t2358r1579b2426],
6	CI	NN	O	ci	dep	2	SENT_159	[p9l1611t2358r1692b2426],
7	)	CD	NUMBER	)	num	8	SENT_159	[p9l1611t2358r1692b2426],
8	P	NN	O	p	dep	6	SENT_159	[p9l2044t2360r2075b2411],

1	Performance	NNP	O	Performance	nn	2	SENT_160	[p9l13t2540r408b2595],
2	status	NN	O	status	_	0	SENT_160	[p9l436t2546r615b2595],
3	2-3	CD	NUMBER	2-3	num	2	SENT_160	[p9l644t2542r756b2595],
4	57.74	CD	NUMBER	57.74	num	5	SENT_160	[p9l1029t2542r1208b2595],
5	(	NN	O	(	dep	30	SENT_160	[p9l1242t2540r1450b2608],
6	3.70	CD	NUMBER	3.70	dep	5	SENT_160	[p9l1242t2540r1450b2608],
7	;	:	O	;	_	0	SENT_160	[p9l1242t2540r1450b2608],
8	901.25	CD	NUMBER	901.25	number	9	SENT_160	[p9l1483t2540r1727b2609],
9	)	CD	NUMBER	)	dep	6	SENT_160	[p9l1483t2540r1727b2609],
10	0.004	CD	NUMBER	0.004	num	11	SENT_160	[p9l1971t2542r2147b2595],
11	2846	CD	DATE	2846	dep	20	SENT_160	[p9l10t2629r170b2682],
12	A	DT	O	a	det	14	SENT_160	[p9l197t2629r369b2693],
13	>	JJR	O	>	amod	14	SENT_160	[p9l197t2629r369b2693],
14	T	NN	O	t	dep	11	SENT_160	[p9l197t2629r369b2693],
15	,	,	O	,	_	0	SENT_160	[p9l197t2629r369b2693],
16	|	CD	NUMBER	|	num	17	SENT_160	[p9l405t2629r777b2682],
17	VS14	NN	O	vs14	appos	14	SENT_160	[p9l405t2629r777b2682],
18	+1	CD	NUMBER	+1	num	19	SENT_160	[p9l405t2629r777b2682],
19	G	NN	O	g	dep	20	SENT_160	[p9l405t2629r777b2682],
20	>	JJR	O	>	dep	22	SENT_160	[p9l405t2629r777b2682],
21	6.20	CD	NUMBER	6.20	dep	20	SENT_160	[p9l1033t2629r1170b2682],
22	(	NN	O	(	dep	6	SENT_160	[p9l1201t2627r1385b2695],
23	1.18	CD	NUMBER	1.18	num	22	SENT_160	[p9l1201t2627r1385b2695],
24	;	:	O	;	_	0	SENT_160	[p9l1201t2627r1385b2695],
25	32.56	CD	NUMBER	32.56	number	26	SENT_160	[p9l1416t2627r1620b2695],
26	)	CD	NUMBER	)	dep	6	SENT_160	[p9l1416t2627r1620b2695],
27	0.031	CD	NUMBER	0.031	dep	30	SENT_160	[p9l1972t2629r2141b2682],
28	A	DT	O	a	det	30	SENT_160	[p9l7t2716r52b2767],
29	low	JJ	O	low	amod	30	SENT_160	[p9l81t2714r191b2768],
30	clearance	NN	O	clearance	dep	34	SENT_160	[p9l218t2714r512b2768],
31	of	IN	O	of	_	0	SENT_160	[p9l542t2714r603b2768],
32	5-FU	JJ	O	5-fu	amod	33	SENT_160	[p9l629t2716r771b2768],
33	Age	NN	O	age	prep_of	30	SENT_160	[p9l7t2802r282b2872],
34	>	JJR	O	>	dep	2	SENT_160	[p9l7t2802r282b2872],
35	75	CD	DURATION	75	num	36	SENT_160	[p9l7t2802r282b2872],
36	years	NNS	NUMBER	year	dep	34	SENT_160	[p9l310t2816r471b2872],
37	0.08	CD	NUMBER	0.08	number	38	SENT_160	[p9l1029t2802r1168b2855],
38	(	CD	NUMBER	(	num	39	SENT_160	[p9l1199t2800r1423b2868],
39	0.005	CD	NUMBER	0.005	dep	36	SENT_160	[p9l1199t2800r1423b2868],
40	;	:	O	;	_	0	SENT_160	[p9l1199t2800r1423b2868],
41	1.09	CD	NUMBER	1.09	number	42	SENT_160	[p9l1459t2800r1621b2868],
42	)	CD	NUMBER	)	dep	2	SENT_160	[p9l1459t2800r1621b2868],
43	0.058	CD	NUMBER	0.058	dep	42	SENT_160	[p9l1967t2802r2148b2855],

1	MTHFR	NNP	O	MTHFR	_	0	SENT_161	[p9l13t2977r239b3028],
2	1298	CD	DATE	1298	num	1	SENT_161	[p9l270t2976r426b3029],
3	A	DT	O	a	det	5	SENT_161	[p9l454t2976r618b3029],
4	>	JJR	O	>	amod	5	SENT_161	[p9l454t2976r618b3029],
5	C	NN	O	c	dep	1	SENT_161	[p9l454t2976r618b3029],

1	A/A	NN	O	a/a	nn	4	SENT_162	[p9l80t3061r196b3122],
2	1.00	CD	NUMBER	1.00	num	4	SENT_162	[p9l1032t3062r1168b3115],
3	(	NN	O	(	nn	4	SENT_162	[p9l1199t3061r1326b3129],
4	ref	NN	O	ref	_	0	SENT_162	[p9l1199t3061r1326b3129],
5	)	CD	NUMBER	)	num	7	SENT_162	[p9l1199t3061r1326b3129],
6	0.056	CD	NUMBER	0.056	num	7	SENT_162	[p9l1967t3062r2148b3115],
7	A/C	NN	O	a/c	dep	17	SENT_162	[p9l80t3148r199b3209],
8	2.54	CD	NUMBER	2.54	number	9	SENT_162	[p9l1029t3149r1168b3202],
9	(	CD	NUMBER	(	num	10	SENT_162	[p9l1199t3148r1382b3216],
10	0.30	CD	NUMBER	0.30	dep	7	SENT_162	[p9l1199t3148r1382b3216],
11	;	:	O	;	_	0	SENT_162	[p9l1199t3148r1382b3216],
12	21.47	CD	NUMBER	21.47	number	13	SENT_162	[p9l1415t3148r1620b3216],
13	)	CD	NUMBER	)	dep	10	SENT_162	[p9l1415t3148r1620b3216],
14	0.393	CD	NUMBER	0.393	num	15	SENT_162	[p9l1967t3149r2146b3202],
15	C/C	NN	O	c/c	dep	17	SENT_162	[p9l83t3235r204b3297],
16	25.99	CD	NUMBER	25.99	num	17	SENT_162	[p9l1029t3236r1212b3290],
17	(	NN	O	(	dep	4	SENT_162	[p9l1242t3235r1426b3303],
18	1.76	CD	NUMBER	1.76	dep	17	SENT_162	[p9l1242t3235r1426b3303],
19	;	:	O	;	_	0	SENT_162	[p9l1242t3235r1426b3303],
20	384.32	CD	NUMBER	384.32	number	21	SENT_162	[p9l1457t3235r1703b3303],
21	)	CD	NUMBER	)	dep	4	SENT_162	[p9l1457t3235r1703b3303],
22	0.018	CD	NUMBER	0.018	dep	21	SENT_162	[p9l1972t3236r2149b3290],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_163	[p9l7t3380r378b3425],
2	:	:	O	:	_	0	SENT_163	[p9l7t3380r378b3425],
3	CI	NN	O	ci	dep	1	SENT_163	[p9l433t3382r499b3434],
4	,	,	O	,	_	0	SENT_163	[p9l433t3382r499b3434],
5	confidence	NN	O	confidence	nn	6	SENT_163	[p9l554t3380r838b3425],
6	interval	NN	O	interval	appos	3	SENT_163	[p9l891t3380r1093b3435],
7	;	:	O	;	_	0	SENT_163	[p9l891t3380r1093b3435],
8	MTHFR	NNP	LOCATION	MTHFR	dep	1	SENT_163	[p9l1150t3382r1350b3435],
9	,	,	O	,	_	0	SENT_163	[p9l1150t3382r1350b3435],
10	methylene	NN	O	methylene	nn	12	SENT_163	[p9l1406t3380r1678b3439],
11	tetrahydrofolate	NN	O	tetrahydrofolate	nn	12	SENT_163	[p9l1729t3380r2149b3439],
12	reductase	NN	O	reductase	appos	8	SENT_163	[p9l11t3439r272b3484],
13	.	.	O	.	_	0	SENT_163	[p9l11t3439r272b3484],

1	model	NN	O	model	nsubjpass	3	SENT_164	[p10l9t84r232b142],
2	is	VBZ	O	be	auxpass	3	SENT_164	[p10l293t87r343b142],
3	shown	VBN	O	show	_	0	SENT_164	[p10l407t84r639b142],
4	in	IN	O	in	_	0	SENT_164	[p10l701t87r771b141],
5	Table	NNP	O	Table	prep_in	3	SENT_164	[p10l830t84r1016b142],
6	5	CD	NUMBER	5	num	5	SENT_164	[p10l1080t86r1136b142],
7	.	.	O	.	_	0	SENT_164	[p10l1080t86r1136b142],

1	Fluorouracil	NNP	O	Fluorouracil	nn	2	SENT_165	[p10l1202t84r1629b142],
2	toxicity	NN	O	toxicity	nsubjpass	5	SENT_165	[p10l1691t87r1964b160],
3	was	VBD	O	be	auxpass	5	SENT_165	[p10l2021t101r2149b142],
4	significantly	RB	O	significantly	advmod	5	SENT_165	[p10l11t178r450b254],
5	linked	VBN	O	link	_	0	SENT_165	[p10l495t178r716b236],
6	to	TO	O	to	_	0	SENT_165	[p10l763t186r833b236],
7	performance	NN	O	performance	nn	8	SENT_165	[p10l880t178r1328b254],
8	status	NN	O	status	prep_to	5	SENT_165	[p10l1379t186r1578b236],
9	>	RBR	O	>	amod	23	SENT_165	[p10l1638t180r1742b236],
10	2	CD	NUMBER	2	dep	9	SENT_165	[p10l1638t180r1742b236],
11	with	IN	O	with	dep	10	SENT_165	[p10l1788t178r1949b236],
12	60	CD	PERCENT	60	number	13	SENT_165	[p10l1999t180r2149b236],
13	%	NN	PERCENT	%	amod	20	SENT_165	[p10l1999t180r2149b236],
14	grade	NN	O	grade	nn	20	SENT_165	[p10l9t273r199b349],
15	3	CD	NUMBER	3	nn	20	SENT_165	[p10l267t275r303b331],
16	and	CC	O	and	_	0	SENT_165	[p10l373t273r503b331],
17	4	CD	NUMBER	4	num	18	SENT_165	[p10l570t276r608b330],
18	events	NNS	O	event	npadvmod	19	SENT_165	[p10l676t281r900b331],
19	(	JJ	O	(	conj_and	15	SENT_165	[p10l969t274r1360b346],
20	P	NN	O	p	pobj	11	SENT_165	[p10l969t274r1360b346],
21	=	JJ	O	=	amod	23	SENT_165	[p10l969t274r1360b346],
22	0.004	CD	NUMBER	0.004	tmod	21	SENT_165	[p10l969t274r1360b346],
23	)	NN	O	)	dep	8	SENT_165	[p10l969t274r1360b346],
24	,	,	O	,	_	0	SENT_165	[p10l969t274r1360b346],
25	low	JJ	O	low	amod	26	SENT_165	[p10l1430t273r1559b331],
26	clearance	NN	O	clearance	prep_to	5	SENT_165	[p10l1623t273r1951b331],
27	and	CC	O	and	_	0	SENT_165	[p10l2019t273r2150b331],
28	heterozygoty	NN	O	heterozygoty	conj_and	8	SENT_165	[p10l9t369r474b445],
29	for	IN	O	for	_	0	SENT_165	[p10l502t369r600b427],
30	DPD	NN	O	dpd	nn	32	SENT_165	[p10l626t371r788b426],
31	(	CD	NUMBER	(	num	32	SENT_165	[p10l821t369r954b441],
32	P	NN	O	p	prep_for	26	SENT_165	[p10l821t369r954b441],
33	:	:	O	:	_	0	SENT_165	[p10l821t369r954b441],
34	0.031	CD	NUMBER	0.031	num	35	SENT_165	[p10l973t369r1211b441],
35	)	NN	O	)	prep_to	5	SENT_165	[p10l973t369r1211b441],
36	,	,	O	,	_	0	SENT_165	[p10l973t369r1211b441],
37	and	CC	O	and	_	0	SENT_165	[p10l1247t369r1378b427],
38	homozygoty	NN	O	homozygoty	nn	39	SENT_165	[p10l1408t369r1856b445],
39	C/C	NN	O	c/c	prep_to	5	SENT_165	[p10l1885t369r2022b434],
40	for	IN	O	for	_	0	SENT_165	[p10l2052t369r2150b427],
41	MTHFR	NNP	O	MTHFR	prep_for	39	SENT_165	[p10l6t466r268b521],
42	1298	CD	DATE	1298	num	41	SENT_165	[p10l319t465r483b521],
43	A	DT	O	a	det	45	SENT_165	[p10l527t465r709b521],
44	>	JJR	O	>	amod	45	SENT_165	[p10l527t465r709b521],
45	C	NN	O	c	dep	39	SENT_165	[p10l527t465r709b521],
46	(	CD	NUMBER	(	num	47	SENT_165	[p10l756t464r1170b536],
47	P	NN	O	p	npadvmod	48	SENT_165	[p10l756t464r1170b536],
48	=	JJ	O	=	amod	45	SENT_165	[p10l756t464r1170b536],
49	0.0018	CD	NUMBER	0.0018	num	50	SENT_165	[p10l756t464r1170b536],
50	)	NN	O	)	advmod	45	SENT_165	[p10l756t464r1170b536],
51	with	IN	O	with	_	0	SENT_165	[p10l1215t464r1376b521],
52	30	CD	PERCENT	30	number	53	SENT_165	[p10l1422t465r1573b521],
53	%	NN	PERCENT	%	amod	54	SENT_165	[p10l1422t465r1573b521],
54	grade	NN	O	grade	prep_with	50	SENT_165	[p10l1617t464r1806b539],
55	3	CD	NUMBER	3	num	59	SENT_165	[p10l1853t465r1888b521],
56	and	CC	O	and	_	0	SENT_165	[p10l1935t464r2066b521],
57	4	CD	NUMBER	4	conj_and	55	SENT_165	[p10l2110t466r2148b521],
58	toxic	JJ	O	toxic	amod	59	SENT_165	[p10l9t561r185b615],
59	events	NNS	O	event	dep	45	SENT_165	[p10l215t565r457b615],
60	.	.	O	.	_	0	SENT_165	[p10l215t565r457b615],

1	Correlation	NN	O	correlation	dep	15	SENT_166	[p10l15t769r364b827],
2	between	IN	O	between	_	0	SENT_166	[p10l395t769r660b827],
3	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_166	[p10l686t769r1172b845],
4	and	CC	O	and	_	0	SENT_166	[p10l1202t769r1326b827],
5	response	NN	O	response	dep	15	SENT_166	[p10l1352t786r1628b845],
6	The	DT	O	the	det	9	SENT_166	[p10l7t864r140b921],
7	global	JJ	O	global	amod	9	SENT_166	[p10l170t864r384b939],
8	objective	JJ	O	objective	amod	9	SENT_166	[p10l414t864r732b939],
9	response	NN	O	response	dep	5	SENT_166	[p10l761t880r1066b939],
10	(	CD	NUMBER	(	num	11	SENT_166	[p10l1100t864r1254b936],
11	OR	NN	O	or	dep	15	SENT_166	[p10l1100t864r1254b936],
12	)	CD	NUMBER	)	number	13	SENT_166	[p10l1100t864r1254b936],
13	(	CD	NUMBER	(	num	15	SENT_166	[p10l1290t864r1640b939],
14	complete	JJ	O	complete	amod	15	SENT_166	[p10l1290t864r1640b939],
15	response	NN	O	response	dep	25	SENT_166	[p10l1670t880r1975b939],
16	plus	CC	O	plus	prep	15	SENT_166	[p10l2004t864r2149b939],
17	partial	JJ	O	partial	amod	18	SENT_166	[p10l9t959r236b1035],
18	response	NN	O	response	dep	16	SENT_166	[p10l269t976r574b1035],
19	(	CD	NUMBER	(	num	20	SENT_166	[p10l612t959r775b1031],
20	PR	NN	O	pr	nsubj	25	SENT_166	[p10l612t959r775b1031],
21	)	CD	NUMBER	)	number	22	SENT_166	[p10l612t959r775b1031],
22	)	CD	NUMBER	)	dep	23	SENT_166	[p10l612t959r775b1031],
23	rate	NN	O	rate	dep	20	SENT_166	[p10l811t966r942b1017],
24	was	VBD	O	be	cop	25	SENT_166	[p10l975t976r1103b1017],
25	32.9	CD	NUMBER	32.9	_	0	SENT_166	[p10l1138t961r1284b1017],
26	with	IN	O	with	_	0	SENT_166	[p10l1318t959r1480b1017],
27	6.6	CD	PERCENT	6.6	num	28	SENT_166	[p10l1515t961r1688b1017],
28	%	NN	PERCENT	%	prep_with	25	SENT_166	[p10l1515t961r1688b1017],
29	of	IN	O	of	_	0	SENT_166	[p10l1722t959r1793b1017],
30	complete	JJ	O	complete	amod	31	SENT_166	[p10l1823t959r2148b1035],
31	response	NN	O	response	prep_of	28	SENT_166	[p10l9t1071r315b1130],
32	(	CD	NUMBER	(	num	34	SENT_166	[p10l348t1054r518b1126],
33	CR	JJ	O	cr	amod	34	SENT_166	[p10l348t1054r518b1126],
34	)	NN	O	)	dep	31	SENT_166	[p10l348t1054r518b1126],
35	.	.	O	.	_	0	SENT_166	[p10l348t1054r518b1126],

1	We	PRP	O	we	nsubj	2	SENT_167	[p10l85t1151r194b1207],
2	considered	VBD	O	consider	_	0	SENT_167	[p10l238t1149r620b1207],
3	the	DT	O	the	det	6	SENT_167	[p10l662t1149r774b1207],
4	‘	NN	O	‘	nn	6	SENT_167	[p10l820t1149r1001b1225],
5	high	JJ	O	high	amod	6	SENT_167	[p10l820t1149r1001b1225],
6	risk	NN	O	risk	dobj	2	SENT_167	[p10l1043t1149r1168b1207],
7	for	IN	O	for	_	0	SENT_167	[p10l1208t1149r1307b1207],
8	toxicity	NN	O	toxicity	nn	10	SENT_167	[p10l1347t1149r1637b1225],
9	’	CD	NUMBER	’	num	10	SENT_167	[p10l1347t1149r1637b1225],
10	patients	NNS	O	patient	prep_for	2	SENT_167	[p10l1681t1152r1963b1225],
11	as	IN	O	as	_	0	SENT_167	[p10l2007t1166r2071b1207],
12	a	DT	O	a	det	14	SENT_167	[p10l2115t1166r2150b1207],
13	possible	JJ	O	possible	amod	14	SENT_167	[p10l9t1243r289b1319],
14	bias	NN	O	bias	prep_as	2	SENT_167	[p10l325t1243r461b1301],
15	for	IN	O	for	_	0	SENT_167	[p10l499t1243r597b1301],
16	the	DT	O	the	det	19	SENT_167	[p10l633t1243r745b1301],
17	efficacy	NN	O	efficacy	nn	19	SENT_167	[p10l784t1243r1053b1319],
18	study	NN	O	study	nn	19	SENT_167	[p10l1089t1243r1281b1319],
19	(	NN	O	(	prep_for	14	SENT_167	[p10l1319t1243r1614b1315],
20	because	IN	O	because	_	0	SENT_167	[p10l1319t1243r1614b1315],
21	of	IN	O	of	_	0	SENT_167	[p10l1652t1243r1724b1301],
22	inadequate	JJ	O	inadequate	amod	23	SENT_167	[p10l1756t1243r2148b1319],
23	dosage	NN	O	dosage	prep_because_of	2	SENT_167	[p10l10t1338r264b1414],
24	,	,	O	,	_	0	SENT_167	[p10l10t1338r264b1414],
25	toxic	JJ	O	toxic	amod	27	SENT_167	[p10l299t1341r475b1396],
26	side	JJ	O	side	amod	27	SENT_167	[p10l506t1338r639b1396],
27	effects	NNS	O	effect	appos	23	SENT_167	[p10l671t1338r892b1396],
28	leading	VBG	O	lead	partmod	27	SENT_167	[p10l922t1338r1183b1414],
29	to	TO	O	to	_	0	SENT_167	[p10l1212t1346r1281b1396],
30	delayed	VBN	O	delay	amod	31	SENT_167	[p10l1312t1338r1582b1414],
31	treatment	NN	O	treatment	prep_to	28	SENT_167	[p10l1612t1346r1980b1409],
32	,	,	O	,	_	0	SENT_167	[p10l1612t1346r1980b1409],
33	bias	NN	O	bias	conj_and	27	SENT_167	[p10l2012t1338r2149b1396],
34	between	IN	O	between	_	0	SENT_167	[p10l7t1434r305b1492],
35	DPD	NN	O	dpd	nn	36	SENT_167	[p10l323t1436r486b1491],
36	SNPs	NNS	O	snp	prep_between	33	SENT_167	[p10l509t1436r677b1492],
37	and	CC	O	and	_	0	SENT_167	[p10l702t1434r833b1492],
38	TS/M	NN	O	ts/m	nn	41	SENT_167	[p10l858t1434r1037b1499],
39	T	NN	O	t	nn	41	SENT_167	[p10l1037t1436r1087b1491],
40	HFR	NN	O	hfr	nn	41	SENT_167	[p10l1080t1436r1225b1491],
41	SNPs	NNS	O	snp	appos	23	SENT_167	[p10l1250t1436r1418b1492],
42	for	IN	O	for	_	0	SENT_167	[p10l1442t1434r1540b1492],
43	interpretation	NN	O	interpretation	prep_for	41	SENT_167	[p10l1562t1437r2059b1510],
44	of	IN	O	of	_	0	SENT_167	[p10l2082t1434r2153b1492],
45	results	NNS	O	result	prep_of	43	SENT_167	[p10l9t1529r280b1601],
46	)	CD	NUMBER	)	dep	41	SENT_167	[p10l9t1529r280b1601],
47	.	.	O	.	_	0	SENT_167	[p10l9t1529r280b1601],

1	Consequently	RB	O	consequently	advmod	6	SENT_168	[p10l335t1529r840b1604],
2	,	,	O	,	_	0	SENT_168	[p10l335t1529r840b1604],
3	the	DT	O	the	det	5	SENT_168	[p10l894t1529r1006b1586],
4	following	JJ	O	following	amod	5	SENT_168	[p10l1057t1528r1395b1604],
5	studies	NNS	O	study	nsubj	6	SENT_168	[p10l1445t1529r1685b1586],
6	(	VBP	O	(	_	0	SENT_168	[p10l1738t1529r2149b1601],
7	correlation	NN	O	correlation	nsubjpass	16	SENT_168	[p10l1738t1529r2149b1601],
8	between	IN	O	between	_	0	SENT_168	[p10l7t1624r304b1681],
9	genotypes	NNS	O	genotype	prep_between	7	SENT_168	[p10l333t1631r691b1699],
10	and	CC	O	and	_	0	SENT_168	[p10l721t1624r852b1681],
11	response	NN	O	response	conj_and	9	SENT_168	[p10l880t1640r1186b1699],
12	or	CC	O	or	_	0	SENT_168	[p10l1216t1640r1287b1681],
13	survival	NN	O	survival	conj_or	9	SENT_168	[p10l1317t1624r1614b1696],
14	)	CD	NUMBER	)	num	13	SENT_168	[p10l1317t1624r1614b1696],
15	were	VBD	O	be	auxpass	16	SENT_168	[p10l1645t1640r1809b1681],
16	analyzed	VBN	O	analyze	dep	6	SENT_168	[p10l1839t1624r2150b1699],
17	on	IN	O	on	_	0	SENT_168	[p10l10t1736r101b1777],
18	67	CD	NUMBER	67	num	19	SENT_168	[p10l129t1721r209b1777],
19	patients	NNS	O	patient	prep_on	16	SENT_168	[p10l236t1722r518b1795],
20	after	IN	O	after	_	0	SENT_168	[p10l545t1719r703b1777],
21	the	DT	O	the	det	22	SENT_168	[p10l727t1719r840b1777],
22	exclusion	NN	O	exclusion	prep_after	16	SENT_168	[p10l868t1719r1204b1777],
23	of	IN	O	of	_	0	SENT_168	[p10l1231t1719r1303b1777],
24	the	DT	O	the	det	25	SENT_168	[p10l1324t1719r1436b1777],
25	nine	CD	NUMBER	nine	prep_of	22	SENT_168	[p10l1463t1722r1620b1777],
26	with	IN	O	with	_	0	SENT_168	[p10l1645t1719r1807b1777],
27	5-FU	NN	O	5-fu	nn	29	SENT_168	[p10l1834t1722r1998b1777],
28	low	JJ	O	low	amod	29	SENT_168	[p10l2023t1719r2151b1777],
29	clearance	NN	O	clearance	prep_with	16	SENT_168	[p10l10t1814r337b1871],
30	and	CC	O	and	_	0	SENT_168	[p10l385t1814r516b1871],
31	there	EX	O	there	expl	32	SENT_168	[p10l560t1814r741b1871],
32	was	VBD	O	be	conj_and	16	SENT_168	[p10l786t1830r913b1871],
33	no	DT	O	no	det	34	SENT_168	[p10l959t1830r1050b1871],
34	difference	NN	O	difference	nsubj	32	SENT_168	[p10l1097t1813r1446b1871],
35	for	IN	O	for	mark	38	SENT_168	[p10l1492t1813r1591b1871],
36	response	NN	O	response	nn	37	SENT_168	[p10l1635t1830r1940b1889],
37	rates	NNS	O	rate	nsubj	38	SENT_168	[p10l1987t1821r2149b1871],
38	(	VBP	O	(	advcl	32	SENT_168	[p10l13t1908r255b1980],
39	34.3	CD	PERCENT	34.3	num	40	SENT_168	[p10l13t1908r255b1980],
40	%	NN	PERCENT	%	dobj	38	SENT_168	[p10l13t1908r255b1980],
41	for	IN	O	for	_	0	SENT_168	[p10l311t1908r409b1966],
42	OR	NN	O	or	prep_for	40	SENT_168	[p10l465t1910r573b1966],
43	and	CC	O	and	_	0	SENT_168	[p10l627t1908r758b1966],
44	7.4	CD	PERCENT	7.4	num	45	SENT_168	[p10l818t1910r988b1966],
45	%	NN	PERCENT	%	dobj	38	SENT_168	[p10l818t1910r988b1966],
46	for	IN	O	for	_	0	SENT_168	[p10l1044t1908r1142b1966],
47	CR	JJ	O	cr	amod	48	SENT_168	[p10l1198t1908r1321b1980],
48	)	NN	O	)	prep_for	45	SENT_168	[p10l1198t1908r1321b1980],
49	in	IN	O	in	_	0	SENT_168	[p10l1380t1911r1451b1965],
50	this	DT	O	this	det	51	SENT_168	[p10l1506t1908r1635b1966],
51	new	JJ	O	new	prep_in	38	SENT_168	[p10l1691t1925r1839b1966],
52	studied	VBN	O	study	partmod	51	SENT_168	[p10l1894t1908r2150b1966],
53	population	NN	O	population	dobj	52	SENT_168	[p10l9t2004r419b2080],
54	.	.	O	.	_	0	SENT_168	[p10l9t2004r419b2080],

1	The	DT	O	the	det	2	SENT_169	[p10l84t2099r216b2157],
2	distribution	NN	O	distribution	nsubjpass	11	SENT_169	[p10l247t2099r666b2157],
3	between	IN	O	between	_	0	SENT_169	[p10l692t2099r989b2157],
4	response	NN	O	response	nn	5	SENT_169	[p10l1018t2116r1323b2175],
5	rates	NNS	O	rate	prep_between	2	SENT_169	[p10l1352t2106r1515b2157],
6	and	CC	O	and	_	0	SENT_169	[p10l1544t2099r1676b2157],
7	the	DT	O	the	det	9	SENT_169	[p10l1704t2099r1816b2157],
8	different	JJ	O	different	amod	9	SENT_169	[p10l1846t2099r2150b2157],
9	genotypes	NNS	O	genotype	prep_between	2	SENT_169	[p10l9t2201r367b2269],
10	is	VBZ	O	be	auxpass	11	SENT_169	[p10l417t2196r467b2251],
11	shown	VBN	O	show	_	0	SENT_169	[p10l518t2193r750b2251],
12	in	IN	O	in	_	0	SENT_169	[p10l800t2196r870b2250],
13	Table	NNP	O	Table	prep_in	11	SENT_169	[p10l917t2193r1102b2251],
14	6	CD	NUMBER	6	num	13	SENT_169	[p10l1155t2195r1210b2251],
15	.	.	O	.	_	0	SENT_169	[p10l1155t2195r1210b2251],

1	No	DT	O	no	det	3	SENT_170	[p10l1262t2196r1365b2251],
2	significant	JJ	O	significant	amod	3	SENT_170	[p10l1417t2193r1788b2269],
3	link	NN	O	link	nsubjpass	5	SENT_170	[p10l1837t2193r1976b2250],
4	was	VBD	O	be	auxpass	5	SENT_170	[p10l2021t2210r2149b2251],
5	noted	VBN	O	note	_	0	SENT_170	[p10l9t2288r232b2346],
6	.	.	O	.	_	0	SENT_170	[p10l9t2288r232b2346],

1	However	RB	O	however	advmod	8	SENT_171	[p10l267t2291r592b2359],
2	,	,	O	,	_	0	SENT_171	[p10l267t2291r592b2359],
3	the	DT	O	the	det	4	SENT_171	[p10l626t2288r739b2346],
4	OR	NN	O	or	nsubjpass	8	SENT_171	[p10l771t2290r878b2346],
5	for	IN	O	for	_	0	SENT_171	[p10l906t2288r1004b2346],
6	3R/3R	NN	O	3r/3r	prep_for	4	SENT_171	[p10l1035t2288r1245b2354],
7	was	VBD	O	be	auxpass	8	SENT_171	[p10l1271t2305r1400b2346],
8	decreased	VBN	O	decrease	_	0	SENT_171	[p10l1430t2288r1771b2346],
9	by	IN	O	by	_	0	SENT_171	[p10l1797t2288r1886b2364],
10	almost	RB	O	almost	quantmod	11	SENT_171	[p10l1913t2289r2150b2346],
11	50	CD	PERCENT	50	num	12	SENT_171	[p10l11t2386r162b2442],
12	%	NN	PERCENT	%	agent	8	SENT_171	[p10l11t2386r162b2442],
13	in	IN	O	in	_	0	SENT_171	[p10l187t2387r258b2441],
14	comparison	NN	O	comparison	prep_in	12	SENT_171	[p10l283t2387r699b2460],
15	with	IN	O	with	_	0	SENT_171	[p10l723t2384r884b2442],
16	other	JJ	O	other	amod	19	SENT_171	[p10l910t2384r1098b2442],
17	T	NN	O	t	nn	19	SENT_171	[p10l1120t2386r1167b2441],
18	SER	NN	O	ser	nn	19	SENT_171	[p10l1170t2386r1298b2442],
19	genotypes	NNS	O	genotype	prep_with	8	SENT_171	[p10l1321t2391r1696b2460],
20	,	,	O	,	_	0	SENT_171	[p10l1321t2391r1696b2460],
21	as	IN	O	as	mark	22	SENT_171	[p10l1727t2401r1792b2442],
22	described	VBN	O	describe	advcl	8	SENT_171	[p10l1818t2384r2150b2442],
23	in	IN	O	in	_	0	SENT_171	[p10l9t2482r80b2536],
24	previous	JJ	O	previous	amod	26	SENT_171	[p10l111t2482r411b2554],
25	clinical	JJ	O	clinical	amod	26	SENT_171	[p10l444t2479r699b2536],
26	studies	NNS	O	study	prep_in	22	SENT_171	[p10l733t2479r992b2536],
27	.	.	O	.	_	0	SENT_171	[p10l733t2479r992b2536],

1	OR	NN	O	or	nsubj	11	SENT_172	[p10l1030t2480r1137b2536],
2	in	IN	O	in	_	0	SENT_172	[p10l1166t2482r1237b2536],
3	the	DT	O	the	det	9	SENT_172	[p10l1268t2479r1381b2536],
4	‘	NNP	O	‘	nn	9	SENT_172	[p10l1416t2479r1609b2554],
5	High	NNP	O	High	nn	9	SENT_172	[p10l1416t2479r1609b2554],
6	TS	NN	O	t	nn	9	SENT_172	[p10l1638t2480r1721b2536],
7	expression	NN	O	expression	nn	9	SENT_172	[p10l1754t2479r2147b2554],
8	’	CD	NUMBER	’	num	9	SENT_172	[p10l1754t2479r2147b2554],
9	population	NN	O	population	prep_in	1	SENT_172	[p10l9t2574r402b2649],
10	also	RB	O	also	advmod	11	SENT_172	[p10l426t2574r561b2631],
11	decreased	VBD	O	decrease	_	0	SENT_172	[p10l586t2574r926b2631],
12	with	IN	O	with	_	0	SENT_172	[p10l949t2574r1110b2631],
13	only	RB	O	only	quantmod	14	SENT_172	[p10l1135t2574r1294b2649],
14	24	CD	NUMBER	24	prep_with	11	SENT_172	[p10l1318t2575r1399b2631],
15	against	IN	O	against	_	0	SENT_172	[p10l1425t2577r1675b2649],
16	40.5	CD	PERCENT	40.5	num	17	SENT_172	[p10l1699t2575r1917b2631],
17	%	NN	PERCENT	%	prep_against	11	SENT_172	[p10l1699t2575r1917b2631],
18	in	IN	O	in	_	0	SENT_172	[p10l1942t2577r2012b2631],
19	the	DT	O	the	det	23	SENT_172	[p10l2036t2574r2148b2631],
20	‘	CD	NUMBER	‘	num	23	SENT_172	[p10l12t2669r196b2727],
21	Low	JJ	O	low	amod	23	SENT_172	[p10l12t2669r196b2727],
22	’	NN	O	’	nn	23	SENT_172	[p10l12t2669r196b2727],
23	group	NN	O	group	prep_in	17	SENT_172	[p10l250t2686r455b2745],
24	(	CD	NUMBER	(	num	27	SENT_172	[p10l510t2670r655b2741],
25	not	RB	O	not	neg	27	SENT_172	[p10l510t2670r655b2741],
26	significant	JJ	O	significant	amod	27	SENT_172	[p10l708t2669r1123b2745],
27	)	NN	O	)	dep	23	SENT_172	[p10l708t2669r1123b2745],
28	.	.	O	.	_	0	SENT_172	[p10l708t2669r1123b2745],

1	Likewise	RB	O	likewise	advmod	6	SENT_173	[p10l1180t2669r1494b2740],
2	,	,	O	,	_	0	SENT_173	[p10l1180t2669r1494b2740],
3	no	DT	O	no	det	4	SENT_173	[p10l1551t2686r1642b2727],
4	variable	NN	O	variable	nsubj	6	SENT_173	[p10l1692t2669r1970b2727],
5	was	VBD	O	be	cop	6	SENT_173	[p10l2021t2686r2148b2727],
6	significant	JJ	O	significant	_	0	SENT_173	[p10l11t2763r382b2839],
7	in	IN	O	in	_	0	SENT_173	[p10l413t2767r483b2821],
8	multivariate	JJ	O	multivariate	amod	9	SENT_173	[p10l514t2764r946b2821],
9	analysis	NN	O	analysis	prep_in	6	SENT_173	[p10l979t2764r1254b2839],
10	of	IN	O	of	_	0	SENT_173	[p10l1286t2763r1358b2821],
11	biological	JJ	O	biological	amod	12	SENT_173	[p10l1383t2764r1730b2839],
12	parameters	NNS	O	parameter	prep_of	9	SENT_173	[p10l1760t2771r2149b2839],
13	for	IN	O	for	_	0	SENT_173	[p10l9t2859r108b2917],
14	predicting	VBG	O	predict	prepc_for	6	SENT_173	[p10l136t2859r500b2935],
15	response	NN	O	response	dobj	14	SENT_173	[p10l528t2876r833b2935],
16	to	TO	O	to	_	0	SENT_173	[p10l863t2866r933b2917],
17	ﬂuorouracil	NN	O	ﬂuorouracil	nn	18	SENT_173	[p10l963t2859r1377b2917],
18	treatment	NN	O	treatment	prep_to	14	SENT_173	[p10l1407t2866r1775b2917],
19	.	.	O	.	_	0	SENT_173	[p10l1407t2866r1775b2917],

1	Correlation	NN	O	correlation	nsubj	15	SENT_174	[p10l15t3089r364b3147],
2	between	IN	O	between	_	0	SENT_174	[p10l395t3089r660b3147],
3	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_174	[p10l686t3089r1172b3165],
4	and	CC	O	and	_	0	SENT_174	[p10l1202t3089r1326b3147],
5	survival	NN	O	survival	conj_and	3	SENT_174	[p10l1351t3089r1595b3147],
6	Among	IN	O	among	_	0	SENT_174	[p10l8t3185r269b3260],
7	67	CD	NUMBER	67	num	8	SENT_174	[p10l297t3185r377b3242],
8	patients	NNS	O	patient	prep_among	15	SENT_174	[p10l405t3187r706b3260],
9	,	,	O	,	_	0	SENT_174	[p10l405t3187r706b3260],
10	the	DT	O	the	det	12	SENT_174	[p10l737t3184r850b3242],
11	OS	NNP	O	OS	nn	12	SENT_174	[p10l879t3185r974b3242],
12	rate	NN	O	rate	nsubj	15	SENT_174	[p10l1001t3191r1132b3242],
13	was	VBD	O	be	cop	15	SENT_174	[p10l1159t3201r1286b3242],
14	5	CD	PERCENT	5	num	15	SENT_174	[p10l1316t3185r1423b3242],
15	%	NN	PERCENT	%	_	0	SENT_174	[p10l1316t3185r1423b3242],
16	at	IN	O	at	advmod	15	SENT_174	[p10l1452t3191r1515b3242],
17	5	CD	DURATION	5	num	18	SENT_174	[p10l1543t3186r1578b3242],
18	years	NNS	NUMBER	year	pobj	16	SENT_174	[p10l1606t3201r1784b3260],
19	(	CD	NUMBER	(	num	20	SENT_174	[p10l1815t3184r2054b3260],
20	Figure	NN	O	figure	rcmod	15	SENT_174	[p10l1815t3184r2054b3260],
21	2	CD	NUMBER	2	num	22	SENT_174	[p10l2083t3184r2146b3256],
22	)	NN	O	)	dobj	20	SENT_174	[p10l2083t3184r2146b3256],
23	in	IN	O	in	_	0	SENT_174	[p10l9t3281r80b3335],
24	agreement	NN	O	agreement	prep_in	22	SENT_174	[p10l127t3286r499b3354],
25	with	IN	O	with	_	0	SENT_174	[p10l544t3278r705b3336],
26	clinical	JJ	O	clinical	amod	27	SENT_174	[p10l752t3278r1006b3336],
27	data	NNS	O	datum	prep_with	20	SENT_174	[p10l1054t3278r1203b3336],
28	from	IN	O	from	_	0	SENT_174	[p10l1250t3278r1419b3336],
29	the	DT	O	the	det	30	SENT_174	[p10l1466t3278r1578b3336],
30	literature	NN	O	literature	prep_from	15	SENT_174	[p10l1626t3279r1967b3336],
31	.	.	O	.	_	0	SENT_174	[p10l1626t3279r1967b3336],

1	The	DT	O	the	det	4	SENT_175	[p10l2016t3278r2148b3336],
2	median	JJ	O	median	amod	4	SENT_175	[p10l9t3373r276b3431],
3	OS	NNP	O	OS	nn	4	SENT_175	[p10l312t3375r406b3431],
4	time	NN	O	time	nsubj	7	SENT_175	[p10l441t3376r600b3431],
5	was	VBD	O	be	cop	7	SENT_175	[p10l634t3390r762b3431],
6	20	CD	DURATION	20	num	7	SENT_175	[p10l799t3375r882b3431],
7	months	NNS	NUMBER	month	_	0	SENT_175	[p10l916t3373r1208b3431],
8	.	.	O	.	_	0	SENT_175	[p10l916t3373r1208b3431],

1	The	DT	O	the	det	8	SENT_176	[p10l1246t3373r1378b3431],
2	median	JJ	O	median	amod	8	SENT_176	[p10l1414t3373r1681b3431],
3	progressionfree	NN	O	progressionfree	nn	8	SENT_176	[p10l1715t3376r2148b3449, p10l9t3469r136b3527],
4	survival	NN	O	survival	nn	8	SENT_176	[p10l169t3469r444b3527],
5	(	CD	NUMBER	(	num	8	SENT_176	[p10l477t3469r642b3541],
6	PFS	NN	O	pf	nn	8	SENT_176	[p10l477t3469r642b3541],
7	)	CD	NUMBER	)	num	8	SENT_176	[p10l477t3469r642b3541],
8	time	NN	O	time	nsubj	11	SENT_176	[p10l676t3472r834b3527],
9	was	VBD	O	be	cop	11	SENT_176	[p10l864t3486r992b3527],
10	100	CD	DURATION	100	num	11	SENT_176	[p10l1029t3471r1150b3527],
11	days	NNS	NUMBER	day	_	0	SENT_176	[p10l1181t3469r1353b3545],
12	.	.	O	.	_	0	SENT_176	[p10l1181t3469r1353b3545],

1	The	DT	O	the	det	3	SENT_177	[p10l1385t3469r1518b3527],
2	log-rank	JJ	O	log-rank	amod	3	SENT_177	[p10l1549t3469r1844b3545],
3	analysis	NN	O	analysis	nsubj	9	SENT_177	[p10l1874t3469r2149b3545],
4	according	VBG	O	accord	_	0	SENT_177	[p10l10t3564r358b3639],
5	to	TO	O	to	prepc_according_to	3	SENT_177	[p10l392t3571r461b3621],
6	clinical	JJ	O	clinical	amod	7	SENT_177	[p10l498t3564r753b3621],
7	characteristics	NNS	O	characteristic	pobj	3	SENT_177	[p10l790t3564r1290b3621],
8	was	VBD	O	be	cop	9	SENT_177	[p10l1325t3580r1452b3621],
9	significant	JJ	O	significant	_	0	SENT_177	[p10l1491t3563r1878b3639],
10	,	,	O	,	_	0	SENT_177	[p10l1491t3563r1878b3639],
11	with	IN	O	with	mark	18	SENT_177	[p10l1917t3564r2079b3621],
12	a	DT	O	a	det	14	SENT_177	[p10l2115t3580r2150b3621],
13	longer	RBR	O	longer	amod	14	SENT_177	[p10l9t3659r236b3734],
14	survival	NN	O	survival	nsubj	18	SENT_177	[p10l264t3659r538b3716],
15	for	IN	O	for	_	0	SENT_177	[p10l567t3658r666b3716],
16	performance	NN	O	performance	nn	17	SENT_177	[p10l692t3658r1141b3734],
17	status	NN	O	status	prep_for	14	SENT_177	[p10l1172t3666r1371b3716],
18	<	JJR	O	<	advcl	9	SENT_177	[p10l1411t3660r1515b3716],
19	2	CD	NUMBER	2	num	21	SENT_177	[p10l1411t3660r1515b3716],
20	(	NN	O	(	nn	21	SENT_177	[p10l1547t3659r1681b3731],
21	P	NN	O	p	dobj	18	SENT_177	[p10l1547t3659r1681b3731],
22	:	:	O	:	_	0	SENT_177	[p10l1547t3659r1681b3731],
23	0.03	CD	NUMBER	0.03	num	24	SENT_177	[p10l1699t3659r1872b3731],
24	)	NN	O	)	dep	21	SENT_177	[p10l1699t3659r1872b3731],
25	and	CC	O	and	_	0	SENT_177	[p10l1905t3659r2036b3716],
26	an	DT	O	a	det	28	SENT_177	[p10l2065t3675r2149b3716],
27	age	NN	O	age	dep	28	SENT_177	[p10l10t3771r123b3830],
28	younger	JJR	O	younger	dep	21	SENT_177	[p10l151t3771r445b3830],
29	than	IN	O	than	_	0	SENT_177	[p10l473t3754r638b3812],
30	75-years	NNS	DURATION	75-year	prep_than	18	SENT_177	[p10l673t3757r956b3830],
31	old	JJ	DURATION	old	amod	33	SENT_177	[p10l987t3754r1099b3812],
32	(	CD	NUMBER	(	tmod	31	SENT_177	[p10l1131t3754r1265b3826],
33	P	NN	O	p	dep	30	SENT_177	[p10l1131t3754r1265b3826],
34	:	:	O	:	_	0	SENT_177	[p10l1131t3754r1265b3826],
35	0.034	CD	NUMBER	0.034	num	36	SENT_177	[p10l1283t3754r1521b3826],
36	)	NN	O	)	dep	30	SENT_177	[p10l1283t3754r1521b3826],
37	.	.	O	.	_	0	SENT_177	[p10l1283t3754r1521b3826],

1	Fluorouracil	NNP	O	Fluorouracil	nn	3	SENT_178	[p11l1341t372r1625b417],
2	outcome	NN	O	outcome	nn	3	SENT_178	[p11l1646t377r1856b417],
3	parameters	NNS	O	parameter	_	0	SENT_178	[p11l1876t377r2149b431],
4	o	NN	O	o	nn	5	SENT_178	[p11l1822t444r1855b485],
5	Capitain	NNP	MISC	Capitain	dep	3	SENT_178	[p11l1875t444r2043b498],
6	et	FW	O	et	nn	7	SENT_178	[p11l2065t448r2101b485],
7	al	FW	O	al	dep	3	SENT_178	[p11l2117t443r2153b485],

1	Table	NNP	O	Table	nn	3	SENT_179	[p11l7t731r196b788],
2	6	CD	NUMBER	6	num	3	SENT_179	[p11l254t733r293b788],
3	Comparison	NN	O	comparison	nsubj	15	SENT_179	[p11l373t734r775b805],
4	of	IN	O	of	_	0	SENT_179	[p11l834t733r902b788],
5	responses	NNS	O	response	prep_of	3	SENT_179	[p11l958t749r1285b805],
6	between	IN	O	between	_	0	SENT_179	[p11l1345t733r1632b788],
7	the	DT	O	the	det	9	SENT_179	[p11l1691t733r1798b788],
8	different	JJ	O	different	amod	9	SENT_179	[p11l1857t733r2150b788],
9	genotypes	NNS	O	genotype	prep_between	5	SENT_179	[p11l9t824r359b889],
10	in	IN	O	in	_	0	SENT_179	[p11l389t818r445b871],
11	population	NN	O	population	prep_in	9	SENT_179	[p11l478t817r840b889],
12	without	IN	O	without	_	0	SENT_179	[p11l869t818r1134b872],
13	risk	NN	O	risk	nn	14	SENT_179	[p11l1163t818r1275b872],
14	factors	NNS	O	factor	prep_without	11	SENT_179	[p11l1298t818r1526b872],
15	(	VBP	O	(	_	0	SENT_179	[p11l1558t818r1664b887],
16	67	CD	NUMBER	67	num	17	SENT_179	[p11l1558t818r1664b887],
17	patients	NNS	O	patient	dobj	15	SENT_179	[p11l1694t818r1988b889],
18	)	IN	O	)	prep	15	SENT_179	[p11l1694t818r1988b889],

1	Polymorphism	NN	O	polymorphism	nn	3	SENT_180	[p11l12t1261r435b1333],
2	TS	NN	O	t	nn	3	SENT_180	[p11l469t1262r537b1316],
3	2R/2R	NN	O	2r/2r	_	0	SENT_180	[p11l82t1346r269b1408],
4	(	CD	NUMBER	(	num	5	SENT_180	[p11l297t1347r359b1415],
5	n	NN	O	n	npadvmod	6	SENT_180	[p11l297t1347r359b1415],
6	=	JJ	O	=	amod	3	SENT_180	[p11l375t1373r423b1391],
7	1	CD	NUMBER	1	number	8	SENT_180	[p11l445t1348r464b1400],
8	1	CD	NUMBER	1	num	12	SENT_180	[p11l487t1347r544b1415],
9	)	NN	O	)	nn	12	SENT_180	[p11l487t1347r544b1415],
10	2R/3R	NN	O	2r/3r	nn	12	SENT_180	[p11l82t1520r269b1582],
11	(	CD	NUMBER	(	num	12	SENT_180	[p11l297t1521r423b1589],
12	n	NN	O	n	dep	3	SENT_180	[p11l297t1521r423b1589],
13	=	JJ	O	=	amod	12	SENT_180	[p11l297t1521r423b1589],
14	35	CD	NUMBER	35	tmod	13	SENT_180	[p11l445t1521r544b1589],
15	)	CD	NUMBER	)	num	18	SENT_180	[p11l445t1521r544b1589],
16	3R/3R	NN	O	3r/3r	nn	18	SENT_180	[p11l85t1694r269b1756],
17	(	NN	O	(	nn	18	SENT_180	[p11l297t1695r544b1763],
18	n	NN	O	n	dep	12	SENT_180	[p11l297t1695r544b1763],
19	=	JJ	O	=	amod	21	SENT_180	[p11l297t1695r544b1763],
20	21	CD	NUMBER	21	tmod	19	SENT_180	[p11l297t1695r544b1763],
21	)	NN	O	)	dep	18	SENT_180	[p11l297t1695r544b1763],

1	Expression	NN	O	expression	nn	2	SENT_181	[p11l12t1960r319b2030],
2	TS	NN	O	t	_	0	SENT_181	[p11l352t1960r420b2013],

1	‘	NN	O	‘	_	0	SENT_182	[p11l83t2045r248b2100],
2	Low	JJ	O	low	amod	5	SENT_182	[p11l83t2045r248b2100],
3	’	NN	O	’	nn	5	SENT_182	[p11l83t2045r248b2100],
4	(	NN	O	(	nn	5	SENT_182	[p11l279t2045r527b2114],
5	n	NN	O	n	dep	1	SENT_182	[p11l279t2045r527b2114],
6	=	JJ	O	=	dep	5	SENT_182	[p11l279t2045r527b2114],
7	42	CD	NUMBER	42	iobj	6	SENT_182	[p11l279t2045r527b2114],
8	)	CD	NUMBER	)	number	9	SENT_182	[p11l279t2045r527b2114],
9	‘	CD	NUMBER	‘	nn	16	SENT_182	[p11l83t2219r269b2291],
10	High	JJ	O	high	amod	13	SENT_182	[p11l83t2219r269b2291],
11	’	NN	O	’	nn	13	SENT_182	[p11l83t2219r269b2291],
12	(	NN	O	(	nn	13	SENT_182	[p11l300t2219r548b2288],
13	n	NN	O	n	dep	9	SENT_182	[p11l300t2219r548b2288],
14	=	JJ	O	=	amod	16	SENT_182	[p11l300t2219r548b2288],
15	25	CD	NUMBER	25	tmod	14	SENT_182	[p11l300t2219r548b2288],
16	)	NN	O	)	dobj	6	SENT_182	[p11l300t2219r548b2288],

1	MTHFR	NN	O	mthfr	_	0	SENT_183	[p11l11t2484r227b2535],
2	677	CD	NUMBER	677	num	3	SENT_183	[p11l258t2483r378b2535],
3	C	NN	O	c	dep	1	SENT_183	[p11l407t2483r504b2535],
4	>	JJR	O	>	amod	5	SENT_183	[p11l407t2483r504b2535],
5	T	NN	O	t	dep	1	SENT_183	[p11l526t2484r563b2535],

1	C/C	NN	O	c/c	_	0	SENT_184	[p11l82t2565r204b2627],
2	(	CD	NUMBER	(	num	3	SENT_184	[p11l234t2566r481b2634],
3	n	NN	O	n	dep	1	SENT_184	[p11l234t2566r481b2634],
4	=	JJ	O	=	dep	3	SENT_184	[p11l234t2566r481b2634],
5	28	CD	NUMBER	28	num	6	SENT_184	[p11l234t2566r481b2634],
6	)	CD	NUMBER	)	iobj	4	SENT_184	[p11l234t2566r481b2634],
7	C/T	NN	O	c/t	nn	9	SENT_184	[p11l82t2740r197b2802],
8	(	NN	O	(	nn	9	SENT_184	[p11l224t2740r350b2808],
9	n	NN	O	n	nn	18	SENT_184	[p11l224t2740r350b2808],
10	:	:	O	:	_	0	SENT_184	[p11l224t2740r350b2808],
11	31	CD	NUMBER	31	number	12	SENT_184	[p11l372t2740r471b2808],
12	)	CD	NUMBER	)	dep	9	SENT_184	[p11l372t2740r471b2808],
13	T/T	NN	O	t/t	nn	15	SENT_184	[p11l79t2914r187b2976],
14	(	NN	O	(	nn	15	SENT_184	[p11l214t2914r420b2982],
15	n	NN	O	n	dep	12	SENT_184	[p11l214t2914r420b2982],
16	=	JJ	O	=	amod	18	SENT_184	[p11l214t2914r420b2982],
17	8	CD	NUMBER	8	tmod	16	SENT_184	[p11l214t2914r420b2982],
18	)	NN	O	)	dobj	4	SENT_184	[p11l214t2914r420b2982],

1	MTHFR	NNP	O	MTHFR	_	0	SENT_185	[p11l11t3180r227b3231],
2	1298	CD	DATE	1298	num	1	SENT_185	[p11l265t3179r416b3231],
3	A	DT	O	a	det	5	SENT_185	[p11l442t3180r542b3231],
4	>	JJR	O	>	amod	5	SENT_185	[p11l442t3180r542b3231],
5	C	NN	O	c	dep	1	SENT_185	[p11l562t3179r604b3231],

1	A/A	NN	O	a/a	nn	3	SENT_186	[p11l79t3263r196b3325],
2	(	CD	NUMBER	(	num	3	SENT_186	[p11l223t3264r350b3332],
3	n	NN	O	n	_	0	SENT_186	[p11l223t3264r350b3332],
4	:	:	O	:	_	0	SENT_186	[p11l223t3264r350b3332],
5	37	CD	NUMBER	37	number	6	SENT_186	[p11l371t3263r470b3332],
6	)	CD	NUMBER	)	num	15	SENT_186	[p11l371t3263r470b3332],
7	A/C	NN	O	a/c	nn	15	SENT_186	[p11l79t3438r198b3500],
8	(	NN	O	(	nn	15	SENT_186	[p11l228t3438r475b3506],
9	n	NN	O	n	dep	15	SENT_186	[p11l228t3438r475b3506],
10	=	JJ	O	=	dep	9	SENT_186	[p11l228t3438r475b3506],
11	25	CD	NUMBER	25	num	12	SENT_186	[p11l228t3438r475b3506],
12	)	CD	NUMBER	)	dep	10	SENT_186	[p11l228t3438r475b3506],
13	C/C	NN	O	c/c	nn	15	SENT_186	[p11l82t3612r204b3674],
14	(	NN	O	(	nn	15	SENT_186	[p11l234t3612r360b3680],
15	n	NN	O	n	dep	3	SENT_186	[p11l234t3612r360b3680],
16	=	JJ	O	=	amod	15	SENT_186	[p11l234t3612r360b3680],
17	5	CD	NUMBER	5	num	18	SENT_186	[p11l378t3612r439b3680],
18	)	NN	O	)	dep	16	SENT_186	[p11l378t3612r439b3680],

1	Objective	NN	O	objective	nn	2	SENT_187	[p11l999t991r1277b1063],
2	response	NN	O	response	_	0	SENT_187	[p11l938t1095r1199b1151],
3	(	CD	PERCENT	(	num	4	SENT_187	[p11l1227t1079r1332b1147],
4	%	NN	PERCENT	%	dep	2	SENT_187	[p11l1227t1079r1332b1147],
5	)	CD	NUMBER	)	dep	2	SENT_187	[p11l1227t1079r1332b1147],

1	36.4	CD	NUMBER	36.4	number	2	SENT_188	[p11l1025t1348r1160b1401],
2	(	CD	NUMBER	(	num	3	SENT_188	[p11l1191t1347r1397b1415],
3	n	NN	O	n	_	0	SENT_188	[p11l1191t1347r1397b1415],
4	=	JJ	O	=	amod	3	SENT_188	[p11l1191t1347r1397b1415],
5	4	CD	NUMBER	4	tmod	4	SENT_188	[p11l1191t1347r1397b1415],
6	)	CD	NUMBER	)	num	7	SENT_188	[p11l1191t1347r1397b1415],
7	CR	NN	O	cr	dep	3	SENT_188	[p11l828t1435r1092b1500],
8	=	JJ	O	=	amod	7	SENT_188	[p11l828t1435r1092b1500],
9	18	CD	NUMBER	18	tmod	8	SENT_188	[p11l828t1435r1092b1500],
10	,	,	O	,	_	0	SENT_188	[p11l828t1435r1092b1500],
11	2	CD	NUMBER	2	number	12	SENT_188	[p11l1126t1435r1160b1487],
12	(	CD	NUMBER	(	num	13	SENT_188	[p11l1191t1434r1397b1502],
13	n	NN	O	n	npadvmod	14	SENT_188	[p11l1191t1434r1397b1502],
14	=	JJ	O	=	amod	9	SENT_188	[p11l1191t1434r1397b1502],
15	2	CD	NUMBER	2	rel	33	SENT_188	[p11l1191t1434r1397b1502],
16	)	CD	NUMBER	)	number	17	SENT_188	[p11l1191t1434r1397b1502],
17	42.9	CD	NUMBER	42.9	num	19	SENT_188	[p11l1019t1522r1160b1575],
18	(	NN	O	(	nn	19	SENT_188	[p11l1191t1521r1439b1589],
19	n	NN	O	n	npadvmod	20	SENT_188	[p11l1191t1521r1439b1589],
20	=	JJ	O	=	amod	15	SENT_188	[p11l1191t1521r1439b1589],
21	15	CD	NUMBER	15	number	22	SENT_188	[p11l1191t1521r1439b1589],
22	)	CD	NUMBER	)	num	23	SENT_188	[p11l1191t1521r1439b1589],
23	CR	NN	O	cr	npadvmod	24	SENT_188	[p11l870t1609r1397b1677],
24	=	JJ	O	=	amod	15	SENT_188	[p11l870t1609r1397b1677],
25	8,6	CD	NUMBER	8,6	number	26	SENT_188	[p11l870t1609r1397b1677],
26	(	CD	NUMBER	(	num	27	SENT_188	[p11l870t1609r1397b1677],
27	n	NN	O	n	npadvmod	28	SENT_188	[p11l870t1609r1397b1677],
28	=	JJ	O	=	amod	15	SENT_188	[p11l870t1609r1397b1677],
29	3	CD	NUMBER	3	num	30	SENT_188	[p11l870t1609r1397b1677],
30	)	NN	O	)	nsubj	33	SENT_188	[p11l870t1609r1397b1677],
31	19.0	CD	NUMBER	19.0	num	33	SENT_188	[p11l1025t1696r1161b1749],
32	(	NN	O	(	nn	33	SENT_188	[p11l1191t1695r1397b1763],
33	n	NN	O	n	rcmod	7	SENT_188	[p11l1191t1695r1397b1763],
34	=	JJ	O	=	amod	41	SENT_188	[p11l1191t1695r1397b1763],
35	4	CD	NUMBER	4	number	36	SENT_188	[p11l1191t1695r1397b1763],
36	)	CD	NUMBER	)	num	37	SENT_188	[p11l1191t1695r1397b1763],
37	CR	NN	O	cr	npadvmod	38	SENT_188	[p11l956t1785r1397b1853],
38	=	JJ	O	=	amod	41	SENT_188	[p11l956t1785r1397b1853],
39	o	NN	O	o	nn	41	SENT_188	[p11l956t1785r1397b1853],
40	(	NN	O	(	nn	41	SENT_188	[p11l956t1785r1397b1853],
41	n	NN	O	n	dobj	33	SENT_188	[p11l956t1785r1397b1853],
42	=	JJ	O	=	amod	43	SENT_188	[p11l956t1785r1397b1853],
43	o	NN	O	o	dep	41	SENT_188	[p11l956t1785r1397b1853],
44	)	IN	O	)	prep	33	SENT_188	[p11l956t1785r1397b1853],

1	40.5	CD	NUMBER	40.5	number	2	SENT_189	[p11l1019t2047r1159b2100],
2	(	CD	NUMBER	(	num	3	SENT_189	[p11l1191t2045r1439b2114],
3	n	NN	O	n	npadvmod	4	SENT_189	[p11l1191t2045r1439b2114],
4	=	JJ	O	=	amod	7	SENT_189	[p11l1191t2045r1439b2114],
5	17	CD	NUMBER	17	number	6	SENT_189	[p11l1191t2045r1439b2114],
6	)	CD	NUMBER	)	num	7	SENT_189	[p11l1191t2045r1439b2114],
7	CR	NN	O	cr	dep	20	SENT_189	[p11l828t2134r1092b2199],
8	=	JJ	O	=	amod	7	SENT_189	[p11l828t2134r1092b2199],
9	11	CD	NUMBER	11	tmod	8	SENT_189	[p11l828t2134r1092b2199],
10	,	,	O	,	_	0	SENT_189	[p11l828t2134r1092b2199],
11	9	CD	NUMBER	9	num	13	SENT_189	[p11l1126t2134r1160b2187],
12	(	NN	O	(	nn	13	SENT_189	[p11l1191t2132r1397b2201],
13	n	NN	O	n	appos	7	SENT_189	[p11l1191t2132r1397b2201],
14	=	JJ	O	=	dep	19	SENT_189	[p11l1191t2132r1397b2201],
15	5	CD	NUMBER	5	dep	14	SENT_189	[p11l1191t2132r1397b2201],
16	)	CD	NUMBER	)	number	17	SENT_189	[p11l1191t2132r1397b2201],
17	24.0	CD	NUMBER	24.0	num	19	SENT_189	[p11l1021t2221r1161b2274],
18	(	NN	O	(	nn	19	SENT_189	[p11l1191t2219r1397b2288],
19	n	NN	O	n	dep	13	SENT_189	[p11l1191t2219r1397b2288],
20	=	JJ	O	=	_	0	SENT_189	[p11l1191t2219r1397b2288],
21	6	CD	NUMBER	6	number	22	SENT_189	[p11l1191t2219r1397b2288],
22	)	CD	NUMBER	)	num	23	SENT_189	[p11l1191t2219r1397b2288],
23	CR	NN	O	cr	npadvmod	24	SENT_189	[p11l956t2309r1161b2362],
24	=	JJ	O	=	amod	29	SENT_189	[p11l956t2309r1161b2362],
25	o	NN	O	o	nn	29	SENT_189	[p11l956t2309r1161b2362],
26	(	NN	O	(	nn	29	SENT_189	[p11l1191t2307r1397b2376],
27	n	NN	O	n	nn	29	SENT_189	[p11l1191t2307r1397b2376],
28	=	JJ	O	=	amod	29	SENT_189	[p11l1191t2307r1397b2376],
29	O	NN	O	o	npadvmod	30	SENT_189	[p11l1191t2307r1397b2376],
30	)	IN	O	)	dep	20	SENT_189	[p11l1191t2307r1397b2376],

1	46.4	CD	NUMBER	46.4	number	2	SENT_190	[p11l1019t2567r1160b2620],
2	(	CD	NUMBER	(	num	3	SENT_190	[p11l1191t2566r1439b2634],
3	n	NN	O	n	_	0	SENT_190	[p11l1191t2566r1439b2634],
4	=	JJ	O	=	amod	3	SENT_190	[p11l1191t2566r1439b2634],
5	13	CD	NUMBER	13	tmod	4	SENT_190	[p11l1191t2566r1439b2634],
6	)	CD	NUMBER	)	num	7	SENT_190	[p11l1191t2566r1439b2634],
7	CR	NN	O	cr	dep	3	SENT_190	[p11l828t2655r1092b2720],
8	=	JJ	O	=	amod	7	SENT_190	[p11l828t2655r1092b2720],
9	10	CD	NUMBER	10	tmod	8	SENT_190	[p11l828t2655r1092b2720],
10	,	,	O	,	_	0	SENT_190	[p11l828t2655r1092b2720],
11	7	CD	NUMBER	7	num	13	SENT_190	[p11l1129t2656r1161b2708],
12	(	NN	O	(	nn	13	SENT_190	[p11l1191t2654r1397b2722],
13	n	NN	O	n	appos	7	SENT_190	[p11l1191t2654r1397b2722],
14	=	JJ	O	=	dep	13	SENT_190	[p11l1191t2654r1397b2722],
15	3	CD	NUMBER	3	num	16	SENT_190	[p11l1191t2654r1397b2722],
16	)	NN	O	)	iobj	14	SENT_190	[p11l1191t2654r1397b2722],
17	22.3	CD	NUMBER	22.3	num	23	SENT_190	[p11l1021t2742r1159b2795],
18	(	NN	O	(	nn	23	SENT_190	[p11l1191t2740r1397b2809],
19	n	NN	O	n	nn	23	SENT_190	[p11l1191t2740r1397b2809],
20	=	JJ	O	=	amod	23	SENT_190	[p11l1191t2740r1397b2809],
21	7	CD	NUMBER	7	number	22	SENT_190	[p11l1191t2740r1397b2809],
22	)	CD	NUMBER	)	dep	20	SENT_190	[p11l1191t2740r1397b2809],
23	CR	NN	O	cr	dobj	14	SENT_190	[p11l870t2829r1092b2893],
24	=	JJ	O	=	amod	23	SENT_190	[p11l870t2829r1092b2893],
25	6	CD	NUMBER	6	tmod	24	SENT_190	[p11l870t2829r1092b2893],
26	,	,	O	,	_	0	SENT_190	[p11l870t2829r1092b2893],
27	5	CD	NUMBER	5	num	29	SENT_190	[p11l1125t2829r1159b2882],
28	(	NN	O	(	nn	29	SENT_190	[p11l1191t2827r1397b2896],
29	n	NN	O	n	appos	7	SENT_190	[p11l1191t2827r1397b2896],
30	=	JJ	O	=	dep	29	SENT_190	[p11l1191t2827r1397b2896],
31	2	CD	NUMBER	2	num	32	SENT_190	[p11l1191t2827r1397b2896],
32	)	CD	NUMBER	)	iobj	30	SENT_190	[p11l1191t2827r1397b2896],
33	37.5	CD	NUMBER	37.5	num	35	SENT_190	[p11l1025t2916r1159b2969],
34	(	NN	O	(	nn	35	SENT_190	[p11l1191t2914r1397b2983],
35	n	NN	O	n	dobj	30	SENT_190	[p11l1191t2914r1397b2983],
36	=	JJ	O	=	dep	35	SENT_190	[p11l1191t2914r1397b2983],
37	3	CD	NUMBER	3	num	39	SENT_190	[p11l1191t2914r1397b2983],
38	)	NN	O	)	nn	39	SENT_190	[p11l1191t2914r1397b2983],
39	CR	NN	O	cr	iobj	36	SENT_190	[p11l956t3005r1161b3058],
40	=	JJ	O	=	amod	45	SENT_190	[p11l956t3005r1161b3058],
41	o	NN	O	o	nn	45	SENT_190	[p11l956t3005r1161b3058],
42	(	NN	O	(	nn	45	SENT_190	[p11l1191t3003r1397b3072],
43	n	NN	O	n	nn	45	SENT_190	[p11l1191t3003r1397b3072],
44	=	JJ	O	=	amod	45	SENT_190	[p11l1191t3003r1397b3072],
45	O	NN	O	o	dobj	36	SENT_190	[p11l1191t3003r1397b3072],
46	)	IN	O	)	amod	45	SENT_190	[p11l1191t3003r1397b3072],

1	37.8	CD	NUMBER	37.8	number	2	SENT_191	[p11l1025t3265r1160b3318],
2	(	CD	NUMBER	(	_	0	SENT_191	[p11l1191t3263r1439b3332],
3	n	NN	O	n	dep	2	SENT_191	[p11l1191t3263r1439b3332],
4	=	JJ	O	=	amod	17	SENT_191	[p11l1191t3263r1439b3332],
5	14	CD	NUMBER	14	number	6	SENT_191	[p11l1191t3263r1439b3332],
6	)	CD	NUMBER	)	num	7	SENT_191	[p11l1191t3263r1439b3332],
7	CR	NN	O	cr	npadvmod	8	SENT_191	[p11l870t3350r1397b3419],
8	=	JJ	O	=	amod	17	SENT_191	[p11l870t3350r1397b3419],
9	8,1	CD	NUMBER	8,1	number	10	SENT_191	[p11l870t3350r1397b3419],
10	(	CD	NUMBER	(	num	11	SENT_191	[p11l870t3350r1397b3419],
11	n	NN	O	n	npadvmod	12	SENT_191	[p11l870t3350r1397b3419],
12	=	JJ	O	=	dep	8	SENT_191	[p11l870t3350r1397b3419],
13	3	CD	NUMBER	3	dep	8	SENT_191	[p11l870t3350r1397b3419],
14	)	NN	O	)	nn	17	SENT_191	[p11l870t3350r1397b3419],
15	32.0	CD	NUMBER	32.0	num	17	SENT_191	[p11l1025t3439r1161b3493],
16	(	NN	O	(	nn	17	SENT_191	[p11l1191t3438r1397b3506],
17	n	NN	O	n	dep	2	SENT_191	[p11l1191t3438r1397b3506],
18	=	JJ	O	=	dep	25	SENT_191	[p11l1191t3438r1397b3506],
19	8	CD	NUMBER	8	number	20	SENT_191	[p11l1191t3438r1397b3506],
20	)	CD	NUMBER	)	num	21	SENT_191	[p11l1191t3438r1397b3506],
21	CR	NN	O	cr	npadvmod	22	SENT_191	[p11l870t3525r1397b3593],
22	=	JJ	O	=	amod	18	SENT_191	[p11l870t3525r1397b3593],
23	8,0	CD	NUMBER	8,0	number	24	SENT_191	[p11l870t3525r1397b3593],
24	(	CD	NUMBER	(	num	25	SENT_191	[p11l870t3525r1397b3593],
25	n	NN	O	n	rcmod	17	SENT_191	[p11l870t3525r1397b3593],
26	=	JJ	O	=	amod	25	SENT_191	[p11l870t3525r1397b3593],
27	2	CD	NUMBER	2	tmod	26	SENT_191	[p11l870t3525r1397b3593],
28	)	CD	NUMBER	)	number	29	SENT_191	[p11l870t3525r1397b3593],
29	20.0	CD	NUMBER	20.0	num	31	SENT_191	[p11l1021t3613r1161b3667],
30	(	NN	O	(	nn	31	SENT_191	[p11l1191t3612r1397b3680],
31	n	NN	O	n	npadvmod	32	SENT_191	[p11l1191t3612r1397b3680],
32	=	JJ	O	=	amod	25	SENT_191	[p11l1191t3612r1397b3680],
33	1	CD	NUMBER	1	number	34	SENT_191	[p11l1191t3612r1397b3680],
34	)	CD	NUMBER	)	num	35	SENT_191	[p11l1191t3612r1397b3680],
35	CR	NN	O	cr	npadvmod	36	SENT_191	[p11l956t3699r1397b3767],
36	=	JJ	O	=	amod	41	SENT_191	[p11l956t3699r1397b3767],
37	o	NN	O	o	nn	41	SENT_191	[p11l956t3699r1397b3767],
38	(	NN	O	(	nn	41	SENT_191	[p11l956t3699r1397b3767],
39	n	NN	O	n	nn	41	SENT_191	[p11l956t3699r1397b3767],
40	=	JJ	O	=	amod	41	SENT_191	[p11l956t3699r1397b3767],
41	O	NN	O	o	npadvmod	42	SENT_191	[p11l956t3699r1397b3767],
42	)	IN	O	)	dep	25	SENT_191	[p11l956t3699r1397b3767],

1	Stability	NN	O	stability	_	0	SENT_192	[p11l1777t991r2053b1063],
2	/	:	O	/	punct	1	SENT_192	[p11l1777t991r2053b1063],

1	progression	NN	O	progression	_	0	SENT_193	[p11l1668t1080r2015b1151],
2	(	CD	PERCENT	(	num	3	SENT_193	[p11l2045t1079r2150b1147],
3	%	NN	PERCENT	%	dep	1	SENT_193	[p11l2045t1079r2150b1147],
4	)	CD	NUMBER	)	dep	1	SENT_193	[p11l2045t1079r2150b1147],

1	63.6	CD	NUMBER	63.6	num	3	SENT_194	[p11l1701t1348r1840b1401],
2	(	CD	NUMBER	(	num	3	SENT_194	[p11l1870t1347r1932b1415],
3	n	NN	O	n	_	0	SENT_194	[p11l1870t1347r1932b1415],
4	=	JJ	O	=	amod	3	SENT_194	[p11l1948t1373r1997b1391],
5	7	CD	NUMBER	7	tmod	4	SENT_194	[p11l2018t1347r2075b1415],
6	)	CD	NUMBER	)	number	7	SENT_194	[p11l2018t1347r2075b1415],
7	57.1	CD	NUMBER	57.1	num	9	SENT_194	[p11l1700t1522r1826b1575],
8	(	NN	O	(	nn	9	SENT_194	[p11l1870t1521r1932b1589],
9	n	NN	O	n	npadvmod	10	SENT_194	[p11l1870t1521r1932b1589],
10	=	JJ	O	=	amod	3	SENT_194	[p11l1948t1547r1997b1565],
11	20	CD	NUMBER	20	dep	3	SENT_194	[p11l2015t1521r2117b1589],
12	)	CD	NUMBER	)	number	13	SENT_194	[p11l2015t1521r2117b1589],
13	81.0	CD	NUMBER	81.0	num	18	SENT_194	[p11l1701t1696r1840b1749],
14	(	NN	O	(	nn	18	SENT_194	[p11l1870t1695r2117b1763],
15	n	NN	O	n	nn	18	SENT_194	[p11l1870t1695r2117b1763],
16	=	JJ	O	=	amod	18	SENT_194	[p11l1870t1695r2117b1763],
17	17	CD	NUMBER	17	num	18	SENT_194	[p11l1870t1695r2117b1763],
18	)	NN	O	)	dep	11	SENT_194	[p11l1870t1695r2117b1763],

1	59.5	CD	NUMBER	59.5	number	2	SENT_195	[p11l1700t2047r1837b2100],
2	(	CD	NUMBER	(	_	0	SENT_195	[p11l1870t2045r2117b2114],
3	n	NN	O	n	dep	2	SENT_195	[p11l1870t2045r2117b2114],
4	=	JJ	O	=	amod	5	SENT_195	[p11l1870t2045r2117b2114],
5	25	CD	NUMBER	25	dep	2	SENT_195	[p11l1870t2045r2117b2114],
6	)	CD	NUMBER	)	number	7	SENT_195	[p11l1870t2045r2117b2114],
7	76.0	CD	NUMBER	76.0	num	12	SENT_195	[p11l1704t2221r1840b2274],
8	(	NN	O	(	nn	12	SENT_195	[p11l1870t2219r1932b2288],
9	n	NN	O	n	nn	12	SENT_195	[p11l1870t2219r1932b2288],
10	=	JJ	O	=	amod	12	SENT_195	[p11l1948t2246r1997b2263],
11	19	CD	NUMBER	19	num	12	SENT_195	[p11l2018t2220r2117b2288],
12	)	NN	O	)	dep	5	SENT_195	[p11l2018t2220r2117b2288],

1	53.6	CD	NUMBER	53.6	number	2	SENT_196	[p11l1700t2567r1840b2620],
2	(	CD	NUMBER	(	num	3	SENT_196	[p11l1870t2566r1997b2634],
3	n	NN	O	n	_	0	SENT_196	[p11l1870t2566r1997b2634],
4	:	:	O	:	_	0	SENT_196	[p11l1870t2566r1997b2634],
5	15	CD	NUMBER	15	number	6	SENT_196	[p11l2018t2566r2117b2634],
6	)	CD	NUMBER	)	dep	3	SENT_196	[p11l2018t2566r2117b2634],
7	77.4	CD	NUMBER	77.4	num	9	SENT_196	[p11l1704t2742r1839b2795],
8	(	NN	O	(	nn	9	SENT_196	[p11l1870t2740r2117b2808],
9	n	NN	O	n	dep	3	SENT_196	[p11l1870t2740r2117b2808],
10	=	JJ	O	=	dep	9	SENT_196	[p11l1870t2740r2117b2808],
11	24	CD	NUMBER	24	num	12	SENT_196	[p11l1870t2740r2117b2808],
12	)	CD	NUMBER	)	iobj	10	SENT_196	[p11l1870t2740r2117b2808],
13	62.5	CD	NUMBER	62.5	num	15	SENT_196	[p11l1701t2916r1837b2969],
14	(	NN	O	(	nn	15	SENT_196	[p11l1870t2914r2075b2982],
15	n	NN	O	n	dobj	10	SENT_196	[p11l1870t2914r2075b2982],
16	=	JJ	O	=	amod	15	SENT_196	[p11l1870t2914r2075b2982],
17	5	CD	NUMBER	5	num	18	SENT_196	[p11l1870t2914r2075b2982],
18	)	NN	O	)	dep	16	SENT_196	[p11l1870t2914r2075b2982],

1	62.2	CD	NUMBER	62.2	number	2	SENT_197	[p11l1701t3265r1839b3318],
2	(	CD	NUMBER	(	num	3	SENT_197	[p11l1870t3263r2117b3332],
3	n	NN	O	n	_	0	SENT_197	[p11l1870t3263r2117b3332],
4	=	JJ	O	=	amod	3	SENT_197	[p11l1870t3263r2117b3332],
5	23	CD	NUMBER	23	tmod	4	SENT_197	[p11l1870t3263r2117b3332],
6	)	CD	NUMBER	)	number	7	SENT_197	[p11l1870t3263r2117b3332],
7	68.0	CD	NUMBER	68.0	num	9	SENT_197	[p11l1701t3439r1840b3493],
8	(	NN	O	(	nn	9	SENT_197	[p11l1870t3438r2117b3506],
9	n	NN	O	n	npadvmod	10	SENT_197	[p11l1870t3438r2117b3506],
10	=	JJ	O	=	amod	3	SENT_197	[p11l1870t3438r2117b3506],
11	17	CD	NUMBER	17	dep	3	SENT_197	[p11l1870t3438r2117b3506],
12	)	CD	NUMBER	)	number	13	SENT_197	[p11l1870t3438r2117b3506],
13	80.0	CD	NUMBER	80.0	num	18	SENT_197	[p11l1701t3613r1840b3667],
14	(	NN	O	(	nn	18	SENT_197	[p11l1870t3612r2075b3680],
15	n	NN	O	n	nn	18	SENT_197	[p11l1870t3612r2075b3680],
16	=	JJ	O	=	amod	18	SENT_197	[p11l1870t3612r2075b3680],
17	4	CD	NUMBER	4	num	18	SENT_197	[p11l1870t3612r2075b3680],
18	)	NN	O	)	dep	11	SENT_197	[p11l1870t3612r2075b3680],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_198	[p12l7t102r378b147],
2	:	:	O	:	_	0	SENT_198	[p12l7t102r378b147],
3	CR	NN	O	cr	dep	1	SENT_198	[p12l431t104r515b157],
4	,	,	O	,	_	0	SENT_198	[p12l431t104r515b157],
5	complete	JJ	O	complete	amod	6	SENT_198	[p12l569t102r812b161],
6	response	NN	O	response	appos	3	SENT_198	[p12l865t116r1105b161],
7	;	:	O	;	_	0	SENT_198	[p12l865t116r1105b161],
8	MTHFR	NNP	LOCATION	MTHFR	dep	1	SENT_198	[p12l1160t104r1350b157],
9	,	,	O	,	_	0	SENT_198	[p12l1160t104r1350b157],
10	methylene	NN	O	methylene	nn	12	SENT_198	[p12l1406t102r1678b161],
11	tetrahydrofolate	NN	O	tetrahydrofolate	nn	12	SENT_198	[p12l1729t102r2149b161],
12	reductase	NN	O	reductase	appos	8	SENT_198	[p12l11t169r272b223],
13	;	:	O	;	_	0	SENT_198	[p12l11t169r272b223],
14	TS	NN	O	t	dep	1	SENT_198	[p12l304t170r371b223],
15	,	,	O	,	_	0	SENT_198	[p12l304t170r371b223],
16	thymidylate	NN	O	thymidylate	nn	17	SENT_198	[p12l397t169r707b228],
17	synthase	NN	O	synthase	appos	14	SENT_198	[p12l731t169r967b228],
18	.	.	O	.	_	0	SENT_198	[p12l731t169r967b228],

1	Univariate	JJ	O	univariate	amod	2	SENT_199	[p12l85t385r455b440],
2	analysis	NN	O	analysis	nsubj	12	SENT_199	[p12l524t383r799b458],
3	for	IN	O	for	_	0	SENT_199	[p12l868t382r966b440],
4	OS	NNP	O	OS	nn	5	SENT_199	[p12l1034t384r1128b440],
5	time	NN	O	time	prep_for	2	SENT_199	[p12l1196t386r1354b440],
6	according	VBG	O	accord	_	0	SENT_199	[p12l1424t383r1771b458],
7	to	TO	O	to	prepc_according_to	5	SENT_199	[p12l1837t390r1906b440],
8	TSER	NN	O	tser	nn	9	SENT_199	[p12l1973t384r2150b440],
9	genotypes	NNS	O	genotype	pobj	5	SENT_199	[p12l9t485r361b554],
10	was	VBD	O	be	cop	12	SENT_199	[p12l390t495r517b536],
11	not	RB	O	not	neg	12	SENT_199	[p12l549t485r668b536],
12	significant	JJ	O	significant	dep	15	SENT_199	[p12l701t478r1066b554],
13	and	CC	O	and	_	0	SENT_199	[p12l1097t478r1227b536],
14	curves	NNS	O	curve	conj_and	12	SENT_199	[p12l1258t495r1476b536],
15	crossed	VBD	O	cross	_	0	SENT_199	[p12l1509t478r1759b536],
16	(	CD	NUMBER	(	num	19	SENT_199	[p12l1794t478r2028b554],
17	Figure	NN	O	figure	nn	19	SENT_199	[p12l1794t478r2028b554],
18	3	CD	NUMBER	3	num	19	SENT_199	[p12l2062t478r2144b550],
19	)	NN	O	)	nsubj	15	SENT_199	[p12l2062t478r2144b550],
20	.	.	O	.	_	0	SENT_199	[p12l2062t478r2144b550],

1	However	RB	O	however	advmod	7	SENT_200	[p12l9t575r334b643],
2	,	,	O	,	_	0	SENT_200	[p12l9t575r334b643],
3	OS	NNP	O	OS	nn	4	SENT_200	[p12l395t574r490b631],
4	medians	NNS	O	median	nsubj	7	SENT_200	[p12l545t573r841b631],
5	were	VBD	O	be	cop	7	SENT_200	[p12l895t590r1059b631],
6	very	RB	O	very	advmod	7	SENT_200	[p12l1112t590r1265b649],
7	different	JJ	O	different	_	0	SENT_200	[p12l1318t573r1621b631],
8	among	IN	O	among	_	0	SENT_200	[p12l1676t590r1922b649],
9	TSER	NN	O	tser	nn	10	SENT_200	[p12l1973t574r2150b631],
10	polymorphisms	NNS	O	polymorphism	prep_among	7	SENT_200	[p12l8t668r583b744],
11	:	:	O	:	_	0	SENT_200	[p12l8t668r583b744],
12	669	CD	NUMBER	669	dep	10	SENT_200	[p12l612t669r754b738],
13	,	,	O	,	_	0	SENT_200	[p12l612t669r754b738],
14	900	CD	NUMBER	900	nn	17	SENT_200	[p12l782t669r909b726],
15	and	CC	O	and	_	0	SENT_200	[p12l932t668r1063b726],
16	270	CD	DURATION	270	nn	17	SENT_200	[p12l1085t669r1212b726],
17	days	NNS	NUMBER	day	appos	12	SENT_200	[p12l1235t668r1388b744],
18	for	IN	O	for	_	0	SENT_200	[p12l1410t668r1509b726],
19	ZR/ZR	NN	O	zr/zr	prep_for	17	SENT_200	[p12l1531t668r1758b738],
20	,	,	O	,	_	0	SENT_200	[p12l1531t668r1758b738],
21	ZR/3R	NN	O	zr/3r	prep_for	17	SENT_200	[p12l1786t668r1997b733],
22	and	CC	O	and	_	0	SENT_200	[p12l2018t668r2149b726],
23	3R/3R	NN	O	3r/3r	prep_for	17	SENT_200	[p12l10t762r237b833],
24	,	,	O	,	_	0	SENT_200	[p12l10t762r237b833],
25	respectively	RB	O	respectively	advmod	7	SENT_200	[p12l270t762r699b838],
26	.	.	O	.	_	0	SENT_200	[p12l270t762r699b838],

1	The	DT	O	the	det	3	SENT_201	[p12l729t762r862b820],
2	log-rank	JJ	O	log-rank	amod	3	SENT_201	[p12l891t762r1187b838],
3	test	NN	O	test	nsubj	6	SENT_201	[p12l1213t770r1336b820],
4	was	VBD	O	be	cop	6	SENT_201	[p12l1362t779r1490b820],
5	highly	RB	O	highly	advmod	6	SENT_201	[p12l1520t762r1750b838],
6	significant	JJ	O	significant	_	0	SENT_201	[p12l1778t762r2149b838],
7	after	IN	O	after	_	0	SENT_201	[p12l9t858r168b916],
8	gathering	VBG	O	gather	prepc_after	6	SENT_201	[p12l196t858r536b934],
9	ZR/3R	NN	O	zr/3r	dobj	8	SENT_201	[p12l565t858r777b923],
10	and	CC	O	and	_	0	SENT_201	[p12l805t858r937b916],
11	ZR/ZR	NN	O	zr/zr	dobj	8	SENT_201	[p12l966t858r1178b923],
12	versus	CC	O	versus	prep	9	SENT_201	[p12l1203t875r1420b916],
13	3R/3R	NN	O	3r/3r	nn	15	SENT_201	[p12l1452t858r1663b923],
14	(	CD	NUMBER	(	num	15	SENT_201	[p12l1694t858r1827b930],
15	P	NN	O	p	dep	12	SENT_201	[p12l1694t858r1827b930],
16	:	:	O	:	_	0	SENT_201	[p12l1694t858r1827b930],
17	0.0066	CD	NUMBER	0.0066	num	18	SENT_201	[p12l1846t858r2129b930],
18	)	NN	O	)	dep	6	SENT_201	[p12l1846t858r2129b930],
19	.	.	O	.	_	0	SENT_201	[p12l1846t858r2129b930],

1	No	DT	O	no	det	2	SENT_202	[p12l84t955r186b1010],
2	difference	NN	O	difference	nsubjpass	4	SENT_202	[p12l221t952r571b1010],
3	was	VBD	O	be	auxpass	4	SENT_202	[p12l603t969r731b1010],
4	found	VBN	O	find	_	0	SENT_202	[p12l766t952r978b1010],
5	between	IN	O	between	_	0	SENT_202	[p12l1009t952r1306b1010],
6	OS	NNP	O	OS	nn	7	SENT_202	[p12l1341t954r1435b1010],
7	time	NN	O	time	prep_between	4	SENT_202	[p12l1469t955r1628b1010],
8	and	CC	O	and	_	0	SENT_202	[p12l1663t952r1795b1010],
9	‘	NN	O	‘	prep_between	4	SENT_202	[p12l1830t952r2041b1028],
10	High	JJ	O	high	amod	7	SENT_202	[p12l1830t952r2041b1028],
11	’	CD	NUMBER	’	tmod	10	SENT_202	[p12l1830t952r2041b1028],
12	or	CC	O	or	_	0	SENT_202	[p12l2078t969r2149b1010],
13	‘	CD	NUMBER	‘	conj_or	11	SENT_202	[p12l11t1048r195b1105],
14	Low	JJ	O	low	amod	17	SENT_202	[p12l11t1048r195b1105],
15	’	NN	O	’	nn	17	SENT_202	[p12l11t1048r195b1105],
16	TS	NN	O	t	nn	17	SENT_202	[p12l220t1049r302b1105],
17	expression	NN	O	expression	dobj	4	SENT_202	[p12l328t1050r701b1123],
18	with	IN	O	with	_	0	SENT_202	[p12l723t1048r885b1105],
19	two	CD	NUMBER	two	num	21	SENT_202	[p12l909t1055r1039b1105],
20	superposable	JJ	O	superposable	amod	21	SENT_202	[p12l1066t1047r1520b1123],
21	curves	NNS	O	curve	prep_with	17	SENT_202	[p12l1546t1064r1767b1105],
22	(	CD	NUMBER	(	num	23	SENT_202	[p12l1795t1048r2034b1123],
23	Figure	NN	O	figure	dep	21	SENT_202	[p12l1795t1048r2034b1123],
24	4	CD	NUMBER	4	num	25	SENT_202	[p12l2060t1048r2144b1120],
25	)	NN	O	)	dep	23	SENT_202	[p12l2060t1048r2144b1120],
26	.	.	O	.	_	0	SENT_202	[p12l2060t1048r2144b1120],

1	Likewise	RB	O	likewise	advmod	4	SENT_203	[p12l9t1142r324b1212],
2	,	,	O	,	_	0	SENT_203	[p12l9t1142r324b1212],
3	there	EX	O	there	expl	4	SENT_203	[p12l354t1142r535b1200],
4	was	VBD	O	be	_	0	SENT_203	[p12l559t1159r687b1200],
5	no	DT	O	no	det	6	SENT_203	[p12l714t1159r805b1200],
6	difference	NN	O	difference	nsubj	4	SENT_203	[p12l831t1142r1181b1200],
7	between	IN	O	between	_	0	SENT_203	[p12l1205t1142r1503b1200],
8	OS	NNP	O	OS	prep_between	6	SENT_203	[p12l1530t1144r1623b1200],
9	or	CC	O	or	_	0	SENT_203	[p12l1651t1159r1722b1200],
10	disease-free	JJ	O	disease-free	amod	13	SENT_203	[p12l1747t1142r2148b1200],
11	progression	NN	O	progression	nn	13	SENT_203	[p12l8t1241r417b1313],
12	survival	NN	O	survival	nn	13	SENT_203	[p12l462t1238r736b1295],
13	times	NNS	O	time	prep_between	6	SENT_203	[p12l780t1241r970b1295],
14	and	CC	O	and	_	0	SENT_203	[p12l1015t1238r1146b1295],
15	the	DT	O	the	det	18	SENT_203	[p12l1189t1238r1302b1295],
16	studied	VBN	O	study	amod	18	SENT_203	[p12l1348t1238r1604b1295],
17	MTHFR	NN	O	mthfr	nn	18	SENT_203	[p12l1645t1240r1907b1295],
18	genotypes	NNS	O	genotype	nsubj	19	SENT_203	[p12l1952t1254r2148b1313, p12l8t1340r191b1408],
19	(	VBP	O	(	conj_and	4	SENT_203	[p12l224t1333r374b1405],
20	677	CD	NUMBER	677	number	21	SENT_203	[p12l224t1333r374b1405],
21	C	NN	O	c	num	23	SENT_203	[p12l406t1334r583b1390],
22	>	JJR	O	>	amod	23	SENT_203	[p12l406t1334r583b1390],
23	T	NN	O	t	dobj	19	SENT_203	[p12l406t1334r583b1390],
24	and	CC	O	and	_	0	SENT_203	[p12l606t1333r738b1390],
25	1298	CD	DATE	1298	dobj	19	SENT_203	[p12l773t1334r937b1390],
26	A	DT	O	a	det	29	SENT_203	[p12l967t1333r1195b1405],
27	>	JJR	O	>	amod	29	SENT_203	[p12l967t1333r1195b1405],
28	C	NN	O	c	nn	29	SENT_203	[p12l967t1333r1195b1405],
29	)	NN	O	)	dep	25	SENT_203	[p12l967t1333r1195b1405],
30	.	.	O	.	_	0	SENT_203	[p12l967t1333r1195b1405],

1	However	RB	O	however	advmod	38	SENT_204	[p12l86t1431r412b1498],
2	,	,	O	,	_	0	SENT_204	[p12l86t1431r412b1498],
3	the	DT	O	the	det	5	SENT_204	[p12l465t1428r578b1486],
4	OS	NNP	O	OS	nn	5	SENT_204	[p12l629t1430r724b1486],
5	rate	NN	O	rate	nsubj	38	SENT_204	[p12l774t1435r905b1486],
6	of	IN	O	of	_	0	SENT_204	[p12l955t1428r1027b1486],
7	the	DT	O	the	det	8	SENT_204	[p12l1072t1428r1185b1486],
8	patients	NNS	O	patient	prep_of	5	SENT_204	[p12l1234t1431r1516b1504],
9	with	IN	O	with	_	0	SENT_204	[p12l1565t1428r1726b1486],
10	the	DT	O	the	det	13	SENT_204	[p12l1775t1428r1888b1486],
11	3R/3R	NN	O	3r/3r	nn	13	SENT_204	[p12l1940t1428r2150b1493],
12	TS	NN	O	t	nn	13	SENT_204	[p12l7t1524r89b1581],
13	genotype	NN	O	genotype	prep_with	8	SENT_204	[p12l132t1530r458b1599],
14	associated	VBN	O	associate	partmod	13	SENT_204	[p12l501t1523r857b1581],
15	with	IN	O	with	_	0	SENT_204	[p12l897t1523r1059b1581],
16	C/C	NN	O	c/c	prep_with	14	SENT_204	[p12l1102t1523r1239b1588],
17	for	IN	O	for	_	0	SENT_204	[p12l1282t1523r1380b1581],
18	677C	NN	O	677c	prep_for	16	SENT_204	[p12l1423t1524r1604b1581],
19	>	JJR	O	>	amod	20	SENT_204	[p12l1621t1525r1730b1580],
20	T	NN	O	t	dep	29	SENT_204	[p12l1621t1525r1730b1580],
21	or	CC	O	or	_	0	SENT_204	[p12l1766t1540r1838b1581],
22	A/A	NN	O	a/a	dep	29	SENT_204	[p12l1877t1523r2010b1588],
23	for	IN	O	for	_	0	SENT_204	[p12l2051t1523r2150b1581],
24	1298A	NN	O	1298a	prep_for	20	SENT_204	[p12l14t1619r366b1676],
25	>	JJR	O	>	amod	26	SENT_204	[p12l14t1619r366b1676],
26	C	NN	O	c	dep	29	SENT_204	[p12l14t1619r366b1676],
27	(	CD	NUMBER	(	number	28	SENT_204	[p12l430t1618r536b1690],
28	16	CD	NUMBER	16	num	29	SENT_204	[p12l430t1618r536b1690],
29	patients	NNS	O	patient	dep	34	SENT_204	[p12l596t1621r878b1694],
30	(	IN	O	(	_	0	SENT_204	[p12l943t1618r1236b1690],
31	23.8	CD	PERCENT	23.8	num	32	SENT_204	[p12l943t1618r1236b1690],
32	%	NN	PERCENT	%	prep_(	29	SENT_204	[p12l943t1618r1236b1690],
33	)	CD	NUMBER	)	num	34	SENT_204	[p12l943t1618r1236b1690],
34	)	NN	O	)	dep	16	SENT_204	[p12l943t1618r1236b1690],
35	was	VBD	O	be	cop	38	SENT_204	[p12l1298t1635r1426b1676],
36	much	JJ	O	much	advmod	38	SENT_204	[p12l1487t1618r1690b1676],
37	statistically	RB	O	statistically	advmod	38	SENT_204	[p12l1752t1618r2151b1694],
38	shorter	JJR	O	shorter	_	0	SENT_204	[p12l10t1712r258b1770],
39	than	IN	O	than	_	0	SENT_204	[p12l302t1712r466b1770],
40	that	DT	O	that	prep_than	38	SENT_204	[p12l511t1712r654b1770],
41	of	IN	O	of	_	0	SENT_204	[p12l699t1712r771b1770],
42	the	DT	O	the	det	43	SENT_204	[p12l810t1712r923b1770],
43	patients	NNS	O	patient	prep_of	40	SENT_204	[p12l967t1715r1250b1788],
44	with	IN	O	with	_	0	SENT_204	[p12l1294t1712r1455b1770],
45	another	DT	O	another	det	52	SENT_204	[p12l1500t1712r1778b1770],
46	genotype	NN	O	genotype	nn	52	SENT_204	[p12l1821t1720r2147b1788],
47	(	NN	O	(	nn	52	SENT_204	[p12l12t1808r331b1884],
48	log	NN	O	log	nn	52	SENT_204	[p12l12t1808r331b1884],
49	—	CD	NUMBER	—	num	52	SENT_204	[p12l12t1808r331b1884],
50	rank	NN	O	rank	nn	52	SENT_204	[p12l12t1808r331b1884],
51	test	NN	O	test	nn	52	SENT_204	[p12l364t1815r488b1866],
52	P	NN	O	p	prep_with	38	SENT_204	[p12l519t1808r912b1880],
53	=	JJ	O	=	amod	52	SENT_204	[p12l519t1808r912b1880],
54	0.0065	CD	NUMBER	0.0065	tmod	53	SENT_204	[p12l519t1808r912b1880],
55	)	CD	NUMBER	)	number	56	SENT_204	[p12l519t1808r912b1880],
56	(	CD	NUMBER	(	num	59	SENT_204	[p12l955t1808r1194b1884],
57	Figure	NNP	O	Figure	nn	59	SENT_204	[p12l955t1808r1194b1884],
58	5	CD	NUMBER	5	num	59	SENT_204	[p12l1232t1808r1315b1880],
59	)	NN	O	)	dep	52	SENT_204	[p12l1232t1808r1315b1880],
60	.	.	O	.	_	0	SENT_204	[p12l1232t1808r1315b1880],

1	The	DT	O	the	det	3	SENT_205	[p12l1352t1808r1485b1866],
2	OS	NNP	O	OS	nn	3	SENT_205	[p12l1523t1809r1617b1866],
3	medians	NNS	O	median	nsubj	9	SENT_205	[p12l1653t1808r1950b1866],
4	were	VBD	O	be	cop	9	SENT_205	[p12l1984t1825r2148b1866],
5	283	CD	PERCENT	283	num	9	SENT_205	[p12l10t1904r133b1960],
6	(	CD	PERCENT	(	number	7	SENT_205	[p12l171t1903r347b1974],
7	95	CD	PERCENT	95	dep	8	SENT_205	[p12l171t1903r347b1974],
8	%	NN	PERCENT	%	dep	9	SENT_205	[p12l171t1903r347b1974],
9	Cl	NN	O	cl	dep	19	SENT_205	[p12l380t1904r457b1960],
10	(	NN	O	(	dep	9	SENT_205	[p12l492t1903r662b1975],
11	163	CD	NUMBER	163	num	10	SENT_205	[p12l492t1903r662b1975],
12	;	:	O	;	_	0	SENT_205	[p12l492t1903r662b1975],
13	603	CD	NUMBER	603	number	14	SENT_205	[p12l699t1903r874b1975],
14	)	CD	NUMBER	)	num	15	SENT_205	[p12l699t1903r874b1975],
15	)	NN	O	)	dep	9	SENT_205	[p12l699t1903r874b1975],
16	and	CC	O	and	_	0	SENT_205	[p12l910t1902r1041b1960],
17	842	CD	DURATION	842	num	18	SENT_205	[p12l1073t1904r1199b1960],
18	days	NNS	NUMBER	day	dep	9	SENT_205	[p12l1230t1902r1384b1978],
19	(	VBP	O	(	_	0	SENT_205	[p12l1418t1903r1595b1974],
20	95	CD	PERCENT	95	number	21	SENT_205	[p12l1418t1903r1595b1974],
21	%	NN	PERCENT	%	amod	23	SENT_205	[p12l1418t1903r1595b1974],
22	CI	NN	O	ci	nn	23	SENT_205	[p12l1627t1904r1705b1960],
23	(	NN	O	(	dobj	19	SENT_205	[p12l1740t1903r1909b1974],
24	515	CD	NUMBER	515	nsubj	19	SENT_205	[p12l1740t1903r1909b1974],
25	;	:	O	;	_	0	SENT_205	[p12l1740t1903r1909b1974],
26	984	CD	NUMBER	984	dep	24	SENT_205	[p12l1945t1903r2144b1975],
27	)	CD	NUMBER	)	num	28	SENT_205	[p12l1945t1903r2144b1975],
28	)	NN	O	)	dep	26	SENT_205	[p12l1945t1903r2144b1975],
29	,	,	O	,	_	0	SENT_205	[p12l1945t1903r2144b1975],
30	respectively	RB	O	respectively	advmod	26	SENT_205	[p12l9t1997r437b2073],
31	.	.	O	.	_	0	SENT_205	[p12l9t1997r437b2073],

1	There	EX	O	there	expl	2	SENT_206	[p12l492t1998r692b2055],
2	was	VBD	O	be	_	0	SENT_206	[p12l743t2014r871b2055],
3	no	DT	O	no	det	5	SENT_206	[p12l923t2014r1014b2055],
4	statistical	JJ	O	statistical	amod	5	SENT_206	[p12l1069t1998r1399b2055],
5	difference	NN	O	difference	nsubj	2	SENT_206	[p12l1451t1997r1800b2055],
6	between	IN	O	between	_	0	SENT_206	[p12l1851t1997r2148b2055],
7	these	DT	O	these	det	8	SENT_206	[p12l8t2093r190b2151],
8	populations	NNS	O	population	prep_between	5	SENT_206	[p12l216t2093r639b2169],
9	of	IN	O	of	_	0	SENT_206	[p12l665t2093r737b2151],
10	16	CD	NUMBER	16	num	11	SENT_206	[p12l763t2095r840b2151],
11	patients	NNS	O	patient	prep_of	8	SENT_206	[p12l866t2096r1148b2169],
12	and	CC	O	and	_	0	SENT_206	[p12l1174t2093r1306b2151],
13	the	DT	O	the	det	14	SENT_206	[p12l1330t2093r1442b2151],
14	others	NNS	O	other	prep_between	5	SENT_206	[p12l1469t2093r1687b2151],
15	in	IN	O	in	_	0	SENT_206	[p12l1712t2096r1783b2150],
16	respect	NN	O	respect	prep_in	14	SENT_206	[p12l1808t2100r2054b2169],
17	to	TO	O	to	_	0	SENT_206	[p12l2078t2100r2148b2151],
18	age	NN	O	age	nn	21	SENT_206	[p12l9t2206r141b2265],
19	,	,	O	,	_	0	SENT_206	[p12l9t2206r141b2265],
20	performance	NN	O	performance	conj_and	21	SENT_206	[p12l175t2189r623b2265],
21	status	NN	O	status	prep_to	2	SENT_206	[p12l655t2197r855b2247],
22	and	CC	O	and	_	0	SENT_206	[p12l886t2190r1017b2247],
23	gender	NN	O	gender	prep_to	2	SENT_206	[p12l1046t2190r1299b2265],
24	.	.	O	.	_	0	SENT_206	[p12l1046t2190r1299b2265],

1	No	DT	O	no	det	2	SENT_207	[p12l84t2287r186b2342],
2	variable	NN	O	variable	dep	8	SENT_207	[p12l208t2285r504b2355],
3	,	,	O	,	_	0	SENT_207	[p12l208t2285r504b2355],
4	except	IN	O	except	_	0	SENT_207	[p12l531t2292r760b2360],
5	age	NN	O	age	nn	7	SENT_207	[p12l783t2301r896b2360],
6	(	CD	NUMBER	(	num	7	SENT_207	[p12l922t2285r989b2357],
7	P	NN	O	p	prep_except	2	SENT_207	[p12l922t2285r989b2357],
8	=	JJ	O	=	_	0	SENT_207	[p12l1005t2313r1056b2331],
9	0.10	CD	NUMBER	0.10	tmod	8	SENT_207	[p12l1075t2286r1224b2342],
10	if	IN	O	if	_	0	SENT_207	[p12l1246t2284r1297b2342],
11	older	JJR	O	older	prep_if	8	SENT_207	[p12l1316t2285r1495b2342],
12	than	IN	O	than	_	0	SENT_207	[p12l1516t2285r1681b2342],
13	75	CD	NUMBER	75	number	14	SENT_207	[p12l1708t2287r1991b2360],
14	—	CD	NUMBER	—	num	15	SENT_207	[p12l1708t2287r1991b2360],
15	years	NNS	NUMBER	year	npadvmod	16	SENT_207	[p12l1708t2287r1991b2360],
16	old	JJ	O	old	amod	33	SENT_207	[p12l2015t2285r2144b2355],
17	,	,	O	,	_	0	SENT_207	[p12l2015t2285r2144b2355],
18	but	CC	O	but	_	0	SENT_207	[p12l7t2380r125b2438],
19	with	IN	O	with	conj_but	16	SENT_207	[p12l148t2380r310b2438],
20	a	DT	O	a	det	22	SENT_207	[p12l335t2397r370b2438],
21	possible	JJ	O	possible	amod	22	SENT_207	[p12l393t2380r673b2456],
22	bias	NN	O	bias	pobj	19	SENT_207	[p12l698t2380r834b2438],
23	such	JJ	O	such	_	0	SENT_207	[p12l861t2380r1021b2438],
24	as	IN	O	as	_	0	SENT_207	[p12l1047t2397r1112b2438],
25	death	NN	O	death	prep_such_as	22	SENT_207	[p12l1138t2380r1336b2438],
26	by	IN	O	by	_	0	SENT_207	[p12l1359t2380r1447b2456],
27	another	DT	O	another	det	28	SENT_207	[p12l1470t2380r1747b2438],
28	cause	NN	O	cause	prep_by	25	SENT_207	[p12l1771t2397r1958b2438],
29	than	IN	O	than	_	0	SENT_207	[p12l1984t2380r2149b2438],
30	lﬂedian	NN	O	lﬂedian	prep_than	28	SENT_207	[p13l1041t501r1243b550],
31	=	JJ	O	=	amod	30	SENT_207	[p13l1263t521r1296b542],
32	20	CD	DURATION	20	tmod	31	SENT_207	[p13l1316t501r1378b550],
33	months	NNS	NUMBER	month	prep_than	11	SENT_207	[p13l1399t501r1612b550],

1	Flarcantaga	NN	O	flarcantaga	dep	6	SENT_208	[p13l783t575r1100b633],
2	at	IN	O	at	_	0	SENT_208	[p13l1120t575r1174b620],
3	survival	NN	O	survival	prep_at	1	SENT_208	[p13l1193t575r1415b624],
4	at	IN	O	at	_	0	SENT_208	[p13l1435t579r1489b620],
5	Eayaalrs	NNP	O	Eayaalrs	prep_at	3	SENT_208	[p13l1505t575r1711b633],
6	=	JJ	O	=	_	0	SENT_208	[p13l1731t591r1764b616],
7	5	CD	PERCENT	5	num	8	SENT_208	[p13l1784t575r1866b620],
8	%	NN	PERCENT	%	dep	6	SENT_208	[p13l1784t575r1866b620],

1	u	FW	O	u	nn	2	SENT_209	[p13l258t1973r287b2022],
2	‘	FW	O	‘	_	0	SENT_209	[p13l603t1952r605b1961],
3	A	DT	O	a	det	4	SENT_209	[p13l687t1962r688b1965],
4	ram	NN	O	ram	dep	2	SENT_209	[p13l807t1973r938b2022],
5	)	CD	NUMBER	)	num	7	SENT_209	[p13l807t1973r938b2022],
6	eon	NN	O	eon	nn	7	SENT_209	[p13l1407t1973r1538b2022],
7	auiin	NN	O	auiin	dep	2	SENT_209	[p13l2009t1973r2141b2022],

1	Erusnrival	JJ	O	erusnrival	amod	2	SENT_210	[p13l885t2071r1116b2116],
2	ﬁlm	NN	O	ﬁlm	_	0	SENT_210	[p13l1136t2071r1260b2116],
3	:	:	O	:	_	0	SENT_210	[p13l1136t2071r1260b2116],
4	[	CD	NUMBER	[	num	5	SENT_210	[p13l1276t2071r1452b2128, p13l12t2200r204b2267],
5	days	NNS	NUMBER	day	dep	2	SENT_210	[p13l1276t2071r1452b2128, p13l12t2200r204b2267],
6	]	CD	NUMBER	]	num	7	SENT_210	[p13l1276t2071r1452b2128, p13l12t2200r204b2267],
7	Figure	NN	O	figure	dep	5	SENT_210	[p13l1276t2071r1452b2128, p13l12t2200r204b2267],

1	2	CD	NUMBER	2	num	2	SENT_211	[p13l230t2201r266b2251],
2	Kap	NN	O	kap	_	0	SENT_211	[p13l337t2200r742b2267],
3	|	CD	NUMBER	|	dep	2	SENT_211	[p13l337t2200r742b2267],
4	an	DT	O	a	dep	3	SENT_211	[p13l337t2200r742b2267],
5	.	.	O	.	_	0	SENT_211	[p13l337t2200r742b2267],

1	—	NN	O	—	_	0	SENT_212	[p13l337t2200r742b2267],
2	.	.	O	.	_	0	SENT_212	[p13l337t2200r742b2267],

1	Meier	NNP	PERSON	Meier	_	0	SENT_213	[p13l337t2200r742b2267],
2	curve	NN	O	curve	dep	1	SENT_213	[p13l765t2215r924b2251],
3	with	IN	O	with	_	0	SENT_213	[p13l947t2200r1075b2251],
4	confidence	NN	O	confidence	nn	5	SENT_213	[p13l1103t2200r1427b2251],
5	interval	NN	O	interval	prep_with	2	SENT_213	[p13l1455t2200r1667b2251],
6	(	CD	NUMBER	(	num	8	SENT_213	[p13l1696t2200r1803b2264],
7	CI	NN	O	ci	nn	8	SENT_213	[p13l1696t2200r1803b2264],
8	)	NN	O	)	dep	1	SENT_213	[p13l1696t2200r1803b2264],
9	at	IN	O	at	_	0	SENT_213	[p13l1830t2205r1885b2251],
10	95	CD	PERCENT	95	num	11	SENT_213	[p13l1909t2201r2045b2251],
11	%	NN	PERCENT	%	prep_at	8	SENT_213	[p13l1909t2201r2045b2251],
12	for	IN	O	for	_	0	SENT_213	[p13l2068t2200r2151b2251],
13	overall	JJ	O	overall	amod	14	SENT_213	[p13l9t2284r199b2336],
14	survival	NN	O	survival	prep_for	11	SENT_213	[p13l227t2284r443b2336],
15	(	CD	NUMBER	(	number	16	SENT_213	[p13l473t2285r569b2349],
16	76	CD	NUMBER	76	num	17	SENT_213	[p13l473t2285r569b2349],
17	patients	NNS	O	patient	dep	1	SENT_213	[p13l599t2285r870b2352],
18	)	CD	NUMBER	)	dep	17	SENT_213	[p13l599t2285r870b2352],
19	.	.	O	.	_	0	SENT_213	[p13l599t2285r870b2352],

1	cancer	NN	O	cancer	nsubj	15	SENT_214	[p13l9t2506r260b2578],
2	)	CD	NUMBER	)	num	1	SENT_214	[p13l9t2506r260b2578],
3	or	CC	O	or	_	0	SENT_214	[p13l326t2523r398b2564],
4	performance	NN	O	performance	nn	5	SENT_214	[p13l458t2506r906b2582],
5	status	NN	O	status	nsubj	15	SENT_214	[p13l970t2513r1170b2564],
6	(	CD	NUMBER	(	num	7	SENT_214	[p13l1236t2506r1624b2578],
7	P	NN	O	p	dep	5	SENT_214	[p13l1236t2506r1624b2578],
8	=	JJ	O	=	amod	7	SENT_214	[p13l1236t2506r1624b2578],
9	0.0008	CD	NUMBER	0.0008	tmod	8	SENT_214	[p13l1236t2506r1624b2578],
10	if	IN	O	if	_	0	SENT_214	[p13l1687t2506r1738b2563],
11	22	CD	NUMBER	22	num	12	SENT_214	[p13l1806t2506r1955b2578],
12	)	CD	NUMBER	)	prep_if	8	SENT_214	[p13l1806t2506r1955b2578],
13	,	,	O	,	_	0	SENT_214	[p13l1806t2506r1955b2578],
14	was	VBD	O	be	cop	15	SENT_214	[p13l2020t2523r2148b2564],
15	significant	JJ	O	significant	_	0	SENT_214	[p13l10t2602r381b2678],
16	in	IN	O	in	_	0	SENT_214	[p13l424t2605r495b2659],
17	uni	FW	O	uni	nn	18	SENT_214	[p13l537t2605r680b2660],
18	—	FW	O	—	prep_in	15	SENT_214	[p13l537t2605r680b2660],
19	or	CC	O	or	_	0	SENT_214	[p13l724t2618r796b2660],
20	multivariate	JJ	O	multivariate	amod	21	SENT_214	[p13l839t2602r1271b2660],
21	analysis	NN	O	analysis	conj_or	18	SENT_214	[p13l1316t2602r1591b2678],
22	for	IN	O	for	_	0	SENT_214	[p13l1635t2602r1733b2660],
23	OS	NN	O	os	prep_for	15	SENT_214	[p13l1777t2603r1872b2660],
24	or	CC	O	or	_	0	SENT_214	[p13l1917t2619r1988b2660],
25	PFS	NN	O	pf	prep_for	15	SENT_214	[p13l2031t2603r2147b2660],
26	according	VBG	O	accord	_	0	SENT_214	[p13l9t2697r357b2773],
27	to	TO	O	to	prepc_according_to	15	SENT_214	[p13l384t2704r454b2755],
28	the	DT	O	the	det	30	SENT_214	[p13l484t2697r597b2755],
29	Cox-regression	NN	MISC	cox-regression	nn	30	SENT_214	[p13l629t2699r1153b2773],
30	method	NN	O	method	pobj	15	SENT_214	[p13l1183t2697r1479b2755],
31	.	.	O	.	_	0	SENT_214	[p13l1183t2697r1479b2755],

1	Discussion	NN	O	discussion	_	0	SENT_215	[p13l11t2901r404b2959],

1	New	NNP	O	New	nsubj	2	SENT_216	[p13l7t3093r166b3148],
2	targeted	VBD	O	target	_	0	SENT_216	[p13l217t3090r504b3166],
3	drugs	NNS	O	drug	nsubj	5	SENT_216	[p13l558t3090r748b3166],
4	have	VBP	O	have	aux	5	SENT_216	[p13l803t3090r968b3148],
5	transformed	VBN	O	transform	ccomp	2	SENT_216	[p13l1022t3090r1456b3148],
6	the	DT	O	the	det	7	SENT_216	[p13l1509t3090r1622b3148],
7	treatment	NN	O	treatment	dobj	5	SENT_216	[p13l1676t3098r2027b3148],
8	of	IN	O	of	_	0	SENT_216	[p13l2081t3090r2153b3148],
9	advanced	JJ	O	advanced	amod	10	SENT_216	[p13l9t3184r344b3241],
10	CRC	NN	ORGANIZATION	crc	prep_of	7	SENT_216	[p13l382t3186r538b3241],
11	but	CC	O	but	_	0	SENT_216	[p13l574t3184r693b3241],
12	the	DT	O	the	det	14	SENT_216	[p13l729t3184r842b3241],
13	median	JJ	O	median	amod	14	SENT_216	[p13l881t3184r1147b3241],
14	OS	NN	O	os	nsubj	15	SENT_216	[p13l1185t3186r1280b3241],
15	is	VBZ	O	be	conj_but	2	SENT_216	[p13l1319t3187r1369b3241],
16	about	IN	DURATION	about	_	0	SENT_216	[p13l1408t3184r1608b3241],
17	24	CD	DURATION	24	num	18	SENT_216	[p13l1646t3186r1728b3241],
18	months	NNS	NUMBER	month	prep_about	15	SENT_216	[p13l1766t3184r2040b3241],
19	in	IN	O	in	_	0	SENT_216	[p13l2078t3187r2148b3241],
20	the	DT	O	the	det	21	SENT_216	[p13l8t3280r121b3338],
21	absence	NN	O	absence	prep_in	18	SENT_216	[p13l168t3280r441b3338],
22	of	IN	O	of	_	0	SENT_216	[p13l487t3280r559b3338],
23	metastasis	NN	O	metastasis	nn	24	SENT_216	[p13l600t3283r959b3338],
24	surgery	NN	O	surgery	prep_of	21	SENT_216	[p13l1006t3297r1273b3356],
25	,	,	O	,	_	0	SENT_216	[p13l1006t3297r1273b3356],
26	and	CC	O	and	_	0	SENT_216	[p13l1323t3280r1454b3338],
27	5-FU	NN	O	5-fu	nsubj	30	SENT_216	[p13l1501t3282r1664b3338],
28	remains	VBZ	O	remain	cop	30	SENT_216	[p13l1709t3283r1989b3338],
29	the	DT	O	the	det	30	SENT_216	[p13l2035t3280r2147b3338],
30	cornerstone	NN	O	cornerstone	conj_and	15	SENT_216	[p13l9t3382r427b3432],
31	of	IN	O	of	_	0	SENT_216	[p13l474t3374r545b3432],
32	the	DT	O	the	det	33	SENT_216	[p13l585t3375r698b3433],
33	combinations	NNS	O	combination	prep_of	30	SENT_216	[p13l744t3375r1249b3432],
34	.	.	O	.	_	0	SENT_216	[p13l744t3375r1249b3432],

1	Furthermore	RB	O	furthermore	advmod	63	SENT_217	[p13l1299t3375r1761b3445],
2	,	,	O	,	_	0	SENT_217	[p13l1299t3375r1761b3445],
3	after	IN	O	after	_	0	SENT_217	[p13l1811t3374r1970b3432],
4	previous	JJ	O	previous	amod	6	SENT_217	[p13l2012t3391r2147b3450, p13l6t3473r193b3527],
5	clinical	JJ	O	clinical	amod	6	SENT_217	[p13l226t3470r481b3527],
6	trials	NNS	O	trial	prep_after	63	SENT_217	[p13l514t3470r685b3527],
7	that	WDT	O	that	nsubj	8	SENT_217	[p13l717t3470r861b3527],
8	showed	VBD	O	show	rcmod	6	SENT_217	[p13l893t3470r1160b3527],
9	an	DT	O	a	det	11	SENT_217	[p13l1193t3486r1277b3527],
10	improved	VBN	O	improve	amod	11	SENT_217	[p13l1309t3470r1650b3545],
11	survival	NN	O	survival	nsubj	34	SENT_217	[p13l1683t3470r1957b3527],
12	with	IN	O	with	_	0	SENT_217	[p13l1987t3470r2149b3527],
13	combinations	NNS	O	combination	prep_with	11	SENT_217	[p13l9t3564r514b3634],
14	,	,	O	,	_	0	SENT_217	[p13l9t3564r514b3634],
15	recent	JJ	O	recent	amod	16	SENT_217	[p13l544t3571r763b3622],
16	multicentric	JJ	O	multicentric	appos	13	SENT_217	[p13l786t3564r1224b3622],
17	randomized	VBN	O	randomize	partmod	16	SENT_217	[p13l1248t3564r1672b3622],
18	clinical	JJ	O	clinical	amod	19	SENT_217	[p13l1697t3564r1952b3622],
19	trials	NNS	O	trial	dobj	17	SENT_217	[p13l1976t3564r2147b3622],
20	comparing	VBG	O	compare	xcomp	17	SENT_217	[p14l9t23r391b95],
21	one	CD	NUMBER	one	dobj	20	SENT_217	[p14l456t36r584b77],
22	versus	CC	O	versus	prep	21	SENT_217	[p14l647t36r864b77],
23	two	CD	NUMBER	two	num	24	SENT_217	[p14l929t27r1060b77],
24	drugs	NNS	O	drug	dep	22	SENT_217	[p14l1125t20r1316b95],
25	in	IN	O	in	_	0	SENT_217	[p14l1381t23r1451b77],
26	first	JJ	ORDINAL	first	amod	29	SENT_217	[p14l1516t19r1812b77],
27	—	NN	O	—	nn	29	SENT_217	[p14l1516t19r1812b77],
28	line	NN	O	line	nn	29	SENT_217	[p14l1516t19r1812b77],
29	therapy	NN	O	therapy	prep_in	24	SENT_217	[p14l1877t20r2151b95],
30	presented	VBN	O	present	partmod	29	SENT_217	[p14l8t115r352b191],
31	in	IN	O	in	_	0	SENT_217	[p14l378t118r449b172],
32	abstract	JJ	O	abstract	amod	33	SENT_217	[p14l476t115r750b173],
33	form	NN	O	form	prep_in	30	SENT_217	[p14l777t115r946b173],
34	showed	VBD	O	show	ccomp	8	SENT_217	[p14l975t115r1242b173],
35	no	DT	O	no	det	37	SENT_217	[p14l1268t132r1359b173],
36	substantial	JJ	O	substantial	amod	37	SENT_217	[p14l1388t115r1770b173],
37	difference	NN	O	difference	dobj	34	SENT_217	[p14l1798t115r2147b173],
38	in	IN	O	in	_	0	SENT_217	[p14l8t213r79b267],
39	OS	NNP	O	OS	prep_in	37	SENT_217	[p14l112t212r206b268],
40	and	CC	O	and	_	0	SENT_217	[p14l240t210r371b268],
41	treatment	NN	O	treatment	nn	42	SENT_217	[p14l402t217r753b268],
42	duration	NN	O	duration	dobj	34	SENT_217	[p14l785t210r1091b268],
43	in	IN	O	in	_	0	SENT_217	[p14l1122t213r1193b267],
44	the	DT	O	the	det	46	SENT_217	[p14l1224t210r1337b268],
45	combined	JJ	O	combined	amod	46	SENT_217	[p14l1370t210r1725b268],
46	group	NN	O	group	prep_in	42	SENT_217	[p14l1756t227r1980b286],
47	,	,	O	,	_	0	SENT_217	[p14l1756t227r1980b286],
48	and	CC	O	and	_	0	SENT_217	[p14l2018t210r2149b268],
49	on	IN	O	on	dobj	34	SENT_217	[p14l9t320r100b361],
50	the	DT	O	the	det	51	SENT_217	[p14l150t303r263b361],
51	contrary	NN	O	contrary	pobj	49	SENT_217	[p14l315t310r616b379],
52	a	DT	O	a	det	55	SENT_217	[p14l665t320r700b361],
53	more	RBR	O	more	advmod	54	SENT_217	[p14l750t320r931b361],
54	important	JJ	O	important	amod	55	SENT_217	[p14l982t306r1343b379],
55	toxicity	NN	O	toxicity	dep	37	SENT_217	[p14l1394t296r1831b379],
56	.25	CD	NUMBER	.25	num	57	SENT_217	[p14l1394t296r1831b379],
57	'28	CD	NUMBER	'28	npadvmod	58	SENT_217	[p14l1394t296r1831b379],
58	Clearly	RB	O	clearly	advmod	55	SENT_217	[p14l1883t303r2144b379],
59	,	,	O	,	_	0	SENT_217	[p14l1883t303r2144b379],
60	these	DT	O	these	det	62	SENT_217	[p14l8t398r190b456],
61	recent	JJ	O	recent	amod	62	SENT_217	[p14l221t406r440b456],
62	results	NNS	O	result	nsubj	63	SENT_217	[p14l470t398r695b456],
63	pose	VBP	O	pose	_	0	SENT_217	[p14l726t415r882b474],
64	both	CC	O	both	dep	63	SENT_217	[p14l912t398r1079b456],
65	the	DT	O	the	det	66	SENT_217	[p14l1109t398r1221b456],
66	problem	NN	O	problem	dep	64	SENT_217	[p14l1252t398r1549b474],
67	of	IN	O	of	_	0	SENT_217	[p14l1580t398r1652b456],
68	the	DT	O	the	det	69	SENT_217	[p14l1677t399r1790b456],
69	choice	NN	O	choice	prep_of	66	SENT_217	[p14l1822t398r2049b456],
70	of	IN	O	of	_	0	SENT_217	[p14l2081t398r2153b456],
71	the	DT	O	the	det	72	SENT_217	[p14l8t494r121b551],
72	drugs	NNS	O	drug	prep_of	69	SENT_217	[p14l187t494r377b569],
73	and	CC	O	and	_	0	SENT_217	[p14l444t494r575b551],
74	that	IN	O	that	dep	75	SENT_217	[p14l640t494r783b551],
75	of	IN	O	of	conj_and	64	SENT_217	[p14l848t493r920b551],
76	their	PRP$	O	they	poss	77	SENT_217	[p14l980t494r1148b551],
77	combination	NN	O	combination	pobj	75	SENT_217	[p14l1213t494r1687b551],
78	.	.	O	.	_	0	SENT_217	[p14l1213t494r1687b551],

1	Thanks	NNS	O	thanks	nsubj	22	SENT_218	[p14l1755t494r2012b551],
2	to	TO	O	to	_	0	SENT_218	[p14l2078t501r2148b551],
3	tremendous	JJ	O	tremendous	amod	4	SENT_218	[p14l8t590r431b648],
4	progress	NN	O	progress	prep_to	1	SENT_218	[p14l467t607r756b666],
5	in	IN	O	in	_	0	SENT_218	[p14l792t593r862b647],
6	molecular	JJ	O	molecular	amod	7	SENT_218	[p14l899t590r1253b648],
7	biology	NN	O	biology	prep_in	4	SENT_218	[p14l1286t590r1563b666],
8	,	,	O	,	_	0	SENT_218	[p14l1286t590r1563b666],
9	several	JJ	O	several	conj_or	7	SENT_218	[p14l1605t590r1842b648],
10	promising	JJ	O	promising	amod	11	SENT_218	[p14l1877t593r2147b666, p14l8t688r121b760],
11	genomic	JJ	O	genomic	amod	9	SENT_218	[p14l185t688r491b760],
12	or	CC	O	or	_	0	SENT_218	[p14l556t701r627b742],
13	genetic	JJ	O	genetic	amod	15	SENT_218	[p14l691t688r946b760],
14	prognostic	JJ	O	prognostic	amod	15	SENT_218	[p14l1010t688r1386b760],
15	factors	NNS	O	factor	conj_or	7	SENT_218	[p14l1451t684r1684b742],
16	have	VBP	O	have	aux	18	SENT_218	[p14l1750t685r1915b742],
17	been	VBN	O	be	auxpass	18	SENT_218	[p14l1979t685r2148b742],
18	reported	VBN	O	report	_	0	SENT_218	[p14l8t780r307b855],
19	and	CC	O	and	_	0	SENT_218	[p14l348t780r480b837],
20	could	MD	O	could	aux	22	SENT_218	[p14l521t780r717b837],
21	be	VB	O	be	cop	22	SENT_218	[p14l756t780r836b837],
22	useful	JJ	O	useful	conj_and	18	SENT_218	[p14l877t779r1088b837],
23	but	CC	O	but	_	0	SENT_218	[p14l1127t780r1246b837],
24	treatment	NN	O	treatment	nn	25	SENT_218	[p14l1287t787r1638b837],
25	strategies	NNS	O	strategy	nsubjpass	28	SENT_218	[p14l1680t783r2004b855],
26	are	VBP	O	be	auxpass	28	SENT_218	[p14l2046t796r2148b837],
27	still	RB	O	still	advmod	28	SENT_218	[p14l10t875r135b933],
28	based	VBN	O	base	conj_but	18	SENT_218	[p14l172t875r370b933],
29	on	IN	O	on	_	0	SENT_218	[p14l408t892r500b933],
30	large	JJ	O	large	amod	32	SENT_218	[p14l537t875r705b951],
31	clinical	JJ	O	clinical	amod	32	SENT_218	[p14l745t875r1000b933],
32	trials	NNS	O	trial	prep_on	28	SENT_218	[p14l1038t875r1210b933],
33	and	CC	O	and	_	0	SENT_218	[p14l1249t875r1381b933],
34	translational	JJ	O	translational	amod	35	SENT_218	[p14l1419t875r1867b933],
35	studies	NNS	O	study	nsubj	38	SENT_218	[p14l1907t875r2147b933],
36	are	VBP	O	be	cop	38	SENT_218	[p14l9t987r110b1028],
37	still	RB	O	still	advmod	38	SENT_218	[p14l179t970r304b1028],
38	ancillary	JJ	O	ancillary	conj_and	18	SENT_218	[p14l370t970r688b1046],
39	.	.	O	.	_	0	SENT_218	[p14l370t970r688b1046],

1	The	DT	O	the	det	2	SENT_219	[p14l756t970r889b1028],
2	purpose	NN	O	purpose	nsubj	6	SENT_219	[p14l954t987r1234b1046],
3	of	IN	O	of	_	0	SENT_219	[p14l1301t970r1373b1028],
4	this	DT	O	this	det	5	SENT_219	[p14l1433t970r1563b1028],
5	study	NN	O	study	prep_of	2	SENT_219	[p14l1631t970r1823b1046],
6	was	VBD	O	be	_	0	SENT_219	[p14l1884t987r2012b1028],
7	to	TO	O	to	aux	9	SENT_219	[p14l2078t977r2148b1028],
8	simultaneously	RB	O	simultaneously	advmod	9	SENT_219	[p14l10t1065r551b1141],
9	characterize	VB	O	characterize	ccomp	6	SENT_219	[p14l599t1065r1020b1123],
10	the	DT	O	the	det	11	SENT_219	[p14l1070t1065r1183b1123],
11	impact	NN	O	impact	nsubj	14	SENT_219	[p14l1233t1068r1477b1141],
12	of	IN	O	of	prep	11	SENT_219	[p14l1526t1065r1598b1123],
13	pretherapeutically	RB	O	pretherapeutically	pcomp	12	SENT_219	[p14l1642t1065r2147b1141, p14l9t1159r173b1235],
14	determined	VBN	O	determine	ccomp	9	SENT_219	[p14l218t1159r627b1217],
15	genetic	JJ	O	genetic	amod	18	SENT_219	[p14l673t1162r928b1235],
16	and	CC	O	and	_	0	SENT_219	[p14l976t1159r1107b1217],
17	epigenetic	JJ	O	epigenetic	amod	18	SENT_219	[p14l1155t1162r1517b1235],
18	factors	NNS	O	factor	dobj	14	SENT_219	[p14l1564t1159r1797b1217],
19	on	IN	O	on	_	0	SENT_219	[p14l1845t1176r1936b1217],
20	5-FU	NN	O	5-fu	nn	21	SENT_219	[p14l1985t1162r2148b1217],
21	tolerance	NN	O	tolerance	prep_on	14	SENT_219	[p14l8t1255r334b1313],
22	and	CC	O	and	_	0	SENT_219	[p14l368t1255r499b1313],
23	efficacy	NN	O	efficacy	conj_and	21	SENT_219	[p14l532t1255r801b1331],
24	and	CC	O	and	_	0	SENT_219	[p14l832t1255r963b1313],
25	based	VBN	O	base	conj_and	14	SENT_219	[p14l993t1255r1191b1313],
26	on	IN	O	on	_	0	SENT_219	[p14l1224t1272r1315b1313],
27	the	DT	O	the	det	29	SENT_219	[p14l1347t1255r1460b1313],
28	relevant	JJ	O	relevant	amod	29	SENT_219	[p14l1493t1255r1780b1313],
29	factors	NNS	O	factor	prep_on	25	SENT_219	[p14l1812t1255r2045b1313],
30	to	TO	O	to	aux	31	SENT_219	[p14l2078t1262r2148b1313],
31	provide	VB	O	provide	xcomp	25	SENT_219	[p14l8t1349r275b1425],
32	physicians	NNS	O	physician	dobj	31	SENT_219	[p14l309t1349r680b1425],
33	with	IN	O	with	_	0	SENT_219	[p14l712t1349r874b1407],
34	some	DT	O	some	det	35	SENT_219	[p14l909t1366r1089b1407],
35	tools	NNS	O	tool	prep_with	31	SENT_219	[p14l1123t1349r1293b1407],
36	to	TO	O	to	aux	37	SENT_219	[p14l1327t1357r1397b1407],
37	decide	VB	O	decide	xcomp	14	SENT_219	[p14l1431t1349r1656b1407],
38	between	IN	O	between	_	0	SENT_219	[p14l1688t1349r1985b1407],
39	one	CD	NUMBER	one	num	40	SENT_219	[p14l2019t1366r2147b1407],
40	drug	NN	O	drug	prep_between	37	SENT_219	[p14l9t1445r170b1520],
41	versus	CC	O	versus	prep	40	SENT_219	[p14l191t1461r408b1502],
42	combined	JJ	O	combined	amod	43	SENT_219	[p14l434t1445r788b1502],
43	therapy	NN	O	therapy	dep	41	SENT_219	[p14l813t1445r1086b1520],
44	in	IN	O	in	_	0	SENT_219	[p14l1108t1448r1179b1502],
45	first	JJ	ORDINAL	first	amod	46	SENT_219	[p14l1203t1444r1339b1502],
46	line	NN	O	line	prep_in	43	SENT_219	[p14l1364t1445r1495b1502],
47	and	CC	O	and	_	0	SENT_219	[p14l1522t1445r1653b1502],
48	to	TO	O	to	aux	49	SENT_219	[p14l1676t1452r1746b1502],
49	tailor	VB	O	tailor	conj_and	9	SENT_219	[p14l1772t1445r1960b1502],
50	5	CD	NUMBER	5	dobj	49	SENT_219	[p14l1985t1447r2148b1502],
51	.	.	O	.	_	0	SENT_219	[p14l1985t1447r2148b1502],

1	—	NN	O	—	_	0	SENT_220	[p14l1985t1447r2148b1502],
2	.	.	O	.	_	0	SENT_220	[p14l1985t1447r2148b1502],

1	FU	NN	O	fu	_	0	SENT_221	[p14l1985t1447r2148b1502],
2	treatment	NN	O	treatment	dep	1	SENT_221	[p14l8t1546r376b1596],
3	.	.	O	.	_	0	SENT_221	[p14l8t1546r376b1596],

1	To	TO	O	to	_	0	SENT_222	[p14l83t1636r168b1691],
2	our	PRP$	O	we	poss	3	SENT_222	[p14l211t1650r330b1691],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_222	[p14l371t1634r771b1709],
4	,	,	O	,	_	0	SENT_222	[p14l371t1634r771b1709],
5	this	DT	O	this	nsubj	9	SENT_222	[p14l818t1634r948b1691],
6	is	VBZ	O	be	cop	9	SENT_222	[p14l991t1637r1041b1691],
7	the	DT	O	the	det	9	SENT_222	[p14l1083t1634r1196b1691],
8	first	JJ	ORDINAL	first	amod	9	SENT_222	[p14l1240t1633r1375b1691],
9	study	NN	O	study	_	0	SENT_222	[p14l1419t1634r1611b1709],
10	analyzing	VBG	O	analyze	partmod	9	SENT_222	[p14l1651t1634r1994b1709],
11	the	DT	O	the	det	12	SENT_222	[p14l2035t1634r2147b1691],
12	impact	NN	O	impact	dobj	10	SENT_222	[p14l8t1732r253b1804],
13	of	IN	O	of	_	0	SENT_222	[p14l309t1728r381b1786],
14	both	CC	O	both	preconj	15	SENT_222	[p14l430t1729r597b1786],
15	TS	NN	O	t	prep_of	12	SENT_222	[p14l651t1730r752b1799],
16	,	,	O	,	_	0	SENT_222	[p14l651t1730r752b1799],
17	DPD	NN	ORGANIZATION	dpd	prep_of	12	SENT_222	[p14l813t1731r971b1786],
18	and	CC	O	and	_	0	SENT_222	[p14l1029t1729r1160b1786],
19	MTHFR	NN	O	mthfr	prep_of	12	SENT_222	[p14l1215t1731r1499b1799],
20	,	,	O	,	_	0	SENT_222	[p14l1215t1731r1499b1799],
21	the	DT	O	the	det	24	SENT_222	[p14l1560t1729r1672b1786],
22	three	CD	NUMBER	three	num	24	SENT_222	[p14l1729t1729r1909b1786],
23	main	JJ	O	main	amod	24	SENT_222	[p14l1966t1732r2148b1786],
24	enzymes	NNS	O	enzyme	dep	15	SENT_222	[p14l9t1841r312b1900],
25	of	IN	O	of	_	0	SENT_222	[p14l347t1824r419b1882],
26	5-FU	NN	O	5-fu	nn	27	SENT_222	[p14l450t1827r613b1882],
27	activity	NN	O	activity	prep_of	12	SENT_222	[p14l648t1827r912b1900],
28	and	CC	O	and	_	0	SENT_222	[p14l945t1824r1076b1882],
29	metabolism	NN	O	metabolism	conj_and	27	SENT_222	[p14l1109t1824r1543b1895],
30	,	,	O	,	_	0	SENT_222	[p14l1109t1824r1543b1895],
31	on	IN	O	on	_	0	SENT_222	[p14l1583t1841r1674b1882],
32	its	PRP$	O	its	poss	33	SENT_222	[p14l1708t1827r1787b1882],
33	tolerance	NN	O	tolerance	prep_on	10	SENT_222	[p14l1821t1824r2147b1882],

1	Fluorouracil	NNP	O	Fluorouracil	_	0	SENT_223	[p14l1106t1981r1245b2003],
2	outcome	NN	O	outcome	nn	3	SENT_223	[p14l1254t1983r1357b2003],
3	parameters	NNS	O	parameter	dep	1	SENT_223	[p14l1366t1983r1500b2010],
4	@	IN	O	@	_	0	SENT_223	[p14l2089t1975r2151b2036],
5	O	NNP	O	O	nn	6	SENT_223	[p14l1105t2017r1122b2037],
6	Capitain	NNP	MISC	Capitain	prep_@	3	SENT_223	[p14l1131t2016r1213b2043],
7	et	FW	O	et	nn	8	SENT_223	[p14l1224t2018r1241b2037],
8	al	FW	O	al	dep	1	SENT_223	[p14l1249t2016r1267b2037],

1	D	NN	O	d	_	0	SENT_224	[p14l517t2933r532b2955],
2	250	CD	NUMBER	250	dep	1	SENT_224	[p14l638t2933r686b2955],
3	5130	CD	NUMBER	5130	rcmod	2	SENT_224	[p14l776t2933r824b2957],
4	1	CD	NUMBER	1	rcmod	3	SENT_224	[p14l914t2933r962b2955],
5	'30	CD	NUMBER	'30	dep	7	SENT_224	[p14l914t2933r962b2955],
6	1	CD	NUMBER	1	dep	5	SENT_224	[p14l1042t2933r1053b2955],
7	DD	NN	O	dd	dep	4	SENT_224	[p14l1058t2933r1106b2957],
8	!	.	O	!	_	0	SENT_224	[p14l1058t2933r1106b2957],
9	)	SYM	O	)	dep	3	SENT_224	[p14l1058t2933r1106b2957],

1	1	CD	NUMBER	1	number	2	SENT_225	[p14l1180t2933r1190b2955],
2	250	CD	NUMBER	250	_	0	SENT_225	[p14l1196t2933r1242b2955],
3	1	CD	NUMBER	1	dep	2	SENT_225	[p14l1318t2933r1329b2955],
4	5011	CD	NUMBER	5011	number	5	SENT_225	[p14l1334t2933r1381b2955],
5	1	CD	NUMBER	1	dep	2	SENT_225	[p14l1454t2933r1465b2955],
6	750 201313	CD	NUMBER	750 201313	num	7	SENT_225	[p14l1594t2933r1658b2957],[p14l1469t2933r1517b2955],
7	2250	CD	DATE	2250	dep	5	SENT_225	[p14l1730t2933r1795b2955],

1	Su	FW	O	su	nn	3	SENT_226	[p14l1009t2979r1044b3003],
2	rvival	FW	O	rvival	nn	3	SENT_226	[p14l1048t2979r1120b3003],
3	time	NN	O	time	_	0	SENT_226	[p14l1130t2979r1189b3003],
4	(	CD	NUMBER	(	num	5	SENT_226	[p14l1198t2979r1282b3009],
5	days	NNS	NUMBER	day	dep	3	SENT_226	[p14l1198t2979r1282b3009],
6	)	IN	O	)	amod	5	SENT_226	[p14l1198t2979r1282b3009],

1	j	NN	O	j	_	0	SENT_227	[p14l466t3045r550b3049],
2	2	CD	NUMBER	2	amod	1	SENT_227	[p14l570t3033r650b3057],
3	|	SYM	O	|	dep	6	SENT_227	[p14l570t3033r650b3057],
4	-	:	O	-	_	0	SENT_227	[p14l570t3033r650b3057],
5	'	''	O	'	_	0	SENT_227	[p14l570t3033r650b3057],
6	I	PRP	O	I	dep	1	SENT_227	[p14l570t3033r650b3057],
7	!	.	O	!	_	0	SENT_227	[p14l570t3033r650b3057],

1	2R	NN	O	2r	nn	2	SENT_228	[p14l570t3033r650b3057],
2	2FlI3H	NN	O	2fli3h	_	0	SENT_228	[p14l570t3063r650b3087],
3	=	JJ	O	=	amod	4	SENT_228	[p14l468t3107r476b3111],
4	3Fll3Fl	NN	O	3fll3fl	dep	2	SENT_228	[p14l572t3097r650b3119],

1	Figure	NNP	O	Figure	_	0	SENT_229	[p14l11t3130r105b3163],
2	3	CD	NUMBER	3	num	1	SENT_229	[p14l119t3130r134b3155],
3	Univariate	NNP	O	Univariate	nn	5	SENT_229	[p14l170t3130r313b3155],
4	overall	JJ	O	overall	amod	5	SENT_229	[p14l327t3130r420b3155],
5	survival	NN	O	survival	dep	1	SENT_229	[p14l433t3130r538b3155],
6	of	IN	O	of	_	0	SENT_229	[p14l553t3130r581b3155],
7	patients	NNS	O	patient	prep_of	1	SENT_229	[p14l593t3130r706b3163],
8	according	VBG	O	accord	_	0	SENT_229	[p14l719t3130r861b3163],
9	to	TO	O	to	prepc_according_to	7	SENT_229	[p14l875t3133r904b3155],
10	TSER	NN	O	tser	nn	11	SENT_229	[p14l916t3130r986b3155],
11	genotypes	NNS	O	genotype	pobj	7	SENT_229	[p14l998t3133r1157b3163],
12	.	.	O	.	_	0	SENT_229	[p14l998t3133r1157b3163],

1	E	NN	O	e	_	0	SENT_230	[p15l361t392r391b442],
2	0.5	CD	NUMBER	0.5	num	1	SENT_230	[p15l408t404r464b426],
3	:	:	O	:	_	0	SENT_230	[p15l408t404r464b426],
4	}	CD	NUMBER	}	dep	1	SENT_230	[p15l408t404r464b426],

1	Survival	NN	O	survival	nn	2	SENT_231	[p15l985t870r1097b894],
2	time	NN	O	time	_	0	SENT_231	[p15l1107t870r1167b892],
3	(	CD	NUMBER	(	num	4	SENT_231	[p15l1175t870r1260b898],
4	days	NNS	NUMBER	day	dep	2	SENT_231	[p15l1175t870r1260b898],
5	)	IN	O	)	amod	4	SENT_231	[p15l1175t870r1260b898],

1	T	NN	O	t	dep	3	SENT_232	[p15l492t932r567b936],
2	IDW	NNP	O	IDW	dep	1	SENT_232	[p15l584t924r631b946],
3	high	JJ	O	high	_	0	SENT_232	[p15l585t962r643b990],

1	Figure	NNP	O	Figure	_	0	SENT_233	[p15l11t990r105b1023],
2	4	CD	NUMBER	4	num	1	SENT_233	[p15l118t991r136b1015],
3	Univariate	NNP	O	Univariate	nn	5	SENT_233	[p15l170t991r313b1015],
4	overall	JJ	O	overall	amod	5	SENT_233	[p15l327t990r419b1015],
5	survival	NN	O	survival	dep	1	SENT_233	[p15l433t990r538b1015],
6	of	IN	O	of	_	0	SENT_233	[p15l553t990r581b1015],
7	patients	NNS	O	patient	prep_of	1	SENT_233	[p15l593t991r706b1023],
8	according	VBG	O	accord	_	0	SENT_233	[p15l719t990r861b1023],
9	to	TO	O	to	prepc_according_to	7	SENT_233	[p15l875t993r904b1015],
10	low	JJ	O	low	pobj	7	SENT_233	[p15l918t990r969b1015],
11	and	CC	O	and	_	0	SENT_233	[p15l981t990r1033b1015],
12	high	JJ	O	high	amod	15	SENT_233	[p15l1049t990r1111b1023],
13	TS	NN	O	t	nn	15	SENT_233	[p15l1124t991r1158b1015],
14	expression	NN	O	expression	nn	15	SENT_233	[p15l1171t991r1322b1023],
15	genotype	NN	O	genotype	pobj	7	SENT_233	[p15l1336t993r1482b1023],
16	.	.	O	.	_	0	SENT_233	[p15l1336t993r1482b1023],

1	TS	NN	O	t	_	0	SENT_234	[p15l1495t991r1538b1020],
2	,	,	O	,	_	0	SENT_234	[p15l1495t991r1538b1020],
3	thymidylate	NN	O	thymidylate	nn	4	SENT_234	[p15l1552t990r1725b1023],
4	synthase	NN	O	synthase	appos	1	SENT_234	[p15l1738t990r1870b1023],
5	.	.	O	.	_	0	SENT_234	[p15l1738t990r1870b1023],

1	and	CC	O	and	cc	10	SENT_235	[p15l10t1098r74b1126],
2	its	PRP$	O	its	poss	3	SENT_235	[p15l92t1100r131b1126],
3	efficacy	NN	O	efficacy	nsubj	10	SENT_235	[p15l151t1098r282b1135],
4	in	IN	O	in	_	0	SENT_235	[p15l300t1100r334b1126],
5	a	DT	O	a	det	7	SENT_235	[p15l353t1106r370b1126],
6	homogeneous	JJ	O	homogeneous	amod	7	SENT_235	[p15l389t1098r634b1135],
7	population	NN	O	population	prep_in	3	SENT_235	[p15l653t1098r845b1135],
8	of	IN	O	of	_	0	SENT_235	[p15l864t1098r899b1126],
9	patients	NNS	O	patient	prep_of	7	SENT_235	[p15l915t1100r1053b1135],
10	treated	VBN	O	treat	_	0	SENT_235	[p15l9t1144r129b1172],
11	with	IN	O	with	_	0	SENT_235	[p15l161t1144r239b1172],
12	a	DT	O	a	det	13	SENT_235	[p15l272t1152r289b1172],
13	5	CD	NUMBER	5	prep_with	10	SENT_235	[p15l323t1145r402b1172],
14	.	.	O	.	_	0	SENT_235	[p15l323t1145r402b1172],

1	—	NN	O	—	_	0	SENT_236	[p15l323t1145r402b1172],
2	.	.	O	.	_	0	SENT_236	[p15l323t1145r402b1172],

1	FU	NN	O	fu	nn	4	SENT_237	[p15l323t1145r402b1172],
2	and	CC	O	and	_	0	SENT_237	[p15l435t1144r500b1172],
3	leucovorin	NN	O	leucovorin	nn	4	SENT_237	[p15l532t1144r717b1172],
4	combination	NN	O	combination	_	0	SENT_237	[p15l750t1144r973b1172],
5	for	IN	O	for	_	0	SENT_237	[p15l1006t1144r1054b1172],
6	advanced	JJ	O	advanced	amod	7	SENT_237	[p15l10t1189r173b1217],
7	CRC	NN	O	crc	prep_for	4	SENT_237	[p15l188t1190r273b1217],
8	.	.	O	.	_	0	SENT_237	[p15l188t1190r273b1217],

1	Indeed	RB	O	indeed	dep	2	SENT_238	[p15l47t1235r165b1263],
2	5	CD	NUMBER	5	_	0	SENT_238	[p15l179t1236r267b1269],
3	.	.	O	.	_	0	SENT_238	[p15l179t1236r267b1269],

1	—	NN	O	—	_	0	SENT_239	[p15l179t1236r267b1269],
2	.	.	O	.	_	0	SENT_239	[p15l179t1236r267b1269],

1	FU	NNP	O	FU	nsubj	10	SENT_240	[p15l179t1236r267b1269],
2	,	,	O	,	_	0	SENT_240	[p15l179t1236r267b1269],
3	the	DT	O	the	det	8	SENT_240	[p15l282t1235r337b1263],
4	most	RBS	O	most	advmod	6	SENT_240	[p15l350t1238r435b1263],
5	commonly	RB	O	commonly	advmod	6	SENT_240	[p15l448t1235r638b1272],
6	used	VBN	O	use	amod	8	SENT_240	[p15l648t1235r727b1263],
7	anticancer	JJ	O	anticancer	amod	8	SENT_240	[p15l740t1236r920b1263],
8	agents	NNS	O	agent	appos	1	SENT_240	[p15l933t1238r1051b1272],
9	,	,	O	,	_	0	SENT_240	[p15l933t1238r1051b1272],
10	provoke	VB	O	provoke	_	0	SENT_240	[p15l9t1281r148b1318],
11	20-25	CD	PERCENT	20-25	num	12	SENT_240	[p15l167t1282r303b1309],
12	%	NN	PERCENT	%	dep	10	SENT_240	[p15l167t1282r303b1309],
13	grade	NN	O	grade	dep	12	SENT_240	[p15l320t1281r413b1318],
14	3	CD	NUMBER	3	num	13	SENT_240	[p15l432t1282r449b1309],
15	and	CC	O	and	_	0	SENT_240	[p15l469t1281r533b1309],
16	4	CD	NUMBER	4	num	19	SENT_240	[p15l551t1282r569b1309],
17	toxic	JJ	O	toxic	amod	19	SENT_240	[p15l587t1282r673b1309],
18	side	JJ	O	side	amod	19	SENT_240	[p15l692t1281r757b1309],
19	effects	NNS	O	effect	conj_and	12	SENT_240	[p15l775t1281r883b1309],
20	and	CC	O	and	_	0	SENT_240	[p15l902t1281r966b1309],
21	0.20.5	CD	PERCENT	0.20.5	num	22	SENT_240	[p15l983t1282r1055b1309, p15l9t1327r95b1355],
22	%	NN	PERCENT	%	conj_and	12	SENT_240	[p15l983t1282r1055b1309, p15l9t1327r95b1355],
23	toxic	JJ	O	toxic	amod	24	SENT_240	[p15l110t1328r196b1355],
24	deaths	NNS	O	death	advmod	12	SENT_240	[p15l212t1327r324b1355],
25	to	TO	O	to	_	0	SENT_240	[p15l339t1330r373b1355],
26	patients	NNS	O	patient	prep_to	24	SENT_240	[p15l389t1328r527b1364],
27	under	IN	O	under	_	0	SENT_240	[p15l542t1327r645b1355],
28	treatment	NN	O	treatment	prep_under	26	SENT_240	[p15l659t1330r831b1355],
29	while	IN	O	while	mark	33	SENT_240	[p15l845t1327r940b1355],
30	many	JJ	O	many	nsubj	33	SENT_240	[p15l956t1335r1055b1364],
31	of	IN	O	of	_	0	SENT_240	[p15l10t1373r44b1401],
32	them	PRP	O	they	prep_of	30	SENT_240	[p15l65t1373r156b1401],
33	are	VBP	O	be	dep	24	SENT_240	[p15l179t1381r228b1401],
34	in	IN	O	in	_	0	SENT_240	[p15l251t1374r286b1401],
35	an	DT	O	a	det	37	SENT_240	[p15l309t1381r350b1401],
36	adjuvant	JJ	O	adjuvant	amod	37	SENT_240	[p15l373t1373r525b1410],
37	setting	NN	O	setting	prep_in	33	SENT_240	[p15l549t1375r673b1410],
38	,	,	O	,	_	0	SENT_240	[p15l549t1375r673b1410],
39	especially	RB	O	especially	advmod	33	SENT_240	[p15l698t1373r866b1410],
40	for	IN	O	for	_	0	SENT_240	[p15l887t1373r935b1401],
41	colon	NN	O	colon	nn	42	SENT_240	[p15l957t1373r1054b1401],
42	cancer	NN	O	cancer	prep_for	33	SENT_240	[p15l10t1427r127b1453],
43	,	,	O	,	_	0	SENT_240	[p15l10t1427r127b1453],
44	and	CC	O	and	_	0	SENT_240	[p15l143t1419r207b1447],
45	potentially	RB	O	potentially	advmod	46	SENT_240	[p15l219t1419r410b1456],
46	cured	VBN	O	cure	dep	10	SENT_240	[p15l422t1419r517b1447],
47	after	IN	O	after	_	0	SENT_240	[p15l530t1419r607b1447],
48	surgery	NN	O	surgery	prep_after	46	SENT_240	[p15l620t1416r769b1456],
49	.	.	O	.	_	0	SENT_240	[p15l620t1416r769b1456],

1	‘‘	NN	O	‘‘	nn	2	SENT_241	[p15l620t1416r769b1456],
2	Individual	NN	O	individual	_	0	SENT_241	[p15l782t1419r960b1447],
3	5	CD	NUMBER	5	dep	2	SENT_241	[p15l974t1420r1054b1447],
4	.	.	O	.	_	0	SENT_241	[p15l974t1420r1054b1447],

1	—	NN	O	—	_	0	SENT_242	[p15l974t1420r1054b1447],
2	.	.	O	.	_	0	SENT_242	[p15l974t1420r1054b1447],

1	FU	NNP	O	FU	nn	3	SENT_243	[p15l974t1420r1054b1447],
2	dose	NN	O	dose	nn	3	SENT_243	[p15l10t1465r86b1493],
3	management	NN	O	management	nsubj	8	SENT_243	[p15l106t1468r334b1502],
4	based	VBN	O	base	_	0	SENT_243	[p15l353t1465r450b1493],
5	on	IN	O	on	prepc_based_on	3	SENT_243	[p15l471t1473r516b1493],
6	a	DT	O	a	det	7	SENT_243	[p15l536t1473r553b1493],
7	pharmacokinetic	JJ	O	pharmacokinetic	pobj	3	SENT_243	[p15l573t1465r867b1502],
8	follow	VBP	O	follow	_	0	SENT_243	[p15l887t1465r1053b1502],
9	—	CD	NUMBER	—	npadvmod	10	SENT_243	[p15l887t1465r1053b1502],
10	up	IN	O	up	advmod	8	SENT_243	[p15l887t1465r1053b1502],

1	Fluorouracil	NNP	O	Fluorouracil	_	0	SENT_244	[p15l660t1642r799b1664],
2	outcome	NN	O	outcome	nn	3	SENT_244	[p15l809t1644r911b1664],
3	parameters	NNS	O	parameter	dep	1	SENT_244	[p15l921t1644r1054b1671],

1	NEW	NNP	O	NEW	_	0	SENT_245	[p15l9t1636r72b1697],

1	permits	NNS	O	permit	nsubj	13	SENT_246	[p15l1105t1100r1235b1135],
2	us	PRP	O	we	nsubj	4	SENT_246	[p15l1245t1106r1282b1126],
3	to	TO	O	to	aux	4	SENT_246	[p15l1293t1102r1327b1126],
4	reach	VB	O	reach	infmod	1	SENT_246	[p15l1338t1098r1431b1126],
5	the	DT	O	the	det	8	SENT_246	[p15l1442t1098r1497b1126],
6	best	JJS	O	best	amod	8	SENT_246	[p15l1507t1098r1576b1126],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_246	[p15l1586t1098r1783b1135],
8	index	NN	O	index	dobj	4	SENT_246	[p15l1794t1098r1891b1126],
9	but	CC	O	but	prep	8	SENT_246	[p15l1901t1098r1959b1126],
10	it	PRP	O	it	dep	9	SENT_246	[p15l1969t1100r1993b1126],
11	does	VBZ	O	do	aux	13	SENT_246	[p15l2004t1098r2080b1126],
12	not	RB	O	not	neg	13	SENT_246	[p15l2091t1102r2150b1126],
13	prevent	VB	O	prevent	_	0	SENT_246	[p15l1105t1147r1237b1181],
14	very	RB	O	very	advmod	15	SENT_246	[p15l1262t1152r1337b1181],
15	early	JJ	O	early	amod	19	SENT_246	[p15l1362t1144r1445b1181],
16	acute	JJ	O	acute	amod	19	SENT_246	[p15l1470t1147r1560b1172],
17	toxic	JJ	O	toxic	amod	19	SENT_246	[p15l1586t1145r1672b1172],
18	side	NN	O	side	nn	19	SENT_246	[p15l1699t1144r1764b1172],
19	effects	NNS	O	effect	dobj	13	SENT_246	[p15l1790t1144r1898b1172],
20	due	JJ	O	due	_	0	SENT_246	[p15l1925t1144r1986b1172],
21	to	TO	O	to	_	0	SENT_246	[p15l2012t1147r2047b1172],
22	DPD	NN	O	dpd	nn	23	SENT_246	[p15l2071t1145r2150b1172],
23	deﬁciency	NN	O	deﬁciency	prep_due_to	19	SENT_246	[p15l1106t1189r1283b1226],
24	and	CC	O	and	_	0	SENT_246	[p15l1312t1189r1376b1217],
25	chronic	JJ	O	chronic	amod	26	SENT_246	[p15l1407t1189r1538b1217],
26	toxicities	NNS	O	toxicity	prep_due_to	19	SENT_246	[p15l1569t1191r1725b1217],
27	such	JJ	O	such	_	0	SENT_246	[p15l1757t1189r1835b1217],
28	as	IN	O	as	_	0	SENT_246	[p15l1866t1197r1897b1217],
29	dacryocystis	NN	O	dacryocysti	prep_such_as	26	SENT_246	[p15l1929t1189r2147b1226],
30	,	,	O	,	_	0	SENT_246	[p15l1929t1189r2147b1226],
31	mainly	RB	O	mainly	advmod	32	SENT_246	[p15l1105t1235r1228b1272],
32	due	JJ	O	due	amod	29	SENT_246	[p15l1246t1235r1307b1263],
33	to	TO	O	to	_	0	SENT_246	[p15l1326t1238r1360b1263],
34	TS	NN	O	t	nn	35	SENT_246	[p15l1381t1236r1421b1263],
35	polymorphism	NN	O	polymorphism	prep_to	13	SENT_246	[p15l1438t1235r1704b1272],
36	.	.	O	.	_	0	SENT_246	[p15l1438t1235r1704b1272],

1	Thus	RB	O	thus	advmod	20	SENT_247	[p15l1724t1235r1817b1269],
2	,	,	O	,	_	0	SENT_247	[p15l1724t1235r1817b1269],
3	in	IN	O	in	_	0	SENT_247	[p15l1838t1236r1873b1263],
4	this	DT	O	this	det	5	SENT_247	[p15l1892t1235r1955b1263],
5	study	NN	O	study	prep_in	20	SENT_247	[p15l1975t1235r2073b1272],
6	,	,	O	,	_	0	SENT_247	[p15l1975t1235r2073b1272],
7	the	DT	O	the	det	9	SENT_247	[p15l2094t1235r2149b1263],
8	two	CD	NUMBER	two	num	9	SENT_247	[p15l1105t1284r1169b1309],
9	regimens	NNS	O	regimen	nsubjpass	20	SENT_247	[p15l1182t1282r1339b1318],
10	of	IN	O	of	_	0	SENT_247	[p15l1353t1281r1388b1309],
11	treatment	NN	O	treatment	prep_of	9	SENT_247	[p15l1399t1284r1570b1309],
12	using	VBG	O	use	partmod	11	SENT_247	[p15l1582t1282r1676b1318],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_247	[p15l1688t1281r1982b1318],
14	monitoring	NN	O	monitoring	dobj	12	SENT_247	[p15l1995t1282r2149b1309, p15l1105t1328r1161b1364],
15	as	IN	O	as	mark	17	SENT_247	[p15l1174t1335r1205b1355],
16	previously	RB	DATE	previously	advmod	17	SENT_247	[p15l1219t1327r1399b1364],
17	described	VBN	O	describe	advcl	12	SENT_247	[p15l1412t1327r1574b1355],
18	were	VBD	O	be	auxpass	20	SENT_247	[p15l1586t1335r1666b1355],
19	well	RB	O	well	advmod	20	SENT_247	[p15l1679t1327r1750b1355],
20	tolerated	VBN	O	tolerate	_	0	SENT_247	[p15l1763t1327r1917b1355],
21	in	IN	O	in	_	0	SENT_247	[p15l1930t1328r1965b1355],
22	an	DT	O	a	det	24	SENT_247	[p15l1978t1335r2020b1355],
23	elderly	JJ	O	elderly	amod	24	SENT_247	[p15l2034t1327r2151b1364],
24	population	NN	O	population	prep_in	20	SENT_247	[p15l1105t1373r1297b1410],
25	with	IN	O	with	_	0	SENT_247	[p15l1311t1373r1390b1401],
26	a	DT	O	a	det	28	SENT_247	[p15l1404t1381r1421b1401],
27	median	JJ	O	median	amod	28	SENT_247	[p15l1436t1373r1566b1401],
28	age	NN	O	age	prep_with	20	SENT_247	[p15l1581t1381r1636b1410],
29	of	IN	O	of	_	0	SENT_247	[p15l1652t1373r1687b1401],
30	71	CD	DURATION	71	num	31	SENT_247	[p15l1702t1374r1737b1401],
31	years	NNS	NUMBER	year	prep_of	28	SENT_247	[p15l1754t1381r1850b1410],
32	.	.	O	.	_	0	SENT_247	[p15l1754t1381r1850b1410],

1	However	RB	O	however	advmod	13	SENT_248	[p15l1867t1374r2026b1407],
2	,	,	O	,	_	0	SENT_248	[p15l1867t1374r2026b1407],
3	10.5	CD	PERCENT	10.5	num	4	SENT_248	[p15l2046t1374r2150b1401],
4	%	NN	PERCENT	%	nsubjpass	13	SENT_248	[p15l2046t1374r2150b1401],
5	of	IN	O	of	_	0	SENT_248	[p15l1106t1419r1141b1447],
6	grade	NN	O	grade	prep_of	4	SENT_248	[p15l1150t1419r1243b1456],
7	3	CD	NUMBER	3	num	6	SENT_248	[p15l1256t1420r1273b1447],
8	and	CC	O	and	_	0	SENT_248	[p15l1286t1419r1350b1447],
9	4	CD	NUMBER	4	num	11	SENT_248	[p15l1362t1420r1381b1447],
10	toxic	JJ	O	toxic	amod	11	SENT_248	[p15l1393t1421r1479b1447],
11	events	NNS	O	event	prep_of	4	SENT_248	[p15l1491t1423r1600b1447],
12	were	VBD	O	be	auxpass	13	SENT_248	[p15l1611t1427r1691b1447],
13	observed	VBN	O	observe	_	0	SENT_248	[p15l1703t1419r1864b1447],
14	.	.	O	.	_	0	SENT_248	[p15l1703t1419r1864b1447],

1	Concerning	VBG	O	concern	_	0	SENT_249	[p15l1879t1420r2083b1456],
2	the	DT	O	the	det	4	SENT_249	[p15l2094t1419r2149b1447],
3	metabolic	JJ	O	metabolic	amod	4	SENT_249	[p15l1105t1465r1276b1493],
4	pathway	NN	O	pathway	pobj	1	SENT_249	[p15l1307t1465r1456b1502],
5	of	IN	O	of	_	0	SENT_249	[p15l1486t1465r1521b1493],
6	5	CD	NUMBER	5	prep_of	4	SENT_249	[p15l1551t1466r1639b1499],
7	.	.	O	.	_	0	SENT_249	[p15l1551t1466r1639b1499],

1	—	NN	O	—	_	0	SENT_250	[p15l1551t1466r1639b1499],
2	.	.	O	.	_	0	SENT_250	[p15l1551t1466r1639b1499],

1	FU	NNP	O	FU	nsubj	4	SENT_251	[p15l1551t1466r1639b1499],
2	,	,	O	,	_	0	SENT_251	[p15l1551t1466r1639b1499],
3	we	PRP	O	we	nsubj	4	SENT_251	[p15l1672t1473r1719b1493],
4	found	VBD	O	find	_	0	SENT_251	[p15l1750t1465r1854b1493],
5	that	IN	O	that	advmod	4	SENT_251	[p15l1884t1465r1955b1493],
6	with	IN	O	with	_	0	SENT_251	[p15l1985t1465r2063b1493],
7	the	DT	O	the	prep_with	4	SENT_251	[p15l2094t1465r2149b1493],

1	O	NN	O	o	nn	2	SENT_252	[p15l895t1678r911b1698],
2	Capitain	NN	MISC	capitain	_	0	SENT_252	[p15l920t1677r1002b1704],
3	et	FW	O	et	nn	4	SENT_252	[p15l1013t1679r1031b1698],
4	al	FW	O	al	dep	2	SENT_252	[p15l1039t1677r1056b1698],

1	E	NN	O	e	nn	2	SENT_253	[p15l251t2240r281b2289],
2	o	NN	O	o	_	0	SENT_253	[p15l299t2242r315b2264],
3	50	CD	NUMBER	50	dep	2	SENT_253	[p15l325t2242r355b2264],

1	0.25	CD	NUMBER	0.25	num	2	SENT_254	[p15l299t2451r355b2475],
2	V	NN	O	v	_	0	SENT_254	[p15l381t2464r384b2465],

1	o.	NN	O	o.	_	0	SENT_255	[p15l299t2663r355b2685],
2	oo	NN	O	oo	nn	3	SENT_255	[p15l299t2663r355b2685],
3	V	NN	O	v	dep	1	SENT_255	[p15l381t2674r384b2675],

1	234	CD	DURATION	234	number	2	SENT_256	[p15l545t2771r595b2793],
2	days	NNS	DURATION	day	_	0	SENT_256	[p15l603t2771r667b2799],
3	842	CD	DURATION	842	num	4	SENT_256	[p15l899t2771r947b2793],
4	days	NNS	NUMBER	day	tmod	2	SENT_256	[p15l955t2771r1021b2799],
5	Survival	JJ	O	survival	amod	6	SENT_256	[p15l1132t2771r1244b2793],
6	time	NN	O	time	tmod	2	SENT_256	[p15l1254t2771r1314b2795],
7	(	CD	NUMBER	(	num	8	SENT_256	[p15l1322t2771r1406b2799],
8	days	NNS	NUMBER	day	dep	2	SENT_256	[p15l1322t2771r1406b2799],
9	)	IN	O	)	amod	8	SENT_256	[p15l1322t2771r1406b2799],

1	Figure	NNP	O	Figure	nsubj	48	SENT_257	[p15l11t2840r105b2873],
2	5	CD	NUMBER	5	num	1	SENT_257	[p15l117t2841r134b2865],
3	Univariate	NNP	O	Univariate	nn	5	SENT_257	[p15l169t2841r312b2865],
4	overall	JJ	O	overall	amod	5	SENT_257	[p15l324t2840r417b2865],
5	survival	NN	O	survival	nsubj	34	SENT_257	[p15l430t2840r535b2865],
6	of	IN	O	of	_	0	SENT_257	[p15l548t2840r576b2865],
7	patients	NNS	O	patient	prep_of	5	SENT_257	[p15l587t2840r700b2873],
8	according	VBG	O	accord	_	0	SENT_257	[p15l711t2840r854b2873],
9	to	TO	O	to	prepc_according_to	7	SENT_257	[p15l866t2843r895b2865],
10	3R/3R	NN	O	3r/3r	pobj	7	SENT_257	[p15l908t2840r993b2868],
11	for	IN	O	for	_	0	SENT_257	[p15l1002t2840r1043b2865],
12	TS	NN	O	t	prep_for	10	SENT_257	[p15l1052t2841r1086b2865],
13	and	CC	O	and	_	0	SENT_257	[p15l1098t2840r1151b2865],
14	A/A	NN	O	a/a	conj_and	12	SENT_257	[p15l1163t2840r1216b2868],
15	for	IN	O	for	_	0	SENT_257	[p15l1225t2840r1266b2865],
16	MTHFR	NNP	O	MTHFR	prep_for	10	SENT_257	[p15l1278t2841r1382b2865],
17	1298	CD	DATE	1298	num	16	SENT_257	[p15l1394t2841r1466b2865],
18	A	DT	O	a	det	20	SENT_257	[p15l1477t2841r1552b2865],
19	>	JJR	O	>	amod	20	SENT_257	[p15l1477t2841r1552b2865],
20	C	NN	O	c	dep	10	SENT_257	[p15l1477t2841r1552b2865],
21	or	CC	O	or	_	0	SENT_257	[p15l1564t2847r1594b2865],
22	3R/3R	NN	O	3r/3r	pobj	7	SENT_257	[p15l1606t2840r1691b2868],
23	for	IN	O	for	_	0	SENT_257	[p15l1700t2840r1741b2865],
24	TS	NN	O	t	prep_for	22	SENT_257	[p15l1750t2841r1784b2865],
25	and	CC	O	and	_	0	SENT_257	[p15l1796t2840r1849b2865],
26	C/C	NN	O	c/c	conj_and	24	SENT_257	[p15l1862t2840r1918b2868],
27	for	IN	O	for	_	0	SENT_257	[p15l1928t2840r1969b2865],
28	MTHFR	NN	O	mthfr	nn	33	SENT_257	[p15l1981t2841r2085b2865],
29	677	CD	NUMBER	677	number	30	SENT_257	[p15l2096t2841r2150b2865],
30	C	NN	O	c	npadvmod	31	SENT_257	[p15l10t2874r83b2898],
31	>	JJR	O	>	amod	33	SENT_257	[p15l10t2874r83b2898],
32	T	NN	O	t	nn	33	SENT_257	[p15l10t2874r83b2898],
33	genotypes	NNS	O	genotype	prep_for	22	SENT_257	[p15l102t2876r252b2906],
34	(	VBP	O	(	rcmod	1	SENT_257	[p15l272t2873r370b2904],
35	16/67	CD	NUMBER	16/67	num	36	SENT_257	[p15l272t2873r370b2904],
36	patients	NNS	O	patient	dobj	34	SENT_257	[p15l391t2874r504b2906],
37	:	:	O	:	_	0	SENT_257	[p15l512t2885r534b2893],
38	23.9	CD	PERCENT	23.9	num	39	SENT_257	[p15l542t2873r649b2904],
39	%	NN	PERCENT	%	dep	36	SENT_257	[p15l542t2873r649b2904],
40	)	CD	NUMBER	)	number	41	SENT_257	[p15l542t2873r649b2904],
41	(	CD	NUMBER	(	num	44	SENT_257	[p15l669t2873r744b2906],
42	gray	JJ	O	gray	amod	44	SENT_257	[p15l669t2873r744b2906],
43	line	NN	O	line	nn	44	SENT_257	[p15l764t2873r824b2904],
44	)	NN	O	)	dep	39	SENT_257	[p15l764t2873r824b2904],
45	and	CC	O	and	_	0	SENT_257	[p15l845t2873r897b2898],
46	other	JJ	O	other	amod	47	SENT_257	[p15l918t2873r995b2898],
47	genotypes	NNS	O	genotype	dep	39	SENT_257	[p15l1013t2876r1164b2906],
48	(	VBP	O	(	_	0	SENT_257	[p15l1184t2873r1270b2904],
49	black	JJ	O	black	amod	51	SENT_257	[p15l1184t2873r1270b2904],
50	line	NN	O	line	nn	51	SENT_257	[p15l1290t2873r1359b2904],
51	)	NN	O	)	dobj	48	SENT_257	[p15l1290t2873r1359b2904],
52	.	.	O	.	_	0	SENT_257	[p15l1290t2873r1359b2904],

1	MTHFR	NNP	LOCATION	MTHFR	_	0	SENT_258	[p15l1381t2874r1493b2903],
2	,	,	O	,	_	0	SENT_258	[p15l1381t2874r1493b2903],
3	methylene	NN	O	methylene	nn	5	SENT_258	[p15l1515t2873r1667b2906],
4	tetrahydrofolate	NN	O	tetrahydrofolate	nn	5	SENT_258	[p15l1686t2873r1919b2906],
5	reductase	NN	O	reductase	appos	1	SENT_258	[p15l1940t2873r2086b2903],
6	;	:	O	;	_	0	SENT_258	[p15l1940t2873r2086b2903],
7	TS	NN	O	t	dep	1	SENT_258	[p15l2106t2874r2148b2903],
8	,	,	O	,	_	0	SENT_258	[p15l2106t2874r2148b2903],
9	thymidylate	NN	O	thymidylate	nn	10	SENT_258	[p15l10t2923r362b2991],
10	synthase	NN	O	synthase	appos	7	SENT_258	[p15l389t2923r659b2991],
11	.	.	O	.	_	0	SENT_258	[p15l389t2923r659b2991],

1	pretherapeutic	JJ	O	pretherapeutic	amod	2	SENT_259	[p15l10t3145r528b3221],
2	detection	NN	O	detection	nsubj	9	SENT_259	[p15l561t3145r910b3215],
3	,	,	O	,	_	0	SENT_259	[p15l561t3145r910b3215],
4	9	CD	NUMBER	9	appos	2	SENT_259	[p15l948t3146r985b3202],
5	of	IN	O	of	_	0	SENT_259	[p15l1020t3145r1091b3203],
6	the	DT	O	the	det	8	SENT_259	[p15l1119t3145r1231b3203],
7	76	CD	NUMBER	76	num	8	SENT_259	[p15l1270t3147r1348b3203],
8	patients	NNS	O	patient	prep_of	4	SENT_259	[p15l1380t3148r1662b3221],
9	were	VBD	O	be	_	0	SENT_259	[p15l1693t3162r1856b3203],
10	at	IN	O	at	_	0	SENT_259	[p15l1891t3152r1954b3203],
11	high	JJ	O	high	amod	12	SENT_259	[p15l1986t3145r2147b3221],
12	risk	NN	O	risk	prep_at	9	SENT_259	[p15l11t3240r135b3298],
13	of	IN	O	of	_	0	SENT_259	[p15l168t3240r240b3298],
14	5-FU	NN	O	5-fu	nn	15	SENT_259	[p15l272t3243r435b3298],
15	toxicity	NN	O	toxicity	prep_of	12	SENT_259	[p15l469t3243r741b3316],
16	because	IN	O	because	_	0	SENT_259	[p15l771t3240r1044b3298],
17	of	IN	O	of	_	0	SENT_259	[p15l1080t3240r1152b3298],
18	a	DT	O	a	det	20	SENT_259	[p15l1182t3257r1217b3298],
19	DPD	NN	O	dpd	nn	20	SENT_259	[p15l1252t3243r1409b3297],
20	deficiency	NN	O	deficiency	prep_because_of	9	SENT_259	[p15l1446t3240r1817b3316],
21	,	,	O	,	_	0	SENT_259	[p15l1446t3240r1817b3316],
22	revealed	VBN	O	reveal	partmod	20	SENT_259	[p15l1856t3240r2148b3298],
23	by	IN	O	by	_	0	SENT_259	[p15l9t3333r96b3408],
24	a	DT	O	a	det	30	SENT_259	[p15l125t3349r159b3390],
25	very	RB	O	very	advmod	26	SENT_259	[p15l187t3349r341b3408],
26	low	JJ	O	low	amod	30	SENT_259	[p15l369t3333r497b3390],
27	pretherapeutic	JJ	O	pretherapeutic	amod	30	SENT_259	[p15l525t3333r1043b3408],
28	UH2/U	NN	O	uh2/u	nn	30	SENT_259	[p15l1073t3332r1313b3402],
29	plasma	NN	O	plasma	nn	30	SENT_259	[p15l1342t3332r1591b3408],
30	ratio	NN	O	ratio	agent	22	SENT_259	[p15l1622t3325r1871b3390],
31	.	.	O	.	_	0	SENT_259	[p15l1622t3325r1871b3390],

1	“	NN	O	“	nsubj	7	SENT_260	[p15l1622t3325r1871b3390],
2	Two	CD	NUMBER	two	num	1	SENT_260	[p15l1901t3335r2049b3390],
3	of	IN	O	of	_	0	SENT_260	[p15l2081t3332r2152b3390],
4	them	PRP	O	they	prep_of	1	SENT_260	[p16l10t17r196b75],
5	were	VBD	O	be	cop	7	SENT_260	[p16l238t34r402b75],
6	heterozygous	JJ	O	heterozygous	amod	7	SENT_260	[p16l447t17r915b93],
7	A/T	NN	O	a/t	_	0	SENT_260	[p16l959t17r1087b82],
8	for	IN	O	for	_	0	SENT_260	[p16l1129t17r1228b75],
9	2846	CD	DATE	2846	prep_for	7	SENT_260	[p16l1272t19r1441b75],
10	A	DT	O	a	det	12	SENT_260	[p16l1485t19r1667b87],
11	>	JJR	O	>	amod	12	SENT_260	[p16l1485t19r1667b87],
12	T	NN	O	t	dep	9	SENT_260	[p16l1485t19r1667b87],
13	,	,	O	,	_	0	SENT_260	[p16l1485t19r1667b87],
14	one	CD	NUMBER	one	appos	9	SENT_260	[p16l1717t34r1845b75],
15	for	IN	O	for	_	0	SENT_260	[p16l1890t17r1988b75],
16	IVS	NNS	O	iv	prep_for	14	SENT_260	[p16l2032t19r2147b75],
17	14	CD	NUMBER	14	dep	14	SENT_260	[p16l16t113r93b168],
18	+	CC	O	+	_	0	SENT_260	[p16l113t123r164b175],
19	1G	CD	NUMBER	1g	npadvmod	20	SENT_260	[p16l188t113r429b182],
20	>	JJR	O	>	conj_+	14	SENT_260	[p16l188t113r429b182],
21	A	DT	O	a	dep	20	SENT_260	[p16l188t113r429b182],
22	,	,	O	,	_	0	SENT_260	[p16l188t113r429b182],
23	the	DT	O	the	det	26	SENT_260	[p16l462t112r575b169],
24	main	JJ	O	main	amod	26	SENT_260	[p16l604t114r786b169],
25	deleterious	JJ	O	deleterious	amod	26	SENT_260	[p16l814t111r1199b169],
26	variants	NNS	O	variant	appos	9	SENT_260	[p16l1227t114r1507b169],
27	of	IN	O	of	_	0	SENT_260	[p16l1537t111r1608b169],
28	the	DT	O	the	det	30	SENT_260	[p16l1632t111r1744b169],
29	DPD	NN	ORGANIZATION	dpd	nn	30	SENT_260	[p16l1774t114r1932b168],
30	gene	NN	O	gene	prep_of	26	SENT_260	[p16l1961t128r2143b187],
31	.	.	O	.	_	0	SENT_260	[p16l1961t128r2143b187],

1	The	DT	O	the	det	4	SENT_261	[p16l9t207r141b265],
2	six	CD	NUMBER	six	num	4	SENT_261	[p16l166t210r261b265],
3	other	JJ	O	other	amod	4	SENT_261	[p16l282t207r471b265],
4	patients	NNS	O	patient	nsubj	5	SENT_261	[p16l492t210r774b283],
5	had	VBD	O	have	_	0	SENT_261	[p16l796t207r928b265],
6	no	DT	O	no	det	7	SENT_261	[p16l950t224r1041b265],
7	DPD	NN	O	dpd	nsubj	9	SENT_261	[p16l1061t210r1223b264],
8	variant	JJ	O	variant	dep	9	SENT_261	[p16l1242t210r1493b265],
9	detected	VBN	O	detect	xcomp	5	SENT_261	[p16l1516t207r1814b265],
10	in	IN	O	in	_	0	SENT_261	[p16l1836t210r1906b264],
11	the	DT	O	the	det	12	SENT_261	[p16l1929t207r2041b265],
12	23	CD	NUMBER	23	prep_in	9	SENT_261	[p16l2065t209r2144b265],
13	that	WDT	O	that	nsubjpass	15	SENT_261	[p16l10t302r154b360],
14	were	VBD	O	be	auxpass	15	SENT_261	[p16l185t319r349b360],
15	analyzed	VBN	O	analyze	rcmod	12	SENT_261	[p16l384t302r712b378],
16	.	.	O	.	_	0	SENT_261	[p16l384t302r712b378],

1	In	IN	O	in	_	0	SENT_262	[p16l751t304r823b359],
2	these	DT	O	these	det	4	SENT_262	[p16l857t302r1039b360],
3	nine	CD	NUMBER	nine	num	4	SENT_262	[p16l1073t305r1231b360],
4	patients	NNS	O	patient	prep_in	12	SENT_262	[p16l1265t305r1565b378],
5	,	,	O	,	_	0	SENT_262	[p16l1265t305r1565b378],
6	nine	CD	NUMBER	nine	npadvmod	7	SENT_262	[p16l1604t305r1761b360],
7	very	RB	O	very	advmod	12	SENT_262	[p16l1794t319r1948b378],
8	early	JJ	O	early	amod	10	SENT_262	[p16l1980t302r2150b378],
9	toxic	JJ	O	toxic	amod	10	SENT_262	[p16l10t400r186b454],
10	events	NNS	O	event	nsubjpass	12	SENT_262	[p16l236t404r459b454],
11	were	VBD	O	be	auxpass	12	SENT_262	[p16l507t413r670b454],
12	described	VBN	O	describe	_	0	SENT_262	[p16l720t397r1068b467],
13	,	,	O	,	_	0	SENT_262	[p16l720t397r1068b467],
14	with	IN	O	with	_	0	SENT_262	[p16l1121t397r1282b454],
15	33.3	CD	PERCENT	33.3	num	16	SENT_262	[p16l1332t398r1550b454],
16	%	NN	PERCENT	%	prep_with	12	SENT_262	[p16l1332t398r1550b454],
17	grade	NN	O	grade	dep	16	SENT_262	[p16l1599t397r1788b472],
18	3	CD	NUMBER	3	num	17	SENT_262	[p16l1840t398r1875b454],
19	and	CC	O	and	_	0	SENT_262	[p16l1928t397r2059b454],
20	4	CD	NUMBER	4	num	22	SENT_262	[p16l2108t399r2146b454],
21	gastrointestinal	JJ	O	gastrointestinal	amod	22	SENT_262	[p16l11t492r559b568],
22	events	NNS	O	event	conj_and	16	SENT_262	[p16l599t499r822b550],
23	in	IN	O	in	_	0	SENT_262	[p16l862t495r932b549],
24	spite	NN	O	spite	_	0	SENT_262	[p16l973t495r1134b568],
25	of	IN	O	of	_	0	SENT_262	[p16l1175t492r1246b550],
26	pharmacological	JJ	O	pharmacological	amod	27	SENT_262	[p16l1281t492r1871b568],
27	adjustment	NN	O	adjustment	prep_in_spite_of	22	SENT_262	[p16l1911t492r2147b568, p16l11t594r197b645],
28	and	CC	O	and	_	0	SENT_262	[p16l234t587r365b645],
29	clinical	JJ	O	clinical	amod	30	SENT_262	[p16l403t587r658b645],
30	observation	NN	O	observation	prep_in_spite_of	22	SENT_262	[p16l696t587r1128b645],
31	.	.	O	.	_	0	SENT_262	[p16l696t587r1128b645],

1	This	DT	O	this	det	2	SENT_263	[p16l1168t587r1317b645],
2	percentage	NN	O	percentage	nsubj	10	SENT_263	[p16l1355t594r1737b663],
3	of	IN	O	of	_	0	SENT_263	[p16l1775t587r1847b645],
4	grade	NN	O	grade	prep_of	2	SENT_263	[p16l1880t587r2069b663],
5	3	CD	NUMBER	3	num	4	SENT_263	[p16l2109t589r2144b645],
6	and	CC	O	and	_	0	SENT_263	[p16l11t682r142b740],
7	4	CD	NUMBER	4	num	9	SENT_263	[p16l164t684r203b739],
8	adverse	JJ	O	adverse	amod	9	SENT_263	[p16l227t682r485b740],
9	events	NNS	O	event	conj_and	4	SENT_263	[p16l509t689r733b740],
10	reached	VBD	O	reach	_	0	SENT_263	[p16l755t682r1030b740],
11	66	CD	PERCENT	66	num	12	SENT_263	[p16l1054t683r1205b740],
12	%	NN	PERCENT	%	dobj	10	SENT_263	[p16l1054t683r1205b740],
13	for	IN	O	for	_	0	SENT_263	[p16l1227t682r1325b740],
14	the	DT	O	the	det	16	SENT_263	[p16l1346t682r1458b740],
15	three	CD	NUMBER	three	num	16	SENT_263	[p16l1481t682r1661b740],
16	patients	NNS	O	patient	prep_for	10	SENT_263	[p16l1684t685r1966b758],
17	with	IN	O	with	_	0	SENT_263	[p16l1986t682r2147b740],
18	DPD	NN	ORGANIZATION	dpd	nn	19	SENT_263	[p16l7t780r169b834],
19	variants	NNS	O	variant	prep_with	10	SENT_263	[p16l205t780r505b835],
20	.	.	O	.	_	0	SENT_263	[p16l205t780r505b835],

1	Thus	RB	O	thus	advmod	11	SENT_264	[p16l546t777r737b847],
2	,	,	O	,	_	0	SENT_264	[p16l546t777r737b847],
3	for	IN	O	for	_	0	SENT_264	[p16l781t777r879b835],
4	early	JJ	O	early	amod	5	SENT_264	[p16l918t777r1089b853],
5	toxicity	NN	O	toxicity	prep_for	11	SENT_264	[p16l1125t780r1407b853],
6	,	,	O	,	_	0	SENT_264	[p16l1125t780r1407b853],
7	a	DT	O	a	det	9	SENT_264	[p16l1451t794r1486b835],
8	significant	JJ	O	significant	amod	9	SENT_264	[p16l1527t777r1897b853],
9	difference	NN	O	difference	nsubjpass	11	SENT_264	[p16l1936t777r2147b835, p16l11t888r170b929],
10	was	VBD	O	be	auxpass	11	SENT_264	[p16l219t888r346b929],
11	found	VBN	O	find	conj_and	11	SENT_264	[p16l398t871r609b929],
12	between	IN	O	between	_	0	SENT_264	[p16l657t871r953b929],
13	populations	NNS	O	population	prep_between	11	SENT_264	[p16l1003t871r1425b947],
14	with	IN	O	with	_	0	SENT_264	[p16l1474t872r1636b929],
15	and	CC	O	and	_	0	SENT_264	[p16l1687t871r1818b929],
16	without	IN	O	without	_	0	SENT_264	[p16l1865t871r2148b929],
17	metabolic	JJ	O	metabolic	amod	19	SENT_264	[p16l11t967r360b1025],
18	risk	NN	O	risk	nn	19	SENT_264	[p16l387t967r512b1025],
19	factors	NNS	O	factor	prep_without	11	SENT_264	[p16l537t967r788b1025],
20	.	.	O	.	_	0	SENT_264	[p16l537t967r788b1025],

1	Clearly	RB	O	clearly	advmod	11	SENT_265	[p16l821t967r1082b1043],
2	,	,	O	,	_	0	SENT_265	[p16l821t967r1082b1043],
3	a	DT	O	a	det	5	SENT_265	[p16l1114t984r1149b1025],
4	pretherapeutic	JJ	O	pretherapeutic	amod	5	SENT_265	[p16l1175t967r1693b1043],
5	detection	NN	O	detection	nsubj	11	SENT_265	[p16l1720t967r2053b1025],
6	of	IN	O	of	_	0	SENT_265	[p16l2080t967r2152b1025],
7	DPD	NN	ORGANIZATION	dpd	nn	8	SENT_265	[p16l11t1064r169b1118],
8	deficiency	NN	O	deficiency	prep_of	5	SENT_265	[p16l220t1061r582b1137],
9	would	MD	O	would	aux	11	SENT_265	[p16l627t1061r848b1119],
10	have	VB	O	have	aux	11	SENT_265	[p16l897t1061r1062b1119],
11	permitted	VBN	O	permit	_	0	SENT_265	[p16l1112t1061r1461b1137],
12	the	DT	O	the	det	13	SENT_265	[p16l1510t1061r1622b1119],
13	avoidance	NN	O	avoidance	dobj	11	SENT_265	[p16l1674t1061r2029b1119],
14	of	IN	O	of	_	0	SENT_265	[p16l2080t1061r2152b1119],
15	these	DT	O	these	det	17	SENT_265	[p16l10t1156r192b1213],
16	adverse	JJ	O	adverse	amod	17	SENT_265	[p16l230t1156r489b1213],
17	events	NNS	O	event	prep_of	13	SENT_265	[p16l527t1163r750b1213],
18	with	IN	O	with	_	0	SENT_265	[p16l785t1156r947b1213],
19	an	DT	O	a	det	21	SENT_265	[p16l984t1172r1068b1213],
20	initial	JJ	O	initial	amod	21	SENT_265	[p16l1104t1156r1314b1213],
21	reduction	NN	O	reduction	prep_with	11	SENT_265	[p16l1350t1156r1693b1213],
22	of	IN	O	of	_	0	SENT_265	[p16l1729t1155r1801b1213],
23	the	DT	O	the	det	25	SENT_265	[p16l1833t1156r1945b1213],
24	5-FU	NN	O	5-fu	nn	25	SENT_265	[p16l1984t1158r2148b1213],
25	dose	NN	O	dose	prep_of	21	SENT_265	[p16l11t1251r167b1309],
26	followed	VBN	O	follow	partmod	25	SENT_265	[p16l219t1251r525b1309],
27	by	IN	O	by	_	0	SENT_265	[p16l575t1251r662b1327],
28	individual	JJ	O	individual	amod	30	SENT_265	[p16l711t1251r1073b1309],
29	dose	NN	O	dose	nn	30	SENT_265	[p16l1126t1251r1281b1309],
30	management	NN	O	management	agent	26	SENT_265	[p16l1334t1258r1818b1327],
31	.	.	O	.	_	0	SENT_265	[p16l1334t1258r1818b1327],

1	Besides	IN	O	besides	advmod	5	SENT_266	[p16l1874t1251r2143b1321],
2	,	,	O	,	_	0	SENT_266	[p16l1874t1251r2143b1321],
3	some	DT	O	some	det	4	SENT_266	[p16l12t1362r193b1403],
4	patients	NNS	O	patient	nsubj	5	SENT_266	[p16l215t1349r497b1421],
5	had	VBD	O	have	_	0	SENT_266	[p16l520t1346r652b1403],
6	an	DT	O	a	det	9	SENT_266	[p16l674t1362r759b1403],
7	accelerated	VBN	O	accelerate	amod	9	SENT_266	[p16l782t1346r1174b1403],
8	5-FU	NN	O	5-fu	nn	9	SENT_266	[p16l1197t1348r1360b1403],
9	metabolism	NN	O	metabolism	dobj	5	SENT_266	[p16l1382t1346r1798b1403],
10	due	JJ	O	due	_	0	SENT_266	[p16l1821t1346r1947b1403],
11	to	TO	O	to	_	0	SENT_266	[p16l1970t1353r2040b1403],
12	an	DT	O	a	det	15	SENT_266	[p16l2063t1362r2148b1403],
13	enhanced	VBN	O	enhance	amod	15	SENT_266	[p16l11t1441r357b1499],
14	DPD	NN	O	dpd	nn	15	SENT_266	[p16l385t1444r542b1498],
15	activity	NN	O	activity	prep_due_to	9	SENT_266	[p16l572t1444r835b1517],
16	that	WDT	O	that	nsubj	17	SENT_266	[p16l860t1441r1003b1499],
17	follows	VBZ	O	follow	rcmod	15	SENT_266	[p16l1030t1441r1282b1499],
18	a	DT	O	a	det	20	SENT_266	[p16l1311t1458r1346b1499],
19	Gaussian	JJ	MISC	gaussian	amod	20	SENT_266	[p16l1374t1443r1690b1499],
20	curve	NN	O	curve	dobj	17	SENT_266	[p16l1719t1458r1908b1499],
21	in	IN	O	in	_	0	SENT_266	[p16l1937t1444r2007b1498],
22	the	DT	O	the	det	23	SENT_266	[p16l2034t1441r2147b1499],
23	population	NN	O	population	prep_in	20	SENT_266	[p16l10t1527r487b1610],
24	.	.	O	.	_	0	SENT_266	[p16l10t1527r487b1610],

1	”	NN	O	”	nsubj	5	SENT_267	[p16l10t1527r487b1610],
2	These	DT	O	these	det	3	SENT_267	[p16l515t1534r717b1592],
3	patients	NNS	O	patient	dep	1	SENT_267	[p16l745t1537r1027b1610],
4	would	MD	O	would	aux	5	SENT_267	[p16l1053t1534r1274b1592],
5	benefit	VB	O	benefit	_	0	SENT_267	[p16l1298t1534r1547b1592],
6	from	IN	O	from	_	0	SENT_267	[p16l1574t1534r1744b1592],
7	intensified	VBN	O	intensify	amod	8	SENT_267	[p16l1771t1534r2148b1592],
8	doses	NNS	O	dose	prep_from	5	SENT_267	[p16l11t1629r198b1686],
9	of	IN	O	of	_	0	SENT_267	[p16l228t1629r300b1686],
10	5-FU	NN	O	5-fu	prep_of	8	SENT_267	[p16l327t1631r508b1686],
11	.	.	O	.	_	0	SENT_267	[p16l327t1631r508b1686],

1	Likewise	RB	O	likewise	advmod	14	SENT_268	[p16l88t1723r402b1794],
2	,	,	O	,	_	0	SENT_268	[p16l88t1723r402b1794],
3	patients	NNS	O	patient	nsubj	14	SENT_268	[p16l431t1726r713b1799],
4	whose	WP$	O	whose	poss	6	SENT_268	[p16l736t1723r959b1781],
5	MT	NNP	O	MT	nn	6	SENT_268	[p16l981t1726r1105b1780],
6	HFR	NNP	O	HFR	dobj	13	SENT_268	[p16l1098t1726r1242b1780],
7	1298	CD	DATE	1298	dep	6	SENT_268	[p16l1274t1725r1438b1781],
8	A	DT	O	a	det	11	SENT_268	[p16l1463t1725r1577b1781],
9	>	JJR	O	>	amod	11	SENT_268	[p16l1463t1725r1577b1781],
10	C	NN	O	c	nn	11	SENT_268	[p16l1594t1725r1645b1781],
11	genotype	NN	O	genotype	nsubj	13	SENT_268	[p16l1670t1731r1996b1799],
12	was	VBD	O	be	cop	13	SENT_268	[p16l2019t1740r2147b1781],
13	C/C	NNP	O	C/C	rcmod	3	SENT_268	[p16l12t1818r149b1884],
14	were	VBD	O	be	_	0	SENT_268	[p16l195t1835r359b1876],
15	significantly	RB	O	significantly	advmod	14	SENT_268	[p16l410t1818r849b1894],
16	at	IN	O	at	_	0	SENT_268	[p16l896t1826r959b1876],
17	higher	JJR	O	higher	amod	18	SENT_268	[p16l1007t1818r1237b1894],
18	risk	NN	O	risk	prep_at	14	SENT_268	[p16l1285t1818r1409b1876],
19	of	IN	O	of	_	0	SENT_268	[p16l1456t1818r1528b1876],
20	toxicity	NN	O	toxicity	prep_of	18	SENT_268	[p16l1572t1821r1844b1894],
21	as	RB	O	as	_	0	SENT_268	[p16l1891t1835r1956b1876],
22	well	RB	O	well	_	0	SENT_268	[p16l2003t1818r2147b1876],
23	(	JJ	O	(	amod	24	SENT_268	[p16l14t1913r404b1985],
24	P	NN	O	p	prep_at	14	SENT_268	[p16l14t1913r404b1985],
25	=	JJ	O	=	amod	27	SENT_268	[p16l14t1913r404b1985],
26	0.018	CD	NUMBER	0.018	tmod	25	SENT_268	[p16l14t1913r404b1985],
27	)	NN	O	)	dep	24	SENT_268	[p16l14t1913r404b1985],
28	.	.	O	.	_	0	SENT_268	[p16l14t1913r404b1985],

1	On	IN	O	on	_	0	SENT_269	[p16l89t2010r195b2066],
2	the	DT	O	the	det	4	SENT_269	[p16l231t2008r344b2066],
3	other	JJ	O	other	amod	4	SENT_269	[p16l382t2008r570b2066],
4	hand	NN	O	hand	prep_on	6	SENT_269	[p16l605t2008r787b2066],
5	we	PRP	O	we	nsubj	6	SENT_269	[p16l821t2025r917b2066],
6	focused	VBD	O	focus	_	0	SENT_269	[p16l954t2008r1222b2066],
7	on	IN	O	on	_	0	SENT_269	[p16l1259t2025r1350b2066],
8	efficacy	NN	O	efficacy	prep_on	6	SENT_269	[p16l1386t2008r1665b2084],
9	.	.	O	.	_	0	SENT_269	[p16l1386t2008r1665b2084],

1	The	DT	O	the	det	3	SENT_270	[p16l1704t2008r1836b2066],
2	OR	NN	O	or	nn	3	SENT_270	[p16l1874t2010r1982b2066],
3	rate	NN	O	rate	nsubj	6	SENT_270	[p16l2016t2016r2146b2066],
4	was	VBD	O	be	cop	6	SENT_270	[p16l9t2120r136b2161],
5	32.9	CD	PERCENT	32.9	num	6	SENT_270	[p16l189t2105r424b2174],
6	%	NN	PERCENT	%	_	0	SENT_270	[p16l189t2105r424b2174],
7	,	,	O	,	_	0	SENT_270	[p16l189t2105r424b2174],
8	with	IN	O	with	_	0	SENT_270	[p16l477t2104r638b2161],
9	6.6	CD	PERCENT	6.6	num	10	SENT_270	[p16l689t2105r862b2161],
10	%	NN	PERCENT	%	prep_with	6	SENT_270	[p16l689t2105r862b2161],
11	of	IN	O	of	_	0	SENT_270	[p16l913t2103r984b2161],
12	complete	JJ	O	complete	amod	13	SENT_270	[p16l1030t2104r1355b2179],
13	responses	NNS	O	response	prep_of	10	SENT_270	[p16l1406t2120r1742b2179],
14	in	IN	O	in	_	0	SENT_270	[p16l1793t2107r1863b2161],
15	monotherapy	NN	O	monotherapy	prep_in	13	SENT_270	[p16l1913t2120r2147b2161, p16l10t2199r293b2275],
16	,	,	O	,	_	0	SENT_270	[p16l1913t2120r2147b2161, p16l10t2199r293b2275],
17	and	CC	O	and	_	0	SENT_270	[p16l349t2199r480b2257],
18	the	DT	O	the	det	20	SENT_270	[p16l531t2199r643b2257],
19	median	JJ	O	median	amod	20	SENT_270	[p16l695t2199r961b2257],
20	OS	NN	O	os	nsubj	27	SENT_270	[p16l1013t2201r1107b2257],
21	and	CC	O	and	_	0	SENT_270	[p16l1160t2199r1291b2257],
22	PFS	NN	O	pf	nsubj	27	SENT_270	[p16l1343t2201r1459b2257],
23	were	VBD	O	be	cop	27	SENT_270	[p16l1509t2216r1672b2257],
24	20	CD	NUMBER	20	number	27	SENT_270	[p16l1725t2201r1808b2257],
25	and	CC	O	and	_	0	SENT_270	[p16l1860t2199r1991b2257],
26	3.3	CD	DURATION	3.3	conj_and	6	SENT_270	[p16l2043t2201r2144b2257],
27	months	NNS	NUMBER	month	conj_and	6	SENT_270	[p16l11t2294r302b2364],
28	,	,	O	,	_	0	SENT_270	[p16l11t2294r302b2364],
29	respectively	RB	O	respectively	advmod	27	SENT_270	[p16l336t2294r764b2369],
30	.	.	O	.	_	0	SENT_270	[p16l336t2294r764b2369],

1	In	IN	O	in	_	0	SENT_271	[p16l88t2392r161b2446],
2	terms	NNS	O	term	prep_in	7	SENT_271	[p16l186t2396r382b2447],
3	of	IN	O	of	_	0	SENT_271	[p16l409t2389r481b2447],
4	response	NN	O	response	prep_of	2	SENT_271	[p16l502t2406r826b2465],
5	,	,	O	,	_	0	SENT_271	[p16l502t2406r826b2465],
6	we	PRP	O	we	nsubj	7	SENT_271	[p16l855t2406r951b2447],
7	found	VBD	O	find	_	0	SENT_271	[p16l978t2389r1189b2447],
8	that	IN	O	that	complm	15	SENT_271	[p16l1215t2389r1358b2447],
9	the	DT	O	the	det	11	SENT_271	[p16l1384t2389r1496b2447],
10	OR	NN	O	or	nn	11	SENT_271	[p16l1525t2391r1632b2447],
11	rate	NN	O	rate	nsubjpass	15	SENT_271	[p16l1656t2396r1787b2447],
12	for	IN	O	for	_	0	SENT_271	[p16l1814t2389r1912b2447],
13	3R/3R	NN	O	3r/3r	prep_for	11	SENT_271	[p16l1939t2389r2149b2454],
14	was	VBD	O	be	auxpass	15	SENT_271	[p16l9t2501r136b2542],
15	decreased	VBN	O	decrease	ccomp	7	SENT_271	[p16l183t2484r523b2542],
16	by	IN	O	by	_	0	SENT_271	[p16l566t2484r654b2560],
17	almost	RB	O	almost	quantmod	18	SENT_271	[p16l698t2484r933b2542],
18	50	CD	PERCENT	50	num	19	SENT_271	[p16l980t2486r1132b2542],
19	%	NN	PERCENT	%	agent	15	SENT_271	[p16l980t2486r1132b2542],
20	in	IN	O	in	_	0	SENT_271	[p16l1177t2487r1248b2541],
21	comparison	NN	O	comparison	prep_in	19	SENT_271	[p16l1293t2487r1709b2560],
22	with	IN	O	with	_	0	SENT_271	[p16l1753t2484r1914b2542],
23	other	JJ	O	other	amod	25	SENT_271	[p16l1960t2484r2149b2542],
24	TSER	NN	O	tser	nn	25	SENT_271	[p16l9t2580r186b2637],
25	genotypes	NNS	O	genotype	prep_with	15	SENT_271	[p16l226t2586r601b2655],
26	,	,	O	,	_	0	SENT_271	[p16l226t2586r601b2655],
27	as	IN	O	as	mark	28	SENT_271	[p16l650t2596r714b2637],
28	described	VBN	O	describe	advcl	15	SENT_271	[p16l758t2579r1089b2637],
29	in	IN	O	in	_	0	SENT_271	[p16l1131t2582r1201b2636],
30	previous	JJ	O	previous	amod	32	SENT_271	[p16l1243t2582r1542b2655],
31	clinical	JJ	O	clinical	amod	32	SENT_271	[p16l1586t2579r1840b2637],
32	studies	NNS	O	study	prep_in	28	SENT_271	[p16l1885t2579r2143b2637],
33	.	.	O	.	_	0	SENT_271	[p16l1885t2579r2143b2637],

1	Likewise	RB	O	likewise	advmod	13	SENT_272	[p16l11t2673r326b2744],
2	,	,	O	,	_	0	SENT_272	[p16l11t2673r326b2744],
3	although	IN	O	although	mark	6	SENT_272	[p16l364t2673r685b2749],
4	statistically	RB	O	statistically	advmod	6	SENT_272	[p16l720t2673r1118b2749],
5	not	RB	O	not	neg	6	SENT_272	[p16l1149t2681r1270b2731],
6	significant	JJ	O	significant	advcl	13	SENT_272	[p16l1304t2673r1692b2749],
7	,	,	O	,	_	0	SENT_272	[p16l1304t2673r1692b2749],
8	the	DT	O	the	det	10	SENT_272	[p16l1730t2673r1842b2731],
9	OR	NN	O	or	nn	10	SENT_272	[p16l1878t2675r1985b2731],
10	rate	NN	O	rate	nsubj	13	SENT_272	[p16l2016t2681r2147b2731],
11	was	VBD	O	be	cop	13	SENT_272	[p16l8t3170r135b3211],
12	24	CD	PERCENT	24	num	13	SENT_272	[p16l177t3154r329b3210],
13	%	NN	PERCENT	%	_	0	SENT_272	[p16l177t3154r329b3210],
14	versus	CC	O	versus	prep	13	SENT_272	[p16l366t3170r583b3211],
15	40.5	CD	PERCENT	40.5	num	16	SENT_272	[p16l624t3154r843b3211],
16	%	NN	PERCENT	%	dep	14	SENT_272	[p16l624t3154r843b3211],
17	in	IN	O	in	_	0	SENT_272	[p16l883t3156r953b3210],
18	‘	CD	NUMBER	‘	num	20	SENT_272	[p16l995t3153r1206b3229],
19	High	JJ	O	high	amod	20	SENT_272	[p16l995t3153r1206b3229],
20	’	NN	O	’	prep_in	16	SENT_272	[p16l995t3153r1206b3229],
21	compared	VBN	O	compare	_	0	SENT_272	[p16l1249t3153r1600b3229],
22	with	IN	O	with	prepc_compared_with	20	SENT_272	[p16l1637t3153r1799b3211],
23	‘	CD	NUMBER	‘	num	25	SENT_272	[p16l1840t3153r2025b3211],
24	Low	JJ	O	low	amod	25	SENT_272	[p16l1840t3153r2025b3211],
25	’	NN	O	’	pobj	20	SENT_272	[p16l1840t3153r2025b3211],
26	TS	NN	O	t	nn	27	SENT_272	[p16l2070t3154r2151b3211],
27	expression	NN	O	expression	dep	25	SENT_272	[p16l10t3251r401b3324],
28	.	.	O	.	_	0	SENT_272	[p16l10t3251r401b3324],

1	We	PRP	O	we	nsubj	2	SENT_273	[p16l85t3345r194b3400],
2	found	VBD	O	find	_	0	SENT_273	[p16l223t3342r435b3400],
3	no	DT	O	no	det	4	SENT_273	[p16l462t3359r553b3400],
4	difference	NN	O	difference	dobj	2	SENT_273	[p16l582t3342r931b3400],
5	between	IN	O	between	_	0	SENT_273	[p16l959t3343r1256b3400],
6	OS	NNP	O	OS	prep_between	4	SENT_273	[p16l1285t3344r1379b3400],
7	and	CC	O	and	_	0	SENT_273	[p16l1409t3342r1539b3400],
8	TS	NN	O	t	nn	9	SENT_273	[p16l1571t3344r1651b3400],
9	expression	NN	O	expression	conj_and	4	SENT_273	[p16l1678t3345r2051b3418],
10	in	IN	O	in	_	0	SENT_273	[p16l2079t3345r2149b3399],
11	contradiction	NN	O	contradiction	prep_in	9	SENT_273	[p16l10t3436r492b3494],
12	with	IN	O	with	_	0	SENT_273	[p16l552t3436r713b3494],
13	previously	RB	DATE	previously	advmod	14	SENT_273	[p16l775t3436r1144b3512],
14	described	VBN	O	describe	prepc_with	2	SENT_273	[p16l1204t3436r1535b3494],
15	resu1ts12	NN	O	resu1ts12	dobj	14	SENT_273	[p16l1597t3429r1970b3494],
16	'14	CD	NUMBER	'14	num	15	SENT_273	[p16l1597t3429r1970b3494],
17	but	CC	O	but	_	0	SENT_273	[p16l2031t3436r2149b3494],
18	interestingly	RB	O	interestingly	advmod	20	SENT_273	[p16l9t3531r458b3607],
19	we	PRP	O	we	nsubj	20	SENT_273	[p16l504t3548r600b3589],
20	found	VBD	O	find	rcmod	15	SENT_273	[p16l651t3531r863b3589],
21	that	IN	O	that	complm	44	SENT_273	[p16l912t3531r1055b3589],
22	an	DT	O	a	det	24	SENT_273	[p16l1105t3548r1190b3589],
23	OS	NN	O	os	nn	24	SENT_273	[p16l1242t3533r1336b3589],
24	rate	NN	O	rate	nsubj	44	SENT_273	[p16l1386t3539r1517b3589],
25	of	IN	O	of	_	0	SENT_273	[p16l1569t3531r1640b3589],
26	28	CD	PERCENT	28	num	27	SENT_273	[p16l1687t3533r1839b3589],
27	%	NN	PERCENT	%	prep_of	24	SENT_273	[p16l1687t3533r1839b3589],
28	for	IN	O	for	_	0	SENT_273	[p16l1889t3531r1987b3589],
29	the	DT	O	the	det	31	SENT_273	[p16l2036t3531r2148b3589],
30	whole	JJ	O	whole	amod	31	SENT_273	[p16l8t3627r223b3685],
31	population	NN	O	population	prep_for	27	SENT_273	[p16l263t3627r656b3703],
32	of	IN	O	of	_	0	SENT_273	[p16l697t3627r768b3685],
33	patients	NNS	O	patient	prep_of	27	SENT_273	[p16l803t3630r1104b3703],
34	,	,	O	,	_	0	SENT_273	[p16l803t3630r1104b3703],
35	sharing	VBG	O	share	partmod	27	SENT_273	[p16l1150t3627r1411b3703],
36	3R/3R	NN	O	3r/3r	nn	38	SENT_273	[p16l1451t3627r1662b3692],
37	TS	NN	O	t	nn	38	SENT_273	[p16l1704t3629r1784b3685],
38	genotype	NN	O	genotype	dobj	35	SENT_273	[p16l1823t3634r2149b3703],
39	associated	VBN	O	associate	partmod	38	SENT_273	[p16l10t3721r366b3779],
40	with	IN	O	with	_	0	SENT_273	[p16l407t3721r569b3779],
41	C/C	NN	O	c/c	prep_with	39	SENT_273	[p16l614t3721r751b3786],
42	for	IN	O	for	_	0	SENT_273	[p16l795t3721r894b3779],
43	677	CD	NUMBER	677	prep_for	27	SENT_273	[p16l938t3723r1062b3779],
44	C	NN	O	c	ccomp	20	SENT_273	[p16l1109t3723r1285b3779],
45	>	JJR	O	>	amod	46	SENT_273	[p16l1109t3723r1285b3779],
46	T	NN	O	t	dobj	44	SENT_273	[p16l1109t3723r1285b3779],
47	or	CC	O	or	_	0	SENT_273	[p16l1323t3738r1395b3779],
48	A/A	NN	O	a/a	dep	53	SENT_273	[p16l1436t3721r1569b3786],
49	for	IN	O	for	_	0	SENT_273	[p16l1611t3721r1710b3779],
50	1298	CD	DATE	1298	prep_for	48	SENT_273	[p16l1758t3723r1922b3779],
51	A	DT	O	a	det	53	SENT_273	[p16l1966t3723r2149b3779],
52	>	JJR	O	>	amod	53	SENT_273	[p16l1966t3723r2149b3779],
53	C	NN	O	c	conj_or	20	SENT_273	[p16l1966t3723r2149b3779],

1	was	VBD	O	be	cop	4	SENT_274	[p17l8t39r135b80],
2	significantly	RB	O	significantly	advmod	4	SENT_274	[p17l220t22r659b98],
3	far	RB	O	far	advmod	4	SENT_274	[p17l740t22r832b80],
4	shorter	JJR	O	shorter	_	0	SENT_274	[p17l915t23r1163b80],
5	than	IN	O	than	_	0	SENT_274	[p17l1244t23r1409b80],
6	that	DT	O	that	prep_than	4	SENT_274	[p17l1491t23r1635b80],
7	of	IN	O	of	_	0	SENT_274	[p17l1717t22r1788b80],
8	patients	NNS	O	patient	prep_of	6	SENT_274	[p17l1866t26r2149b98],
9	with	IN	O	with	_	0	SENT_274	[p17l8t118r169b176],
10	another	DT	O	another	det	11	SENT_274	[p17l207t118r485b176],
11	genotype	NN	O	genotype	prep_with	8	SENT_274	[p17l520t125r865b194],
12	,	,	O	,	_	0	SENT_274	[p17l520t125r865b194],
13	regardless	RB	O	regardless	_	0	SENT_274	[p17l907t118r1251b194],
14	of	IN	O	of	_	0	SENT_274	[p17l1290t118r1361b176],
15	its	PRP$	O	its	poss	18	SENT_274	[p17l1394t121r1473b176],
16	kind	NN	O	kind	nn	18	SENT_274	[p17l1511t118r1670b176],
17	(	CD	NUMBER	(	num	18	SENT_274	[p17l1710t118r2145b190],
18	P	NN	O	p	prep_regardless_of	21	SENT_274	[p17l1710t118r2145b190],
19	=	JJ	O	=	amod	21	SENT_274	[p17l1710t118r2145b190],
20	0.0065	CD	NUMBER	0.0065	num	21	SENT_274	[p17l1710t118r2145b190],
21	)	NN	O	)	appos	11	SENT_274	[p17l1710t118r2145b190],
22	.	.	O	.	_	0	SENT_274	[p17l1710t118r2145b190],

1	Figure	NNP	O	Figure	nsubj	3	SENT_275	[p17l10t216r224b289],
2	5	CD	NUMBER	5	num	1	SENT_275	[p17l277t216r311b271],
3	shows	VBZ	O	show	_	0	SENT_275	[p17l367t213r579b271],
4	the	DT	O	the	det	6	SENT_275	[p17l629t213r742b271],
5	striking	JJ	O	striking	amod	6	SENT_275	[p17l794t213r1061b289],
6	difference	NN	O	difference	dobj	3	SENT_275	[p17l1111t213r1459b271],
7	between	IN	O	between	_	0	SENT_275	[p17l1508t213r1806b271],
8	the	DT	O	the	det	10	SENT_275	[p17l1855t213r1968b271],
9	two	CD	NUMBER	two	num	10	SENT_275	[p17l2019t220r2149b271],
10	curves	NNS	O	curve	prep_between	6	SENT_275	[p17l10t325r249b378],
11	,	,	O	,	_	0	SENT_275	[p17l10t325r249b378],
12	with	IN	O	with	_	0	SENT_275	[p17l283t308r445b366],
13	a	DT	O	a	det	16	SENT_275	[p17l477t325r511b366],
14	median	JJ	O	median	amod	16	SENT_275	[p17l542t308r808b366],
15	survival	NN	O	survival	nn	16	SENT_275	[p17l841t308r1115b366],
16	rate	NN	O	rate	prep_with	3	SENT_275	[p17l1146t315r1277b366],
17	of	IN	O	of	_	0	SENT_275	[p17l1310t308r1381b366],
18	283	CD	NUMBER	283	prep_of	16	SENT_275	[p17l1410t309r1533b366],
19	versus	CC	O	versus	prep	18	SENT_275	[p17l1565t325r1782b366],
20	842	CD	DURATION	842	num	21	SENT_275	[p17l1815t309r1942b366],
21	days	NNS	NUMBER	day	dep	19	SENT_275	[p17l1973t308r2144b384],
22	,	,	O	,	_	0	SENT_275	[p17l1973t308r2144b384],
23	respectively	RB	O	respectively	advmod	3	SENT_275	[p17l9t403r438b479],
24	.	.	O	.	_	0	SENT_275	[p17l9t403r438b479],

1	The	DT	O	the	det	4	SENT_276	[p17l470t403r602b461],
2	other	JJ	O	other	amod	4	SENT_276	[p17l634t403r822b461],
3	major	JJ	O	major	amod	4	SENT_276	[p17l851t406r1058b479],
4	interest	NN	O	interest	nsubj	8	SENT_276	[p17l1087t406r1352b461],
5	of	IN	O	of	_	0	SENT_276	[p17l1382t403r1453b461],
6	this	DT	O	this	det	7	SENT_276	[p17l1479t403r1608b461],
7	finding	NN	O	finding	prep_of	4	SENT_276	[p17l1638t403r1898b479],
8	is	VBZ	O	be	_	0	SENT_276	[p17l1926t406r1977b461],
9	that	IN	O	that	complm	20	SENT_276	[p17l2006t403r2150b461],
10	clearly	RB	O	clearly	advmod	20	SENT_276	[p17l10t497r242b573],
11	the	DT	O	the	det	13	SENT_276	[p17l272t497r384b555],
12	OS	NNP	O	OS	nn	13	SENT_276	[p17l420t499r514b555],
13	rate	NN	O	rate	nsubj	20	SENT_276	[p17l548t505r678b555],
14	of	IN	O	of	_	0	SENT_276	[p17l712t497r784b555],
15	this	DT	O	this	det	16	SENT_276	[p17l812t498r942b555],
16	population	NN	O	population	prep_of	13	SENT_276	[p17l974t497r1367b573],
17	of	IN	O	of	_	0	SENT_276	[p17l1401t497r1472b555],
18	patients	NNS	O	patient	prep_of	16	SENT_276	[p17l1499t500r1781b573],
19	remained	VBD	O	remain	cop	20	SENT_276	[p17l1815t497r2150b555],
20	poor	JJ	O	poor	ccomp	8	SENT_276	[p17l9t610r173b669],
21	despite	IN	O	despite	_	0	SENT_276	[p17l243t593r491b669],
22	the	DT	O	the	det	25	SENT_276	[p17l562t593r674b651],
23	second-line	JJ	O	second-line	amod	25	SENT_276	[p17l747t593r1151b651],
24	combined	JJ	O	combined	amod	25	SENT_276	[p17l1223t593r1578b651],
25	therapy	NN	O	therapy	prep_despite	20	SENT_276	[p17l1649t593r1922b669],
26	with	IN	O	with	_	0	SENT_276	[p17l1988t593r2150b651],
27	oxaliplatin	NN	O	oxaliplatin	prep_with	20	SENT_276	[p17l10t687r394b763],
28	or	CC	O	or	_	0	SENT_276	[p17l433t704r505b745],
29	irinotecan	NN	O	irinotecan	conj_or	27	SENT_276	[p17l542t690r923b745],
30	.	.	O	.	_	0	SENT_276	[p17l542t690r923b745],

1	Thus	RB	O	thus	advmod	16	SENT_277	[p17l964t687r1155b758],
2	,	,	O	,	_	0	SENT_277	[p17l964t687r1155b758],
3	an	DT	O	a	det	4	SENT_277	[p17l1200t704r1285b745],
4	initial	JJ	O	initial	nsubj	16	SENT_277	[p17l1323t688r1533b745],
5	intensified	VBN	O	intensify	partmod	4	SENT_277	[p17l1572t687r1950b745],
6	firstline	NN	O	firstline	nn	7	SENT_277	[p17l1988t687r2148b745, p17l9t783r141b840],
7	therapy	NN	O	therapy	dobj	5	SENT_277	[p17l176t783r458b858],
8	,	,	O	,	_	0	SENT_277	[p17l176t783r458b858],
9	with	IN	O	with	_	0	SENT_277	[p17l495t783r656b840],
10	a	DT	O	a	det	12	SENT_277	[p17l691t799r726b840],
11	targeted	VBN	O	target	amod	12	SENT_277	[p17l760t783r1046b858],
12	therapy	NN	O	therapy	prep_with	5	SENT_277	[p17l1080t783r1353b858],
13	would	MD	O	would	aux	16	SENT_277	[p17l1382t783r1604b840],
14	probably	RB	O	probably	advmod	16	SENT_277	[p17l1637t783r1952b858],
15	have	VB	O	have	aux	16	SENT_277	[p17l1983t783r2148b840],
16	been	VBN	O	be	_	0	SENT_277	[p17l7t877r177b934],
17	of	IN	O	of	_	0	SENT_277	[p17l207t877r279b934],
18	interest	NN	O	interest	prep_of	16	SENT_277	[p17l304t880r586b934],
19	.	.	O	.	_	0	SENT_277	[p17l304t880r586b934],

1	These	DT	O	these	det	2	SENT_278	[p17l84t972r286b1029],
2	results	NNS	O	result	nsubj	12	SENT_278	[p17l310t972r553b1042],
3	,	,	O	,	_	0	SENT_278	[p17l310t972r553b1042],
4	both	CC	O	both	dep	2	SENT_278	[p17l579t972r746b1029],
5	in	IN	O	in	_	0	SENT_278	[p17l769t975r839b1029],
6	terms	NNS	O	term	prep_in	7	SENT_278	[p17l862t979r1058b1029],
7	of	IN	O	of	conj	2	SENT_278	[p17l1082t971r1154b1029],
8	tolerance	NN	O	tolerance	pobj	7	SENT_278	[p17l1172t972r1498b1029],
9	and	CC	O	and	_	0	SENT_278	[p17l1523t972r1654b1029],
10	efficacy	NN	O	efficacy	pobj	7	SENT_278	[p17l1677t971r1955b1047],
11	,	,	O	,	_	0	SENT_278	[p17l1677t971r1955b1047],
12	have	VBP	O	have	_	0	SENT_278	[p17l1984t972r2149b1029],
13	a	DT	O	a	det	15	SENT_278	[p17l10t1084r45b1125],
14	crucial	JJ	O	crucial	amod	15	SENT_278	[p17l83t1067r317b1125],
15	impact	NN	O	impact	dobj	12	SENT_278	[p17l355t1070r599b1143],
16	on	IN	O	on	_	0	SENT_278	[p17l637t1084r729b1125],
17	clinical	JJ	O	clinical	amod	18	SENT_278	[p17l767t1067r1022b1125],
18	practice	NN	O	practice	prep_on	15	SENT_278	[p17l1060t1070r1355b1143],
19	.	.	O	.	_	0	SENT_278	[p17l1060t1070r1355b1143],

1	First	RB	ORDINAL	first	advmod	17	SENT_279	[p17l1398t1070r1564b1137],
2	,	,	O	,	_	0	SENT_279	[p17l1398t1070r1564b1137],
3	indeed	RB	O	indeed	advmod	17	SENT_279	[p17l1607t1067r1864b1138],
4	,	,	O	,	_	0	SENT_279	[p17l1607t1067r1864b1138],
5	from	IN	O	from	_	0	SENT_279	[p17l1906t1067r2076b1125],
6	a	DT	O	a	det	9	SENT_279	[p17l2115t1084r2150b1125],
7	simple	JJ	O	simple	amod	9	SENT_279	[p17l11t1162r240b1238],
8	blood	NN	O	blood	nn	9	SENT_279	[p17l263t1162r467b1220],
9	sample	NN	O	sample	prep_from	17	SENT_279	[p17l493t1162r737b1238],
10	taken	VBN	O	take	partmod	9	SENT_279	[p17l761t1162r956b1220],
11	before	IN	O	before	_	0	SENT_279	[p17l978t1162r1198b1220],
12	chemotherapy	NN	O	chemotherapy	prep_before	10	SENT_279	[p17l1223t1162r1749b1238],
13	,	,	O	,	_	0	SENT_279	[p17l1223t1162r1749b1238],
14	physicians	NNS	O	physician	nsubjpass	17	SENT_279	[p17l1777t1162r2149b1238],
15	can	MD	O	can	aux	17	SENT_279	[p17l10t1274r132b1315],
16	be	VB	O	be	auxpass	17	SENT_279	[p17l188t1257r268b1315],
17	warned	VBN	O	warn	ccomp	64	SENT_279	[p17l326t1257r588b1315],
18	of	IN	O	of	_	0	SENT_279	[p17l646t1257r718b1315],
19	a	DT	O	a	det	21	SENT_279	[p17l772t1274r807b1315],
20	high	JJ	O	high	amod	21	SENT_279	[p17l864t1257r1026b1333],
21	risk	NN	O	risk	prep_of	17	SENT_279	[p17l1085t1257r1209b1315],
22	of	IN	O	of	_	0	SENT_279	[p17l1266t1257r1337b1315],
23	severe	JJ	O	severe	amod	43	SENT_279	[p17l1393t1274r1604b1315],
24	or	CC	O	or	_	0	SENT_279	[p17l1664t1274r1735b1315],
25	even	RB	O	even	advmod	26	SENT_279	[p17l1793t1274r1957b1315],
26	lifethreatening	VBG	O	lifethreaten	amod	43	SENT_279	[p17l2015t1257r2148b1315, p17l9t1352r425b1428],
27	toxicity	NN	O	toxicity	dobj	26	SENT_279	[p17l475t1355r748b1428],
28	for	IN	O	for	_	0	SENT_279	[p17l797t1352r895b1410],
29	a	DT	O	a	det	30	SENT_279	[p17l947t1369r981b1410],
30	patient	NN	O	patient	prep_for	27	SENT_279	[p17l1032t1355r1301b1428],
31	,	,	O	,	_	0	SENT_279	[p17l1032t1355r1301b1428],
32	that	WDT	O	that	nsubj	35	SENT_279	[p17l1357t1352r1500b1410],
33	is	VBZ	O	be	cop	35	SENT_279	[p17l1551t1355r1602b1410],
34	relevant	JJ	O	relevant	amod	35	SENT_279	[p17l1654t1352r1940b1410],
35	DPD	NN	O	dpd	rcmod	30	SENT_279	[p17l1988t1355r2150b1409],
36	and/or	JJ	O	and/or	amod	38	SENT_279	[p17l10t1446r246b1512],
37	MTHFR	NN	O	mthfr	nn	38	SENT_279	[p17l270t1449r532b1503],
38	variants	NNS	O	variant	npadvmod	35	SENT_279	[p17l558t1449r839b1504],
39	regardless	RB	O	regardless	_	0	SENT_279	[p17l868t1446r1211b1522],
40	of	IN	O	of	_	0	SENT_279	[p17l1241t1446r1312b1504],
41	the	DT	O	the	det	42	SENT_279	[p17l1335t1446r1448b1504],
42	5-FU	NN	O	5-fu	prep_regardless_of	35	SENT_279	[p17l1478t1449r1641b1504],
43	regimens	NNS	O	regimen	prep_of	21	SENT_279	[p17l1669t1449r1989b1522],
44	and	CC	O	and	_	0	SENT_279	[p17l2019t1446r2150b1504],
45	the	DT	O	the	det	46	SENT_279	[p17l9t1540r122b1598],
46	type	NN	O	type	nsubj	51	SENT_279	[p17l152t1547r302b1616],
47	of	IN	O	of	_	0	SENT_279	[p17l334t1540r405b1598],
48	cancer	NN	O	cancer	prep_of	46	SENT_279	[p17l431t1533r822b1598],
49	.23	CD	NUMBER	.23	number	50	SENT_279	[p17l431t1533r822b1598],
50	'29	CD	NUMBER	'29	num	48	SENT_279	[p17l431t1533r822b1598],
51	Taking	VBG	O	take	conj_and	17	SENT_279	[p17l851t1540r1089b1616],
52	into	IN	O	into	_	0	SENT_279	[p17l1118t1543r1261b1598],
53	account	NN	O	account	prep_into	51	SENT_279	[p17l1292t1547r1573b1598],
54	the	DT	O	the	det	56	SENT_279	[p17l1602t1540r1715b1598],
55	wide	JJ	O	wide	amod	56	SENT_279	[p17l1743t1540r1909b1598],
56	use	NN	O	use	dobj	51	SENT_279	[p17l1938t1557r2051b1598],
57	of	IN	O	of	_	0	SENT_279	[p17l2082t1540r2153b1598],
58	5-FU	NN	O	5-fu	nn	61	SENT_279	[p17l11t1638r174b1693],
59	and	CC	O	and	_	0	SENT_279	[p17l206t1635r337b1693],
60	other	JJ	O	other	nn	61	SENT_279	[p17l369t1635r557b1693],
61	ﬂuoropyrimidines	NNS	O	ﬂuoropyrimidines	prep_of	56	SENT_279	[p17l587t1635r1246b1711],
62	,	,	O	,	_	0	SENT_279	[p17l587t1635r1246b1711],
63	this	DT	O	this	nsubj	64	SENT_279	[p17l1283t1635r1412b1693],
64	is	VBZ	O	be	_	0	SENT_279	[p17l1444t1638r1494b1693],
65	of	IN	O	of	_	0	SENT_279	[p17l1527t1635r1598b1693],
66	major	JJ	O	major	amod	67	SENT_279	[p17l1624t1638r1832b1711],
67	interest	NN	O	interest	prep_of	64	SENT_279	[p17l1862t1638r2145b1693],
68	.	.	O	.	_	0	SENT_279	[p17l1862t1638r2145b1693],

1	In	IN	O	in	_	0	SENT_280	[p17l10t1733r83b1788],
2	practice	NN	O	practice	prep_in	22	SENT_280	[p17l117t1734r412b1806],
3	,	,	O	,	_	0	SENT_280	[p17l117t1734r412b1806],
4	in	IN	O	in	_	0	SENT_280	[p17l453t1734r524b1788],
5	cases	NNS	O	case	prep_in	6	SENT_280	[p17l560t1747r732b1788],
6	of	IN	O	of	nsubjpass	22	SENT_280	[p17l768t1730r840b1788],
7	a	DT	O	a	det	9	SENT_280	[p17l873t1747r907b1788],
8	DPD	NN	O	dpd	nn	9	SENT_280	[p17l943t1733r1101b1788],
9	deficiency	NN	O	deficiency	pobj	6	SENT_280	[p17l1138t1730r1510b1806],
10	,	,	O	,	_	0	SENT_280	[p17l1138t1730r1510b1806],
11	either	CC	O	either	dep	6	SENT_280	[p17l1551t1731r1757b1788],
12	5-FU	NN	O	5-fu	nn	14	SENT_280	[p17l1793t1733r1956b1788],
13	dose	NN	O	dose	nn	14	SENT_280	[p17l1993t1731r2149b1788],
14	management	NN	O	management	conj	6	SENT_280	[p17l9t1833r476b1902],
15	based	VBN	O	base	partmod	14	SENT_280	[p17l504t1826r701b1884],
16	on	IN	O	on	_	0	SENT_280	[p17l731t1843r823b1884],
17	a	DT	O	a	det	19	SENT_280	[p17l853t1843r888b1884],
18	pharmacokinetic	JJ	O	pharmacokinetic	amod	19	SENT_280	[p17l917t1826r1518b1902],
19	follow-up	NN	O	follow-up	prep_on	15	SENT_280	[p17l1547t1826r1888b1902],
20	can	MD	O	can	aux	22	SENT_280	[p17l1918t1843r2041b1884],
21	be	VB	O	be	auxpass	22	SENT_280	[p17l2068t1826r2148b1884],
22	proposed	VBN	O	propose	_	0	SENT_280	[p17l9t1921r334b1996],
23	after	IN	O	after	_	0	SENT_280	[p17l365t1920r523b1978],
24	a	DT	O	a	det	27	SENT_280	[p17l553t1937r588b1978],
25	reduced	VBN	O	reduce	amod	27	SENT_280	[p17l619t1921r898b1978],
26	first	JJ	ORDINAL	first	amod	27	SENT_280	[p17l928t1920r1064b1978],
27	dose	NN	O	dose	prep_after	22	SENT_280	[p17l1094t1921r1250b1978],
28	of	IN	O	of	_	0	SENT_280	[p17l1282t1920r1354b1978],
29	5	CD	NUMBER	5	prep_of	27	SENT_280	[p17l1382t1923r1545b1978],
30	.	.	O	.	_	0	SENT_280	[p17l1382t1923r1545b1978],

1	—	NN	O	—	_	0	SENT_281	[p17l1382t1923r1545b1978],
2	.	.	O	.	_	0	SENT_281	[p17l1382t1923r1545b1978],

1	FU	NN	O	fu	nsubj	30	SENT_282	[p17l1382t1923r1545b1978],
2	or	CC	O	or	_	0	SENT_282	[p17l1576t1937r1648b1978],
3	the	DT	O	the	det	4	SENT_282	[p17l1676t1921r1789b1978],
4	switch	NN	O	switch	conj_or	1	SENT_282	[p17l1822t1921r2049b1978],
5	to	TO	O	to	_	0	SENT_282	[p17l2079t1928r2149b1978],
6	another	DT	O	another	det	7	SENT_282	[p17l10t2014r288b2072],
7	drug	NN	O	drug	prep_to	4	SENT_282	[p17l326t2014r503b2090],
8	,	,	O	,	_	0	SENT_282	[p17l326t2014r503b2090],
9	such	JJ	O	such	mwe	10	SENT_282	[p17l547t2014r707b2072],
10	as	IN	O	as	conj_or	1	SENT_282	[p17l746t2031r811b2072],
11	raltitrexed	JJ	O	raltitrexed	amod	12	SENT_282	[p17l849t2007r1302b2072],
12	.29	CD	NUMBER	.29	pobj	10	SENT_282	[p17l849t2007r1302b2072],
13	In	IN	O	in	_	0	SENT_282	[p17l1342t2017r1415b2071],
14	the	DT	O	the	det	15	SENT_282	[p17l1452t2014r1565b2072],
15	case	NN	O	case	prep_in	30	SENT_282	[p17l1604t2031r1744b2072],
16	of	IN	O	of	_	0	SENT_282	[p17l1784t2014r1856b2072],
17	MT	NNP	O	MT	nn	18	SENT_282	[p17l1886t2017r2011b2071],
18	HFR	NNP	O	HFR	prep_of	15	SENT_282	[p17l2003t2017r2148b2071],
19	1298	CD	DATE	1298	num	18	SENT_282	[p17l15t2112r179b2168],
20	A	DT	O	a	det	24	SENT_282	[p17l208t2112r391b2168],
21	>	JJR	O	>	dep	22	SENT_282	[p17l208t2112r391b2168],
22	C	NN	O	c	amod	24	SENT_282	[p17l208t2112r391b2168],
23	homozygote	NN	O	homozygote	nn	24	SENT_282	[p17l420t2110r861b2186],
24	variant	NN	O	variant	nsubj	30	SENT_282	[p17l888t2113r1156b2180],
25	,	,	O	,	_	0	SENT_282	[p17l888t2113r1156b2180],
26	the	DT	O	the	det	27	SENT_282	[p17l1190t2110r1302b2168],
27	toxicity	NN	O	toxicity	appos	24	SENT_282	[p17l1331t2113r1604b2186],
28	is	VBZ	O	be	cop	30	SENT_282	[p17l1630t2113r1681b2168],
29	not	RB	O	not	neg	30	SENT_282	[p17l1710t2117r1831b2168],
30	due	JJ	O	due	_	0	SENT_282	[p17l1860t2110r1986b2168],
31	to	TO	O	to	_	0	SENT_282	[p17l2015t2117r2085b2168],
32	a	DT	O	a	det	34	SENT_282	[p17l2115t2127r2150b2168],
33	metabolic	JJ	O	metabolic	amod	34	SENT_282	[p17l9t2205r360b2263],
34	deficiency	NN	O	deficiency	prep_to	30	SENT_282	[p17l392t2205r764b2281],
35	.	.	O	.	_	0	SENT_282	[p17l392t2205r764b2281],

1	Then	RB	O	then	dep	3	SENT_283	[p17l798t2205r983b2263],
2	a	DT	O	a	det	3	SENT_283	[p17l1015t2222r1050b2263],
3	5	CD	NUMBER	5	_	0	SENT_283	[p17l1083t2207r1246b2263],
4	.	.	O	.	_	0	SENT_283	[p17l1083t2207r1246b2263],

1	—	NN	O	—	_	0	SENT_284	[p17l1083t2207r1246b2263],
2	.	.	O	.	_	0	SENT_284	[p17l1083t2207r1246b2263],

1	FU	NNP	O	FU	nn	3	SENT_285	[p17l1083t2207r1246b2263],
2	dose	NN	O	dose	nn	3	SENT_285	[p17l1279t2205r1435b2263],
3	reduction	NN	O	reduction	nsubj	9	SENT_285	[p17l1467t2205r1811b2263],
4	could	MD	O	could	aux	6	SENT_285	[p17l1843t2205r2039b2263],
5	be	VB	O	be	cop	6	SENT_285	[p17l2068t2205r2148b2263],
6	useful	JJ	O	useful	_	0	SENT_285	[p17l8t2299r219b2357],
7	but	CC	O	but	_	0	SENT_285	[p17l253t2299r372b2357],
8	might	MD	O	might	aux	9	SENT_285	[p17l408t2299r621b2375],
9	impact	VB	O	impact	conj_but	6	SENT_285	[p17l657t2302r901b2375],
10	the	DT	O	the	det	11	SENT_285	[p17l937t2299r1049b2357],
11	efficacy	NN	O	efficacy	dobj	9	SENT_285	[p17l1087t2299r1366b2375],
12	.	.	O	.	_	0	SENT_285	[p17l1087t2299r1366b2375],

1	Thus	RB	O	thus	advmod	9	SENT_286	[p17l1405t2299r1596b2370],
2	,	,	O	,	_	0	SENT_286	[p17l1405t2299r1596b2370],
3	a	DT	O	a	det	6	SENT_286	[p17l1637t2316r1672b2357],
4	much	RB	O	much	advmod	5	SENT_286	[p17l1708t2299r1911b2357],
5	closer	JJR	O	closer	amod	6	SENT_286	[p17l1948t2299r2150b2357],
6	follow-up	NN	O	follow-up	nsubjpass	9	SENT_286	[p17l9t2395r348b2471],
7	will	MD	O	will	aux	9	SENT_286	[p17l375t2395r505b2452],
8	be	VB	O	be	auxpass	9	SENT_286	[p17l530t2395r611b2453],
9	proposed	VBN	O	propose	_	0	SENT_286	[p17l638t2395r964b2471],
10	and	CC	O	and	_	0	SENT_286	[p17l992t2395r1123b2453],
11	a	DT	O	a	det	13	SENT_286	[p17l1151t2412r1185b2453],
12	dose	NN	O	dose	nn	13	SENT_286	[p17l1213t2395r1368b2453],
13	reduction	NN	O	reduction	conj_and	9	SENT_286	[p17l1397t2395r1740b2453],
14	at	IN	O	at	_	0	SENT_286	[p17l1768t2402r1832b2453],
15	the	DT	O	the	det	17	SENT_286	[p17l1859t2395r1971b2453],
16	very	JJ	O	very	amod	17	SENT_286	[p17l1997t2412r2151b2471],
17	beginning	NN	O	beginning	prep_at	13	SENT_286	[p17l6t2490r370b2566],
18	of	IN	O	of	_	0	SENT_286	[p17l399t2490r470b2548],
19	a	DT	O	a	det	22	SENT_286	[p17l497t2507r531b2548],
20	relevant	JJ	O	relevant	amod	22	SENT_286	[p17l560t2490r847b2548],
21	adverse	JJ	O	adverse	amod	22	SENT_286	[p17l877t2490r1136b2548],
22	event	NN	O	event	prep_of	17	SENT_286	[p17l1167t2497r1378b2548],
23	.	.	O	.	_	0	SENT_286	[p17l1167t2497r1378b2548],

1	Besides	IN	O	besides	advmod	17	SENT_287	[p17l86t2584r355b2655],
2	,	,	O	,	_	0	SENT_287	[p17l86t2584r355b2655],
3	the	DT	O	the	det	4	SENT_287	[p17l391t2584r503b2642],
4	question	NN	O	question	nsubj	17	SENT_287	[p17l537t2587r843b2660],
5	of	IN	O	of	_	0	SENT_287	[p17l876t2584r948b2642],
6	the	DT	O	the	dep	7	SENT_287	[p17l975t2585r1087b2642],
7	one	CD	NUMBER	one	prep_of	4	SENT_287	[p17l1120t2601r1249b2642],
8	or	CC	O	or	_	0	SENT_287	[p17l1283t2601r1354b2642],
9	two	CD	NUMBER	two	conj_or	7	SENT_287	[p17l1384t2592r1515b2642],
10	even	RB	O	even	advmod	4	SENT_287	[p17l1548t2601r1713b2642],
11	three	CD	NUMBER	three	num	12	SENT_287	[p17l1744t2584r1924b2642],
12	drugs	NNS	O	drug	pobj	10	SENT_287	[p17l1958t2584r2148b2660],
13	in	IN	O	in	_	0	SENT_287	[p17l9t2682r79b2736],
14	first-line	JJ	O	first-line	amod	15	SENT_287	[p17l117t2679r413b2737],
15	therapy	NN	O	therapy	prep_in	10	SENT_287	[p17l452t2679r725b2755],
16	remains	VBZ	O	remain	cop	17	SENT_287	[p17l760t2682r1039b2737],
17	unresolved	JJ	O	unresolved	_	0	SENT_287	[p17l1077t2679r1484b2750],
18	,	,	O	,	_	0	SENT_287	[p17l1077t2679r1484b2750],
19	except	IN	O	except	dep	17	SENT_287	[p17l1527t2687r1756b2755],
20	in	IN	O	in	_	0	SENT_287	[p17l1793t2682r1864b2736],
21	case	NN	O	case	_	0	SENT_287	[p17l1902t2696r2042b2737],
22	of	IN	O	of	_	0	SENT_287	[p17l2081t2679r2153b2737],
23	selected	VBN	O	select	amod	24	SENT_287	[p17l10t2775r287b2833],
24	patients	NNS	O	patient	prep_in_case_of	17	SENT_287	[p17l308t2778r609b2851],
25	,	,	O	,	_	0	SENT_287	[p17l308t2778r609b2851],
26	such	JJ	O	such	_	0	SENT_287	[p17l637t2775r798b2833],
27	as	IN	O	as	_	0	SENT_287	[p17l821t2792r885b2833],
28	those	DT	O	those	prep_such_as	24	SENT_287	[p17l908t2775r1097b2833],
29	with	IN	O	with	_	0	SENT_287	[p17l1118t2775r1280b2833],
30	potentially	RB	O	potentially	advmod	31	SENT_287	[p17l1301t2775r1691b2851],
31	resectable	JJ	O	resectable	amod	38	SENT_287	[p17l1710t2775r2054b2833],
32	or	CC	O	or	_	0	SENT_287	[p17l2078t2792r2149b2833],
33	curable	JJ	O	curable	amod	38	SENT_287	[p17l9t2870r263b2927],
34	liver	NN	O	liver	nn	38	SENT_287	[p17l301t2870r456b2927],
35	and/or	NN	O	and/or	nn	38	SENT_287	[p17l493t2869r729b2935],
36	lung	NN	O	lung	nn	38	SENT_287	[p17l764t2870r924b2945],
37	metastatic	JJ	O	metastatic	amod	38	SENT_287	[p17l960t2873r1324b2927],
38	disease	NN	O	disease	prep_with	28	SENT_287	[p17l1361t2870r1622b2927],
39	.	.	O	.	_	0	SENT_287	[p17l1361t2870r1622b2927],

1	For	IN	O	for	_	0	SENT_288	[p17l1664t2872r1775b2927],
2	the	DT	O	the	det	4	SENT_288	[p17l1811t2870r1923b2927],
3	other	JJ	O	other	amod	4	SENT_288	[p17l1961t2870r2150b2927],
4	ones	NNS	O	one	prep_for	18	SENT_288	[p17l9t2982r187b3035],
5	,	,	O	,	_	0	SENT_288	[p17l9t2982r187b3035],
6	who	WP	O	who	nsubj	7	SENT_288	[p17l223t2965r376b3023],
7	represent	VBP	O	represent	rcmod	4	SENT_288	[p17l409t2972r736b3041],
8	the	DT	O	the	det	9	SENT_288	[p17l767t2965r880b3023],
9	majority	NN	O	majority	dobj	7	SENT_288	[p17l914t2968r1217b3041],
10	of	IN	O	of	_	0	SENT_288	[p17l1248t2965r1319b3023],
11	the	DT	O	the	det	12	SENT_288	[p17l1347t2965r1460b3023],
12	patients	NNS	O	patient	prep_of	9	SENT_288	[p17l1493t2968r1793b3041],
13	,	,	O	,	_	0	SENT_288	[p17l1493t2968r1793b3041],
14	intensification	NN	O	intensification	nsubj	18	SENT_288	[p17l1830t2965r2148b3023, p17l9t3063r230b3118],
15	has	VBZ	O	have	aux	18	SENT_288	[p17l261t3060r377b3118],
16	not	RB	O	not	neg	18	SENT_288	[p17l409t3067r530b3118],
17	clearly	RB	O	clearly	advmod	18	SENT_288	[p17l562t3060r794b3136],
18	proved	VBD	O	prove	_	0	SENT_288	[p17l822t3060r1068b3136],
19	its	PRP$	O	its	poss	20	SENT_288	[p17l1098t3063r1178b3118],
20	superiority	NN	O	superiority	dobj	18	SENT_288	[p17l1212t3063r1594b3136],
21	in	IN	O	in	_	0	SENT_288	[p17l1623t3063r1694b3117],
22	terms	NNS	O	term	prep_in	18	SENT_288	[p17l1725t3067r1921b3118],
23	of	IN	O	of	_	0	SENT_288	[p17l1953t3060r2025b3118],
24	OS	NN	O	os	prep_of	22	SENT_288	[p17l2053t3062r2148b3118],
25	and	CC	O	and	_	0	SENT_288	[p17l9t3155r141b3212],
26	has	VBZ	O	have	aux	27	SENT_288	[p17l204t3155r320b3212],
27	shown	VBN	O	show	conj_and	18	SENT_288	[p17l386t3155r618b3212],
28	an	DT	O	a	det	30	SENT_288	[p17l683t3171r768b3212],
29	increased	VBN	O	increase	amod	30	SENT_288	[p17l832t3155r1162b3212],
30	frequency	NN	O	frequency	dobj	27	SENT_288	[p17l1226t3154r1580b3230],
31	of	IN	O	of	_	0	SENT_288	[p17l1642t3154r1714b3212],
32	toxic	JJ	O	toxic	amod	34	SENT_288	[p17l1773t3158r1949b3212],
33	side	JJ	O	side	amod	34	SENT_288	[p17l2015t3155r2148b3212],
34	effects	NNS	O	effect	prep_of	30	SENT_288	[p17l9t3241r401b3306],
35	.27	CD	NUMBER	.27	number	36	SENT_288	[p17l9t3241r401b3306],
36	'28	CD	NUMBER	'28	num	37	SENT_288	[p17l9t3241r401b3306],
37	Pharmacognenomics	NNS	O	pharmacognenomic	nsubj	41	SENT_288	[p17l478t3248r1220b3324],
38	and	CC	O	and	_	0	SENT_288	[p17l1297t3248r1428b3306],
39	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	37	SENT_288	[p17l1502t3248r2147b3324],
40	could	MD	O	could	aux	41	SENT_288	[p17l9t3344r205b3401],
41	help	VB	O	help	rcmod	34	SENT_288	[p17l244t3343r398b3419],
42	the	DT	O	the	det	43	SENT_288	[p17l437t3343r549b3401],
43	clinician	NN	O	clinician	dobj	41	SENT_288	[p17l590t3343r895b3401],
44	to	TO	O	to	aux	45	SENT_288	[p17l934t3351r1004b3401],
45	decide	VB	O	decide	infmod	43	SENT_288	[p17l1044t3343r1269b3401],
46	whether	IN	O	whether	complm	50	SENT_288	[p17l1307t3343r1602b3401],
47	or	CC	O	or	_	0	SENT_288	[p17l1640t3360r1712b3401],
48	not	RB	O	not	conj_or	50	SENT_288	[p17l1749t3351r1870b3401],
49	he	PRP	O	he	nsubj	50	SENT_288	[p17l1908t3344r1992b3401],
50	has	VBZ	O	have	ccomp	45	SENT_288	[p17l2032t3343r2148b3401],
51	to	TO	O	to	aux	52	SENT_288	[p17l9t3446r78b3497],
52	intensify	VB	O	intensify	xcomp	50	SENT_288	[p17l142t3439r455b3515],
53	the	DT	O	the	det	55	SENT_288	[p17l515t3439r628b3497],
54	chemotherapy	NN	O	chemotherapy	nn	55	SENT_288	[p17l693t3439r1209b3515],
55	regimen	NN	O	regimen	dobj	52	SENT_288	[p17l1269t3442r1577b3515],
56	.	.	O	.	_	0	SENT_288	[p17l1269t3442r1577b3515],

1	As	IN	O	as	_	0	SENT_289	[p17l1644t3440r1724b3497],
2	such	JJ	O	such	prep_such_as	30	SENT_289	[p17l1790t3439r1967b3509],
3	,	,	O	,	_	0	SENT_289	[p17l1790t3439r1967b3509],
4	the	DT	O	the	det	5	SENT_289	[p17l2035t3439r2148b3497],
5	detection	NN	O	detection	nsubj	30	SENT_289	[p17l9t3533r342b3591],
6	of	IN	O	of	_	0	SENT_289	[p17l388t3533r460b3591],
7	3R/3R	NN	O	3r/3r	nn	9	SENT_289	[p17l503t3533r714b3599],
8	TS	NN	O	t	nn	9	SENT_289	[p17l761t3535r842b3591],
9	genotype	NN	O	genotype	prep_of	5	SENT_289	[p17l886t3541r1212b3609],
10	associated	VBN	O	associate	partmod	9	SENT_289	[p17l1260t3533r1616b3591],
11	with	IN	O	with	_	0	SENT_289	[p17l1659t3533r1821b3591],
12	C/C	NN	O	c/c	prep_with	10	SENT_289	[p17l1868t3533r2005b3599],
13	for	IN	O	for	_	0	SENT_289	[p17l2051t3533r2150b3591],
14	677	CD	NUMBER	677	number	15	SENT_289	[p17l11t3630r134b3686],
15	C	NN	O	c	num	17	SENT_289	[p17l167t3630r343b3686],
16	>	JJR	O	>	amod	17	SENT_289	[p17l167t3630r343b3686],
17	T	NN	O	t	prep_for	12	SENT_289	[p17l167t3630r343b3686],
18	or	CC	O	or	_	0	SENT_289	[p17l367t3645r438b3686],
19	A/A	NN	O	a/a	prep_for	12	SENT_289	[p17l464t3628r597b3694],
20	for	IN	O	for	_	0	SENT_289	[p17l626t3628r724b3686],
21	1298	CD	DATE	1298	prep_for	19	SENT_289	[p17l758t3630r922b3686],
22	A	DT	O	a	det	24	SENT_289	[p17l952t3630r1152b3699],
23	>	JJR	O	>	amod	24	SENT_289	[p17l952t3630r1152b3699],
24	C	NN	O	c	dep	19	SENT_289	[p17l952t3630r1152b3699],
25	,	,	O	,	_	0	SENT_289	[p17l952t3630r1152b3699],
26	is	VBZ	O	be	cop	30	SENT_289	[p17l1186t3631r1237b3686],
27	a	DT	O	a	det	30	SENT_289	[p17l1267t3645r1302b3686],
28	major	JJ	O	major	amod	30	SENT_289	[p17l1330t3631r1538b3704],
29	predictive	JJ	O	predictive	amod	30	SENT_289	[p17l1566t3629r1916b3704],
30	factor	NN	O	factor	_	0	SENT_289	[p17l1946t3628r2149b3686],
31	of	IN	O	of	_	0	SENT_289	[p17l9t3724r81b3782],
32	failure	NN	O	failure	conj_and	32	SENT_289	[p17l128t3724r351b3782],
33	to	TO	O	to	_	0	SENT_289	[p17l403t3731r473b3782],
34	5-FU	NN	O	5-fu	prep_to	32	SENT_289	[p17l527t3726r690b3782],
35	and	CC	O	and	_	0	SENT_289	[p17l743t3724r873b3782],
36	of	IN	O	of	_	0	SENT_289	[p17l925t3724r997b3782],
37	a	DT	O	a	det	41	SENT_289	[p17l1045t3741r1080b3782],
38	very	RB	O	very	advmod	39	SENT_289	[p17l1128t3741r1282b3800],
39	short	JJ	O	short	amod	41	SENT_289	[p17l1333t3724r1513b3782],
40	survival	NN	O	survival	nn	41	SENT_289	[p17l1566t3724r1840b3782],
41	rate	NN	O	rate	prep_of	32	SENT_289	[p17l1891t3731r2041b3782],
42	.	.	O	.	_	0	SENT_289	[p17l1891t3731r2041b3782],

1	It	PRP	O	it	nsubj	3	SENT_290	[p17l2097t3726r2149b3782],
2	obviously	RB	O	obviously	advmod	3	SENT_290	[p18l9t17r353b92],
3	requires	VBZ	O	require	_	0	SENT_290	[p18l381t20r660b92],
4	an	DT	O	a	det	7	SENT_290	[p18l692t33r777b74],
5	immediately	RB	O	immediately	advmod	6	SENT_290	[p18l807t17r1255b92],
6	intensified	VBN	O	intensify	amod	7	SENT_290	[p18l1283t16r1660b74],
7	combination	NN	O	combination	dobj	3	SENT_290	[p18l1691t17r2148b74],
8	with	IN	O	with	_	0	SENT_290	[p18l7t112r168b170],
9	another	DT	O	another	det	11	SENT_290	[p18l203t112r481b170],
10	cytotoxic	JJ	O	cytotoxic	amod	11	SENT_290	[p18l513t115r842b188],
11	drug	NN	O	drug	prep_with	7	SENT_290	[p18l875t112r1036b188],
12	such	JJ	O	such	_	0	SENT_290	[p18l1071t112r1231b170],
13	as	IN	O	as	_	0	SENT_290	[p18l1265t129r1330b170],
14	oxaliplatin	NN	O	oxaliplatin	prep_such_as	11	SENT_290	[p18l1365t112r1749b188],
15	or	CC	O	or	_	0	SENT_290	[p18l1783t129r1854b170],
16	irinotecan	NN	O	irinotecan	conj_or	14	SENT_290	[p18l1887t115r2148b170, p18l9t224r132b265],
17	and	CC	O	and	_	0	SENT_290	[p18l176t207r308b265],
18	a	DT	O	a	det	20	SENT_290	[p18l353t224r387b265],
19	targeted	VBN	O	target	amod	20	SENT_290	[p18l431t207r718b283],
20	therapy	NN	O	therapy	conj_and	7	SENT_290	[p18l762t207r1044b283],
21	,	,	O	,	_	0	SENT_290	[p18l762t207r1044b283],
22	such	JJ	O	such	_	0	SENT_290	[p18l1095t207r1256b265],
23	as	IN	O	as	_	0	SENT_290	[p18l1301t224r1365b265],
24	an	DT	O	a	det	25	SENT_290	[p18l1412t224r1496b265],
25	anti-VEGF	NN	O	anti-vegf	prep_such_as	7	SENT_290	[p18l1541t209r1903b265],
26	or	CC	O	or	_	0	SENT_290	[p18l1948t224r2020b265],
27	an	DT	O	a	det	28	SENT_290	[p18l2064t224r2149b265],
28	anti	JJ	O	anti	prep_such_as	7	SENT_290	[p18l9t292r679b357],
29	.	.	O	.	_	0	SENT_290	[p18l9t292r679b357],

1	—	NN	O	—	_	0	SENT_291	[p18l9t292r679b357],
2	.	.	O	.	_	0	SENT_291	[p18l9t292r679b357],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_292	[p18l9t292r679b357],
2	.8	CD	NUMBER	.8	num	1	SENT_292	[p18l9t292r679b357],
3	'	''	DATE	'	_	0	SENT_292	[p18l9t292r679b357],
4	14	CD	DATE	14	nsubj	21	SENT_292	[p18l9t292r679b357],
5	'	''	DATE	'	_	0	SENT_292	[p18l9t292r679b357],
6	18	CD	DATE	18	dep	4	SENT_292	[p18l9t292r679b357],
7	‘	CD	NUMBER	‘	num	9	SENT_292	[p18l9t292r679b357],
8	Z2	NN	O	z2	nn	9	SENT_292	[p18l9t292r679b357],
9	Intensification	NN	O	intensification	dep	4	SENT_292	[p18l721t300r1242b358],
10	using	VBG	O	use	partmod	4	SENT_292	[p18l1282t303r1475b376],
11	one	CD	NUMBER	one	nn	15	SENT_292	[p18l1515t317r1644b358],
12	or	CC	O	or	_	0	SENT_292	[p18l1687t317r1759b358],
13	two	CD	NUMBER	two	nn	15	SENT_292	[p18l1799t307r1929b358],
14	additional	JJ	O	additional	amod	15	SENT_292	[p18l1972t300r2148b358, p18l8t396r216b454],
15	drugs	NNS	O	drug	dobj	10	SENT_292	[p18l272t396r462b472],
16	with	IN	O	with	_	0	SENT_292	[p18l516t396r677b454],
17	different	JJ	O	different	amod	19	SENT_292	[p18l733t396r1037b454],
18	metabolism	NN	O	metabolism	nn	19	SENT_292	[p18l1092t396r1508b454],
19	pathways	NNS	O	pathway	prep_with	10	SENT_292	[p18l1563t396r1896b472],
20	could	MD	O	could	aux	21	SENT_292	[p18l1953t396r2149b454],
21	restore	VB	O	restore	rcmod	1	SENT_292	[p18l9t496r244b546],
22	the	DT	O	the	det	23	SENT_292	[p18l299t489r412b546],
23	efficacy	NN	O	efficacy	dobj	21	SENT_292	[p18l467t488r747b564],
24	.	.	O	.	_	0	SENT_292	[p18l467t488r747b564],

1	Marcuello	NNP	O	Marcuello	nsubjpass	44	SENT_293	[p18l804t488r1157b546],
2	et	FW	O	et	nsubj	5	SENT_293	[p18l1213t494r1273b546],
3	al.	FW	O	al.	nn	4	SENT_293	[p18l1321t482r1468b546],
4	”	FW	O	”	dep	2	SENT_293	[p18l1321t482r1468b546],
5	suggested	VBD	O	suggest	rcmod	1	SENT_293	[p18l1524t488r1863b564],
6	that	IN	O	that	complm	15	SENT_293	[p18l1917t489r2060b546],
7	a	DT	O	a	det	9	SENT_293	[p18l2114t505r2149b546],
8	combined	JJ	O	combined	amod	9	SENT_293	[p18l9t585r364b643],
9	regimen	NN	O	regimen	nsubj	15	SENT_293	[p18l417t588r707b661],
10	with	IN	O	with	_	0	SENT_293	[p18l759t585r920b643],
11	irinotecan	NN	O	irinotecan	prep_with	9	SENT_293	[p18l973t588r1336b643],
12	or	CC	O	or	_	0	SENT_293	[p18l1390t602r1462b643],
13	oxaliplatin	NN	O	oxaliplatin	prep_with	9	SENT_293	[p18l1515t585r1899b661],
14	could	MD	O	could	aux	15	SENT_293	[p18l1953t585r2149b643],
15	reduce	VB	O	reduce	ccomp	5	SENT_293	[p18l9t679r241b737],
16	the	DT	O	the	det	18	SENT_293	[p18l294t679r406b737],
17	predictive	JJ	O	predictive	amod	18	SENT_293	[p18l459t680r809b755],
18	value	NN	O	value	dobj	15	SENT_293	[p18l860t679r1048b737],
19	of	IN	O	of	_	0	SENT_293	[p18l1102t679r1173b737],
20	the	DT	O	the	det	23	SENT_293	[p18l1221t680r1334b737],
21	MT	NNP	O	MT	nn	23	SENT_293	[p18l1384t682r1508b736],
22	HFR	NNP	O	HFR	nn	23	SENT_293	[p18l1501t682r1646b736],
23	genotype	NN	O	genotype	prep_of	18	SENT_293	[p18l1699t687r2025b755],
24	in	IN	O	in	_	0	SENT_293	[p18l2078t682r2149b736],
25	contradiction	NN	O	contradiction	prep_in	23	SENT_293	[p18l9t774r491b832],
26	to	TO	O	to	_	0	SENT_293	[p18l579t782r649b832],
27	other	JJ	O	other	amod	29	SENT_293	[p18l739t774r928b832],
28	previous	JJ	O	previous	amod	29	SENT_293	[p18l1015t777r1315b850],
29	studies	NNS	O	study	prep_to	25	SENT_293	[p18l1406t774r1646b832],
30	with	IN	O	with	_	0	SENT_293	[p18l1733t774r1895b832],
31	5-FU	NN	O	5-fu	prep_with	29	SENT_293	[p18l1985t777r2149b832],
32	alone	RB	O	alone	advmod	25	SENT_293	[p18l9t861r534b926],
33	.19	CD	NUMBER	.19	pobj	32	SENT_293	[p18l9t861r534b926],
34	'	''	O	'	_	0	SENT_293	[p18l9t861r534b926],
35	2	CD	NUMBER	2	dep	18	SENT_293	[p18l9t861r534b926],
36	°	NN	O	°	dep	35	SENT_293	[p18l9t861r534b926],
37	'	''	DATE	'	_	0	SENT_293	[p18l9t861r534b926],
38	21	CD	DATE	21	number	39	SENT_293	[p18l9t861r534b926],
39	'23	CD	DATE	'23	dep	18	SENT_293	[p18l9t861r534b926],
40	No	DT	O	no	det	41	SENT_293	[p18l566t871r669b926],
41	results	NNS	O	result	dep	39	SENT_293	[p18l700t868r925b926],
42	have	VBP	O	have	aux	44	SENT_293	[p18l957t868r1121b926],
43	been	VBN	O	be	auxpass	44	SENT_293	[p18l1151t868r1321b926],
44	reported	VBN	O	report	_	0	SENT_293	[p18l1351t868r1650b944],
45	with	IN	O	with	_	0	SENT_293	[p18l1678t868r1840b926],
46	both	DT	O	both	preconj	47	SENT_293	[p18l1869t868r2036b926],
47	TS	NN	O	t	prep_with	44	SENT_293	[p18l2070t870r2150b926],
48	and	CC	O	and	_	0	SENT_293	[p18l9t964r141b1021],
49	MT	NN	O	mt	nn	51	SENT_293	[p18l166t966r290b1021],
50	HFR	NN	O	hfr	nn	51	SENT_293	[p18l283t966r428b1021],
51	genotypes	NNS	O	genotype	prep_with	44	SENT_293	[p18l459t971r835b1039],
52	.	.	O	.	_	0	SENT_293	[p18l459t971r835b1039],

1	On	IN	O	on	_	0	SENT_294	[p18l87t1060r194b1116],
2	the	DT	O	the	det	3	SENT_294	[p18l242t1059r355b1116],
3	contrary	NN	O	contrary	prep_on	12	SENT_294	[p18l406t1066r716b1134],
4	,	,	O	,	_	0	SENT_294	[p18l406t1066r716b1134],
5	the	DT	O	the	det	7	SENT_294	[p18l770t1059r882b1116],
6	other	JJ	O	other	amod	7	SENT_294	[p18l933t1059r1122b1116],
7	TS	NN	O	t	nsubj	12	SENT_294	[p18l1173t1060r1254b1116],
8	and	CC	O	and	_	0	SENT_294	[p18l1302t1059r1433b1116],
9	MTHFR	NN	O	mthfr	nn	10	SENT_294	[p18l1478t1061r1740b1116],
10	genotypes	NNS	O	genotype	nsubj	12	SENT_294	[p18l1790t1066r2148b1134],
11	are	VBP	O	be	cop	12	SENT_294	[p18l9t1171r111b1212],
12	predictive	JJ	O	predictive	_	0	SENT_294	[p18l148t1154r499b1230],
13	of	IN	O	of	_	0	SENT_294	[p18l539t1154r610b1212],
14	very	RB	O	very	advmod	15	SENT_294	[p18l641t1171r795b1230],
15	long	JJ	O	long	amod	16	SENT_294	[p18l830t1154r989b1230],
16	survival	NN	O	survival	prep_of	12	SENT_294	[p18l1027t1154r1301b1212],
17	with	IN	O	with	_	0	SENT_294	[p18l1337t1154r1499b1212],
18	5-FU	NN	O	5-fu	prep_with	16	SENT_294	[p18l1538t1157r1701b1212],
19	plus	CC	O	plus	prep	18	SENT_294	[p18l1739t1154r1883b1230],
20	folinic	JJ	O	folinic	amod	21	SENT_294	[p18l1921t1154r2148b1212],
21	acid	NN	O	acid	dep	19	SENT_294	[p18l9t1249r152b1307],
22	alone	RB	O	alone	advmod	12	SENT_294	[p18l214t1249r424b1319],
23	,	,	O	,	_	0	SENT_294	[p18l214t1249r424b1319],
24	and	CC	O	and	_	0	SENT_294	[p18l492t1249r623b1307],
25	pose	VB	O	pose	conj_and	12	SENT_294	[p18l684t1266r841b1325],
26	the	DT	O	the	det	27	SENT_294	[p18l904t1249r1016b1307],
27	question	NN	O	question	dobj	25	SENT_294	[p18l1080t1252r1386b1325],
28	of	IN	O	of	_	0	SENT_294	[p18l1449t1249r1521b1307],
29	the	DT	O	the	det	30	SENT_294	[p18l1578t1249r1691b1307],
30	interest	NN	O	interest	prep_of	27	SENT_294	[p18l1754t1252r2019b1307],
31	of	IN	O	of	_	0	SENT_294	[p18l2081t1249r2153b1307],
32	intensified	VBN	O	intensify	prep_of	30	SENT_294	[p18l9t1344r386b1402],
33	and	CC	O	and	_	0	SENT_294	[p18l435t1344r566b1402],
34	combined	VBN	O	combine	amod	35	SENT_294	[p18l615t1344r970b1402],
35	protocols	NNS	O	protocol	conj_and	32	SENT_294	[p18l1017t1344r1365b1420],
36	.	.	O	.	_	0	SENT_294	[p18l1017t1344r1365b1420],

1	Actually	RB	O	actually	advmod	23	SENT_295	[p18l1416t1344r1721b1420],
2	,	,	O	,	_	0	SENT_295	[p18l1416t1344r1721b1420],
3	except	IN	O	except	_	0	SENT_295	[p18l1775t1351r2003b1420],
4	for	IN	O	for	_	0	SENT_295	[p18l2051t1344r2150b1402],
5	some	DT	O	some	det	6	SENT_295	[p18l10t1455r191b1496],
6	patients	NNS	O	patient	prep_except_for	23	SENT_295	[p18l246t1441r528b1514],
7	who	WP	O	who	nsubj	15	SENT_295	[p18l581t1438r734b1496],
8	could	MD	O	could	aux	9	SENT_295	[p18l790t1438r986b1496],
9	benefit	VB	O	benefit	rcmod	6	SENT_295	[p18l1038t1438r1287b1496],
10	from	IN	O	from	_	0	SENT_295	[p18l1341t1438r1511b1496],
11	early	JJ	O	early	amod	13	SENT_295	[p18l1566t1438r1737b1514],
12	metastasis	NN	O	metastasis	nn	13	SENT_295	[p18l1789t1441r2148b1496],
13	surgery	NN	O	surgery	prep_from	9	SENT_295	[p18l10t1551r266b1610],
14	and	CC	O	and	_	0	SENT_295	[p18l300t1534r432b1592],
15	need	VB	O	need	rcmod	6	SENT_295	[p18l466t1534r635b1592],
16	an	DT	O	a	det	19	SENT_295	[p18l671t1551r755b1592],
17	immediate	JJ	O	immediate	amod	19	SENT_295	[p18l791t1534r1169b1592],
18	intensified	VBN	O	intensify	amod	19	SENT_295	[p18l1205t1534r1582b1592],
19	chemotherapy	NN	O	chemotherapy	dobj	15	SENT_295	[p18l1618t1534r2144b1610],
20	,	,	O	,	_	0	SENT_295	[p18l1618t1534r2144b1610],
21	the	DT	O	the	det	22	SENT_295	[p18l8t1628r121b1686],
22	question	NN	O	question	nsubj	23	SENT_295	[p18l166t1631r472b1704],
23	remains	VBZ	O	remain	_	0	SENT_295	[p18l515t1631r795b1686],
24	of	IN	O	of	_	0	SENT_295	[p18l840t1628r911b1686],
25	the	DT	O	the	det	27	SENT_295	[p18l950t1628r1063b1686],
26	initial	JJ	O	initial	amod	27	SENT_295	[p18l1107t1628r1316b1686],
27	combination	NN	O	combination	prep_of	23	SENT_295	[p18l1360t1628r1817b1686],
28	and	CC	O	and	_	0	SENT_295	[p18l1861t1628r1992b1686],
29	the	DT	O	the	det	30	SENT_295	[p18l2035t1628r2148b1686],
30	risk	NN	O	risk	prep_of	23	SENT_295	[p18l9t1723r133b1781],
31	of	IN	O	of	_	0	SENT_295	[p18l176t1723r248b1781],
32	toxic	JJ	O	toxic	amod	34	SENT_295	[p18l288t1726r463b1781],
33	side	JJ	O	side	amod	34	SENT_295	[p18l509t1723r642b1781],
34	effects	NNS	O	effect	prep_of	30	SENT_295	[p18l687t1723r927b1781],
35	.	.	O	.	_	0	SENT_295	[p18l687t1723r927b1781],

1	This	DT	O	this	nsubj	2	SENT_296	[p18l974t1723r1123b1781],
2	is	VBZ	O	be	_	0	SENT_296	[p18l1169t1726r1219b1781],
3	of	IN	O	of	_	0	SENT_296	[p18l1265t1723r1336b1781],
4	major	JJ	O	major	amod	5	SENT_296	[p18l1376t1726r1583b1799],
5	importance	NN	O	importance	prep_of	2	SENT_296	[p18l1627t1726r2033b1799],
6	in	IN	O	in	_	0	SENT_296	[p18l2078t1726r2149b1780],
7	the	DT	O	the	det	9	SENT_296	[p18l8t1819r121b1877],
8	adjuvant	JJ	O	adjuvant	amod	9	SENT_296	[p18l167t1819r479b1895],
9	setting	NN	O	setting	prep_in	5	SENT_296	[p18l523t1822r778b1895],
10	.	.	O	.	_	0	SENT_296	[p18l523t1822r778b1895],

1	Undoubtedly	NNP	O	Undoubtedly	tmod	8	SENT_297	[p18l826t1819r1307b1895],
2	,	,	O	,	_	0	SENT_297	[p18l826t1819r1307b1895],
3	the	DT	O	the	det	5	SENT_297	[p18l1355t1819r1468b1877],
4	FOLFOX	NNP	O	FOLFOX	nn	5	SENT_297	[p18l1513t1821r1814b1877],
5	regimen	NN	O	regimen	nsubj	8	SENT_297	[p18l1858t1822r2149b1895],
6	has	VBZ	O	have	aux	8	SENT_297	[p18l9t1914r124b1971],
7	statistically	RB	O	statistically	advmod	8	SENT_297	[p18l181t1914r580b1989],
8	improved	VBN	O	improve	_	0	SENT_297	[p18l632t1914r973b1989],
9	the	DT	O	the	det	11	SENT_297	[p18l1027t1914r1139b1971],
10	cure	NN	O	cure	nn	11	SENT_297	[p18l1196t1930r1342b1971],
11	rate	NN	O	rate	dobj	8	SENT_297	[p18l1398t1921r1528b1971],
12	compared	VBN	O	compare	_	0	SENT_297	[p18l1584t1914r1935b1989],
13	with	IN	O	with	prepc_compared_with	8	SENT_297	[p18l1987t1914r2148b1971],
14	LVSFUZ	NN	ORGANIZATION	lvsfuz	pobj	8	SENT_297	[p18l9t2008r284b2064],
15	in	IN	O	in	_	0	SENT_297	[p18l324t2010r394b2064],
16	patients	NNS	O	patient	prep_in	14	SENT_297	[p18l432t2010r715b2082],
17	with	IN	O	with	_	0	SENT_297	[p18l753t2007r914b2064],
18	pT3N1	NN	O	pt3n1	nn	20	SENT_297	[p18l953t2008r1186b2082],
19	colon	NN	O	colon	nn	20	SENT_297	[p18l1231t2007r1429b2064],
20	cancer	NN	O	cancer	prep_with	16	SENT_297	[p18l1468t2000r1779b2064],
21	.	.	O	.	_	0	SENT_297	[p18l1468t2000r1779b2064],

1	”	NN	O	”	ccomp	5	SENT_298	[p18l1468t2000r1779b2064],
2	However	RB	O	however	advmod	1	SENT_298	[p18l1819t2009r2144b2077],
3	,	,	O	,	_	0	SENT_298	[p18l1819t2009r2144b2077],
4	oxaliplatin	NN	O	oxaliplatin	nsubj	5	SENT_298	[p18l9t2103r393b2179],
5	provokes	VBZ	O	provoke	_	0	SENT_298	[p18l424t2103r741b2179],
6	severe	JJ	O	severe	amod	8	SENT_298	[p18l775t2120r986b2161],
7	chronic	JJ	O	chronic	amod	8	SENT_298	[p18l1020t2103r1290b2161],
8	neuropathy	NN	O	neuropathy	dobj	5	SENT_298	[p18l1322t2103r1738b2179],
9	in	IN	O	in	_	0	SENT_298	[p18l1767t2106r1837b2160],
10	18-20	CD	PERCENT	18-20	num	11	SENT_298	[p18l1875t2105r2148b2161],
11	%	NN	PERCENT	%	prep_in	8	SENT_298	[p18l1875t2105r2148b2161],
12	of	IN	O	of	_	0	SENT_298	[p18l9t2198r81b2256],
13	patients	NNS	O	patient	prep_of	11	SENT_298	[p18l137t2201r419b2274],
14	that	IN	O	that	nsubj	25	SENT_298	[p18l482t2198r625b2256],
15	leads	VBZ	O	lead	rcmod	13	SENT_298	[p18l687t2198r861b2256],
16	to	TO	O	to	_	0	SENT_298	[p18l923t2205r993b2256],
17	a	DT	O	a	det	23	SENT_298	[p18l1056t2215r1091b2256],
18	prolonged	JJ	O	prolonged	amod	23	SENT_298	[p18l1152t2198r1515b2274],
19	and	CC	O	and	_	0	SENT_298	[p18l1578t2198r1709b2256],
20	sometimes	RB	O	sometimes	advmod	18	SENT_298	[p18l1772t2201r2148b2256],
21	irreversible	JJ	O	irreversible	amod	22	SENT_298	[p18l9t2293r397b2351],
22	functional	JJ	O	functional	conj_and	18	SENT_298	[p18l445t2293r813b2351],
23	impairment	NN	O	impairment	prep_to	15	SENT_298	[p18l860t2296r1282b2369],
24	and	CC	O	and	_	0	SENT_298	[p18l1329t2293r1460b2351],
25	alters	VBZ	O	alter	conj_and	15	SENT_298	[p18l1508t2293r1693b2351],
26	the	DT	O	the	det	27	SENT_298	[p18l1741t2293r1853b2351],
27	quality	NN	O	quality	dobj	25	SENT_298	[p18l1902t2293r2151b2369],
28	of	IN	O	of	_	0	SENT_298	[p18l9t2387r81b2445],
29	life	NN	O	life	prep_of	27	SENT_298	[p18l146t2387r272b2445],
30	.	.	O	.	_	0	SENT_298	[p18l146t2387r272b2445],

1	Moreover	RB	O	moreover	advmod	7	SENT_299	[p18l345t2390r699b2458],
2	,	,	O	,	_	0	SENT_299	[p18l345t2390r699b2458],
3	this	DT	O	this	det	4	SENT_299	[p18l773t2387r903b2445],
4	protocol	NN	O	protocol	nsubjpass	7	SENT_299	[p18l972t2388r1271b2463],
5	is	VBZ	O	be	auxpass	7	SENT_299	[p18l1340t2390r1391b2445],
6	now	RB	DATE	now	advmod	7	SENT_299	[p18l1461t2404r1615b2445],
7	extended	VBN	O	extend	_	0	SENT_299	[p18l1683t2387r2009b2445],
8	to	TO	O	to	_	0	SENT_299	[p18l2078t2395r2148b2445],
9	pT3NO	NN	O	pt3no	nn	10	SENT_299	[p18l8t2484r246b2559],
10	patients	NNS	O	patient	prep_to	7	SENT_299	[p18l275t2486r557b2559],
11	whose	WP$	O	whose	poss	12	SENT_299	[p18l585t2483r808b2541],
12	risk	NN	O	risk	nsubj	17	SENT_299	[p18l838t2483r963b2541],
13	of	IN	O	of	_	0	SENT_299	[p18l991t2483r1062b2541],
14	recurrence	NN	O	recurrence	prep_of	12	SENT_299	[p18l1087t2500r1457b2541],
15	is	VBZ	O	be	cop	17	SENT_299	[p18l1488t2486r1538b2541],
16	30	CD	PERCENT	30	num	17	SENT_299	[p18l1570t2484r1739b2541],
17	%	NN	PERCENT	%	rcmod	10	SENT_299	[p18l1570t2484r1739b2541],
18	.	.	O	.	_	0	SENT_299	[p18l1570t2484r1739b2541],

1	Obviously	RB	O	obviously	advmod	6	SENT_300	[p18l1774t2483r2144b2559],
2	,	,	O	,	_	0	SENT_300	[p18l1774t2483r2144b2559],
3	some	DT	O	some	det	4	SENT_300	[p18l10t2594r191b2635],
4	patients	NNS	O	patient	nsubj	6	SENT_300	[p18l236t2580r518b2653],
5	would	MD	O	would	aux	6	SENT_300	[p18l562t2577r784b2635],
6	benefit	VB	O	benefit	_	0	SENT_300	[p18l826t2577r1075b2635],
7	from	IN	O	from	_	0	SENT_300	[p18l1120t2577r1289b2635],
8	5-FU	NN	O	5-fu	prep_from	6	SENT_300	[p18l1336t2580r1499b2635],
9	plus	CC	O	plus	prep	8	SENT_300	[p18l1544t2577r1688b2653],
10	folinic	JJ	O	folinic	amod	11	SENT_300	[p18l1734t2577r1961b2635],
11	acid	NN	O	acid	dep	9	SENT_300	[p18l2006t2577r2149b2635],
12	only	RB	O	only	nn	15	SENT_300	[p18l9t2672r169b2748],
13	and	CC	O	and	_	0	SENT_300	[p18l208t2672r339b2730],
14	the	DT	O	the	nn	15	SENT_300	[p18l380t2672r492b2730],
15	screening	NN	O	screening	dobj	6	SENT_300	[p18l536t2675r872b2748],
16	for	IN	O	for	_	0	SENT_300	[p18l912t2672r1010b2730],
17	3R/3R	NN	O	3r/3r	nn	19	SENT_300	[p18l1051t2672r1262b2738],
18	TS	NN	O	t	nn	19	SENT_300	[p18l1304t2674r1385b2730],
19	genotype	NN	O	genotype	prep_for	15	SENT_300	[p18l1424t2680r1750b2748],
20	associated	VBN	O	associate	partmod	19	SENT_300	[p18l1793t2672r2149b2730],
21	with	IN	O	with	_	0	SENT_300	[p18l7t2768r168b2826],
22	C/C	NN	O	c/c	prep_with	20	SENT_300	[p18l201t2768r337b2833],
23	for	IN	O	for	_	0	SENT_300	[p18l369t2768r467b2826],
24	677	CD	NUMBER	677	number	25	SENT_300	[p18l500t2770r623b2826],
25	C	NN	O	c	npadvmod	26	SENT_300	[p18l657t2770r833b2826],
26	>	JJR	O	>	amod	46	SENT_300	[p18l657t2770r833b2826],
27	T	NN	O	t	dobj	36	SENT_300	[p18l657t2770r833b2826],
28	or	CC	O	or	_	0	SENT_300	[p18l859t2785r931b2826],
29	A/A	NN	O	a/a	dobj	36	SENT_300	[p18l959t2768r1092b2833],
30	for	IN	O	for	_	0	SENT_300	[p18l1122t2768r1220b2826],
31	1298	CD	DATE	1298	prep_for	27	SENT_300	[p18l1256t2770r1420b2826],
32	A	DT	O	a	det	34	SENT_300	[p18l1451t2770r1634b2826],
33	>	JJR	O	>	amod	34	SENT_300	[p18l1451t2770r1634b2826],
34	C	NN	O	c	nsubj	36	SENT_300	[p18l1451t2770r1634b2826],
35	could	MD	O	could	aux	36	SENT_300	[p18l1666t2768r1862b2826],
36	help	VB	O	help	ccomp	26	SENT_300	[p18l1893t2768r2047b2844],
37	to	TO	O	to	aux	38	SENT_300	[p18l2078t2775r2148b2826],
38	detect	VB	O	detect	xcomp	36	SENT_300	[p18l9t2863r223b2920],
39	patients	NNS	O	patient	dobj	38	SENT_300	[p18l280t2866r563b2938],
40	free	JJ	O	free	advmod	39	SENT_300	[p18l621t2862r748b2920],
41	of	IN	O	of	_	0	SENT_300	[p18l808t2862r880b2920],
42	these	DT	O	these	det	44	SENT_300	[p18l934t2863r1116b2920],
43	poor	JJ	O	poor	amod	44	SENT_300	[p18l1174t2879r1339b2938],
44	prognosis	NN	O	prognosis	prep_of	39	SENT_300	[p18l1395t2866r1736b2938],
45	molecular	JJ	O	molecular	amod	46	SENT_300	[p18l1795t2863r2150b2920],
46	factors	NNS	O	factor	prep_for	22	SENT_300	[p18l9t2956r260b3014],
47	.	.	O	.	_	0	SENT_300	[p18l9t2956r260b3014],

1	Over	IN	O	over	_	0	SENT_301	[p18l87t3054r254b3110],
2	the	DT	DURATION	the	det	5	SENT_301	[p18l281t3052r394b3110],
3	past	JJ	DURATION	past	amod	5	SENT_301	[p18l422t3059r564b3128],
4	few	JJ	DURATION	few	amod	5	SENT_301	[p18l591t3052r714b3110],
5	years	NNS	DURATION	year	prep_over	10	SENT_301	[p18l738t3069r934b3128],
6	,	,	O	,	_	0	SENT_301	[p18l738t3069r934b3128],
7	intensive	JJ	O	intensive	amod	8	SENT_301	[p18l967t3055r1289b3110],
8	efforts	NNS	O	effort	nsubj	10	SENT_301	[p18l1319t3052r1539b3110],
9	have	VBP	O	have	aux	10	SENT_301	[p18l1567t3052r1732b3110],
10	focused	VBN	O	focus	_	0	SENT_301	[p18l1761t3052r2029b3110],
11	on	IN	O	on	_	0	SENT_301	[p18l2057t3069r2149b3110],
12	the	DT	O	the	det	13	SENT_301	[p18l9t3147r121b3205],
13	problem	NN	O	problem	prep_on	10	SENT_301	[p18l144t3147r441b3223],
14	of	IN	O	of	_	0	SENT_301	[p18l464t3147r536b3205],
15	prognostic	JJ	O	prognostic	amod	16	SENT_301	[p18l553t3150r930b3223],
16	factors	NNS	O	factor	prep_of	13	SENT_301	[p18l953t3147r1204b3217],
17	,	,	O	,	_	0	SENT_301	[p18l953t3147r1204b3217],
18	both	CC	O	both	dep	10	SENT_301	[p18l1229t3147r1397b3205],
19	in	IN	O	in	conj	10	SENT_301	[p18l1419t3150r1489b3204],
20	terms	NNS	O	term	pobj	19	SENT_301	[p18l1512t3154r1707b3205],
21	of	IN	O	of	_	0	SENT_301	[p18l1732t3147r1804b3205],
22	tolerance	NN	O	tolerance	prep_of	20	SENT_301	[p18l1822t3147r2148b3205],
23	and	CC	O	and	_	0	SENT_301	[p18l9t3242r141b3300],
24	efficacy	NN	O	efficacy	prep_of	20	SENT_301	[p18l203t3242r481b3318],
25	.	.	O	.	_	0	SENT_301	[p18l203t3242r481b3318],

1	Our	PRP$	O	we	poss	2	SENT_302	[p18l549t3243r684b3300],
2	results	NNS	O	result	nsubj	3	SENT_302	[p18l744t3242r969b3300],
3	confirm	VBP	O	confirm	_	0	SENT_302	[p18l1032t3242r1313b3300],
4	the	DT	O	the	det	5	SENT_302	[p18l1374t3242r1487b3300],
5	interest	NN	O	interest	dobj	3	SENT_302	[p18l1550t3245r1815b3300],
6	for	IN	O	for	_	0	SENT_302	[p18l1876t3242r1975b3300],
7	the	DT	O	the	det	8	SENT_302	[p18l2035t3242r2148b3300],
8	detection	NN	O	detection	prep_for	5	SENT_302	[p18l9t3336r342b3394],
9	of	IN	O	of	_	0	SENT_302	[p18l390t3336r462b3394],
10	genetic	JJ	O	genetic	amod	11	SENT_302	[p18l505t3339r760b3412],
11	factors	NNS	O	factor	prep_of	8	SENT_302	[p18l807t3336r1040b3394],
12	such	JJ	O	such	_	0	SENT_302	[p18l1090t3336r1250b3394],
13	as	IN	O	as	_	0	SENT_302	[p18l1299t3353r1363b3394],
14	TS	NN	O	t	nn	19	SENT_302	[p18l1415t3338r1512b3407],
15	,	,	O	,	_	0	SENT_302	[p18l1415t3338r1512b3407],
16	DPD	NN	O	dpd	conj_or	14	SENT_302	[p18l1561t3339r1723b3393],
17	or	CC	O	or	_	0	SENT_302	[p18l1771t3353r1842b3394],
18	MTHFR	NN	O	mthfr	nn	19	SENT_302	[p18l1886t3339r2148b3393],
19	polymorphisms	NNS	O	polymorphism	prep_such_as	11	SENT_302	[p18l8t3432r564b3508],
20	and	CC	O	and	_	0	SENT_302	[p18l632t3432r763b3490],
21	their	PRP$	O	they	poss	23	SENT_302	[p18l828t3432r996b3490],
22	potential	JJ	O	potential	amod	23	SENT_302	[p18l1060t3432r1381b3508],
23	impact	NN	O	impact	prep_such_as	11	SENT_302	[p18l1447t3435r1691b3508],
24	in	IN	O	in	_	0	SENT_302	[p18l1756t3435r1827b3489],
25	clinical	JJ	O	clinical	amod	26	SENT_302	[p18l1893t3432r2148b3490],
26	practice	NN	O	practice	prep_in	3	SENT_302	[p18l8t3529r303b3602],
27	.	.	O	.	_	0	SENT_302	[p18l8t3529r303b3602],

1	We	PRP	O	we	nsubj	3	SENT_303	[p18l363t3529r473b3584],
2	have	VBP	O	have	aux	3	SENT_303	[p18l531t3526r696b3584],
3	shown	VBN	O	show	_	0	SENT_303	[p18l755t3526r987b3584],
4	that	IN	O	that	complm	9	SENT_303	[p18l1044t3526r1188b3584],
5	this	DT	O	this	det	6	SENT_303	[p18l1244t3526r1373b3584],
6	adjustment	NN	O	adjustment	nsubjpass	9	SENT_303	[p18l1431t3526r1833b3602],
7	can	MD	O	can	aux	9	SENT_303	[p18l1890t3543r2013b3584],
8	be	VB	O	be	auxpass	9	SENT_303	[p18l2068t3526r2148b3584],
9	performed	VBN	O	perform	ccomp	3	SENT_303	[p18l8t3621r377b3697],
10	routinely	RB	O	routinely	advmod	9	SENT_303	[p18l413t3621r741b3697],
11	using	VBG	O	use	xcomp	9	SENT_303	[p18l773t3624r965b3697],
12	both	DT	O	both	det	15	SENT_303	[p18l998t3621r1165b3679],
13	simple	JJ	O	simple	amod	15	SENT_303	[p18l1203t3621r1432b3697],
14	biomolecular	JJ	O	biomolecular	amod	15	SENT_303	[p18l1466t3621r1937b3679],
15	techniques	NNS	O	technique	dobj	11	SENT_303	[p18l1972t3621r2148b3679, p18l9t3720r241b3793],
16	and	CC	O	and	_	0	SENT_303	[p18l264t3717r395b3775],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_303	[p18l417t3717r1018b3793],
18	monitoring	NN	O	monitoring	dobj	11	SENT_303	[p18l1040t3720r1449b3793],
19	and	CC	O	and	_	0	SENT_303	[p18l1470t3717r1601b3775],
20	therefore	RB	O	therefore	advmod	25	SENT_303	[p18l1623t3717r1943b3775],
21	these	DT	O	these	det	22	SENT_303	[p18l1966t3717r2148b3775],
22	factors	NNS	O	factor	nsubjpass	25	SENT_303	[p19l9t16r242b74],
23	should	MD	O	should	aux	25	SENT_303	[p19l277t17r516b74],
24	be	VB	O	be	auxpass	25	SENT_303	[p19l547t17r627b74],
25	used	VBN	O	use	conj_and	3	SENT_303	[p19l661t17r821b74],
26	in	IN	O	in	_	0	SENT_303	[p19l854t20r924b74],
27	future	JJ	DATE	future	amod	28	SENT_303	[p19l959t16r1170b74],
28	trials	NNS	O	trial	prep_in	25	SENT_303	[p19l1205t17r1377b74],
29	for	IN	O	for	_	0	SENT_303	[p19l1411t16r1510b74],
30	tailoring	VBG	O	tailor	prepc_for	25	SENT_303	[p19l1542t17r1846b92],
31	therapy	NN	O	therapy	dobj	30	SENT_303	[p19l1878t17r2151b92],
32	and	CC	O	and	_	0	SENT_303	[p19l9t112r141b169],
33	design	NN	O	design	dobj	30	SENT_303	[p19l181t112r408b187],
34	specifically	RB	O	specifically	advmod	30	SENT_303	[p19l450t111r840b187],
35	the	DT	O	the	det	36	SENT_303	[p19l878t112r991b169],
36	treatments	NNS	O	treatment	npadvmod	30	SENT_303	[p19l1032t119r1412b169],
37	for	IN	O	for	_	0	SENT_303	[p19l1453t111r1552b169],
38	patients	NNS	O	patient	prep_for	30	SENT_303	[p19l1590t115r1872b187],
39	with	IN	O	with	_	0	SENT_303	[p19l1912t112r2073b169],
40	a	DT	O	a	det	43	SENT_303	[p19l2114t128r2149b169],
41	given	VBN	O	give	amod	43	SENT_303	[p19l9t210r201b283],
42	biologic	JJ	O	biologic	amod	43	SENT_303	[p19l228t207r513b283],
43	feature	NN	O	feature	prep_with	38	SENT_303	[p19l542t207r803b265],
44	.	.	O	.	_	0	SENT_303	[p19l542t207r803b265],

1	Fluorouracil	NNP	O	Fluorouracil	nn	3	SENT_304	[p19l9t448r293b493],
2	outcome	NN	O	outcome	nn	3	SENT_304	[p19l313t453r524b493],
3	parameters	NNS	O	parameter	_	0	SENT_304	[p19l543t453r817b507],
4	mg	NN	O	mg	nn	6	SENT_304	[p19l2025t436r2151b560],
5	o	NN	O	o	nn	6	SENT_304	[p19l8t520r42b561],
6	Capitain	NNP	MISC	Capitain	dep	3	SENT_304	[p19l61t520r229b574],
7	et	FW	O	et	nn	8	SENT_304	[p19l251t524r287b561],
8	al	FW	O	al	dep	3	SENT_304	[p19l303t519r339b561],

1	Materials	NNPS	O	Materials	_	0	SENT_305	[p19l11t807r368b864],
2	and	CC	O	and	_	0	SENT_305	[p19l398t807r539b864],
3	methods	NNS	O	method	conj_and	1	SENT_305	[p19l573t807r907b864],

1	Patients	NNS	O	patient	nsubj	5	SENT_306	[p19l12t995r264b1051],
2	This	DT	O	this	det	4	SENT_306	[p19l7t1089r156b1147],
3	retrospective	JJ	O	retrospective	amod	4	SENT_306	[p19l204t1092r656b1165],
4	study	NN	O	study	dep	1	SENT_306	[p19l706t1089r899b1165],
5	included	VBD	O	include	_	0	SENT_306	[p19l943t1089r1252b1147],
6	76	CD	NUMBER	76	num	7	SENT_306	[p19l1304t1091r1382b1147],
7	patients	NNS	O	patient	dobj	5	SENT_306	[p19l1429t1092r1711b1165],
8	treated	VBN	O	treat	partmod	7	SENT_306	[p19l1759t1089r2004b1147],
9	for	IN	O	for	_	0	SENT_306	[p19l2051t1089r2149b1147],
10	advanced	JJ	O	advanced	amod	11	SENT_306	[p19l9t1184r343b1242],
11	CRC	NN	ORGANIZATION	crc	prep_for	8	SENT_306	[p19l371t1185r527b1242],
12	with	IN	O	with	prep	8	SENT_306	[p19l551t1184r713b1242],
13	two	CD	NUMBER	two	num	15	SENT_306	[p19l739t1191r869b1242],
14	different	JJ	O	different	amod	15	SENT_306	[p19l897t1184r1200b1242],
15	regimens	NNS	O	regimen	pobj	12	SENT_306	[p19l1226t1187r1565b1260],
16	,	,	O	,	_	0	SENT_306	[p19l1226t1187r1565b1260],
17	weekly	JJ	SET	weekly	conj_or	15	SENT_306	[p19l1594t1184r1840b1260],
18	or	CC	O	or	_	0	SENT_306	[p19l1864t1201r1936b1242],
19	every	DT	SET	every	det	21	SENT_306	[p19l1961t1201r2151b1260],
20	2	CD	SET	2	num	21	SENT_306	[p19l9t1280r48b1335],
21	weeks	NNS	NUMBER	week	conj_or	15	SENT_306	[p19l90t1278r316b1349],
22	,	,	O	,	_	0	SENT_306	[p19l90t1278r316b1349],
23	but	CC	O	but	_	0	SENT_306	[p19l363t1278r482b1336],
24	including	VBG	O	include	prep	8	SENT_306	[p19l525t1278r867b1354],
25	only	JJ	O	only	amod	26	SENT_306	[p19l911t1279r1071b1354],
26	ﬂuorouracil	NN	O	ﬂuorouracil	pobj	24	SENT_306	[p19l1112t1278r1526b1336],
27	and	CC	O	and	_	0	SENT_306	[p19l1572t1278r1703b1336],
28	leucovorin	NN	O	leucovorin	pobj	24	SENT_306	[p19l1746t1278r2144b1336],
29	.	.	O	.	_	0	SENT_306	[p19l1746t1278r2144b1336],

1	To	TO	O	to	aux	3	SENT_307	[p19l7t1376r91b1431],
2	be	VB	O	be	cop	3	SENT_307	[p19l117t1373r197b1431],
3	eligible	JJ	O	eligible	purpcl	8	SENT_307	[p19l225t1373r478b1449],
4	for	IN	O	for	_	0	SENT_307	[p19l506t1373r605b1431],
5	inclusion	NN	O	inclusion	prep_for	3	SENT_307	[p19l630t1373r977b1444],
6	,	,	O	,	_	0	SENT_307	[p19l630t1373r977b1444],
7	patients	NNS	O	patient	nsubj	21	SENT_307	[p19l1009t1376r1291b1449],
8	had	VBD	O	have	_	0	SENT_307	[p19l1319t1373r1450b1431],
9	to	TO	O	to	aux	10	SENT_307	[p19l1477t1381r1546b1431],
10	be	VB	O	be	xcomp	8	SENT_307	[p19l1572t1374r1653b1431],
11	over	IN	O	over	_	0	SENT_307	[p19l1681t1390r1833b1431],
12	18-years	NNS	DURATION	18-year	prep_over	10	SENT_307	[p19l1865t1375r2147b1449],
13	old	JJ	DURATION	old	amod	18	SENT_307	[p19l9t1469r137b1539],
14	,	,	O	,	_	0	SENT_307	[p19l9t1469r137b1539],
15	present	JJ	DATE	present	amod	18	SENT_307	[p19l177t1476r436b1545],
16	measurable	JJ	O	measurable	amod	18	SENT_307	[p19l471t1469r870b1527],
17	metastatic	JJ	O	metastatic	amod	18	SENT_307	[p19l906t1472r1269b1527],
18	lesions	NNS	O	lesion	dep	12	SENT_307	[p19l1304t1469r1562b1539],
19	,	,	O	,	_	0	SENT_307	[p19l1304t1469r1562b1539],
20	and	CC	O	and	_	0	SENT_307	[p19l1602t1469r1734b1527],
21	have	VBP	O	have	conj_and	8	SENT_307	[p19l1769t1469r1934b1527],
22	a	DT	O	a	det	24	SENT_307	[p19l1970t1486r2005b1527],
23	life	NN	O	life	nn	24	SENT_307	[p19l2040t1469r2147b1527],
24	expectancy	NN	O	expectancy	dobj	21	SENT_307	[p19l9t1571r409b1639],
25	of	IN	O	of	_	0	SENT_307	[p19l458t1563r530b1621],
26	at	IN	DURATION	at	quantmod	28	SENT_307	[p19l578t1571r642b1621],
27	least	JJS	DURATION	least	mwe	26	SENT_307	[p19l692t1563r850b1621],
28	3	CD	DURATION	3	num	29	SENT_307	[p19l902t1565r938b1621],
29	months	NNS	NUMBER	month	prep_of	24	SENT_307	[p19l993t1563r1285b1621],
30	.	.	O	.	_	0	SENT_307	[p19l993t1563r1285b1621],

1	It	PRP	O	it	nsubj	5	SENT_308	[p19l1341t1566r1393b1621],
2	was	VBD	O	be	cop	5	SENT_308	[p19l1443t1580r1570b1621],
3	a	DT	O	a	det	5	SENT_308	[p19l1624t1580r1658b1621],
4	first	JJ	ORDINAL	first	amod	5	SENT_308	[p19l1710t1563r1846b1621],
5	line	NN	O	line	_	0	SENT_308	[p19l1897t1563r2028b1621],
6	of	IN	O	of	_	0	SENT_308	[p19l2081t1563r2153b1621],
7	treatment	NN	O	treatment	prep_of	5	SENT_308	[p19l8t1666r359b1716],
8	for	IN	O	for	_	0	SENT_308	[p19l386t1658r485b1716],
9	83	CD	PERCENT	83	num	10	SENT_308	[p19l512t1660r664b1716],
10	%	NN	PERCENT	%	prep_for	7	SENT_308	[p19l512t1660r664b1716],
11	of	IN	O	of	_	0	SENT_308	[p19l692t1658r764b1716],
12	patients	NNS	O	patient	prep_of	10	SENT_308	[p19l786t1662r1086b1734],
13	,	,	O	,	_	0	SENT_308	[p19l786t1662r1086b1734],
14	and	CC	O	and	_	0	SENT_308	[p19l1120t1659r1251b1716],
15	a	DT	DURATION	a	det	19	SENT_308	[p19l1279t1675r1313b1716],
16	second	JJ	DURATION	second	amod	19	SENT_308	[p19l1342t1659r1586b1716],
17	or	CC	O	or	_	0	SENT_308	[p19l1614t1675r1685b1716],
18	more	RBR	O	more	conj_or	16	SENT_308	[p19l1711t1675r1892b1716],
19	line	NN	O	line	conj_and	5	SENT_308	[p19l1921t1659r2052b1716],
20	of	IN	O	of	_	0	SENT_308	[p19l2081t1658r2153b1716],
21	treatment	NN	O	treatment	prep_of	19	SENT_308	[p19l8t1761r359b1812],
22	for	IN	O	for	_	0	SENT_308	[p19l414t1754r512b1812],
23	17	CD	PERCENT	17	num	24	SENT_308	[p19l573t1756r738b1812],
24	%	NN	PERCENT	%	prep_for	21	SENT_308	[p19l573t1756r738b1812],
25	.	.	O	.	_	0	SENT_308	[p19l573t1756r738b1812],

1	All	DT	O	all	det	2	SENT_309	[p19l797t1754r894b1811],
2	patients	NNS	O	patient	nsubjpass	4	SENT_309	[p19l949t1757r1232b1830],
3	were	VBD	O	be	auxpass	4	SENT_309	[p19l1286t1771r1450b1812],
4	required	VBN	O	require	dep	13	SENT_309	[p19l1506t1754r1801b1830],
5	to	TO	O	to	aux	6	SENT_309	[p19l1857t1761r1926b1812],
6	have	VB	O	have	xcomp	4	SENT_309	[p19l1982t1754r2147b1812],
7	normal	JJ	O	normal	amod	9	SENT_309	[p19l8t1849r264b1906],
8	bone	NN	O	bone	nn	9	SENT_309	[p19l318t1849r494b1906],
9	marrow	NN	O	marrow	dobj	6	SENT_309	[p19l551t1865r825b1906],
10	and	CC	O	and	_	0	SENT_309	[p19l879t1849r1010b1906],
11	organ	NN	O	organ	nn	12	SENT_309	[p19l1066t1865r1267b1924],
12	functions	NNS	O	function	dobj	6	SENT_309	[p19l1323t1848r1658b1906],
13	(	VBP	O	(	_	0	SENT_309	[p19l1718t1849r2151b1924],
14	particularly	RB	O	particularly	advmod	13	SENT_309	[p19l1718t1849r2151b1924],
15	cardiac	JJ	O	cardiac	amod	17	SENT_309	[p19l9t1943r257b2001],
16	function	NN	O	function	nn	17	SENT_309	[p19l289t1943r618b2015],
17	)	NN	O	)	nsubj	13	SENT_309	[p19l289t1943r618b2015],
18	before	IN	O	before	_	0	SENT_309	[p19l652t1943r872b2001],
19	the	DT	O	the	det	20	SENT_309	[p19l905t1943r1017b2001],
20	administration	NN	O	administration	prep_before	17	SENT_309	[p19l1051t1943r1579b2001],
21	of	IN	O	of	_	0	SENT_309	[p19l1612t1943r1684b2001],
22	ﬂuorouracil	NN	O	ﬂuorouracil	prep_of	20	SENT_309	[p19l1711t1943r2143b2001],
23	.	.	O	.	_	0	SENT_309	[p19l1711t1943r2143b2001],

1	Performance	NNP	O	Performance	nn	2	SENT_310	[p19l9t2039r454b2097],
2	status	NN	O	status	nsubjpass	4	SENT_310	[p19l492t2046r691b2097],
3	was	VBD	O	be	auxpass	4	SENT_310	[p19l725t2056r853b2097],
4	evaluated	VBN	O	evaluate	_	0	SENT_310	[p19l889t2039r1228b2097],
5	as	IN	O	as	mark	6	SENT_310	[p19l1264t2056r1329b2097],
6	defined	VBN	O	define	advcl	4	SENT_310	[p19l1366t2039r1631b2097],
7	by	IN	O	by	_	0	SENT_310	[p19l1663t2039r1751b2115],
8	the	DT	O	the	det	12	SENT_310	[p19l1784t2039r1896b2097],
9	World	NNP	ORGANIZATION	World	nn	12	SENT_310	[p19l1931t2039r2149b2097],
10	Health	NNP	ORGANIZATION	Health	nn	12	SENT_310	[p19l9t2134r246b2192],
11	Organization	NNP	ORGANIZATION	Organization	nn	12	SENT_310	[p19l273t2135r738b2210],
12	(	NNP	O	(	prep_by	6	SENT_310	[p19l767t2134r1036b2206],
13	WHO	WP	O	who	dep	6	SENT_310	[p19l767t2134r1036b2206],
14	)	RB	O	)	advmod	13	SENT_310	[p19l767t2134r1036b2206],
15	.	.	O	.	_	0	SENT_310	[p19l767t2134r1036b2206],

1	Written	VBN	O	write	csubjpass	5	SENT_311	[p19l1065t2136r1338b2192],
2	informed	JJ	O	informed	amod	3	SENT_311	[p19l1364t2134r1692b2192],
3	consent	NN	O	consent	dobj	1	SENT_311	[p19l1718t2141r1996b2192],
4	was	VBD	O	be	auxpass	5	SENT_311	[p19l2020t2151r2147b2192],
5	obtained	VBN	O	obtain	_	0	SENT_311	[p19l9t2228r321b2286],
6	from	IN	O	from	_	0	SENT_311	[p19l362t2228r532b2286],
7	all	DT	O	all	det	8	SENT_311	[p19l574t2228r656b2286],
8	patients	NNS	O	patient	prep_from	5	SENT_311	[p19l697t2231r979b2304],
9	before	IN	O	before	_	0	SENT_311	[p19l1019t2228r1238b2286],
10	taking	VBG	O	take	prepc_before	5	SENT_311	[p19l1281t2228r1504b2304],
11	peripheral	JJ	O	peripheral	amod	13	SENT_311	[p19l1543t2228r1905b2304],
12	blood	NN	O	blood	nn	13	SENT_311	[p19l1944t2228r2149b2286],
13	samples	NNS	O	sample	dobj	10	SENT_311	[p19l10t2323r286b2399],
14	for	IN	O	for	_	0	SENT_311	[p19l312t2323r411b2381],
15	biomolecular	JJ	O	biomolecular	amod	16	SENT_311	[p19l433t2323r904b2381],
16	analysis	NN	O	analysis	prep_for	10	SENT_311	[p19l929t2323r1223b2399],
17	.	.	O	.	_	0	SENT_311	[p19l929t2323r1223b2399],

1	A	DT	O	a	det	3	SENT_312	[p19l1252t2325r1303b2380],
2	computed	JJ	O	computed	amod	3	SENT_312	[p19l1328t2323r1686b2399],
3	tomography	NN	O	tomography	nsubjpass	6	SENT_312	[p19l1711t2323r2150b2399],
4	scan	VB	O	scan	dep	3	SENT_312	[p19l10t2436r162b2477],
5	was	VBD	O	be	auxpass	6	SENT_312	[p19l191t2436r320b2477],
6	performed	VBN	O	perform	_	0	SENT_312	[p19l350t2419r720b2495],
7	before	IN	O	before	mark	16	SENT_312	[p19l749t2419r968b2477],
8	the	DT	O	the	det	9	SENT_312	[p19l1000t2419r1113b2477],
9	beginning	NN	O	beginning	nsubjpass	16	SENT_312	[p19l1143t2419r1507b2495],
10	of	IN	O	of	_	0	SENT_312	[p19l1537t2419r1609b2477],
11	treatment	NN	O	treatment	nn	14	SENT_312	[p19l1635t2426r1986b2477],
12	and	CC	O	and	_	0	SENT_312	[p19l2018t2419r2148b2477],
13	metastatic	JJ	O	metastatic	conj_and	11	SENT_312	[p19l8t2515r372b2569],
14	lesions	NNS	O	lesion	prep_of	9	SENT_312	[p19l401t2512r641b2569],
15	were	VBD	O	be	auxpass	16	SENT_312	[p19l669t2529r833b2569],
16	measured	VBN	O	measure	advcl	6	SENT_312	[p19l863t2512r1220b2569],
17	.	.	O	.	_	0	SENT_312	[p19l863t2512r1220b2569],

1	Chemotherapy	NN	O	chemotherapy	nn	3	SENT_313	[p19l13t2705r485b2781],
2	regimen	NN	O	regimen	nn	3	SENT_313	[p19l510t2707r765b2781],
3	description	NN	O	description	_	0	SENT_313	[p19l796t2705r1139b2781],
4	Two	CD	NUMBER	two	num	5	SENT_313	[p19l7t2803r154b2858],
5	regimens	NNS	O	regimen	nsubjpass	11	SENT_313	[p19l193t2804r513b2876],
6	of	IN	O	of	_	0	SENT_313	[p19l553t2800r625b2858],
7	5-FU	NN	O	5-fu	prep_of	5	SENT_313	[p19l660t2803r823b2858],
8	plus	CC	O	plus	prep	7	SENT_313	[p19l861t2801r1005b2876],
9	leucovorin	NN	O	leucovorin	dep	8	SENT_313	[p19l1043t2801r1423b2858],
10	were	VBD	O	be	auxpass	11	SENT_313	[p19l1459t2817r1623b2858],
11	administered	VBN	O	administer	rcmod	3	SENT_313	[p19l1662t2801r2143b2871],
12	,	,	O	,	_	0	SENT_313	[p19l1662t2801r2143b2871],
13	either	CC	O	either	dep	11	SENT_313	[p19l9t2896r214b2954],
14	by	IN	O	by	conj	11	SENT_313	[p19l233t2896r321b2972],
15	a	DT	O	a	det	18	SENT_313	[p19l341t2913r376b2954],
16	weekly	JJ	SET	weekly	amod	18	SENT_313	[p19l396t2896r642b2972],
17	4-h	JJ	O	4-h	amod	18	SENT_313	[p19l662t2896r777b2953],
18	5-FU	NN	O	5-fu	pobj	14	SENT_313	[p19l801t2898r964b2954],
19	continuous	JJ	O	continuous	amod	25	SENT_313	[p19l987t2899r1388b2954],
20	infusion	NN	O	infusion	nn	25	SENT_313	[p19l1411t2896r1705b2954],
21	(	CD	NUMBER	(	num	25	SENT_313	[p19l1731t2896r1997b2968],
22	FUFOL	NN	ORGANIZATION	fufol	nn	25	SENT_313	[p19l1731t2896r1997b2968],
23	4	CD	NUMBER	4	num	25	SENT_313	[p19l2019t2898r2057b2953],
24	h	NN	O	h	nn	25	SENT_313	[p19l2075t2896r2145b2968],
25	)	NN	O	)	nsubj	30	SENT_313	[p19l2075t2896r2145b2968],
26	through	IN	O	through	_	0	SENT_313	[p19l8t2989r297b3064],
27	a	DT	O	a	det	29	SENT_313	[p19l332t3006r366b3046],
28	battery	NN	O	battery	nn	29	SENT_313	[p19l397t2989r985b3064],
29	—	NN	O	—	prep_through	30	SENT_313	[p19l397t2989r985b3064],
30	operated	VBD	O	operate	rcmod	18	SENT_313	[p19l397t2989r985b3064],
31	pump	NN	O	pump	dobj	30	SENT_313	[p19l1017t3006r1226b3064],
32	after	IN	O	after	_	0	SENT_313	[p19l1261t2988r1419b3046],
33	100	CD	NUMBER	100	num	34	SENT_313	[p19l1457t2990r1579b3046],
34	mg/m2	NN	O	mg/m2	prep_after	30	SENT_313	[p19l1596t2981r1842b3064],
35	intravenous	JJ	O	intravenous	amod	34	SENT_313	[p19l1875t2992r2147b3047, p20l8t34r177b75],

1	bolus	NN	O	bolus	nsubj	15	SENT_314	[p20l214t17r404b75],
2	of	IN	O	of	_	0	SENT_314	[p20l443t17r514b75],
3	leucovorin	NN	O	leucovorin	prep_of	1	SENT_314	[p20l548t17r945b87],
4	,	,	O	,	_	0	SENT_314	[p20l548t17r945b87],
5	or	CC	O	or	_	0	SENT_314	[p20l988t34r1060b75],
6	every	DT	SET	every	det	12	SENT_314	[p20l1097t34r1286b93],
7	2	CD	SET	2	num	8	SENT_314	[p20l1323t18r1362b74],
8	weeks	NNS	NUMBER	week	tmod	9	SENT_314	[p20l1398t17r1605b75],
9	46-h	JJ	O	46-h	amod	12	SENT_314	[p20l1644t17r1804b75],
10	so-called	JJ	O	so-called	amod	12	SENT_314	[p20l1843t17r2148b75],
11	LVSFUZ	JJ	O	lvsfuz	amod	12	SENT_314	[p20l9t111r284b167],
12	(	NN	O	(	conj_or	1	SENT_314	[p20l331t110r455b181],
13	‘	CD	NUMBER	‘	dep	15	SENT_314	[p20l331t110r455b181],
14	de	FW	O	de	nn	15	SENT_314	[p20l331t110r455b181],
15	Gramont	FW	O	gramont	_	0	SENT_314	[p20l500t109r840b167],
16	’	FW	O	’	dep	15	SENT_314	[p20l500t109r840b167],
17	tailored	VBN	O	tailor	partmod	16	SENT_314	[p20l884t110r1156b167],
18	regimen	NNS	O	regimen	dobj	17	SENT_314	[p20l1199t110r1512b185],
19	)	RB	O	)	advmod	17	SENT_314	[p20l1199t110r1512b185],
20	after	IN	O	after	_	0	SENT_314	[p20l1559t109r1718b167],
21	200	CD	NUMBER	200	num	22	SENT_314	[p20l1760t111r1887b167],
22	mg/m2	NN	O	mg/m2	prep_after	17	SENT_314	[p20l1903t102r2149b185],
23	intravenous	JJ	O	intravenous	amod	24	SENT_314	[p20l8t207r429b262],
24	bolus	NN	O	bolus	nsubj	42	SENT_314	[p20l471t204r661b262],
25	of	IN	O	of	_	0	SENT_314	[p20l706t204r778b262],
26	leucovorin	NN	O	leucovorin	prep_of	24	SENT_314	[p20l817t204r1197b262],
27	and	CC	O	and	_	0	SENT_314	[p20l1241t204r1372b262],
28	400	CD	NUMBER	400	num	30	SENT_314	[p20l1416t205r1543b262],
29	mg/m2	NN	O	mg/m2	nn	30	SENT_314	[p20l1560t196r1805b280],
30	bolus	NN	O	bolus	nsubj	42	SENT_314	[p20l1846t204r2036b262],
31	of	IN	O	of	_	0	SENT_314	[p20l2081t204r2152b262],
32	5-FU	NN	O	5-fu	prep_of	30	SENT_314	[p20l10t291r307b356],
33	.4	CD	NUMBER	.4	number	34	SENT_314	[p20l10t291r307b356],
34	'31	CD	NUMBER	'31	dep	30	SENT_314	[p20l10t291r307b356],
35	The	DT	O	the	det	37	SENT_314	[p20l343t298r476b356],
36	initial	JJ	O	initial	amod	37	SENT_314	[p20l510t298r720b356],
37	dose	NN	O	dose	dep	34	SENT_314	[p20l755t298r911b356],
38	was	VBD	O	be	cop	42	SENT_314	[p20l943t315r1071b356],
39	1200	CD	DATE	1200	num	42	SENT_314	[p20l1112t300r1277b356],
40	or	CC	DATE	or	_	0	SENT_314	[p20l1312t315r1384b356],
41	2500	CD	DATE	2500	num	42	SENT_314	[p20l1417t300r1588b356],
42	mg/m2	NN	O	mg/m2	rcmod	22	SENT_314	[p20l1605t291r1867b374],
43	,	,	O	,	_	0	SENT_314	[p20l1605t291r1867b374],
44	respectively	RB	O	respectively	advmod	42	SENT_314	[p20l1906t315r2147b374, p20l8t393r216b469],
45	.	.	O	.	_	0	SENT_314	[p20l1906t315r2147b374, p20l8t393r216b469],

1	Previous	JJ	O	previous	amod	2	SENT_315	[p20l269t396r565b451],
2	studies	NNS	O	study	nsubj	3	SENT_315	[p20l615t393r855b451],
3	showed	VBD	O	show	_	0	SENT_315	[p20l905t393r1171b451],
4	a	DT	O	a	det	6	SENT_315	[p20l1219t410r1254b451],
5	significant	JJ	O	significant	amod	6	SENT_315	[p20l1303t393r1674b469],
6	relationship	NN	O	relationship	dobj	3	SENT_315	[p20l1722t393r2148b469],
7	between	IN	O	between	_	0	SENT_315	[p20l6t489r303b547],
8	5-FU	JJ	O	5-fu	amod	9	SENT_315	[p20l330t491r493b547],
9	area	NN	O	area	prep_between	6	SENT_315	[p20l519t506r660b547],
10	under	IN	O	under	_	0	SENT_315	[p20l684t489r894b547],
11	curve	NN	O	curve	nn	14	SENT_315	[p20l917t506r1107b547],
12	(	CD	NUMBER	(	num	14	SENT_315	[p20l1136t489r1349b561],
13	AUC	NN	O	auc	nn	14	SENT_315	[p20l1136t489r1349b561],
14	)	NN	O	)	prep_under	3	SENT_315	[p20l1136t489r1349b561],
15	in	IN	O	in	_	0	SENT_315	[p20l1377t492r1447b546],
16	plasma	NN	O	plasma	prep_in	3	SENT_315	[p20l1472t489r1721b565],
17	and	CC	O	and	_	0	SENT_315	[p20l1746t489r1877b547],
18	on	IN	O	on	_	0	SENT_315	[p20l1903t506r1993b547],
19	one	CD	NUMBER	one	num	21	SENT_315	[p20l2019t506r2148b547],
20	hand	NN	O	hand	nn	21	SENT_315	[p20l8t584r191b642],
21	tolerance	NN	O	tolerance	prep_on	37	SENT_315	[p20l244t584r570b642],
22	and	CC	O	and	_	0	SENT_315	[p20l627t584r758b642],
23	on	IN	O	on	_	0	SENT_315	[p20l813t601r904b642],
24	the	DT	O	the	det	27	SENT_315	[p20l959t584r1071b642],
25	other	JJ	O	other	amod	27	SENT_315	[p20l1127t584r1316b642],
26	hand	NN	O	hand	nn	27	SENT_315	[p20l1369t584r1552b642],
27	efficacy	NN	O	efficacy	conj_and	21	SENT_315	[p20l1606t584r1875b660],
28	and	CC	O	and	_	0	SENT_315	[p20l1928t584r2059b642],
29	a	DT	O	a	det	31	SENT_315	[p20l2114t601r2149b642],
30	targeted	VBN	O	target	amod	31	SENT_315	[p20l8t677r295b752],
31	AUC	NN	O	auc	conj_and	27	SENT_315	[p20l325t678r491b734],
32	of	IN	O	of	_	0	SENT_315	[p20l523t676r594b734],
33	25	CD	NUMBER	25	num	34	SENT_315	[p20l622t678r701b734],
34	mghl	NN	O	mghl	prep_of	31	SENT_315	[p20l721t670r1005b752],
35	‘	NN	O	‘	nsubj	37	SENT_315	[p20l721t670r1005b752],
36	1	CD	NUMBER	1	num	35	SENT_315	[p20l721t670r1005b752],
37	had	VBD	O	have	conj_and	3	SENT_315	[p20l1040t677r1171b734],
38	be	VB	O	be	auxpass	39	SENT_315	[p20l1200t677r1280b734],
39	determined	VBN	O	determine	ccomp	37	SENT_315	[p20l1313t677r1738b747],
40	,	,	O	,	_	0	SENT_315	[p20l1313t677r1738b747],
41	suitable	JJ	O	suitable	amod	47	SENT_315	[p20l1776t677r2046b734],
42	to	TO	O	to	_	0	SENT_315	[p20l2078t684r2148b734],
43	different	JJ	O	different	amod	44	SENT_315	[p20l9t771r313b829],
44	kinds	NNS	O	kind	prep_to	41	SENT_315	[p20l357t771r546b829],
45	of	IN	O	of	_	0	SENT_315	[p20l592t771r663b829],
46	5-FU	NN	O	5-fu	prep_of	44	SENT_315	[p20l705t774r868b829],
47	infusions	NNS	O	infusion	dobj	39	SENT_315	[p20l914t764r1327b829],
48	.	.	O	.	_	0	SENT_315	[p20l914t764r1327b829],

1	”	NN	O	”	ccomp	7	SENT_316	[p20l914t764r1327b829],
2	Thus	RB	O	thus	advmod	1	SENT_316	[p20l1370t771r1561b841],
3	,	,	O	,	_	0	SENT_316	[p20l1370t771r1561b841],
4	5-FU	NN	O	5-fu	nn	5	SENT_316	[p20l1612t774r1775b829],
5	dose	NN	O	dose	nsubjpass	7	SENT_316	[p20l1820t771r1976b829],
6	was	VBD	O	be	auxpass	7	SENT_316	[p20l2020t788r2148b829],
7	tailored	VBN	O	tailor	_	0	SENT_316	[p20l8t867r280b925],
8	to	TO	O	to	aux	9	SENT_316	[p20l309t874r378b925],
9	reach	VB	O	reach	xcomp	7	SENT_316	[p20l408t867r599b925],
10	this	DT	O	this	det	11	SENT_316	[p20l628t867r757b925],
11	AUC	NN	O	auc	dobj	9	SENT_316	[p20l786t868r952b925],
12	using	VBG	O	use	partmod	11	SENT_316	[p20l981t870r1173b943],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_316	[p20l1201t867r1802b943],
14	monitoring	NN	O	monitoring	dobj	12	SENT_316	[p20l1831t870r2148b925, p20l8t963r121b1036],
15	as	IN	O	as	mark	16	SENT_316	[p20l157t977r221b1018],
16	described	VBN	O	describe	dep	14	SENT_316	[p20l259t960r591b1018],
17	previously	RB	DATE	previously	advmod	16	SENT_316	[p20l626t953r1073b1036],
18	.33	CD	NUMBER	.33	dobj	16	SENT_316	[p20l626t953r1073b1036],
19	Brieﬂy	NNP	O	Brieﬂy	tmod	12	SENT_316	[p20l1112t960r1350b1036],
20	,	,	O	,	_	0	SENT_316	[p20l1112t960r1350b1036],
21	5	CD	NUMBER	5	appos	19	SENT_316	[p20l1393t962r1556b1018],
22	.	.	O	.	_	0	SENT_316	[p20l1393t962r1556b1018],

1	—	NN	O	—	_	0	SENT_317	[p20l1393t962r1556b1018],
2	.	.	O	.	_	0	SENT_317	[p20l1393t962r1556b1018],

1	FU	NNP	O	FU	nsubjpass	6	SENT_318	[p20l1393t962r1556b1018],
2	individual	JJ	O	individual	amod	4	SENT_318	[p20l1592t960r1955b1018],
3	dose	NN	O	dose	nn	4	SENT_318	[p20l1992t960r2148b1018],
4	management	NN	O	management	dep	1	SENT_318	[p20l8t1063r475b1131],
5	was	VBD	O	be	auxpass	6	SENT_318	[p20l507t1072r635b1113],
6	performed	VBN	O	perform	_	0	SENT_318	[p20l670t1055r1040b1131],
7	weekly	JJ	SET	weekly	dobj	6	SENT_318	[p20l1072t1056r1318b1131],
8	or	CC	O	or	_	0	SENT_318	[p20l1351t1072r1422b1113],
9	bi-weekly	JJ	SET	bi-weekly	dobj	6	SENT_318	[p20l1454t1055r1794b1131],
10	based	VBN	O	base	_	0	SENT_318	[p20l1824t1055r2022b1113],
11	on	IN	O	on	prepc_based_on	6	SENT_318	[p20l2057t1072r2148b1113],
12	5	CD	NUMBER	5	pobj	6	SENT_318	[p20l10t1153r173b1209],
13	.	.	O	.	_	0	SENT_318	[p20l10t1153r173b1209],

1	—	NN	O	—	_	0	SENT_319	[p20l10t1153r173b1209],
2	.	.	O	.	_	0	SENT_319	[p20l10t1153r173b1209],

1	FU	NNP	O	FU	nsubjpass	36	SENT_320	[p20l10t1153r173b1209],
2	steady	JJ	O	steady	amod	6	SENT_320	[p20l220t1151r630b1227],
3	—	NN	O	—	nn	6	SENT_320	[p20l220t1151r630b1227],
4	state	NN	O	state	nn	6	SENT_320	[p20l220t1151r630b1227],
5	plasma	NN	O	plasma	nn	6	SENT_320	[p20l675t1151r924b1227],
6	concentrations	NNS	O	concentration	nsubjpass	32	SENT_320	[p20l968t1154r1499b1209],
7	measured	VBN	O	measure	dep	6	SENT_320	[p20l1544t1151r1883b1209],
8	at	IN	O	at	_	0	SENT_320	[p20l1928t1158r1991b1209],
9	the	DT	O	the	det	11	SENT_320	[p20l2035t1151r2147b1209],
10	previous	JJ	O	previous	amod	11	SENT_320	[p20l8t1249r307b1322],
11	administration	NN	O	administration	prep_at	7	SENT_320	[p20l359t1246r904b1316],
12	,	,	O	,	_	0	SENT_320	[p20l359t1246r904b1316],
13	at	IN	O	at	_	0	SENT_320	[p20l960t1253r1023b1304],
14	3h	NN	O	3h	prep_at	7	SENT_320	[p20l1075t1246r1176b1304],
15	for	IN	O	for	_	0	SENT_320	[p20l1226t1246r1324b1304],
16	weekly	JJ	SET	weekly	amod	17	SENT_320	[p20l1372t1246r1618b1322],
17	5-FU	NN	O	5-fu	prep_for	14	SENT_320	[p20l1667t1248r1831b1304],
18	or	CC	O	or	_	0	SENT_320	[p20l1881t1263r1953b1304],
19	43h	JJ	O	43h	amod	20	SENT_320	[p20l2002t1246r2149b1304],
20	infusion	NN	O	infusion	conj_or	14	SENT_320	[p20l8t1340r302b1398],
21	for	IN	O	for	_	0	SENT_320	[p20l359t1340r457b1398],
22	LVSFUZ	NNP	O	LVSFUZ	prep_for	20	SENT_320	[p20l513t1342r789b1398],
23	and	CC	O	and	_	0	SENT_320	[p20l846t1340r977b1398],
24	guided	VBN	O	guide	dep	6	SENT_320	[p20l1033t1340r1273b1416],
25	by	IN	O	by	_	0	SENT_320	[p20l1327t1341r1414b1416],
26	a	DT	O	a	det	30	SENT_320	[p20l1469t1357r1503b1398],
27	dose-adjustment	JJ	O	dose-adjustment	amod	30	SENT_320	[p20l1560t1340r2148b1416],
28	chart	NN	O	chart	nn	30	SENT_320	[p20l9t1427r278b1492],
29	.32	CD	NUMBER	.32	num	30	SENT_320	[p20l9t1427r278b1492],
30	Treatment	NN	O	treatment	prep_by	24	SENT_320	[p20l328t1437r694b1492],
31	was	VBD	O	be	auxpass	32	SENT_320	[p20l744t1451r872b1492],
32	continued	VBN	O	continue	rcmod	1	SENT_320	[p20l925t1434r1288b1492],
33	until	IN	O	until	_	0	SENT_320	[p20l1338t1434r1510b1492],
34	progression	NN	O	progression	prep_until	32	SENT_320	[p20l1561t1437r1970b1510],
35	was	VBD	O	be	auxpass	36	SENT_320	[p20l2020t1451r2147b1492],
36	documented	VBN	O	document	_	0	SENT_320	[p20l9t1530r473b1588],
37	.	.	O	.	_	0	SENT_320	[p20l9t1530r473b1588],

1	Then	RB	O	then	advmod	13	SENT_321	[p20l509t1530r710b1601],
2	,	,	O	,	_	0	SENT_321	[p20l509t1530r710b1601],
3	a	DT	O	a	det	5	SENT_321	[p20l750t1547r785b1588],
4	second-line	JJ	O	second-line	amod	5	SENT_321	[p20l820t1530r1224b1588],
5	therapy	NN	O	therapy	nsubjpass	13	SENT_321	[p20l1259t1530r1532b1606],
6	combining	VBG	O	combine	partmod	5	SENT_321	[p20l1564t1530r1950b1606],
7	5-FU	NN	O	5-fu	dobj	6	SENT_321	[p20l1985t1533r2148b1588],
8	to	TO	O	to	_	0	SENT_321	[p20l8t1634r78b1684],
9	oxaliplatin	NN	O	oxaliplatin	prep_to	6	SENT_321	[p20l109t1627r492b1702],
10	or	CC	O	or	_	0	SENT_321	[p20l523t1643r594b1684],
11	irinotecan	NN	O	irinotecan	prep_to	6	SENT_321	[p20l622t1630r985b1684],
12	was	VBD	O	be	auxpass	13	SENT_321	[p20l1013t1643r1141b1684],
13	proposed	VBN	O	propose	_	0	SENT_321	[p20l1170t1627r1513b1702],
14	.	.	O	.	_	0	SENT_321	[p20l1170t1627r1513b1702],

1	Fo	NN	O	fo	nsubjpass	16	SENT_322	[p20l12t1819r317b1895],
2	/	:	O	/	punct	10	SENT_322	[p20l12t1819r317b1895],
3	/	:	O	/	punct	6	SENT_322	[p20l12t1819r317b1895],
4	ow-up	JJ	O	ow-up	amod	6	SENT_322	[p20l12t1819r317b1895],
5	Every	DT	SET	every	det	6	SENT_322	[p20l9t1918r204b1991],
6	week	NN	SET	week	dep	10	SENT_322	[p20l237t1915r417b1973],
7	or	CC	O	or	_	0	SENT_322	[p20l453t1932r524b1973],
8	every	DT	SET	every	det	9	SENT_322	[p20l562t1932r751b1991],
9	2	CD	SET	2	conj_or	6	SENT_322	[p20l788t1917r827b1972],
10	weeks	NNS	NUMBER	week	dep	1	SENT_322	[p20l863t1915r1088b1985],
11	,	,	O	,	_	0	SENT_322	[p20l863t1915r1088b1985],
12	a	DT	O	a	det	14	SENT_322	[p20l1132t1932r1166b1973],
13	physical	JJ	O	physical	amod	14	SENT_322	[p20l1204t1915r1494b1991],
14	examination	NN	O	examination	appos	10	SENT_322	[p20l1533t1918r1984b1973],
15	was	VBD	O	be	auxpass	16	SENT_322	[p20l2020t1932r2147b1973],
16	performed	VBN	O	perform	_	0	SENT_322	[p20l8t2010r377b2086],
17	and	CC	O	and	_	0	SENT_322	[p20l427t2010r558b2068],
18	toxic	JJ	O	toxic	amod	20	SENT_322	[p20l607t2013r783b2068],
19	adverse	JJ	O	adverse	amod	20	SENT_322	[p20l833t2010r1091b2068],
20	events	NNS	O	event	nsubjpass	22	SENT_322	[p20l1143t2017r1366b2068],
21	were	VBD	O	be	auxpass	22	SENT_322	[p20l1414t2027r1578b2068],
22	evaluated	VBN	O	evaluate	conj_and	16	SENT_322	[p20l1629t2010r1968b2068],
23	and	CC	O	and	_	0	SENT_322	[p20l2018t2010r2149b2068],
24	graded	VBN	O	grade	conj_and	22	SENT_322	[p20l8t2105r263b2181],
25	.	.	O	.	_	0	SENT_322	[p20l8t2105r263b2181],

1	Treatment	NN	O	treatment	nn	2	SENT_323	[p20l318t2107r685b2163],
2	efficacy	NN	O	efficacy	nsubjpass	4	SENT_323	[p20l739t2105r1007b2181],
3	was	VBD	O	be	auxpass	4	SENT_323	[p20l1056t2122r1185b2163],
4	evaluated	VBN	O	evaluate	_	0	SENT_323	[p20l1239t2105r1577b2163],
5	by	IN	O	by	_	0	SENT_323	[p20l1628t2105r1716b2181],
6	comparing	VBG	O	compare	agent	4	SENT_323	[p20l1767t2108r2149b2181],
7	metastatic	JJ	O	metastatic	amod	9	SENT_323	[p20l8t2201r372b2255],
8	lesion	NN	O	lesion	nn	9	SENT_323	[p20l410t2198r619b2255],
9	measurements	NNS	O	measurement	dobj	6	SENT_323	[p20l657t2206r1169b2255],
10	before	IN	O	before	_	0	SENT_323	[p20l1206t2198r1425b2255],
11	and	CC	O	and	_	0	SENT_323	[p20l1465t2198r1597b2255],
12	after	IN	O	after	_	0	SENT_323	[p20l1635t2198r1793b2255],
13	3months	NNS	O	3month	prep_before	6	SENT_323	[p20l1831t2198r2148b2255],
14	then	RB	O	then	advmod	16	SENT_323	[p20l8t2293r172b2351],
15	every	DT	O	every	det	16	SENT_323	[p20l203t2310r392b2369],
16	semester	NN	O	semester	tmod	6	SENT_323	[p20l422t2301r738b2351],
17	.	.	O	.	_	0	SENT_323	[p20l422t2301r738b2351],

1	Data	NNS	O	datum	nsubjpass	3	SENT_324	[p20l773t2296r936b2351],
2	were	VBD	O	be	auxpass	3	SENT_324	[p20l964t2310r1127b2351],
3	collected	VBN	O	collect	_	0	SENT_324	[p20l1160t2293r1476b2351],
4	until	IN	O	until	_	0	SENT_324	[p20l1505t2293r1676b2351],
5	the	DT	O	the	det	6	SENT_324	[p20l1707t2293r1819b2351],
6	death	NN	O	death	prep_until	3	SENT_324	[p20l1852t2293r2050b2351],
7	of	IN	O	of	_	0	SENT_324	[p20l2081t2293r2153b2351],
8	the	DT	O	the	det	9	SENT_324	[p20l8t2389r121b2447],
9	patient	NN	O	patient	prep_of	6	SENT_324	[p20l168t2392r420b2465],
10	or	CC	O	or	_	0	SENT_324	[p20l467t2406r538b2447],
11	until	IN	O	until	_	0	SENT_324	[p20l583t2389r753b2447],
12	the	DT	O	the	det	13	SENT_324	[p20l800t2389r913b2447],
13	study	NN	O	study	poss	17	SENT_324	[p20l962t2389r1200b2465],
14	’s	POS	O	’s	_	0	SENT_324	[p20l962t2389r1200b2465],
15	date	NN	O	date	nn	17	SENT_324	[p20l1248t2389r1395b2447],
16	point	NN	O	point	nn	17	SENT_324	[p20l1442t2392r1633b2465],
17	(	NN	O	(	conj_or	6	SENT_324	[p20l1683t2389r1741b2461],
18	1	CD	DATE	1	dep	17	SENT_324	[p20l1683t2389r1741b2461],
19	December	NNP	DATE	December	tmod	17	SENT_324	[p20l1794t2389r2149b2447],
20	2004	CD	DATE	2004	num	19	SENT_324	[p20l9t2483r225b2555],
21	)	CD	NUMBER	)	dep	3	SENT_324	[p20l9t2483r225b2555],

1	Assessment	NNP	O	Assessment	nsubjpass	7	SENT_325	[p20l7t2678r372b2733],
2	of	IN	O	of	_	0	SENT_325	[p20l399t2675r465b2733],
3	response	NN	O	response	prep_of	1	SENT_325	[p20l486t2692r762b2751],
4	The	DT	O	the	det	5	SENT_325	[p20l6t2771r139b2828],
5	response	NN	O	response	dep	3	SENT_325	[p20l164t2787r469b2846],
6	was	VBD	O	be	auxpass	7	SENT_325	[p20l493t2787r621b2828],
7	assessed	VBN	O	assess	_	0	SENT_325	[p20l647t2771r929b2828],
8	according	VBG	O	accord	_	0	SENT_325	[p20l954t2771r1301b2846],
9	to	TO	O	to	prepc_according_to	7	SENT_325	[p20l1324t2778r1394b2828],
10	Response	NN	O	response	nn	12	SENT_325	[p20l1420t2773r1743b2846],
11	Evaluation	NN	O	evaluation	nn	12	SENT_325	[p20l1769t2771r2148b2828],
12	Criteria	NNS	O	criterion	pobj	7	SENT_325	[p20l10t2868r274b2924],
13	in	IN	O	in	_	0	SENT_325	[p20l315t2869r385b2923],
14	Solid	JJ	O	solid	amod	15	SENT_325	[p20l427t2866r600b2924],
15	Tumors	NNS	O	tumor	prep_in	12	SENT_325	[p20l639t2868r905b2924],
16	Group	NNP	O	Group	nn	17	SENT_325	[p20l949t2868r1171b2942],
17	Criteria	NNP	O	Criteria	dep	15	SENT_325	[p20l1214t2868r1479b2924],
18	and	CC	O	and	_	0	SENT_325	[p20l1521t2866r1652b2924],
19	in	IN	O	in	_	0	SENT_325	[p20l1693t2869r1763b2923],
20	reviewing	VBG	O	review	conj_and	15	SENT_325	[p20l1804t2869r2150b2942],
21	computed	JJ	O	computed	amod	23	SENT_325	[p20l9t2961r367b3036],
22	tomography	NN	O	tomography	nn	23	SENT_325	[p20l406t2961r846b3036],
23	scans	NNS	O	scan	dobj	20	SENT_325	[p20l885t2977r1086b3018],
24	.	.	O	.	_	0	SENT_325	[p20l885t2977r1086b3018],

1	The	DT	O	the	det	2	SENT_326	[p20l1129t2961r1262b3018],
2	OS	NNP	O	OS	nsubjpass	4	SENT_326	[p20l1304t2962r1399b3018],
3	was	VBD	O	be	auxpass	4	SENT_326	[p20l1438t2977r1566b3018],
4	defined	VBN	O	define	_	0	SENT_326	[p20l1607t2960r1872b3018],
5	by	IN	O	by	_	0	SENT_326	[p20l1910t2961r1997b3036],
6	the	DT	O	the	det	7	SENT_326	[p20l2035t2961r2147b3018],
7	period	NN	O	period	agent	4	SENT_326	[p20l8t3056r234b3131],
8	between	IN	O	between	_	0	SENT_326	[p20l262t3056r559b3113],
9	the	DT	O	the	det	10	SENT_326	[p20l589t3056r702b3113],
10	date	NN	O	date	prep_between	7	SENT_326	[p20l733t3056r880b3113],
11	of	IN	O	of	_	0	SENT_326	[p20l912t3055r984b3113],
12	diagnosis	NN	O	diagnosis	prep_of	10	SENT_326	[p20l1010t3056r1337b3131],
13	and	CC	O	and	_	0	SENT_326	[p20l1369t3056r1500b3113],
14	the	DT	O	the	det	15	SENT_326	[p20l1530t3056r1642b3113],
15	date	NN	O	date	conj_and	10	SENT_326	[p20l1674t3056r1821b3113],
16	of	IN	O	of	_	0	SENT_326	[p20l1853t3055r1924b3113],
17	death	NN	O	death	prep_of	15	SENT_326	[p20l1950t3056r2148b3113],
18	regardless	RB	O	regardless	_	0	SENT_326	[p20l8t3151r352b3227],
19	of	IN	O	of	_	0	SENT_326	[p20l379t3151r451b3209],
20	the	DT	O	the	det	24	SENT_326	[p20l472t3151r585b3209],
21	cause	NN	O	cause	nn	24	SENT_326	[p20l613t3168r800b3209],
22	or	CC	O	or	_	0	SENT_326	[p20l828t3168r899b3209],
23	point	NN	O	point	nn	24	SENT_326	[p20l924t3154r1115b3227],
24	date	NN	O	date	prep_regardless_of	4	SENT_326	[p20l1141t3151r1307b3209],
25	.	.	O	.	_	0	SENT_326	[p20l1141t3151r1307b3209],

1	PFS	NN	O	pf	nsubjpass	3	SENT_327	[p20l1338t3153r1454b3209],
2	was	VBD	O	be	auxpass	3	SENT_327	[p20l1480t3168r1608b3209],
3	defined	VBN	O	define	_	0	SENT_327	[p20l1635t3151r1900b3209],
4	by	IN	O	by	_	0	SENT_327	[p20l1924t3151r2012b3227],
5	the	DT	O	the	agent	3	SENT_327	[p20l2035t3151r2147b3209],

1	@	IN	O	@	_	0	SENT_328	[p20l8t3582r135b3706],
2	Fluorouracil	NNP	O	Fluorouracil	nn	4	SENT_328	[p20l1341t3594r1625b3639],
3	outcome	NN	O	outcome	nn	4	SENT_328	[p20l1646t3599r1856b3639],
4	parameters	NNS	O	parameter	nn	5	SENT_328	[p20l1876t3599r2149b3653],
5	o	NN	O	o	pobj	1	SENT_328	[p20l1822t3666r1855b3707],
6	Capitain	NNP	MISC	Capitain	dep	5	SENT_328	[p20l1875t3666r2043b3720],
7	et	FW	O	et	nn	9	SENT_328	[p20l2065t3670r2101b3707],
8	al	FW	O	al	nn	9	SENT_328	[p20l2117t3665r2153b3707],
9	period	NN	O	period	dep	5	SENT_328	[p21l8t143r235b219],
10	between	IN	O	between	_	0	SENT_328	[p21l288t143r585b201],
11	the	DT	O	the	det	12	SENT_328	[p21l640t143r753b201],
12	date	NN	O	date	prep_between	9	SENT_328	[p21l810t143r957b201],
13	of	IN	O	of	_	0	SENT_328	[p21l1014t143r1085b201],
14	diagnosis	NN	O	diagnosis	prep_of	12	SENT_328	[p21l1137t143r1464b219],
15	and	CC	O	and	_	0	SENT_328	[p21l1521t143r1653b201],
16	the	DT	O	the	det	17	SENT_328	[p21l1708t143r1820b201],
17	date	NN	O	date	pobj	1	SENT_328	[p21l1878t143r2024b201],
18	of	IN	O	of	_	0	SENT_328	[p21l2081t143r2153b201],
19	progression	NN	O	progression	prep_of	17	SENT_328	[p21l8t242r417b315],
20	(	CD	NUMBER	(	num	19	SENT_328	[p21l452t239r749b311],
21	clinical	JJ	O	clinical	amod	27	SENT_328	[p21l452t239r749b311],
22	,	,	O	,	_	0	SENT_328	[p21l452t239r749b311],
23	biological	JJ	O	biological	conj_or	21	SENT_328	[p21l784t239r1130b315],
24	or	CC	O	or	_	0	SENT_328	[p21l1164t256r1235b297],
25	radiological	JJ	O	radiological	conj_or	21	SENT_328	[p21l1266t239r1681b315],
26	progression	NN	O	progression	nn	27	SENT_328	[p21l1712t239r2144b315],
27	)	NN	O	)	dep	17	SENT_328	[p21l1712t239r2144b315],
28	or	CC	O	or	_	0	SENT_328	[p21l9t350r81b390],
29	death	NN	O	death	conj_or	27	SENT_328	[p21l109t333r326b390],
30	.	.	O	.	_	0	SENT_328	[p21l109t333r326b390],

1	Assessment	NNP	O	Assessment	nsubjpass	23	SENT_329	[p21l7t547r372b601],
2	of	IN	O	of	_	0	SENT_329	[p21l400t544r466b601],
3	tolerance	NN	O	tolerance	prep_of	1	SENT_329	[p21l489t544r779b601],
4	All	DT	O	all	det	6	SENT_329	[p21l7t639r105b696],
5	adverse	JJ	O	adverse	amod	6	SENT_329	[p21l135t639r394b697],
6	events	NNS	O	event	dep	3	SENT_329	[p21l425t647r666b710],
7	,	,	O	,	_	0	SENT_329	[p21l425t647r666b710],
8	especially	RB	O	especially	advmod	10	SENT_329	[p21l701t639r1043b715],
9	gastrointestinal	JJ	O	gastrointestinal	amod	10	SENT_329	[p21l1070t639r1619b715],
10	events	NNS	O	event	dep	3	SENT_329	[p21l1649t647r1890b710],
11	,	,	O	,	_	0	SENT_329	[p21l1649t647r1890b710],
12	mucositis	NN	O	mucositis	dep	3	SENT_329	[p21l1924t656r2148b697, p21l10t738r161b805],
13	,	,	O	,	_	0	SENT_329	[p21l1924t656r2148b697, p21l10t738r161b805],
14	hand-foot	JJ	O	hand-foot	amod	15	SENT_329	[p21l233t735r586b793],
15	syndrome	NN	O	syndrome	conj_and	6	SENT_329	[p21l655t735r1023b811],
16	,	,	O	,	_	0	SENT_329	[p21l655t735r1023b811],
17	conjunctival	JJ	O	conjunctival	amod	18	SENT_329	[p21l1096t735r1540b811],
18	irritation	NN	O	irritation	conj_and	6	SENT_329	[p21l1608t738r1945b805],
19	,	,	O	,	_	0	SENT_329	[p21l1608t738r1945b805],
20	and	CC	O	and	_	0	SENT_329	[p21l2018t735r2149b793],
21	leukopenia	NN	O	leukopenia	conj_and	6	SENT_329	[p21l9t829r400b905],
22	were	VBD	O	be	auxpass	23	SENT_329	[p21l426t846r589b887],
23	recorded	VBN	O	record	_	0	SENT_329	[p21l618t829r925b887],
24	and	CC	O	and	_	0	SENT_329	[p21l954t829r1085b887],
25	graded	VBN	O	grade	conj_and	23	SENT_329	[p21l1113t829r1350b905],
26	for	IN	O	for	advmod	27	SENT_329	[p21l1378t829r1476b887],
27	severity	NN	O	severity	dobj	25	SENT_329	[p21l1505t832r1776b905],
28	according	VBG	O	accord	_	0	SENT_329	[p21l1802t829r2150b905],
29	to	TO	O	to	prepc_according_to	27	SENT_329	[p21l8t932r78b982],
30	WHO	WP	O	who	dep	31	SENT_329	[p21l99t926r300b982],
31	scales	NNS	O	scale	rcmod	27	SENT_329	[p21l324t925r537b982],
32	.	.	O	.	_	0	SENT_329	[p21l324t925r537b982],

1	Hemograms	NNS	O	hemogram	nsubjpass	3	SENT_330	[p21l564t927r990b1000],
2	were	VBD	O	be	auxpass	3	SENT_330	[p21l1011t941r1175b982],
3	performed	VBN	O	perform	_	0	SENT_330	[p21l1197t924r1566b1000],
4	every	DT	SET	every	det	5	SENT_330	[p21l1589t941r1778b1000],
5	week	NN	SET	week	tmod	3	SENT_330	[p21l1795t925r1990b995],
6	,	,	O	,	_	0	SENT_330	[p21l1795t925r1990b995],
7	and	CC	O	and	_	0	SENT_330	[p21l2018t925r2149b982],
8	ionograms	NN	O	ionogram	nn	16	SENT_330	[p21l9t1023r401b1096],
9	,	,	O	,	_	0	SENT_330	[p21l9t1023r401b1096],
10	urea	NN	O	urea	nn	16	SENT_330	[p21l449t1037r618b1090],
11	,	,	O	,	_	0	SENT_330	[p21l449t1037r618b1090],
12	creatinine	NN	O	creatinine	nn	16	SENT_330	[p21l668t1023r1022b1078],
13	and	CC	O	and	_	0	SENT_330	[p21l1069t1020r1200b1078],
14	liver	NN	O	liver	nn	16	SENT_330	[p21l1245t1020r1400b1078],
15	enzyme	NN	O	enzyme	nn	16	SENT_330	[p21l1445t1037r1716b1096],
16	tests	NNS	O	test	dep	19	SENT_330	[p21l1762t1027r1915b1078],
17	every	DT	SET	every	det	19	SENT_330	[p21l1962t1037r2151b1096],
18	2	CD	SET	2	num	19	SENT_330	[p21l10t1115r49b1170],
19	weeks	NNS	NUMBER	week	conj_and	3	SENT_330	[p21l76t1114r302b1171],
20	.	.	O	.	_	0	SENT_330	[p21l76t1114r302b1171],

1	In	IN	O	in	_	0	SENT_331	[p21l86t1211r159b1266],
2	the	DT	O	the	det	3	SENT_331	[p21l193t1209r305b1266],
3	event	NN	O	event	conj_and	3	SENT_331	[p21l342t1216r536b1266],
4	of	IN	O	of	_	0	SENT_331	[p21l570t1208r642b1266],
5	significant	JJ	O	significant	amod	8	SENT_331	[p21l674t1208r1045b1284],
6	grade	NN	O	grade	nn	8	SENT_331	[p21l1080t1209r1269b1284],
7	2	CD	NUMBER	2	num	8	SENT_331	[p21l1306t1210r1345b1266],
8	toxicity	NN	O	toxicity	prep_of	3	SENT_331	[p21l1380t1212r1662b1284],
9	,	,	O	,	_	0	SENT_331	[p21l1380t1212r1662b1284],
10	and	CC	O	and	_	0	SENT_331	[p21l1702t1209r1833b1266],
11	without	IN	O	without	_	0	SENT_331	[p21l1866t1209r2149b1266],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_331	[p21l8t1304r609b1380],
13	recommendations	NNS	O	recommendation	prep_without	3	SENT_331	[p21l638t1304r1282b1362],
14	for	IN	O	for	_	0	SENT_331	[p21l1312t1304r1411b1362],
15	a	DT	O	a	det	16	SENT_331	[p21l1440t1321r1474b1362],
16	decrease	NN	O	decrease	prep_for	13	SENT_331	[p21l1504t1304r1815b1374],
17	,	,	O	,	_	0	SENT_331	[p21l1504t1304r1815b1374],
18	the	DT	O	the	det	19	SENT_331	[p21l1849t1304r1961b1362],
19	dose	NN	O	dose	nsubjpass	21	SENT_331	[p21l1992t1304r2147b1362],
20	was	VBD	O	be	auxpass	21	SENT_331	[p21l7t1416r135b1457],
21	reduced	VBN	O	reduce	_	0	SENT_331	[p21l188t1399r468b1457],
22	by	IN	O	by	_	0	SENT_331	[p21l518t1399r606b1475],
23	10	CD	PERCENT	10	num	24	SENT_331	[p21l662t1400r828b1457],
24	%	NN	PERCENT	%	agent	21	SENT_331	[p21l662t1400r828b1457],
25	.	.	O	.	_	0	SENT_331	[p21l662t1400r828b1457],

1	In	IN	O	in	_	0	SENT_332	[p21l886t1401r958b1456],
2	cases	NNS	O	case	prep_in	11	SENT_332	[p21l1012t1416r1184b1457],
3	of	IN	O	of	_	0	SENT_332	[p21l1238t1399r1310b1457],
4	grade	NN	O	grade	nn	6	SENT_332	[p21l1359t1399r1548b1475],
5	3	CD	NUMBER	3	num	6	SENT_332	[p21l1603t1400r1639b1457],
6	toxicity	NN	O	toxicity	prep_of	2	SENT_332	[p21l1695t1402r1977b1475],
7	,	,	O	,	_	0	SENT_332	[p21l1695t1402r1977b1475],
8	the	DT	O	the	det	9	SENT_332	[p21l2035t1399r2148b1457],
9	treatment	NN	O	treatment	nsubjpass	11	SENT_332	[p21l8t1501r359b1552],
10	was	VBD	O	be	auxpass	11	SENT_332	[p21l394t1511r523b1552],
11	interrupted	VBN	O	interrupt	_	0	SENT_332	[p21l561t1494r964b1570],
12	until	IN	O	until	mark	16	SENT_332	[p21l1001t1494r1172b1552],
13	toxic	JJ	O	toxic	amod	14	SENT_332	[p21l1210t1497r1386b1552],
14	manifestations	NNS	O	manifestation	nsubjpass	18	SENT_332	[p21l1423t1494r1947b1552],
15	were	VBD	O	be	auxpass	16	SENT_332	[p21l1984t1511r2148b1552],
16	resolved	VBN	O	resolve	advcl	11	SENT_332	[p21l9t1587r300b1644],
17	and	CC	O	and	_	0	SENT_332	[p21l340t1587r471b1644],
18	restarted	VBN	O	restart	conj_and	16	SENT_332	[p21l510t1587r816b1644],
19	with	IN	O	with	_	0	SENT_332	[p21l853t1587r1015b1644],
20	a	DT	O	a	det	21	SENT_332	[p21l1055t1604r1089b1644],
21	decrease	NN	O	decrease	prep_with	16	SENT_332	[p21l1129t1587r1422b1644],
22	of	IN	O	of	_	0	SENT_332	[p21l1463t1587r1534b1644],
23	25	CD	PERCENT	25	num	24	SENT_332	[p21l1570t1589r1740b1644],
24	%	NN	PERCENT	%	prep_of	21	SENT_332	[p21l1570t1589r1740b1644],
25	.	.	O	.	_	0	SENT_332	[p21l1570t1589r1740b1644],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_333	[p21l1782t1590r2149b1644],
2	was	VBD	O	be	auxpass	3	SENT_333	[p21l7t1700r135b1741],
3	stopped	VBN	O	stop	_	0	SENT_333	[p21l167t1683r444b1759],
4	in	RP	O	in	prt	3	SENT_333	[p21l472t1686r543b1740],
5	cases	NNS	O	case	dobj	3	SENT_333	[p21l573t1700r745b1741],
6	of	IN	O	of	_	0	SENT_333	[p21l776t1683r847b1741],
7	grade	NN	O	grade	nn	9	SENT_333	[p21l872t1683r1062b1759],
8	4	CD	NUMBER	4	num	9	SENT_333	[p21l1093t1685r1131b1740],
9	toxicity	NN	O	toxicity	prep_of	5	SENT_333	[p21l1161t1686r1445b1759],
10	.	.	O	.	_	0	SENT_333	[p21l1161t1686r1445b1759],

1	Fluorouracil	NN	O	fluorouracil	nn	2	SENT_334	[p21l12t1895r384b1952],
2	clearance	NN	O	clearance	nsubjpass	7	SENT_334	[p21l410t1895r711b1952],
3	5-FU	JJ	O	5-fu	amod	4	SENT_334	[p21l10t1992r174b2048],
4	clearance	NN	O	clearance	dep	2	SENT_334	[p21l242t1990r569b2048],
5	was	VBD	O	be	auxpass	7	SENT_334	[p21l636t2007r764b2048],
6	systematically	RB	O	systematically	advmod	7	SENT_334	[p21l834t1990r1333b2066],
7	calculated	VBN	O	calculate	_	0	SENT_334	[p21l1398t1990r1755b2048],
8	for	IN	O	for	_	0	SENT_334	[p21l1823t1990r1921b2048],
9	each	DT	O	each	det	10	SENT_334	[p21l1988t1990r2149b2048],
10	patient	NN	O	patient	prep_for	7	SENT_334	[p21l8t2088r277b2161],
11	,	,	O	,	_	0	SENT_334	[p21l8t2088r277b2161],
12	especially	RB	O	especially	advmod	20	SENT_334	[p21l329t2085r672b2161],
13	since	IN	O	since	dep	20	SENT_334	[p21l717t2088r892b2143],
14	a	DT	O	a	det	16	SENT_334	[p21l940t2102r975b2143],
15	low	JJ	O	low	amod	16	SENT_334	[p21l1020t2085r1149b2143],
16	clearance	NN	O	clearance	nsubjpass	20	SENT_334	[p21l1194t2085r1522b2143],
17	can	MD	O	can	aux	20	SENT_334	[p21l1570t2102r1692b2143],
18	possibly	RB	O	possibly	advmod	20	SENT_334	[p21l1738t2085r2026b2161],
19	be	VB	O	be	auxpass	20	SENT_334	[p21l2068t2085r2148b2143],
20	linked	VBN	O	link	ccomp	7	SENT_334	[p21l9t2181r230b2239],
21	to	TO	O	to	_	0	SENT_334	[p21l258t2188r328b2239],
22	unknown	JJ	O	unknown	amod	24	SENT_334	[p21l356t2181r700b2239],
23	epigenetic	JJ	O	epigenetic	amod	24	SENT_334	[p21l729t2184r1092b2257],
24	factors	NNS	O	factor	prep_to	20	SENT_334	[p21l1120t2181r1353b2239],
25	that	WDT	O	that	nsubj	26	SENT_334	[p21l1383t2181r1526b2239],
26	enhance	VBP	O	enhance	rcmod	24	SENT_334	[p21l1555t2181r1853b2239],
27	the	DT	O	the	det	28	SENT_334	[p21l1883t2181r1996b2239],
28	risk	NN	O	risk	dobj	26	SENT_334	[p21l2026t2181r2150b2239],
29	of	IN	O	of	_	0	SENT_334	[p21l9t2276r81b2334],
30	toxicity	NN	O	toxicity	prep_of	28	SENT_334	[p21l106t2279r389b2352],
31	.	.	O	.	_	0	SENT_334	[p21l106t2279r389b2352],

1	This	DT	O	this	det	2	SENT_335	[p21l83t2372r233b2429],
2	clearance	NN	O	clearance	nsubjpass	4	SENT_335	[p21l272t2372r600b2429],
3	was	VBD	O	be	auxpass	4	SENT_335	[p21l638t2388r766b2429],
4	calculated	VBN	O	calculate	_	0	SENT_335	[p21l806t2372r1162b2429],
5	by	IN	O	by	_	0	SENT_335	[p21l1199t2372r1287b2447],
6	the	DT	O	the	det	9	SENT_335	[p21l1323t2372r1435b2429],
7	following	VBG	O	follow	amod	9	SENT_335	[p21l1474t2371r1813b2447],
8	pharmacological	JJ	O	pharmacological	amod	9	SENT_335	[p21l1850t2372r2148b2447, p21l9t2467r323b2543],
9	formula	NN	O	formulum	agent	4	SENT_335	[p21l352t2467r650b2525],
10	:	:	O	:	_	0	SENT_335	[p21l352t2467r650b2525],

1	Fluorouracil	NN	O	fluorouracil	nn	2	SENT_336	[p21l398t2572r786b2628],
2	clearance	NN	O	clearance	dep	7	SENT_336	[p21l803t2572r1094b2628],
3	[	CD	NUMBER	[	dep	2	SENT_336	[p21l1117t2569r1181b2646],
4	(	NN	O	(	dep	7	SENT_336	[p21l1117t2569r1181b2646],
5	1	CD	NUMBER	1	num	4	SENT_336	[p21l1117t2569r1181b2646],
6	X	NN	O	x	nn	7	SENT_336	[p21l1192t2589r1229b2626],
7	h	NN	O	h	dep	11	SENT_336	[p21l1243t2569r1307b2646],
8	)	CD	NUMBER	)	dep	7	SENT_336	[p21l1243t2569r1307b2646],
9	/	:	O	/	punct	11	SENT_336	[p21l1318t2556r1457b2646],
10	m2	CD	NUMBER	m2	num	11	SENT_336	[p21l1318t2556r1457b2646],
11	]	CD	NUMBER	]	_	0	SENT_336	[p21l1318t2556r1457b2646],

1	_	NNP	O	_	dep	9	SENT_337	[p21l476t2788r527b2791],
2	Continuous	JJ	O	continuous	amod	3	SENT_337	[p21l556t2712r920b2766],
3	infusion	NN	O	infusion	dep	1	SENT_337	[p21l938t2710r1196b2766],
4	speed	NN	O	speed	dep	9	SENT_337	[p21l1214t2710r1390b2784],
5	[	CD	NUMBER	[	num	4	SENT_337	[p21l1413t2707r1554b2784],
6	(	CD	NUMBER	(	num	9	SENT_337	[p21l1413t2707r1554b2784],
7	mg	NN	O	mg	nn	9	SENT_337	[p21l1413t2707r1554b2784],
8	x	NN	O	x	nn	9	SENT_337	[p21l1565t2727r1602b2764],
9	h	NN	O	h	dep	13	SENT_337	[p21l1616t2707r1679b2784],
10	)	CD	NUMBER	)	dep	9	SENT_337	[p21l1616t2707r1679b2784],
11	/	:	O	/	punct	13	SENT_337	[p21l1691t2694r1830b2784],
12	m2	CD	NUMBER	m2	num	13	SENT_337	[p21l1691t2694r1830b2784],
13	]	CD	NUMBER	]	_	0	SENT_337	[p21l1691t2694r1830b2784],

1	Steady	JJ	O	steady	amod	2	SENT_338	[p21l621t2858r998b2932],
2	—	NN	O	—	dep	5	SENT_338	[p21l621t2858r998b2932],
3	state	NN	O	state	dep	2	SENT_338	[p21l621t2858r998b2932],
4	FU	NNP	O	FU	dep	5	SENT_338	[p21l1016t2863r1106b2914],
5	concentration	NN	O	concentration	dep	10	SENT_338	[p21l1122t2860r1559b2914],
6	[	CD	NUMBER	[	num	7	SENT_338	[p21l1582t2855r1694b2932],
7	mg	NN	O	mg	dep	5	SENT_338	[p21l1582t2855r1694b2932],
8	/	:	O	/	punct	10	SENT_338	[p21l1698t2855r1728b2932],
9	1	CD	NUMBER	1	num	10	SENT_338	[p21l1733t2855r1765b2932],
10	]	CD	NUMBER	]	_	0	SENT_338	[p21l1733t2855r1765b2932],

1	with	IN	O	with	_	0	SENT_339	[p21l61t2988r223b3045],
2	continuous	JJ	O	continuous	amod	4	SENT_339	[p21l282t2991r683b3045],
3	infusion	NN	O	infusion	nn	4	SENT_339	[p21l743t2987r1037b3045],
4	speed	NN	O	speed	pobj	1	SENT_339	[p21l1097t2988r1545b3063],
5	=	JJ	O	=	amod	4	SENT_339	[p21l1097t2988r1545b3063],
6	5	CD	NUMBER	5	tmod	5	SENT_339	[p21l1097t2988r1545b3063],
7	.	.	O	.	_	0	SENT_339	[p21l1097t2988r1545b3063],

1	—	NN	O	—	_	0	SENT_340	[p21l1097t2988r1545b3063],
2	.	.	O	.	_	0	SENT_340	[p21l1097t2988r1545b3063],

1	FU	NNP	O	FU	nn	4	SENT_341	[p21l1097t2988r1545b3063],
2	dose	NN	O	dose	nn	4	SENT_341	[p21l1605t2988r1760b3045],
3	(	NN	O	(	nn	4	SENT_341	[p21l1823t2981r2148b3063],
4	mg/m2	NN	O	mg/m2	_	0	SENT_341	[p21l1823t2981r2148b3063],
5	)	CD	NUMBER	)	dep	4	SENT_341	[p21l1823t2981r2148b3063],
6	/	:	O	/	punct	8	SENT_341	[p21l1823t2981r2148b3063],
7	infusion	NN	O	infusion	nn	8	SENT_341	[p21l9t3084r303b3142],
8	period	NN	O	period	dep	5	SENT_341	[p21l365t3084r592b3160],
9	(	CD	NUMBER	(	num	11	SENT_341	[p21l658t3084r773b3156],
10	h	NN	O	h	nn	11	SENT_341	[p21l658t3084r773b3156],
11	)	NN	O	)	dep	5	SENT_341	[p21l658t3084r773b3156],
12	.	.	O	.	_	0	SENT_341	[p21l658t3084r773b3156],

1	Thus	RB	O	thus	advmod	16	SENT_342	[p21l838t3084r1011b3142],
2	5-FU	JJ	O	5-fu	amod	3	SENT_342	[p21l1077t3087r1240b3142],
3	clearance	NN	O	clearance	nsubj	16	SENT_342	[p21l1304t3084r1632b3142],
4	for	IN	O	for	_	0	SENT_342	[p21l1696t3084r1794b3142],
5	‘	CD	NUMBER	‘	prep_for	3	SENT_342	[p21l1858t3084r2149b3142],
6	tailored	VBN	O	tailor	partmod	3	SENT_342	[p21l1858t3084r2149b3142],
7	LV5FU2	NN	O	lv5fu2	nn	9	SENT_342	[p21l9t3178r303b3236],
8	’	NN	O	’	nn	9	SENT_342	[p21l9t3178r303b3236],
9	regimen	NN	O	regimen	dobj	6	SENT_342	[p21l357t3181r648b3254],
10	was	VBD	O	be	cop	16	SENT_342	[p21l697t3195r825b3236],
11	132.84	CD	NUMBER	132.84	num	12	SENT_342	[p21l883t3179r1386b3244],
12	i43	NN	O	i43	npadvmod	16	SENT_342	[p21l883t3179r1386b3244],
13	.37	CD	NUMBER	.37	num	14	SENT_342	[p21l883t3179r1386b3244],
14	L	NN	O	l	npadvmod	15	SENT_342	[p21l1440t3170r1749b3243],
15	>	JJR	O	>	amod	12	SENT_342	[p21l1440t3170r1749b3243],
16	<	JJR	O	<	_	0	SENT_342	[p21l1440t3170r1749b3243],
17	h/m2	CD	NUMBER	h/m2	tmod	16	SENT_342	[p21l1440t3170r1749b3243],
18	and	CC	O	and	_	0	SENT_342	[p21l1801t3178r1933b3236],
19	5-FU	JJ	O	5-fu	amod	20	SENT_342	[p21l1986t3180r2148b3236],
20	clearance	NN	O	clearance	tmod	16	SENT_342	[p21l9t3272r331b3330],
21	for	IN	O	for	_	0	SENT_342	[p21l354t3272r451b3330],
22	‘	CD	NUMBER	‘	num	24	SENT_342	[p21l474t3272r733b3330],
23	FUFOL	NN	O	fufol	nn	24	SENT_342	[p21l474t3272r733b3330],
24	4h	NN	O	4h	prep_for	20	SENT_342	[p21l753t3272r861b3329],
25	’	NN	O	’	nn	26	SENT_342	[p21l753t3272r861b3329],
26	regimen	NN	O	regimen	nsubj	28	SENT_342	[p21l885t3275r1170b3348],
27	was	VBD	O	be	cop	28	SENT_342	[p21l1191t3289r1317b3330],
28	103.4	CD	NUMBER	103.4	rcmod	24	SENT_342	[p21l1345t3273r1529b3330],
29	i	FW	O	i	dep	28	SENT_342	[p21l1545t3280r1594b3338],
30	51.52	CD	NUMBER	51.52	num	33	SENT_342	[p21l1610t3273r1799b3330],
31	L	NN	O	l	nn	33	SENT_342	[p21l1821t3274r1862b3329],
32	x	NN	O	x	nn	33	SENT_342	[p21l1886t3290r1923b3328],
33	h/m2	NN	O	h/m2	dep	17	SENT_342	[p21l1948t3265r2144b3337],
34	.	.	O	.	_	0	SENT_342	[p21l1948t3265r2144b3337],

1	Using	VBG	O	use	_	0	SENT_343	[p21l8t3371r212b3444],
2	the	DT	O	the	det	6	SENT_343	[p21l243t3368r355b3426],
3	reduced	VBN	O	reduce	amod	6	SENT_343	[p21l389t3368r668b3426],
4	difference	NN	O	difference	nn	6	SENT_343	[p21l700t3368r1049b3426],
5	distribution	NN	O	distribution	nn	6	SENT_343	[p21l1083t3368r1502b3426],
6	method	NN	O	method	dobj	1	SENT_343	[p21l1534t3368r1829b3439],
7	,	,	O	,	_	0	SENT_343	[p21l1534t3368r1829b3439],
8	patients	NNS	O	patient	appos	6	SENT_343	[p21l1866t3371r2148b3444],
9	with	IN	O	with	_	0	SENT_343	[p21l7t3462r168b3520],
10	FU	NN	O	fu	nn	11	SENT_343	[p21l209t3465r304b3520],
11	clearance	NN	O	clearance	prep_with	8	SENT_343	[p21l346t3462r673b3520],
12	below	IN	O	below	_	0	SENT_343	[p21l713t3462r926b3520],
13	89.47	CD	NUMBER	89.47	prep_below	11	SENT_343	[p21l966t3464r1157b3520],
14	(	CD	NUMBER	(	num	15	SENT_343	[p21l1203t3462r1246b3534],
15	l	NN	O	l	tmod	11	SENT_343	[p21l1203t3462r1246b3534],
16	x	NN	O	x	nn	17	SENT_343	[p21l1272t3481r1310b3518],
17	h/m2	NN	O	h/m2	dep	23	SENT_343	[p21l1335t3454r1540b3534],
18	)	CD	NUMBER	)	num	19	SENT_343	[p21l1335t3454r1540b3534],
19	(	CD	NUMBER	(	dep	17	SENT_343	[p21l1588t3462r2145b3534],
20	132.84	CD	NUMBER	132.84	num	21	SENT_343	[p21l1588t3462r2145b3534],
21	i43	NN	O	i43	dep	23	SENT_343	[p21l1588t3462r2145b3534],
22	.37	CD	NUMBER	.37	num	23	SENT_343	[p21l1588t3462r2145b3534],
23	)	NN	O	)	dep	8	SENT_343	[p21l1588t3462r2145b3534],
24	for	IN	O	for	_	0	SENT_343	[p21l9t3556r107b3614],
25	‘	CD	NUMBER	‘	prep_for	23	SENT_343	[p21l172t3556r463b3614],
26	tailored	VBN	O	tailor	partmod	8	SENT_343	[p21l172t3556r463b3614],
27	LV5FU2	NN	O	lv5fu2	nn	28	SENT_343	[p21l528t3556r822b3614],
28	’	NN	O	’	dobj	26	SENT_343	[p21l528t3556r822b3614],
29	and	CC	O	and	_	0	SENT_343	[p21l890t3556r1021b3614],
30	inferior	JJ	O	inferior	conj_and	1	SENT_343	[p21l1084t3556r1349b3614],
31	to	TO	O	to	_	0	SENT_343	[p21l1412t3563r1482b3614],
32	52.22	CD	NUMBER	52.22	num	34	SENT_343	[p21l1548t3558r1740b3614],
33	(	CD	NUMBER	(	num	34	SENT_343	[p21l1808t3556r1852b3628],
34	l	NN	O	l	prep_to	30	SENT_343	[p21l1808t3556r1852b3628],
35	x	CC	O	x	_	0	SENT_343	[p21l1877t3575r1915b3612],
36	h/m2	NN	O	h/m2	nn	37	SENT_343	[p21l1941t3549r2145b3628],
37	)	NN	O	)	conj_x	34	SENT_343	[p21l1941t3549r2145b3628],

1	(	NN	O	(	nsubjpass	12	SENT_344	[p22l12t20r525b92],
2	103.4	CD	NUMBER	103.4	num	3	SENT_344	[p22l12t20r525b92],
3	i51	NN	O	i51	dep	1	SENT_344	[p22l12t20r525b92],
4	.52	CD	NUMBER	.52	num	5	SENT_344	[p22l12t20r525b92],
5	)	NN	O	)	dep	1	SENT_344	[p22l12t20r525b92],
6	for	IN	O	for	_	0	SENT_344	[p22l559t19r658b77],
7	‘	CD	NUMBER	‘	num	10	SENT_344	[p22l689t20r952b77],
8	FUFOL	NN	O	fufol	nn	10	SENT_344	[p22l689t20r952b77],
9	4h	NN	O	4h	nn	10	SENT_344	[p22l982t20r1104b77],
10	’	NN	O	’	prep_for	5	SENT_344	[p22l982t20r1104b77],
11	were	VBD	O	be	auxpass	12	SENT_344	[p22l1134t36r1298b77],
12	considered	VBN	O	consider	_	0	SENT_344	[p22l1330t20r1712b77],
13	as	IN	O	as	_	0	SENT_344	[p22l1744t36r1809b77],
14	having	VBG	O	have	prepc_as	12	SENT_344	[p22l1840t20r2084b95],
15	a	DT	O	a	det	17	SENT_344	[p22l2114t36r2149b77],
16	high	JJ	O	high	amod	17	SENT_344	[p22l9t115r171b191],
17	risk	NN	O	risk	dobj	14	SENT_344	[p22l200t115r325b173],
18	of	IN	O	of	_	0	SENT_344	[p22l353t115r424b173],
19	toxicity	NN	O	toxicity	prep_of	17	SENT_344	[p22l450t118r733b191],
20	.	.	O	.	_	0	SENT_344	[p22l450t118r733b191],

1	Genotyping	VBG	O	genotype	amod	3	SENT_345	[p22l14t328r382b403],
2	Genomic	JJ	O	genomic	amod	3	SENT_345	[p22l10t424r333b480],
3	DNA	NN	O	dna	nsubjpass	5	SENT_345	[p22l364t424r533b479],
4	was	VBD	O	be	auxpass	5	SENT_345	[p22l559t439r687b480],
5	extracted	VBN	O	extract	_	0	SENT_345	[p22l718t422r1044b480],
6	from	IN	O	from	_	0	SENT_345	[p22l1074t422r1243b480],
7	peripheral	JJ	O	peripheral	amod	8	SENT_345	[p22l1273t422r1634b498],
8	leukocytes	NNS	O	leukocyte	prep_from	5	SENT_345	[p22l1665t422r2035b498],
9	by	IN	O	by	_	0	SENT_345	[p22l2064t422r2151b498],
10	the	DT	O	the	det	12	SENT_345	[p22l8t516r121b573],
11	salting	VBG	O	salt	amod	12	SENT_345	[p22l153t516r533b591],
12	—	NN	O	—	agent	5	SENT_345	[p22l153t516r533b591],
13	out	IN	O	out	_	0	SENT_345	[p22l153t516r533b591],
14	procedure	NN	O	procedure	prep_out	12	SENT_345	[p22l561t508r1003b591],
15	.	.	O	.	_	0	SENT_345	[p22l561t508r1003b591],

1	“	NN	O	“	nn	2	SENT_346	[p22l561t508r1003b591],
2	Determination	NN	O	determination	_	0	SENT_346	[p22l13t613r471b669],
3	of	IN	O	of	_	0	SENT_346	[p22l506t611r572b669],
4	TSER	NN	O	tser	nn	5	SENT_346	[p22l601t613r748b669],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_346	[p22l777t611r1249b687],
6	.	.	O	.	_	0	SENT_346	[p22l777t611r1249b687],

1	For	IN	O	for	_	0	SENT_347	[p22l1335t614r1446b669],
2	the	DT	O	the	det	3	SENT_347	[p22l1478t611r1591b669],
3	analysis	NN	O	analysis	prep_for	15	SENT_347	[p22l1626t611r1901b687],
4	of	IN	O	of	_	0	SENT_347	[p22l1936t611r2007b669],
5	the	DT	O	the	det	7	SENT_347	[p22l2036t611r2148b669],
6	28-repeat	JJ	O	28-repeat	amod	7	SENT_347	[p22l10t710r339b784],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_347	[p22l365t708r908b784],
8	,	,	O	,	_	0	SENT_347	[p22l365t708r908b784],
9	a	DT	O	a	det	10	SENT_347	[p22l940t725r975b766],
10	fragment	NN	O	fragment	nsubjpass	15	SENT_347	[p22l1001t708r1323b784],
11	containing	VBG	O	contain	partmod	10	SENT_347	[p22l1350t711r1737b784],
12	the	DT	O	the	det	13	SENT_347	[p22l1762t708r1875b766],
13	repeats	NNS	O	repeat	dobj	11	SENT_347	[p22l1903t715r2149b784],
14	was	VBD	O	be	auxpass	15	SENT_347	[p22l8t820r135b861],
15	amplified	VBN	O	amplify	_	0	SENT_347	[p22l184t803r520b879],
16	using	VBG	O	use	xcomp	15	SENT_347	[p22l565t806r758b879],
17	the	DT	O	the	det	20	SENT_347	[p22l803t803r916b861],
18	two	CD	NUMBER	two	num	20	SENT_347	[p22l963t810r1094b861],
19	following	VBG	O	follow	amod	20	SENT_347	[p22l1141t803r1480b879],
20	primers	NNS	O	primer	dobj	16	SENT_347	[p22l1525t806r1811b879],
21	:	:	O	:	_	0	SENT_347	[p22l1525t806r1811b879],
22	Forward	RB	O	forward	advmod	25	SENT_347	[p22l1863t803r2150b861],
23	primer	NN	O	primer	nsubjpass	25	SENT_347	[p22l9t899r247b971],
24	was	VBD	O	be	auxpass	25	SENT_347	[p22l269t912r397b953],
25	determined	VBN	O	determine	conj_and	15	SENT_347	[p22l423t896r831b953],
26	after	IN	O	after	_	0	SENT_347	[p22l856t895r1014b953],
27	research	NN	O	research	prep_after	25	SENT_347	[p22l1038t896r1326b953],
28	on	IN	O	on	_	0	SENT_347	[p22l1351t913r1443b953],
29	Primer	NN	O	primer	nn	31	SENT_347	[p22l1468t898r1702b953],
30	3	CD	NUMBER	3	num	31	SENT_347	[p22l1727t897r1763b953],
31	Output	NN	O	output	prep_on	25	SENT_347	[p22l1791t890r2102b971],
32	©	CD	NUMBER	©	number	33	SENT_347	[p22l1791t890r2102b971],
33	—	CD	NUMBER	—	num	34	SENT_347	[p22l2129t931r2149b937],
34	CGCGGAAGGGGTCCTGC	NN	O	cgcggaaggggtcctgc	dep	25	SENT_347	[p22l11t994r997b1050],
35	-	:	O	-	_	0	SENT_347	[p22l11t994r997b1050],
36	and	CC	O	and	_	0	SENT_347	[p22l1067t992r1198b1050],
37	reverse	VB	O	reverse	csubj	41	SENT_347	[p22l1265t1009r1508b1050],
38	primer	NN	O	primer	dobj	37	SENT_347	[p22l1575t995r1813b1068],
39	as	IN	O	as	prep	37	SENT_347	[p22l1880t1009r1945b1050],
40	previously	RB	DATE	previously	advmod	41	SENT_347	[p22l2013t1009r2148b1068, p22l7t1086r264b1162],
41	described	VBN	O	describe	conj_and	15	SENT_347	[p22l302t1086r633b1144],
42	by	IN	O	by	_	0	SENT_347	[p22l670t1086r758b1162],
43	Kawakami	NNP	PERSON	Kawakami	prep_by	41	SENT_347	[p22l795t1086r1158b1144],
44	et	FW	O	et	nn	45	SENT_347	[p22l1198t1092r1259b1144],
45	al.	FW	O	al.	dobj	41	SENT_347	[p22l1292t1080r1406b1144],
46	7	CD	NUMBER	7	amod	45	SENT_347	[p22l1292t1080r1406b1144],
47	-	:	O	-	_	0	SENT_347	[p22l1447t1088r2149b1144],
48	TCCGAGCCGGCC	NN	O	tccgagccggcc	nn	49	SENT_347	[p22l1447t1088r2149b1144],
49	ACAGGCAT	NN	O	acaggcat	dep	45	SENT_347	[p22l8t1181r481b1237],
50	-	:	O	-	_	0	SENT_347	[p22l8t1181r481b1237],
51	.	.	O	.	_	0	SENT_347	[p22l8t1181r481b1237],

1	Expected	VBN	O	expect	dep	6	SENT_348	[p22l87t1275r405b1351],
2	fragment	NN	O	fragment	nn	3	SENT_348	[p22l430t1275r752b1351],
3	sizes	NNS	O	size	nsubj	6	SENT_348	[p22l779t1278r933b1333],
4	were	VBD	O	be	cop	6	SENT_348	[p22l957t1292r1120b1333],
5	108	CD	NUMBER	108	num	6	SENT_348	[p22l1153t1277r1273b1333],
6	bp	NN	O	bp	_	0	SENT_348	[p22l1289t1275r1377b1351],
7	for	IN	O	for	_	0	SENT_348	[p22l1403t1275r1501b1333],
8	ZR	NN	O	zr	prep_for	6	SENT_348	[p22l1526t1277r1615b1332],
9	and	CC	O	and	_	0	SENT_348	[p22l1640t1275r1771b1333],
10	136	CD	NUMBER	136	num	11	SENT_348	[p22l1802t1277r1923b1333],
11	pb	NN	O	pb	conj_and	6	SENT_348	[p22l1940t1275r2027b1351],
12	for	IN	O	for	_	0	SENT_348	[p22l2052t1275r2150b1333],
13	3R	NN	O	3r	prep_for	11	SENT_348	[p22l11t1370r116b1427],
14	.	.	O	.	_	0	SENT_348	[p22l11t1370r116b1427],

1	In	IN	O	in	_	0	SENT_349	[p22l153t1371r226b1426],
2	each	DT	O	each	det	3	SENT_349	[p22l260t1369r420b1427],
3	case	NN	O	case	prep_in	8	SENT_349	[p22l454t1386r612b1439],
4	,	,	O	,	_	0	SENT_349	[p22l454t1386r612b1439],
5	PCR	NN	O	pcr	nn	6	SENT_349	[p22l651t1370r797b1427],
6	tests	NNS	O	test	nsubjpass	8	SENT_349	[p22l828t1376r981b1427],
7	were	VBD	O	be	auxpass	8	SENT_349	[p22l1012t1386r1176b1427],
8	run	VBN	O	run	_	0	SENT_349	[p22l1209t1386r1332b1427],
9	on	IN	O	on	_	0	SENT_349	[p22l1366t1386r1457b1427],
10	HYBAID	NN	ORGANIZATION	hybaid	prep_on	8	SENT_349	[p22l1491t1370r1782b1426],
11	in	IN	O	in	_	0	SENT_349	[p22l1816t1372r1886b1426],
12	a	DT	O	a	det	16	SENT_349	[p22l1920t1386r1954b1427],
13	50	CD	NUMBER	50	number	14	SENT_349	[p22l1989t1370r2070b1427],
14	pal	NN	O	pal	amod	16	SENT_349	[p22l2087t1369r2149b1441],
15	final	JJ	O	final	amod	16	SENT_349	[p22l9t1465r168b1523],
16	volume	NN	O	volume	prep_in	8	SENT_349	[p22l204t1465r471b1523],
17	containing	VBG	O	contain	partmod	16	SENT_349	[p22l510t1468r898b1541],
18	1	CD	NUMBER	1	num	19	SENT_349	[p22l939t1467r968b1522],
19	id	NN	O	id	dobj	17	SENT_349	[p22l990t1465r1053b1537],
20	of	IN	O	of	_	0	SENT_349	[p22l1091t1465r1162b1523],
21	genomic	JJ	O	genomic	amod	26	SENT_349	[p22l1196t1468r1501b1541],
22	DNA	NN	O	dna	nn	26	SENT_349	[p22l1539t1466r1708b1522],
23	(	NN	O	(	nn	26	SENT_349	[p22l1748t1465r1900b1537],
24	100	CD	NUMBER	100	num	26	SENT_349	[p22l1748t1465r1900b1537],
25	Hg/M1	NN	O	hg/m1	nn	26	SENT_349	[p22l1916t1465r2145b1541],
26	)	NN	O	)	prep_of	19	SENT_349	[p22l1916t1465r2145b1541],
27	,	,	O	,	_	0	SENT_349	[p22l1916t1465r2145b1541],
28	5	CD	NUMBER	5	num	31	SENT_349	[p22l11t1562r45b1617],
29	#	#	MONEY	#	number	30	SENT_349	[p22l65t1560r128b1632],
30	1	CD	MONEY	1	amod	31	SENT_349	[p22l65t1560r128b1632],
31	buffer	NN	O	buffer	conj_and	26	SENT_349	[p22l164t1559r375b1617],
32	10	CD	NUMBER	10	number	33	SENT_349	[p22l419t1561r496b1617],
33	x	NN	O	x	amod	31	SENT_349	[p22l522t1578r598b1630],
34	,	,	O	,	_	0	SENT_349	[p22l522t1578r598b1630],
35	3	CD	NUMBER	3	num	39	SENT_349	[p22l643t1561r678b1617],
36	ul	NN	O	ul	nn	39	SENT_349	[p22l697t1559r760b1632],
37	MgCl2	NN	O	mgcl2	nn	39	SENT_349	[p22l797t1560r1034b1635],
38	25	CD	NUMBER	25	num	39	SENT_349	[p22l1073t1561r1152b1617],
39	mM	NN	O	mm	appos	31	SENT_349	[p22l1172t1572r1317b1630],
40	,	,	O	,	_	0	SENT_349	[p22l1172t1572r1317b1630],
41	2111	CD	NUMBER	2111	num	42	SENT_349	[p22l1361t1560r1479b1632],
42	dNTPs	NNS	O	dntp	appos	31	SENT_349	[p22l1518t1560r1759b1630],
43	,	,	O	,	_	0	SENT_349	[p22l1518t1560r1759b1630],
44	0.4	CD	NUMBER	0.4	num	47	SENT_349	[p22l1803t1561r1907b1617],
45	ill	JJ	O	ill	amod	47	SENT_349	[p22l1925t1559r1988b1632],
46	Taq	NN	O	taq	nn	47	SENT_349	[p22l2024t1562r2150b1635],
47	Polymerase	NN	O	polymerase	appos	42	SENT_349	[p22l10t1655r427b1731],
48	,	,	O	,	_	0	SENT_349	[p22l10t1655r427b1731],
49	2.5	CD	NUMBER	2.5	appos	31	SENT_349	[p22l461t1657r562b1713],
50	id	VBD	O	id	rcmod	49	SENT_349	[p22l582t1655r645b1728],
51	DMSO	NN	ORGANIZATION	dmso	nn	52	SENT_349	[p22l672t1657r900b1713],
52	(	NN	O	(	dobj	50	SENT_349	[p22l932t1655r1054b1727],
53	for	IN	O	for	_	0	SENT_349	[p22l932t1655r1054b1727],
54	final	JJ	O	final	dep	56	SENT_349	[p22l1081t1655r1240b1713],
55	5	CD	PERCENT	5	number	56	SENT_349	[p22l1269t1657r1377b1713],
56	%	NN	PERCENT	%	amod	58	SENT_349	[p22l1269t1657r1377b1713],
57	volume	NN	O	volume	nn	58	SENT_349	[p22l1402t1655r1714b1727],
58	)	NN	O	)	prep_for	50	SENT_349	[p22l1402t1655r1714b1727],
59	,	,	O	,	_	0	SENT_349	[p22l1402t1655r1714b1727],
60	1	CD	NUMBER	1	appos	58	SENT_349	[p22l1753t1657r1781b1712],
61	#	#	MONEY	#	dep	62	SENT_349	[p22l1803t1655r1865b1728],
62	1	CD	MONEY	1	dep	60	SENT_349	[p22l1803t1655r1865b1728],
63	of	IN	O	of	_	0	SENT_349	[p22l1894t1655r1966b1713],
64	each	DT	O	each	det	65	SENT_349	[p22l1989t1655r2149b1713],
65	specific	JJ	O	specific	prep_of	62	SENT_349	[p22l11t1750r270b1826],
66	forward	RB	O	forward	advmod	50	SENT_349	[p22l296t1750r570b1808],
67	and	CC	O	and	_	0	SENT_349	[p22l596t1750r728b1808],
68	reverse	VB	O	reverse	conj_and	50	SENT_349	[p22l753t1767r995b1808],
69	primer	NN	O	primer	nn	70	SENT_349	[p22l1021t1753r1259b1826],
70	(	NN	O	(	dobj	68	SENT_349	[p22l1288t1750r1395b1822],
71	10	CD	NUMBER	10	num	70	SENT_349	[p22l1288t1750r1395b1822],
72	,	,	O	,	_	0	SENT_349	[p22l1412t1750r1533b1823],
73	uM	NN	O	um	nn	74	SENT_349	[p22l1412t1750r1533b1823],
74	)	NN	O	)	prep_of	19	SENT_349	[p22l1412t1750r1533b1823],
75	and	CC	O	and	_	0	SENT_349	[p22l1563t1750r1694b1808],
76	34.1	CD	NUMBER	34.1	number	77	SENT_349	[p22l1721t1752r1864b1808],
77	[	CD	NUMBER	[	prep_of	19	SENT_349	[p22l1886t1750r1948b1823],
78	11	CD	NUMBER	11	num	79	SENT_349	[p22l1886t1750r1948b1823],
79	H20	NN	O	h20	dep	77	SENT_349	[p22l1975t1752r2145b1820],
80	.	.	O	.	_	0	SENT_349	[p22l1975t1752r2145b1820],

1	After	IN	O	after	_	0	SENT_350	[p22l85t1844r258b1902],
2	35	CD	NUMBER	35	num	3	SENT_350	[p22l288t1846r367b1902],
3	cycles	NNS	O	cycle	prep_after	39	SENT_350	[p22l401t1845r606b1920],
4	of	IN	O	of	_	0	SENT_350	[p22l637t1844r708b1902],
5	amplification	NN	O	amplification	nn	7	SENT_350	[p22l734t1844r1210b1920],
6	(	NN	O	(	nn	7	SENT_350	[p22l1244t1845r1730b1917],
7	denaturation	NN	O	denaturation	prep_of	3	SENT_350	[p22l1244t1845r1730b1917],
8	at	IN	O	at	_	0	SENT_350	[p22l1760t1852r1823b1902],
9	94	CD	NUMBER	94	number	10	SENT_350	[p22l1853t1846r2022b1902],
10	°	CD	NUMBER	°	num	11	SENT_350	[p22l1853t1846r2022b1902],
11	C	NN	O	c	prep_at	7	SENT_350	[p22l1853t1846r2022b1902],
12	for	IN	O	for	_	0	SENT_350	[p22l2052t1844r2150b1902],
13	30	CD	NUMBER	30	num	14	SENT_350	[p22l11t1942r93b1998],
14	s	NNS	O	s	prep_for	11	SENT_350	[p22l111t1957r154b2011],
15	,	,	O	,	_	0	SENT_350	[p22l111t1957r154b2011],
16	annealing	NN	O	annealing	prep_at	7	SENT_350	[p22l195t1940r548b2016],
17	at	IN	O	at	_	0	SENT_350	[p22l582t1947r645b1998],
18	62	CD	NUMBER	62	number	19	SENT_350	[p22l682t1942r850b1998],
19	°	CD	NUMBER	°	num	20	SENT_350	[p22l682t1942r850b1998],
20	C	NN	O	c	prep_at	16	SENT_350	[p22l682t1942r850b1998],
21	for	IN	O	for	_	0	SENT_350	[p22l884t1940r983b1998],
22	60	CD	NUMBER	60	num	23	SENT_350	[p22l1019t1942r1101b1998],
23	s	NNS	O	s	prep_for	20	SENT_350	[p22l1119t1957r1162b2011],
24	,	,	O	,	_	0	SENT_350	[p22l1119t1957r1162b2011],
25	and	CC	O	and	_	0	SENT_350	[p22l1202t1940r1333b1998],
26	extension	NN	O	extension	conj_and	11	SENT_350	[p22l1369t1943r1714b1998],
27	at	IN	O	at	_	0	SENT_350	[p22l1750t1947r1813b1998],
28	72	CD	NUMBER	72	number	29	SENT_350	[p22l1853t1942r2018b1998],
29	°	CD	NUMBER	°	num	30	SENT_350	[p22l1853t1942r2018b1998],
30	C	NN	O	c	prep_at	26	SENT_350	[p22l1853t1942r2018b1998],
31	for	IN	O	for	_	0	SENT_350	[p22l2052t1940r2150b1998],
32	1	CD	DURATION	1	num	34	SENT_350	[p22l15t2037r44b2092],
33	min	NN	DURATION	min	nn	34	SENT_350	[p22l66t2035r253b2107],
34	)	NN	O	)	prep_for	30	SENT_350	[p22l66t2035r253b2107],
35	,	,	O	,	_	0	SENT_350	[p22l66t2035r253b2107],
36	amplification	NN	O	amplification	nn	37	SENT_350	[p22l321t2035r797b2111],
37	products	NNS	O	product	nsubjpass	39	SENT_350	[p22l858t2035r1166b2111],
38	were	VBD	O	be	auxpass	39	SENT_350	[p22l1227t2052r1391b2093],
39	electrophoresed	VBN	O	electrophorese	_	0	SENT_350	[p22l1455t2035r2017b2111],
40	in	IN	O	in	_	0	SENT_350	[p22l2079t2038r2149b2092],
41	1	CD	NUMBER	1	prep_in	39	SENT_350	[p22l15t2132r44b2187],
42	x	CC	O	x	_	0	SENT_350	[p22l75t2148r112b2186],
43	TBE	NN	O	tbe	conj_x	39	SENT_350	[p22l136t2132r273b2187],
44	on	IN	O	on	_	0	SENT_350	[p22l331t2147r422b2188],
45	agarose	NN	O	agarose	nn	46	SENT_350	[p22l481t2147r740b2206],
46	gel	NN	O	gel	prep_on	43	SENT_350	[p22l800t2130r899b2206],
47	at	IN	O	at	_	0	SENT_350	[p22l959t2137r1023b2188],
48	2	CD	PERCENT	2	num	49	SENT_350	[p22l1082t2131r1190b2187],
49	%	NN	PERCENT	%	prep_at	43	SENT_350	[p22l1082t2131r1190b2187],
50	with	IN	O	with	_	0	SENT_350	[p22l1247t2130r1408b2188],
51	ethidium	NN	O	ethidium	nn	52	SENT_350	[p22l1468t2130r1794b2188],
52	bromide	NN	O	bromide	prep_with	49	SENT_350	[p22l1850t2130r2148b2188],
53	1	CD	NUMBER	1	num	52	SENT_350	[p22l15t2225r44b2280],
54	x	CC	O	x	_	0	SENT_350	[p22l75t2242r112b2279],
55	(	CD	NUMBER	(	number	56	SENT_350	[p22l141t2223r267b2295],
56	0.5	CD	NUMBER	0.5	num	57	SENT_350	[p22l141t2223r267b2295],
57	iig/iil	NN	O	iig/iil	conj_x	49	SENT_350	[p22l287t2223r487b2299],
58	)	CD	NUMBER	)	number	59	SENT_350	[p22l287t2223r487b2299],
59	(	CD	NUMBER	(	num	57	SENT_350	[p22l523t2223r762b2299],
60	Figure	NNP	O	Figure	dep	49	SENT_350	[p22l523t2223r762b2299],
61	6	CD	NUMBER	6	num	60	SENT_350	[p22l794t2216r1120b2295],
62	)	CD	NUMBER	)	number	63	SENT_350	[p22l794t2216r1120b2295],
63	.12	CD	NUMBER	.12	num	64	SENT_350	[p22l794t2216r1120b2295],
64	‘	NN	O	‘	dep	60	SENT_350	[p22l794t2216r1120b2295],
65	14	CD	NUMBER	14	number	66	SENT_350	[p22l794t2216r1120b2295],
66	'21	CD	NUMBER	'21	num	64	SENT_350	[p22l794t2216r1120b2295],

1	Determination	NN	O	determination	_	0	SENT_351	[p22l13t2454r471b2510],
2	of	IN	O	of	_	0	SENT_351	[p22l504t2453r570b2510],
3	G	NN	O	g	amod	6	SENT_351	[p22l595t2455r705b2510],
4	>	JJR	O	>	dep	3	SENT_351	[p22l595t2455r705b2510],
5	C	NN	O	c	nn	6	SENT_351	[p22l726t2455r771b2510],
6	SNP	NN	O	snp	prep_of	1	SENT_351	[p22l799t2455r945b2510],
7	.	.	O	.	_	0	SENT_351	[p22l799t2455r945b2510],

1	For	IN	O	for	_	0	SENT_352	[p22l1030t2456r1142b2510],
2	the	DT	O	the	det	3	SENT_352	[p22l1172t2453r1285b2510],
3	determination	NN	O	determination	prep_for	23	SENT_352	[p22l1318t2453r1828b2510],
4	of	IN	O	of	_	0	SENT_352	[p22l1861t2453r1933b2510],
5	G	NN	O	g	prep_of	3	SENT_352	[p22l1961t2455r2149b2510],
6	>	JJR	O	>	amod	8	SENT_352	[p22l1961t2455r2149b2510],
7	C	NN	O	c	nn	8	SENT_352	[p22l1961t2455r2149b2510],
8	SNP	NN	O	snp	nsubjpass	23	SENT_352	[p22l10t2549r149b2606],
9	within	IN	O	within	_	0	SENT_352	[p22l183t2548r418b2606],
10	the	DT	O	the	det	12	SENT_352	[p22l454t2548r567b2606],
11	second	JJ	ORDINAL	second	amod	12	SENT_352	[p22l605t2548r849b2606],
12	repeat	NN	O	repeat	prep_within	8	SENT_352	[p22l885t2555r1102b2624],
13	in	IN	O	in	_	0	SENT_352	[p22l1138t2551r1208b2605],
14	the	DT	O	the	det	16	SENT_352	[p22l1244t2548r1357b2606],
15	3R	NN	O	3r	nn	16	SENT_352	[p22l1395t2549r1484b2606],
16	allele	NN	O	allele	prep_in	12	SENT_352	[p22l1520t2548r1720b2618],
17	,	,	O	,	_	0	SENT_352	[p22l1520t2548r1720b2618],
18	restrictionfragment	NN	O	restrictionfragment	nn	21	SENT_352	[p22l1761t2551r2148b2606, p22l9t2643r332b2719],
19	length	NN	O	length	nn	21	SENT_352	[p22l371t2643r599b2719],
20	polymorphism	NN	O	polymorphism	nn	21	SENT_352	[p22l638t2643r1164b2719],
21	analysis	NN	O	analysis	appos	16	SENT_352	[p22l1204t2643r1479b2719],
22	was	VBD	O	be	auxpass	23	SENT_352	[p22l1517t2660r1646b2701],
23	used	VBN	O	use	_	0	SENT_352	[p22l1683t2643r1862b2701],
24	.	.	O	.	_	0	SENT_352	[p22l1683t2643r1862b2701],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	11	SENT_353	[p22l1906t2643r2144b2719],
2	,	,	O	,	_	0	SENT_353	[p22l1906t2643r2144b2719],
3	amplification	NN	O	amplification	nn	4	SENT_353	[p22l10t2738r486b2814],
4	products	NNS	O	product	appos	1	SENT_353	[p22l520t2738r828b2814],
5	for	IN	O	for	_	0	SENT_353	[p22l864t2738r962b2796],
6	3R/3R	NN	O	3r/3r	nn	9	SENT_353	[p22l998t2738r1209b2803],
7	or	CC	O	or	_	0	SENT_353	[p22l1243t2755r1314b2796],
8	ZR/3R	NN	O	zr/3r	nn	9	SENT_353	[p22l1349t2738r1560b2803],
9	genotypes	NNS	O	genotype	prep_for	4	SENT_353	[p22l1593t2745r1951b2814],
10	were	VBD	O	be	auxpass	11	SENT_353	[p22l1985t2755r2148b2796],
11	purified	VBN	O	purify	_	0	SENT_353	[p22l9t2833r287b2909],
12	using	VBG	O	use	xcomp	11	SENT_353	[p22l384t2836r577b2909],
13	the	DT	O	the	det	16	SENT_353	[p22l674t2833r786b2891],
14	QIAquick	NN	O	qiaquick	nn	16	SENT_353	[p22l887t2833r1223b2909],
15	system	NN	O	system	nn	16	SENT_353	[p22l1322t2840r1560b2909],
16	kit	NN	O	kit	dobj	12	SENT_353	[p22l1659t2833r1750b2891],
17	(	CD	NUMBER	(	num	16	SENT_353	[p22l1852t2833r2144b2909],
18	Qiagen	NNP	ORGANIZATION	Qiagen	nn	22	SENT_353	[p22l1852t2833r2144b2909],
19	,	,	O	,	_	0	SENT_353	[p22l1852t2833r2144b2909],
20	Courtabeeuf	NNP	PERSON	Courtabeeuf	appos	22	SENT_353	[p22l11t2927r463b2998],
21	,	,	O	,	_	0	SENT_353	[p22l11t2927r463b2998],
22	France	NNP	LOCATION	France	nsubjpass	11	SENT_353	[p22l502t2928r754b2999],
23	)	CD	NUMBER	)	num	22	SENT_353	[p22l502t2928r754b2999],
24	using	VBG	O	use	partmod	22	SENT_353	[p22l789t2930r981b3003],
25	the	DT	O	the	det	28	SENT_353	[p22l1012t2927r1124b2985],
26	selective	JJ	O	selective	amod	28	SENT_353	[p22l1159t2927r1454b2985],
27	binding	NN	O	binding	nn	28	SENT_353	[p22l1485t2927r1766b3003],
28	properties	NNS	O	property	dobj	24	SENT_353	[p22l1795t2930r2148b3003],
29	of	IN	O	of	_	0	SENT_353	[p22l10t3023r81b3081],
30	a	DT	O	a	det	32	SENT_353	[p22l124t3040r159b3081],
31	silica-gel	JJ	O	silica-gel	amod	32	SENT_353	[p22l206t3023r508b3099],
32	membrane	NN	O	membrane	prep_of	28	SENT_353	[p22l555t3023r954b3081],
33	.	.	O	.	_	0	SENT_353	[p22l555t3023r954b3081],

1	According	VBG	O	accord	_	0	SENT_354	[p22l1003t3023r1366b3099],
2	to	TO	O	to	prepc_according_to	8	SENT_354	[p22l1411t3030r1481b3081],
3	provided	VBN	O	provide	amod	4	SENT_354	[p22l1527t3023r1842b3099],
4	buffers	NNS	O	buffer	pobj	8	SENT_354	[p22l1886t3023r2145b3093],
5	,	,	O	,	_	0	SENT_354	[p22l1886t3023r2145b3093],
6	impurities	NNS	O	impurity	nsubjpass	8	SENT_354	[p22l9t3121r370b3194],
7	were	VBD	O	be	auxpass	8	SENT_354	[p22l397t3135r561b3176],
8	washed	VBN	O	wash	_	0	SENT_354	[p22l590t3118r854b3176],
9	away	RB	O	away	advmod	8	SENT_354	[p22l883t3135r1062b3194],
10	and	CC	O	and	_	0	SENT_354	[p22l1089t3118r1221b3176],
11	the	DT	O	the	det	13	SENT_354	[p22l1249t3118r1362b3176],
12	pure	JJ	O	pure	amod	13	SENT_354	[p22l1391t3135r1548b3194],
13	DNA	NN	MISC	dna	nsubjpass	15	SENT_354	[p22l1579t3120r1748b3175],
14	was	VBD	O	be	auxpass	15	SENT_354	[p22l1773t3135r1901b3176],
15	eluted	VBN	O	elute	conj_and	8	SENT_354	[p22l1932t3118r2150b3176],
16	during	IN	O	during	_	0	SENT_354	[p22l10t3213r245b3288],
17	centrifugation	NN	O	centrifugation	prep_during	15	SENT_354	[p22l310t3212r816b3288],
18	(	CD	NUMBER	(	number	19	SENT_354	[p22l886t3213r990b3285],
19	13	CD	NUMBER	13	dep	17	SENT_354	[p22l886t3213r990b3285],
20	ooo	NN	O	ooo	nn	22	SENT_354	[p22l1010t3214r1138b3270],
21	tr/min	JJ	O	tr/min	amod	22	SENT_354	[p22l1154t3212r1430b3285],
22	)	NN	O	)	dep	19	SENT_354	[p22l1154t3212r1430b3285],
23	.	.	O	.	_	0	SENT_354	[p22l1154t3212r1430b3285],

1	Purified	VBN	O	purify	partmod	9	SENT_355	[p22l1501t3212r1775b3270],
2	products	NNS	O	product	nsubj	4	SENT_355	[p22l1841t3213r2148b3288],
3	(	CD	NUMBER	(	num	4	SENT_355	[p22l13t3308r120b3380],
4	30	CD	NUMBER	30	xcomp	1	SENT_355	[p22l13t3308r120b3380],
5	,	,	O	,	_	0	SENT_355	[p22l136t3308r222b3381],
6	ul	NN	O	ul	nn	7	SENT_355	[p22l136t3308r222b3381],
7	)	NN	O	)	nsubjpass	9	SENT_355	[p22l136t3308r222b3381],
8	were	VBD	O	be	auxpass	9	SENT_355	[p22l258t3325r422b3366],
9	digested	VBN	O	digest	_	0	SENT_355	[p22l457t3308r747b3384],
10	with	IN	O	with	_	0	SENT_355	[p22l779t3308r940b3366],
11	the	DT	O	the	det	12	SENT_355	[p22l973t3308r1086b3366],
12	Haelll	NNP	O	Haelll	prep_with	9	SENT_355	[p22l1117t3311r1329b3366],
13	(	CD	NUMBER	(	num	12	SENT_355	[p22l1368t3308r1620b3384],
14	Sigma	NNP	O	Sigma	nn	18	SENT_355	[p22l1368t3308r1620b3384],
15	,	,	O	,	_	0	SENT_355	[p22l1368t3308r1620b3384],
16	Lyon	NNP	LOCATION	Lyon	appos	18	SENT_355	[p22l1660t3311r1853b3384],
17	,	,	O	,	_	0	SENT_355	[p22l1660t3311r1853b3384],
18	France	NNP	LOCATION	France	dep	25	SENT_355	[p22l1893t3309r2146b3380],
19	)	CD	NUMBER	)	num	18	SENT_355	[p22l1893t3309r2146b3380],
20	restriction	NN	O	restriction	dep	18	SENT_355	[p22l9t3406r372b3461],
21	enzyme	NN	O	enzyme	dep	25	SENT_355	[p22l413t3420r685b3479],
22	(	CD	NUMBER	(	num	21	SENT_355	[p22l730t3403r984b3475],
23	GGCC	NN	O	ggcc	nn	25	SENT_355	[p22l730t3403r984b3475],
24	restriction	NN	O	restriction	nn	25	SENT_355	[p22l1025t3406r1388b3461],
25	site	NN	O	site	dep	9	SENT_355	[p22l1430t3404r1569b3475],
26	)	CD	NUMBER	)	dep	25	SENT_355	[p22l1430t3404r1569b3475],
27	for	IN	O	for	_	0	SENT_355	[p22l1614t3403r1712b3461],
28	150	CD	DURATION	150	num	29	SENT_355	[p22l1758t3405r1879b3461],
29	min	NN	DURATION	min	prep_for	26	SENT_355	[p22l1896t3406r2039b3460],
30	in	IN	O	in	_	0	SENT_355	[p22l2079t3406r2149b3460],
31	the	DT	O	the	det	32	SENT_355	[p22l9t3498r122b3556],
32	presence	NN	O	presence	prep_in	29	SENT_355	[p22l151t3515r456b3574],
33	of	IN	O	of	_	0	SENT_355	[p22l487t3498r559b3556],
34	buffer	NN	O	buffer	prep_of	32	SENT_355	[p22l581t3498r793b3556],
35	2	CD	NUMBER	2	number	34	SENT_355	[p22l822t3499r861b3555],
36	(	CD	NUMBER	(	number	34	SENT_355	[p22l894t3498r956b3570],
37	4	CD	NUMBER	4	number	34	SENT_355	[p22l894t3498r956b3570],
38	ill	RB	O	ill	advmod	34	SENT_355	[p22l974t3498r1036b3570],
39	for	IN	O	for	_	0	SENT_355	[p22l1066t3498r1164b3556],
40	a	DT	O	a	det	42	SENT_355	[p22l1193t3515r1228b3556],
41	final	JJ	O	final	amod	42	SENT_355	[p22l1257t3498r1416b3556],
42	concentration	NN	O	concentration	prep_for	9	SENT_355	[p22l1446t3501r1946b3556],
43	1	CD	NUMBER	1	num	42	SENT_355	[p22l1981t3500r2010b3555],
44	x	CC	O	x	_	0	SENT_355	[p22l2041t3516r2078b3554],
45	)	CD	NUMBER	)	prep_for	9	SENT_355	[p22l2103t3498r2145b3570],
46	.	.	O	.	_	0	SENT_355	[p22l2103t3498r2145b3570],

1	Finally	RB	O	finally	advmod	30	SENT_356	[p22l10t3593r260b3669],
2	,	,	O	,	_	0	SENT_356	[p22l10t3593r260b3669],
3	digested	VBN	O	digest	amod	5	SENT_356	[p22l309t3593r599b3669],
4	PCR	NN	O	pcr	nn	5	SENT_356	[p22l642t3595r788b3651],
5	products	NNS	O	product	nsubj	30	SENT_356	[p22l829t3593r1136b3669],
6	were	VBD	O	be	auxpass	7	SENT_356	[p22l1177t3610r1341b3651],
7	loaded	VBN	O	load	rcmod	5	SENT_356	[p22l1385t3593r1621b3651],
8	into	IN	O	into	_	0	SENT_356	[p22l1663t3596r1807b3651],
9	adjacent	JJ	O	adjacent	amod	10	SENT_356	[p22l1851t3593r2149b3669],
10	lanes	NNS	O	lane	prep_into	7	SENT_356	[p22l9t3688r187b3745],
11	on	IN	O	on	_	0	SENT_356	[p22l214t3704r305b3745],
12	a	DT	O	a	det	16	SENT_356	[p22l332t3704r366b3745],
13	3	CD	PERCENT	3	number	14	SENT_356	[p22l393t3689r501b3745],
14	%	NN	PERCENT	%	amod	16	SENT_356	[p22l393t3689r501b3745],
15	agarose	NN	O	agarose	nn	16	SENT_356	[p22l527t3704r785b3763],
16	gel	NN	O	gel	prep_on	7	SENT_356	[p22l812t3687r911b3763],
17	containing	VBG	O	contain	partmod	16	SENT_356	[p22l938t3690r1325b3763],
18	ethidium	NN	O	ethidium	nn	19	SENT_356	[p22l1350t3687r1677b3745],
19	bromide	NN	O	bromide	dobj	17	SENT_356	[p22l1700t3687r1998b3745],
20	1	CD	NUMBER	1	number	21	SENT_356	[p22l2031t3689r2060b3744],
21	x	NN	O	x	amod	19	SENT_356	[p22l2091t3706r2128b3743],
22	and	CC	O	and	_	0	SENT_356	[p23l10t19r141b77],
23	electrophoresed	VBN	O	electrophorese	rcmod	5	SENT_356	[p23l171t19r734b95],
24	in	IN	O	in	_	0	SENT_356	[p23l763t22r833b76],
25	1	CD	NUMBER	1	prep_in	23	SENT_356	[p23l868t21r897b76],
26	x	CC	O	x	_	0	SENT_356	[p23l928t37r965b75],
27	T	NN	O	t	prep_in	23	SENT_356	[p23l989t21r1036b76],
28	BE	VBP	O	be	cop	30	SENT_356	[p23l1039t21r1126b76],
29	(	CD	NUMBER	(	num	30	SENT_356	[p23l1158t19r1397b95],
30	Figure	NNP	O	Figure	_	0	SENT_356	[p23l1158t19r1397b95],
31	7	CD	NUMBER	7	num	30	SENT_356	[p23l1433t12r1755b91],
32	)	CD	NUMBER	)	number	33	SENT_356	[p23l1433t12r1755b91],
33	.12	CD	NUMBER	.12	num	34	SENT_356	[p23l1433t12r1755b91],
34	‘	NN	O	‘	dep	30	SENT_356	[p23l1433t12r1755b91],
35	14	CD	NUMBER	14	num	36	SENT_356	[p23l1433t12r1755b91],
36	'21	CD	NUMBER	'21	dep	34	SENT_356	[p23l1433t12r1755b91],

1	Determination	NN	O	determination	_	0	SENT_357	[p23l13t250r471b307],
2	of	IN	O	of	_	0	SENT_357	[p23l495t249r561b307],
3	DPD	NN	O	dpd	nn	7	SENT_357	[p23l576t252r717b306],
4	and	CC	O	and	_	0	SENT_357	[p23l740t249r865b307],
5	M	NN	O	m	nn	7	SENT_357	[p23l884t252r948b306],
6	THFR	NN	O	thfr	nn	7	SENT_357	[p23l956t252r1113b307],
7	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_357	[p23l1132t249r1634b325],
8	.	.	O	.	_	0	SENT_357	[p23l1132t249r1634b325],

1	The	DT	O	the	det	2	SENT_358	[p23l1716t249r1849b307],
2	analysis	NN	O	analysis	nsubjpass	10	SENT_358	[p23l1874t249r2149b325],
3	of	IN	O	of	_	0	SENT_358	[p23l10t344r82b402],
4	DPD	NN	O	dpd	nn	8	SENT_358	[p23l152t347r315b401],
5	and	CC	O	and	_	0	SENT_358	[p23l393t344r525b402],
6	MT	NN	O	mt	nn	8	SENT_358	[p23l600t347r725b401],
7	HFR	NN	O	hfr	nn	8	SENT_358	[p23l717t347r863b401],
8	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_358	[p23l942t344r1498b420],
9	was	VBD	O	be	auxpass	10	SENT_358	[p23l1576t361r1704b402],
10	based	VBN	O	base	_	0	SENT_358	[p23l1781t344r1979b402],
11	on	IN	O	on	_	0	SENT_358	[p23l2059t361r2150b402],
12	pyrosequencing	NN	O	pyrosequencing	nn	13	SENT_358	[p23l9t444r575b517],
13	technology	NN	O	technology	prep_on	10	SENT_358	[p23l650t441r1052b517],
14	(	NN	O	(	nn	19	SENT_358	[p23l1129t441r1757b513],
15	bioluminometric	JJ	O	bioluminometric	amod	19	SENT_358	[p23l1129t441r1757b513],
16	real-time	JJ	O	real-time	amod	19	SENT_358	[p23l1833t441r2148b499],
17	sequence	NN	O	sequence	nn	19	SENT_358	[p23l11t553r331b612],
18	determination	NN	O	determination	nn	19	SENT_358	[p23l362t536r918b609],
19	)	NN	O	)	dep	13	SENT_358	[p23l362t536r918b609],
20	.	.	O	.	_	0	SENT_358	[p23l362t536r918b609],

1	For	IN	O	for	_	0	SENT_359	[p23l82t635r194b691],
2	DPD	NN	ORGANIZATION	dpd	nn	3	SENT_359	[p23l236t635r399b690],
3	polymorphisms	NNS	O	polymorphism	prep_for	9	SENT_359	[p23l441t633r964b709],
4	,	,	O	,	_	0	SENT_359	[p23l441t633r964b709],
5	four	CD	NUMBER	four	num	6	SENT_359	[p23l1020t633r1166b691],
6	SNPS	NNS	O	snp	nsubjpass	9	SENT_359	[p23l1216t635r1385b691],
7	were	VBD	O	be	auxpass	9	SENT_359	[p23l1435t650r1599b691],
8	systematically	RB	O	systematically	advmod	9	SENT_359	[p23l1653t633r2152b709],
9	analyzed	VBN	O	analyze	_	0	SENT_359	[p23l10t729r338b805],
10	:	:	O	:	_	0	SENT_359	[p23l10t729r338b805],
11	IVS	NNS	O	iv	dobj	9	SENT_359	[p23l398t731r513b787],
12	14	CD	NUMBER	14	number	13	SENT_359	[p23l575t731r972b792],
13	+1	CD	NUMBER	+1	num	14	SENT_359	[p23l575t731r972b792],
14	G	NN	O	g	npadvmod	15	SENT_359	[p23l575t731r972b792],
15	>	JJR	O	>	dep	11	SENT_359	[p23l575t731r972b792],
16	A	DT	O	a	dep	15	SENT_359	[p23l575t731r972b792],
17	within	IN	O	within	_	0	SENT_359	[p23l1022t729r1258b787],
18	intron	NN	O	intron	prep_within	15	SENT_359	[p23l1313t732r1537b787],
19	14	CD	NUMBER	14	num	18	SENT_359	[p23l1598t731r1693b799],
20	,	,	O	,	_	0	SENT_359	[p23l1598t731r1693b799],
21	2846	CD	DATE	2846	appos	11	SENT_359	[p23l1754t731r1924b787],
22	A	DT	O	a	det	24	SENT_359	[p23l1978t731r2151b787],
23	>	JJR	O	>	amod	24	SENT_359	[p23l1978t731r2151b787],
24	T	NN	O	t	dep	21	SENT_359	[p23l1978t731r2151b787],
25	within	IN	O	within	_	0	SENT_359	[p23l8t824r243b881],
26	exon	NN	O	exon	prep_within	24	SENT_359	[p23l279t840r452b882],
27	22	CD	NUMBER	22	num	26	SENT_359	[p23l489t825r589b894],
28	,	,	O	,	_	0	SENT_359	[p23l489t825r589b894],
29	1679	CD	DATE	1679	num	30	SENT_359	[p23l635t825r799b881],
30	T	NN	O	t	dobj	9	SENT_359	[p23l835t825r1017b881],
31	>	JJR	O	>	amod	32	SENT_359	[p23l835t825r1017b881],
32	G	NN	O	g	dep	30	SENT_359	[p23l835t825r1017b881],
33	within	IN	O	within	_	0	SENT_359	[p23l1051t824r1286b881],
34	exon	NN	O	exon	prep_within	32	SENT_359	[p23l1323t840r1496b882],
35	13	CD	NUMBER	13	num	34	SENT_359	[p23l1537t825r1612b882],
36	and	CC	O	and	_	0	SENT_359	[p23l1651t824r1783b882],
37	464	CD	NUMBER	464	num	38	SENT_359	[p23l1818t825r1944b881],
38	T	NN	O	t	conj_and	11	SENT_359	[p23l1980t825r2150b881],
39	>	JJR	O	>	dep	38	SENT_359	[p23l1980t825r2150b881],
40	A	DT	O	a	dep	39	SENT_359	[p23l1980t825r2150b881],

1	50	CD	NUMBER	50	num	2	SENT_360	[p23l987t1033r1060b1084],
2	bp	NN	O	bp	_	0	SENT_360	[p23l1085t1032r1162b1097],
3	Scale	NNP	O	Scale	dep	2	SENT_360	[p23l988t1112r1163b1164],

1	G3D	NN	O	g3d	nn	4	SENT_361	[p23l378t1182r444b1208],
2	3Rl3R	NN	O	3rl3r	nn	4	SENT_361	[p23l1041t1182r1134b1208],
3	2Rl2R	NN	O	2rl2r	nn	4	SENT_361	[p23l1208t1181r1301b1206],
4	G3PDH	NN	O	g3pdh	_	0	SENT_361	[p23l1341t1182r1452b1207],
5	T	NN	O	t	nn	7	SENT_361	[p23l1465t1210r1485b1234],
6	marker	NN	O	marker	nn	7	SENT_361	[p23l1572t1179r1681b1204],
7	gDNA	NN	O	gdna	dep	4	SENT_361	[p23l615t1231r706b1263],
8	of	IN	O	of	_	0	SENT_361	[p23l716t1231r747b1256],
9	patients	NNS	O	patient	prep_of	7	SENT_361	[p23l758t1231r883b1262],

1	.	.	O	.	_	0	SENT_362	[p23l355t1278r375b1298],

1	‘	NN	O	‘	nn	2	SENT_363	[p23l355t1278r375b1298],
2	Y	NN	O	y	_	0	SENT_363	[p23l393t1278r423b1302],
3	}	CD	NUMBER	}	dep	2	SENT_363	[p23l393t1278r423b1302],
4	.	.	O	.	_	0	SENT_363	[p23l393t1278r423b1302],

1	F.	NNP	O	F.	_	0	SENT_364	[p23l436t1278r731b1312],
2	.	.	O	.	_	0	SENT_364	[p23l436t1278r731b1312],

1	zjv	NN	O	zjv	_	0	SENT_365	[p23l436t1278r731b1312],
2	____	CD	NUMBER	____	dep	1	SENT_365	[p23l436t1278r731b1312],
3	.	.	O	.	_	0	SENT_365	[p23l436t1278r731b1312],

1	.	.	O	.	_	0	SENT_366	[p23l436t1278r731b1312],

1	__	NN	O	__	_	0	SENT_367	[p23l771t1279r791b1280],

1	1	CD	NUMBER	1	_	0	SENT_368	[p23l1504t1452r1538b1481],
2	-.1	CD	NUMBER	-.1	dep	1	SENT_368	[p23l1504t1452r1538b1481],
3	‘	NN	O	‘	rcmod	2	SENT_368	[p23l1504t1452r1538b1481],
4	,	,	O	,	_	0	SENT_368	[p23l1597t1455r1642b1485],
5	,	,	O	,	_	0	SENT_368	[p23l1597t1455r1642b1485],
6	_	CD	NUMBER	_	num	7	SENT_368	[p23l1673t1483r1678b1485],
7	MD	NN	O	md	dep	3	SENT_368	[p23l1277t1510r1326b1535],
8	-	:	O	-	_	0	SENT_368	[p23l1337t1523r1347b1528],
9	Patient	NN	O	patient	nn	10	SENT_368	[p23l1461t1510r1569b1535],
10	gDNA	NN	O	gdna	dep	2	SENT_368	[p23l1580t1510r1671b1542],

1	Figure	NNP	O	Figure	nn	3	SENT_369	[p23l11t1576r105b1609],
2	6	CD	NUMBER	6	num	3	SENT_369	[p23l119t1576r137b1601],
3	Thymidylate	NNP	O	Thymidylate	nsubj	10	SENT_369	[p23l169t1576r349b1609],
4	synthase	NN	O	synthase	nn	10	SENT_369	[p23l362t1576r486b1609],
5	enhancer	NN	O	enhancer	nn	10	SENT_369	[p23l500t1576r635b1601],
6	region	NN	O	region	nn	10	SENT_369	[p23l649t1576r739b1609],
7	(	CD	NUMBER	(	num	10	SENT_369	[p23l754t1576r845b1608],
8	TSER	NN	O	tser	nn	10	SENT_369	[p23l754t1576r845b1608],
9	)	NN	O	)	nn	10	SENT_369	[p23l754t1576r845b1608],
10	analysis	NN	O	analysis	_	0	SENT_369	[p23l860t1576r968b1609],
11	by	IN	O	by	_	0	SENT_369	[p23l983t1576r1017b1609],
12	PCR	NN	O	pcr	prep_by	10	SENT_369	[p23l1032t1576r1096b1601],
13	.	.	O	.	_	0	SENT_369	[p23l1032t1576r1096b1601],

1	Products	NNPS	O	Products	nsubjpass	4	SENT_370	[p23l1112t1576r1236b1601],
2	can	MD	O	can	aux	4	SENT_370	[p23l1250t1583r1299b1601],
3	be	VB	O	be	auxpass	4	SENT_370	[p23l1314t1576r1348b1601],
4	separated	VBN	O	separate	_	0	SENT_370	[p23l1362t1576r1501b1609],
5	in	IN	O	in	_	0	SENT_370	[p23l1517t1576r1540b1601],
6	1	CD	NUMBER	1	prep_in	4	SENT_370	[p23l1557t1576r1566b1601],
7	x	CC	O	x	_	0	SENT_370	[p23l1583t1584r1600b1601],
8	TBE	NN	O	tbe	prep_in	4	SENT_370	[p23l1621t1577r1675b1601],
9	on	IN	O	on	_	0	SENT_370	[p23l1689t1583r1724b1601],
10	2	CD	PERCENT	2	number	11	SENT_370	[p23l1739t1576r1786b1601],
11	%	NN	PERCENT	%	amod	13	SENT_370	[p23l1739t1576r1786b1601],
12	gel	NN	O	gel	nn	13	SENT_370	[p23l1800t1576r1842b1609],
13	electrophoresis	NN	O	electrophoresis	prep_on	8	SENT_370	[p23l1857t1576r2074b1609],
14	with	IN	O	with	_	0	SENT_370	[p23l2087t1576r2149b1601],
15	ethidium	NN	O	ethidium	nn	16	SENT_370	[p23l10t1617r139b1642],
16	bromide	NN	O	bromide	prep_with	13	SENT_370	[p23l161t1617r282b1642],
17	1	CD	NUMBER	1	num	16	SENT_370	[p23l304t1617r313b1642],
18	x	CC	O	x	_	0	SENT_370	[p23l331t1617r414b1649],
19	(	CD	NUMBER	(	number	20	SENT_370	[p23l331t1617r414b1649],
20	0.5	CD	NUMBER	0.5	num	21	SENT_370	[p23l331t1617r414b1649],
21	pg	NN	O	pg	conj_x	6	SENT_370	[p23l423t1617r518b1650],
22	/	:	O	/	punct	25	SENT_370	[p23l423t1617r518b1650],
23	,	,	O	,	_	0	SENT_370	[p23l423t1617r518b1650],
24	ul	NN	O	ul	nn	25	SENT_370	[p23l423t1617r518b1650],
25	)	NN	O	)	dep	21	SENT_370	[p23l423t1617r518b1650],
26	.	.	O	.	_	0	SENT_370	[p23l423t1617r518b1650],

1	Sizes	NNS	O	size	nsubjpass	6	SENT_371	[p23l541t1617r608b1642],
2	of	IN	O	of	_	0	SENT_371	[p23l628t1617r656b1642],
3	different	JJ	O	different	amod	4	SENT_371	[p23l676t1617r798b1642],
4	fragments	NNS	O	fragment	prep_of	1	SENT_371	[p23l815t1617r962b1650],
5	are	VBP	O	be	auxpass	6	SENT_371	[p23l983t1624r1025b1642],
6	indicated	VBN	O	indicate	_	0	SENT_371	[p23l1047t1617r1178b1642],
7	on	IN	O	on	_	0	SENT_371	[p23l1200t1624r1235b1642],
8	the	DT	O	the	det	11	SENT_371	[p23l1256t1617r1302b1642],
9	right	JJ	O	right	amod	11	SENT_371	[p23l1324t1617r1391b1650],
10	(	NN	O	(	nn	11	SENT_371	[p23l1411t1617r1568b1650],
11	fragments	NNS	O	fragment	prep_on	6	SENT_371	[p23l1411t1617r1568b1650],
12	of	IN	O	of	_	0	SENT_371	[p23l1588t1617r1617b1642],
13	136	CD	NUMBER	136	num	15	SENT_371	[p23l1637t1617r1690b1642],
14	bases	NNS	O	basis	nn	15	SENT_371	[p23l1712t1617r1788b1642],
15	pairs	NNS	O	pair	prep_of	11	SENT_371	[p23l1809t1617r1875b1650],
16	(	CD	NUMBER	(	num	18	SENT_371	[p23l1895t1617r1955b1650],
17	bp	NN	O	bp	nn	18	SENT_371	[p23l1895t1617r1955b1650],
18	)	NN	O	)	tmod	6	SENT_371	[p23l1895t1617r1955b1650],
19	and	CC	O	and	_	0	SENT_371	[p23l1976t1617r2029b1642],
20	108	CD	NUMBER	108	num	21	SENT_371	[p23l2052t1617r2105b1642],
21	bp	NN	O	bp	tmod	6	SENT_371	[p23l2114t1617r2150b1650],
22	corresponding	VBG	O	correspond	partmod	21	SENT_371	[p23l10t1658r219b1691],
23	to	TO	O	to	_	0	SENT_371	[p23l246t1661r275b1683],
24	3R	NN	O	3r	prep_to	22	SENT_371	[p23l304t1659r339b1683],
25	and	CC	O	and	_	0	SENT_371	[p23l365t1658r418b1683],
26	2R	NN	O	2r	prep_to	22	SENT_371	[p23l446t1659r489b1688],
27	,	,	O	,	_	0	SENT_371	[p23l446t1659r489b1688],
28	respectively	RB	O	respectively	advmod	18	SENT_371	[p23l519t1658r707b1691],
29	)	CD	NUMBER	)	dep	18	SENT_371	[p23l519t1658r707b1691],
30	.	.	O	.	_	0	SENT_371	[p23l519t1658r707b1691],

1	G3PDH	NN	O	g3pdh	nsubj	11	SENT_372	[p23l737t1658r1491b1691],
2	=	JJ	O	=	amod	9	SENT_372	[p23l737t1658r1491b1691],
3	g	NN	O	g	nn	9	SENT_372	[p23l737t1658r1491b1691],
4	|	NN	O	|	nn	9	SENT_372	[p23l737t1658r1491b1691],
5	ycera	NN	O	ycera	nn	9	SENT_372	[p23l737t1658r1491b1691],
6	|	CD	NUMBER	|	num	9	SENT_372	[p23l737t1658r1491b1691],
7	dehyde-3-phosphodehydrogenase	NN	O	dehyde-3-phosphodehydrogenase	nn	9	SENT_372	[p23l737t1658r1491b1691],
8	(	NN	O	(	nn	9	SENT_372	[p23l1519t1658r1601b1691],
9	gene	NN	O	gene	dep	1	SENT_372	[p23l1519t1658r1601b1691],
10	constitutively	RB	O	constitutively	advmod	11	SENT_372	[p23l1628t1658r1821b1691],
11	expressed	VBN	O	express	_	0	SENT_372	[p23l1847t1658r1989b1691],
12	in	IN	O	in	_	0	SENT_372	[p23l2017t1658r2041b1683],
13	cells	NNS	O	cell	prep_in	11	SENT_372	[p23l2069t1658r2149b1689],
14	)	CD	NUMBER	)	dep	13	SENT_372	[p23l2069t1658r2149b1689],
15	.	.	O	.	_	0	SENT_372	[p23l2069t1658r2149b1689],

1	G3D	NN	O	g3d	_	0	SENT_373	[p23l10t1700r220b1724],
2	:	:	O	:	_	0	SENT_373	[p23l10t1700r220b1724],
3	G3PDH	NN	O	g3pdh	dep	1	SENT_373	[p23l10t1700r220b1724],
4	with	IN	O	with	_	0	SENT_373	[p23l234t1699r296b1724],
5	dimethylsulfoxide	NN	O	dimethylsulfoxide	nn	8	SENT_373	[p23l310t1699r568b1732],
6	(	CD	NUMBER	(	num	8	SENT_373	[p23l581t1699r709b1730],
7	DMSO	NN	ORGANIZATION	dmso	nn	8	SENT_373	[p23l581t1699r709b1730],
8	)	NN	O	)	prep_with	3	SENT_373	[p23l581t1699r709b1730],
9	.	.	O	.	_	0	SENT_373	[p23l581t1699r709b1730],

1	MD	NN	O	md	_	0	SENT_374	[p23l725t1700r801b1724],
2	—	CD	NUMBER	—	num	1	SENT_374	[p23l725t1700r801b1724],
3	:	:	O	:	_	0	SENT_374	[p23l811t1699r964b1732],
4	negative	JJ	O	negative	amod	5	SENT_374	[p23l811t1699r964b1732],
5	marker	NN	O	marker	dep	1	SENT_374	[p23l978t1699r1079b1724],
6	with	IN	O	with	_	0	SENT_374	[p23l1089t1699r1151b1724],
7	DMSO	NN	ORGANIZATION	dmso	prep_with	5	SENT_374	[p23l1167t1700r1270b1724],
8	.	.	O	.	_	0	SENT_374	[p23l1167t1700r1270b1724],

1	Fluorouracil	NNP	O	Fluorouracil	nn	3	SENT_375	[p23l1106t1918r1245b1940],
2	outcome	NN	O	outcome	nn	3	SENT_375	[p23l1254t1920r1357b1940],
3	parameters	NNS	O	parameter	_	0	SENT_375	[p23l1366t1920r1500b1947],
4	o	NN	O	o	nn	5	SENT_375	[p23l1105t1953r1122b1974],
5	Capitain	NNP	MISC	Capitain	dep	3	SENT_375	[p23l1131t1953r1213b1980],
6	et	FW	O	et	nn	8	SENT_375	[p23l1224t1955r1241b1974],
7	al	FW	O	al	nn	8	SENT_375	[p23l1249t1953r1267b1974],
8	mg	NN	O	mg	dep	5	SENT_375	[p23l2089t1912r2151b1973],
9	265	CD	NUMBER	265	dep	3	SENT_375	[p23l2097t2003r2149b2024],

1	a	DT	O	a	det	3	SENT_376	[p23l385t2099r406b2123],
2	32	CD	NUMBER	32	num	3	SENT_376	[p23l599t2099r634b2124],
3	28	CD	NUMBER	28	_	0	SENT_376	[p23l831t2099r867b2124],
4	66	CD	NUMBER	66	number	5	SENT_376	[p23l1125t2099r1160b2124],
5	10	CD	NUMBER	10	dep	3	SENT_376	[p23l1377t2099r1411b2124],
6	mg	NN	O	mg	nn	8	SENT_376	[p23l385t2170r445b2201],
7	—	NN	O	—	nn	8	SENT_376	[p23l471t2135r1467b2214],
8	kr	NN	O	kr	dep	5	SENT_376	[p23l471t2135r1467b2214],
9	136	CD	NUMBER	136	num	10	SENT_376	[p23l1482t2148r1535b2173],
10	bp	NN	O	bp	dep	3	SENT_376	[p23l1547t2147r1585b2179],

1	1	CD	NUMBER	1	_	0	SENT_377	[p23l454t2209r463b2233],
2	Hae	NNP	O	Hae	nn	4	SENT_377	[p23l707t2225r765b2251],
3	III	NNP	O	III	nn	4	SENT_377	[p23l778t2225r801b2250],
4	Hae	NNP	O	Hae	dep	1	SENT_377	[p23l904t2227r962b2252],
5	III	NNP	O	III	nn	6	SENT_377	[p23l975t2227r997b2252],
6	Hae	NNP	O	Hae	poss	8	SENT_377	[p23l1347t2215r1405b2240],
7	'	POS	O	'	_	0	SENT_377	[p23l1418t2215r1441b2239],
8	”	NN	O	”	dep	4	SENT_377	[p23l1418t2215r1441b2239],

1	W	NNP	O	W	_	0	SENT_378	[p23l387t2370r446b2395],
2	—	CD	NUMBER	—	num	3	SENT_378	[p23l471t2335r1469b2414],
3	kr	NN	O	kr	dep	1	SENT_378	[p23l471t2335r1469b2414],
4	36	CD	NUMBER	36	num	5	SENT_378	[p23l1499t2347r1535b2372],
5	bp	NN	O	bp	dep	1	SENT_378	[p23l1547t2347r1585b2378],

1	1	CD	NUMBER	1	num	2	SENT_379	[p23l454t2411r463b2435],
2	Hae	NN	O	ha	_	0	SENT_379	[p23l707t2428r765b2453],
3	I	PRP	O	I	nsubj	4	SENT_379	[p23l778t2428r800b2453],
4	”	VBP	O	”	rcmod	2	SENT_379	[p23l778t2428r800b2453],
5	Hae	NNP	O	Hae	nn	6	SENT_379	[p23l1346t2416r1404b2441],
6	Ill	NNP	O	Ill	dobj	4	SENT_379	[p23l1417t2416r1440b2441],

1	ZR	NN	O	zr	_	0	SENT_380	[p23l405t2577r446b2601],
2	j	SYM	O	j	dep	1	SENT_380	[p23l471t2563r644b2568],
3	-	:	O	-	_	0	SENT_380	[p23l665t2563r670b2568],
4	‘	NN	O	‘	dep	1	SENT_380	[p23l688t2563r693b2568],
5	~	NN	O	~	rcmod	4	SENT_380	[p23l712t2563r716b2568],
6	‘	CD	NUMBER	‘	dep	5	SENT_380	[p23l735t2563r740b2568],
7	~	SYM	O	~	dep	5	SENT_380	[p23l759t2563r763b2568],
8	-	:	O	-	_	0	SENT_380	[p23l782t2563r787b2568],
9	~	NN	O	~	dep	4	SENT_380	[p23l806t2563r810b2568],
10	‘	CD	NUMBER	‘	num	11	SENT_380	[p23l829t2563r834b2568],
11	|	CD	NUMBER	|	dep	9	SENT_380	[p23l852t2542r1469b2621],
12	:	:	O	:	_	0	SENT_380	[p23l852t2542r1469b2621],
13	|	CD	NUMBER	|	dep	9	SENT_380	[p23l852t2542r1469b2621],
14	:	:	O	:	_	0	SENT_380	[p23l852t2542r1469b2621],
15	l	NN	O	l	dep	13	SENT_380	[p23l852t2542r1469b2621],
16	.	.	O	.	_	0	SENT_380	[p23l852t2542r1469b2621],

1	—	NN	O	—	_	0	SENT_381	[p23l852t2542r1469b2621],
2	.	.	O	.	_	0	SENT_381	[p23l852t2542r1469b2621],

1	X-i	NN	O	x-i	_	0	SENT_382	[p23l852t2542r1469b2621],
2	108	CD	NUMBER	108	dep	1	SENT_382	[p23l1482t2554r1535b2579],
3	up	IN	O	up	_	0	SENT_382	[p23l1547t2554r1585b2585],
4	1	CD	NUMBER	1	prep_up	2	SENT_382	[p23l454t2615r463b2639],
5	Hae	NNP	O	Hae	nn	7	SENT_382	[p23l916t2633r974b2658],
6	Ill	NNP	O	Ill	nn	7	SENT_382	[p23l987t2633r1009b2658],
7	Hae	NNP	O	Hae	poss	4	SENT_382	[p23l1347t2611r1404b2636],
8	'	POS	O	'	_	0	SENT_382	[p23l1417t2611r1440b2636],
9	"	''	O	"	punct	2	SENT_382	[p23l1417t2611r1440b2636],

1	b	NN	O	b	nn	3	SENT_383	[p23l385t2707r407b2738],
2	Negative	JJ	O	negative	amod	3	SENT_383	[p23l484t2719r620b2751],
3	3Rgl3Rg	NN	O	3rgl3rg	_	0	SENT_383	[p23l1218t2726r1351b2759],
4	50	CD	NUMBER	50	num	6	SENT_383	[p23l1463t2707r1499b2732],
5	bp	NN	O	bp	nn	6	SENT_383	[p23l1511t2707r1549b2738],
6	scale	NN	O	scale	dep	3	SENT_383	[p23l1560t2707r1642b2732],
7	marker	NN	O	marker	nn	13	SENT_383	[p23l498t2759r607b2784],
8	3Rc/3Flg	NN	O	3rc/3flg	nn	13	SENT_383	[p23l699t2759r830b2791],
9	3Rc	NN	O	3rc	nn	13	SENT_383	[p23l915t2775r1045b2800],
10	,3	CD	NUMBER	,3	num	13	SENT_383	[p23l915t2775r1045b2800],
11	Rc	NN	O	rc	nn	13	SENT_383	[p23l915t2775r1045b2800],
12	3Rc/3Rc	NN	O	3rc/3rc	nn	13	SENT_383	[p23l1344t2771r1474b2797],
13	marker	NN	O	marker	dep	3	SENT_383	[p23l1499t2747r1608b2772],

1	94	CD	NUMBER	94	num	2	SENT_384	[p23l1642t2902r1678b2926],
2	bp	NN	O	bp	_	0	SENT_384	[p23l1689t2901r1727b2933],
3	66	CD	NUMBER	66	num	4	SENT_384	[p23l1642t2936r1678b2960],
4	bp	NN	O	bp	dep	2	SENT_384	[p23l1689t2935r1727b2967],
5	28/32	CD	NUMBER	28/32	num	6	SENT_384	[p23l1642t2971r1724b2997],
6	bp	NN	O	bp	dep	2	SENT_384	[p23l1736t2972r1774b3003],

1	Figure	NN	O	figure	nn	4	SENT_385	[p23l11t3053r105b3086],
2	7	CD	NUMBER	7	num	4	SENT_385	[p23l117t3054r133b3078],
3	Haelll	NN	O	haelll	nn	4	SENT_385	[p23l168t3054r244b3078],
4	restriction	NN	O	restriction	nn	5	SENT_385	[p23l258t3053r399b3078],
5	map	NN	O	map	nsubj	11	SENT_385	[p23l412t3060r475b3086],
6	of	IN	O	of	_	0	SENT_385	[p23l486t3053r514b3078],
7	TS	NN	O	t	nn	10	SENT_385	[p23l522t3054r556b3078],
8	tandem	JJ	O	tandem	amod	10	SENT_385	[p23l567t3053r678b3078],
9	repeat	NN	O	repeat	nn	10	SENT_385	[p23l691t3056r782b3086],
10	fragments	NNS	O	fragment	prep_of	5	SENT_385	[p23l791t3053r938b3086],
11	produced	VBN	O	produce	_	0	SENT_385	[p23l949t3053r1087b3086],
12	in	IN	O	in	_	0	SENT_385	[p23l1099t3053r1122b3078],
13	the	DT	O	the	det	15	SENT_385	[p23l1134t3053r1180b3078],
14	RFLP	NN	MISC	rflp	nn	15	SENT_385	[p23l1193t3054r1257b3078],
15	analysis	NN	O	analysis	prep_in	11	SENT_385	[p23l1268t3053r1385b3086],
16	.	.	O	.	_	0	SENT_385	[p23l1268t3053r1385b3086],

1	(	NN	O	(	nsubj	6	SENT_386	[p23l1398t3053r1436b3084],
2	a	DT	O	a	det	3	SENT_386	[p23l1398t3053r1436b3084],
3	)	NN	O	)	dep	1	SENT_386	[p23l1398t3053r1436b3084],
4	This	DT	O	this	det	5	SENT_386	[p23l1446t3053r1504b3078],
5	map	NN	O	map	dep	1	SENT_386	[p23l1516t3060r1579b3086],
6	shows	VBZ	O	show	_	0	SENT_386	[p23l1589t3053r1678b3078],
7	the	DT	O	the	det	10	SENT_386	[p23l1688t3053r1734b3078],
8	Haelll	NN	O	haelll	nn	10	SENT_386	[p23l1746t3054r1823b3078],
9	restriction	NN	O	restriction	nn	10	SENT_386	[p23l1836t3053r1977b3078],
10	sites	NNS	O	site	dobj	6	SENT_386	[p23l1989t3053r2049b3078],
11	within	IN	O	within	_	0	SENT_386	[p23l2059t3053r2149b3078],
12	the	DT	O	the	det	13	SENT_386	[p23l9t3094r55b3119],
13	fragments	NNS	O	fragment	prep_within	6	SENT_386	[p23l64t3094r210b3127],
14	produced	VBN	O	produce	partmod	13	SENT_386	[p23l221t3094r358b3127],
15	by	IN	O	by	_	0	SENT_386	[p23l370t3094r404b3127],
16	PCR	NN	O	pcr	agent	14	SENT_386	[p23l415t3095r479b3119],
17	.	.	O	.	_	0	SENT_386	[p23l415t3095r479b3119],

1	ATG	NN	ORGANIZATION	atg	nn	2	SENT_387	[p23l489t3095r550b3119],
2	codon	NN	O	codon	nsubjpass	4	SENT_387	[p23l561t3094r651b3119],
3	is	VBZ	O	be	auxpass	4	SENT_387	[p23l663t3095r681b3119],
4	indicated	VBN	O	indicate	_	0	SENT_387	[p23l692t3094r823b3119],
5	by	IN	O	by	_	0	SENT_387	[p23l835t3094r869b3127],
6	the	DT	O	the	det	8	SENT_387	[p23l878t3094r924b3119],
7	red	JJ	O	red	amod	8	SENT_387	[p23l935t3094r979b3119],
8	cross	NN	O	cross	agent	4	SENT_387	[p23l990t3101r1068b3119],
9	.	.	O	.	_	0	SENT_387	[p23l990t3101r1068b3119],

1	Theorical	JJ	O	theorical	amod	3	SENT_388	[p23l1078t3094r1209b3119],
2	different	JJ	O	different	amod	3	SENT_388	[p23l1220t3094r1342b3119],
3	sizes	NNS	O	size	nsubj	12	SENT_388	[p23l1351t3094r1414b3119],
4	(	JJ	O	(	amod	6	SENT_388	[p23l1425t3094r1513b3125],
5	bases	NNS	O	basis	nn	6	SENT_388	[p23l1425t3094r1513b3125],
6	pairs	NNS	O	pair	dep	3	SENT_388	[p23l1524t3094r1600b3127],
7	)	CD	NUMBER	)	dep	3	SENT_388	[p23l1524t3094r1600b3127],
8	of	IN	O	of	_	0	SENT_388	[p23l1611t3094r1639b3119],
9	the	DT	O	the	det	11	SENT_388	[p23l1647t3094r1693b3119],
10	DNA	NN	MISC	dna	nn	11	SENT_388	[p23l1704t3095r1773b3119],
11	fragments	NNS	O	fragment	prep_of	7	SENT_388	[p23l1780t3094r1927b3127],
12	produced	VBN	O	produce	_	0	SENT_388	[p23l1938t3094r2075b3127],
13	after	IN	O	after	mark	18	SENT_388	[p23l2086t3094r2151b3119],
14	digestion	NN	O	digestion	nsubjpass	18	SENT_388	[p23l9t3135r141b3168],
15	with	IN	O	with	_	0	SENT_388	[p23l151t3135r214b3160],
16	Haelll	NN	PERSON	haelll	prep_with	14	SENT_388	[p23l226t3136r303b3160],
17	are	VBP	O	be	auxpass	18	SENT_388	[p23l315t3142r357b3160],
18	shown	VBN	O	show	advcl	12	SENT_388	[p23l368t3135r470b3160],
19	.	.	O	.	_	0	SENT_388	[p23l368t3135r470b3160],

1	An	DT	O	a	det	4	SENT_389	[p23l481t3136r519b3160],
2	Haelll	NN	O	haelll	nn	4	SENT_389	[p23l531t3136r608b3160],
3	restriction	NN	O	restriction	nn	4	SENT_389	[p23l621t3135r762b3160],
4	site	NN	O	site	nsubjpass	14	SENT_389	[p23l773t3135r820b3160],
5	within	IN	O	within	_	0	SENT_389	[p23l829t3135r919b3160],
6	the	DT	O	the	det	8	SENT_389	[p23l930t3135r976b3160],
7	second	JJ	ORDINAL	second	amod	8	SENT_389	[p23l986t3135r1087b3160],
8	repeat	NN	O	repeat	prep_within	4	SENT_389	[p23l1100t3138r1190b3168],
9	of	IN	O	of	_	0	SENT_389	[p23l1200t3135r1228b3160],
10	the	DT	O	the	det	12	SENT_389	[p23l1236t3135r1282b3160],
11	3R	NN	O	3r	nn	12	SENT_389	[p23l1294t3135r1329b3160],
12	allele	NN	O	allele	prep_of	8	SENT_389	[p23l1338t3135r1410b3160],
13	is	VBZ	O	be	auxpass	14	SENT_389	[p23l1421t3135r1439b3160],
14	removed	VBN	O	remove	_	0	SENT_389	[p23l1451t3135r1577b3160],
15	with	IN	O	with	_	0	SENT_389	[p23l1587t3135r1649b3160],
16	G	NN	O	g	prepc_with	14	SENT_389	[p23l1661t3135r1682b3160],
17	—	CD	NUMBER	—	num	20	SENT_389	[p23l1698t3135r1752b3160],
18	>	JJR	O	>	amod	20	SENT_389	[p23l1698t3135r1752b3160],
19	C	NN	O	c	nn	20	SENT_389	[p23l1698t3135r1752b3160],
20	SNP	NN	O	snp	dobj	16	SENT_389	[p23l1763t3135r1829b3160],
21	.	.	O	.	_	0	SENT_389	[p23l1763t3135r1829b3160],

1	Thus	RB	O	thus	advmod	3	SENT_390	[p23l1840t3135r1909b3160],
2	digestion	NN	O	digestion	nsubj	3	SENT_390	[p23l1919t3135r2050b3168],
3	allows	VBZ	O	allow	_	0	SENT_390	[p23l2062t3135r2150b3160],
4	for	IN	O	for	_	0	SENT_390	[p23l8t3176r49b3201],
5	screening	NN	O	screening	prep_for	3	SENT_390	[p23l58t3176r195b3209],
6	of	IN	O	of	_	0	SENT_390	[p23l207t3176r235b3201],
7	this	DT	O	this	det	8	SENT_390	[p23l243t3176r293b3201],
8	SNP	NN	O	snp	prep_of	5	SENT_390	[p23l304t3177r371b3201],
9	.	.	O	.	_	0	SENT_390	[p23l304t3177r371b3201],

1	(	NN	O	(	nn	2	SENT_391	[p23l383t3176r425b3207],
2	b	NN	O	b	nsubjpass	10	SENT_391	[p23l383t3176r425b3207],
3	)	CD	NUMBER	)	tmod	2	SENT_391	[p23l383t3176r425b3207],
4	Finally	RB	O	finally	advmod	3	SENT_391	[p23l437t3176r534b3209],
5	,	,	O	,	_	0	SENT_391	[p23l437t3176r534b3209],
6	digested	VBN	O	digest	partmod	2	SENT_391	[p23l546t3176r668b3209],
7	PCR	NN	O	pcr	nn	8	SENT_391	[p23l681t3177r738b3201],
8	products	NNS	O	product	dobj	6	SENT_391	[p23l748t3176r874b3209],
9	were	VBD	O	be	auxpass	10	SENT_391	[p23l883t3183r954b3201],
10	loaded	VBN	O	load	_	0	SENT_391	[p23l965t3176r1061b3201],
11	into	IN	O	into	_	0	SENT_391	[p23l1073t3176r1128b3201],
12	adjacent	JJ	O	adjacent	amod	13	SENT_391	[p23l1139t3176r1262b3209],
13	lanes	NNS	O	lane	prep_into	10	SENT_391	[p23l1272t3176r1343b3201],
14	on	IN	O	on	_	0	SENT_391	[p23l1354t3183r1389b3201],
15	a	DT	O	a	det	19	SENT_391	[p23l1400t3183r1414b3201],
16	3	CD	PERCENT	3	number	17	SENT_391	[p23l1427t3177r1473b3201],
17	%	NN	PERCENT	%	amod	19	SENT_391	[p23l1427t3177r1473b3201],
18	agarose	NN	O	agarose	nn	19	SENT_391	[p23l1484t3183r1595b3209],
19	gel	NN	O	gel	prep_on	10	SENT_391	[p23l1605t3176r1647b3209],
20	containing	VBG	O	contain	partmod	19	SENT_391	[p23l1658t3176r1812b3209],
21	ethidium	NN	O	ethidium	nn	22	SENT_391	[p23l1823t3176r1952b3201],
22	bromide	NN	O	bromide	npadvmod	25	SENT_391	[p23l1964t3176r2086b3201],
23	1	CD	NUMBER	1	number	24	SENT_391	[p23l2098t3176r2107b3201],
24	>	JJR	O	>	amod	22	SENT_391	[p23l2124t3184r2141b3200],
25	<	JJR	O	<	acomp	20	SENT_391	[p23l2124t3184r2141b3200],
26	and	CC	O	and	_	0	SENT_391	[p23l9t3217r62b3242],
27	electrophoresed	VBN	O	electrophorese	conj_and	10	SENT_391	[p23l76t3217r308b3250],
28	in	IN	O	in	_	0	SENT_391	[p23l323t3217r347b3242],
29	1	CD	NUMBER	1	num	31	SENT_391	[p23l363t3218r372b3242],
30	x	NN	O	x	nn	31	SENT_391	[p23l389t3225r406b3241],
31	TBE	NN	O	tbe	prep_in	27	SENT_391	[p23l427t3218r488b3242],
32	.	.	O	.	_	0	SENT_391	[p23l427t3218r488b3242],

1	For	IN	O	for	_	0	SENT_392	[p23l504t3218r549b3242],
2	each	DT	O	each	det	3	SENT_392	[p23l561t3217r626b3242],
3	patient	NN	O	patient	prep_for	8	SENT_392	[p23l642t3217r750b3250],
4	,	,	O	,	_	0	SENT_392	[p23l642t3217r750b3250],
5	the	DT	O	the	det	6	SENT_392	[p23l764t3217r810b3242],
6	genotype	NN	O	genotype	nsubjpass	8	SENT_392	[p23l824t3220r961b3250],
7	was	VBD	O	be	auxpass	8	SENT_392	[p23l974t3224r1028b3242],
8	analyzed	VBN	O	analyze	_	0	SENT_392	[p23l1041t3217r1176b3250],
9	.	.	O	.	_	0	SENT_392	[p23l1041t3217r1176b3250],

1	RFLP	NN	MISC	rflp	nn	5	SENT_393	[p23l1192t3218r1264b3247],
2	,	,	O	,	_	0	SENT_393	[p23l1192t3218r1264b3247],
3	restriction-fragment	NN	O	restriction-fragment	dep	5	SENT_393	[p23l1281t3217r1570b3250],
4	length	NN	O	length	nn	5	SENT_393	[p23l1583t3217r1673b3250],
5	polymorphism	NN	O	polymorphism	_	0	SENT_393	[p23l1689t3217r1906b3250],
6	;	:	O	;	_	0	SENT_393	[p23l1689t3217r1906b3250],
7	TS	NN	O	t	dep	5	SENT_393	[p23l1920t3218r1963b3247],
8	,	,	O	,	_	0	SENT_393	[p23l1920t3218r1963b3247],
9	thymidylate	NN	O	thymidylate	nn	10	SENT_393	[p23l1977t3217r2150b3250],
10	synthase	NN	O	synthase	appos	7	SENT_393	[p23l9t3258r141b3291],
11	.	.	O	.	_	0	SENT_393	[p23l9t3258r141b3291],

1	Table	NNP	O	Table	_	0	SENT_394	[p23l8t3357r101b3385],
2	7	CD	NUMBER	7	num	3	SENT_394	[p23l116t3358r133b3385],
3	DPD	NN	ORGANIZATION	dpd	dep	1	SENT_394	[p23l173t3359r240b3384],
4	and	CC	O	and	_	0	SENT_394	[p23l252t3358r311b3385],
5	MTHFR	NN	O	mthfr	nn	6	SENT_394	[p23l327t3359r437b3385],
6	pyrosequencing	NN	O	pyrosequencing	dep	1	SENT_394	[p23l449t3358r720b3393],
7	.	.	O	.	_	0	SENT_394	[p23l449t3358r720b3393],

1	Primers	NNS	O	primer	nsubj	2	SENT_395	[p23l736t3358r857b3385],
2	used	VBN	O	use	_	0	SENT_395	[p23l871t3358r944b3385],
3	for	IN	O	for	_	0	SENT_395	[p23l957t3358r1006b3385],
4	biotinyled	JJ	O	biotinyled	amod	5	SENT_395	[p23l1018t3357r1181b3393],
5	PCR	NN	O	pcr	prep_for	2	SENT_395	[p23l1197t3358r1260b3385],
6	and	CC	O	and	_	0	SENT_395	[p23l1272t3357r1332b3385],
7	annealed	VBD	O	anneal	conj_and	2	SENT_395	[p23l1346t3358r1495b3385],
8	primers	NNS	O	primer	dobj	7	SENT_395	[p23l1510t3358r1633b3393],
9	used	VBN	O	use	partmod	8	SENT_395	[p23l1647t3358r1720b3385],
10	for	IN	O	for	_	0	SENT_395	[p23l1733t3358r1781b3385],
11	bioluminometric	JJ	O	bioluminometric	amod	14	SENT_395	[p23l1794t3358r2065b3385],
12	realtime	NN	O	realtime	nn	14	SENT_395	[p23l2079t3357r2149b3385, p23l9t3399r82b3426],
13	sequence	NN	O	sequence	nn	14	SENT_395	[p23l96t3407r249b3434],
14	determination	NN	O	determination	prep_for	9	SENT_395	[p23l263t3399r497b3426],

1	SNPS	NNP	O	SNPS	nn	2	SENT_396	[p23l195t3484r269b3510],
2	Exon	NNP	O	Exon	dep	12	SENT_396	[p23l523t3484r591b3510],
3	PCR	NN	O	pcr	nn	4	SENT_396	[p23l964t3484r1021b3510],
4	primers	NNS	O	primer	dep	2	SENT_396	[p23l1033t3483r1143b3518],
5	5	CD	NUMBER	5	number	6	SENT_396	[p23l1155t3484r1174b3510],
6	’	CD	NUMBER	’	num	7	SENT_396	[p23l1180t3483r1187b3493],
7	—	NN	O	—	npadvmod	8	SENT_396	[p23l1202t3494r1230b3507],
8	>	JJR	O	>	amod	4	SENT_396	[p23l1202t3494r1230b3507],
9	3	CD	NUMBER	3	num	10	SENT_396	[p23l1250t3483r1280b3510],
10	’	NN	O	’	dep	12	SENT_396	[p23l1250t3483r1280b3510],
11	Annealed	JJ	O	annealed	amod	12	SENT_396	[p23l1645t3483r1785b3510],
12	primers	NNS	O	primer	_	0	SENT_396	[p23l1795t3484r1905b3518],
13	Size	NN	O	size	nn	16	SENT_396	[p23l2019t3483r2076b3510],
14	(	CD	NUMBER	(	num	16	SENT_396	[p23l2090t3483r2150b3518],
15	pb	NN	O	pb	nn	16	SENT_396	[p23l2090t3483r2150b3518],
16	)	NN	O	)	dep	12	SENT_396	[p23l2090t3483r2150b3518],

1	Forward	RB	O	forward	dep	3	SENT_397	[p23l829t3572r949b3599],
2	Biotinyled	JJ	O	biotinyled	amod	3	SENT_397	[p23l1212t3572r1356b3607],
3	reverse	NN	O	reverse	_	0	SENT_397	[p23l1368t3580r1468b3599],

1	DPD	NN	O	dpd	_	0	SENT_398	[p24l11t31r76b56],
2	|	SYM	O	|	dep	5	SENT_398	[p24l196t31r314b57],
3	VS14	NN	O	vs14	nn	5	SENT_398	[p24l196t31r314b57],
4	+1	CD	NUMBER	+1	num	5	SENT_398	[p24l196t31r314b57],
5	G	NN	O	g	rcmod	1	SENT_398	[p24l324t31r346b57],
6	>	JJR	O	>	dep	1	SENT_398	[p24l355t31r405b57],
7	A	DT	O	a	det	12	SENT_398	[p24l355t31r405b57],
8	Intron	NN	O	intron	nn	12	SENT_398	[p24l485t31r575b57],
9	14	CD	NUMBER	14	num	12	SENT_398	[p24l592t31r628b56],
10	atcagtgagaaaacggctgc	NN	O	atcagtgagaaaacggctgc	nn	12	SENT_398	[p24l707t33r1059b65],
11	taaacattcaccaacttatgcca	NN	O	taaacattcaccaacttatgcca	nn	12	SENT_398	[p24l1145t33r1513b65],
12	aggctgactttccaga	NN	O	aggctgactttccaga	dep	6	SENT_398	[p24l1611t33r1879b65],
13	150	CD	NUMBER	150	number	14	SENT_398	[p24l2056t31r2112b57],
14	464	CD	NUMBER	464	num	15	SENT_398	[p24l193t73r252b99],
15	T	NN	O	t	npadvmod	16	SENT_398	[p24l265t73r342b99],
16	>	JJR	O	>	amod	12	SENT_398	[p24l265t73r342b99],
17	A	DT	O	a	det	21	SENT_398	[p24l265t73r342b99],
18	5	CD	NUMBER	5	num	21	SENT_398	[p24l557t73r573b99],
19	ttatggagctgctaagatga	NN	O	ttatggagctgctaagatga	nn	21	SENT_398	[p24l706t75r1043b107],
20	atcatacatacctcagtagcaaa	NN	O	atcatacatacctcagtagcaaa	nn	21	SENT_398	[p24l1145t75r1523b107],
21	cccattaatattggt	NN	O	cccattaatattggt	dep	6	SENT_398	[p24l1611t75r1846b107],
22	200	CD	NUMBER	200	number	23	SENT_398	[p24l2055t73r2112b99],
23	1679	CD	DATE	1679	num	24	SENT_398	[p24l196t115r272b141],
24	T	NN	O	t	npadvmod	25	SENT_398	[p24l285t115r334b141],
25	>	JJR	O	>	amod	26	SENT_398	[p24l285t115r334b141],
26	G	NN	O	g	dep	21	SENT_398	[p24l342t115r364b141],
27	1	CD	NUMBER	1	number	28	SENT_398	[p24l538t115r548b140],
28	3	CD	NUMBER	3	dep	21	SENT_398	[p24l559t115r574b141],
29	aatatggagcttccgtttct	NN	O	aatatggagcttccgtttct	nn	31	SENT_398	[p24l707t117r1025b149],
30	gagagaaagttttggtgagg	NN	O	gagagaaagttttggtgagg	nn	31	SENT_398	[p24l1145t117r1497b149],
31	ccagccaccagcacatcaa	NN	O	ccagccaccagcacatcaa	dep	28	SENT_398	[p24l1611t117r1938b149],
32	204	CD	NUMBER	204	number	33	SENT_398	[p24l2055t115r2112b141],
33	2846	CD	DATE	2846	dep	28	SENT_398	[p24l194t157r272b183],
34	A	DT	O	a	det	36	SENT_398	[p24l285t157r307b182],
35	>	JJR	O	>	amod	36	SENT_398	[p24l314t157r362b183],
36	T	NN	O	t	dep	33	SENT_398	[p24l314t157r362b183],
37	22	CD	NUMBER	22	num	40	SENT_398	[p24l537t157r574b182],
38	aagcactgcagtaccttggaa	NN	O	aagcactgcagtaccttggaa	nn	40	SENT_398	[p24l707t159r1065b191],
39	tcatgtagcatttaccacagttga	NN	O	tcatgtagcatttaccacagttga	nn	40	SENT_398	[p24l1145t159r1531b191],
40	gcaagttgtggctatga	NN	O	gcaagttgtggctatga	dep	33	SENT_398	[p24l1611t159r1899b191],
41	1	CD	NUMBER	1	number	42	SENT_398	[p24l2056t157r2066b182],
42	07	CD	NUMBER	07	dep	40	SENT_398	[p24l2075t157r2112b183],

1	M	NN	O	m	nn	2	SENT_399	[p24l11t242r40b267],
2	THFR	NN	O	thfr	dep	10	SENT_399	[p24l44t242r116b268],
3	677	CD	NUMBER	677	num	4	SENT_399	[p24l195t242r252b268],
4	C	NN	O	c	dep	2	SENT_399	[p24l267t242r288b268],
5	>	JJR	O	>	amod	6	SENT_399	[p24l296t249r318b268],
6	T	NN	O	t	dep	10	SENT_399	[p24l325t242r344b267],
7	4	CD	NUMBER	4	num	10	SENT_399	[p24l556t242r574b267],
8	tattggcaggttaccccaaa	NN	O	tattggcaggttaccccaaa	nn	10	SENT_399	[p24l706t244r1039b276],
9	ctcacctggatgggaaagat	NN	O	ctcacctggatgggaaagat	nn	10	SENT_399	[p24l1145t244r1492b276],
10	agaaggtgtctgcgg	NN	O	agaaggtgtctgcgg	dep	16	SENT_399	[p24l1611t244r1877b276],
11	208	CD	NUMBER	208	dep	10	SENT_399	[p24l2055t242r2112b268],
12	1	CD	NUMBER	1	number	13	SENT_399	[p24l196t284r205b309],
13	298	CD	NUMBER	298	dep	11	SENT_399	[p24l214t284r272b310],
14	A	DT	O	a	det	16	SENT_399	[p24l285t284r307b309],
15	>	JJR	O	>	amod	16	SENT_399	[p24l314t290r336b310],
16	C	NN	O	c	dep	20	SENT_399	[p24l344t284r366b310],
17	7	CD	NUMBER	7	num	19	SENT_399	[p24l558t284r574b309],
18	gccaggggcaattcctctt	NN	O	gccaggggcaattcctctt	nn	19	SENT_399	[p24l707t286r1026b318],
19	cttccagcatcactcactttgt	NN	O	cttccagcatcactcactttgt	dep	16	SENT_399	[p24l1145t286r1489b318],
20	ggagctgaccagtgaag	NN	O	ggagctgaccagtgaag	_	0	SENT_399	[p24l1611t286r1918b318],
21	202	CD	NUMBER	202	num	20	SENT_399	[p24l2055t284r2112b310],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_400	[p24l8t376r189b398],
2	:	:	O	:	_	0	SENT_400	[p24l8t376r189b398],
3	CR	NN	O	cr	dep	1	SENT_400	[p24l208t376r249b403],
4	,	,	O	,	_	0	SENT_400	[p24l208t376r249b403],
5	complete	JJ	O	complete	amod	6	SENT_400	[p24l269t376r387b405],
6	response	NN	O	response	appos	3	SENT_400	[p24l406t382r523b405],
7	;	:	O	;	_	0	SENT_400	[p24l406t382r523b405],
8	DPD	NN	ORGANIZATION	dpd	dep	1	SENT_400	[p24l543t377r606b403],
9	,	,	O	,	_	0	SENT_400	[p24l543t377r606b403],
10	dihydropyrimidine	NN	O	dihydropyrimidine	nn	11	SENT_400	[p24l625t376r860b405],
11	dehydrogenase	NN	O	dehydrogenase	appos	8	SENT_400	[p24l878t376r1081b405],
12	;	:	O	;	_	0	SENT_400	[p24l878t376r1081b405],
13	MTHFR	NNP	LOCATION	MTHFR	dep	1	SENT_400	[p24l1101t377r1198b403],
14	,	,	O	,	_	0	SENT_400	[p24l1101t377r1198b403],
15	methylene	NN	O	methylene	nn	18	SENT_400	[p24l1218t376r1352b405],
16	tetrahydrofolate	NN	O	tetrahydrofolate	nn	18	SENT_400	[p24l1369t376r1574b405],
17	reductase	NN	O	reductase	nn	18	SENT_400	[p24l1592t376r1713b398],
18	enzyme	NN	O	enzyme	appos	13	SENT_400	[p24l1730t382r1836b405],
19	;	:	O	;	_	0	SENT_400	[p24l1730t382r1836b405],
20	SNP	NN	ORGANIZATION	snp	dep	1	SENT_400	[p24l1855t376r1914b403],
21	,	,	O	,	_	0	SENT_400	[p24l1855t376r1914b403],
22	single-nucleotide	JJ	O	single-nucleotide	amod	23	SENT_400	[p24l1932t376r2149b405],
23	polymorphism	NN	O	polymorphism	appos	20	SENT_400	[p24l12t422r402b481],
24	.	.	O	.	_	0	SENT_400	[p24l12t422r402b481],

1	within	IN	O	within	dep	7	SENT_401	[p24l8t635r243b693],
2	exon	NN	O	exon	pobj	1	SENT_401	[p24l270t652r443b693],
3	5	CD	NUMBER	5	num	2	SENT_401	[p24l470t638r526b705],
4	,	,	O	,	_	0	SENT_401	[p24l470t638r526b705],
5	a	DT	O	a	det	7	SENT_401	[p24l558t652r592b693],
6	nonsense	NN	O	nonsense	nn	7	SENT_401	[p24l618t652r948b693],
7	mutation	NN	O	mutation	_	0	SENT_401	[p24l974t638r1306b693],
8	recently	RB	DATE	recently	advmod	9	SENT_401	[p24l1332t635r1619b711],
9	individualized	VBN	O	individualize	partmod	7	SENT_401	[p24l1642t635r2150b693],
10	in	IN	O	in	_	0	SENT_401	[p24l10t732r80b786],
11	our	PRP$	O	we	poss	13	SENT_401	[p24l110t747r229b787],
12	research	NN	O	research	nn	13	SENT_401	[p24l257t729r546b787],
13	unit	NN	O	unit	prep_in	9	SENT_401	[p24l574t722r891b787],
14	.35	CD	NUMBER	.35	number	15	SENT_401	[p24l574t722r891b787],
15	'36	CD	NUMBER	'36	dep	13	SENT_401	[p24l574t722r891b787],

1	These	DT	O	these	det	2	SENT_402	[p24l84t825r286b883],
2	SNPs	NNS	O	snp	nsubjpass	4	SENT_402	[p24l314t826r482b883],
3	are	VBP	O	be	auxpass	4	SENT_402	[p24l510t842r611b883],
4	associated	VBN	O	associate	_	0	SENT_402	[p24l639t825r995b883],
5	with	IN	O	with	_	0	SENT_402	[p24l1019t825r1180b883],
6	severe	JJ	O	severe	amod	8	SENT_402	[p24l1208t842r1419b883],
7	DPD	NN	O	dpd	nn	8	SENT_402	[p24l1446t827r1604b882],
8	deficiency	NN	O	deficiency	prep_with	4	SENT_402	[p24l1632t825r1994b901],
9	and	CC	O	and	_	0	SENT_402	[p24l2019t825r2150b883],
10	a	DT	O	a	det	13	SENT_402	[p24l10t936r45b977],
11	potential	JJ	O	potential	amod	13	SENT_402	[p24l73t919r394b995],
12	life-threatening	JJ	O	life-threatening	amod	13	SENT_402	[p24l424t919r978b995],
13	toxicity	NN	O	toxicity	prep_with	4	SENT_402	[p24l1006t922r1279b995],
14	under	IN	O	under	_	0	SENT_402	[p24l1305t920r1515b977],
15	a	DT	O	a	det	17	SENT_402	[p24l1544t936r1578b977],
16	5-FU	JJ	O	5-fu	amod	17	SENT_402	[p24l1610t922r1773b977],
17	regimen	NN	O	regimen	prep_under	4	SENT_402	[p24l1802t922r2110b995],
18	.	.	O	.	_	0	SENT_402	[p24l1802t922r2110b995],

1	For	IN	O	for	_	0	SENT_403	[p24l83t1016r194b1071],
2	MTHFR	NN	O	mthfr	nn	3	SENT_403	[p24l212t1016r473b1070],
3	polymorphisms	NNS	O	polymorphism	prep_for	15	SENT_403	[p24l492t1013r1015b1090],
4	,	,	O	,	_	0	SENT_403	[p24l492t1013r1015b1090],
5	the	DT	O	the	det	9	SENT_403	[p24l1045t1013r1157b1071],
6	two	CD	NUMBER	two	num	9	SENT_403	[p24l1184t1021r1314b1071],
7	most	RBS	O	most	advmod	8	SENT_403	[p24l1340t1021r1514b1071],
8	common	JJ	O	common	amod	9	SENT_403	[p24l1540t1030r1859b1071],
9	SNPs	NNS	O	snp	appos	3	SENT_403	[p24l1885t1015r2054b1071],
10	in	IN	O	in	_	0	SENT_403	[p24l2079t1016r2150b1070],
11	the	DT	O	the	det	13	SENT_403	[p24l9t1109r122b1167],
12	Caucasian	JJ	LOCATION	caucasian	amod	13	SENT_403	[p24l146t1111r504b1167],
13	population	NN	O	population	prep_in	9	SENT_403	[p24l526t1109r919b1185],
14	were	VBD	O	be	auxpass	15	SENT_403	[p24l939t1126r1103b1167],
15	analyzed	VBN	O	analyze	_	0	SENT_403	[p24l1126t1109r1454b1185],
16	:	:	O	:	_	0	SENT_403	[p24l1126t1109r1454b1185],
17	677	CD	NUMBER	677	number	18	SENT_403	[p24l1484t1111r1607b1167],
18	C	NN	O	c	num	19	SENT_403	[p24l1632t1109r1956b1167],
19	>	JJR	O	>	dobj	15	SENT_403	[p24l1632t1109r1956b1167],
20	Tand	NNP	O	Tand	dep	19	SENT_403	[p24l1632t1109r1956b1167],
21	1298	CD	DATE	1298	num	20	SENT_403	[p24l1984t1111r2148b1167],
22	A	DT	O	a	det	27	SENT_403	[p24l8t1197r372b1262],
23	>	JJR	O	>	dep	24	SENT_403	[p24l8t1197r372b1262],
24	C.	NN	O	c.	amod	27	SENT_403	[p24l8t1197r372b1262],
25	2	CD	NUMBER	2	number	26	SENT_403	[p24l8t1197r372b1262],
26	°	CD	NUMBER	°	num	27	SENT_403	[p24l8t1197r372b1262],
27	‘	NN	O	‘	dep	20	SENT_403	[p24l8t1197r372b1262],
28	23	CD	NUMBER	23	nsubjpass	15	SENT_403	[p24l8t1197r372b1262],

1	For	IN	O	for	_	0	SENT_404	[p24l87t1303r198b1358],
2	each	DT	O	each	det	3	SENT_404	[p24l251t1301r411b1358],
3	polymorphism	NN	O	polymorphism	prep_for	12	SENT_404	[p24l463t1301r1006b1376],
4	,	,	O	,	_	0	SENT_404	[p24l463t1301r1006b1376],
5	a	DT	O	a	det	8	SENT_404	[p24l1065t1317r1100b1358],
6	prior	JJ	O	prior	amod	8	SENT_404	[p24l1152t1304r1324b1376],
7	biotinyled	JJ	O	biotinyled	amod	8	SENT_404	[p24l1373t1301r1739b1376],
8	PCR	NN	O	pcr	nsubj	12	SENT_404	[p24l1793t1302r1939b1358],
9	with	IN	O	with	_	0	SENT_404	[p24l1988t1301r2149b1358],
10	specific	JJ	O	specific	amod	11	SENT_404	[p24l11t1396r271b1472],
11	primers	NNS	O	primer	prep_with	8	SENT_404	[p24l327t1399r594b1472],
12	(	VBP	O	(	_	0	SENT_404	[p24l656t1396r863b1468],
13	Table	NNP	O	Table	dobj	12	SENT_404	[p24l656t1396r863b1468],
14	7	CD	NUMBER	7	num	15	SENT_404	[p24l927t1396r985b1468],
15	)	NN	O	)	nsubjpass	17	SENT_404	[p24l927t1396r985b1468],
16	was	VBD	O	be	auxpass	17	SENT_404	[p24l1044t1413r1172b1454],
17	performed	VBN	O	perform	rcmod	13	SENT_404	[p24l1229t1396r1616b1472],
18	.	.	O	.	_	0	SENT_404	[p24l1229t1396r1616b1472],

1	Brieﬂy	NNP	O	Brieﬂy	nn	3	SENT_405	[p24l1679t1396r1918b1472],
2	,	,	O	,	_	0	SENT_405	[p24l1679t1396r1918b1472],
3	DNA	NNP	O	DNA	nsubj	30	SENT_405	[p24l1981t1398r2150b1453],
4	simple	JJ	O	simple	amod	5	SENT_405	[p24l11t1491r241b1566],
5	strands	NNS	O	strand	nsubjpass	7	SENT_405	[p24l292t1491r541b1548],
6	were	VBD	O	be	auxpass	7	SENT_405	[p24l588t1507r752b1548],
7	obtained	VBN	O	obtain	rcmod	3	SENT_405	[p24l801t1491r1114b1548],
8	by	IN	O	by	_	0	SENT_405	[p24l1159t1491r1247b1566],
9	the	DT	O	the	det	10	SENT_405	[p24l1293t1491r1405b1548],
10	purification	NN	O	purification	agent	7	SENT_405	[p24l1454t1490r1872b1566],
11	of	IN	O	of	_	0	SENT_405	[p24l1921t1490r1992b1548],
12	the	DT	O	the	det	15	SENT_405	[p24l2036t1491r2149b1548],
13	biotinyled	JJ	O	biotinyled	amod	15	SENT_405	[p24l8t1586r374b1662],
14	PCR	NN	O	pcr	nn	15	SENT_405	[p24l417t1588r563b1644],
15	products	NNS	O	product	prep_of	10	SENT_405	[p24l604t1586r912b1662],
16	with	IN	O	with	_	0	SENT_405	[p24l954t1586r1115b1644],
17	Sepharose	NN	O	sepharose	nn	18	SENT_405	[p24l1159t1586r1510b1662],
18	balls	NNS	O	ball	prep_with	7	SENT_405	[p24l1551t1586r1712b1644],
19	coupled	VBN	O	couple	conj_and	19	SENT_405	[p24l1756t1586r2037b1662],
20	to	TO	O	to	_	0	SENT_405	[p24l2079t1593r2149b1644],
21	streptavidine	NN	O	streptavidine	prep_to	19	SENT_405	[p24l11t1681r471b1757],
22	and	CC	O	and	_	0	SENT_405	[p24l540t1681r671b1739],
23	after	IN	O	after	_	0	SENT_405	[p24l739t1681r897b1739],
24	denaturation	NN	O	denaturation	prep_after	19	SENT_405	[p24l964t1681r1426b1739],
25	with	IN	O	with	_	0	SENT_405	[p24l1491t1681r1652b1739],
26	washing	VBG	O	wash	prepc_with	19	SENT_405	[p24l1718t1681r2014b1757],
27	in	IN	O	in	_	0	SENT_405	[p24l2079t1684r2150b1738],
28	different	JJ	O	different	amod	29	SENT_405	[p24l10t1776r314b1834],
29	baths	NNS	O	bath	prep_in	26	SENT_405	[p24l343t1776r534b1834],
30	(	VBP	O	(	_	0	SENT_405	[p24l570t1776r866b1848],
31	ethanol	NN	O	ethanol	nsubj	33	SENT_405	[p24l570t1776r866b1848],
32	70	CD	PERCENT	70	num	33	SENT_405	[p24l903t1777r1068b1846],
33	%	NN	PERCENT	%	xcomp	30	SENT_405	[p24l903t1777r1068b1846],
34	,	,	O	,	_	0	SENT_405	[p24l903t1777r1068b1846],
35	then	RB	O	then	advmod	33	SENT_405	[p24l1104t1776r1269b1834],
36	NaOH	NN	O	naoh	nn	50	SENT_405	[p24l1298t1777r1518b1834],
37	0.2	CD	NUMBER	0.2	num	38	SENT_405	[p24l1551t1777r1730b1834],
38	M	NN	O	m	nn	50	SENT_405	[p24l1551t1777r1730b1834],
39	and	CC	O	and	_	0	SENT_405	[p24l1761t1776r1893b1834],
40	finally	RB	O	finally	advmod	41	SENT_405	[p24l1924t1776r2152b1852],
41	washing	VBG	O	wash	nn	50	SENT_405	[p24l8t1870r304b1946],
42	buffer	NN	O	buffer	nn	43	SENT_405	[p24l344t1870r556b1928],
43	pH	NN	O	ph	dobj	41	SENT_405	[p24l598t1873r702b1946],
44	7.6	CD	NUMBER	7.6	dep	43	SENT_405	[p24l753t1872r853b1928],
45	which	WDT	O	which	nsubj	46	SENT_405	[p24l896t1870r1117b1928],
46	washed	VBD	O	wash	rcmod	43	SENT_405	[p24l1159t1870r1423b1928],
47	away	RB	O	away	prt	46	SENT_405	[p24l1468t1887r1647b1946],
48	unbiotinyled	JJ	O	unbiotinyled	amod	49	SENT_405	[p24l1687t1870r2150b1946],
49	products	NNS	O	product	dobj	46	SENT_405	[p24l9t1966r362b2042],
50	)	NN	O	)	dep	33	SENT_405	[p24l9t1966r362b2042],
51	.	.	O	.	_	0	SENT_405	[p24l9t1966r362b2042],

1	These	DT	O	these	nsubj	9	SENT_406	[p24l419t1966r620b2024],
2	purified	VBN	O	purify	partmod	1	SENT_406	[p24l674t1966r952b2042],
3	DNA	NN	O	dna	nn	5	SENT_406	[p24l1006t1968r1176b2023],
4	simple	JJ	O	simple	amod	5	SENT_406	[p24l1230t1966r1459b2042],
5	strands	NNS	O	strand	dobj	2	SENT_406	[p24l1516t1966r1766b2024],
6	were	VBD	O	be	cop	9	SENT_406	[p24l1818t1983r1981b2024],
7	the	DT	O	the	det	9	SENT_406	[p24l2036t1966r2148b2024],
8	target	NN	O	target	nn	9	SENT_406	[p24l9t2068r211b2137],
9	templates	NNS	O	template	_	0	SENT_406	[p24l282t2061r624b2137],
10	for	IN	O	for	_	0	SENT_406	[p24l697t2061r795b2119],
11	sequencing	NN	O	sequencing	prep_for	9	SENT_406	[p24l867t2064r1267b2137],
12	by	IN	O	by	_	0	SENT_406	[p24l1334t2061r1422b2137],
13	synthesis	NN	O	synthesis	prep_by	9	SENT_406	[p24l1492t2061r1831b2137],
14	.	.	O	.	_	0	SENT_406	[p24l1492t2061r1831b2137],

1	Indeed	RB	O	indeed	advmod	4	SENT_407	[p24l1908t2061r2150b2119],
2	the	DT	O	the	det	4	SENT_407	[p24l9t2156r122b2214],
3	sequential	JJ	O	sequential	amod	4	SENT_407	[p24l179t2156r540b2232],
4	addition	NN	O	addition	nsubj	7	SENT_407	[p24l596t2156r895b2214],
5	of	IN	O	of	_	0	SENT_407	[p24l951t2156r1022b2214],
6	nucleotides	NNS	O	nucleotide	prep_of	4	SENT_407	[p24l1073t2156r1479b2214],
7	(	VBP	O	(	dep	33	SENT_407	[p24l1537t2156r1778b2228],
8	dNTP	NN	O	dntp	nsubj	20	SENT_407	[p24l1537t2156r1778b2228],
9	)	CD	NUMBER	)	num	8	SENT_407	[p24l1537t2156r1778b2228],
10	into	IN	O	into	_	0	SENT_407	[p24l1837t2159r1981b2214],
11	the	DT	O	the	det	14	SENT_407	[p24l2036t2156r2148b2214],
12	growing	VBG	O	grow	amod	14	SENT_407	[p24l9t2253r299b2326],
13	DNA	NN	MISC	dna	nn	14	SENT_407	[p24l345t2252r514b2307],
14	chain	NN	O	chain	prep_into	8	SENT_407	[p24l559t2250r756b2308],
15	from	IN	O	from	_	0	SENT_407	[p24l802t2250r972b2308],
16	an	DT	O	a	det	18	SENT_407	[p24l1018t2267r1103b2308],
17	annealed	JJ	O	annealed	amod	18	SENT_407	[p24l1150t2250r1471b2308],
18	primer	NN	O	primer	prep_from	14	SENT_407	[p24l1516t2253r1754b2326],
19	was	VBD	O	be	cop	20	SENT_407	[p24l1798t2267r1926b2308],
20	complementary	JJ	O	complementary	ccomp	7	SENT_407	[p24l1973t2267r2148b2308, p24l9t2346r418b2421],
21	to	TO	O	to	_	0	SENT_407	[p24l477t2353r547b2403],
22	these	DT	O	these	det	24	SENT_407	[p24l609t2345r791b2403],
23	target	NN	O	target	nn	24	SENT_407	[p24l854t2353r1057b2421],
24	templates	NNS	O	template	prep_to	20	SENT_407	[p24l1119t2345r1461b2421],
25	and	CC	O	and	_	0	SENT_407	[p24l1525t2345r1656b2403],
26	each	DT	O	each	det	27	SENT_407	[p24l1719t2346r1879b2403],
27	incorporation	NN	O	incorporation	prep_to	20	SENT_407	[p24l1941t2348r2148b2403, p24l9t2444r314b2517],
28	of	IN	O	of	_	0	SENT_407	[p24l358t2441r430b2499],
29	dNTP	NN	O	dntp	prep_of	27	SENT_407	[p24l470t2441r664b2499],
30	by	IN	O	by	_	0	SENT_407	[p24l706t2441r793b2517],
31	DNA	NN	O	dna	nn	32	SENT_407	[p24l836t2443r1005b2498],
32	polymerase	NN	O	polymerase	prep_by	20	SENT_407	[p24l1047t2441r1449b2517],
33	led	VBD	O	lead	_	0	SENT_407	[p24l1495t2441r1600b2499],
34	to	TO	O	to	_	0	SENT_407	[p24l1643t2448r1713b2499],
35	the	DT	O	the	det	36	SENT_407	[p24l1757t2441r1870b2499],
36	release	NN	O	release	prep_to	33	SENT_407	[p24l1915t2441r2148b2499],
37	of	IN	O	of	_	0	SENT_407	[p24l10t2535r82b2593],
38	a	DT	O	a	det	39	SENT_407	[p24l140t2552r174b2593],
39	pyrophosphate	NN	O	pyrophosphate	prep_of	36	SENT_407	[p24l235t2535r770b2611],
40	(	CD	NUMBER	(	num	42	SENT_407	[p24l836t2536r1015b2611],
41	Ppi	NN	MISC	ppus	nn	42	SENT_407	[p24l836t2536r1015b2611],
42	)	NN	O	)	nsubj	33	SENT_407	[p24l836t2536r1015b2611],
43	.	.	O	.	_	0	SENT_407	[p24l836t2536r1015b2611],

1	This	DT	O	this	det	2	SENT_408	[p24l1079t2536r1229b2593],
2	Ppi	NN	O	ppus	nsubjpass	4	SENT_408	[p24l1292t2538r1401b2611],
3	was	VBD	O	be	auxpass	4	SENT_408	[p24l1461t2552r1589b2593],
4	converted	VBN	O	convert	_	0	SENT_408	[p24l1653t2535r2005b2593],
5	by	IN	O	by	_	0	SENT_408	[p24l2064t2535r2152b2611],
6	ATP	NN	ORGANIZATION	atp	nn	7	SENT_408	[p24l8t2632r147b2688],
7	sulfurylase	NN	O	sulfurylase	agent	4	SENT_408	[p24l221t2630r594b2706],
8	into	IN	O	into	_	0	SENT_408	[p24l667t2634r811b2688],
9	ATP	NN	O	atp	prep_into	4	SENT_408	[p24l883t2632r1022b2688],
10	serving	VBG	O	serve	partmod	9	SENT_408	[p24l1095t2634r1349b2706],
11	as	IN	O	as	_	0	SENT_408	[p24l1420t2647r1485b2688],
12	a	DT	O	a	det	13	SENT_408	[p24l1559t2647r1594b2688],
13	substrate	NN	O	substrate	prep_as	10	SENT_408	[p24l1667t2631r1979b2688],
14	for	IN	O	for	_	0	SENT_408	[p24l2052t2630r2150b2688],
15	Luciferase	NN	O	luciferase	nn	16	SENT_408	[p24l10t2726r359b2784],
16	enzyme	NN	O	enzyme	prep_for	13	SENT_408	[p24l434t2743r725b2802],
17	.	.	O	.	_	0	SENT_408	[p24l434t2743r725b2802],

1	The	DT	O	the	det	3	SENT_409	[p24l801t2726r934b2784],
2	produced	VBN	O	produce	amod	3	SENT_409	[p24l1007t2726r1341b2802],
3	light	NN	O	light	nsubjpass	5	SENT_409	[p24l1413t2726r1578b2802],
4	was	VBD	O	be	auxpass	5	SENT_409	[p24l1649t2743r1777b2784],
5	detected	VBN	O	detect	_	0	SENT_409	[p24l1852t2726r2150b2784],
6	as	IN	O	as	_	0	SENT_409	[p24l10t2837r75b2878],
7	evidence	NN	O	evidence	prep_as	5	SENT_409	[p24l107t2821r417b2878],
8	of	IN	O	of	_	0	SENT_409	[p24l450t2820r521b2878],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_409	[p24l548t2821r923b2878],
10	incorporation	NN	O	incorporation	prep_of	7	SENT_409	[p24l955t2824r1446b2896],
11	and	CC	O	and	_	0	SENT_409	[p24l1478t2821r1609b2878],
12	was	VBD	O	be	auxpass	13	SENT_409	[p24l1638t2837r1767b2878],
13	translated	VBN	O	translate	conj_and	5	SENT_409	[p24l1798t2821r2149b2878],
14	as	IN	O	as	_	0	SENT_409	[p24l10t2934r75b2975],
15	an	DT	O	a	det	17	SENT_409	[p24l191t2934r276b2975],
16	on-screen	JJ	O	on-screen	amod	17	SENT_409	[p24l390t2934r732b2975],
17	pyrogram	NN	O	pyrogram	prep_as	13	SENT_409	[p24l845t2934r1206b2993],
18	.	.	O	.	_	0	SENT_409	[p24l845t2934r1206b2993],

1	Pyrosequencing	VBG	O	pyrosequence	_	0	SENT_410	[p24l1325t2920r1887b2993],
2	data	NNS	O	datum	dobj	1	SENT_410	[p24l2001t2917r2150b2975],
3	(	NN	O	(	nn	5	SENT_410	[p24l13t3012r402b3088],
4	pyrogram	NN	O	pyrogram	nn	5	SENT_410	[p24l13t3012r402b3088],
5	)	NN	O	)	nsubj	9	SENT_410	[p24l13t3012r402b3088],
6	for	IN	O	for	_	0	SENT_410	[p24l475t3012r574b3070],
7	each	DT	O	each	det	8	SENT_410	[p24l643t3012r803b3070],
8	patient	NN	O	patient	prep_for	5	SENT_410	[p24l872t3015r1124b3088],
9	were	VBD	O	be	rcmod	2	SENT_410	[p24l1192t3029r1355b3070],
10	then	RB	O	then	advmod	9	SENT_410	[p24l1425t3012r1589b3070],
11	compared	VBN	O	compare	_	0	SENT_410	[p24l1660t3012r2010b3088],
12	to	TO	O	to	prepc_compared_to	9	SENT_410	[p24l2079t3019r2149b3070],
13	theoretical	JJ	O	theoretical	amod	14	SENT_410	[p24l9t3107r389b3165],
14	patterns	NNS	O	pattern	pobj	9	SENT_410	[p24l422t3114r710b3183],
15	and	CC	O	and	_	0	SENT_410	[p24l746t3107r877b3165],
16	the	DT	O	the	det	17	SENT_410	[p24l910t3107r1022b3165],
17	genotype	NN	O	genotype	pobj	9	SENT_410	[p24l1057t3114r1383b3183],
18	was	VBD	O	be	auxpass	20	SENT_410	[p24l1416t3124r1544b3165],
19	easily	RB	O	easily	advmod	20	SENT_410	[p24l1580t3107r1776b3183],
20	identified	VBN	O	identify	aux	1	SENT_410	[p24l1807t3107r2149b3165],
21	(	CD	NUMBER	(	num	24	SENT_410	[p24l13t3202r251b3277],
22	Figure	NN	O	figure	nn	24	SENT_410	[p24l13t3202r251b3277],
23	8	CD	NUMBER	8	num	24	SENT_410	[p24l284t3202r367b3274],
24	)	NN	O	)	nsubj	1	SENT_410	[p24l284t3202r367b3274],
25	.	.	O	.	_	0	SENT_410	[p24l284t3202r367b3274],

1	@	IN	O	@	dep	5	SENT_411	[p24l36t3603r99b3664],
2	Fluorouracil	NNP	O	Fluorouracil	nn	4	SENT_411	[p24l687t3609r826b3631],
3	outcome	NN	O	outcome	nn	4	SENT_411	[p24l836t3611r938b3631],
4	parameters	NNS	O	parameter	pobj	1	SENT_411	[p24l948t3611r1081b3638],
5	o	NN	O	o	_	0	SENT_411	[p24l921t3644r938b3665],
6	Capitain	NNP	MISC	Capitain	dep	5	SENT_411	[p24l947t3644r1029b3671],
7	et	FW	O	et	nn	8	SENT_411	[p24l1040t3646r1057b3665],
8	al	FW	O	al	amod	6	SENT_411	[p24l1065t3644r1083b3665],

1	.	.	O	.	_	0	SENT_412	[p25l1441t713r1443b719],

1	I	PRP	O	I	_	0	SENT_413	[p25l1531t706r1534b719],
2	I	PRP	O	I	dep	1	SENT_413	[p25l1622t706r1625b719],
3	T	NN	O	t	nn	5	SENT_413	[p25l1432t739r1451b762],
4	G	NN	O	g	nn	5	SENT_413	[p25l1522t739r1542b762],
5	A	NN	O	a	dep	1	SENT_413	[p25l1613t739r1633b762],

1	ITI	NNP	O	ITI	dep	9	SENT_414	[p25l677t739r694b762],
2	(	NN	O	(	nn	4	SENT_414	[p25l766t739r784b762],
3	D	NN	O	d	nn	4	SENT_414	[p25l766t739r784b762],
4	O	NN	O	o	dep	1	SENT_414	[p25l888t739r908b762],
5	G	NN	O	g	dep	9	SENT_414	[p25l978t739r998b762],
6	)	CD	NUMBER	)	num	5	SENT_414	[p25l978t739r998b762],
7	>	JJR	O	>	amod	9	SENT_414	[p25l1069t713r1089b762],
8	_	NN	O	_	nn	9	SENT_414	[p25l1069t713r1089b762],
9	o	NN	O	o	dep	13	SENT_414	[p25l1159t739r1180b762],
10	U	NNP	O	U	dep	9	SENT_414	[p25l1251t739r1270b803],
11	'	POS	O	'	_	0	SENT_414	[p25l1251t739r1270b803],
12	I	PRP	O	I	dep	10	SENT_414	[p25l1251t739r1270b803],
13	—	VBP	O	—	_	0	SENT_414	[p25l1251t739r1270b803],
14	l	NN	O	l	nn	15	SENT_414	[p25l1251t739r1270b803],
15	O	NN	O	o	dobj	13	SENT_414	[p25l1341t739r1361b762],

1	2.0	CD	NUMBER	2.0	_	0	SENT_415	[p25l495t852r538b876],
2	1-0	CD	NUMBER	1-0	nsubj	5	SENT_415	[p25l497t862r575b1076],
3	]	SYM	O	]	dep	5	SENT_415	[p25l497t862r575b1076],
4	-	:	O	-	_	0	SENT_415	[p25l583t968r586b970],
5	-	:	O	-	_	0	SENT_415	[p25l601t968r604b970],
6	-	:	O	-	_	0	SENT_415	[p25l618t968r622b970],
7	-	:	O	-	_	0	SENT_415	[p25l636t968r639b970],
8	I	PRP	O	I	nsubj	9	SENT_415	[p25l654t968r657b970],
9	*	VBP	O	*	parataxis	5	SENT_415	[p25l671t968r1045b1084],
10	'	''	O	'	_	0	SENT_415	[p25l1167t915r1228b1084],
11	I	PRP	O	I	npadvmod	12	SENT_415	[p25l1235t968r1239b970],
12	>	JJR	O	>	amod	1	SENT_415	[p25l1253t968r1257b970],
13	-	:	O	-	_	0	SENT_415	[p25l1271t968r1274b970],
14	I	PRP	O	I	dep	17	SENT_415	[p25l1288t968r1292b970],
15	-	:	O	-	_	0	SENT_415	[p25l1306t968r1309b970],
16	I	PRP	O	I	dep	14	SENT_415	[p25l1324t968r1327b970],
17	I	PRP	O	I	dep	12	SENT_415	[p25l1341t968r1345b970],
18	-	:	O	-	_	0	SENT_415	[p25l1359t968r1362b970],
19	1	CD	NUMBER	1	number	20	SENT_415	[p25l1399t862r1602b1084],
20	*	CD	NUMBER	*	num	21	SENT_415	[p25l1399t862r1602b1084],
21	o	NN	O	o	dep	1	SENT_415	[p25l495t1064r538b1087],
22	,	,	O	,	_	0	SENT_415	[p25l495t1064r538b1087],
23	o	NN	O	o	nn	24	SENT_415	[p25l495t1064r538b1087],
24	I	NN	O	i	appos	21	SENT_415	[p25l623t1069r626b1084],
25	-	:	O	-	_	0	SENT_415	[p25l1052t1021r1114b1084],
26	I	PRP	O	I	dep	21	SENT_415	[p25l1311t1069r1314b1084],

1	C	NN	O	c	nn	3	SENT_416	[p25l614t1104r635b1129],
2	G	NN	O	g	nn	3	SENT_416	[p25l728t1104r750b1129],
3	A	NN	O	a	_	0	SENT_416	[p25l843t1105r864b1129],
4	G	NN	O	g	nn	6	SENT_416	[p25l957t1104r979b1129],
5	T	NN	O	t	nn	6	SENT_416	[p25l1073t1105r1093b1129],
6	C	NN	O	c	dep	3	SENT_416	[p25l1187t1104r1208b1129],
7	T	NN	O	t	nn	9	SENT_416	[p25l1302t1105r1322b1129],
8	G	NN	O	g	nn	9	SENT_416	[p25l1416t1104r1437b1129],
9	A	NN	O	a	dep	3	SENT_416	[p25l1531t1105r1552b1129],

1	Figure	NN	O	figure	nn	3	SENT_417	[p25l38t1169r132b1202],
2	8	CD	NUMBER	8	num	3	SENT_417	[p25l145t1170r163b1194],
3	Example	NN	O	example	nsubj	17	SENT_417	[p25l198t1169r319b1202],
4	of	IN	O	of	_	0	SENT_417	[p25l332t1169r360b1194],
5	pyrogram	NN	O	pyrogram	prep_of	3	SENT_417	[p25l372t1176r512b1202],
6	(	CD	NUMBER	(	num	5	SENT_417	[p25l526t1169r586b1202],
7	up	RP	O	up	prep	5	SENT_417	[p25l526t1169r586b1202],
8	)	CD	NUMBER	)	dep	7	SENT_417	[p25l526t1169r586b1202],
9	and	CC	O	and	_	0	SENT_417	[p25l599t1169r652b1194],
10	pattern	NN	O	pattern	prep_of	3	SENT_417	[p25l667t1172r770b1202],
11	(	CD	NUMBER	(	num	10	SENT_417	[p25l784t1169r889b1200],
12	down	IN	O	down	advmod	10	SENT_417	[p25l784t1169r889b1200],
13	)	CD	NUMBER	)	pobj	12	SENT_417	[p25l784t1169r889b1200],
14	for	IN	O	for	_	0	SENT_417	[p25l901t1169r941b1194],
15	MTHFR	NN	O	mthfr	prep_for	10	SENT_417	[p25l954t1170r1058b1194],
16	677	CD	NUMBER	677	num	15	SENT_417	[p25l1071t1170r1125b1194],
17	C	NN	O	c	_	0	SENT_417	[p25l1139t1170r1212b1194],
18	>	JJR	O	>	amod	20	SENT_417	[p25l1139t1170r1212b1194],
19	T	NN	O	t	nn	20	SENT_417	[p25l1139t1170r1212b1194],
20	heterozygote	NN	O	heterozygote	dobj	17	SENT_417	[p25l1225t1169r1423b1202],
21	.	.	O	.	_	0	SENT_417	[p25l1225t1169r1423b1202],

1	MTHFR	NNP	LOCATION	MTHFR	_	0	SENT_418	[p25l1439t1170r1550b1199],
2	,	,	O	,	_	0	SENT_418	[p25l1439t1170r1550b1199],
3	methylene	NN	O	methylene	nn	5	SENT_418	[p25l1566t1169r1718b1202],
4	tetrahydrofolate	NN	O	tetrahydrofolate	nn	5	SENT_418	[p25l1731t1169r1964b1202],
5	reductase	NN	O	reductase	appos	1	SENT_418	[p25l1978t1169r2123b1194],
6	.	.	O	.	_	0	SENT_418	[p25l1978t1169r2123b1194],

1	Statistical	JJ	O	statistical	amod	3	SENT_419	[p25l11t1356r323b1414],
2	analysis	NN	O	analysis	nn	3	SENT_419	[p25l349t1356r600b1432],
3	Statistics	NNS	O	statistics	nsubjpass	5	SENT_419	[p25l8t1454r314b1510],
4	were	VBD	O	be	auxpass	5	SENT_419	[p25l347t1469r510b1510],
5	performed	VBN	O	perform	_	0	SENT_419	[p25l545t1452r915b1528],
6	using	VBG	O	use	xcomp	5	SENT_419	[p25l946t1455r1139b1528],
7	SPSS	NNP	ORGANIZATION	SPSS	nsubj	10	SENT_419	[p25l1172t1454r1325b1510],
8	software	NN	O	software	nn	10	SENT_419	[p25l1361t1452r1654b1510],
9	(	CD	NUMBER	(	num	10	SENT_419	[p25l1692t1452r2024b1528],
10	Chicago	NNP	LOCATION	Chicago	xcomp	6	SENT_419	[p25l1692t1452r2024b1528],
11	,	,	O	,	_	0	SENT_419	[p25l1692t1452r2024b1528],
12	IL	NN	O	il	appos	10	SENT_419	[p25l2063t1455r2147b1522],
13	,	,	O	,	_	0	SENT_419	[p25l2063t1455r2147b1522],
14	USA	NNP	LOCATION	USA	appos	12	SENT_419	[p25l7t1545r200b1617],
15	)	CD	NUMBER	)	num	14	SENT_419	[p25l7t1545r200b1617],
16	.	.	O	.	_	0	SENT_419	[p25l7t1545r200b1617],

1	X2	NN	O	x2	nn	2	SENT_420	[p25l227t1537r294b1617],
2	test	NN	O	test	nsubjpass	9	SENT_420	[p25l316t1552r439b1603],
3	and	CC	O	and	_	0	SENT_420	[p25l463t1545r594b1603],
4	Fisher	NNP	PERSON	Fisher	poss	7	SENT_420	[p25l617t1545r874b1603],
5	's	POS	O	's	_	0	SENT_420	[p25l617t1545r874b1603],
6	exact	JJ	O	exact	amod	7	SENT_420	[p25l897t1552r1080b1603],
7	test	NN	O	test	nsubjpass	9	SENT_420	[p25l1102t1552r1226b1603],
8	were	VBD	O	be	auxpass	9	SENT_420	[p25l1246t1562r1410b1603],
9	used	VBN	O	use	_	0	SENT_420	[p25l1432t1545r1593b1603],
10	for	IN	O	for	_	0	SENT_420	[p25l1615t1545r1714b1603],
11	comparison	NN	O	comparison	prep_for	9	SENT_420	[p25l1734t1548r2151b1621],
12	of	IN	O	of	_	0	SENT_420	[p25l8t1641r80b1699],
13	different	JJ	O	different	amod	14	SENT_420	[p25l131t1641r434b1699],
14	frequencies	NNS	O	frequency	prep_of	11	SENT_420	[p25l489t1641r910b1717],
15	.	.	O	.	_	0	SENT_420	[p25l489t1641r910b1717],

1	The	DT	O	the	det	3	SENT_421	[p25l967t1641r1100b1699],
2	or-error	JJ	O	or-error	amod	3	SENT_421	[p25l1156t1658r1389b1699],
3	risk	NN	O	risk	nsubjpass	6	SENT_421	[p25l1442t1641r1568b1699],
4	was	VBD	O	be	auxpass	6	SENT_421	[p25l1618t1658r1746b1699],
5	classically	RB	O	classically	advmod	6	SENT_421	[p25l1802t1641r2154b1717],
6	chosen	VBN	O	choose	_	0	SENT_421	[p25l8t1735r257b1793],
7	as	IN	O	as	_	0	SENT_421	[p25l305t1752r370b1793],
8	5	CD	PERCENT	5	num	9	SENT_421	[p25l419t1737r545b1793],
9	%	NN	PERCENT	%	prep_as	6	SENT_421	[p25l419t1737r545b1793],
10	.	.	O	.	_	0	SENT_421	[p25l419t1737r545b1793],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_422	[p25l597t1735r1086b1811],
2	.	.	O	.	_	0	SENT_422	[p25l597t1735r1086b1811],

1	—	NN	O	—	_	0	SENT_423	[p25l597t1735r1086b1811],
2	.	.	O	.	_	0	SENT_423	[p25l597t1735r1086b1811],

1	Meier	JJR	PERSON	meier	amod	2	SENT_424	[p25l597t1735r1086b1811],
2	estimates	NNS	O	estimate	nsubjpass	7	SENT_424	[p25l1133t1738r1460b1793],
3	and	CC	O	and	_	0	SENT_424	[p25l1509t1735r1640b1793],
4	log-rank	JJ	O	log-rank	amod	5	SENT_424	[p25l1687t1735r1983b1811],
5	test	NN	O	test	conj_and	2	SENT_424	[p25l2028t1743r2152b1793],
6	were	VBD	O	be	auxpass	7	SENT_424	[p25l6t1848r169b1889],
7	employed	VBN	O	employ	_	0	SENT_424	[p25l201t1831r550b1907],
8	in	IN	O	in	_	0	SENT_424	[p25l580t1834r650b1888],
9	univariate	JJ	O	univariate	amod	10	SENT_424	[p25l678t1834r1037b1889],
10	analysis	NN	O	analysis	prep_in	7	SENT_424	[p25l1069t1831r1344b1907],
11	of	IN	O	of	_	0	SENT_424	[p25l1375t1831r1447b1889],
12	OS	NNP	O	OS	prep_of	10	SENT_424	[p25l1473t1832r1568b1889],
13	and	CC	O	and	_	0	SENT_424	[p25l1599t1831r1730b1889],
14	PFS	NNP	O	PFS	conj_and	12	SENT_424	[p25l1761t1832r1896b1889],
15	.	.	O	.	_	0	SENT_424	[p25l1761t1832r1896b1889],

1	The	DT	O	the	det	3	SENT_425	[p25l83t1925r215b1983],
2	Cox-regression	NN	MISC	cox-regression	nn	3	SENT_425	[p25l268t1927r793b2001],
3	method	NN	O	method	nsubjpass	5	SENT_425	[p25l845t1925r1123b1983],
4	was	VBD	O	be	auxpass	5	SENT_425	[p25l1171t1942r1299b1983],
5	used	VBN	O	use	_	0	SENT_425	[p25l1348t1925r1509b1983],
6	for	IN	O	for	_	0	SENT_425	[p25l1559t1925r1658b1983],
7	toxicity	NN	O	toxicity	nn	10	SENT_425	[p25l1707t1928r1981b2001],
8	risk	NN	O	risk	nn	10	SENT_425	[p25l2029t1925r2154b1983],
9	multivariate	JJ	O	multivariate	amod	10	SENT_425	[p25l8t2021r440b2078],
10	analysis	NN	O	analysis	prep_for	5	SENT_425	[p25l505t2020r800b2096],
11	.	.	O	.	_	0	SENT_425	[p25l505t2020r800b2096],

1	The	DT	O	the	det	3	SENT_426	[p25l865t2020r998b2078],
2	same	JJ	O	same	amod	3	SENT_426	[p25l1063t2037r1237b2078],
3	method	NN	O	method	nsubjpass	5	SENT_426	[p25l1301t2020r1580b2078],
4	was	VBD	O	be	auxpass	5	SENT_426	[p25l1640t2037r1769b2078],
5	used	VBN	O	use	_	0	SENT_426	[p25l1830t2021r1991b2078],
6	for	IN	O	for	_	0	SENT_426	[p25l2054t2020r2153b2078],
7	response	NN	O	response	prep_for	5	SENT_426	[p25l8t2133r313b2192],
8	to	TO	O	to	_	0	SENT_426	[p25l345t2123r414b2174],
9	FU-based	JJ	MISC	fu-based	amod	10	SENT_426	[p25l446t2116r767b2174],
10	treatment	NN	O	treatment	prep_to	5	SENT_426	[p25l797t2123r1148b2174],
11	or	CC	O	or	_	0	SENT_426	[p25l1179t2133r1251b2174],
12	OS	NN	O	os	conj_or	10	SENT_426	[p25l1281t2118r1375b2174],
13	and	CC	O	and	_	0	SENT_426	[p25l1407t2116r1539b2174],
14	PFS	NN	O	pf	nn	16	SENT_426	[p25l1570t2118r1686b2174],
15	multivariate	JJ	O	multivariate	amod	16	SENT_426	[p25l1717t2116r2150b2174],
16	analysis	NN	O	analysis	prep_to	5	SENT_426	[p25l8t2211r303b2286],
17	.	.	O	.	_	0	SENT_426	[p25l8t2211r303b2286],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_427	[p25l6t2405r729b2481],

1	We	PRP	O	we	nsubj	3	SENT_428	[p25l6t2592r104b2642],
2	would	MD	O	would	aux	3	SENT_428	[p25l139t2590r336b2641],
3	like	VB	O	like	_	0	SENT_428	[p25l371t2590r482b2642],
4	to	TO	O	to	aux	5	SENT_428	[p25l518t2596r580b2641],
5	thank	VB	O	thank	xcomp	3	SENT_428	[p25l617t2590r803b2641],
6	the	DT	O	the	det	10	SENT_428	[p25l836t2590r936b2642],
7	Comité	NNP	O	Comité	nn	10	SENT_428	[p25l974t2587r1205b2642],
8	Départemental	NNP	O	Départemental	nn	10	SENT_428	[p25l1242t2587r1712b2658],
9	du	NNP	O	du	nn	10	SENT_428	[p25l1748t2590r1828b2641],
10	Maine	NNP	LOCATION	Maine	dobj	5	SENT_428	[p25l1862t2592r2059b2642],
11	et	FW	O	et	nn	15	SENT_428	[p25l2096t2596r2152b2642],
12	Loire	FW	ORGANIZATION	loire	nn	15	SENT_428	[p25l8t2677r164b2726],
13	de	FW	ORGANIZATION	de	nn	15	SENT_428	[p25l186t2675r257b2726],
14	la	FW	ORGANIZATION	la	nn	15	SENT_428	[p25l278t2675r331b2726],
15	Ligue	FW	ORGANIZATION	ligue	dep	10	SENT_428	[p25l353t2677r521b2742],
16	Contre	NNP	ORGANIZATION	Contre	nn	18	SENT_428	[p25l543t2676r759b2726],
17	Le	NNP	ORGANIZATION	Le	nn	18	SENT_428	[p25l781t2677r849b2726],
18	Cancer	NNP	ORGANIZATION	Cancer	dep	10	SENT_428	[p25l872t2676r1092b2726],
19	and	CC	O	and	_	0	SENT_428	[p25l1112t2674r1229b2726],
20	the	DT	O	the	det	22	SENT_428	[p25l1249t2675r1350b2726],
21	Rotary	JJ	MISC	rotary	amod	22	SENT_428	[p25l1372t2677r1578b2742],
22	club	NN	O	club	dobj	5	SENT_428	[p25l1597t2675r1729b2726],
23	of	IN	O	of	_	0	SENT_428	[p25l1751t2674r1815b2726],
24	Angers	NNP	O	Angers	prep_of	22	SENT_428	[p25l1831t2676r2044b2742],
25	for	IN	O	for	_	0	SENT_428	[p25l2066t2674r2153b2726],
26	their	PRP$	O	they	poss	28	SENT_428	[p25l7t2760r157b2811],
27	financial	JJ	O	financial	amod	28	SENT_428	[p25l181t2759r457b2811],
28	support	NN	O	support	prep_for	5	SENT_428	[p25l485t2766r740b2827],
29	.	.	O	.	_	0	SENT_428	[p25l485t2766r740b2827],

1	Duality	NN	O	duality	_	0	SENT_429	[p25l10t2951r286b3027],
2	of	IN	O	of	_	0	SENT_429	[p25l314t2951r395b3009],
3	interest	NN	O	interest	prep_of	1	SENT_429	[p25l423t2951r721b3009],

1	The	DT	O	the	det	2	SENT_430	[p25l6t3130r129b3188],
2	authors	NNS	O	author	nsubj	3	SENT_430	[p25l160t3130r408b3188],
3	declare	VBP	O	declare	_	0	SENT_430	[p25l439t3130r677b3188],
4	that	IN	O	that	complm	6	SENT_430	[p25l707t3130r842b3188],
5	they	PRP	O	they	nsubj	6	SENT_430	[p25l868t3130r1014b3206],
6	have	VBP	O	have	ccomp	3	SENT_430	[p25l1046t3130r1198b3188],
7	no	DT	O	no	det	8	SENT_430	[p25l1232t3147r1312b3188],
8	duality	NN	O	duality	dobj	6	SENT_430	[p25l1343t3130r1569b3206],
9	of	IN	O	of	_	0	SENT_430	[p25l1598t3130r1663b3188],
10	interest	NN	O	interest	prep_of	8	SENT_430	[p25l1692t3131r1953b3188],
11	.	.	O	.	_	0	SENT_430	[p25l1692t3131r1953b3188],

1	References	NNS	O	reference	_	0	SENT_431	[p25l10t3324r424b3383],

1	1	CD	NUMBER	1	_	0	SENT_432	[p25l43t3506r60b3553],
2	Advanced	NNP	O	Advanced	nn	6	SENT_432	[p25l138t3505r414b3554],
3	Colorectal	NNP	O	Colorectal	nn	6	SENT_432	[p25l465t3505r744b3554],
4	Cancer	NNP	O	Cancer	nn	6	SENT_432	[p25l796t3506r992b3554],
5	Meta-Analysis	NNP	O	Meta-Analysis	nn	6	SENT_432	[p25l1041t3505r1421b3569],
6	Project	NNP	O	Project	dep	1	SENT_432	[p25l1473t3506r1675b3569],
7	.	.	O	.	_	0	SENT_432	[p25l1473t3506r1675b3569],

1	Modulation	NN	O	modulation	nsubj	20	SENT_433	[p25l1730t3505r2049b3554],
2	of	IN	O	of	_	0	SENT_433	[p25l2100t3505r2154b3554],
3	fluorouracil	NN	O	fluorouracil	prep_of	1	SENT_433	[p25l138t3581r451b3629],
4	by	IN	O	by	_	0	SENT_433	[p25l483t3581r548b3644],
5	leucovorin	NN	O	leucovorin	prep_by	3	SENT_433	[p25l576t3581r861b3629],
6	in	IN	O	in	_	0	SENT_433	[p25l893t3582r937b3629],
7	patients	NNS	O	patient	prep_in	5	SENT_433	[p25l969t3582r1186b3644],
8	with	IN	O	with	_	0	SENT_433	[p25l1211t3581r1331b3629],
9	advanced	JJ	O	advanced	amod	11	SENT_433	[p25l1360t3581r1626b3629],
10	Colorectal	JJ	O	colorectal	amod	11	SENT_433	[p25l1655t3581r1922b3629],
11	cancer	NN	O	cancer	prep_with	7	SENT_433	[p25l1952t3595r2148b3629],
12	:	:	O	:	_	0	SENT_433	[p25l1952t3595r2148b3629],
13	evidence	NN	O	evidence	dep	7	SENT_433	[p25l140t3657r387b3706],
14	in	IN	O	in	_	0	SENT_433	[p25l415t3658r459b3705],
15	terms	NNS	O	term	prep_in	13	SENT_433	[p25l487t3663r643b3706],
16	of	IN	O	of	_	0	SENT_433	[p25l669t3657r723b3706],
17	response	NN	O	response	nn	18	SENT_433	[p25l748t3671r990b3721],
18	rate	NN	O	rate	prep_of	15	SENT_433	[p25l1019t3663r1121b3706],
19	(	CD	NUMBER	(	num	18	SENT_433	[p25l1148t3658r1256b3718],
20	see	VBP	O	see	_	0	SENT_433	[p25l1148t3658r1256b3718],
21	comments	NNS	O	comment	dobj	20	SENT_433	[p25l1283t3657r1614b3718],
22	)	CD	NUMBER	)	tmod	20	SENT_433	[p25l1283t3657r1614b3718],
23	.	.	O	.	_	0	SENT_433	[p25l1283t3657r1614b3718],

1	/	:	O	/	punct	3	SENT_434	[p25l1640t3659r1661b3717],
2	Clin	NNP	O	Clin	nn	3	SENT_434	[p25l1688t3657r1786b3706],
3	Oncol	NNP	O	Oncol	_	0	SENT_434	[p25l1814t3657r1969b3706],
4	1992	CD	DATE	1992	dep	3	SENT_434	[p25l1994t3659r2148b3716],
5	;	:	O	;	_	0	SENT_434	[p25l1994t3659r2148b3716],
6	10	CD	NUMBER	10	dep	3	SENT_434	[p25l144t3734r225b3781],
7	:	:	O	:	_	0	SENT_434	[p25l144t3734r225b3781],
8	896-903	CD	NUMBER	896-903	dep	6	SENT_434	[p25l254t3734r516b3781],
9	.	.	O	.	_	0	SENT_434	[p25l254t3734r516b3781],

1	Pinedo	NNP	PERSON	Pinedo	nn	2	SENT_435	[p26l143t21r330b69],
2	HM	NNS	O	hm	_	0	SENT_435	[p26l362t23r474b80],
3	,	,	O	,	_	0	SENT_435	[p26l362t23r474b80],
4	Peters	NNP	PERSON	Peters	nn	6	SENT_435	[p26l509t23r671b69],
5	GF	NN	O	gf	nn	6	SENT_435	[p26l700t22r806b80],
6	]	NN	O	]	appos	2	SENT_435	[p26l700t22r806b80],
7	.	.	O	.	_	0	SENT_435	[p26l700t22r806b80],

1	Fluorouracilz	NNP	O	Fluorouracilz	_	0	SENT_436	[p26l840t21r1178b69],
2	biochemistry	NN	O	biochemistry	dep	1	SENT_436	[p26l1212t21r1570b84],
3	and	CC	O	and	_	0	SENT_436	[p26l1598t21r1699b69],
4	pharmacology	NN	O	pharmacology	dep	1	SENT_436	[p26l1732t21r2148b84],
5	.	.	O	.	_	0	SENT_436	[p26l1732t21r2148b84],

1	/	:	O	/	punct	3	SENT_437	[p26l136t99r157b157],
2	Clin	NNP	O	Clin	nn	3	SENT_437	[p26l183t97r280b146],
3	Oncol	NNP	O	Oncol	_	0	SENT_437	[p26l308t97r463b146],
4	1988	CD	DATE	1988	dep	3	SENT_437	[p26l487t99r641b156],
5	;	:	O	;	_	0	SENT_437	[p26l487t99r641b156],
6	6	CD	NUMBER	6	dep	3	SENT_437	[p26l669t99r718b146],
7	:	:	O	:	_	0	SENT_437	[p26l669t99r718b146],
8	1653-1664	CD	DATE	1653-1664	dep	6	SENT_437	[p26l750t99r1083b146],
9	.	.	O	.	_	0	SENT_437	[p26l750t99r1083b146],

1	Poon	NNP	PERSON	Poon	nn	2	SENT_438	[p26l143t176r279b223],
2	MA	NNP	PERSON	MA	_	0	SENT_438	[p26l304t176r411b233],
3	,	,	O	,	_	0	SENT_438	[p26l304t176r411b233],
4	O'Connell	NNP	PERSON	O'Connell	nn	6	SENT_438	[p26l435t174r715b223],
5	M	NNP	O	M	nn	6	SENT_438	[p26l741t176r825b234],
6	]	NN	O	]	appos	2	SENT_438	[p26l741t176r825b234],
7	,	,	O	,	_	0	SENT_438	[p26l741t176r825b234],
8	Wieand	NNP	O	Wieand	nn	9	SENT_438	[p26l847t174r1057b223],
9	HS	NN	O	h	appos	2	SENT_438	[p26l1082t176r1169b233],
10	,	,	O	,	_	0	SENT_438	[p26l1082t176r1169b233],
11	Krook	NNP	PERSON	Krook	nn	12	SENT_438	[p26l1196t174r1354b223],
12	JE	NNP	O	JE	appos	2	SENT_438	[p26l1371t176r1432b234],
13	,	,	O	,	_	0	SENT_438	[p26l1371t176r1432b234],
14	Gerstner	NNP	PERSON	Gerstner	nn	15	SENT_438	[p26l1457t176r1695b223],
15	JD	NNP	O	JD	appos	2	SENT_438	[p26l1711t176r1788b234],
16	,	,	O	,	_	0	SENT_438	[p26l1711t176r1788b234],
17	Tschetter	NNP	PERSON	Tschetter	nn	18	SENT_438	[p26l1810t174r2070b223],
18	LK	NNP	O	LK	appos	2	SENT_438	[p26l2090t176r2153b223],
19	et	FW	O	et	nn	20	SENT_438	[p26l142t257r191b299],
20	al.	FW	O	al.	dep	18	SENT_438	[p26l245t251r303b299],
21	.	.	O	.	_	0	SENT_438	[p26l245t251r303b299],

1	Biochemical	JJ	MISC	biochemical	amod	2	SENT_439	[p26l366t251r696b299],
2	modulation	NN	O	modulation	_	0	SENT_439	[p26l757t251r1075b299],
3	of	IN	O	of	_	0	SENT_439	[p26l1135t251r1189b299],
4	fluorouracil	NN	O	fluorouracil	prep_of	2	SENT_439	[p26l1240t251r1553b299],
5	with	IN	O	with	_	0	SENT_439	[p26l1611t251r1731b299],
6	leucovorin	NN	O	leucovorin	prep_with	4	SENT_439	[p26l1792t251r2078b299],
7	'	''	O	'	_	0	SENT_439	[p26l2139t267r2148b276],
8	confirmatory	JJ	O	confirmatory	amod	9	SENT_439	[p26l140t327r500b390],
9	evidence	NN	O	evidence	dep	4	SENT_439	[p26l541t327r787b375],
10	of	IN	O	of	_	0	SENT_439	[p26l830t327r884b375],
11	improved	VBN	O	improve	amod	12	SENT_439	[p26l925t327r1188b390],
12	efficacy	NN	O	efficacy	prep_of	9	SENT_439	[p26l1232t327r1440b390],
13	in	IN	O	in	_	0	SENT_439	[p26l1482t328r1527b375],
14	advanced	JJ	O	advanced	amod	16	SENT_439	[p26l1572t327r1837b375],
15	colorectal	JJ	O	colorectal	amod	16	SENT_439	[p26l1882t327r2148b375],
16	cancer	NN	O	cancer	prep_in	12	SENT_439	[p26l140t417r337b452],
17	.	.	O	.	_	0	SENT_439	[p26l140t417r337b452],

1	/	:	O	/	punct	2	SENT_440	[p26l362t405r383b463],
2	Clin	NN	O	clin	_	0	SENT_440	[p26l408t403r505b452],
3	Oncol1991	NN	O	oncol1991	dep	2	SENT_440	[p26l534t403r866b462],
4	;	:	O	;	_	0	SENT_440	[p26l534t403r866b462],
5	9	CD	NUMBER	9	dep	2	SENT_440	[p26l895t405r944b452],
6	:	:	O	:	_	0	SENT_440	[p26l895t405r944b452],
7	1967-1972	CD	DATE	1967-1972	dep	5	SENT_440	[p26l975t405r1309b452],
8	.	.	O	.	_	0	SENT_440	[p26l975t405r1309b452],

1	The	DT	O	the	_	0	SENT_441	[p26l6t655r108b701],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nn	2	SENT_442	[p26l135t655r677b715],
2	journal	NN	O	journal	_	0	SENT_442	[p26l699t655r893b711],
3	de	IN	O	de	_	0	SENT_442	[p26l135t729r201b777],
4	Gramont	NNP	MISC	Gramont	nn	5	SENT_442	[p26l223t730r474b777],
5	A	NNP	MISC	A	prep_de	2	SENT_442	[p26l490t731r543b787],
6	,	,	O	,	_	0	SENT_442	[p26l490t731r543b787],
7	Bosset	NNP	PERSON	Bosset	nn	8	SENT_442	[p26l570t731r743b777],
8	JF	NNP	O	JF	appos	2	SENT_442	[p26l759t731r819b789],
9	,	,	O	,	_	0	SENT_442	[p26l759t731r819b789],
10	Milan	NNP	ORGANIZATION	Milan	nn	11	SENT_442	[p26l846t729r996b777],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_442	[p26l1020t730r1074b787],
12	,	,	O	,	_	0	SENT_442	[p26l1020t730r1074b787],
13	Rougier	NNP	PERSON	Rougier	nn	14	SENT_442	[p26l1101t730r1313b792],
14	P	NN	O	p	appos	2	SENT_442	[p26l1333t731r1376b787],
15	,	,	O	,	_	0	SENT_442	[p26l1333t731r1376b787],
16	Bouche	NNP	ORGANIZATION	Bouche	nn	17	SENT_442	[p26l1403t729r1606b777],
17	O	NNP	ORGANIZATION	O	appos	2	SENT_442	[p26l1627t730r1688b788],
18	,	,	O	,	_	0	SENT_442	[p26l1627t730r1688b788],
19	Etienne	NNP	PERSON	Etienne	nn	20	SENT_442	[p26l1715t730r1917b777],
20	PL	NNP	O	PL	appos	2	SENT_442	[p26l1941t731r2001b777],
21	et	FW	O	et	nn	22	SENT_442	[p26l2021t734r2070b777],
22	al.	FW	O	al.	dep	20	SENT_442	[p26l2088t729r2146b777],
23	.	.	O	.	_	0	SENT_442	[p26l2088t729r2146b777],

1	Randomized	VBN	O	randomize	_	0	SENT_443	[p26l138t805r480b853],
2	trial	NN	O	trial	dobj	1	SENT_443	[p26l516t805r616b853],
3	comparing	VBG	O	compare	partmod	2	SENT_443	[p26l652t806r953b869],
4	monthly	JJ	SET	monthly	advmod	6	SENT_443	[p26l992t805r1224b869],
5	low-dose	JJ	O	low-dose	amod	6	SENT_443	[p26l1259t805r1508b853],
6	leucovorin	NN	O	leucovorin	dobj	3	SENT_443	[p26l1544t805r1829b853],
7	and	CC	O	and	_	0	SENT_443	[p26l1866t805r1967b853],
8	fluorouracil	NN	O	fluorouracil	nn	9	SENT_443	[p26l2000t805r2148b853, p26l135t880r318b929],
9	bolus	NN	O	bolus	dobj	3	SENT_443	[p26l363t880r508b929],
10	with	IN	O	with	_	0	SENT_443	[p26l547t880r667b929],
11	bimonthly	JJ	SET	bimonthly	amod	15	SENT_443	[p26l713t880r1000b944],
12	high	JJ	O	high	amod	15	SENT_443	[p26l1042t880r1317b944],
13	—	NN	O	—	nn	15	SENT_443	[p26l1042t880r1317b944],
14	dose	NN	O	dose	nn	15	SENT_443	[p26l1042t880r1317b944],
15	leucovorin	NN	O	leucovorin	prep_with	6	SENT_443	[p26l1361t880r1646b929],
16	and	CC	O	and	_	0	SENT_443	[p26l1690t880r1791b929],
17	fluorouracil	NN	O	fluorouracil	nn	18	SENT_443	[p26l1833t880r2146b929],
18	bolus	NN	O	bolus	prep_with	6	SENT_443	[p26l137t957r283b1006],
19	plus	CC	O	plus	_	0	SENT_443	[p26l307t957r415b1021],
20	continuous	JJ	O	continuous	amod	21	SENT_443	[p26l438t958r748b1006],
21	infusion	NN	O	infusion	dobj	3	SENT_443	[p26l772t957r986b1006],
22	for	IN	O	for	_	0	SENT_443	[p26l1009t957r1087b1006],
23	advanced	JJ	O	advanced	amod	25	SENT_443	[p26l1107t957r1373b1006],
24	colorectal	JJ	O	colorectal	amod	25	SENT_443	[p26l1397t957r1665b1006],
25	cancer	NN	O	cancer	prep_for	21	SENT_443	[p26l1690t971r1886b1006],
26	:	:	O	:	_	0	SENT_443	[p26l1690t971r1886b1006],
27	a	DT	O	a	det	30	SENT_443	[p26l1912t971r1939b1006],
28	French	JJ	MISC	french	amod	30	SENT_443	[p26l1965t957r2147b1006],
29	intergroup	NN	O	intergroup	nn	30	SENT_443	[p26l136t1034r432b1096],
30	study	NN	O	study	dep	6	SENT_443	[p26l457t1033r622b1096],
31	.	.	O	.	_	0	SENT_443	[p26l457t1033r622b1096],

1	/	:	O	/	punct	3	SENT_444	[p26l647t1035r668b1092],
2	Clin	NNP	O	Clin	nn	3	SENT_444	[p26l694t1033r791b1081],
3	Oncol	NNP	O	Oncol	_	0	SENT_444	[p26l819t1033r975b1081],
4	1997	CD	DATE	1997	dep	3	SENT_444	[p26l998t1034r1153b1091],
5	;	:	O	;	_	0	SENT_444	[p26l998t1034r1153b1091],
6	15	CD	NUMBER	15	dep	3	SENT_444	[p26l1185t1034r1267b1081],
7	:	:	O	:	_	0	SENT_444	[p26l1185t1034r1267b1081],
8	808-815	CD	NUMBER	808-815	dep	6	SENT_444	[p26l1296t1034r1559b1081],
9	.	.	O	.	_	0	SENT_444	[p26l1296t1034r1559b1081],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_445	[p26l138t1108r304b1157],
2	S	NNP	O	S	_	0	SENT_445	[p26l329t1110r371b1167],
3	,	,	O	,	_	0	SENT_445	[p26l329t1110r371b1167],
4	Collie-Duguid	NNP	O	Collie-Duguid	nn	5	SENT_445	[p26l397t1108r782b1172],
5	E	NNP	O	E	appos	2	SENT_445	[p26l809t1111r849b1167],
6	,	,	O	,	_	0	SENT_445	[p26l809t1111r849b1167],
7	Li	NNP	PERSON	Li	nn	8	SENT_445	[p26l876t1110r913b1156],
8	T	NN	PERSON	t	appos	2	SENT_445	[p26l933t1111r982b1167],
9	,	,	O	,	_	0	SENT_445	[p26l933t1111r982b1167],
10	Liu	NNP	PERSON	Liu	nn	11	SENT_445	[p26l1010t1110r1083b1157],
11	X	NNP	O	X	appos	2	SENT_445	[p26l1106t1110r1159b1167],
12	,	,	O	,	_	0	SENT_445	[p26l1106t1110r1159b1167],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_445	[p26l1186t1108r1405b1157],
14	HL	NNS	O	hl	appos	2	SENT_445	[p26l1431t1111r1516b1157],
15	.	.	O	.	_	0	SENT_445	[p26l1431t1111r1516b1157],

1	Ethnic	JJ	O	ethnic	amod	2	SENT_446	[p26l1542t1108r1710b1157],
2	variation	NN	O	variation	_	0	SENT_446	[p26l1729t1110r1968b1157],
3	in	IN	O	in	_	0	SENT_446	[p26l1994t1110r2038b1156],
4	the	DT	O	the	det	9	SENT_446	[p26l2060t1108r2149b1157],
5	thymidylate	NN	O	thymidylate	nn	9	SENT_446	[p26l134t1185r467b1249],
6	synthase	NN	O	synthase	nn	9	SENT_446	[p26l487t1185r726b1249],
7	enhancer	NN	O	enhancer	nn	9	SENT_446	[p26l746t1185r1008b1234],
8	region	NN	O	region	nn	9	SENT_446	[p26l1028t1186r1201b1249],
9	polymorphism	NN	O	polymorphism	prep_in	2	SENT_446	[p26l1226t1185r1627b1249],
10	among	IN	O	among	_	0	SENT_446	[p26l1651t1199r1846b1249],
11	Caucasian	JJ	MISC	caucasian	amod	14	SENT_446	[p26l1869t1186r2147b1234],
12	and	CC	O	and	_	0	SENT_446	[p26l135t1261r236b1309],
13	Asian	JJ	MISC	asian	amod	14	SENT_446	[p26l262t1262r406b1309],
14	populations	NNS	O	population	prep_among	2	SENT_446	[p26l437t1261r778b1324],
15	.	.	O	.	_	0	SENT_446	[p26l437t1261r778b1324],

1	Genomics	NNS	O	genomic	_	0	SENT_447	[p26l811t1262r1068b1309],
2	1999	CD	DATE	1999	num	1	SENT_447	[p26l1095t1262r1250b1319],
3	;	:	O	;	_	0	SENT_447	[p26l1095t1262r1250b1319],
4	58	CD	NUMBER	58	num	6	SENT_447	[p26l1278t1262r1363b1309],
5	:	:	O	:	_	0	SENT_447	[p26l1278t1262r1363b1309],
6	310-312	CD	NUMBER	310-312	dep	1	SENT_447	[p26l1395t1262r1655b1309],
7	.	.	O	.	_	0	SENT_447	[p26l1395t1262r1655b1309],

1	Horie	NNP	PERSON	Horie	nn	2	SENT_448	[p26l138t1338r283b1385],
2	N	NNP	O	N	_	0	SENT_448	[p26l313t1339r371b1396],
3	,	,	O	,	_	0	SENT_448	[p26l313t1339r371b1396],
4	Aiba	NNP	LOCATION	Aiba	nn	5	SENT_448	[p26l399t1337r521b1385],
5	H	NNP	LOCATION	H	appos	2	SENT_448	[p26l552t1339r606b1396],
6	,	,	O	,	_	0	SENT_448	[p26l552t1339r606b1396],
7	Oguro	NNP	LOCATION	Oguro	nn	8	SENT_448	[p26l637t1338r816b1400],
8	K	NNP	LOCATION	K	appos	2	SENT_448	[p26l846t1339r892b1396],
9	,	,	O	,	_	0	SENT_448	[p26l846t1339r892b1396],
10	Hojo	NNP	PERSON	Hojo	nn	11	SENT_448	[p26l926t1338r1052b1400],
11	H	NNP	PERSON	H	appos	2	SENT_448	[p26l1083t1339r1136b1396],
12	,	,	O	,	_	0	SENT_448	[p26l1083t1339r1136b1396],
13	Takeishi	NNP	PERSON	Takeishi	nn	16	SENT_448	[p26l1165t1337r1384b1385],
14	K.	NNP	PERSON	K.	nn	16	SENT_448	[p26l1416t1339r1462b1385],
15	Functional	JJ	PERSON	functional	amod	16	SENT_448	[p26l1495t1337r1780b1385],
16	analysis	NN	O	analysis	appos	2	SENT_448	[p26l1809t1337r2019b1401],
17	and	CC	O	and	_	0	SENT_448	[p26l2046t1337r2147b1385],
18	DNA	NN	O	dna	nn	19	SENT_448	[p26l138t1415r269b1460],
19	polymorphism	NN	O	polymorphism	appos	2	SENT_448	[p26l307t1412r709b1476],
20	of	IN	O	of	_	0	SENT_448	[p26l749t1412r803b1461],
21	the	DT	O	the	det	24	SENT_448	[p26l837t1412r925b1461],
22	tandemly	RB	O	tandemly	advmod	23	SENT_448	[p26l961t1412r1226b1476],
23	repeated	VBN	O	repeat	amod	24	SENT_448	[p26l1264t1412r1505b1476],
24	sequences	NNS	O	sequence	prep_of	5	SENT_448	[p26l1544t1427r1831b1476],
25	in	IN	O	in	_	0	SENT_448	[p26l1870t1414r1915b1460],
26	the	DT	O	the	det	31	SENT_448	[p26l1953t1412r2042b1461],
27	5	CD	NUMBER	5	num	28	SENT_448	[p26l2079t1411r2149b1461, p26l134t1489r363b1538],
28	’	NN	O	’	npadvmod	29	SENT_448	[p26l2079t1411r2149b1461, p26l134t1489r363b1538],
29	terminal	JJ	O	terminal	amod	31	SENT_448	[p26l2079t1411r2149b1461, p26l134t1489r363b1538],
30	regulatory	JJ	O	regulatory	amod	31	SENT_448	[p26l388t1489r673b1553],
31	region	NN	O	region	prep_in	24	SENT_448	[p26l695t1490r868b1553],
32	of	IN	O	of	_	0	SENT_448	[p26l890t1489r944b1538],
33	the	DT	O	the	det	35	SENT_448	[p26l961t1489r1050b1538],
34	human	JJ	O	human	amod	35	SENT_448	[p26l1073t1489r1265b1538],
35	gene	NN	O	gene	prep_of	31	SENT_448	[p26l1288t1503r1424b1553],
36	for	IN	O	for	_	0	SENT_448	[p26l1442t1489r1521b1538],
37	thymidylate	NN	O	thymidylate	nn	38	SENT_448	[p26l1538t1489r1871b1553],
38	synthase	NN	O	synthase	prep_for	35	SENT_448	[p26l1891t1489r2146b1553],
39	.	.	O	.	_	0	SENT_448	[p26l1891t1489r2146b1553],

1	Cell	NN	O	cell	nn	3	SENT_449	[p26l139t1565r235b1613],
2	Struct	NNP	O	Struct	nn	3	SENT_449	[p26l257t1566r412b1613],
3	Funct	NNP	O	Funct	_	0	SENT_449	[p26l437t1567r580b1613],
4	1995	CD	DATE	1995	num	3	SENT_449	[p26l605t1566r760b1623],
5	;	:	O	;	_	0	SENT_449	[p26l605t1566r760b1623],
6	20	CD	NUMBER	20	num	8	SENT_449	[p26l789t1566r874b1613],
7	:	:	O	:	_	0	SENT_449	[p26l789t1566r874b1613],
8	191-197	CD	NUMBER	191-197	dep	3	SENT_449	[p26l905t1566r1166b1613],
9	.	.	O	.	_	0	SENT_449	[p26l905t1566r1166b1613],

1	Kawakami	NNP	PERSON	Kawakami	nn	2	SENT_450	[p26l138t1642r416b1691],
2	K	NNP	PERSON	K	_	0	SENT_450	[p26l442t1644r488b1701],
3	,	,	O	,	_	0	SENT_450	[p26l442t1644r488b1701],
4	Salonga	NNP	PERSON	Salonga	nn	5	SENT_450	[p26l513t1642r732b1706],
5	D	NNP	O	D	appos	2	SENT_450	[p26l756t1644r811b1701],
6	,	,	O	,	_	0	SENT_450	[p26l756t1644r811b1701],
7	Park	NNP	O	Park	nn	8	SENT_450	[p26l839t1642r952b1691],
8	JM	NN	O	jm	appos	2	SENT_450	[p26l970t1644r1059b1702],
9	,	,	O	,	_	0	SENT_450	[p26l970t1644r1059b1702],
10	Danenberg	NNP	ORGANIZATION	Danenberg	nn	11	SENT_450	[p26l1086t1642r1394b1706],
11	KD	NN	ORGANIZATION	kd	appos	2	SENT_450	[p26l1420t1644r1513b1701],
12	,	,	O	,	_	0	SENT_450	[p26l1420t1644r1513b1701],
13	Uetake	NN	O	uetake	nn	14	SENT_450	[p26l1540t1642r1727b1691],
14	H	NN	O	h	appos	2	SENT_450	[p26l1751t1644r1804b1701],
15	,	,	O	,	_	0	SENT_450	[p26l1751t1644r1804b1701],
16	Brabenderl	NNP	O	Brabenderl	appos	2	SENT_450	[p26l1831t1642r2146b1702],
17	et	FW	O	et	nn	18	SENT_450	[p26l137t1724r186b1767],
18	al.	FW	O	al.	dep	16	SENT_450	[p26l228t1718r286b1767],
19	.	.	O	.	_	0	SENT_450	[p26l228t1718r286b1767],

1	Different	JJ	O	different	amod	2	SENT_451	[p26l338t1718r579b1767],
2	lengths	NNS	O	length	nsubj	13	SENT_451	[p26l625t1718r826b1782],
3	of	IN	O	of	_	0	SENT_451	[p26l872t1718r925b1767],
4	a	DT	O	a	det	7	SENT_451	[p26l967t1732r994b1767],
5	polymorphic	JJ	O	polymorphic	amod	7	SENT_451	[p26l1042t1718r1396b1782],
6	repeat	NN	O	repeat	nn	7	SENT_451	[p26l1443t1724r1618b1782],
7	sequence	NN	O	sequence	prep_of	2	SENT_451	[p26l1661t1732r1923b1782],
8	in	IN	O	in	_	0	SENT_451	[p26l1969t1719r2014b1766],
9	the	DT	O	the	det	12	SENT_451	[p26l2061t1718r2149b1767],
10	thymidylate	NN	O	thymidylate	nn	12	SENT_451	[p26l134t1794r467b1858],
11	synthase	NN	O	synthase	nn	12	SENT_451	[p26l487t1794r725b1858],
12	gene	NN	O	gene	prep_in	7	SENT_451	[p26l746t1808r882b1858],
13	affect	VBP	O	affect	_	0	SENT_451	[p26l902t1794r1054b1843],
14	translational	JJ	O	translational	amod	15	SENT_451	[p26l1071t1794r1409b1843],
15	efficiency	NN	O	efficiency	dobj	13	SENT_451	[p26l1432t1794r1693b1858],
16	but	CC	O	but	_	0	SENT_451	[p26l1713t1794r1806b1843],
17	not	RB	O	not	_	0	SENT_451	[p26l1826t1800r1917b1843],
18	its	PRP$	O	its	poss	20	SENT_451	[p26l1937t1795r1993b1843],
19	gene	NN	O	gene	nn	20	SENT_451	[p26l2013t1808r2149b1858],
20	expression	NN	O	expression	dobj	13	SENT_451	[p26l135t1871r444b1934],
21	.	.	O	.	_	0	SENT_451	[p26l135t1871r444b1934],

1	Clin	NNP	O	Clin	nn	3	SENT_452	[p26l477t1870r575b1918],
2	Cancer	NNP	O	Cancer	nn	3	SENT_452	[p26l602t1871r789b1918],
3	Res	NNP	O	Res	_	0	SENT_452	[p26l810t1872r895b1918],
4	2001	CD	DATE	2001	num	3	SENT_452	[p26l918t1871r1048b1918],
5	;	:	O	;	_	0	SENT_452	[p26l1063t1886r1075b1929],
6	7	CD	NUMBER	7	num	8	SENT_452	[p26l1107t1872r1153b1918],
7	:	:	O	:	_	0	SENT_452	[p26l1107t1872r1153b1918],
8	4096-4101	CD	DURATION	4096-4101	dep	3	SENT_452	[p26l1180t1871r1518b1918],
9	.	.	O	.	_	0	SENT_452	[p26l1180t1871r1518b1918],

1	Pullarkat	NNP	O	Pullarkat	nn	5	SENT_453	[p26l138t1945r374b1994],
2	ST	JJ	O	st	amod	5	SENT_453	[p26l396t1947r474b2004],
3	,	,	O	,	_	0	SENT_453	[p26l396t1947r474b2004],
4	Stoehlmacher	NNP	PERSON	Stoehlmacher	dep	5	SENT_453	[p26l503t1945r889b1994],
5	J	NNP	PERSON	J	nsubj	13	SENT_453	[p26l909t1948r938b2005],
6	,	,	O	,	_	0	SENT_453	[p26l909t1948r938b2005],
7	Ghaderi	NNP	PERSON	Ghaderi	nn	8	SENT_453	[p26l965t1945r1184b1994],
8	V	NNP	O	V	appos	5	SENT_453	[p26l1206t1947r1257b2004],
9	,	,	O	,	_	0	SENT_453	[p26l1206t1947r1257b2004],
10	Xiong	NNP	O	Xiong	nn	11	SENT_453	[p26l1284t1947r1447b2009],
11	YP	NNP	O	YP	appos	8	SENT_453	[p26l1469t1947r1552b2004],
12	,	,	O	,	_	0	SENT_453	[p26l1469t1947r1552b2004],
13	lngles	VBZ	O	lngle	_	0	SENT_453	[p26l1582t1945r1740b2009],
14	SA	NNP	O	SA	dobj	13	SENT_453	[p26l1764t1947r1846b2004],
15	,	,	O	,	_	0	SENT_453	[p26l1764t1947r1846b2004],
16	Sherrod	NNP	PERSON	Sherrod	nn	17	SENT_453	[p26l1874t1945r2088b1994],
17	A	NNP	O	A	appos	14	SENT_453	[p26l2112t1948r2151b1993],
18	et	FW	O	et	nn	19	SENT_453	[p26l137t2028r186b2071],
19	al.	FW	O	al.	dep	17	SENT_453	[p26l215t2022r273b2071],
20	.	.	O	.	_	0	SENT_453	[p26l215t2022r273b2071],

1	Thymidylate	NNP	O	Thymidylate	nn	4	SENT_454	[p26l306t2022r653b2086],
2	synthase	NN	O	synthase	nn	4	SENT_454	[p26l684t2022r923b2086],
3	gene	NN	O	gene	nn	4	SENT_454	[p26l956t2036r1092b2086],
4	polymorphism	NN	O	polymorphism	nsubj	5	SENT_454	[p26l1126t2022r1528b2086],
5	determines	VBZ	O	determine	_	0	SENT_454	[p26l1562t2022r1872b2071],
6	response	NN	O	response	dobj	5	SENT_454	[p26l1907t2036r2149b2086],
7	and	CC	O	and	_	0	SENT_454	[p26l135t2098r236b2146],
8	toxicity	NN	O	toxicity	dobj	5	SENT_454	[p26l282t2099r487b2161],
9	of	IN	O	of	_	0	SENT_454	[p26l530t2098r584b2146],
10	5-FU	NN	O	5-fu	nn	11	SENT_454	[p26l626t2100r752b2146],
11	chemotherapy	NN	O	chemotherapy	prep_of	6	SENT_454	[p26l799t2098r1222b2161],
12	.	.	O	.	_	0	SENT_454	[p26l799t2098r1222b2161],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_455	[p26l1272t2098r1793b2161],
2	/	:	O	/	punct	3	SENT_455	[p26l1831t2100r1852b2158],
3	2001	CD	DATE	2001	dep	1	SENT_455	[p26l1893t2099r2050b2156],
4	;	:	O	;	_	0	SENT_455	[p26l1893t2099r2050b2156],
5	1	CD	NUMBER	1	num	7	SENT_455	[p26l2102t2099r2146b2146],
6	:	:	O	:	_	0	SENT_455	[p26l2102t2099r2146b2146],
7	65-70	CD	NUMBER	65-70	dep	3	SENT_455	[p26l136t2176r326b2222],
8	.	.	O	.	_	0	SENT_455	[p26l136t2176r326b2222],

1	Etienne	NN	PERSON	etienne	nn	2	SENT_456	[p26l138t2251r340b2298],
2	MC	NNP	PERSON	MC	_	0	SENT_456	[p26l366t2251r477b2308],
3	,	,	O	,	_	0	SENT_456	[p26l366t2251r477b2308],
4	Chazal	NNP	O	Chazal	nn	5	SENT_456	[p26l504t2249r686b2298],
5	M	NNP	O	M	appos	2	SENT_456	[p26l714t2252r781b2308],
6	,	,	O	,	_	0	SENT_456	[p26l714t2252r781b2308],
7	Laurent	NNP	PERSON	Laurent	appos	5	SENT_456	[p26l810t2251r1161b2313],
8	.	.	O	.	_	0	SENT_456	[p26l810t2251r1161b2313],

1	—	NN	O	—	_	0	SENT_457	[p26l810t2251r1161b2313],
2	.	.	O	.	_	0	SENT_457	[p26l810t2251r1161b2313],

1	Puig	NNP	PERSON	Puig	nn	2	SENT_458	[p26l810t2251r1161b2313],
2	P	NN	PERSON	p	_	0	SENT_458	[p26l1188t2252r1231b2308],
3	,	,	O	,	_	0	SENT_458	[p26l1188t2252r1231b2308],
4	Magne	NNP	PERSON	Magne	nn	5	SENT_458	[p26l1260t2252r1452b2313],
5	N	NNP	PERSON	N	appos	2	SENT_458	[p26l1477t2252r1535b2308],
6	,	,	O	,	_	0	SENT_458	[p26l1477t2252r1535b2308],
7	Rosty	NNP	O	Rosty	nn	8	SENT_458	[p26l1565t2252r1709b2313],
8	C	NNP	O	C	appos	2	SENT_458	[p26l1731t2251r1786b2308],
9	,	,	O	,	_	0	SENT_458	[p26l1731t2251r1786b2308],
10	Formento	NNP	O	Formento	nn	11	SENT_458	[p26l1814t2252r2083b2298],
11	JL	NNP	O	JL	appos	2	SENT_458	[p26l2104t2252r2151b2309],
12	et	FW	O	et	nn	13	SENT_458	[p26l137t2332r186b2375],
13	al.	FW	O	al.	dep	11	SENT_458	[p26l229t2326r287b2375],
14	.	.	O	.	_	0	SENT_458	[p26l229t2326r287b2375],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_459	[p26l340t2327r632b2390],
2	value	NN	O	value	_	0	SENT_459	[p26l676t2326r821b2375],
3	of	IN	O	of	_	0	SENT_459	[p26l868t2326r921b2375],
4	tumoral	JJ	O	tumoral	amod	6	SENT_459	[p26l964t2326r1180b2375],
5	thymidylate	NN	O	thymidylate	nn	6	SENT_459	[p26l1228t2326r1561b2390],
6	synthase	NN	O	synthase	prep_of	2	SENT_459	[p26l1607t2326r1846b2390],
7	and	CC	O	and	_	0	SENT_459	[p26l1893t2326r1994b2375],
8	p53	NN	O	p53	prep_of	2	SENT_459	[p26l2044t2328r2147b2390],
9	in	IN	O	in	_	0	SENT_459	[p26l137t2403r181b2450],
10	metastatic	JJ	O	metastatic	amod	13	SENT_459	[p26l232t2403r517b2450],
11	colorectal	JJ	O	colorectal	amod	13	SENT_459	[p26l563t2402r830b2450],
12	cancer	NN	O	cancer	nn	13	SENT_459	[p26l879t2416r1063b2450],
13	patients	NNS	O	patient	prep_in	8	SENT_459	[p26l1109t2403r1327b2465],
14	receiving	VBG	O	receive	partmod	13	SENT_459	[p26l1375t2403r1622b2465],
15	fluorouracil	NN	O	fluorouracil	nn	16	SENT_459	[p26l1668t2402r1982b2450],
16	chemotherapy	NN	O	chemotherapy	dobj	14	SENT_459	[p26l2031t2402r2149b2450, p26l137t2477r457b2541],
17	:	:	O	:	_	0	SENT_459	[p26l2031t2402r2149b2450, p26l137t2477r457b2541],
18	phenotypic	JJ	O	phenotypic	amod	21	SENT_459	[p26l488t2477r802b2541],
19	and	CC	O	and	_	0	SENT_459	[p26l827t2477r928b2526],
20	genotypic	JJ	O	genotypic	conj_and	18	SENT_459	[p26l956t2479r1236b2541],
21	analyses	NNS	O	analysis	dep	8	SENT_459	[p26l1260t2477r1502b2541],
22	.	.	O	.	_	0	SENT_459	[p26l1260t2477r1502b2541],

1	/	:	O	/	punct	3	SENT_460	[p26l1527t2480r1548b2537],
2	Clin	NNP	O	Clin	nn	3	SENT_460	[p26l1574t2477r1672b2526],
3	Oncol	NNP	O	Oncol	_	0	SENT_460	[p26l1699t2477r1855b2526],
4	2002	CD	DATE	2002	dep	3	SENT_460	[p26l1875t2479r2032b2536],
5	;	:	O	;	_	0	SENT_460	[p26l1875t2479r2032b2536],
6	20	CD	NUMBER	20	dep	3	SENT_460	[p26l2062t2479r2146b2526],
7	:	:	O	:	_	0	SENT_460	[p26l2062t2479r2146b2526],
8	2832-2843	CD	DATE	2832-2843	dep	6	SENT_460	[p26l135t2555r472b2602],
9	.	.	O	.	_	0	SENT_460	[p26l135t2555r472b2602],

1	lacopetta	NN	O	lacopetta	nn	2	SENT_461	[p26l143t2632r397b2693],
2	B	NN	O	b	nsubj	23	SENT_461	[p26l441t2632r485b2688],
3	,	,	O	,	_	0	SENT_461	[p26l441t2632r485b2688],
4	Grieu	NNP	O	Grieu	nn	5	SENT_461	[p26l529t2631r676b2678],
5	F	NN	O	f	appos	2	SENT_461	[p26l722t2632r761b2688],
6	,	,	O	,	_	0	SENT_461	[p26l722t2632r761b2688],
7	Joseph	NNP	PERSON	Joseph	nn	8	SENT_461	[p26l802t2630r983b2693],
8	D	NNP	PERSON	D	appos	2	SENT_461	[p26l1029t2632r1084b2688],
9	,	,	O	,	_	0	SENT_461	[p26l1029t2632r1084b2688],
10	Elsaleh	NNP	O	Elsaleh	nn	13	SENT_461	[p26l1130t2630r1310b2678],
11	H.	NNP	O	H.	nn	13	SENT_461	[p26l1355t2632r1409b2678],
12	A	NNP	O	A	nn	13	SENT_461	[p26l1450t2632r1489b2678],
13	polymorphism	NN	O	polymorphism	appos	2	SENT_461	[p26l1529t2630r1930b2693],
14	in	IN	O	in	_	0	SENT_461	[p26l1975t2631r2019b2678],
15	the	DT	O	the	det	17	SENT_461	[p26l2060t2630r2149b2678],
16	enhancer	NN	O	enhancer	nn	17	SENT_461	[p26l140t2706r400b2755],
17	region	NN	O	region	prep_in	13	SENT_461	[p26l429t2707r603b2770],
18	of	IN	O	of	_	0	SENT_461	[p26l634t2706r688b2755],
19	the	DT	O	the	det	22	SENT_461	[p26l714t2706r803b2755],
20	thymidylate	NN	O	thymidylate	nn	22	SENT_461	[p26l831t2706r1164b2770],
21	synthase	NN	O	synthase	nn	22	SENT_461	[p26l1193t2706r1432b2770],
22	promoter	NN	O	promoter	prep_of	17	SENT_461	[p26l1464t2712r1728b2770],
23	influences	VBZ	O	influence	_	0	SENT_461	[p26l1756t2706r2032b2755],
24	the	DT	O	the	det	25	SENT_461	[p26l2060t2706r2149b2755],
25	survival	NN	O	survival	dobj	23	SENT_461	[p26l139t2781r341b2830],
26	of	IN	O	of	_	0	SENT_461	[p26l379t2781r433b2830],
27	colorectal	JJ	O	colorectal	amod	29	SENT_461	[p26l464t2781r732b2830],
28	cancer	NN	O	cancer	nn	29	SENT_461	[p26l769t2796r953b2830],
29	patients	NNS	O	patient	prep_of	25	SENT_461	[p26l987t2783r1204b2845],
30	treated	VBN	O	treat	partmod	29	SENT_461	[p26l1238t2781r1434b2830],
31	with	IN	O	with	_	0	SENT_461	[p26l1469t2781r1589b2830],
32	5-fluorouracil	NN	O	5-fluorouracil	prep_with	30	SENT_461	[p26l1626t2781r2014b2830],
33	.	.	O	.	_	0	SENT_461	[p26l1626t2781r2014b2830],

1	Br	NN	O	br	_	0	SENT_462	[p26l2054t2784r2109b2829],
2	/	:	O	/	punct	1	SENT_462	[p26l2132t2784r2153b2841],
3	Cancer	NNP	O	Cancer	dep	1	SENT_462	[p26l144t2860r330b2907],
4	2001	CD	DATE	2001	dep	3	SENT_462	[p26l349t2859r506b2917],
5	;	:	O	;	_	0	SENT_462	[p26l349t2859r506b2917],
6	85	CD	NUMBER	85	dep	3	SENT_462	[p26l534t2859r620b2907],
7	:	:	O	:	_	0	SENT_462	[p26l534t2859r620b2907],
8	827-830	CD	NUMBER	827-830	dep	6	SENT_462	[p26l650t2859r913b2907],
9	.	.	O	.	_	0	SENT_462	[p26l650t2859r913b2907],

1	Popat	NNP	PERSON	Popat	nn	2	SENT_463	[p26l143t2937r301b2998],
2	S	NNP	O	S	_	0	SENT_463	[p26l334t2936r377b2994],
3	,	,	O	,	_	0	SENT_463	[p26l334t2936r377b2994],
4	Matakidou	NNP	O	Matakidou	nn	5	SENT_463	[p26l417t2935r711b2983],
5	A	NNP	O	A	conj_and	2	SENT_463	[p26l745t2937r798b2993],
6	,	,	O	,	_	0	SENT_463	[p26l745t2937r798b2993],
7	Houlston	NNP	PERSON	Houlston	nn	11	SENT_463	[p26l838t2935r1083b2983],
8	R.	NNP	PERSON	R.	nn	11	SENT_463	[p26l1123t2937r1167b2983],
9	Thymidylate	NNP	PERSON	Thymidylate	nn	11	SENT_463	[p26l1202t2935r1548b2998],
10	synthase	NN	O	synthase	nn	11	SENT_463	[p26l1582t2935r1821b2998],
11	expression	NN	O	expression	conj_and	2	SENT_463	[p26l1856t2936r2147b2998],
12	and	CC	O	and	_	0	SENT_463	[p26l140t3011r241b3060],
13	prognosis	NN	O	prognosis	conj_and	2	SENT_463	[p26l285t3012r552b3075],
14	in	IN	O	in	_	0	SENT_463	[p26l593t3012r638b3059],
15	colorectal	JJ	O	colorectal	amod	16	SENT_463	[p26l680t3011r947b3060],
16	cancer	NN	O	cancer	prep_in	13	SENT_463	[p26l989t3025r1186b3060],
17	:	:	O	:	_	0	SENT_463	[p26l989t3025r1186b3060],
18	a	DT	O	a	det	20	SENT_463	[p26l1229t3025r1256b3060],
19	systematic	JJ	O	systematic	amod	20	SENT_463	[p26l1296t3012r1587b3075],
20	review	NN	O	review	dep	2	SENT_463	[p26l1627t3012r1807b3060],
21	and	CC	O	and	_	0	SENT_463	[p26l1845t3011r1946b3060],
22	metaanalysis	NN	O	metaanalysis	conj_and	20	SENT_463	[p26l1990t3017r2149b3060, p26l140t3087r364b3151],
23	.	.	O	.	_	0	SENT_463	[p26l1990t3017r2149b3060, p26l140t3087r364b3151],

1	/	:	O	/	punct	3	SENT_464	[p26l389t3089r410b3147],
2	Clin	NNP	O	Clin	nn	3	SENT_464	[p26l436t3087r534b3136],
3	Oncol	NNP	O	Oncol	_	0	SENT_464	[p26l561t3087r717b3136],
4	2004	CD	DATE	2004	dep	3	SENT_464	[p26l738t3089r895b3146],
5	;	:	O	;	_	0	SENT_464	[p26l738t3089r895b3146],
6	22	CD	NUMBER	22	dep	3	SENT_464	[p26l925t3088r1009b3136],
7	:	:	O	:	_	0	SENT_464	[p26l925t3088r1009b3136],
8	529-536	CD	NUMBER	529-536	dep	6	SENT_464	[p26l1038t3088r1302b3136],
9	.	.	O	.	_	0	SENT_464	[p26l1038t3088r1302b3136],

1	Kawakami	NNP	PERSON	Kawakami	nn	2	SENT_465	[p26l143t3163r421b3211],
2	K	NNP	PERSON	K	_	0	SENT_465	[p26l466t3165r512b3221],
3	,	,	O	,	_	0	SENT_465	[p26l466t3165r512b3221],
4	Watanabe	NNP	PERSON	Watanabe	nn	6	SENT_465	[p26l554t3163r837b3211],
5	G.	NNP	PERSON	G.	nn	6	SENT_465	[p26l879t3164r937b3211],
6	Identification	NN	PERSON	identification	appos	2	SENT_465	[p26l983t3163r1344b3211],
7	and	CC	O	and	_	0	SENT_465	[p26l1387t3163r1488b3211],
8	functional	JJ	O	functional	amod	9	SENT_465	[p26l1528t3163r1805b3211],
9	analysis	NN	O	analysis	appos	2	SENT_465	[p26l1848t3163r2058b3226],
10	of	IN	O	of	_	0	SENT_465	[p26l2098t3163r2152b3211],
11	single	JJ	O	single	amod	13	SENT_465	[p26l139t3239r299b3302],
12	nucleotide	NN	O	nucleotide	nn	13	SENT_465	[p26l340t3239r631b3287],
13	polymorphism	NN	O	polymorphism	prep_of	9	SENT_465	[p26l672t3239r1074b3303],
14	in	IN	O	in	_	0	SENT_465	[p26l1117t3240r1162b3287],
15	the	DT	O	the	det	18	SENT_465	[p26l1202t3239r1291b3287],
16	tandem	JJ	O	tandem	amod	18	SENT_465	[p26l1328t3239r1542b3287],
17	repeat	NN	O	repeat	nn	18	SENT_465	[p26l1586t3244r1761b3303],
18	sequence	NN	O	sequence	prep_in	13	SENT_465	[p26l1797t3253r2059b3303],
19	of	IN	O	of	_	0	SENT_465	[p26l2098t3239r2152b3287],
20	thymidylate	NN	O	thymidylate	nn	22	SENT_465	[p26l139t3314r471b3378],
21	synthase	NN	O	synthase	nn	22	SENT_465	[p26l497t3314r736b3378],
22	gene	NN	O	gene	prep_of	18	SENT_465	[p26l762t3329r914b3378],
23	.	.	O	.	_	0	SENT_465	[p26l762t3329r914b3378],

1	Cancer	NN	O	cancer	_	0	SENT_466	[p26l947t3316r1133b3363],
2	Res	NNP	O	Res	dep	1	SENT_466	[p26l1154t3317r1239b3363],
3	2003	CD	DATE	2003	num	2	SENT_466	[p26l1262t3316r1420b3373],
4	;	:	O	;	_	0	SENT_466	[p26l1262t3316r1420b3373],
5	63	CD	NUMBER	63	num	7	SENT_466	[p26l1448t3316r1534b3363],
6	:	:	O	:	_	0	SENT_466	[p26l1448t3316r1534b3363],
7	6004-6007	CD	DURATION	6004-6007	dep	1	SENT_466	[p26l1563t3316r1899b3363],
8	.	.	O	.	_	0	SENT_466	[p26l1563t3316r1899b3363],

1	Mandola	NNP	PERSON	Mandola	nn	2	SENT_467	[p26l143t3391r385b3440],
2	MV	NNP	O	MV	dep	18	SENT_467	[p26l423t3393r528b3450],
3	,	,	O	,	_	0	SENT_467	[p26l423t3393r528b3450],
4	Stoehlmacher	NNP	PERSON	Stoehlmacher	nn	5	SENT_467	[p26l567t3391r954b3440],
5	J	NNP	PERSON	J	appos	2	SENT_467	[p26l983t3393r1013b3451],
6	,	,	O	,	_	0	SENT_467	[p26l983t3393r1013b3451],
7	Muller-Weeks	NNP	O	Muller-Weeks	nn	8	SENT_467	[p26l1053t3391r1429b3440],
8	S	NNP	O	S	appos	2	SENT_467	[p26l1464t3393r1507b3450],
9	,	,	O	,	_	0	SENT_467	[p26l1464t3393r1507b3450],
10	Cesarone	NNP	O	Cesarone	nn	11	SENT_467	[p26l1544t3392r1801b3440],
11	G	NNP	O	G	appos	2	SENT_467	[p26l1836t3392r1894b3450],
12	,	,	O	,	_	0	SENT_467	[p26l1836t3392r1894b3450],
13	Yu	NNP	PERSON	Yu	nn	14	SENT_467	[p26l1929t3393r1996b3440],
14	MC	NNP	PERSON	MC	appos	2	SENT_467	[p26l2035t3392r2146b3450],
15	,	,	O	,	_	0	SENT_467	[p26l2035t3392r2146b3450],
16	Lenz	NNP	PERSON	Lenz	nn	17	SENT_467	[p26l143t3470r266b3516],
17	H	NNP	O	H	appos	2	SENT_467	[p26l301t3470r354b3527],
18	]	CD	NUMBER	]	_	0	SENT_467	[p26l301t3470r354b3527],
19	et	FW	O	et	nn	20	SENT_467	[p26l391t3473r440b3516],
20	al.	FW	O	al.	dep	18	SENT_467	[p26l470t3468r528b3516],
21	.	.	O	.	_	0	SENT_467	[p26l470t3468r528b3516],

1	A	DT	O	a	det	5	SENT_468	[p26l562t3470r602b3516],
2	novel	JJ	O	novel	amod	5	SENT_468	[p26l635t3468r779b3516],
3	single	JJ	O	single	amod	5	SENT_468	[p26l815t3468r974b3531],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_468	[p26l1009t3468r1300b3516],
5	polymorphism	NN	O	polymorphism	nsubj	24	SENT_468	[p26l1335t3468r1738b3531],
6	within	IN	O	within	_	0	SENT_468	[p26l1771t3468r1944b3516],
7	the	DT	O	the	det	12	SENT_468	[p26l1978t3468r2067b3516],
8	5	CD	NUMBER	5	num	9	SENT_468	[p26l2101t3467r2147b3516],
9	’	NN	O	’	npadvmod	10	SENT_468	[p26l2101t3467r2147b3516],
10	tandem	JJ	O	tandem	amod	12	SENT_468	[p26l139t3544r352b3593],
11	repeat	NN	O	repeat	nn	12	SENT_468	[p26l410t3550r584b3608],
12	polymorphism	NN	O	polymorphism	prep_within	5	SENT_468	[p26l637t3544r1039b3608],
13	of	IN	O	of	_	0	SENT_468	[p26l1094t3544r1148b3593],
14	the	DT	O	the	det	17	SENT_468	[p26l1196t3544r1285b3593],
15	thymidylate	NN	O	thymidylate	nn	17	SENT_468	[p26l1336t3544r1669b3608],
16	synthase	NN	O	synthase	nn	17	SENT_468	[p26l1721t3544r1960b3608],
17	gene	NN	O	gene	prep_of	12	SENT_468	[p26l2013t3559r2149b3608],
18	abolishes	VBZ	O	abolish	_	0	SENT_468	[p26l143t3619r395b3668],
19	USF	NN	ORGANIZATION	usf	nn	20	SENT_468	[p26l428t3621r574b3668],
20	—	NN	O	—	dobj	18	SENT_468	[p26l428t3621r574b3668],
21	1	CD	NUMBER	1	number	22	SENT_468	[p26l428t3621r574b3668],
22	binding	NN	O	binding	amod	20	SENT_468	[p26l620t3619r830b3683],
23	and	CC	O	and	_	0	SENT_468	[p26l864t3619r964b3668],
24	alters	VBZ	O	alter	conj_and	18	SENT_468	[p26l998t3619r1142b3668],
25	transcriptional	JJ	O	transcriptional	amod	26	SENT_468	[p26l1172t3619r1567b3683],
26	activity	NN	O	activity	dobj	24	SENT_468	[p26l1602t3621r1813b3683],
27	.	.	O	.	_	0	SENT_468	[p26l1602t3621r1813b3683],

1	Cancer	NN	O	cancer	_	0	SENT_469	[p26l1851t3621r2037b3668],
2	Res	NNP	O	Res	dep	1	SENT_469	[p26l2064t3622r2148b3668],
3	2003	CD	DATE	2003	num	2	SENT_469	[p26l143t3696r300b3753],
4	;	:	O	;	_	0	SENT_469	[p26l143t3696r300b3753],
5	63	CD	NUMBER	63	num	7	SENT_469	[p26l328t3696r414b3743],
6	:	:	O	:	_	0	SENT_469	[p26l328t3696r414b3743],
7	2898-2904	CD	DATE	2898-2904	dep	1	SENT_469	[p26l442t3696r778b3743],
8	.	.	O	.	_	0	SENT_469	[p26l442t3696r778b3743],

1	Fluorouracil	NNP	O	Fluorouracil	nn	3	SENT_470	[p27l10t3650r294b3695],
2	outcome	NN	O	outcome	nn	3	SENT_470	[p27l314t3655r524b3695],
3	parameters	NNS	O	parameter	_	0	SENT_470	[p27l543t3655r817b3709],
4	o	NN	O	o	nn	5	SENT_470	[p27l9t3722r43b3763],
5	Capitain	NNP	MISC	Capitain	dep	3	SENT_470	[p27l62t3722r230b3776],
6	et	FW	O	et	nn	7	SENT_470	[p27l251t3726r288b3763],
7	al	FW	O	al	dep	3	SENT_470	[p27l304t3721r340b3763],

1	Marcuello	NNP	O	Marcuello	nn	2	SENT_471	[p27l146t16r418b64],
2	E	NNP	O	E	nsubj	33	SENT_471	[p27l450t18r490b74],
3	,	,	O	,	_	0	SENT_471	[p27l450t18r490b74],
4	Altes	NNP	O	Altes	nn	5	SENT_471	[p27l520t16r652b64],
5	A	NNP	O	A	appos	2	SENT_471	[p27l679t18r731b74],
6	,	,	O	,	_	0	SENT_471	[p27l679t18r731b74],
7	Del	NNP	LOCATION	Del	nn	9	SENT_471	[p27l767t16r852b64],
8	Rio	NNP	LOCATION	Rio	nn	9	SENT_471	[p27l886t17r966b64],
9	E	NNP	LOCATION	E	appos	2	SENT_471	[p27l998t18r1038b74],
10	,	,	O	,	_	0	SENT_471	[p27l998t18r1038b74],
11	Cesar	NNP	PERSON	Cesar	nn	12	SENT_471	[p27l1072t17r1224b64],
12	A	NNP	O	A	appos	2	SENT_471	[p27l1248t18r1300b75],
13	,	,	O	,	_	0	SENT_471	[p27l1248t18r1300b75],
14	Menoyo	NNP	PERSON	Menoyo	nn	15	SENT_471	[p27l1336t18r1562b79],
15	A	NNP	O	A	appos	2	SENT_471	[p27l1589t18r1642b74],
16	,	,	O	,	_	0	SENT_471	[p27l1589t18r1642b74],
17	Baiget	NNP	O	Baiget	nn	21	SENT_471	[p27l1677t17r1849b79],
18	M.	NNP	O	M.	nn	21	SENT_471	[p27l1878t18r1946b64],
19	Single	JJ	O	single	amod	21	SENT_471	[p27l1979t16r2145b79],
20	nucleotide	NN	O	nucleotide	nn	21	SENT_471	[p27l145t91r435b140],
21	polymorphism	NN	O	polymorphism	appos	2	SENT_471	[p27l501t91r902b155],
22	in	IN	O	in	_	0	SENT_471	[p27l969t93r1014b139],
23	the	DT	O	the	det	28	SENT_471	[p27l1079t91r1167b140],
24	5	CD	NUMBER	5	num	28	SENT_471	[p27l1231t91r1278b140],
25	’	NN	O	’	nn	28	SENT_471	[p27l1231t91r1278b140],
26	tandem	JJ	O	tandem	amod	28	SENT_471	[p27l1343t91r1555b140],
27	repeat	NN	O	repeat	nn	28	SENT_471	[p27l1624t97r1798b155],
28	sequences	NNS	O	sequence	prep_in	21	SENT_471	[p27l1860t106r2145b155],
29	of	IN	O	of	_	0	SENT_471	[p27l143t167r197b216],
30	thymidylate	NN	O	thymidylate	nn	32	SENT_471	[p27l233t167r565b231],
31	synthase	NN	O	synthase	nn	32	SENT_471	[p27l605t167r842b231],
32	gene	NN	O	gene	prep_of	21	SENT_471	[p27l884t182r1020b231],
33	predicts	VBZ	O	predict	_	0	SENT_471	[p27l1062t167r1279b231],
34	for	IN	O	for	_	0	SENT_471	[p27l1316t167r1394b216],
35	response	NN	O	response	prep_for	33	SENT_471	[p27l1434t182r1676b231],
36	to	TO	O	to	_	0	SENT_471	[p27l1715t173r1770b216],
37	fluorouracilbased	JJ	O	fluorouracilbased	amod	38	SENT_471	[p27l1809t167r2144b216, p27l145t244r301b293],
38	chemotherapy	NN	O	chemotherapy	prep_to	33	SENT_471	[p27l347t244r754b308],
39	in	IN	O	in	_	0	SENT_471	[p27l798t245r842b292],
40	advanced	JJ	O	advanced	amod	43	SENT_471	[p27l889t244r1154b293],
41	colorectal	JJ	O	colorectal	amod	43	SENT_471	[p27l1200t244r1466b293],
42	cancer	NN	O	cancer	nn	43	SENT_471	[p27l1513t258r1696b293],
43	patients	NNS	O	patient	prep_in	38	SENT_471	[p27l1739t245r1972b308],
44	.	.	O	.	_	0	SENT_471	[p27l1739t245r1972b308],

1	Int	NN	O	int	_	0	SENT_472	[p27l2021t246r2093b293],
2	/	:	O	/	punct	1	SENT_472	[p27l2128t246r2149b304],
3	Cancer	NNP	O	Cancer	dep	1	SENT_472	[p27l146t320r333b367],
4	2004	CD	DATE	2004	dep	3	SENT_472	[p27l351t320r508b377],
5	;	:	O	;	_	0	SENT_472	[p27l351t320r508b377],
6	112	CD	NUMBER	112	dep	3	SENT_472	[p27l541t320r658b367],
7	:	:	O	:	_	0	SENT_472	[p27l541t320r658b367],
8	733-737	CD	NUMBER	733-737	dep	6	SENT_472	[p27l690t320r949b367],
9	.	.	O	.	_	0	SENT_472	[p27l690t320r949b367],

1	Lu	NNP	O	Lu	nn	2	SENT_473	[p27l146t397r203b443],
2	Z	NNP	O	Z	_	0	SENT_473	[p27l228t397r279b453],
3	,	,	O	,	_	0	SENT_473	[p27l228t397r279b453],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_473	[p27l304t394r482b458],
5	R	NNP	PERSON	R	appos	2	SENT_473	[p27l510t397r553b453],
6	,	,	O	,	_	0	SENT_473	[p27l510t397r553b453],
7	Diasio	NNP	O	Diasio	nn	8	SENT_473	[p27l582t396r745b443],
8	RB	NN	O	rb	appos	5	SENT_473	[p27l771t397r852b443],
9	.	.	O	.	_	0	SENT_473	[p27l771t397r852b443],

1	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	3	SENT_474	[p27l880t394r1403b458],
2	dehydrogenase	NN	O	dehydrogenase	nn	3	SENT_474	[p27l1427t394r1856b458],
3	activity	NN	O	activity	_	0	SENT_474	[p27l1878t396r2075b458],
4	in	IN	O	in	_	0	SENT_474	[p27l2099t396r2143b442],
5	human	JJ	O	human	amod	9	SENT_474	[p27l145t471r336b520],
6	peripheral	JJ	O	peripheral	amod	9	SENT_474	[p27l390t471r666b535],
7	blood	NN	O	blood	nn	9	SENT_474	[p27l720t471r875b520],
8	mononuclear	JJ	O	mononuclear	amod	9	SENT_474	[p27l929t471r1300b520],
9	cells	NNS	O	cell	prep_in	3	SENT_474	[p27l1346t471r1461b520],
10	and	CC	O	and	_	0	SENT_474	[p27l1510t471r1611b520],
11	liver	NN	O	liver	prep_in	3	SENT_474	[p27l1664t471r1789b520],
12	:	:	O	:	_	0	SENT_474	[p27l1664t471r1789b520],
13	population	NN	O	population	nn	14	SENT_474	[p27l1844t471r2143b535],
14	characteristics	NNS	O	characteristic	dep	3	SENT_474	[p27l143t547r531b595],
15	newly	RB	O	newly	advmod	16	SENT_474	[p27l563t547r725b610],
16	identified	VBN	O	identify	amod	18	SENT_474	[p27l754t547r1011b595],
17	deficient	JJ	O	deficient	amod	18	SENT_474	[p27l1043t547r1282b595],
18	patients	NNS	O	patient	dep	14	SENT_474	[p27l1311t548r1543b610],
19	,	,	O	,	_	0	SENT_474	[p27l1311t548r1543b610],
20	and	CC	O	and	_	0	SENT_474	[p27l1577t547r1677b595],
21	clinical	JJ	O	clinical	amod	22	SENT_474	[p27l1708t547r1893b595],
22	implication	NN	O	implication	conj_and	14	SENT_474	[p27l1926t547r2145b610, p27l142t624r247b671],
23	in	IN	O	in	_	0	SENT_474	[p27l276t624r321b671],
24	5	CD	NUMBER	5	prep_in	22	SENT_474	[p27l347t623r715b671],
25	—	NN	O	—	dep	22	SENT_474	[p27l347t623r715b671],
26	f	FW	O	f	nn	25	SENT_474	[p27l347t623r715b671],
27	|	FW	O	|	nn	25	SENT_474	[p27l347t623r715b671],
28	uorouraci	FW	O	uorouraci	nn	25	SENT_474	[p27l347t623r715b671],
29	|	FW	O	|	dep	25	SENT_474	[p27l347t623r715b671],
30	chemotherapy	NN	O	chemotherapy	dep	25	SENT_474	[p27l743t623r1163b687],
31	.	.	O	.	_	0	SENT_474	[p27l743t623r1163b687],

1	Cancer	NNP	O	Cancer	nn	2	SENT_475	[p27l1196t624r1382b671],
2	Res	NNP	O	Res	_	0	SENT_475	[p27l1402t625r1486b671],
3	1993	CD	DATE	1993	num	2	SENT_475	[p27l1512t624r1666b682],
4	;	:	O	;	_	0	SENT_475	[p27l1512t624r1666b682],
5	53	CD	NUMBER	53	num	7	SENT_475	[p27l1694t624r1778b671],
6	:	:	O	:	_	0	SENT_475	[p27l1694t624r1778b671],
7	5433-5438	CD	DURATION	5433-5438	dep	2	SENT_475	[p27l1806t624r2142b671],
8	.	.	O	.	_	0	SENT_475	[p27l1806t624r2142b671],

1	Etienne	NN	PERSON	etienne	_	0	SENT_476	[p27l146t700r347b747],
2	MC	NNP	PERSON	MC	dep	1	SENT_476	[p27l378t700r489b757],
3	,	,	O	,	_	0	SENT_476	[p27l378t700r489b757],
4	Lagrange	NNP	LOCATION	Lagrange	nn	6	SENT_476	[p27l522t701r777b762],
5	]	CD	NUMBER	]	num	6	SENT_476	[p27l804t701r864b758],
6	L	NN	O	l	appos	2	SENT_476	[p27l804t701r864b758],
7	,	,	O	,	_	0	SENT_476	[p27l804t701r864b758],
8	Dassonville	NNP	PERSON	Dassonville	nn	9	SENT_476	[p27l897t698r1202b747],
9	O	NNP	PERSON	O	appos	2	SENT_476	[p27l1230t700r1291b757],
10	,	,	O	,	_	0	SENT_476	[p27l1230t700r1291b757],
11	Fleming	NNP	PERSON	Fleming	nn	12	SENT_476	[p27l1325t698r1542b762],
12	R	NNP	PERSON	R	appos	2	SENT_476	[p27l1574t701r1617b757],
13	,	,	O	,	_	0	SENT_476	[p27l1574t701r1617b757],
14	Thyss	NNP	O	Thyss	nn	15	SENT_476	[p27l1646t698r1798b762],
15	A	NNP	O	A	appos	2	SENT_476	[p27l1823t701r1875b757],
16	,	,	O	,	_	0	SENT_476	[p27l1823t701r1875b757],
17	Renee	NNP	PERSON	Renee	nn	18	SENT_476	[p27l1909t701r2072b747],
18	N	NNP	PERSON	N	appos	2	SENT_476	[p27l2103t701r2142b746],
19	et	FW	O	et	nn	20	SENT_476	[p27l144t781r194b824],
20	al.	FW	O	al.	dep	18	SENT_476	[p27l221t775r278b824],
21	.	.	O	.	_	0	SENT_476	[p27l221t775r278b824],

1	Population	NNP	O	Population	nn	2	SENT_477	[p27l314t775r608b839],
2	study	NN	O	study	_	0	SENT_477	[p27l640t775r791b839],
3	of	IN	O	of	_	0	SENT_477	[p27l819t775r873b824],
4	dihydropyrimidine	NN	O	dihydropyrimidine	prep_of	2	SENT_477	[p27l900t775r1416b839],
5	in	IN	O	in	_	0	SENT_477	[p27l1449t776r1493b823],
6	cancer	NN	O	cancer	nn	7	SENT_477	[p27l1525t789r1708b824],
7	patients	NNS	O	patient	prep_in	2	SENT_477	[p27l1738t776r1970b839],
8	.	.	O	.	_	0	SENT_477	[p27l1738t776r1970b839],

1	/	:	O	/	punct	3	SENT_478	[p27l1999t777r2020b835],
2	Clin	NNP	O	Clin	nn	3	SENT_478	[p27l2050t775r2147b824],
3	Oncol	NNP	O	Oncol	_	0	SENT_478	[p27l146t850r302b898],
4	1994	CD	DATE	1994	dep	3	SENT_478	[p27l325t851r479b908],
5	;	:	O	;	_	0	SENT_478	[p27l325t851r479b908],
6	12	CD	NUMBER	12	dep	3	SENT_478	[p27l511t851r592b898],
7	:	:	O	:	_	0	SENT_478	[p27l511t851r592b898],
8	2248-2253	CD	DATE	2248-2253	dep	6	SENT_478	[p27l622t851r956b898],
9	.	.	O	.	_	0	SENT_478	[p27l622t851r956b898],

1	Keku	NN	ORGANIZATION	keku	nn	2	SENT_479	[p27l146t925r274b974],
2	T	NN	ORGANIZATION	t	dep	19	SENT_479	[p27l298t928r347b984],
3	,	,	O	,	_	0	SENT_479	[p27l298t928r347b984],
4	Millikan	NNP	ORGANIZATION	Millikan	nn	5	SENT_479	[p27l377t925r588b974],
5	R	NNP	ORGANIZATION	R	appos	2	SENT_479	[p27l618t928r661b984],
6	,	,	O	,	_	0	SENT_479	[p27l618t928r661b984],
7	Worley	NNP	PERSON	Worley	nn	8	SENT_479	[p27l686t925r883b989],
8	K	NNP	PERSON	K	appos	2	SENT_479	[p27l909t927r955b984],
9	,	,	O	,	_	0	SENT_479	[p27l909t927r955b984],
10	Winkel	NNP	PERSON	Winkel	nn	11	SENT_479	[p27l981t925r1166b974],
11	S	NNP	O	S	appos	2	SENT_479	[p27l1195t927r1237b984],
12	,	,	O	,	_	0	SENT_479	[p27l1195t927r1237b984],
13	Eaton	NNP	ORGANIZATION	Eaton	nn	14	SENT_479	[p27l1268t928r1418b974],
14	A	NNP	ORGANIZATION	A	appos	2	SENT_479	[p27l1443t928r1495b984],
15	,	,	O	,	_	0	SENT_479	[p27l1443t928r1495b984],
16	Biscocho	NNP	PERSON	Biscocho	nn	17	SENT_479	[p27l1526t925r1766b974],
17	L	NNP	O	L	appos	2	SENT_479	[p27l1794t928r1820b973],
18	et	FW	O	et	nn	19	SENT_479	[p27l1844t931r1893b974],
19	al.	FW	O	al.	_	0	SENT_479	[p27l1915t925r1972b974],
20	5,10	CD	NUMBER	5,10	num	23	SENT_479	[p27l2000t927r2145b984, p27l146t1002r892b1066],
21	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	23	SENT_479	[p27l2000t927r2145b984, p27l146t1002r892b1066],
22	reductase	NN	O	reductase	nn	23	SENT_479	[p27l916t1002r1181b1051],
23	codon	NN	O	codon	dep	19	SENT_479	[p27l1203t1002r1375b1051],
24	677	CD	NUMBER	677	num	27	SENT_479	[p27l1400t1004r1504b1051],
25	and	CC	O	and	_	0	SENT_479	[p27l1527t1002r1627b1051],
26	1298	CD	DATE	1298	num	27	SENT_479	[p27l1655t1003r1792b1051],
27	polymorphisms	NNS	O	polymorphism	dep	23	SENT_479	[p27l1818t1002r2144b1066, p27l144t1079r260b1125],
28	and	CC	O	and	_	0	SENT_479	[p27l308t1078r409b1125],
29	colon	NN	O	colon	nn	30	SENT_479	[p27l460t1078r609b1125],
30	cancer	NN	O	cancer	conj_and	23	SENT_479	[p27l660t1092r842b1125],
31	in	IN	O	in	_	0	SENT_479	[p27l890t1079r935b1125],
32	African	JJ	MISC	african	amod	33	SENT_479	[p27l983t1078r1173b1125],
33	Americans	NNPS	MISC	Americans	prep_in	30	SENT_479	[p27l1221t1079r1510b1125],
34	and	CC	O	and	_	0	SENT_479	[p27l1558t1078r1658b1125],
35	Whites	NNPS	O	Whites	prep_in	30	SENT_479	[p27l1707t1078r1911b1125],
36	.	.	O	.	_	0	SENT_479	[p27l1707t1078r1911b1125],

1	Cancer	NN	O	cancer	_	0	SENT_480	[p27l1966t1079r2152b1125],

1	Epidemiology	NNP	O	Epidemiology	_	0	SENT_481	[p27l145t1154r499b1218],
2	2002	CD	DATE	2002	num	1	SENT_481	[p27l519t1155r676b1213],
3	;	:	O	;	_	0	SENT_481	[p27l519t1155r676b1213],
4	11	CD	NUMBER	11	num	6	SENT_481	[p27l709t1155r789b1202],
5	:	:	O	:	_	0	SENT_481	[p27l709t1155r789b1202],
6	1611-1621	CD	DATE	1611-1621	dep	1	SENT_481	[p27l821t1155r1154b1202],
7	.	.	O	.	_	0	SENT_481	[p27l821t1155r1154b1202],

1	Sohn	NNP	PERSON	Sohn	nn	3	SENT_482	[p27l144t1228r280b1276],
2	K	NNP	O	K	nn	3	SENT_482	[p27l333t1230r396b1287],
3	]	NNP	O	]	_	0	SENT_482	[p27l333t1230r396b1287],
4	,	,	O	,	_	0	SENT_482	[p27l333t1230r396b1287],
5	Croxford	NNP	O	Croxford	nn	6	SENT_482	[p27l446t1228r690b1276],
6	R	NNP	O	R	appos	3	SENT_482	[p27l742t1231r785b1286],
7	,	,	O	,	_	0	SENT_482	[p27l742t1231r785b1286],
8	Yates	NNP	ORGANIZATION	Yates	nn	9	SENT_482	[p27l833t1230r977b1276],
9	Z	NNP	ORGANIZATION	Z	appos	3	SENT_482	[p27l1024t1231r1074b1286],
10	,	,	O	,	_	0	SENT_482	[p27l1024t1231r1074b1286],
11	Lucock	NNP	O	Lucock	nn	12	SENT_482	[p27l1127t1228r1317b1276],
12	M	NNP	O	M	appos	3	SENT_482	[p27l1365t1231r1432b1286],
13	,	,	O	,	_	0	SENT_482	[p27l1365t1231r1432b1286],
14	Kimi	NNP	PERSON	Kimi	nn	15	SENT_482	[p27l1485t1230r1603b1276],
15	Yl	NNP	PERSON	Yl	appos	3	SENT_482	[p27l1649t1230r1713b1276],
16	.	.	O	.	_	0	SENT_482	[p27l1649t1230r1713b1276],

1	Effect	NN	O	effect	_	0	SENT_483	[p27l1766t1228r1915b1276],
2	of	IN	O	of	_	0	SENT_483	[p27l1960t1228r2014b1276],
3	the	DT	O	the	det	5	SENT_483	[p27l2057t1228r2145b1276],
4	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	5	SENT_483	[p27l145t1305r890b1369],
5	reductase	NN	O	reductase	prep_of	1	SENT_483	[p27l916t1305r1180b1354],
6	C67	NN	O	c67	dep	1	SENT_483	[p27l1204t1306r1316b1354],
7	7T	NN	O	7t	nn	8	SENT_483	[p27l1324t1307r1390b1353],
8	polymorphism	NN	O	polymorphism	dep	6	SENT_483	[p27l1414t1305r1815b1369],
9	on	IN	O	on	prep	8	SENT_483	[p27l1841t1319r1908b1354],
10	chemosensitivity	NN	O	chemosensitivity	dep	16	SENT_483	[p27l1934t1305r2145b1354, p27l142t1382r411b1444],
11	of	IN	O	of	_	0	SENT_483	[p27l460t1381r513b1429],
12	colon	NN	O	colon	prep_of	10	SENT_483	[p27l559t1381r709b1429],
13	and	CC	O	and	_	0	SENT_483	[p27l760t1381r861b1429],
14	breast	NN	O	breast	prep_of	10	SENT_483	[p27l914t1381r1080b1429],
15	cancer	NN	O	cancer	nn	16	SENT_483	[p27l1127t1395r1310b1429],
16	cells	NNS	O	cell	dep	9	SENT_483	[p27l1357t1381r1471b1429],
17	to	TO	O	to	_	0	SENT_483	[p27l1519t1386r1574b1429],
18	5-fluorouracil	NN	O	5-fluorouracil	prep_to	16	SENT_483	[p27l1623t1381r1991b1429],
19	and	CC	O	and	_	0	SENT_483	[p27l2043t1381r2143b1429],
20	methotrexate	NN	O	methotrexate	prep_to	16	SENT_483	[p27l145t1455r535b1503],
21	.	.	O	.	_	0	SENT_483	[p27l145t1455r535b1503],
22	]	SYM	O	]	dep	8	SENT_483	[p27l560t1458r581b1514],

1	Natl	NNP	O	Natl	nn	3	SENT_484	[p27l605t1455r722b1503],
2	Cancer	NNP	O	Cancer	nn	3	SENT_484	[p27l746t1457r932b1503],
3	Inst	NNP	O	Inst	_	0	SENT_484	[p27l953t1458r1049b1503],
4	2004	CD	DATE	2004	num	3	SENT_484	[p27l1070t1457r1227b1513],
5	;	:	O	;	_	0	SENT_484	[p27l1070t1457r1227b1513],
6	96	CD	NUMBER	96	num	8	SENT_484	[p27l1256t1457r1341b1503],
7	:	:	O	:	_	0	SENT_484	[p27l1256t1457r1341b1503],
8	134-144	CD	NUMBER	134-144	dep	3	SENT_484	[p27l1373t1457r1632b1503],
9	.	.	O	.	_	0	SENT_484	[p27l1373t1457r1632b1503],

1	Cohen	NNP	PERSON	Cohen	nn	2	SENT_485	[p27l143t1532r324b1581],
2	V	NNP	O	V	_	0	SENT_485	[p27l366t1534r417b1591],
3	,	,	O	,	_	0	SENT_485	[p27l366t1534r417b1591],
4	Panet-Raymond	NNP	PERSON	Panet-Raymond	nn	5	SENT_485	[p27l466t1532r905b1596],
5	V	NNP	O	V	appos	2	SENT_485	[p27l947t1534r998b1591],
6	,	,	O	,	_	0	SENT_485	[p27l947t1534r998b1591],
7	Sabbaghian	NNP	O	Sabbaghian	nn	8	SENT_485	[p27l1045t1532r1370b1596],
8	N	NNP	O	N	appos	2	SENT_485	[p27l1417t1534r1457b1580],
9	et	FW	O	et	nn	10	SENT_485	[p27l1504t1538r1554b1581],
10	al.	FW	O	al.	dep	8	SENT_485	[p27l1593t1532r1651b1581],
11	.	.	O	.	_	0	SENT_485	[p27l1593t1532r1651b1581],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	3	SENT_486	[p27l1700t1532r2144b1596, p27l145t1608r460b1672],
2	reductase	NN	O	reductase	nn	3	SENT_486	[p27l492t1608r756b1657],
3	polymorphism	NN	O	polymorphism	_	0	SENT_486	[p27l787t1608r1188b1672],
4	in	IN	O	in	_	0	SENT_486	[p27l1221t1609r1265b1656],
5	advanced	JJ	O	advanced	amod	7	SENT_486	[p27l1296t1608r1561b1657],
6	colorectal	JJ	O	colorectal	amod	7	SENT_486	[p27l1592t1608r1858b1657],
7	cancer	NN	O	cancer	prep_in	3	SENT_486	[p27l1890t1622r2086b1657],
8	:	:	O	:	_	0	SENT_486	[p27l1890t1622r2086b1657],
9	a	DT	O	a	det	12	SENT_486	[p27l2118t1622r2144b1657],
10	novel	JJ	O	novel	amod	12	SENT_486	[p27l145t1684r289b1732],
11	genomic	JJ	O	genomic	amod	12	SENT_486	[p27l316t1685r560b1747],
12	predictor	NN	O	predictor	dep	3	SENT_486	[p27l586t1684r839b1748],
13	of	IN	O	of	_	0	SENT_486	[p27l861t1684r915b1732],
14	clinical	JJ	O	clinical	amod	15	SENT_486	[p27l936t1684r1121b1732],
15	response	NN	O	response	prep_of	12	SENT_486	[p27l1150t1698r1391b1748],
16	to	TO	O	to	_	0	SENT_486	[p27l1415t1690r1470b1732],
17	fluoropyrimidine-based	JJ	O	fluoropyrimidine-based	amod	18	SENT_486	[p27l1493t1684r2143b1748],
18	chemotherapy	NN	O	chemotherapy	prep_to	15	SENT_486	[p27l143t1759r563b1823],
19	.	.	O	.	_	0	SENT_486	[p27l143t1759r563b1823],

1	Clin	NNP	O	Clin	nn	3	SENT_487	[p27l596t1759r694b1808],
2	Cancer	NNP	O	Cancer	nn	3	SENT_487	[p27l721t1761r907b1808],
3	Res	NNP	O	Res	_	0	SENT_487	[p27l928t1762r1012b1808],
4	2003	CD	DATE	2003	num	3	SENT_487	[p27l1036t1761r1193b1818],
5	;	:	O	;	_	0	SENT_487	[p27l1036t1761r1193b1818],
6	9	CD	NUMBER	9	num	8	SENT_487	[p27l1221t1761r1270b1808],
7	:	:	O	:	_	0	SENT_487	[p27l1221t1761r1270b1808],
8	1611-1615	CD	DATE	1611-1615	dep	3	SENT_487	[p27l1301t1761r1634b1808],
9	.	.	O	.	_	0	SENT_487	[p27l1301t1761r1634b1808],

1	Etienne	NN	PERSON	etienne	_	0	SENT_488	[p27l146t1837r347b1885],
2	MC	NNP	PERSON	MC	dep	1	SENT_488	[p27l372t1837r484b1895],
3	,	,	O	,	_	0	SENT_488	[p27l372t1837r484b1895],
4	Formento	NNP	O	Formento	nn	5	SENT_488	[p27l511t1838r778b1885],
5	JL	NNP	O	JL	appos	2	SENT_488	[p27l799t1838r860b1896],
6	,	,	O	,	_	0	SENT_488	[p27l799t1838r860b1896],
7	Chazal	NNP	O	Chazal	nn	8	SENT_488	[p27l886t1836r1067b1885],
8	M	NN	O	m	appos	2	SENT_488	[p27l1094t1838r1161b1895],
9	,	,	O	,	_	0	SENT_488	[p27l1094t1838r1161b1895],
10	Francoual	JJ	O	francoual	amod	11	SENT_488	[p27l1190t1836r1452b1885],
11	M	NN	O	m	appos	2	SENT_488	[p27l1480t1838r1547b1895],
12	,	,	O	,	_	0	SENT_488	[p27l1480t1838r1547b1895],
13	Magne	NNP	PERSON	Magne	nn	14	SENT_488	[p27l1576t1838r1767b1900],
14	N	NNP	PERSON	N	appos	2	SENT_488	[p27l1792t1838r1850b1895],
15	,	,	O	,	_	0	SENT_488	[p27l1792t1838r1850b1895],
16	Formento	NNP	O	Formento	nn	17	SENT_488	[p27l1878t1838r2145b1885],
17	P	NN	O	p	appos	2	SENT_488	[p27l146t1914r173b1960],
18	et	FW	O	et	nn	19	SENT_488	[p27l200t1917r249b1960],
19	al.	FW	O	al.	dep	17	SENT_488	[p27l272t1912r329b1960],
20	.	.	O	.	_	0	SENT_488	[p27l272t1912r329b1960],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	4	SENT_489	[p27l361t1912r1107b1975],
2	reductase	NN	O	reductase	nn	4	SENT_489	[p27l1136t1912r1399b1960],
3	gene	NN	O	gene	nn	4	SENT_489	[p27l1425t1926r1561b1975],
4	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_489	[p27l1589t1912r2017b1975],
5	and	CC	O	and	_	0	SENT_489	[p27l2043t1912r2143b1960],
6	response	NN	O	response	nsubj	12	SENT_489	[p27l145t2002r386b2051],
7	to	TO	O	to	dep	6	SENT_489	[p27l409t1993r464b2036],
8	f	FW	O	f	nn	11	SENT_489	[p27l485t1987r985b2036],
9	|	FW	O	|	nn	11	SENT_489	[p27l485t1987r985b2036],
10	uorouracil	NN	O	uorouracil	nn	11	SENT_489	[p27l485t1987r985b2036],
11	—	NN	O	—	dep	6	SENT_489	[p27l485t1987r985b2036],
12	based	VBN	O	base	_	0	SENT_489	[p27l485t1987r985b2036],
13	treatment	NN	O	treatment	dobj	12	SENT_489	[p27l1010t1993r1288b2036],
14	in	IN	O	in	_	0	SENT_489	[p27l1311t1989r1356b2035],
15	advanced	JJ	O	advanced	amod	18	SENT_489	[p27l1381t1987r1646b2036],
16	colorectal	JJ	O	colorectal	amod	18	SENT_489	[p27l1672t1987r1939b2036],
17	cancer	NN	O	cancer	nn	18	SENT_489	[p27l1965t2002r2148b2036],
18	patients	NNS	O	patient	prep_in	13	SENT_489	[p27l145t2065r377b2127],
19	.	.	O	.	_	0	SENT_489	[p27l145t2065r377b2127],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_490	[p27l409t2063r893b2127],
2	2004	CD	DATE	2004	num	1	SENT_490	[p27l916t2065r1073b2122],
3	;	:	O	;	_	0	SENT_490	[p27l916t2065r1073b2122],
4	14	CD	NUMBER	14	num	6	SENT_490	[p27l1106t2065r1186b2112],
5	:	:	O	:	_	0	SENT_490	[p27l1106t2065r1186b2112],
6	1-8	CD	NUMBER	1-8	dep	1	SENT_490	[p27l1218t2065r1331b2112],
7	.	.	O	.	_	0	SENT_490	[p27l1218t2065r1331b2112],

1	Jakobsen	NNP	PERSON	Jakobsen	nn	2	SENT_491	[p27l141t2140r385b2200],
2	A	NNP	O	A	_	0	SENT_491	[p27l428t2142r481b2199],
3	,	,	O	,	_	0	SENT_491	[p27l428t2142r481b2199],
4	Nielsen	NNP	ORGANIZATION	Nielsen	nn	5	SENT_491	[p27l531t2140r729b2189],
5	JN	NN	ORGANIZATION	jn	appos	2	SENT_491	[p27l773t2142r852b2200],
6	,	,	O	,	_	0	SENT_491	[p27l773t2142r852b2200],
7	Gyldenkerne	NN	O	gyldenkerne	nn	8	SENT_491	[p27l899t2140r1252b2204],
8	N	NN	O	n	appos	2	SENT_491	[p27l1298t2142r1356b2199],
9	,	,	O	,	_	0	SENT_491	[p27l1298t2142r1356b2199],
10	Lindeberg	NNP	PERSON	Lindeberg	nn	13	SENT_491	[p27l1406t2140r1680b2204],
11	J.	NNP	O	J.	nn	13	SENT_491	[p27l1725t2142r1754b2200],
12	Thymidylate	NNP	O	Thymidylate	nn	13	SENT_491	[p27l1799t2140r2145b2204],
13	synthase	NN	O	synthase	appos	8	SENT_491	[p27l142t2216r380b2280],
14	and	CC	O	and	_	0	SENT_491	[p27l402t2216r502b2264],
15	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	nn	16	SENT_491	[p27l528t2216r1273b2280],
16	reductase	NN	O	reductase	appos	8	SENT_491	[p27l1297t2216r1561b2264],
17	gene	NN	O	gene	nn	18	SENT_491	[p27l1583t2230r1718b2279],
18	polymorphism	NN	O	polymorphism	dep	2	SENT_491	[p27l1742t2216r2142b2280],
19	in	IN	O	in	_	0	SENT_491	[p27l144t2293r189b2339],
20	normal	JJ	O	normal	amod	21	SENT_491	[p27l229t2291r420b2340],
21	tissue	NN	O	tissue	prep_in	18	SENT_491	[p27l458t2293r611b2340],
22	as	IN	O	as	_	0	SENT_491	[p27l647t2306r699b2340],
23	predictors	NNS	O	predictor	prep_as	21	SENT_491	[p27l737t2291r1013b2355],
24	of	IN	O	of	_	0	SENT_491	[p27l1048t2291r1102b2340],
25	fluorouracil	NN	O	fluorouracil	nn	26	SENT_491	[p27l1133t2291r1446b2340],
26	sensitivity	NN	O	sensitivity	prep_of	23	SENT_491	[p27l1484t2293r1768b2355],
27	.	.	O	.	_	0	SENT_491	[p27l1484t2293r1768b2355],

1	/	:	O	/	punct	3	SENT_492	[p27l1803t2294r1824b2351],
2	Clin	NNP	O	Clin	nn	3	SENT_492	[p27l1860t2291r1957b2340],
3	Oncol	NNP	O	Oncol	_	0	SENT_492	[p27l1995t2291r2150b2340],
4	2005	CD	DATE	2005	dep	3	SENT_492	[p27l143t2368r300b2425],
5	;	:	O	;	_	0	SENT_492	[p27l143t2368r300b2425],
6	23	CD	NUMBER	23	dep	3	SENT_492	[p27l330t2368r414b2415],
7	:	:	O	:	_	0	SENT_492	[p27l330t2368r414b2415],
8	1365-1369	CD	DATE	1365-1369	dep	6	SENT_492	[p27l445t2368r778b2415],
9	.	.	O	.	_	0	SENT_492	[p27l445t2368r778b2415],

1	Lu	NNP	PERSON	Lu	nn	2	SENT_493	[p27l146t2445r203b2491],
2	JW	NNP	PERSON	JW	_	0	SENT_493	[p27l241t2444r330b2502],
3	,	,	O	,	_	0	SENT_493	[p27l241t2444r330b2502],
4	Gao	NNP	O	Gao	nn	5	SENT_493	[p27l371t2444r481b2491],
5	CM	NN	O	cm	appos	2	SENT_493	[p27l519t2444r632b2501],
6	,	,	O	,	_	0	SENT_493	[p27l519t2444r632b2501],
7	Wu	NNP	LOCATION	Wu	nn	8	SENT_493	[p27l670t2444r761b2491],
8	JZ	NNP	LOCATION	JZ	appos	5	SENT_493	[p27l799t2445r868b2502],
9	,	,	O	,	_	0	SENT_493	[p27l799t2445r868b2502],
10	Sun	NNP	LOCATION	Sun	nn	11	SENT_493	[p27l910t2444r1008b2491],
11	XF	NNP	LOCATION	XF	appos	5	SENT_493	[p27l1047t2444r1130b2502],
12	,	,	O	,	_	0	SENT_493	[p27l1047t2444r1130b2502],
13	Wang	NNP	PERSON	Wang	nn	14	SENT_493	[p27l1168t2444r1330b2506],
14	L	NNP	PERSON	L	appos	5	SENT_493	[p27l1372t2445r1410b2501],
15	,	,	O	,	_	0	SENT_493	[p27l1372t2445r1410b2501],
16	Feng	NNP	O	Feng	nn	17	SENT_493	[p27l1454t2445r1583b2506],
17	JF	NNP	O	JF	appos	5	SENT_493	[p27l1621t2445r1681b2503],
18	.	.	O	.	_	0	SENT_493	[p27l1621t2445r1681b2503],

1	Relationship	NN	O	relationship	dep	12	SENT_494	[p27l1723t2443r2057b2506],
2	of	IN	O	of	_	0	SENT_494	[p27l2094t2443r2148b2491],
3	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	6	SENT_494	[p27l145t2519r890b2583],
4	reductase	NN	O	reductase	nn	6	SENT_494	[p27l966t2519r1231b2568],
5	C677T	NN	O	c677t	nn	6	SENT_494	[p27l1305t2521r1491b2568],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_494	[p27l1565t2519r1966b2583],
7	and	CC	O	and	_	0	SENT_494	[p27l2042t2519r2143b2568],
8	chemosensitivity	NN	O	chemosensitivity	conj_and	1	SENT_494	[p27l143t2594r605b2658],
9	to	TO	O	to	_	0	SENT_494	[p27l627t2600r681b2643],
10	5	CD	NUMBER	5	num	11	SENT_494	[p27l704t2594r1072b2643],
11	—	CD	NUMBER	—	prep_to	8	SENT_494	[p27l704t2594r1072b2643],
12	f	FW	O	f	_	0	SENT_494	[p27l704t2594r1072b2643],
13	|	FW	O	|	nn	15	SENT_494	[p27l704t2594r1072b2643],
14	uorouraci	FW	O	uorouraci	nn	15	SENT_494	[p27l704t2594r1072b2643],
15	|	NN	O	|	dep	12	SENT_494	[p27l704t2594r1072b2643],
16	in	IN	O	in	_	0	SENT_494	[p27l1099t2596r1144b2642],
17	gastric	JJ	O	gastric	amod	18	SENT_494	[p27l1168t2596r1349b2658],
18	carcinoma	NN	O	carcinoma	prep_in	15	SENT_494	[p27l1371t2596r1675b2643],
19	.	.	O	.	_	0	SENT_494	[p27l1371t2596r1675b2643],

1	Chinese	JJ	LOCATION	chinese	_	0	SENT_495	[p27l1705t2594r1908b2643],
2	/	:	O	/	punct	3	SENT_495	[p27l1923t2597r1944b2654],
3	Cancer	NN	O	cancer	dep	1	SENT_495	[p27l1966t2596r2152b2643],
4	2004	CD	DATE	2004	num	3	SENT_495	[p27l143t2671r300b2728],
5	;	:	O	;	_	0	SENT_495	[p27l143t2671r300b2728],
6	23	CD	NUMBER	23	num	8	SENT_495	[p27l330t2671r414b2718],
7	:	:	O	:	_	0	SENT_495	[p27l330t2671r414b2718],
8	958-962	CD	NUMBER	958-962	dep	3	SENT_495	[p27l442t2671r705b2718],
9	.	.	O	.	_	0	SENT_495	[p27l442t2671r705b2718],

1	Marcuello	NNP	O	Marcuello	nn	2	SENT_496	[p27l146t2746r418b2794],
2	E	NNP	O	E	_	0	SENT_496	[p27l460t2748r500b2804],
3	,	,	O	,	_	0	SENT_496	[p27l460t2748r500b2804],
4	Altes	NNP	O	Altes	nn	5	SENT_496	[p27l541t2746r672b2794],
5	A	NNP	O	A	appos	2	SENT_496	[p27l709t2748r762b2804],
6	,	,	O	,	_	0	SENT_496	[p27l709t2748r762b2804],
7	Menoyo	NNP	PERSON	Menoyo	nn	8	SENT_496	[p27l807t2748r1034b2809],
8	A	NNP	O	A	appos	2	SENT_496	[p27l1071t2748r1123b2804],
9	,	,	O	,	_	0	SENT_496	[p27l1071t2748r1123b2804],
10	Del	NNP	PERSON	Del	nn	12	SENT_496	[p27l1169t2746r1254b2794],
11	Rio	NNP	PERSON	Rio	nn	12	SENT_496	[p27l1299t2747r1379b2794],
12	E	NNP	PERSON	E	appos	2	SENT_496	[p27l1421t2748r1461b2804],
13	,	,	O	,	_	0	SENT_496	[p27l1421t2748r1461b2804],
14	Baiget	NNP	PERSON	Baiget	nn	16	SENT_496	[p27l1507t2747r1678b2809],
15	M.	NNP	PERSON	M.	nn	16	SENT_496	[p27l1718t2748r1785b2794],
16	Methylenetetrahydrofolate	NNP	PERSON	Methylenetetrahydrofolate	appos	2	SENT_496	[p27l1830t2746r2145b2809, p27l142t2822r590b2886],
17	reductase	NN	O	reductase	nn	19	SENT_496	[p27l616t2822r879b2871],
18	gene	NN	O	gene	nn	19	SENT_496	[p27l902t2837r1038b2886],
19	polymorphisms	NNS	O	polymorphism	dep	16	SENT_496	[p27l1062t2822r1505b2886],
20	:	:	O	:	_	0	SENT_496	[p27l1062t2822r1505b2886],
21	genomic	JJ	O	genomic	amod	22	SENT_496	[p27l1530t2824r1774b2886],
22	predictors	NNS	O	predictor	dep	2	SENT_496	[p27l1797t2822r2073b2886],
23	of	IN	O	of	_	0	SENT_496	[p27l2094t2822r2148b2871],
24	clinical	JJ	O	clinical	amod	25	SENT_496	[p27l143t2898r328b2947],
25	response	NN	O	response	prep_of	22	SENT_496	[p27l382t2912r623b2962],
26	to	TO	O	to	_	0	SENT_496	[p27l673t2904r727b2947],
27	fluoropyrimidine-based	JJ	O	fluoropyrimidine-based	amod	28	SENT_496	[p27l775t2898r1425b2962],
28	chemotherapy	NN	O	chemotherapy	prep_to	22	SENT_496	[p27l1478t2898r1912b2962],
29	?	.	O	?	_	0	SENT_496	[p27l1478t2898r1912b2962],

1	Cancer	NNP	O	Cancer	nn	3	SENT_497	[p27l1966t2899r2152b2947],
2	Chemother	NNP	O	Chemother	nn	3	SENT_497	[p27l146t2973r442b3020],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_497	[p27l463t2973r748b3020],
4	2006	CD	DATE	2006	num	3	SENT_497	[p27l769t2974r926b3030],
5	;	:	O	;	_	0	SENT_497	[p27l769t2974r926b3030],
6	57	CD	NUMBER	57	num	8	SENT_497	[p27l955t2975r1039b3020],
7	:	:	O	:	_	0	SENT_497	[p27l955t2975r1039b3020],
8	835-840	CD	NUMBER	835-840	dep	3	SENT_497	[p27l1069t2974r1331b3020],
9	.	.	O	.	_	0	SENT_497	[p27l1069t2974r1331b3020],

1	Gamelin	NNP	O	Gamelin	nn	2	SENT_498	[p27l143t3049r373b3097],
2	E	NNP	O	E	_	0	SENT_498	[p27l408t3051r448b3108],
3	,	,	O	,	_	0	SENT_498	[p27l408t3051r448b3108],
4	Boisdron	NNP	PERSON	Boisdron	appos	2	SENT_498	[p27l484t3049r884b3097],
5	.	.	O	.	_	0	SENT_498	[p27l484t3049r884b3097],

1	—	NN	O	—	_	0	SENT_499	[p27l484t3049r884b3097],
2	.	.	O	.	_	0	SENT_499	[p27l484t3049r884b3097],

1	Ce	NN	O	ce	_	0	SENT_500	[p27l484t3049r884b3097],
2	|	CD	NUMBER	|	num	3	SENT_500	[p27l484t3049r884b3097],
3	|	NN	O	|	dep	1	SENT_500	[p27l484t3049r884b3097],
4	e	SYM	O	e	dep	5	SENT_500	[p27l484t3049r884b3097],
5	M	NN	O	m	dep	17	SENT_500	[p27l918t3051r985b3108],
6	,	,	O	,	_	0	SENT_500	[p27l918t3051r985b3108],
7	Cuuerin-Meyer	NNP	O	Cuuerin-Meyer	nn	8	SENT_500	[p27l1018t3050r1407b3113],
8	V	NNP	O	V	appos	5	SENT_500	[p27l1432t3051r1483b3108],
9	,	,	O	,	_	0	SENT_500	[p27l1432t3051r1483b3108],
10	Delva	NNP	PERSON	Delva	nn	11	SENT_500	[p27l1520t3049r1669b3097],
11	R	NNP	PERSON	R	appos	5	SENT_500	[p27l1703t3051r1746b3108],
12	,	,	O	,	_	0	SENT_500	[p27l1703t3051r1746b3108],
13	Lortholary	NNP	O	Lortholary	nn	14	SENT_500	[p27l1783t3049r2063b3113],
14	A	NNP	O	A	appos	5	SENT_500	[p27l2089t3051r2142b3108],
15	,	,	O	,	_	0	SENT_500	[p27l2089t3051r2142b3108],
16	Genevieve	NNP	PERSON	Genevieve	appos	5	SENT_500	[p27l143t3126r431b3173],
17	F	NN	O	f	dep	1	SENT_500	[p27l458t3127r481b3172],
18	et	FW	O	et	nn	19	SENT_500	[p27l507t3130r556b3173],
19	al.	FW	O	al.	dep	17	SENT_500	[p27l578t3124r635b3173],
20	.	.	O	.	_	0	SENT_500	[p27l578t3124r635b3173],

1	Correlation	NN	O	correlation	_	0	SENT_501	[p27l664t3124r971b3173],
2	between	IN	O	between	_	0	SENT_501	[p27l1000t3124r1236b3173],
3	uracil	NN	O	uracil	prep_between	1	SENT_501	[p27l1264t3124r1407b3173],
4	and	CC	O	and	_	0	SENT_501	[p27l1433t3124r1534b3173],
5	dihydrouracil	NN	O	dihydrouracil	nn	7	SENT_501	[p27l1560t3124r1924b3188],
6	plasma	NN	O	plasma	nn	7	SENT_501	[p27l1953t3124r2144b3188],
7	ratio	NN	O	ratio	prep_between	1	SENT_501	[p27l145t3202r281b3260],
8	,	,	O	,	_	0	SENT_501	[p27l145t3202r281b3260],
9	fluorouracil	NN	O	fluorouracil	nn	11	SENT_501	[p27l307t3201r620b3250],
10	(	CD	NUMBER	(	num	11	SENT_501	[p27l648t3201r820b3262],
11	5-FU	NN	O	5-fu	prep_between	1	SENT_501	[p27l648t3201r820b3262],
12	)	CD	NUMBER	)	num	14	SENT_501	[p27l648t3201r820b3262],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_501	[p27l847t3201r1311b3265],
14	parameters	NNS	O	parameter	dep	11	SENT_501	[p27l1337t3207r1660b3265],
15	,	,	O	,	_	0	SENT_501	[p27l1337t3207r1660b3265],
16	and	CC	O	and	_	0	SENT_501	[p27l1688t3201r1789b3250],
17	tolerance	NN	O	tolerance	conj_and	3	SENT_501	[p27l1815t3201r2072b3250],
18	in	IN	O	in	_	0	SENT_501	[p27l2099t3202r2143b3249],
19	patients	NNS	O	patient	prep_in	17	SENT_501	[p27l145t3278r362b3340],
20	with	IN	O	with	_	0	SENT_501	[p27l402t3277r522b3325],
21	advanced	JJ	O	advanced	amod	23	SENT_501	[p27l567t3277r832b3325],
22	colorectal	JJ	O	colorectal	amod	23	SENT_501	[p27l876t3277r1143b3325],
23	cancer	NN	O	cancer	prep_with	19	SENT_501	[p27l1188t3291r1371b3325],
24	:	:	O	:	_	0	SENT_501	[p27l1413t3293r1422b3325],
25	a	DT	O	a	det	27	SENT_501	[p27l1467t3291r1494b3325],
26	potential	JJ	O	potential	amod	27	SENT_501	[p27l1539t3277r1781b3340],
27	interest	NN	O	interest	dep	1	SENT_501	[p27l1828t3278r2032b3325],
28	for	IN	O	for	_	0	SENT_501	[p27l2070t3277r2148b3325],
29	predicting	VBG	O	predict	prepc_for	27	SENT_501	[p27l145t3352r424b3416],
30	5-FU	NN	O	5-fu	nn	31	SENT_501	[p27l458t3355r583b3401],
31	toxicity	NN	O	toxicity	dobj	29	SENT_501	[p27l615t3354r819b3416],
32	and	CC	O	and	_	0	SENT_501	[p27l849t3352r949b3401],
33	determining	VBG	O	determine	prepc_for	27	SENT_501	[p27l982t3352r1323b3416],
34	optimal	JJ	O	optimal	amod	36	SENT_501	[p27l1356t3352r1565b3416],
35	5-FU	NN	O	5-fu	nn	36	SENT_501	[p27l1598t3355r1724b3401],
36	dosage	NN	O	dosage	dobj	33	SENT_501	[p27l1756t3352r1969b3416],
37	.	.	O	.	_	0	SENT_501	[p27l1756t3352r1969b3416],

1	/	:	O	/	punct	2	SENT_502	[p27l1998t3355r2019b3412],
2	Clin	NN	O	clin	_	0	SENT_502	[p27l2050t3352r2147b3401],
3	Oncol1999	NN	O	oncol1999	dep	2	SENT_502	[p27l146t3428r479b3485],
4	;	:	O	;	_	0	SENT_502	[p27l146t3428r479b3485],
5	17	CD	NUMBER	17	dep	2	SENT_502	[p27l511t3429r592b3476],
6	:	:	O	:	_	0	SENT_502	[p27l511t3429r592b3476],
7	1105-1110	CD	DATE	1105-1110	dep	5	SENT_502	[p27l624t3429r956b3476],
8	.	.	O	.	_	0	SENT_502	[p27l624t3429r956b3476],

1	de	IN	O	de	dep	6	SENT_503	[p28l146t219r212b267],
2	Gramont	NNP	O	Gramont	nn	3	SENT_503	[p28l232t221r480b267],
3	A	NNP	O	A	pobj	1	SENT_503	[p28l495t222r547b277],
4	,	,	O	,	_	0	SENT_503	[p28l495t222r547b277],
5	Figer	NNP	PERSON	Figer	nn	6	SENT_503	[p28l573t221r704b282],
6	A	NNP	O	A	_	0	SENT_503	[p28l719t222r771b277],
7	,	,	O	,	_	0	SENT_503	[p28l719t222r771b277],
8	Seymour	NNP	PERSON	Seymour	nn	9	SENT_503	[p28l795t221r1039b282],
9	M	NNP	PERSON	M	appos	6	SENT_503	[p28l1058t222r1125b277],
10	,	,	O	,	_	0	SENT_503	[p28l1058t222r1125b277],
11	Homerin	NNP	O	Homerin	nn	12	SENT_503	[p28l1150t221r1384b267],
12	M	NNP	O	M	appos	6	SENT_503	[p28l1408t222r1475b277],
13	,	,	O	,	_	0	SENT_503	[p28l1408t222r1475b277],
14	Hmissi	NNP	O	Hmissi	nn	15	SENT_503	[p28l1501t221r1671b267],
15	A	NNP	O	A	appos	6	SENT_503	[p28l1690t222r1742b277],
16	,	,	O	,	_	0	SENT_503	[p28l1690t222r1742b277],
17	Cassidy	NNP	PERSON	Cassidy	nn	18	SENT_503	[p28l1766t219r1997b282],
18	]	NNP	O	]	appos	6	SENT_503	[p28l1766t219r1997b282],
19	et	FW	O	et	nn	20	SENT_503	[p28l2021t225r2070b267],
20	al.	FW	O	al.	dep	18	SENT_503	[p28l2086t219r2143b267],
21	.	.	O	.	_	0	SENT_503	[p28l2086t219r2143b267],

1	Leucovorin	NNP	O	Leucovorin	_	0	SENT_504	[p28l149t296r444b343],
2	and	CC	O	and	_	0	SENT_504	[p28l470t295r569b343],
3	fluorouracil	NN	O	fluorouracil	conj_and	1	SENT_504	[p28l593t295r900b343],
4	with	IN	O	with	dep	1	SENT_504	[p28l924t295r1042b343],
5	or	CC	O	or	_	0	SENT_504	[p28l1068t309r1125b343],
6	without	IN	O	without	dep	1	SENT_504	[p28l1145t295r1360b343],
7	oxaliplatin	NN	O	oxaliplatin	pobj	4	SENT_504	[p28l1382t295r1661b358],
8	as	IN	O	as	_	0	SENT_504	[p28l1688t309r1740b343],
9	first-line	JJ	O	first-line	amod	10	SENT_504	[p28l1761t295r1978b343],
10	treatment	NN	O	treatment	prep_as	7	SENT_504	[p28l2001t301r2146b343, p28l148t375r292b417],
11	in	IN	O	in	dep	1	SENT_504	[p28l316t371r360b417],
12	advanced	JJ	O	advanced	amod	14	SENT_504	[p28l386t370r648b417],
13	colorectal	JJ	O	colorectal	amod	14	SENT_504	[p28l674t370r934b417],
14	cancer	NN	O	cancer	pobj	11	SENT_504	[p28l962t384r1153b417],
15	.	.	O	.	_	0	SENT_504	[p28l962t384r1153b417],

1	/	:	O	/	punct	3	SENT_505	[p28l1178t372r1198b429],
2	Clin	NNP	O	Clin	nn	3	SENT_505	[p28l1223t370r1319b417],
3	Oncol	NNP	O	Oncol	_	0	SENT_505	[p28l1346t370r1498b417],
4	2000	CD	DATE	2000	dep	3	SENT_505	[p28l1518t371r1672b427],
5	;	:	O	;	_	0	SENT_505	[p28l1518t371r1672b427],
6	18	CD	NUMBER	18	dep	3	SENT_505	[p28l1704t371r1784b417],
7	:	:	O	:	_	0	SENT_505	[p28l1704t371r1784b417],
8	2938-2947	CD	DATE	2938-2947	dep	6	SENT_505	[p28l1812t371r2142b417],
9	.	.	O	.	_	0	SENT_505	[p28l1812t371r2142b417],

1	Douillard	NNP	O	Douillard	nn	2	SENT_506	[p28l149t445r397b493],
2	JY	NN	O	jy	_	0	SENT_506	[p28l420t447r484b504],
3	,	,	O	,	_	0	SENT_506	[p28l420t447r484b504],
4	Cunningham	NNP	PERSON	Cunningham	nn	5	SENT_506	[p28l509t445r873b508],
5	D	NNP	O	D	appos	2	SENT_506	[p28l900t447r956b503],
6	,	,	O	,	_	0	SENT_506	[p28l900t447r956b503],
7	Roth	NNP	PERSON	Roth	nn	8	SENT_506	[p28l983t445r1105b493],
8	AD	NN	O	ad	appos	2	SENT_506	[p28l1126t447r1226b503],
9	,	,	O	,	_	0	SENT_506	[p28l1126t447r1226b503],
10	Navarro	NNP	PERSON	Navarro	nn	11	SENT_506	[p28l1254t447r1472b493],
11	M	NNP	O	M	appos	2	SENT_506	[p28l1497t447r1564b503],
12	,	,	O	,	_	0	SENT_506	[p28l1497t447r1564b503],
13	James	NNP	PERSON	James	nn	14	SENT_506	[p28l1587t447r1748b504],
14	RD	NNP	PERSON	RD	appos	2	SENT_506	[p28l1772t447r1862b503],
15	,	,	O	,	_	0	SENT_506	[p28l1772t447r1862b503],
16	Karasek	NNP	PERSON	Karasek	nn	17	SENT_506	[p28l1890t445r2096b493],
17	P	NN	O	p	appos	2	SENT_506	[p28l2119t447r2146b492],
18	et	FW	O	et	nn	19	SENT_506	[p28l148t525r197b567],
19	al.	FW	O	al.	dep	17	SENT_506	[p28l218t519r275b567],
20	.	.	O	.	_	0	SENT_506	[p28l218t519r275b567],

1	Irinotecan	NNP	O	Irinotecan	nsubj	2	SENT_507	[p28l304t521r577b567],
2	combined	VBN	O	combine	_	0	SENT_507	[p28l602t519r880b567],
3	with	IN	O	with	_	0	SENT_507	[p28l904t519r1024b567],
4	fluorouracil	NN	O	fluorouracil	prep_with	2	SENT_507	[p28l1047t519r1359b567],
5	compared	VBN	O	compare	_	0	SENT_507	[p28l1385t519r1665b582],
6	with	IN	O	with	prepc_compared_with	2	SENT_507	[p28l1688t519r1808b567],
7	fluorouracil	NN	O	fluorouracil	pobj	2	SENT_507	[p28l1831t519r2143b567],
8	alone	RB	O	alone	advmod	7	SENT_507	[p28l146t596r295b644],
9	as	IN	O	as	_	0	SENT_507	[p28l328t610r380b644],
10	first-line	JJ	O	first-line	amod	11	SENT_507	[p28l409t596r631b644],
11	treatment	NN	O	treatment	prep_as	7	SENT_507	[p28l662t602r940b644],
12	for	IN	O	for	_	0	SENT_507	[p28l967t596r1045b644],
13	metastatic	JJ	O	metastatic	amod	15	SENT_507	[p28l1077t597r1360b644],
14	colorectal	JJ	O	colorectal	amod	15	SENT_507	[p28l1392t596r1658b644],
15	cancer	NN	O	cancer	prep_for	11	SENT_507	[p28l1692t610r1888b644],
16	:	:	O	:	_	0	SENT_507	[p28l1692t610r1888b644],
17	a	DT	O	a	det	20	SENT_507	[p28l1924t610r1950b644],
18	multicentre	JJ	O	multicentre	amod	19	SENT_507	[p28l1985t596r2145b644, p28l146t676r318b718],
19	randomised	JJ	O	randomised	amod	20	SENT_507	[p28l347t671r670b718],
20	trial	NN	O	trial	dep	15	SENT_507	[p28l698t671r816b718],
21	.	.	O	.	_	0	SENT_507	[p28l698t671r816b718],

1	Lancet	NNP	O	Lancet	_	0	SENT_508	[p28l847t673r1020b718],
2	2000	CD	DATE	2000	num	1	SENT_508	[p28l1042t672r1199b728],
3	;	:	O	;	_	0	SENT_508	[p28l1042t672r1199b728],
4	355	CD	NUMBER	355	num	6	SENT_508	[p28l1229t672r1349b718],
5	:	:	O	:	_	0	SENT_508	[p28l1229t672r1349b718],
6	1041-1047	CD	DATE	1041-1047	dep	1	SENT_508	[p28l1380t672r1713b718],
7	.	.	O	.	_	0	SENT_508	[p28l1380t672r1713b718],

1	Seymour	NNP	PERSON	Seymour	nn	3	SENT_509	[p28l148t748r394b809],
2	MT.	NNP	PERSON	MT.	nn	3	SENT_509	[p28l422t748r525b794],
3	Fluorouracil	NNP	PERSON	Fluorouracil	_	0	SENT_509	[p28l558t746r895b804],
4	,	,	O	,	_	0	SENT_509	[p28l558t746r895b804],
5	oxaliplatin	NN	O	oxaliplatin	nn	8	SENT_509	[p28l926t746r1211b809],
6	and	CC	O	and	_	0	SENT_509	[p28l1241t746r1342b794],
7	CPT11	NN	O	cpt11	nn	8	SENT_509	[p28l1372t748r1541b794],
8	use	NN	O	use	conj_and	3	SENT_509	[p28l1583t760r1670b794],
9	and	CC	O	and	_	0	SENT_509	[p28l1698t746r1799b794],
10	sequencing	NN	O	sequencing	nn	12	SENT_509	[p28l1828t747r2144b809],
11	(	CD	NUMBER	(	num	12	SENT_509	[p28l147t821r303b881],
12	MRC	NNP	O	MRC	conj_and	3	SENT_509	[p28l147t821r303b881],
13	FOCUS	NN	O	focus	dep	3	SENT_509	[p28l326t821r559b881],
14	)	CD	NUMBER	)	num	13	SENT_509	[p28l326t821r559b881],
15	:	:	O	:	_	0	SENT_509	[p28l326t821r559b881],
16	a	DT	O	a	det	19	SENT_509	[p28l583t835r610b869],
17	2135-patient	JJ	O	2135-patient	amod	19	SENT_509	[p28l631t822r995b884],
18	randomizede	NN	O	randomizede	nn	19	SENT_509	[p28l1015t821r1377b869],
19	trial	NN	O	trial	dep	3	SENT_509	[p28l1398t821r1498b869],
20	in	IN	O	in	_	0	SENT_509	[p28l1523t822r1567b868],
21	advanced	JJ	O	advanced	amod	23	SENT_509	[p28l1590t821r1855b869],
22	colorectal	JJ	O	colorectal	amod	23	SENT_509	[p28l1878t821r2143b869],
23	cancer	NN	O	cancer	prep_in	19	SENT_509	[p28l146t896r450b943],
24	.	.	O	.	_	0	SENT_509	[p28l146t896r450b943],

1	The	DT	O	the	det	3	SENT_510	[p28l146t896r450b943],
2	UK	NNP	O	UK	nn	3	SENT_510	[p28l475t898r552b943],
3	NCRI	NNP	ORGANIZATION	NCRI	_	0	SENT_510	[p28l575t897r711b943],
4	colorectal	JJ	O	colorectal	amod	7	SENT_510	[p28l735t896r1002b943],
5	clinical	JJ	O	clinical	amod	7	SENT_510	[p28l1026t896r1211b943],
6	studies	NNS	O	study	nn	7	SENT_510	[p28l1235t896r1425b943],
7	group	NN	O	group	dep	3	SENT_510	[p28l1447t910r1628b958],
8	.	.	O	.	_	0	SENT_510	[p28l1447t910r1628b958],

1	/	:	O	/	punct	3	SENT_511	[p28l1650t898r1670b954],
2	Clin	NNP	O	Clin	nn	3	SENT_511	[p28l1693t896r1790b943],
3	Oncol	NNP	O	Oncol	_	0	SENT_511	[p28l1814t896r1969b943],
4	2005	CD	DATE	2005	dep	3	SENT_511	[p28l1986t897r2143b953],
5	;	:	O	;	_	0	SENT_511	[p28l1986t897r2143b953],
6	23	CD	NUMBER	23	number	7	SENT_511	[p28l147t971r387b1034],
7	(	CD	NUMBER	(	num	9	SENT_511	[p28l147t971r387b1034],
8	supp	NN	O	supp	nn	9	SENT_511	[p28l147t971r387b1034],
9	|	NN	O	|	dep	4	SENT_511	[p28l147t971r387b1034],
10	16S	NN	O	16	dep	9	SENT_511	[p28l419t971r556b1031],
11	)	CD	NUMBER	)	num	10	SENT_511	[p28l419t971r556b1031],
12	:	:	O	:	_	0	SENT_511	[p28l419t971r556b1031],
13	250	CD	NUMBER	250	dep	16	SENT_511	[p28l585t972r722b1019],
14	$	$	MONEY	$	dep	13	SENT_511	[p28l585t972r722b1019],
15	(	CD	MONEY	(	num	14	SENT_511	[p28l749t971r908b1030],
16	abstr	NN	O	abstr	dep	18	SENT_511	[p28l749t971r908b1030],
17	3518	CD	NUMBER	3518	num	16	SENT_511	[p28l933t971r1110b1030],
18	)	NN	O	)	dep	3	SENT_511	[p28l933t971r1110b1030],
19	.	.	O	.	_	0	SENT_511	[p28l933t971r1110b1030],

1	Bouché	JJ	PERSON	bouché	amod	2	SENT_512	[p28l149t1042r351b1094],
2	O	NN	PERSON	o	_	0	SENT_512	[p28l376t1047r437b1104],
3	,	,	O	,	_	0	SENT_512	[p28l376t1047r437b1104],
4	Castaing	NNP	O	Castaing	nn	5	SENT_512	[p28l465t1047r702b1109],
5	M	NNP	O	M	appos	2	SENT_512	[p28l731t1048r798b1104],
6	,	,	O	,	_	0	SENT_512	[p28l731t1048r798b1104],
7	Etienne	NNP	PERSON	Etienne	nn	8	SENT_512	[p28l829t1047r1030b1094],
8	PL	NNP	PERSON	PL	appos	2	SENT_512	[p28l1057t1048r1116b1093],
9	et	FW	O	et	nn	10	SENT_512	[p28l1140t1051r1189b1094],
10	al.	FW	O	al.	dep	8	SENT_512	[p28l1210t1045r1267b1094],
11	.	.	O	.	_	0	SENT_512	[p28l1210t1045r1267b1094],

1	Randomized	VBN	O	randomize	_	0	SENT_513	[p28l1297t1045r1638b1094],
2	strategical	JJ	O	strategical	amod	3	SENT_513	[p28l1664t1045r1943b1109],
3	trial	NN	O	trial	dobj	1	SENT_513	[p28l1969t1045r2069b1094],
4	of	IN	O	of	_	0	SENT_513	[p28l2095t1045r2149b1094],
5	chemotherapy	NN	O	chemotherapy	prep_of	3	SENT_513	[p28l146t1122r553b1185],
6	in	IN	O	in	_	0	SENT_513	[p28l612t1123r656b1169],
7	metastatic	JJ	O	metastatic	amod	13	SENT_513	[p28l719t1123r1003b1170],
8	colorectal	JJ	O	colorectal	amod	13	SENT_513	[p28l1062t1122r1328b1170],
9	cancer	NN	O	cancer	dep	8	SENT_513	[p28l1389t1136r1572b1170],
10	(	CD	NUMBER	(	num	9	SENT_513	[p28l1629t1122r1798b1182],
11	FFCD	NN	O	ffcd	nn	13	SENT_513	[p28l1629t1122r1798b1182],
12	2000-05	CD	DATE	2000-05	num	13	SENT_513	[p28l1858t1122r2143b1182],
13	)	NN	O	)	prep_in	1	SENT_513	[p28l1858t1122r2143b1182],
14	:	:	O	:	_	0	SENT_513	[p28l1858t1122r2143b1182],
15	Preliminary	JJ	O	preliminary	amod	16	SENT_513	[p28l149t1197r458b1259],
16	results	NNS	O	result	dep	13	SENT_513	[p28l485t1197r670b1244],
17	.	.	O	.	_	0	SENT_513	[p28l485t1197r670b1244],

1	Am	NNP	O	Am	nn	4	SENT_514	[p28l699t1199r786b1244],
2	Soc	NNP	O	Soc	nn	4	SENT_514	[p28l812t1198r904b1244],
3	Clin	NNP	O	Clin	nn	4	SENT_514	[p28l928t1197r1025b1244],
4	Oncol	NNP	O	Oncol	_	0	SENT_514	[p28l1052t1197r1207b1244],
5	2007	CD	DATE	2007	num	7	SENT_514	[p28l1228t1198r1384b1244],
6	:	:	O	:	_	0	SENT_514	[p28l1228t1198r1384b1244],
7	180	CD	NUMBER	180	dep	4	SENT_514	[p28l1416t1198r1550b1244],
8	$	$	MONEY	$	dep	7	SENT_514	[p28l1416t1198r1550b1244],
9	(	CD	MONEY	(	num	8	SENT_514	[p28l1578t1197r1744b1256],
10	Abstr	NNP	O	Abstr	dep	4	SENT_514	[p28l1578t1197r1744b1256],
11	4069	CD	NUMBER	4069	number	12	SENT_514	[p28l1765t1197r1946b1256],
12	)	CD	NUMBER	)	dep	10	SENT_514	[p28l1765t1197r1946b1256],
13	.	.	O	.	_	0	SENT_514	[p28l1765t1197r1946b1256],

1	Boisdron-Celle	NNP	O	Boisdron-Celle	nn	2	SENT_515	[p28l149t1272r550b1320],
2	M	NNP	O	M	_	0	SENT_515	[p28l576t1274r643b1330],
3	,	,	O	,	_	0	SENT_515	[p28l576t1274r643b1330],
4	Remaud	NNP	O	Remaud	nn	5	SENT_515	[p28l673t1272r895b1320],
5	G	NNP	O	G	appos	2	SENT_515	[p28l922t1274r979b1330],
6	,	,	O	,	_	0	SENT_515	[p28l922t1274r979b1330],
7	Traore	NNP	PERSON	Traore	nn	8	SENT_515	[p28l1004t1274r1181b1320],
8	S	NNP	O	S	appos	2	SENT_515	[p28l1207t1274r1250b1330],
9	,	,	O	,	_	0	SENT_515	[p28l1207t1274r1250b1330],
10	Poirier	NNP	ORGANIZATION	Poirier	nn	11	SENT_515	[p28l1280t1273r1453b1320],
11	AL	NNP	ORGANIZATION	AL	appos	2	SENT_515	[p28l1472t1274r1555b1330],
12	,	,	O	,	_	0	SENT_515	[p28l1472t1274r1555b1330],
13	Morel	NNP	PERSON	Morel	nn	14	SENT_515	[p28l1585t1272r1741b1320],
14	A	NNP	O	A	appos	2	SENT_515	[p28l1765t1274r1817b1330],
15	,	,	O	,	_	0	SENT_515	[p28l1765t1274r1817b1330],
16	Gamelin	NNP	O	Gamelin	nn	17	SENT_515	[p28l1845t1272r2074b1320],
17	E.	NNP	O	E.	appos	2	SENT_515	[p28l2103t1274r2143b1320],
18	5-Fluororuacil-related	JJ	O	5-fluororuacil-related	amod	20	SENT_515	[p28l146t1347r742b1395],
19	severe	JJ	O	severe	amod	20	SENT_515	[p28l806t1361r977b1395],
20	toxicity	NN	O	toxicity	dep	17	SENT_515	[p28l1039t1348r1257b1410],
21	:	:	O	:	_	0	SENT_515	[p28l1039t1348r1257b1410],
22	a	DT	O	a	det	23	SENT_515	[p28l1323t1361r1350b1395],
23	comparison	NN	O	comparison	dep	2	SENT_515	[p28l1413t1348r1736b1410],
24	of	IN	O	of	_	0	SENT_515	[p28l1801t1347r1854b1395],
25	different	JJ	O	different	amod	26	SENT_515	[p28l1914t1347r2148b1395],
26	methods	NNS	O	method	prep_of	23	SENT_515	[p28l148t1422r390b1469],
27	for	IN	O	for	_	0	SENT_515	[p28l447t1422r525b1469],
28	the	DT	O	the	det	30	SENT_515	[p28l581t1422r669b1469],
29	pretherapeutic	JJ	O	pretherapeutic	amod	30	SENT_515	[p28l731t1422r1138b1484],
30	detection	NN	O	detection	prep_for	26	SENT_515	[p28l1197t1422r1457b1469],
31	of	IN	O	of	_	0	SENT_515	[p28l1519t1422r1573b1469],
32	dihydropyrimidine	NN	O	dihydropyrimidine	nn	34	SENT_515	[p28l1630t1422r2145b1484],
33	dehydrogenase	NN	O	dehydrogenase	nn	34	SENT_515	[p28l146t1497r574b1559],
34	deficiency	NN	O	deficiency	prep_of	30	SENT_515	[p28l600t1497r893b1559],
35	.	.	O	.	_	0	SENT_515	[p28l600t1497r893b1559],

1	Cancer	NNP	O	Cancer	nn	2	SENT_516	[p28l926t1498r1112b1544],
2	Lett	NNP	O	Lett	_	0	SENT_516	[p28l1133t1499r1231b1544],
3	2007	CD	DATE	2007	num	2	SENT_516	[p28l1252t1498r1409b1554],
4	;	:	O	;	_	0	SENT_516	[p28l1252t1498r1409b1554],
5	249	CD	NUMBER	249	num	7	SENT_516	[p28l1438t1498r1559b1544],
6	:	:	O	:	_	0	SENT_516	[p28l1438t1498r1559b1544],
7	271-282	CD	NUMBER	271-282	dep	2	SENT_516	[p28l1588t1498r1849b1544],
8	.	.	O	.	_	0	SENT_516	[p28l1588t1498r1849b1544],

1	André	JJ	PERSON	andré	amod	2	SENT_517	[p28l144t1568r310b1620],
2	T	NN	PERSON	t	_	0	SENT_517	[p28l331t1574r379b1630],
3	,	,	O	,	_	0	SENT_517	[p28l331t1574r379b1630],
4	Boni	NNP	PERSON	Boni	nn	5	SENT_517	[p28l407t1573r524b1620],
5	C	NNP	O	C	appos	2	SENT_517	[p28l548t1573r602b1630],
6	,	,	O	,	_	0	SENT_517	[p28l548t1573r602b1630],
7	Mounedji	NNP	LOCATION	Mounedji	appos	5	SENT_517	[p28l630t1571r1131b1635],
8	.	.	O	.	_	0	SENT_517	[p28l630t1571r1131b1635],

1	—	NN	O	—	_	0	SENT_518	[p28l630t1571r1131b1635],
2	.	.	O	.	_	0	SENT_518	[p28l630t1571r1131b1635],

1	Boudiaf	NNP	PERSON	Boudiaf	nn	2	SENT_519	[p28l630t1571r1131b1635],
2	L	NNP	PERSON	L	_	0	SENT_519	[p28l1153t1574r1191b1630],
3	,	,	O	,	_	0	SENT_519	[p28l1153t1574r1191b1630],
4	Navarro	NNP	PERSON	Navarro	nn	5	SENT_519	[p28l1220t1574r1438b1620],
5	M	NNP	O	M	appos	2	SENT_519	[p28l1463t1574r1530b1630],
6	,	,	O	,	_	0	SENT_519	[p28l1463t1574r1530b1630],
7	Tabernero	NNP	PERSON	Tabernero	nn	8	SENT_519	[p28l1553t1571r1838b1620],
8	J	NNP	PERSON	J	appos	2	SENT_519	[p28l1859t1574r1889b1631],
9	,	,	O	,	_	0	SENT_519	[p28l1859t1574r1889b1631],
10	Hickist	NNP	O	Hickist	nn	11	SENT_519	[p28l1917t1571r2095b1620],
11	T	NN	O	t	appos	2	SENT_519	[p28l2113t1574r2149b1619],
12	et	FW	O	et	nn	13	SENT_519	[p28l148t1654r197b1696],
13	al.	FW	O	al.	dep	11	SENT_519	[p28l245t1648r303b1696],
14	.	.	O	.	_	0	SENT_519	[p28l245t1648r303b1696],

1	Multicenter	JJ	O	multicenter	amod	3	SENT_520	[p28l361t1648r681b1696],
2	international	JJ	O	international	amod	3	SENT_520	[p28l731t1648r1079b1696],
3	study	NN	O	study	_	0	SENT_520	[p28l1132t1648r1283b1711],
4	of	IN	O	of	_	0	SENT_520	[p28l1333t1648r1387b1696],
5	oxaliplatin/5-fluorouraci	JJ	O	oxaliplatin/5-fluorouraci	amod	6	SENT_520	[p28l1435t1648r2146b1711],
6	|	NN	O	|	prep_of	3	SENT_520	[p28l1435t1648r2146b1711],
7	/	:	O	/	punct	3	SENT_520	[p28l1435t1648r2146b1711],
8	leucovorin	NN	O	leucovorin	dep	3	SENT_520	[p28l148t1723r434b1770],
9	in	IN	O	in	_	0	SENT_520	[p28l486t1724r531b1770],
10	the	DT	O	the	det	12	SENT_520	[p28l582t1723r669b1770],
11	adjuvant	JJ	O	adjuvant	amod	12	SENT_520	[p28l719t1723r960b1785],
12	treatment	NN	O	treatment	prep_in	8	SENT_520	[p28l1007t1728r1284b1770],
13	of	IN	O	of	_	0	SENT_520	[p28l1332t1723r1386b1770],
14	colon	NN	O	colon	nn	15	SENT_520	[p28l1432t1723r1581b1770],
15	cancer	NN	O	cancer	prep_of	8	SENT_520	[p28l1633t1737r1816b1770],
16	(	CD	NUMBER	(	num	19	SENT_520	[p28l1863t1723r2145b1782],
17	MOSAIC	NNP	O	MOSAIC	nn	19	SENT_520	[p28l1863t1723r2145b1782],
18	)	CD	NUMBER	)	num	19	SENT_520	[p28l1863t1723r2145b1782],
19	investigators	NNS	O	investigator	dep	15	SENT_520	[p28l148t1799r511b1861],
20	.	.	O	.	_	0	SENT_520	[p28l148t1799r511b1861],

1	Oxaliplatin	NN	O	oxaliplatin	_	0	SENT_521	[p28l564t1798r879b1861],
2	,	,	O	,	_	0	SENT_521	[p28l564t1798r879b1861],
3	fluorouracil	NN	O	fluorouracil	conj_and	1	SENT_521	[p28l930t1798r1260b1856],
4	,	,	O	,	_	0	SENT_521	[p28l930t1798r1260b1856],
5	and	CC	O	and	_	0	SENT_521	[p28l1314t1798r1414b1846],
6	leucovorin	NN	O	leucovorin	conj_and	1	SENT_521	[p28l1468t1798r1753b1846],
7	as	IN	O	as	_	0	SENT_521	[p28l1805t1812r1857b1846],
8	adjuvant	JJ	O	adjuvant	amod	9	SENT_521	[p28l1907t1798r2148b1861],
9	treatment	NN	O	treatment	prep_as	1	SENT_521	[p28l145t1878r423b1921],
10	for	IN	O	for	_	0	SENT_521	[p28l444t1873r522b1921],
11	colon	NN	O	colon	nn	12	SENT_521	[p28l545t1873r694b1921],
12	cancer	NN	O	cancer	prep_for	1	SENT_521	[p28l722t1887r918b1921],
13	.	.	O	.	_	0	SENT_521	[p28l722t1887r918b1921],

1	N	NN	O	n	dep	2	SENT_522	[p28l949t1875r994b1920],
2	Engl	NNP	LOCATION	Engl	dep	4	SENT_522	[p28l1018t1873r1167b1935],
3	/	:	O	/	punct	4	SENT_522	[p28l1018t1873r1167b1935],
4	Med	VBD	O	med	_	0	SENT_522	[p28l1191t1873r1310b1921],
5	2004	CD	DATE	2004	dobj	4	SENT_522	[p28l1330t1874r1487b1931],
6	;	:	O	;	_	0	SENT_522	[p28l1330t1874r1487b1931],
7	350	CD	NUMBER	350	num	9	SENT_522	[p28l1517t1874r1636b1921],
8	:	:	O	:	_	0	SENT_522	[p28l1517t1874r1636b1921],
9	2343-2351	CD	DATE	2343-2351	dep	5	SENT_522	[p28l1665t1874r2001b1921],
10	.	.	O	.	_	0	SENT_522	[p28l1665t1874r2001b1921],

1	Gamelin	NNP	MISC	Gamelin	nn	2	SENT_523	[p28l147t1948r376b1996],
2	E	NNP	O	E	_	0	SENT_523	[p28l424t1950r464b2006],
3	,	,	O	,	_	0	SENT_523	[p28l424t1950r464b2006],
4	Boisdron-Celle	NNP	PERSON	Boisdron-Celle	nn	6	SENT_523	[p28l514t1948r913b1996],
5	M.	NNP	PERSON	M.	nn	6	SENT_523	[p28l960t1950r1027b1996],
6	Dose-monitoring	NN	PERSON	dose-monitoring	appos	2	SENT_523	[p28l1076t1949r1545b2011],
7	of	IN	O	of	_	0	SENT_523	[p28l1591t1948r1645b1996],
8	5-fluorouracil	NN	O	5-fluorouracil	prep_of	6	SENT_523	[p28l1685t1948r2052b1996],
9	in	IN	O	in	_	0	SENT_523	[p28l2100t1949r2144b1995],
10	patients	NNS	O	patient	prep_in	8	SENT_523	[p28l148t2024r365b2085],
11	with	IN	O	with	_	0	SENT_523	[p28l388t2023r507b2070],
12	colorectal	JJ	O	colorectal	prep_with	10	SENT_523	[p28l533t2023r800b2070],
13	or	CC	O	or	_	0	SENT_523	[p28l826t2037r883b2070],
14	head	NN	O	head	nn	17	SENT_523	[p28l906t2023r1038b2070],
15	and	CC	O	and	_	0	SENT_523	[p28l1064t2023r1164b2070],
16	neck	NN	O	neck	conj_and	14	SENT_523	[p28l1192t2023r1318b2070],
17	cancer	NN	O	cancer	prep_with	10	SENT_523	[p28l1341t2037r1537b2070],
18	.	.	O	.	_	0	SENT_523	[p28l1341t2037r1537b2070],

1	Status	NN	O	status	_	0	SENT_524	[p28l1565t2024r1730b2070],
2	of	IN	O	of	_	0	SENT_524	[p28l1754t2023r1808b2070],
3	the	DT	O	the	det	4	SENT_524	[p28l1828t2023r1916b2070],
4	art	NN	O	art	prep_of	1	SENT_524	[p28l1940t2028r2027b2070],
5	.	.	O	.	_	0	SENT_524	[p28l1940t2028r2027b2070],

1	Crit	NNP	O	Crit	nn	4	SENT_525	[p28l2058t2024r2150b2070],
2	Rev	NN	O	rev	nn	4	SENT_525	[p28l149t2100r242b2146],
3	Oncol	NN	O	oncol	nn	4	SENT_525	[p28l264t2098r419b2146],
4	Hematol	NN	O	hematol	_	0	SENT_525	[p28l442t2098r668b2146],
5	1999	CD	DATE	1999	dep	4	SENT_525	[p28l691t2100r845b2156],
6	;	:	O	;	_	0	SENT_525	[p28l691t2100r845b2156],
7	30	CD	NUMBER	30	num	9	SENT_525	[p28l876t2100r959b2146],
8	:	:	O	:	_	0	SENT_525	[p28l876t2100r959b2146],
9	71-79	CD	NUMBER	71-79	dep	4	SENT_525	[p28l991t2100r1177b2146],
10	.	.	O	.	_	0	SENT_525	[p28l991t2100r1177b2146],

1	Gamelin	NN	MISC	gamelin	nn	2	SENT_526	[p28l147t2173r376b2221],
2	E	NN	O	e	_	0	SENT_526	[p28l405t2175r445b2231],
3	,	,	O	,	_	0	SENT_526	[p28l405t2175r445b2231],
4	Danquechin-Dorval	JJ	O	danquechin-dorval	amod	5	SENT_526	[p28l475t2173r1014b2236],
5	E	NN	O	e	appos	2	SENT_526	[p28l1044t2175r1084b2231],
6	,	,	O	,	_	0	SENT_526	[p28l1044t2175r1084b2231],
7	Dumesnil	NNP	PERSON	Dumesnil	nn	8	SENT_526	[p28l1114t2173r1370b2221],
8	Y	NN	PERSON	y	appos	2	SENT_526	[p28l1394t2175r1442b2231],
9	,	,	O	,	_	0	SENT_526	[p28l1394t2175r1442b2231],
10	Maillard	NNP	PERSON	Maillard	nn	12	SENT_526	[p28l1472t2173r1692b2221],
11	P	NN	O	p	nn	12	SENT_526	[p28l1720t2175r1780b2232],
12	]	NN	O	]	appos	2	SENT_526	[p28l1720t2175r1780b2232],
13	,	,	O	,	_	0	SENT_526	[p28l1720t2175r1780b2232],
14	Goudier	NNP	O	Goudier	nn	16	SENT_526	[p28l1808t2173r2034b2221],
15	M	NNP	O	M	nn	16	SENT_526	[p28l2059t2175r2143b2232],
16	]	NN	O	]	appos	2	SENT_526	[p28l2059t2175r2143b2232],
17	,	,	O	,	_	0	SENT_526	[p28l2059t2175r2143b2232],
18	Burtin	NNP	PERSON	Burtin	nn	19	SENT_526	[p28l149t2249r309b2295],
19	PC	NNP	O	PC	appos	2	SENT_526	[p28l365t2249r436b2295],
20	et	FW	O	et	nn	21	SENT_526	[p28l489t2253r537b2295],
21	al.	FW	O	al.	dep	19	SENT_526	[p28l585t2248r643b2295],
22	.	.	O	.	_	0	SENT_526	[p28l585t2248r643b2295],

1	Relationship	NN	O	relationship	_	0	SENT_527	[p28l699t2248r1033b2310],
2	between	IN	O	between	_	0	SENT_527	[p28l1086t2248r1321b2295],
3	5-fluorouracil	NN	O	5-fluorouracil	nn	5	SENT_527	[p28l1375t2248r1743b2295],
4	(	CD	NUMBER	(	num	5	SENT_527	[p28l1796t2248r1967b2307],
5	5-FU	NN	O	5-fu	prep_between	1	SENT_527	[p28l1796t2248r1967b2307],
6	)	CD	NUMBER	)	num	5	SENT_527	[p28l1796t2248r1967b2307],
7	dose	NN	O	dose	nn	8	SENT_527	[p28l2019t2248r2146b2295],
8	intensity	NN	O	intensity	nsubj	18	SENT_527	[p28l148t2324r381b2386],
9	and	CC	O	and	_	0	SENT_527	[p28l403t2323r503b2371],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_527	[p28l527t2323r844b2386],
11	response	NN	O	response	nsubj	18	SENT_527	[p28l869t2337r1109b2386],
12	in	IN	O	in	_	0	SENT_527	[p28l1134t2324r1179b2370],
13	patients	NNS	O	patient	prep_in	8	SENT_527	[p28l1206t2324r1422b2386],
14	with	IN	O	with	_	0	SENT_527	[p28l1444t2323r1563b2371],
15	advanced	JJ	O	advanced	amod	17	SENT_527	[p28l1588t2323r1852b2371],
16	colorectal	JJ	O	colorectal	amod	17	SENT_527	[p28l1878t2323r2143b2371],
17	cancer	NN	O	cancer	prep_with	13	SENT_527	[p28l146t2411r329b2445],
18	receiving	VBG	O	receive	rcmod	1	SENT_527	[p28l357t2399r602b2460],
19	infusional	JJ	O	infusional	amod	20	SENT_527	[p28l634t2397r893b2445],
20	therapy	NN	O	therapy	dobj	18	SENT_527	[p28l923t2397r1136b2460],
21	containing	VBG	O	contain	xcomp	18	SENT_527	[p28l1162t2399r1456b2460],
22	5-FU	NN	O	5-fu	dobj	21	SENT_527	[p28l1487t2400r1629b2445],
23	.	.	O	.	_	0	SENT_527	[p28l1487t2400r1629b2445],

1	Cancer	NN	O	cancer	_	0	SENT_528	[p28l1665t2399r1851b2445],
2	1996	CD	DATE	1996	num	1	SENT_528	[p28l1874t2399r2028b2455],
3	;	:	O	;	_	0	SENT_528	[p28l1874t2399r2028b2455],
4	77	CD	NUMBER	77	num	6	SENT_528	[p28l2062t2400r2143b2445],
5	:	:	O	:	_	0	SENT_528	[p28l2062t2400r2143b2445],
6	441-451	CD	NUMBER	441-451	dep	1	SENT_528	[p28l145t2474r409b2521],
7	.	.	O	.	_	0	SENT_528	[p28l145t2474r409b2521],

1	Gamelin	NNP	MISC	Gamelin	nn	2	SENT_529	[p28l147t2550r376b2597],
2	E	NNP	O	E	_	0	SENT_529	[p28l423t2552r463b2607],
3	,	,	O	,	_	0	SENT_529	[p28l423t2552r463b2607],
4	Boisdron-Celle	NNP	O	Boisdron-Celle	nn	5	SENT_529	[p28l510t2550r910b2597],
5	M	NNP	O	M	appos	2	SENT_529	[p28l954t2552r1021b2608],
6	,	,	O	,	_	0	SENT_529	[p28l954t2552r1021b2608],
7	Delva	NNP	PERSON	Delva	nn	8	SENT_529	[p28l1069t2550r1219b2597],
8	R	NNP	PERSON	R	appos	2	SENT_529	[p28l1264t2552r1307b2607],
9	,	,	O	,	_	0	SENT_529	[p28l1264t2552r1307b2607],
10	Regimbeau	NNP	ORGANIZATION	Regimbeau	nn	11	SENT_529	[p28l1355t2550r1661b2612],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_529	[p28l1706t2551r1760b2607],
12	,	,	O	,	_	0	SENT_529	[p28l1706t2551r1760b2607],
13	Cailleux	NNP	O	Cailleux	nn	14	SENT_529	[p28l1805t2550r2024b2597],
14	PE	NNP	O	PE	appos	2	SENT_529	[p28l2068t2552r2143b2607],
15	,	,	O	,	_	0	SENT_529	[p28l2068t2552r2143b2607],
16	Alleaume	NNP	O	Alleaume	nn	17	SENT_529	[p28l144t2625r402b2673],
17	C	NNP	O	C	appos	2	SENT_529	[p28l429t2627r468b2673],
18	et	FW	O	et	nn	19	SENT_529	[p28l496t2631r544b2673],
19	al.	FW	O	al.	dep	17	SENT_529	[p28l568t2625r626b2673],
20	.	.	O	.	_	0	SENT_529	[p28l568t2625r626b2673],

1	Long-term	JJ	O	long-term	amod	3	SENT_530	[p28l658t2627r946b2688],
2	weekly	JJ	SET	weekly	amod	3	SENT_530	[p28l972t2625r1164b2688],
3	treatment	NN	O	treatment	_	0	SENT_530	[p28l1187t2631r1465b2673],
4	of	IN	O	of	_	0	SENT_530	[p28l1489t2625r1542b2673],
5	colorectal	JJ	O	colorectal	amod	7	SENT_530	[p28l1566t2625r1832b2673],
6	metastatic	JJ	O	metastatic	amod	7	SENT_530	[p28l1863t2626r2146b2673],
7	cancer	NN	O	cancer	prep_of	3	SENT_530	[p28l146t2715r329b2749],
8	with	IN	O	with	_	0	SENT_530	[p28l374t2701r493b2749],
9	fluorouracil	NN	O	fluorouracil	prep_with	7	SENT_530	[p28l542t2701r855b2749],
10	and	CC	O	and	_	0	SENT_530	[p28l907t2701r1007b2749],
11	leucovorin	NN	O	leucovorin	conj_and	9	SENT_530	[p28l1060t2701r1363b2749],
12	:	:	O	:	_	0	SENT_530	[p28l1060t2701r1363b2749],
13	results	NNS	O	result	dep	3	SENT_530	[p28l1417t2701r1588b2749],
14	of	IN	O	of	_	0	SENT_530	[p28l1638t2701r1692b2749],
15	a	DT	O	a	det	18	SENT_530	[p28l1737t2715r1764b2749],
16	multicentric	JJ	O	multicentric	amod	18	SENT_530	[p28l1816t2701r2146b2749],
17	prospective	JJ	O	prospective	amod	18	SENT_530	[p28l148t2777r465b2838],
18	trial	NN	O	trial	prep_of	13	SENT_530	[p28l484t2776r584b2823],
19	of	IN	O	of	_	0	SENT_530	[p28l607t2776r660b2823],
20	fluorouracil	NN	O	fluorouracil	nn	22	SENT_530	[p28l675t2776r987b2823],
21	dosage	NN	O	dosage	nn	22	SENT_530	[p28l1009t2776r1206b2838],
22	optimization	NN	O	optimization	prep_of	18	SENT_530	[p28l1226t2777r1574b2838],
23	by	IN	O	by	_	0	SENT_530	[p28l1599t2776r1664b2838],
24	pharmacokinetic	JJ	O	pharmacokinetic	amod	25	SENT_530	[p28l1684t2776r2146b2838],
25	monitoring	NN	O	monitoring	prep_by	22	SENT_530	[p28l148t2852r456b2914],
26	in	IN	O	in	_	0	SENT_530	[p28l486t2852r530b2898],
27	152	CD	NUMBER	152	num	28	SENT_530	[p28l561t2853r662b2899],
28	patients	NNS	O	patient	prep_in	25	SENT_530	[p28l691t2852r923b2914],
29	.	.	O	.	_	0	SENT_530	[p28l691t2852r923b2914],

1	/	:	O	/	punct	2	SENT_531	[p28l948t2853r969b2910],
2	Clin	NN	O	clin	_	0	SENT_531	[p28l994t2851r1092b2899],
3	Oncol1998	NN	O	oncol1998	dep	2	SENT_531	[p28l1119t2851r1451b2909],
4	;	:	O	;	_	0	SENT_531	[p28l1119t2851r1451b2909],
5	16	CD	NUMBER	16	dep	2	SENT_531	[p28l1484t2853r1565b2899],
6	:	:	O	:	_	0	SENT_531	[p28l1484t2853r1565b2899],
7	1470-1478	CD	DATE	1470-1478	dep	5	SENT_531	[p28l1596t2853r1928b2899],
8	.	.	O	.	_	0	SENT_531	[p28l1596t2853r1928b2899],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_532	[p28l149t2925r304b2973],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_532	[p28l337t2927r419b2983],
3	,	,	O	,	_	0	SENT_532	[p28l337t2927r419b2983],
4	Dykes	NNP	PERSON	Dykes	nn	5	SENT_532	[p28l461t2925r621b2988],
5	DD	NNP	O	DD	appos	2	SENT_532	[p28l659t2928r761b2983],
6	,	,	O	,	_	0	SENT_532	[p28l659t2928r761b2983],
7	Polesky	NNP	O	Polesky	nn	9	SENT_532	[p28l802t2925r1002b2988],
8	H.	NNP	O	H.	nn	9	SENT_532	[p28l1039t2928r1092b2973],
9	A	NNP	O	A	appos	2	SENT_532	[p28l1128t2928r1168b2973],
10	simple	JJ	O	simple	amod	9	SENT_532	[p28l1200t2925r1378b2988],
11	salting	VBG	O	salt	partmod	9	SENT_532	[p28l1413t2925r1591b2988],
12	out	RP	O	out	prt	11	SENT_532	[p28l1629t2931r1721b2973],
13	procedure	NN	O	procedure	dobj	11	SENT_532	[p28l1757t2925r2038b2988],
14	for	IN	O	for	_	0	SENT_532	[p28l2071t2925r2149b2973],
15	extracting	VBG	O	extract	prepc_for	11	SENT_532	[p28l146t3002r424b3064],
16	DNA	NN	O	dna	dobj	15	SENT_532	[p28l449t3003r580b3048],
17	from	IN	O	from	_	0	SENT_532	[p28l596t3001r726b3049],
18	human	JJ	O	human	amod	20	SENT_532	[p28l751t3001r942b3049],
19	nucleated	JJ	O	nucleated	amod	20	SENT_532	[p28l967t3001r1234b3049],
20	cells	NNS	O	cell	prep_from	15	SENT_532	[p28l1257t3001r1387b3049],
21	.	.	O	.	_	0	SENT_532	[p28l1257t3001r1387b3049],

1	Nucleic	JJ	O	nucleic	amod	2	SENT_533	[p28l1412t3001r1606b3049],
2	Acids	NNS	O	acid	_	0	SENT_533	[p28l1619t3001r1756b3049],
3	Res	NNP	O	Res	dep	2	SENT_533	[p28l1776t3003r1860b3049],
4	1989	CD	DATE	1989	num	3	SENT_533	[p28l1881t3002r2035b3059],
5	;	:	O	;	_	0	SENT_533	[p28l1881t3002r2035b3059],
6	16	CD	NUMBER	16	num	8	SENT_533	[p28l2063t3002r2143b3049],
7	:	:	O	:	_	0	SENT_533	[p28l2063t3002r2143b3049],
8	1915	CD	DATE	1915	dep	2	SENT_533	[p28l149t3078r304b3124],
9	.	.	O	.	_	0	SENT_533	[p28l149t3078r304b3124],

1	Morel	NNP	O	Morel	nn	2	SENT_534	[p29l149t21r305b69],
2	A	NNP	O	A	_	0	SENT_534	[p29l327t23r379b79],
3	,	,	O	,	_	0	SENT_534	[p29l327t23r379b79],
4	Boisdron-Celle	NNP	O	Boisdron-Celle	nn	5	SENT_534	[p29l407t21r807b69],
5	M	NNP	O	M	appos	2	SENT_534	[p29l832t23r899b79],
6	,	,	O	,	_	0	SENT_534	[p29l832t23r899b79],
7	Fey	NNP	ORGANIZATION	Fey	nn	8	SENT_534	[p29l927t23r1016b84],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_534	[p29l1039t23r1077b79],
9	,	,	O	,	_	0	SENT_534	[p29l1039t23r1077b79],
10	Soulie	NNP	PERSON	Soulie	nn	11	SENT_534	[p29l1104t21r1267b69],
11	P	NN	O	p	appos	2	SENT_534	[p29l1292t23r1334b79],
12	,	,	O	,	_	0	SENT_534	[p29l1292t23r1334b79],
13	Craipeau	NNP	O	Craipeau	nn	14	SENT_534	[p29l1361t22r1605b84],
14	MC	NNP	O	MC	appos	2	SENT_534	[p29l1631t23r1742b79],
15	,	,	O	,	_	0	SENT_534	[p29l1631t23r1742b79],
16	Traore	NNP	PERSON	Traore	nn	17	SENT_534	[p29l1766t23r1943b69],
17	S	NNP	O	S	appos	2	SENT_534	[p29l1966t23r1993b69],
18	et	FW	O	et	nn	19	SENT_534	[p29l2017t27r2066b69],
19	al.	FW	O	al.	dep	17	SENT_534	[p29l2085t21r2143b69],
20	.	.	O	.	_	0	SENT_534	[p29l2085t21r2143b69],

1	Clinical	JJ	O	clinical	amod	2	SENT_535	[p29l147t96r344b144],
2	relevance	NN	O	relevance	_	0	SENT_535	[p29l378t96r637b144],
3	of	IN	O	of	_	0	SENT_535	[p29l666t96r720b144],
4	different	JJ	O	different	amod	7	SENT_535	[p29l746t96r980b144],
5	dihydropyrimidine	NN	O	dihydropyrimidine	nn	7	SENT_535	[p29l1008t96r1524b159],
6	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_535	[p29l1553t96r1980b159],
7	gene	NN	O	gene	prep_of	2	SENT_535	[p29l2010t110r2146b158],
8	single	JJ	O	single	amod	10	SENT_535	[p29l146t171r304b233],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_535	[p29l358t171r648b218],
10	polymorphisms	NNS	O	polymorphism	dep	2	SENT_535	[p29l701t171r1128b233],
11	on	IN	O	on	_	0	SENT_535	[p29l1179t185r1246b218],
12	5-fluorouracil	NN	O	5-fluorouracil	nn	13	SENT_535	[p29l1300t171r1667b218],
13	tolerance	NN	O	tolerance	prep_on	10	SENT_535	[p29l1720t171r1992b218],
14	.	.	O	.	_	0	SENT_535	[p29l1720t171r1992b218],

1	Mol	NNP	O	Mol	nn	3	SENT_536	[p29l2049t171r2152b218],
2	Cancer	NNP	O	Cancer	nn	3	SENT_536	[p29l150t247r336b293],
3	Ther	NNP	O	Ther	_	0	SENT_536	[p29l360t246r478b293],
4	2006	CD	DATE	2006	num	3	SENT_536	[p29l496t247r653b303],
5	;	:	O	;	_	0	SENT_536	[p29l496t247r653b303],
6	5	CD	NUMBER	5	num	8	SENT_536	[p29l682t248r730b293],
7	:	:	O	:	_	0	SENT_536	[p29l682t248r730b293],
8	2895-2904	CD	DATE	2895-2904	dep	3	SENT_536	[p29l759t247r1093b293],
9	.	.	O	.	_	0	SENT_536	[p29l759t247r1093b293],

1	Morel	NNP	O	Morel	nn	2	SENT_537	[p29l149t321r305b369],
2	A	NNP	O	A	_	0	SENT_537	[p29l360t323r412b379],
3	,	,	O	,	_	0	SENT_537	[p29l360t323r412b379],
4	Boisdron-Celle	NNP	O	Boisdron-Celle	nn	5	SENT_537	[p29l473t321r873b369],
5	M	NNP	O	M	appos	2	SENT_537	[p29l931t323r998b379],
6	,	,	O	,	_	0	SENT_537	[p29l931t323r998b379],
7	Fey	NNP	ORGANIZATION	Fey	nn	8	SENT_537	[p29l1060t323r1149b384],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_537	[p29l1205t323r1243b379],
9	,	,	O	,	_	0	SENT_537	[p29l1205t323r1243b379],
10	Laine-Cessac	NNP	PERSON	Laine-Cessac	nn	11	SENT_537	[p29l1305t322r1655b369],
11	P	NN	PERSON	p	appos	2	SENT_537	[p29l1712t323r1755b379],
12	,	,	O	,	_	0	SENT_537	[p29l1712t323r1755b379],
13	Gamelin	NNP	PERSON	Gamelin	nn	15	SENT_537	[p29l1813t321r2043b369],
14	E.	NNP	O	E.	nn	15	SENT_537	[p29l2103t323r2143b369],
15	Identification	NN	O	identification	appos	2	SENT_537	[p29l149t396r509b444],
16	of	IN	O	of	_	0	SENT_537	[p29l542t396r596b444],
17	a	DT	O	a	det	19	SENT_537	[p29l624t410r651b444],
18	novel	JJ	O	novel	amod	19	SENT_537	[p29l685t396r829b444],
19	mutation	NN	O	mutation	prep_of	15	SENT_537	[p29l864t397r1114b444],
20	in	IN	O	in	_	0	SENT_537	[p29l1149t397r1193b443],
21	the	DT	O	the	det	24	SENT_537	[p29l1226t396r1314b444],
22	dihydropyrimidine	NN	O	dihydropyrimidine	nn	24	SENT_537	[p29l1346t396r1861b459],
23	dehydrogenase	NN	O	dehydrogenase	nn	24	SENT_537	[p29l1893t396r2146b459, p29l146t485r338b533],
24	gene	NN	O	gene	prep_in	19	SENT_537	[p29l362t485r497b533],
25	in	IN	O	in	_	0	SENT_537	[p29l522t472r566b518],
26	a	DT	O	a	det	27	SENT_537	[p29l591t485r618b518],
27	patient	NN	O	patient	prep_in	24	SENT_537	[p29l643t472r838b533],
28	with	IN	O	with	_	0	SENT_537	[p29l857t471r976b518],
29	a	DT	O	a	det	31	SENT_537	[p29l1002t485r1028b518],
30	lethal	JJ	O	lethal	amod	31	SENT_537	[p29l1054t471r1199b518],
31	outcome	NN	O	outcome	prep_with	27	SENT_537	[p29l1225t476r1471b518],
32	following	VBG	O	follow	_	0	SENT_537	[p29l1492t471r1750b533],
33	5-fluorouracil	NN	O	5-fluorouracil	nn	34	SENT_537	[p29l1776t471r2143b518],
34	administration	NN	O	administration	prep_following	31	SENT_537	[p29l146t546r546b594],
35	and	CC	O	and	_	0	SENT_537	[p29l568t546r668b594],
36	the	DT	O	the	det	37	SENT_537	[p29l690t546r778b594],
37	determination	NN	O	determination	conj_and	34	SENT_537	[p29l798t546r1191b594],
38	of	IN	O	of	_	0	SENT_537	[p29l1213t546r1267b594],
39	its	PRP$	O	its	poss	40	SENT_537	[p29l1285t547r1342b594],
40	frequency	NN	O	frequency	prep_of	37	SENT_537	[p29l1359t546r1638b609],
41	in	IN	O	in	_	0	SENT_537	[p29l1658t547r1703b593],
42	a	DT	O	a	det	43	SENT_537	[p29l1725t560r1751b594],
43	population	NN	O	population	prep_in	40	SENT_537	[p29l1775t546r2072b609],
44	of	IN	O	of	_	0	SENT_537	[p29l2095t546r2149b594],
45	500	CD	NUMBER	500	num	46	SENT_537	[p29l146t622r251b669],
46	patients	NNS	O	patient	prep_of	43	SENT_537	[p29l278t622r495b684],
47	with	IN	O	with	_	0	SENT_537	[p29l517t621r637b669],
48	colorectal	JJ	O	colorectal	amod	49	SENT_537	[p29l664t621r929b669],
49	carcinoma	NN	O	carcinoma	prep_with	46	SENT_537	[p29l957t622r1260b669],
50	.	.	O	.	_	0	SENT_537	[p29l957t622r1260b669],

1	Clin	NNP	O	Clin	nn	2	SENT_538	[p29l1292t621r1389b669],
2	Biochem	NNP	O	Biochem	_	0	SENT_538	[p29l1414t621r1634b669],
3	2007	CD	DATE	2007	num	2	SENT_538	[p29l1658t622r1814b679],
4	;	:	O	;	_	0	SENT_538	[p29l1658t622r1814b679],
5	40	CD	NUMBER	40	num	7	SENT_538	[p29l1841t622r1927b669],
6	:	:	O	:	_	0	SENT_538	[p29l1841t622r1927b669],
7	11-17	CD	DATE	11-17	dep	2	SENT_538	[p29l1957t622r2143b669],
8	.	.	O	.	_	0	SENT_538	[p29l1957t622r2143b669],

